UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended February 29, 2024 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to ______

 

Commission File No. 814-00732

 

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

 

Maryland   20-8700615
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification Number)

 

535 Madison Avenue

New York, New York 10022

(Address of principal executive offices)

 

(212) 906-7800

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange
on which registered
Common Stock, par value $0.001 per share   SAR   The New York Stock Exchange
6.00% Notes due 2027   SAT   The New York Stock Exchange
8.00% Notes due 2027   SAJ   The New York Stock Exchange
8.125% Notes due 2027   SAY   The New York Stock Exchange
8.50% Notes due 2027   SAZ   The New York Stock Exchange

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The aggregate market value of the voting and non-voting common stock held by non-affiliates of the registrant as of August 31, 2023 was approximately $271.2 million based upon a closing price of $25.85 reported for such date by the New York Stock Exchange.

 

The number of outstanding common shares of the registrant as of May 3, 2024 was 13,698,966.

 

 

 

 

 

 

NOTE ABOUT REFERENCES

 

In this Annual Report on Form 10-K (the “Annual Report”), the “Company,” “we,” “us” and “our” refer to Saratoga Investment Corp. and its wholly owned subsidiaries, Saratoga Investment Funding LLC, Saratoga Investment Funding II LLC, Saratoga Investment Corp. SBIC LP, Saratoga Investment Corp. SBIC II LP, and Saratoga Investment Corp. SBIC III LP, unless the context otherwise requires. We refer to Saratoga Investment Advisors, LLC, our investment adviser, as “Saratoga Investment Advisors,” the “Investment Adviser” or the “Manager.”

 

NOTE ABOUT FORWARD-LOOKING STATEMENTS

 

Some of the statements in this Annual Report constitute forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “will” and “would” or the negative of these terms or other comparable terminology.

 

We have based the forward-looking statements included in this Annual Report information available to us on the date of this Annual Report, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements occurring after the date of this Annual Report, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

 

The forward-looking statements contained in this Annual Report involve risks and uncertainties, including statements as to:

 

  our future operating results;

 

the introduction, withdrawal, success and timing of business initiatives and strategies;

 

changes in political, economic or industry conditions, the interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

 

the relative and absolute investment performance and operations of our Manager;

 

the impact of increased competition;

 

our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

 

the unfavorable resolution of any future legal proceedings;

 

our business prospects and the operational and financial performance of our portfolio companies, including their ability to achieve our respective objectives as a result of the current economic conditions caused by, among other things, elevated levels of inflation, and a rising interest rate environment, and the effects of the disruptions caused thereby on our ability to continue to effectively manage our business;

 

i

 

 

the impact of investments that we expect to make and future acquisitions and divestitures;

 

our contractual arrangements and relationships with third parties;

 

the dependence of our future success on the general economy and its impact on the industries in which we invest;

 

the ability of our portfolio companies to achieve their objectives;

 

our expected financings and investments;

 

our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiaries, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

 

the adequacy of our cash resources and working capital;

 

the timing of cash flows, if any, from the operations of our portfolio companies;

 

the impact of interest rate volatility, including the replacement of LIBOR with alternative reference rates, on our results, particularly because we use leverage as part of our investment strategy;

 

the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;

 

the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

 

the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;

 

the impact of changes to tax legislation and, generally, our tax position;

 

our ability to access capital and any future financings by us;

 

the ability of our Manager to attract and retain highly talented professionals; and

 

the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments.

 

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. Important assumptions include our ability to originate new loans and investments, borrowing costs and levels of profitability and the availability of additional capital. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Annual Report should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described in “Risk Factors” in this Annual Report under Item 1A. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Annual Report. 

 

ii

 

 

PART I  
Item 1. Business 1
Item 1A. Risk Factors 28
Item 1B. Unresolved Staff Comments 63
Item 1C. Cybersecurity 63
Item 2. Properties 63
Item 3. Legal Proceedings 63
Item 4. Mine Safety Disclosures 63
   
PART II  
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 64
Item 6. [Reserved] 71
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 71
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 114
Item 8. Consolidated Financial Statements and Supplementary Data 115
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 115
Item 9A. Controls and Procedures 115
Item 9B. Other Information 116
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 116
   
PART III  
Item 10. Directors, Executive Officers and Corporate Governance 117
Item 11. Executive Compensation 119
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 120
Item 13. Certain Relationships and Related Transactions, and Director Independence 121
Item 14. Principal Accounting Fees and Services 122
   
PART IV  
Item 15. Exhibits, Consolidated Financial Statement Schedules 123
Item 16. Form 10-K Summary 127
   
Signatures 128

 

iii

 

 

PART I

 

ITEM 1. BUSINESS

 

General

 

We are a specialty finance company that provides customized financing solutions to U.S middle-market businesses. Our investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from our investments. We primarily invest in senior and unitranche leveraged loans and mezzanine debt and, to a lesser extent, equity issued by private U.S. middle-market companies, which we define as companies having annual earnings before interest, taxes, depreciation and amortization (“EBITDA”) of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. Our investments generally provide financing for change of ownership transactions, strategic acquisitions, recapitalizations, and growth initiatives in partnership with business owners, management teams and financial sponsors. Our investment activities are externally managed and advised by Saratoga Investment Advisors, LLC, a New York-based investment firm affiliated with Saratoga Partners, a middle-market private equity investment firm.

 

Our portfolio is comprised primarily of investments in leveraged loans issued by middle-market companies. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt with below investment grade or “junk” ratings or, if not rated, would be rated below investment grade or “junk” and, as a result, carry a higher risk of default. Leveraged loans also have the benefit of security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. Term loans are loans that do not allow the borrowers to repay all or a portion of the loans prior to maturity and then re-borrow such repaid amounts under the loan again. We also invest in mezzanine debt and make equity investments in middle-market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company.

 

While our primary focus is to generate current income and capital appreciation from our debt and equity investments in middle-market companies, we may invest up to 30.0% of our portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, including securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded, joint ventures and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of Investment Company Act of 1940, as amended (“1940 Act”), which includes private equity funds, to no more than 15% of our net assets.

 

As of February 29, 2024, we had total assets of $1,191.2 million and investments in 55 portfolio companies, excluding an investment in the subordinated notes of one collateralized loan obligation fund, Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), which had a fair value of $9.5 million as of February 29, 2024, investments in the Class F-2-R-3 Note of the Saratoga CLO which as of February 29, 2024 had a fair value of $8.9 million, and investments in the Saratoga Senior Loan Fund I JV LLC (“SLF JV”) and its subsidiaries, a joint venture which as of February 29, 2024 had a fair value of $25.2  million. The overall portfolio composition as of February 29, 2024 consisted of 85.7% of first lien term loans, 1.6% of second lien term loans, 1.4% of unsecured loans, 2.7% of structured finance securities and 8.6% of equity interests. As of February 29, 2024, the weighted average yield on all of our investments, including our investment in the subordinated notes of Saratoga CLO and Class F-2-R-3 Note was approximately 11.4%. The weighted average yield of our investments is not the same as a return on investment for our stockholders and, among other things, is calculated before the payment of our fees and expenses. As of February 29, 2024, our total return based on market value was -3.92% and our total return based on net asset value (“NAV”) per share was 4.20%. As of February 28, 2023, our total return based on market value was 10.35% and our total return based on NAV was 9.46%. Total return based on market value is the change in the ending market value of the Company’s common stock plus dividends distributed during the period assuming participation in the Company’s dividend reinvestment plan divided by the beginning market value of the Company’s common stock. Total return based on NAV is the change in ending NAV per share plus dividends distributed per share paid during the period assuming participation in the Company’s dividend reinvestment plan divided by the beginning NAV per share. While total return based on NAV and total return based on market value reflect fund expenses, they do not reflect any sales load that may be paid by investors. As of February 29, 2024, approximately 99.4% of our first lien debt investments were fully collateralized in the sense that the portfolio companies in which we held such investments had an enterprise value or our investment had an asset coverage equal to or greater than the principal amount of the related debt investment. The Company uses enterprise value to assess the level of collateralization of its portfolio companies. The enterprise value of a portfolio company is determined by analyzing various factors, including EBITDA, cash flows from operations less capital expenditures and other pertinent factors, such as recent offers to purchase a portfolio company’s securities or other liquidation events. As a result, while we consider a portfolio company to be collateralized if its enterprise value exceeds the amount of our loan, we do not hold tangible assets as collateral in our portfolio companies that we would obtain in the event of a default. Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at February 29, 2024, was composed of $640.8 million in aggregate principal amount of predominantly senior secured first lien term loans. A first loss position means that we will suffer the first economic losses if losses are incurred on loans held by the Saratoga CLO. As a result, this investment is subject to unique risks. See Part I. Item 1A. “Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of subordinated notes representing the lowest-rated securities issued by a pool of predominantly senior secured first lien term loans and is subject to additional risks and volatility. All losses in the pool of loans will be borne by our subordinated notes and only after the value of our subordinated notes is reduced to zero will the higher-rated notes issued by the pool bear any losses.”

 

1

 

 

We are an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act. As a BDC, we are required to comply with various regulatory requirements, including limitations on our use of debt. We finance our investments through borrowings. However, as a BDC, we are only generally allowed to borrow amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowing, or 150% if we obtain the required approvals from our directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act) of the Company (“independent directors”) and/or stockholders. On April 16, 2018, our board of directors, including, a majority of our independent directors, approved of us becoming subject to a minimum asset coverage ratio of 150% under Sections 18(a)(1) and 18(a)(2) of the 1940 Act. The 150% asset coverage ratio became effective on April 16, 2019.

 

We have elected to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). As a RIC, we generally will not be subject to U.S. federal income tax on any net ordinary income or capital gains that we timely distribute to our stockholders if we meet certain source-of-income, annual distribution and asset diversification requirements.

 

In addition, we have had three wholly owned subsidiaries that are each licensed as a small business investment company (“SBIC”) and regulated by the Small Business Administration (“SBA”). On March 28, 2012, our wholly owned subsidiary, Saratoga Investment Corp. SBIC LP (“SBIC LP”), received an SBIC license from the Small Business Administration (the “SBA”). On August 14, 2019, our wholly owned subsidiary, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), also received an SBIC license from the SBA. On September 29, 2022, our wholly owned subsidiary, Saratoga Investment Corp. SBIC III LP (“SBIC III LP” and, together with SBIC LP and SBIC II LP, the “SBIC Subsidiaries”), also received an SBIC license from the SBA, which provides up to $175.0 million in additional long-term capital in the form of SBA-guaranteed debentures. As a result, Saratoga’s SBA relationship increased from $325.0 million to $350.0 million of committed capital. For two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million. Our wholly owned SBIC Subsidiaries are able to borrow funds from the SBA against the SBIC’s regulatory capital (which generally approximates equity capital in the respective SBIC) and is subject to customary regulatory requirements, including, but not limited to, periodic examination by the SBA. Following the debentures being fully repaid to the SBA, SBIC LP surrendered its license on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. See “Item 1. Business—Small Business Investment Company Regulations.”

 

We received exemptive relief from the U.S. Securities and Exchange Commission (the “SEC”) to permit us to exclude the senior securities issued by the SBIC Subsidiaries from the definition of senior securities in the asset coverage requirement under the 1940 Act. This allows the Company increased flexibility under the asset coverage requirement by permitting it to borrow up to $350.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

 

The Company has established wholly owned subsidiaries, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MAC, Inc., SIA-MDP, Inc., SIA-PP Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT, Inc., SIA-Vector, Inc. and SIA-VR, Inc., which are structured as Delaware entities that are treated as corporations for U.S. federal income tax purposes and are intended to facilitate the Company’s compliance with the requirements to be treated as a RIC under the Code by holding equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). These entities are consolidated for accounting purposes but are not consolidated for U.S. federal income tax purposes and may incur U.S. federal income tax expenses as a result of their ownership of portfolio companies. In February 2022, SIA-GH, Inc., SIA-TT Inc. and SIA-VR, Inc. was liquidated following the sale of equity held by each of the portfolio companies and will be dissolved following the end of the entity’s indemnification period.

 

2

 

 

On October 26, 2021, the Company and TJHA JV I LLC (“TJHA”) entered into a Limited Liability Company Agreement (the “LLC Agreement”) to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2021-1 Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets. The Company and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally. The Company and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, with the Company providing $43.75 million and TJHA providing $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note will pay a fixed rate of 10.0% per annum and is due and payable in full on October 20, 2033. As of February 29, 2024, the Company and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. For the year ended February 29, 2024, the Company earned $1.8 million of interest income related to SLF JV, which is included in interest income. SLF JV’s initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00% per annum and was due and payable in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing. The Company has determined that SLF JV is an investment company under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, ASC Topic 810, Consolidation, concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate SLF JV.

  

Corporate Information

 

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

 

Our corporate offices are located at 535 Madison Avenue, New York, New York 10022. Our telephone number is (212) 906-7800. We maintain a website on the Internet at www.saratogainvestmentcorp.com. Information contained on our website is not incorporated by reference into this Annual Report, and you should not consider that information to be part of this Annual Report.

 

Saratoga Investment Advisors

 

General

 

Our Investment Adviser was formed in 2010 as a Delaware limited liability company and became our investment adviser in July 2010. Our Investment Adviser is led by four principals, Christian L. Oberbeck, Michael J. Grisius, Thomas V. Inglesby, and Charles G. Phillips, with 36, 34, 37 and 27 years of experience in leveraged finance, respectively, and the Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary, Henri J. Steenkamp, who has 25 years of experience in financial services and leveraged finance. Our Investment Adviser is affiliated with Saratoga Partners, a middle-market private equity investment firm. Saratoga Partners was established in 1984 to be the middle-market private investment arm of Dillon Read & Co. Inc. and has been independent of Dillon Read & Co. Inc. and its successor entity, SBC Warburg Dillon Read, since 1998. Saratoga Partners has a 35-year history of private investments in middle-market companies and focuses on public and private equity, preferred stock, and senior and mezzanine debt investments.

 

3

 

 

Our Relationship with Saratoga Investment Advisors

 

We utilize the personnel, infrastructure, relationships and experience of Saratoga Investment Advisors to enhance the growth of our business. We currently have no employees and each of our executive officers is also an officer of Saratoga Investment Advisors.

 

We have entered into an investment advisory and management agreement (the “Management Agreement”) with Saratoga Investment Advisors. Pursuant to the 1940 Act, the initial term of the Management Agreement was for two years from its effective date of July 30, 2010, and will remain in effect on a year-to-year basis if approved annually at an in-person meeting of the board of directors, a majority of whom must be independent directors. Most recently, our board of directors approved the renewal of the Management Agreement for an additional one-year term at an in-person meeting held on July 6, 2023. Pursuant to the Management Agreement, Saratoga Investment Advisors implements our business strategy on a day-to-day basis and performs certain services for us under the direction of our board of directors. Saratoga Investment Advisors is responsible for, among other duties, performing all of our day-to-day functions, determining investment criteria, sourcing, analyzing and executing investment transactions, asset sales, financings and performing asset management duties.

 

Saratoga Investment Advisors has formed an investment committee to advise and consult with its senior management team with respect to our investment policies, investment portfolio holdings, financing and leveraging strategies and investment guidelines. We believe that the collective experience of the investment committee members across a variety of fixed income asset classes will benefit us. The investment committee must unanimously approve all investments in excess of $1.0 million made by us. In addition, all sales of our investments must be approved by all four of our investment committee members. The current members of the investment committee are Messrs. Oberbeck, Grisius, Inglesby, and Phillips.

 

We have also entered into a separate Administration Agreement (the “Administration Agreement”) with Saratoga Investment Advisors pursuant to which Saratoga Investment Advisors furnishes us with office facilities, equipment and clerical, bookkeeping and record keeping services. The Administration Agreement has an initial term of two years from its effective date of July 30, 2010, and will remain in effect on a year-to-year basis, subject to annual approval by our board of directors, a majority of whom must be our independent directors. Most recently, on July 6, 2023, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $3.275 million to $4.3 million effective August 1, 2023. Under the Administration Agreement, Saratoga Investment Advisors also performs, or oversees the performance of our required administrative services, which include, among other things, being responsible for the financial records which we are required to maintain, preparing reports for our stockholders and reports required to be filed with the SEC. Payments under the Administration Agreement will be equal to an amount based upon the allocable portion of Saratoga Investment Advisors’ overhead in performing its obligations under the Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs relating to the performance of services under the Administration Agreement.

 

Investments

 

Our portfolio is comprised primarily of investments in leveraged loans (both first and second lien term loans) issued by middle-market companies. Investments in middle-market companies are generally less liquid than equivalent investments in companies with larger capitalizations. These investments are sourced in both the primary and secondary markets through a network of relationships with commercial and investment banks, commercial finance companies and financial sponsors. The leveraged loans that we purchase are generally used to finance buyouts, strategic acquisitions, growth initiatives, recapitalizations and other types of transactions. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt which are invested by companies with below investment grade or “junk” ratings or, if not rated, would be rated below investment grade or “junk” and, as a result, carry a higher risk of default. Leveraged loans also have the benefit of security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. For a discussion of the risks pertaining to our secured investments, see Part I. Item 1A. “Risk Factors—Our investments may be risky, and you could lose all or part of your investment.”

 

4

 

 

As part of our long-term strategy, we also invest in mezzanine debt and make equity investments in middle-market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company. See Part I. Item 1A. “Risk Factors—If we make unsecured debt investments, we may lack adequate protection in the event our portfolio companies become distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event our portfolio companies default on their indebtedness.”

 

Substantially all of the debt investments held in our portfolio hold a non-investment grade rating by one or more rating agencies or, if not rated, would be rated below investment grade if rated, which are often referred to as “junk.” As of February 29, 2024, 77.8% of our debt portfolio at fair value consisted of debt securities for which issuers were not required to make principal payments until the maturity of such debt securities, which could result in a substantial loss to us if such issuers are unable to refinance or repay their debt at maturity. Such “interest-only” loans are structured such that the borrower makes only interest payments throughout the life of the loan and makes a large, “balloon payment” at the end of the loan term. The ability of a borrower to make or refinance a balloon payment may be affected by a number of factors, including the financial condition of the borrower, prevailing economic conditions, higher interest rates, and collateral values. If the interest-only loan borrower is unable to make or refinance a balloon payment, we may experience greater losses than if the loan were structured as amortizing. As of February 29, 2024, 19.7% of our interest-only loans provided for contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loan’s term, and 49.6% of such investments elected to pay a portion of interest due in PIK. In addition, 99.5% of our debt investments at February 29, 2024, had variable interest rates that reset periodically based on benchmarks such as BSBY, SOFR and the prime rate. As a result, significant increases in such benchmarks in the future may make it more difficult for these borrowers to service their obligations under the debt investments that we hold.

 

As a BDC, we are required to comply with certain regulatory requirements. For instance, as a BDC, we may not acquire any assets other than “qualifying assets” as specified in the 1940 Act unless, at the time of and after giving effect to such acquisition, at least 70% of our total assets are qualifying assets. See “Business—Business Development Company Regulations – Qualifying Assets.”

 

While our primary focus is to generate current income and capital appreciation from our debt and equity investments in middle-market companies, we may invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, private equity, securities of public companies that are not thinly traded, joint ventures and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15% of its net assets.

 

Leveraged loans

 

Our leveraged loan portfolio is comprised primarily of first lien and second lien term loans. First lien term loans are secured by a first priority perfected security interest on all or substantially all of the assets of the borrower and typically include a first priority pledge of the capital stock of the borrower. First lien term loans hold a first priority with regard to right of payment. Generally, first lien term loans offer floating rate interest payments, have a stated maturity of five to seven years, and have a fixed amortization schedule. First lien term loans generally have restrictive financial and negative covenants. Second lien term loans are secured by a second priority perfected security interest on all or substantially all of the assets of the borrower and typically include a second priority pledge of the capital stock of the borrower. Second lien term loans hold a second priority with regard to right of payment. Second lien term loans offer either floating rate or fixed rate interest payments, generally have a stated maturity of five to eight years and may or may not have a fixed amortization schedule. Second lien term loans that do not have fixed amortization schedules require payment of the principal amount of the loan upon the maturity date of the loan. Second lien term loans have less restrictive financial and negative covenants than those that govern first lien term loans.

 

5

 

 

Mezzanine debt

 

Mezzanine debt usually ranks subordinate in priority of payment to senior debt and is often unsecured. However, mezzanine debt ranks senior to common and preferred equity in a borrowers’ capital structure. Mezzanine debt typically has fixed rate interest payments and a stated maturity of six to eight years and does not have fixed amortization schedules.

 

In some cases, our debt investments may provide for a portion of the interest payable to be payment-in-kind interest (“PIK”). To the extent interest is PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation.

 

Equity Investments

 

Equity investments may consist of preferred equity that is expected to pay dividends on a current basis in the form of cash or additional equity or preferred equity that does not pay current dividends. Preferred equity at times may also have PIK interest payable. Preferred equity generally has a preference over common equity as to distributions on liquidation and dividends. In some cases, we may acquire common equity. In general, our equity investments are not control-oriented investments and we expect that in many cases we will acquire equity securities as part of a group of private equity investors in which we are not the lead investor.

 

Opportunistic Investments

 

Opportunistic investments may include investments in distressed debt, which may include securities of companies in bankruptcy, debt and equity securities of public companies that are not thinly traded, emerging market debt, structured finance vehicles such as collateralized loan obligation funds and debt of middle-market companies located outside the United States. See Note 4 and Note 5 for more information about Saratoga CLO and SLF JV and SLF 2022.

 

On January 22, 2008, GSC Group, Inc., as asset manager, with Lehman Brothers raising the financing, entered into a collateral management agreement with Saratoga CLO. Saratoga CLO was structured with five tranches of debt, plus residual notes. Saratoga CLO’s five tranches of debt were purchased by a wide variety of CLO debt market participants. In addition, we purchased for $30.0 million all of the outstanding subordinated notes of Saratoga CLO.

 

Pursuant to its terms, the investment period for Saratoga CLO ended in January 2013, and certain restrictions in such terms limited portfolio reinvestment. As a result, the Company determined that it was in its best interest to refinance Saratoga CLO given its investment attractiveness, and has refinanced this multiple times since then. The Company did not originate any of the loan assets included in the formation of Saratoga CLO, nor has it done so since the subsequent refinancing transactions. Moreover, the Company does not expect to originate any of the loans in the Saratoga CLO portfolio prospectively. The Company has from time to time co-invested in loans with the Saratoga CLO. The Company currently has no co-investments between it and Saratoga CLO.

 

With respect to our advisory services to Saratoga CLO, and in particular the underwriting standards used when determining which investments qualify for inclusion in the Saratoga CLO, they are substantially similar to the process employed in selecting the Company’s investments. All of the credit metrics for a Saratoga CLO investment are reviewed and documented in the same manner as they would be for an investment for the Company, with some minor differences. For example, the Saratoga CLO investment process also includes multiple rating agency review and analysis of the loan investment and the assigned corporate ratings, which typically does not apply to a prospective investment of the Company. Lastly, a Saratoga CLO investment also considers the likely secondary liquidity of the loan in considering the investment, whereas the Company’s investments are generally illiquid.

 

6

 

 

The Saratoga CLO investment period was initially refinanced in October 2013 and its reinvestment period extended to October 2016. On November 15, 2016, we completed a second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018. On December 14, 2018, we completed a third refinancing and upsize of the Saratoga CLO (the “2013-1 Reset CLO Notes”). This refinancing, among other things, extended the non-call period and reinvestment period to January 20, 2020 and January 20, 2021, respectively, and extended its legal final date to January 20, 2030. Following this refinancing, the Saratoga CLO portfolio increased from approximately $300.0 million in aggregate principal amount to approximately $500.0 million of predominantly senior secured first lien term loans. As part of the refinancing of its liabilities, we also purchased $2.5 million in aggregate principal amount of the Class F-R-2 and $7.5 million aggregate principal amount of the Class G-R-2 notes tranches of the Saratoga CLO at par, with a coupon of LIBOR plus 8.75% and LIBOR plus 10.00%, respectively. We also redeemed our existing $4.5 million aggregate principal amount of the Class F Notes tranche of the Saratoga CLO at par. The Class F-R-2 Notes and Class G-R-2 Notes tranches are the seventh and eighth tranches in the capital structure of Saratoga CLO and are subordinated to the other debt classes of Saratoga CLO, respectively. The Class F-R-2 and Class G-R-2 tranches are senior to the subordinated notes, which is effectively the equity position in Saratoga CLO. As a result, the other tranches of debt in Saratoga CLO rank ahead of the $2.5 million Class F-R-2 tranche and $7.5 million Class G-R-2 tranche and ahead of the aggregate principal amount of our position in the subordinated notes, with respect to priority of payments in the event of a default or a liquidation. We also purchased an aggregate principal amount of $39.5 million of subordinated notes, which is in addition to the $30.0 million of subordinated notes issued in 2013 that were reset with an extended legal final date to January 20, 2030. Following the refinancing, Saratoga Investment Corp. owns 100% of the Class F-R-2, Class G-R-2 and the subordinated notes of the Saratoga CLO. On February 11, 2020, we entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO, pursuant to which CLO 2013-1 Warehouse 2 may borrow from time to time up to $20.0 million from the Company in order to provide capital necessary to support warehouse activities. On October 23, 2020, the CLO 2013-1 Warehouse 2 Loan was increased to $25.0 million availability, which was immediately fully drawn. The interest rate was also amended to be based on a pricing grid, starting at an annual rate of 3M USD LIBOR + 4.46%. On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, and extended its legal maturity to April 2033. A non-call period ending February 2022 was also added. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full. After the current end of the reinvestment period in April 2024, the Company continues to consider refinancing the Saratoga CLO, subject to market conditions. A refinancing transaction entails finding existing and new investors that are willing to provide debt financing to Saratoga CLO which extends the investment period of the CLO on terms that are acceptable to it and in an amount sufficient to allow it to repay all of its existing debt holders. Prior to refinancing Saratoga CLO’s indebtedness after, Saratoga CLO will be required to use investment repayments by portfolio companies received after April 2024 to repay its outstanding indebtedness.

   

At February 29, 2024, the aggregate fair value of our investments in Saratoga Investment Corp. CLO 2013-1 F-2-R-3 Notes and subordinated notes of the Saratoga CLO was $8.9 million and $9.5 million, respectively.

 

The terms of the subordinated notes of Saratoga CLO entitles the Company to the residual net interest income in Saratoga CLO, which is paid on a quarterly basis after payment of all expenses, assuming that the Saratoga CLO remains in compliance with its various debt and rating agency compliance tests. The Company’s investment in the subordinated notes of Saratoga CLO can be sold or transferred at any time. The Company has held 100% of the subordinated notes of Saratoga CLO since the inception of Saratoga CLO.

 

Generally, the interests of the holders of the various classes of securities issued by the Saratoga CLO are aligned with the interests of the Company as holder of the subordinated notes. The investors in the various debt tranches of the securities issued by the Saratoga CLO are interested in the regular payment of interest income from the Saratoga CLO and the overcollateralization of the underlying loan assets relative to the Saratoga CLO debt issued. On the other hand, the subordinated note holders might prefer purchasing higher yielding riskier assets that could increase returns while the returns of the holders of the debt securities remain unchanged.

 

7

 

 

With respect to the collateral management agreement that the Company has entered into with Saratoga CLO, while the agreement is similar to the investment advisory and management agreement between the Company and Saratoga Investment Advisors in that it is an asset management agreement, there are material differences between the two. For example, pursuant to Section 15 of the 1940 Act, the Management Agreement with Saratoga Investment Advisors has an initial term of two years, with annual renewals to be approved at an in-person meeting of the Company’s board of directors. The contract can be terminated by the Company’s board of directors or stockholders with 60 days’ notice, with no penalty for termination. The collateral management agreement that the Company has entered into with Saratoga CLO, on the other hand, has no renewal requirement. The Saratoga CLO collateral management agreement may be terminated for cause at the direction of a majority of the most senior class of the Saratoga CLO securities then outstanding, excluding any securities held by the Company or any affiliate thereof or any other entity over which the Company or an affiliate thereof has discretionary authority over voting such securities, which securities are disregarded for this purpose. If the Saratoga CLO collateral management agreement is terminated, the manager remains in place until a new manager is appointed by the issuer at the direction of either (i) a majority of the Saratoga CLO subordinated notes, and not rejected by a majority of the most senior class of CLO securities then outstanding, or (ii)  a majority of the most senior class of CLO securities then outstanding, and not rejected by a majority of the Saratoga CLO subordinated notes, in each case within 20 days of notice of a vote regarding the successor manager. If no successor investment manager shall have been appointed within 120 days after the date of notice of resignation by the investment manager, the resigning investment manager, a majority of the controlling class or a majority of the subordinated notes may petition any court of competent jurisdiction for the appointment of a successor investment manager without the approval of the holders of the notes. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Prior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, we received a base management fee of 0.25% per annum and a subordinated management fee of 0.25% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

 

The securities issued by the Saratoga CLO do not have any external credit enhancement features that would minimize the potential losses to the subordinated notes. Saratoga CLO recognized realized losses on extinguishment of debt of approximately $3.0 million, $1.2 million, $6.1 million and $3.4 million in the fiscal years ended February 28, 2021, February 28, 2019, February 28, 2017 and February 28, 2014, respectively, related to the February 2021, December 2018, November 2016 and October 2013 refinancing, primarily as a result of repurchasing securities at par at the refinancing that was previously issued at a discount, as well as the acceleration of the amortization of the legal and accounting costs associated with the refinancing. The cost of the refinancing was effectively borne by the Company as the holder of the subordinated notes in Saratoga CLO. The indenture for the Saratoga CLO contemplates the issuance of additional securities from time to time, pursuant to an amendment to the indenture and subject to various requirements and conditions, including the consent of the Company (in its capacity as investment manager) and the consent of the of the holders of a majority of the subordinated notes (all of which are held by the Company) and, except in certain limited circumstances, the consent of the holders of a majority (by principal amount) the Class A-1 Notes. The Saratoga CLO could also issue additional securities pursuant to a refinancing of the existing securities. The costs of any such future refinancing would effectively be borne by the Company as the holder of the subordinated notes in Saratoga CLO. On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

 

The Company does not believe that any representations or warranties made by the Company as manager of Saratoga CLO or investor in the subordinated notes could materially affect the Company. However, because the Company acts as the collateral manager to Saratoga CLO, it may be subject to claims by third-party investors in Saratoga CLO for alleged or actual negligent acts, errors or omissions or breach of fiduciary duties committed in the scope of performing its services as the collateral manager.

 

8

 

 

As of February 29, 2024, the Saratoga CLO portfolio consisted of $640.8 million in aggregate principal amount of primarily senior secured first lien term loans. At February 29, 2024, 94.8% of the Saratoga CLO portfolio consisted of such loans to 347 borrowers with an average exposure to each borrower of $1.8 million. The weighted average maturity of the portfolio is 4.07 years. In addition, Saratoga CLO held $12.1 million in cash at February 29, 2024. Our investments in the Saratoga CLO falls into our 30% “bucket” of non-qualifying assets under the 1940 Act and currently has an aggregate cost basis of approximately $32.3 million, which is net of all principal payments made by Saratoga CLO on the Company’s total investment in the subordinate notes of Saratoga CLO is $57.8 which consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021.

 

On October 26, 2021, the Company and TJHA JV I LLC entered into the LLC Agreement to co-manage SLF JV. SLF JV is a joint venture that invests in the debt or equity interests of collateralized loan obligations, loans, notes and other debt instruments. As of February 29, 2024, the Company has membership interests with a fair value of $9.4 million and an unsecured loan with a fair value of $15.8 million in the SLF JV, and an investment in the Class E notes of the SLF JV’s wholly owned CLO (“SLF 2022”) with a fair value of $12.3 million. As of February 29, 2024, the SLF JV has an investment in the subordinated debt of SLF 2022 with a fair value of $30.7 million.

 

Prospective portfolio company characteristics

 

Our Investment Adviser generally selects portfolio companies with one or more of the following characteristics:

 

a history of generating stable earnings and strong free cash flow;

 

well-constructed balance sheets with the ability to withstand industry cycles, supported by sustainable enterprise values;

 

reasonable debt-to-cash flow multiples;

 

exceptional management with meaningful stake;

 

industry leadership with competitive advantages and sustainable market shares and growth prospects in attractive and healthy sectors; and

 

capital structures that provide appropriate terms and reasonable covenants.

 

Investment selection

 

In managing us, Saratoga Investment Advisors employs the same investment philosophy and portfolio management methodologies used by Saratoga Partners. Through this investment selection process, based on quantitative and qualitative analysis, Saratoga Investment Advisors seeks to identify portfolio companies with superior fundamental risk-reward profiles and strong, defensible business franchises with the goal of minimizing principal losses while maximizing risk-adjusted returns. Saratoga Investment Advisors’ investment process emphasizes the following:

 

bottom-up, company-specific research and analysis;

 

capital preservation, low volatility and minimization of downside risk; and

 

investing with experienced management teams that hold meaningful equity ownership in their businesses.

 

Our Investment Adviser’s investment process generally includes the following steps:

 

Initial screening. A brief analysis identifies the investment opportunity and reviews the merits of the transaction. The initial screening memorandum provides a brief description of the company, its industry, competitive position, capital structure, financials, equity sponsor and deal economics. If the deal is determined to be attractive by the senior members of the deal team, the opportunity is fully analyzed.

 

9

 

 

  Full analysis. A full analysis includes:

 

Business and Industry analysis—a review of the company’s business position, competitive dynamics within its industry, cost and growth drivers and technological and geographic factors. Business and industry research often includes meetings with industry experts, consultants, other investors, customers and competitors.

 

Company analysis—a review of the company’s historical financial performance, future projections, cash flow characteristics, balance sheet strength, liquidation value, legal, financial and accounting risks, contingent liabilities, market share analysis and growth prospects.

 

Structural/security analysis—a thorough legal document analysis including but not limited to an assessment of financial and negative covenants, events of default, enforceability of liens and voting rights.

 

  Approval of the investment committee. The investment is then presented to the investment committee for approval. The investment committee must unanimously approve all investments in excess of $1 million made by us. In addition, all sales of our investments must be approved by all four of our investment committee members. The members of our investment committee are Christian L. Oberbeck, Michael J. Grisius, Thomas V. Inglesby, and Charles G. Phillips.

 

Investment structure

 

In general, our Investment Adviser intends to select investments with financial covenants and terms that reduce leverage over time, thereby enhancing credit quality. These methods include:

 

maintenance leverage covenants requiring a decreasing ratio of debt to cash flow;

 

maintenance cash flow covenants requiring an increasing ratio of cash flow to the sum of interest expense and capital expenditures; and

 

debt incurrence prohibitions, limiting a company’s ability to re-lever.

 

In addition, limitations on asset sales and capital expenditures should prevent a company from changing the nature of its business or capitalization without our consent.

 

Our Investment Adviser seeks, where appropriate, to limit the downside potential of our investments by:

 

requiring a total return on our investments (including both interest and potential equity appreciation) that compensates us for credit risk;

 

requiring companies to use a portion of their excess cash flow to repay debt;

 

selecting investments with covenants that incorporate call protection as part of the investment structure; and

 

selecting investments with affirmative and negative covenants, default penalties, lien protection, change of control provisions and board rights, including either observation or participation rights.

 

10

 

 

Valuation process

 

We account for our investments at fair value in accordance with FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), as determined in good faith using written policies and procedures adopted by our board of directors. Investments for which market quotations are readily available are recorded in our consolidated financial statements at such market quotations subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as determined in good faith by our board of directors based on input from Saratoga Investment Advisors, our audit committee and an independent valuation firm engaged by our board of directors. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

 

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with the senior management; and

 

an independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. We use a third-party independent valuation firm to value our investment in the subordinated notes of Saratoga CLO, the Class F-2-R-3 Notes tranche of the Saratoga CLO and the Class E Notes tranche of the SLF 2022 every quarter.

 

In addition, all our investments are subject to the following valuation process:

 

the audit committee of our board of directors reviews and approves each preliminary valuation and our Investment Adviser and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

our board of directors discusses the valuations and approves the fair value of each investment in good faith based on the input of our Investment Adviser, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

 

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by Saratoga Investment Advisors and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

 

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our NAV could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

 

11

 

 

Rule 2a-5 under the 1940 Act (“Rule 2a-5”) establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides the recordkeeping requirements associated with fair value determinations. While our board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, the Company has adopted certain revisions to its valuation policies and procedures in order comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

  

Ongoing relationships with and monitoring of portfolio companies

 

Saratoga Investment Advisors will closely monitor each investment we make and, when appropriate, will conduct a regular dialogue with both the management team and other debtholders and seek specifically tailored financial reporting. In addition, in certain circumstances, senior investment professionals of Saratoga Investment Advisors may take board seats or board observation seats.

 

Distributions

 

Our distributions, if any, will be determined by our board of directors and paid out of assets legally available for distribution. Any such distributions generally will be taxable to our stockholders, including to those stockholders who receive additional shares of our common stock pursuant to our dividend reinvestment plan. Prior to January 2009, we paid quarterly dividends to our stockholders. However, in January 2009, we suspended the practice of paying quarterly dividends to our stockholders and thereafter paid five annual dividend distributions (December 2013, 2012, 2011, 2010 and 2009) to our stockholders since such time, which distributions were made with a combination of cash and the issuance of shares of our common stock as discussed more fully below.

 

On September 24, 2014, we announced the recommencement of quarterly dividends to our stockholders and have subsequently made distributions under this new policy. We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

 

In order to maintain our tax treatment as a RIC, we generally must, among other things, for each fiscal year, timely distribute an amount equal to at least 90% of our ordinary net taxable income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, reduced by deductible expenses. In addition, we will be subject to a non-deductible 4% U.S. federal excise tax to the extent we do not distribute during the calendar year at least (1) 98% of our net ordinary income for the calendar year, (2) 98.2% of our capital gain net income for the one year period ending on October 31 of the calendar year and (3) any net ordinary income and capital gain net income that we recognized for preceding years, but were not distributed during such years, and on which we paid no U.S. federal income tax. For the 2023 calendar year, the Company did not make sufficient distributions such that we did incur the U.S. federal excise tax. We may elect to not distribute a portion of our ordinary income for the 2024 calendar year and/or portion of the capital gains in excess of capital losses realized during the one-year period ending October 31, 2024, if any, and, if we do so, we would expect to incur U.S. federal taxes as a result.

  

12

 

 

We may distribute taxable dividends that are payable in cash or shares of our common stock at the election of each stockholder. Under certain applicable provisions of the Code and the Treasury regulations and a revenue procedure issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC. The IRS has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under the revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive the lesser of (a) the portion of the distribution such shareholder has elected to receive in cash or (b) an amount equal to his or her entire distribution times the percentage limitation on cash available for distribution. If these and certain other requirements are met, for U.S. federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock. Stockholders receiving such distributions will be required to include the full amount of the dividend as ordinary income (or as long-term capital gain or qualified dividend income to the extent such distribution is properly reported as such) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result of receiving distributions in the form of our common stock, a U.S. stockholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock he or she receives as a dividend in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the dividend, depending on the market price of our stock at the time of the sale. Furthermore, with respect to non-U.S. stockholders, we may be required to withhold U.S. federal tax with respect to such dividends, including in respect of all or a portion of such dividend that is payable in stock. In addition, if a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on dividends, it may put downward pressure on the trading price of our stock. 

 

Competition

 

Our primary competitors in providing financing to private middle-market companies include public and private investment funds (including private equity funds, mezzanine funds, BDCs and SBICs), commercial and investment banks and commercial financing companies. Additionally, alternative investment vehicles, such as hedge funds, frequently invest in middle-market companies. As a result, competition for investment opportunities at middle-market companies can be intense, and in the past couple of years we believe there has been an increase in the amount of debt capital available on average. This has resulted in a somewhat more competitive environment for making new investments. Many middle-market companies are still unable to raise senior debt financing through traditional large financial institutions, and we believe this approach to financing remains difficult as implementation of U.S. and international financial reforms, such as Basel 3, limits the capacity of large financial institutions to hold non-investment grade leveraged loans on their balance sheets. We believe that many of these financial institutions have deemphasized their service and product offerings to middle-market companies in particular.

  

Many of our competitors are substantially larger and have considerably greater financial and marketing resources than us. For example, some competitors may have access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which may allow them to consider a wider variety of investments and establish more relationships than us. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC or that the Code imposes on us as a RIC. We use the industry information available to the investment professionals of Saratoga Investment Advisors to assess investment risks and determine appropriate pricing for our investments in portfolio companies. In addition, we believe that the investment professionals of our Investment Adviser enable us to learn about, and compete effectively for, financing opportunities with attractive leveraged companies in the industries in which we seek to invest.

 

For additional information concerning the competitive risks we face, please see Part I. Item 1A. “Risk Factors—We operate in a highly competitive market for investment opportunities.”

 

Staffing

 

We do not currently have any employees and do not expect to have any employees in the future. Services necessary for our business are provided by individuals who are employees of Saratoga Investment Advisors, pursuant to the terms of the Management Agreement and the Administration Agreement. For a discussion of the Management Agreement, see “Business—Investment Advisory and Management Agreement” below. We reimburse Saratoga Investment Advisors for our allocable portion of expenses incurred by it in performing its obligations under the Administration Agreement, including rent and our allocable portion of the cost of our officers and their respective staffs, subject to certain limitations. For a discussion of the Administration Agreement, see “Business—Administration Agreement” below.

 

13

 

 

Investment Advisory and Management Agreement

 

Saratoga Investment Advisors serves as our investment adviser. Our Investment Adviser was formed in 2010 as a Delaware limited liability company and became our investment advisor in July 2010. Subject to the overall supervision of our board of directors, Saratoga Investment Advisors manages our day-to-day operations and provides investment advisory and management services to us. Under the terms of the Management Agreement, Saratoga Investment Advisors:

 

determines the composition of our portfolio, the nature and timing of the changes to our portfolio and the manner of implementing such changes;

 

identifies, evaluates and negotiates the structure of the investments we make (including performing due diligence on our prospective portfolio companies);

 

closes and monitors the investments we make; and

 

determines the securities and other assets that we purchase, retain or sell.

 

Saratoga Investment Advisors services under the Management Agreement are not exclusive, and it is free to furnish similar services to other entities.

 

Management Fee and Incentive Fee

 

Pursuant to the Management Agreement with Saratoga Investment Advisors, we pay Saratoga Investment Advisors a fee for investment advisory and management services consisting of two components—a base management fee and an incentive fee.

 

The base management fee is paid quarterly in arrears, and equals 1.75% per annum of our gross assets (other than cash or cash equivalents but including assets purchased with borrowed funds) and calculated at the end of each fiscal quarter based on the average value of our gross assets (other than cash or cash equivalents but including assets purchased with borrowed funds) as of the end of such fiscal quarter and the end of the immediate prior fiscal quarter. As a result, Saratoga Investment Advisors will benefit as we incur debt or use leverage to purchase assets. Our board of directors will monitor the conflicts presented by this compensation structure by approving the amount of leverage that we may incur. Base management fees for any partial month or quarter are appropriately pro-rated.

 

The incentive fee has the following two parts:

 

The first part is calculated and payable quarterly in arrears based on our pre-incentive fee net investment income for the immediately preceding fiscal quarter. Pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees that we receive from portfolio companies) accrued during the fiscal quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement, and any interest expense and dividends paid on any issued and outstanding preferred stock or debt security, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as market discount, debt instruments with PIK interest, preferred stock with PIK dividends and zero-coupon securities), accrued income that we have not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses, unrealized capital appreciation or depreciation or realized gains or losses resulting from the extinguishment of our own debt. Pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets (defined as total assets less liabilities) at the end of the immediately preceding fiscal quarter, is compared to a “hurdle rate” of 1.875% per quarter, subject to a “catch up” provision. The base management fee is calculated prior to giving effect to the payment of any incentive fees.

 

14

 

 

We pay Saratoga Investment Advisors an incentive fee with respect to our pre-incentive fee net investment income in each fiscal quarter as follows:

 

no incentive fee in any fiscal quarter in which our pre-incentive fee net investment income does not exceed the quarterly hurdle rate of 1.875%;

 

100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors;

 

20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. We refer to the amount specified in clause (B) as the “catch-up.” The “catch-up” provision is intended to provide Saratoga Investment Advisors with an incentive fee of 20.0% on all of our pre-incentive fee net investment income as if a hurdle rate did not apply when our pre-incentive fee net investment income exceeds 2.344% in any fiscal quarter. Notwithstanding the foregoing, with respect to any period ending on or prior to December 31, 2010, Saratoga Investment Advisors was only entitled to 20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeded 1.875% in any fiscal quarter without any catch-up provision. These calculations are appropriately pro-rated when such calculations are applicable for any period of less than three months.

 

There is no accumulation of amounts from quarter to quarter on either the hurdle rate or the parameters set by the “catch-up” mechanism or any claw back of amounts previously paid to Saratoga Investment Advisors if subsequent quarters are below the quarterly hurdle or the “catch-up” parameters. Furthermore, there is no delay of payment to Saratoga Investment Advisors if prior quarters are below the quarterly hurdle or “catch-up.”

 

The following is a graphical representation of the calculation of the income-related portion of the incentive fee subsequent to any period ending after December 31, 2010:

 

Quarterly Incentive Fee Based on “Pre-Incentive Fee Net Investment Income”

 

Pre-Incentive Fee Net Investment Income

(expressed as a percentage of the value of net assets)

 

 

 

Percentage of Pre-Incentive Fee Net Investment

Income allocated to income-related portion of incentive fee

  

The second part of the incentive fee, the capital gains fee, is determined and payable in arrears as of the end of each fiscal year (or, upon termination of the Management Agreement), and is calculated at the end of each applicable fiscal year by subtracting (1) the sum of our cumulative aggregate realized capital losses and aggregate unrealized capital depreciation from (2) our cumulative aggregate realized capital gains, in each case calculated from May 31, 2010 on each investment in the Company’s portfolio. If such amount is positive at the end of such year, then the capital gains fee for such year is equal to 20.0% of such amount, less the cumulative aggregate amount of capital gains fees paid in all prior years. If such amount is negative, then there is no capital gains fee for such year.

 

15

 

 

Under the Management Agreement, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and Saratoga Investment Advisors will be entitled to 20.0% of net capital gains that arise after May 31, 2010. In addition, the cost basis for computing our realized gains and losses on investments held by us as of May 31, 2010 equals the fair value of such investments as of such date.

 

Examples of Quarterly Incentive Fee Calculation

 

Example 1: Income Related Portion of Incentive Fee(1):

 

Assumptions

 

Hurdle rate(2) = 1.875%

 

Management fee(3) = 0.4375%

 

Other expenses (legal, accounting, custodian, transfer agent, etc.)(4) = 0.33%

 

Alternative 1

 

Additional Assumptions

 

Investment income (including interest, dividends, fees, etc.) = 1.25%

 

Pre-incentive fee net investment income (investment income–(management fee + other expenses)) = 0.4825% Pre-incentive fee net investment income does not exceed hurdle rate, therefore there is no incentive fee.

 

Alternative 2

 

Additional Assumptions

 

Investment income (including interest, dividends, fees, etc.) = 3.0%

 

Pre-incentive fee net investment income (investment income–(management fee + other expenses)) = 2.2325%

 

Pre-incentive fee net investment income exceeds hurdle rate, but does not fully satisfy the “catch-up” provision, therefore the income related portion of the incentive fee is 0.3575%.

 

Incentive Fee  = (100.0% × (pre-incentive fee net investment income–1.875%)
  = 100.0%(2.2325%–1.875%)
  = 100.0%(0.3575%)
  = 0.3575%

 

(1)The hypothetical amount of pre-incentive fee net investment income shown is based on a percentage of total net assets.

 

(2)Represents 7.5% hurdle rate.

 

(3)Represents 1.75% annualized management fee. For the purposes of this example, we have assumed that we have not incurred any indebtedness and that we maintain no cash or cash equivalents.

 

(4)The “catch-up” provision is intended to provide our Investment Adviser with an incentive fee of 20.0% on all pre-incentive fee net investment income as if a hurdle rate did not apply when our net investment income exceeds 2.344% in any fiscal quarter.

 

16

 

 

 

Alternative 3

 

Additional Assumptions

 

  Investment income (including interest, dividends, fees, etc.) = 3.5%

 

  Pre-Incentive Fee Net Investment Income (investment income–(management fee + other expenses) = 2.7325%

 

Pre-incentive fee net investment income exceeds the hurdle rate, and fully satisfies the “catch-up” provision, therefore the income related portion of the incentive fee is 0.5467%.

 

Incentive fee = 100.0% × pre-incentive fee net investment income (subject to “catch-up”)(4)
Incentive fee = 100.0% × “catch-up” + (20.0% × (Pre-incentive fee net investment income–2.344%))
Catch up = 2.344%–1.875%
  = 0.469%
Incentive fee = (100.0% × 0.469%) +(20.0% ×(2.7325%–2.344%))
  = 0.469% +(20.0% × 0.3885%)
  = 0.469% + 0.0777%
  = 0.5467%

 

Example 2: Capital Gains Portion of Incentive Fee:

 

Alternative 1

 

Assumptions(1)

 

  Year 1: $20.0 million investment made in Company A (“Investment A”), and $30.0 million investment made in Company B (“Investment B”)

 

  Year 2: Investment A is sold for $50.0 million and fair market value (“FMV”) of Investment B determined to be $32.0 million

 

  Year 3: FMV of Investment B determined to be $25.0 million

 

  Year 4: Investment B sold for $31.0 million

 

The capital gains portion of the incentive fee, if any, calculated under the cumulative method would be:

 

  Year 1: None

 

  Year 2: $6 million (20.0% multiplied by $30.0 million realized capital gains on sale of Investment A)

 

  Year 3: None; $5 million (20.0% multiplied by ($30.0 million realized cumulative capital gains less $5.0 million cumulative capital depreciation)) less $6.0 million (capital gains incentive fee paid in Year 2)

 

  Year 4: $200,000; $6.2 million (20.0% multiplied by $31.0 million cumulative realized capital gains) less $6.0 million (capital gains incentive fee paid in Year 2)

 

17

 

 

Alternative 2

 

Assumptions(1)

 

  Year 1: $20.0 million investment made in Company A (“Investment A”), $30.0 million investment made in Company B (“Investment B”) and $25.0 million investment made in Company C (“Investment C”)

 

  Year 2: Investment A sold for $50.0 million, FMV of Investment B determined to be $25.0 million and FMV of Investment C determined to be $25.0 million

 

  Year 3: FMV of Investment B determined to be $27.0 million and Investment C sold for $30.0 million

 

(1) The examples assume that Investment A and Investment B were acquired by us subsequent to May 31, 2010. If Investment A and B were acquired by us prior to May 31, 2010, then the cost basis for computing our realized gains and losses on such investments would equal the fair value of such investments as of May 31, 2010.

  

  Year 4: FMV of Investment B determined to be $35.0 million

 

  Year 5: Investment B sold for $20.0 million

 

The capital gains portion of the incentive fee, if any, calculated under the cumulative method would be:

 

  Year 1: None

 

  Year 2: $5.0 million (20.0% multiplied by $25.0 million ($30.0 million realized capital gains on Investment A less $5.0 million unrealized capital depreciation on Investment B))

 

  Year 3: $1.4 million ($6.4 million (20.0% multiplied by $32.0 million ($35.0 million cumulative realized capital gains less $3.0 million unrealized capital depreciation)) less $5.0 million (capital gains incentive fee paid in Year 2))

 

  Year 4: None

 

  Year 5: None ($5.0 million (20.0% multiplied by $25.0 million (cumulative realized capital gains of $35.0 million less realized capital losses of $10.0 million)) less $6.4 million (cumulative capital gains incentive fee paid in Year 2 and Year 3))

 

The Management Agreement with Saratoga Investment Advisors was initially approved for a two year period by our board of directors at an in-person meeting of the directors, including a majority of our independent directors, and was approved by our stockholders at the special meeting of stockholders held on July 30, 2010. Following the initial two year period, our board of directors has approved the renewal of the Management Agreement annually for an additional one-year term every year, with the last renewal approved at an in-person meeting on July 6, 2023. 

 

In approving renewal of the Management Agreement for an additional one-year term, the directors considered, among other things, (i) the nature, extent and quality of the advisory and other services to be provided to us by Saratoga Investment Advisors; (ii) our investment performance and the investment performance of Saratoga Investment Advisors; (iii) the expected costs of the services to be provided by Saratoga Investment Advisors (including management fees, advisory fees and expense ratios) as compared to other companies within the industry, and the profits expected to be realized by Saratoga Investment Advisors; (iv) the limited potential for economies of scale in investment management associated with managing us; and (v) Saratoga Investment Advisors estimated pro forma profitability with respect to managing us.

 

Payment of our expenses

 

The Management Agreement provides that all investment professionals of Saratoga Investment Advisors and its staff, when and to the extent engaged in providing investment advisory services required to be provided by Saratoga Investment Advisors, and the compensation and routine overhead expenses of such personnel allocable to such services, will be provided and paid for by Saratoga Investment Advisors and not by us.

 

We bear all costs and expenses of our operations and transactions, including those relating to:

 

  organization;

 

  calculating our NAV (including the cost and expenses of any independent valuation firm);

 

  expenses incurred by our Investment Adviser payable to third parties, including agents, consultants or other advisers, in monitoring financial and legal affairs for us and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

18

 

 

  expenses incurred by our Investment Adviser payable for travel and due diligence on our prospective portfolio companies;

 

  interest payable on debt, if any, incurred to finance our investments;

 

  offerings of our common stock and other securities;

 

  investment advisory and management fees;

 

  fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

  transfer agent and custodial fees;

 

  federal and state registration fees;

 

  all costs of registration and listing our common stock on any securities exchange;

 

  U.S. federal, state and local taxes;

 

  independent directors’ fees and expenses;

 

  costs of preparing and filing reports or other documents required by governmental bodies (including the Securities and Exchange Commission (the “SEC”) and the SBA);

 

  costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

  our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

  direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

  administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under the Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

 

Duration and Termination

 

The Management Agreement will remain in effect continuously, unless terminated under the termination provisions of the Management Agreement. The Management Agreement provides that it may be terminated at any time, without the payment of any penalty, upon 60 days written notice, by the vote of stockholders holding a majority of our outstanding voting securities, or by the vote of our directors or by Saratoga Investment Advisors.

 

The Management Agreement will, unless terminated as described above, continue in effect from year to year so long as it is approved at least annually by (i) the vote of the board of directors, or by the vote of stockholders holding a majority of our outstanding voting securities, and (ii) the vote of a majority of our directors who are not parties to the Management Agreement or “interested persons” (as such term is defined in Section 2(a)(19) of the 1940 Act) of any party to such agreement, in accordance with the requirements of the 1940 Act.

 

19

 

 

Indemnification

 

Under the Management Agreement, Saratoga Investment Advisors and certain of its affiliates are not liable to us for any action taken or omitted to be taken by Saratoga Investment Advisors in connection with the performance of any of its duties or obligations under the agreement or otherwise as an investment adviser to us, except to the extent specified in Section 36(b) of the 1940 Act concerning loss resulting from a breach of fiduciary duty (as the same is finally determined by judicial proceedings) with respect to the receipt of compensation for services and except to the extent such action or omission constitutes gross negligence, willful misfeasance, bad faith or reckless disregard of its duties and obligations under the agreement.

 

We also provide indemnification to Saratoga Investment Advisors and certain of its affiliates for damages, liabilities, costs and expenses incurred by them in or by reason of any pending, threatened or completed action, suit, investigation or other proceeding arising out of or otherwise based upon the performance of any of its duties or obligations under the agreement or otherwise as an investment adviser to us. However, we would not provide indemnification against any liability to us or our security holders to which Saratoga Investment Advisors or such affiliates would otherwise be subject by reason of willful misfeasance, bad faith or gross negligence in the performance of any such person’s duties or by reason of the reckless disregard of its duties and obligations under the agreement.

 

Organization of the Investment Adviser

 

Saratoga Investment Advisors is registered as an investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). The principal executive offices of Saratoga Investment Advisors are located at 535 Madison Avenue, New York, New York 10022.

 

Administration Agreement

 

Pursuant to a separate Administration Agreement, Saratoga Investment Advisors, who also serves as our administrator, furnishes us with office facilities, equipment and clerical, book-keeping and record keeping services. Under the Administration Agreement, our administrator also performs, or oversees the performance of, our required administrative services, which include, among other things, being responsible for the financial records which we are required to maintain, preparing reports for our stockholders and reports required to be filed with the SEC. In addition, our administrator assists us in determining and publishing our NAV, oversees the preparation and filing of our tax returns and the printing and dissemination of reports to our stockholders, and generally oversees the payment of our expenses and the performance of administrative and professional services rendered to us by others. Payments under the Administration Agreement equal an amount based upon our allocable portion of our administrator’s overhead in performing its obligations under the Administration Agreement, including rent and our allocable portion of the cost of our officers and their respective staffs relating to the performance of services under this agreement (including travel expenses). Our allocable portion is based on the proportion that our total assets bears to the total assets administered or managed by our administrator. Under the Administration Agreement, our administrator also provides managerial assistance, on our behalf, to those portfolio companies who accept our offer of assistance. The Administration Agreement may be terminated by either party without penalty upon 60 days written notice to the other party. Our board of directors, including a majority of independent directors, will annually review the compensation we pay to the Adviser to determine that the provisions of the Administrative Agreement are carried out satisfactorily and to determine, among other things, whether the fees payable under such agreement are reasonable in light of the services provided. Our board of directors reviews the methodology employed in determining how the expenses are allocated to us and any proposed allocation of administrative expenses among us and any affiliates of the Adviser. Our board of directors then assesses the reasonableness of such reimbursements for expenses allocated to us based on the breadth, depth and quality of the administrative services as compared to the estimated cost to us of obtaining similar services from third-party service providers known to be available. In addition, our board of directors considers whether any single third-party service provider would be capable of providing all such services at comparable cost and quality. Finally, our board of directors compares the total amount paid to the Adviser for such services as a percentage of our net assets to the same ratio as reported by other comparable funds. Most recently, on July 6, 2023, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $3.275 million to $4.3 million effective August 1, 2023.

 

20

 

 

Indemnification

 

Under the Administration Agreement, Saratoga Investment Advisors and certain of its affiliates are not liable to us for any action taken or omitted to be taken by Saratoga Investment Advisors in connection with the performance of any of its duties or obligations under the agreement.

 

We also provide indemnification to Saratoga Investment Advisors and certain of its affiliates for damages, liabilities, costs and expenses incurred by them in or by reason of any pending, threatened or completed action, suit, investigation or other proceeding arising out of or otherwise based upon the performance of any of its duties or obligations under the agreement or otherwise as an administrator to us. However, we do not provide indemnification against any liability to us or our security holders to which Saratoga Investment Advisors or such affiliates would otherwise be subject by reason of willful misfeasance, bad faith or gross negligence in the performance of any such person’s duties or by reason of the reckless disregard of its duties and obligations under the agreement.

 

License Agreement

 

We entered into a trademark license agreement with Saratoga Investment Advisors, pursuant to which Saratoga Investment Advisors grants us a non-exclusive, royalty-free license to use the name “Saratoga.” Under this agreement, we have a right to use the “Saratoga” name, for so long as Saratoga Investment Advisors or one of its affiliates remains our Investment Adviser. Other than with respect to this limited license, we have no legal right to the “Saratoga” name. Saratoga Investment Advisors has the right to terminate the license agreement if it is no longer acting as our investment adviser. In the event the Management Agreement is terminated, we would be required to change our name to eliminate the use of the name “Saratoga.”

 

Business Development Company Regulations

 

We have elected to be regulated as a BDC under the 1940 Act. As with other companies regulated by the 1940 Act, a BDC must adhere to certain substantive regulatory requirements. The 1940 Act contains prohibitions and restrictions relating to transactions between BDCs and their affiliates (including any investment advisers or sub-advisers), principal underwriters and affiliates of those affiliates or underwriters, and requires that a majority of the directors be independent directors. In addition, the 1940 Act provides that we may not change the nature of our business so as to cease to be, or to withdraw our election to be regulated as, a BDC, unless approved by “a majority of our outstanding voting securities,” as defined in the 1940 Act. A majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (i) 67.0% or more of such company’s stock present at a meeting if more than 50.0% of the outstanding stock of such company is present and represented by proxy or (ii) more than 50.0% of the outstanding stock of such company.

 

We do not intend to acquire securities issued by any investment company (including Section 3(c)(1) and Section 3(c)(7) funds for this purpose, and mutual funds, registered closed-end funds and BDCs) that exceed the limits imposed by the 1940 Act. Under these limits, except for registered money market funds, we generally cannot acquire more than 3% of the voting stock of the investment company’s total outstanding voting stock, invest more than 5% of the value of our total assets in the securities of one investment company or invest more than 10% of the aggregate value of our total assets in the securities of more than one investment company. With regard to that portion of our portfolio invested in securities issued by investment companies, it should be noted that such investments might subject our stockholders to additional expenses.

 

We are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect us against larceny and embezzlement. Furthermore, as a BDC, we are prohibited from protecting any director or officer against any liability to us or our stockholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person’s office.

 

We and our investment adviser have adopted and implemented written policies and procedures reasonably designed to prevent violation of the federal securities laws and review these policies and procedures annually for their adequacy and the effectiveness of their implementation. We and the Investment Adviser have designated a chief compliance officer to be responsible for administering these policies and procedures. We expect to be periodically examined by the SEC for compliance with the federal securities laws, including the 1940 Act.

 

21

 

 

Qualifying assets

 

A BDC must have been organized and have its principal place of business in the United States and must be operated for the purpose of making investments in the types of securities described in (1), (2) or (3) below. Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in Section 55(a) of the 1940 Act, which are referred to as qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70.0% of the company’s total assets. The principal categories of qualifying assets relevant to our business are the following:

 

  (1) Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions) is an eligible portfolio company, or from any person who is, or has been during the preceding 13 months, an affiliated person of an eligible portfolio company, or from any other person, subject to such rules as may be prescribed by the SEC. An eligible portfolio company is defined in the 1940 Act as any issuer which:

 

  (a) is organized under the laws of, and has its principal place of business in, the United States;

 

  (b) is not an investment company (other than a small business investment company wholly owned by the BDC) or a company that would be an investment company but for certain exclusions under the 1940 Act; and

 

  (c) satisfies either of the following:

 

  (i) does not have any class of securities listed on a national securities exchange;

 

  (ii) has a class of securities listed on a national securities exchange but has an aggregate market value of outstanding voting and non-voting common equity of less than $250.0 million;

 

  (iii) is controlled by a BDC or a group of companies including a BDC and the BDC has an affiliated person who is a director of the eligible portfolio company;

 

  (iv) is a small and solvent company having total assets of not more than $4.0 million and capital and surplus of not less than $2.0 million; or

 

  (v) meets such other criteria as may established by the SEC. (2) Securities of any eligible portfolio company which we control.

 

  (3) Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements.

 

  (4) Securities of an eligible portfolio company purchased from any person in a private transaction if there is no ready market for such securities and we already own at least 60.0% of the outstanding equity of the eligible portfolio company.

 

  (5) Securities received in exchange for or distributed on or with respect to securities described in (1) through (4) above, or pursuant to the exercise of options, warrants or rights relating to such securities.

 

  (6) Cash, cash equivalents, U.S. Government securities or high-quality debt securities maturing in one year or less from the time of investment.

 

The regulations defining qualifying assets may change over time. We may adjust our investment focus as needed to comply with and/or take advantage of any regulatory, legislative, administrative or judicial actions in this area.

 

22

 

 

Significant managerial assistance to portfolio companies

 

A BDC generally must offer to make available to the issuer of the securities in which it invests significant managerial assistance, except in circumstances where either (i) the BDC controls such issuer of securities or (ii) the BDC purchases such securities in conjunction with one or more other persons acting together and one of the other persons in the group makes available such managerial assistance. As a BDC, we must offer, and must provide upon request, managerial assistance to our portfolio companies. Making available significant managerial assistance means, among other things, any arrangement whereby the BDC, through its directors, officers or employees or those of its investment adviser or administrator, offers to provide, and, if accepted, does so provide, significant guidance and counsel concerning the management, operations or business objectives and policies of a portfolio company. This assistance could involve, among other things, monitoring the operations of our portfolio companies, participating in board and management meetings, consulting with and advising officers of portfolio companies and providing other organizational and financial guidance. Pursuant to a separate Administration Agreement, Saratoga Investment Advisors provides such managerial assistance on our behalf to portfolio companies that request this assistance, recognizing that our involvement with each investment will vary based on factors including the size of the company, the nature of our investment, the company’s overall stage of development and our relative position in the capital structure. We may receive fees for these services.

 

Temporary investments

 

As a BDC, pending investment in other types of “qualifying assets,” as described above, our investments may consist of cash, cash equivalents, U.S. Government securities or high-quality debt securities maturing in one year or less from the time of investment, which we refer to, collectively, as temporary investments, so that 70.0% of our assets are qualifying assets. Typically, we will invest in U.S. Treasury bills or in repurchase agreements, provided that such agreements are fully collateralized by cash or securities issued by the U.S. Government or its agencies. A repurchase agreement involves the purchase by an investor, such as us, of a specified security and the simultaneous agreement by the seller to repurchase it at an agreed-upon future date and at a price which is greater than the purchase price by an amount that reflects an agreed-upon interest rate. There is no percentage restriction on the proportion of our assets that may be invested in such repurchase agreements. However, if more than 25.0% of our total assets constitute repurchase agreements from a single counterparty, we would not meet the asset-diversification requirements in order to qualify as a RIC for U.S. federal income tax purposes. Thus, we do not intend to enter into repurchase agreements with a single counterparty in excess of this limit. Our Investment Adviser will monitor the creditworthiness of the counterparties with which we enter into repurchase agreement transactions.

  

Indebtedness and senior securities

 

As a BDC, we are permitted, under specified conditions, to issue multiple classes of indebtedness and one class of shares of stock, senior to our common stock, if our asset coverage, as defined in the 1940 Act, is at least equal to 200% immediately after each such issuance or 150% if certain requirements are met. On April 16, 2018, our board of directors, including a majority of our independent directors, approved of us becoming subject to a minimum asset coverage ratio of 150% under Sections 18(a)(1) and 18(a)(2) of the 1940 Act. The 150% asset coverage ratio became effective on April 16, 2019. See “Risk Factors – Effective April 16, 2019, our asset coverage requirement was reduced from 200% to 150%, which may increase the risk of investing in the Company.” We may also borrow amounts up to 5.0% of the value of our total assets for temporary or emergency purposes without regard to asset coverage.

 

The 1940 Act also limits the amount of warrants, options and rights to common stock that we may issue and the terms of such securities.

 

Common stock

 

We generally are not able to issue and sell our common stock at a price below NAV per share. We may, however, sell our common stock, warrants, options or rights to acquire our common stock, at a price below the current NAV of the common stock if our board of directors determines that such sale is in our best interests and that of our stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price which, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). We may also make rights offerings to our stockholders at prices per share less than the NAV per share, subject to applicable requirements of the 1940 Act.

 

23

 

 

Code of ethics

 

As a BDC, we and Saratoga Investment Advisors have each adopted a code of ethics pursuant to Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act, respectively, that establishes procedures for personal investments and restricts certain personal securities transactions. Personnel subject to each code may invest in securities for their personal investment accounts, including securities that may be purchased or held by us, so long as such investments are made in accordance with the code’s requirements. In addition, each code of ethics is available on the EDGAR database on the SEC’s website at www.sec.gov. Our code of ethics is also available on our corporate governance webpage at http://ir.saratogainvestmentcorp.com/corporate-governance.

 

Proxy voting policies and procedures

 

SEC registered investment advisers that have the authority to vote (client) proxies (which authority may be implied from a general grant of investment discretion) are required to adopt policies and procedures reasonably designed to ensure that the adviser votes proxies in the best interests of its clients. Registered investment advisers also must maintain certain records on proxy voting. In most cases, we will invest in securities that do not generally entitle us to voting rights in our portfolio companies. When we do have voting rights, we will delegate the exercise of such rights to our Investment Adviser.

 

Saratoga Investment Advisors has particular proxy voting policies and procedures in place. In determining how to vote, officers of Saratoga Investment Advisors will consult with each other, taking into account our interests and the interests of our investors, as well as any potential conflicts of interest. Saratoga Investment Advisors will consult with legal counsel to identify potential conflicts of interest. Where a potential conflict of interest exists, Saratoga Investment Advisors may, if it so elects, resolve it by following the recommendation of a disinterested third party, by seeking the direction of our independent directors or, in extreme cases, by abstaining from voting. While Saratoga Investment Advisors may retain an outside service to provide voting recommendations and to assist in analyzing votes, it will not delegate its voting authority to any third party.

 

An officer of Saratoga Investment Advisors will keep a written record of how all such proxies are voted. It will retain records of (1) proxy voting policies and procedures, (2) all proxy statements received (or it may rely on proxy statements filed on the SEC’s EDGAR system in lieu thereof), (3) all votes cast, (4) investor requests for voting information, and (5) any specific documents prepared or received in connection with a decision on a proxy vote. If it uses an outside service, Saratoga Investment Advisors may rely on such service to maintain copies of proxy statements and records, so long as such service will provide a copy of such documents promptly upon request.

  

Saratoga Investment Advisors’ proxy voting policies are not exhaustive and are designed to be responsive to the wide range of issues that may be subject to a proxy vote. In general, Saratoga Investment Advisors will vote our proxies in accordance with these guidelines unless: (1) it has determined otherwise due to the specific and unusual facts and circumstances with respect to a particular vote, (2) the subject matter of the vote is not covered by these guidelines, (3) a material conflict of interest is present, or (4) it finds it necessary to vote contrary to its general guidelines to maximize stockholder value or our best interests.

 

In reviewing proxy issues, Saratoga Investment Advisors generally will use the following guidelines:

 

Elections of Directors: In general, Saratoga Investment Advisors will vote in favor of the management-proposed slate of directors. If there is a proxy fight for seats on a portfolio company’s board of directors, or Saratoga Investment Advisors determines that there are other compelling reasons for withholding our vote, it will determine the appropriate vote on the matter. It may withhold votes for directors that fail to act on key issues, such as failure to: (1) implement proposals to declassify a board, (2) implement a majority vote requirement, (3) submit a rights plan to a stockholder vote or (4) act on tender offers where a majority of stockholders have tendered their shares. Finally, Saratoga Investment Advisors may withhold votes for directors of non-U.S. issuers where there is insufficient information about the nominees disclosed in the proxy statement.

 

Appointment of Auditors: We believe that a portfolio company remains in the best position to choose its independent auditors and Saratoga Investment Advisors will generally support management’s recommendation in this regard.

 

Changes in Capital Structure: Changes in a portfolio company’s organizational documents may be required by state or federal regulation. In general, Saratoga Investment Advisors will cast our votes in accordance with the management on such proposals. However, Saratoga Investment Advisors will consider carefully any proposal regarding a change in corporate structure that is not required by state or federal regulation.

 

24

 

 

Corporate Restructurings, Mergers and Acquisitions: We believe proxy votes dealing with corporate reorganizations are an extension of the investment decision. Accordingly, Saratoga Investment Advisors will analyze such proposals on a case-by-case basis and vote in accordance with its perception of our interests.

 

Proposals Affecting Stockholder Rights: We will generally vote in favor of proposals that give stockholders a greater voice in the affairs of a portfolio company and oppose any measure that seeks to limit such rights. However, when analyzing such proposals, Saratoga Investment Advisors will balance the financial impact of the proposal against any impairment of stockholder rights as well as of our investment in the portfolio company.

 

Corporate Governance: We recognize the importance of good corporate governance. Accordingly, Saratoga Investment Advisors will generally favor proposals that promote transparency and accountability within a portfolio company.

 

Anti-Takeover Measures: Saratoga Investment Advisors will evaluate, on a case-by-case basis, any proposals regarding anti- takeover measures to determine the likely effect on stockholder value dilution.

 

Share Splits: Saratoga Investment Advisors will generally vote with management on share split matters.

 

Limited Liability of Directors: Saratoga Investment Advisors will generally vote with management on matters that could adversely affect the limited liability of directors.

 

Social and Corporate Responsibility: Saratoga Investment Advisors will review proposals related to social, political and environmental issues to determine whether they may adversely affect stockholder value. It may abstain from voting on such proposals where they do not have a readily determinable financial impact on stockholder value.

 

Privacy principles

 

We are committed to protecting the privacy of our stockholders. The following explains the privacy policies of Saratoga Investment Corp., Saratoga Investment Advisors and their affiliated companies.

 

We will safeguard, according to strict standards of security and confidentiality, all information we receive about our stockholders.

  

Generally, we do not receive any non-public personal information relating to our stockholders, although certain non-public personal information of our stockholders may become available to us. The only information we collect from stockholders is the holder’s name, address, number of shares and social security number. This information is used only so that we can send annual reports and other information about us to the stockholder and send the stockholder proxy statements or other information required by law. We restrict access to non-public personal information about our stockholders to our Investment Adviser’s and Administrator’s employees with a legitimate business need for the information. We maintain physical, electronic and procedural safeguards designed to protect the non-public personal information of our stockholders.

 

We do not share this information with any non-affiliated third party except as described below:

 

  Authorized Employees of Saratoga Investment Advisors. It is our policy that only authorized employees of Saratoga Investment Advisors who need to know a stockholder’s personal information will have access to it.

 

  Service Providers. We may disclose your personal information to companies that provide services on our behalf, such as recordkeeping, processing a stockholder’s trades, and mailing stockholder information. These companies are required to protect our stockholders’ information and use it solely for the purpose for which they received it.

 

  Courts and Government Officials. If required by law, we may disclose a stockholder’s personal information in accordance with a court order or at the request of government regulators. Only that information required by law, subpoena, or court order will be disclosed.

 

25

 

 

Compliance with applicable laws

 

As a BDC, we are periodically examined by the SEC for compliance with the federal securities laws, including the 1940 Act.

 

We are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect us against larceny and embezzlement. Furthermore, as a BDC, we are prohibited from protecting any director or officer against any liability to us or our stockholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person’s office.

 

We and Saratoga Investment Advisors are each required to adopt and implement written policies and procedures reasonably designed to prevent violation of the federal securities laws, review these policies and procedures annually for their adequacy and the effectiveness of their implementation, and designate a chief compliance officer to be responsible for administering the policies and procedures.

 

The New York Stock Exchange (“NYSE”) Corporate Governance Regulations

 

The NYSE has adopted corporate governance regulations that listed companies must comply with. We are in compliance with such corporate governance listing standards applicable to the Company.

 

Affiliated Transactions

 

The Company may be prohibited under the 1940 Act from participating in certain transactions with certain of its affiliates without the prior approval of our independent directors and, in some cases, the prior approval of the SEC. On December 12, 2023, the SEC granted an exemptive order (collectively, the “Order”) that permits the Company to participate in negotiated co-investment transactions with certain other funds and accounts managed and controlled by Saratoga Investment Advisors or a control affiliate thereof, subject to the satisfaction of certain conditions. Pursuant to the Order, the Company is permitted to co-invest with such affiliates if a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Board’s independent directors make certain conclusions in connection with a co-investment transaction, including, but not limited to, that (1) the terms of the potential co-investment transaction, including the consideration to be paid, are reasonable and fair to the Company and its shareholders and do not involve overreaching in respect of the Company or its shareholders on the part of any person concerned, and (2) the potential co-investment transaction is consistent with the interests of the Company’s shareholders and is consistent with its then-current investment objective and strategies. Neither the Company nor its affiliates that are permitted to rely on the Order are obligated to invest or co-invest when investment opportunities are referred to the Company or them.

 

Small Business Investment Company Regulations

 

Our wholly owned subsidiaries, SBIC LP, SBIC II LP, and SBIC III LP, received an SBIC license from the SBA on March 28, 2012, August 14, 2019, and September 29, 2022, respectively. Following the debentures being fully repaid to the SBA, SBIC LP surrendered its license on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company.

 

The SBIC licenses allows our SBIC Subsidiaries to obtain leverage by issuing SBA-guaranteed debentures, subject to the satisfaction of certain customary procedures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed at the time of issuance at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

 

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $24.0 million and have average annual fully taxed net income not exceeding $8.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to “smaller enterprises” as defined by the SBA. A smaller enterprise is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

 

26

 

 

The Company’s wholly owned SBIC Subsidiaries are able to borrow funds from the SBA against each SBIC’s regulatory capital (which generally approximates equity capital in the respective SBIC). The SBIC Subsidiaries are subject to customary regulatory requirements including but not limited to, a periodic examination by the SBA and requirements to maintain certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that the SBIC Subsidiaries will receive SBA-guaranteed debenture funding, which is subject to SBA approval and continued compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to each SBIC Subsidiaries’ assets over the Company’s stockholders and debtholders in the event that the Company liquidates such SBIC Subsidiary or the SBA exercises its remedies under the SBA-guaranteed debentures issued by the SBIC Subsidiary upon an event of default.

 

The Company received exemptive relief from the SEC to permit it to exclude the senior securities of the SBIC subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage requirement under the 1940 Act. This allows the Company increased flexibility under the asset coverage requirement by permitting it to borrow up to $350.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

 

For two or more SBIC’s under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital. Our wholly owned SBIC Subsidiaries may borrow funds from the SBA against its respective regulatory capital (which generally approximates equity capital) that is paid in and is subject to customary regulatory requirements, including, but not limited to, an examination by the SBA. The SBIC Subsidiaries have $308.4 million of committed capital on an aggregate basis. SBA regulations currently limit the amount of SBA-guaranteed debentures that an individual SBIC may issue to $175.0 million when it has at least $87.5 million in regulatory capital.

 

As of February 29, 2024, SBIC LP was dissolved. As of February 29, 2024, we have funded SBIC II LP with an aggregate total of $87.5 million of equity capital and have $175.0 million of SBA-guaranteed debentures outstanding, and we have funded SBIC III LP with an aggregate total of $66.7 million of equity capital and have $39.0 million of SBA-guaranteed debentures outstanding.

 

Available Information

 

We file with or submit to the SEC annual, quarterly and current periodic reports, proxy statements and other information meeting the informational requirements of the Securities Exchange of 1934, as amended (the “Exchange Act”). The SEC maintains an Internet website that contains reports, proxy and information statements and other information filed electronically by us with the SEC at www.sec.gov.

 

Our Internet address is www.saratogainvestmentcorp.com. We make available free of charge on our Internet website our Annual Report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information contained on our website is not incorporated by reference into this Annual Report, and you should not consider that information to be part of this Annual Report.

 

27

 

 

ITEM 1A. RISK FACTORS

 

Investing in our securities involves a number of significant risks. In addition to other information contained in this Annual Report on Form 10-K, you should consider carefully the following information before making an investment in our securities. The risks set forth below are the principal risks with respect to the Company generally and with respect to BDCs, they may not be the only risks we face. This section nonetheless describes the principal risk factors associated with investment in the Company specifically, as well as those factors generally associated with investment in a company with investment objectives, investment policies, capital structure or trading markets similar to the Company’s. If any of the risks occur, our business, financial condition and results of operations could be materially adversely affected. In such case, our NAV and the trading price of our securities could decline and you may lose all or part of your investment.

 

SUMMARY OF RISK FACTORS

 

The following is a summary of the principal risks that you should carefully consider before investing in our securities. These and other risk factors are described more fully in this “Item 1A. Risk Factors.”

 

Risks Related to Our Business and Structure 

 

We employ leverage, which magnifies the potential for gain or loss on amounts invested and may increase the risk of investing in us.

 

We are exposed to risks associated with changes in interest rates including potential effects on our cost of capital and net investment income.

 

The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.

 

Risks Related to the Current Environment

 

  Global economic, political and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.

 

  Inflation may adversely affect the business results of operations and financial condition of our portfolio companies, which may, in turn, impact the valuation of such portfolio companies.

  

  We are currently operating in a period of capital markets disruption and economic uncertainty.

 

  Economic recessions or downturns could impair the ability of our portfolio companies to repay loans and harm our operating results.

 

Risks Related to Our Adviser and Its Affiliates

 

  We may be obligated to pay Saratoga Investment Advisors incentive fees even if we incur a net loss, or there is a decline in the value of our portfolio.

 

  The way in which the base management and incentive fees under the Management Agreement is determined may encourage Saratoga Investment Advisors to take actions that may not be in our best interests.

 

  Saratoga Investment Advisors’ liability is limited under the Management Agreement and we will indemnify Saratoga Investment Advisors against certain liabilities, which may lead it to act in a riskier manner on our behalf than it would when acting for its own account.

 

  Our ability to enter into transactions with our affiliates is restricted.

 

Risks Related to Our Investments

 

  A majority of our debt investments are not required to make principal payments until the maturity of such debt securities and are generally riskier than other types of loans.

 

  The lack of liquidity in our investments may adversely affect our business.

 

  Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of subordinated notes representing the lowest-rated securities issued by a pool of predominantly senior secured first lien term loans and is subject to additional risks and volatility. All losses in the pool of loans will be borne by our subordinated notes and only after the value of our subordinated notes is reduced to zero will the higher-rated notes issued by the pool bear any losses.

 

  Investments in equity securities involve a substantial degree of risk.

 

28

 

 

Risks Related to Our Common Stock

 

  We may choose to pay dividends in our own stock, in which case you may be required to pay tax in excess of the cash you receive.

 

  Due to the current market conditions, we may defer our dividends and choose to incur U.S. federal excise tax in order preserve cash and maintain flexibility.

 

  The market price of our common stock may fluctuate significantly.

 

  There is a risk that you may not receive distributions or that our distributions may not grow over time.

 

Risks Related to Our Notes

 

 

The Notes are unsecured and therefore are effectively subordinated to any existing and future secured indebtedness, including indebtedness under our Encina Credit Facility and our Live Oak Credit Facility.

 

  An active trading market for the Public Notes may not develop or be sustained, which could limit the market price of the Public Notes or the ability to sell them.

 

RISKS RELATED TO OUR BUSINESS AND STRUCTURE

 

We employ leverage, which magnifies the potential for gain or loss on amounts invested and may increase the risk of investing in us.

 

Borrowings, also known as leverage, magnify the potential for gain or loss on amounts invested and, therefore, increase the risks associated with investing in us. We borrow from and issue senior debt securities to banks and other lenders that is secured by a lien on our assets. Holders of these senior securities have fixed dollar claims on our assets that are superior to the claims of the holders of our securities. Leverage is generally considered a speculative investment technique. Any increase in our income in excess of interest payable on our outstanding indebtedness would cause our net income to increase more than it would have had we not incurred leverage, while any decrease in our income would cause net income to decline more sharply than it would have had we not incurred leverage. Such a decline could negatively affect our ability to make common stock distributions or scheduled debt payments, including with respect to the Notes, as defined below. There can be no assurance that our leveraging strategy will be successful.

 

Our outstanding indebtedness imposes, and additional debt we may incur in the future will likely impose, financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC. A failure to add new debt facilities or issue additional debt securities or other evidences of indebtedness in lieu of or in addition to existing indebtedness could have a material adverse effect on our business, financial condition or results of operations.

 

As of February 29, 2024, there were $35.0 million outstanding borrowings under the Encina Credit Facility. As of February 29, 2024, we had issued $214.0 million in SBA-guaranteed debentures and our $20.0 million principal amount of 8.75% fixed-rate notes due 2025 (the “8.75% 2025 Notes”), $12.0 million principal amount of 7.00% fixed-rate notes due 2025 (the “7.00% 2025 Notes”), our $5.0 million principal amount of 7.75% fixed-rate notes due in 2025 (the “7.75% 2025 Notes”), our $175.0 million principal amount of 4.375% fixed-rate notes due in 2026 (the “4.375% 2026 Notes”), our $75.0 million principal amount of 4.35% fixed-rate notes due in 2027 (the “4.35% 2027 Notes”), our $105.5 million principal amount of 6.00% fixed-rate notes due in 2027 (the “6.00% 2027 Notes”), our $15.0 million principal amount of 6.25% fixed-rate notes due in 2027 (the “6.25% 2027 Notes”) our $46.0 million principal amount of 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”), our $60.375 million principal amount of 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) and our $57.5 million principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes” and together with the 6.00% 2027 Notes, the 8.00% 2027 Notes, and the 8.125% 2027 Notes, the “Public Notes”). Together, the 8.75% 2025 Notes, 7.00% 2025 Notes, the 7.75% 2025 Notes, the 4.35% 2027 Notes, the 6.00% 2027 Notes, the 6.25% 2027 Notes, the 8.00% 2027 Notes, the 8.125% 2027 Notes, and the 8.50% 2028 Notes are referred to as the “Notes”. We may incur additional indebtedness in the future, including, but not limited to, borrowings under the Encina Credit Facility, the Live Oak Credit Facility, or the issuance of additional debt securities in one or more public or private offerings, although there can be no assurance that we will be successful in doing so. Our ability to service our debt depends largely on our financial performance and is subject to prevailing economic conditions and competitive pressures. The amount of leverage that we employ at any particular time will depend on our management’s and our board of directors’ assessment of market and other factors at the time of any proposed borrowing.

 

29

 

 

As a BDC, we are generally permitted to issue senior securities only in amounts such that our asset coverage ratio equals at least 150% of total assets to total borrowings and other senior securities, which include all of our borrowings (other than the senior securities of SBIC II LP’s and SBIC III LP’s under the terms of our SEC exemptive relief) and any preferred stock we may issue in the future. If this ratio declines below 150%, we may not be able to incur additional debt and may need to sell a portion of our investments to repay some debt when it is disadvantageous to do so, and we may not be able to make distributions to our stockholders.

 

The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns, net of expenses. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below.

 

Assumed Return on Our Portfolio

(net of expenses)

 

   -10.0%  -5.0%  0%  5%  10%
Assumed Return on Portfolio (Net of Expenses)               
Corresponding Return to Common Stockholder (1)  -46%  -30%  -14%  2%  18%

 

(1)Assumes $1,148.7 billion in average total assets, $792.8 million in average debt outstanding, $355.3 million in average net assets and an average interest rate of 6.2%. Actual interest payments may be different. The various return scenarios above exclude borrowing costs, which are then separately deducted from the net return to common stockholders calculated based on average debt outstanding and average interest rate.

 

Substantially all of the assets of SIF II and SIF III are subject to security interests under our Encina Credit Facility and our Live Oak Facility, respectively, and all of each SBIC Subsidiary’s assets are subject to claims of the SBA with respect to SBA-guaranteed debentures we issue and if we default on our obligations thereunder, we may suffer adverse consequences, including the foreclosure on our assets.

 

Substantially all of the assets of SIF II and SIF III are pledged as collateral under the Encina Credit Facility and the Live Oak Credit Facility, respectively, and all of each SBIC Subsidiary’s assets are subject to a superior claim by the SBA pursuant to the SBA-guaranteed debentures. If we default on our obligations under the Encina Credit Facility, the Live Oak Credit Facility, or the SBA-guaranteed debentures, Encina Lender Finance, LLC, Live Oak Banking Company, and/or the SBA may have the right to foreclose upon and sell, or otherwise transfer, the collateral subject to their security interests or superior claim. In such event, we may be forced to sell our investments to raise funds to repay our outstanding borrowings in order to avoid foreclosure and these forced sales may be at times and at prices we would not consider advantageous. Moreover, such deleveraging of our company could significantly impair our ability to effectively operate our business in the manner in which we have historically operated.

 

In addition, if Encina Lender Finance, LLC, the lender under the Encina Credit Facility, or the Live Oak Banking Company, the lender under the Live Oak Credit Facility, exercise their right to sell the assets pledged under the Encina Credit Facility or the Live Oak Credit Facility, respectively, such sales may be completed at distressed sale prices, thereby diminishing or potentially eliminating the amount of cash available to us after repayment of the amounts outstanding under the Encina Credit Facility or the Live Oak Credit Facility.

 

We are exposed to risks associated with changes in interest rates including potential effects on our cost of capital and net investment income.

 

General interest rate fluctuations and changes in credit spreads on floating rate loans may have a substantial negative impact on our investments and investment opportunities and, accordingly, may have a material adverse effect on our rate of return on invested capital. In addition, in response to market indicators showing a rise in inflation, since March 2022, the Federal Reserve has been rapidly increasing interest rates. Although the Federal Reserve left its benchmark rates steady in the fourth quarter of 2023, it has indicated that additional rate increases in the future may be necessary to mitigate inflationary pressures and there can be no assurance that the Federal Reserve will not make upwards adjustments to the federal funds rate in the future. However, there are reports that the Federal Reserve may begin to cut the benchmark rates in 2024. An increase in interest rates would make it more expensive to use debt to finance our investments. Decreases in credit spreads on debt that pays a floating rate of return would have an impact on the income generation of our floating rate assets. Trading prices for debt that pays a fixed rate of return tend to fall as interest rates rise. Trading prices tend to fluctuate more for fixed rate securities that have longer maturities. Although we have no policy governing the maturities of our investments, under current market conditions we expect that we will invest in a portfolio of debt generally having maturities of up to ten years. This means that we will be subject to greater risk (other things being equal) than an entity investing solely in shorter-term securities.

 

30

 

 

Because we may borrow to fund our investments, a portion of our net investment income may be dependent upon the difference between the interest rate at which we borrow funds and the interest rate at which we invest these funds. A portion of our investments will have fixed interest rates, while a portion of our borrowings will likely have floating interest rates. As a result, a significant change in market interest rates could have a material adverse effect on our net investment income. In periods of rising interest rates, our cost of funds could increase, which would reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum (or “floor”) interest rates, while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may temporarily increase our interest expense, even though our interest income from investments is not increasing in a corresponding manner if market rates remain lower than the existing floor rate. If general interest rates rise, there is also a risk that the portfolio companies in which we hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with us. Rising interest rates could also cause portfolio companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on us to provide fixed rate loans to our portfolio companies, which could adversely affect our net investment income, as increases in our cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments.

 

We may hedge against such interest rate fluctuations by using standard hedging instruments such as futures, options and forward contracts, subject to applicable legal requirements, including without limitation, all necessary registrations (or exemptions from registration) with the Commodity Futures Trading Commission. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.

 

The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.

 

LIBOR, the London Interbank Offered Rate, is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. Prior to June 30, 2023, LIBOR was typically the reference rate used in floating-rate loans identified by the Investment Adviser.

 

The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances.

 

In the United States, the Secured Overnight Financing Rate (“SOFR”) is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding US. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.

 

All of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate (“CME Term SOFR”), or a similarly accepted alternative rate. CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used.

 

31

 

 

Uncertainty about U.S. Presidential Administration initiatives could negatively impact our business, financial condition and results of operations.

 

The U.S. government periodically calls for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and difficult-to-quantify macroeconomic and political risks with potentially far-reaching implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current presidential administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.

 

There are significant potential conflicts of interest which could adversely impact our investment returns.

 

Our executive officers and directors, and the members of our Investment Adviser, serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do or of investment funds managed by our affiliates. Accordingly, they may have obligations to investors in those entities, the fulfillment of which might not be in the best interests of us or our stockholders. For example, Christian L. Oberbeck, our chief executive officer and managing member of our Investment Adviser, is the managing partner of Saratoga Partners, a middle-market private equity investment firm. In addition, the principals of our Investment Adviser may manage other funds which may from time to time have overlapping investment objectives with those of us and accordingly invest in, whether principally or secondarily, asset classes similar to those targeted by us. If this should occur, the principals of our Investment Adviser will face conflicts of interest in the allocation of investment opportunities to us and such other funds. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected in the event investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and Investment Adviser, and the members of our Investment Adviser.

 

Changes in laws or regulations governing our operations, or changes in the interpretation thereof, and any failure by us to comply with laws or regulations governing our operations may adversely affect our business.

 

We are subject to regulation at the local, state and federal level. New legislation may be enacted or new interpretations, rulings or regulations could be adopted, including those governing the types of investments we are permitted to make, any of which could harm us and our stockholders, potentially with retroactive effect. For example, the current U.S. presidential administration could support an enhanced regulatory agenda that imposes greater costs on all sectors and on financial services companies in particular. In addition, any change to the SBA’s current debenture program could have a significant impact on our ability to obtain low-cost leverage and, therefore, our competitive advantage over other funds.

 

Legal, tax and regulatory changes could occur that may adversely affect us. For example, from time to time the market for private equity transactions has been (and is currently being) adversely affected by a decrease in the availability of senior and subordinated financings for transactions, in part in response to credit market disruptions and/or regulatory pressures on providers of financing to reduce or eliminate their exposure to the risks involved in such transactions.

 

Additionally, any changes to the laws and regulations governing our operations related to permitted investments may cause us to alter our investment strategy in order to meet our investment objectives. Such changes could result in material differences to the strategies and plans set forth in this Annual Report and may shift our investment focus from the areas of expertise of our Investment Adviser to other types of investments in which our Investment Adviser may have little or no expertise or experience. Any such changes, if they occur, could have a material adverse effect on our results of operations and the value of your investment.

 

32

 

 

Legislative or other actions relating to taxes could have a negative effect on the Company.

 

Legislative or other actions relating to taxes could have a negative effect on the Company and its investors. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the IRS and the U.S. Treasury Department. We cannot predict with certainty how any changes in the tax laws might affect the Company, its investments or its investors. New legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could significantly and negatively affect the Company’s ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to the Company and its investors of such qualification or could have other adverse consequences. You are urged to consult with your tax advisor with respect to the impact of the status of any legislative, regulatory or administrative developments and proposals and their potential effect on your investment in our securities.

 

There is uncertainty surrounding potential legal, regulatory and policy changes by the current presidential administration and Congress in the United States that may directly affect financial institutions and the global economy.

 

Following the November 2022 elections in the United States, the Democratic Party controls the Presidency and the Senate, with the Republican Party controlling the House of Representatives. Despite political tensions and uncertainty in a divided legislature, changes in federal policy, including tax policies, and at regulatory agencies are expected to occur over time through policy and personnel changes, which may lead to changes involving the level of oversight and focus on the financial services industry or the tax rates paid by corporate entities. The nature, timing and economic and political effects of potential changes to the current legal and regulatory framework affecting financial institutions remain highly uncertain. Uncertainty surrounding future changes may adversely affect our operating environment and therefore our business, financial condition, results of operations and growth prospects.

 

Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us.

 

There has been ongoing discussion and commentary regarding potential significant changes to United States trade policies, treaties and tariffs. The current U.S. presidential administration, along with Congress, has created significant uncertainty about the future relationship between the United States and other countries with respect to the trade policies, treaties and tariffs. These developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade and, in particular, trade between the impacted nations and the United States. Any of these factors could depress economic activity and restrict our portfolio companies’ access to suppliers or customers and have a material adverse effect on their business, financial condition and results of operations, which in turn would negatively impact us.

 

We are dependent on information systems and systems failures could significantly disrupt our business, which may, in turn, negatively affect the market price of our common stock and our ability to pay dividends.

 

Our business is dependent on our and third parties’ communications and information systems. Any failure or interruption of those systems, including as a result of the termination of an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business. There could be:

 

  sudden electrical or telecommunications outages;

 

  natural disasters such as earthquakes, tornadoes and hurricanes;

 

33

 

 

  disease pandemics or other serious public health events, such as the ongoing COVID-19 pandemic;

 

  events arising from local or larger scale political or social matters, including terrorist acts;

 

  acts of war; and

 

  cyber-attacks.

 

These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our common stock and our ability to pay dividends to our stockholders.

 

Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited.

 

In 2020, the SEC adopted Rule 18f-4 under the 1940 Act, which relates to the use of derivatives and other transactions that create future payment or delivery obligations by BDCs (and other funds that are registered investment companies). Under Rule 18f-4, for which compliance was required beginning in August 2022, BDCs that use derivatives are subject to a value-at-risk (“VaR”) leverage limit, certain derivatives risk management program and testing requirements and requirements related to board reporting. These requirements apply unless the BDC qualifies as a “limited derivatives user,” as defined in Rule 18f-4. A BDC that enters into reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of Section 18, as modified by Section 61, of the 1940 Act when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivatives transactions under Rule 18f-4. In addition, under Rule 18f-4, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this requirement, it is required to treat the unfunded commitment as a derivatives transaction subject to the aforementioned requirements of Rule 18f-4. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts. However, if we fail to qualify as a limited derivatives user and become subject to the additional requirements under Rule 18f-4, compliance with such requirements may increase cost of doing business, which could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

 

Internal and external cyber threats, as well as other disasters, could impair our ability to conduct business effectively.

 

We, and others in our industry, are the targets of malicious cyber activity. A successful cyber-attach, whether perpetrated by criminal or state-sponsored actors, against us or our service providers, or an accidental disclosure of non-public information, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data, especially personal and other confidential information.

 

Saratoga Investment Advisors and third-party service providers with which we do business depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to unauthorized access, acquisition, use, alteration, or destruction, such as from the insertion of malware (including ransomware) physical and electronic break-ins or unauthorized tampering, unauthorized access, or system failures and disruptions of our computer systems, networks and date. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, personal and other information processed, stored in, and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, misappropriation of assets, loss of personal information, litigation, regulatory enforcement action and penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. We may have to make a significant investment to fix or replace any inoperable or compromised systems or to modify or enhance its cybersecurity controls, procedures and measures. Similarly, the public perception that we or our affiliates may have been the target of a cybersecurity threat, whether successful or not, also could have a material adverse effect on our reputation and lead to financial losses from loss of business, depending on the nature and severity of the threat.

 

34

 

 

If unauthorized parties gain access to such information and technology systems, they may be able to steal, publish, delete or modify private and sensitive information, including nonpublic personal information related to stockholders (and their beneficial owners) and material nonpublic information. The systems we have implemented to manage risks relating to these types of events could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified even with sophisticated prevention and detection systems, potentially resulting in further harm and preventing them from being addressed appropriately. The failure of these systems or of disaster recovery plans for any reason could cause significant interruptions in our and our investment advisor’s operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders, material nonpublic information and other sensitive information in our possession.

 

Third parties with which we do business are sources of cybersecurity or other technological risks. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. Cybersecurity failures or breaches to Saratoga Investment Advisors and other service providers (including, but not limited to, accountants, custodians, transfer agents and administrators), and the issuers of securities in which we invest, also have the ability to cause disruptions and impact business operations, potentially resulting in financial losses, interference with our ability to calculate its NAV, impediments to trading, the inability of our shareholders to transact business, violations of applicable privacy and other laws, regulatory fines, penalties, reputation damages, reimbursement of other compensation costs, or additional compliance costs. Our disaster recovery programs may not be sufficient to mitigate the harm that may result from such a disaster or disruption. In addition, insurance and other safeguards might only partially reimburse us for our losses, if at all. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, acquisitions, use, alteration or destruction of data, or other cybersecurity incidents that affects our data, resulting in increased costs and other consequences as described above. The Company does not control the cybersecurity measures put in place by such third parties, and such third parties could have limited indemnification obligations to the Company and its affiliates. If such a third party fails to adopt or adhere to adequate cybersecurity procedures, or if despite such procedures its networks or systems are breached, information relating to investor transactions and/or personal information of investors may be lost or improperly accessed, used or disclosed.

 

In addition, cybersecurity has become a top priority for regulators around the world. Privacy and information security laws and regulation changes, and compliance with those changes, may result in cost increases due to system changes and the development of new administrative processes. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks. We currently maintain insurance coverage relating to cybersecurity risks; however, we may be required to expend significant additional resources to modify our protective measures or to investigate and remediate vulnerabilities or other exposures, and we may be subject to litigation and financial losses that are not fully insured.

 

Cybersecurity risks and cyber incidents may adversely affect our business or the business of our portfolio companies by causing a disruption to our operations or the operations of our portfolio companies, a compromise or corruption of our confidential information or the confidential information of our portfolio companies and/or damage to our business relationships or the business relationships of our portfolio companies, all of which could negatively impact the business, financial condition and operating results of us or our portfolio companies.

 

A cybersecurity incident is considered to be an unauthorized occurrence, or a series of related unauthorized occurrences, on or conducted through a company’s information systems that jeopardizes the confidentiality, integrity, or availability of a company’s information systems or any information residing therein.. These incidents may be an intentional attack or an unintentional event and could involve gaining unauthorized access to our information systems or those of our portfolio companies or third-party vendors for purposes of misappropriating assets, stealing confidential information, corrupting data or causing operational disruption. Despite careful security and controls design, the information technology system of our portfolio companies and our third-party vendors, may be subject to security breaches and cyber-attacks the result of which could include disrupted operations, misstated or unreliable financial data, liability for stolen assets or information, increased cybersecurity protection and insurance costs, litigation and damage to business relationships. As our portfolio companies’ and our third party vendor’s reliance on technology has increased, so have the risks posed to our information systems, both internal and those provided by third-party service providers, and the information systems of our portfolio companies and third-party vendors. We have implemented processes, procedures and internal controls to help mitigate cybersecurity risks and cyber intrusions, but these measures, as well as our increased awareness of the nature and extent of a risk of a cyber-incident, do not guarantee that a cyber-incident will not occur and/or that our financial results, operations or confidential information will not be negatively impacted by such an incident.

 

35

 

 

Regulations governing our operation as a BDC will affect our ability to raise additional capital.

 

Our business requires a substantial amount of additional capital. We may acquire additional capital from the issuance of senior securities or other indebtedness or the issuance of additional shares of our common stock. However, we may not be able to raise additional capital in the future on favorable terms or at all. We may issue debt securities or preferred securities, which we refer to collectively as “senior securities,” and we may borrow money from banks or other financial institutions, up to the maximum amount permitted by the 1940 Act.

 

We are not generally able to issue and sell our common stock at a price below NAV per share. We may, however, sell our common stock, or issue warrants, options or rights to acquire our common stock, at a price below the current NAV of the common stock if our board of directors determines that such sale is in our best interests and the best interests of our stockholders, and the holders of a majority of our outstanding voting securities have approved such issuances within the prior year. In any such case, the price at which our securities are to be issued and sold may not be less than a price which, in the determination of our board of directors, closely approximates the market value of such securities (less any commission or discount). If our common stock trades at a discount to NAV, this restriction could adversely affect our ability to raise capital. We do not currently have stockholder approval of issuances below NAV.

 

Effective April 16, 2019, our asset coverage requirement was reduced from 200% to 150%, which may increase the risk of investing in the Company.

 

The 1940 Act generally prohibits BDCs from incurring indebtedness unless immediately after such borrowing we have an asset coverage for total borrowings of at least 200% (i.e., the amount of debt may not exceed 50% of the value of our assets). However, on March 23, 2018, the Small Business Credit Availability Act modified the 1940 Act by allowing a BDC to increase the maximum amount of leverage it may incur from an asset coverage ratio of 200% to an asset coverage ratio of 150%, if certain requirements are met. Under the 1940 Act, we were allowed to increase our leverage capacity once the majority of our independent directors approved an increase in our leverage capacity, with such approval becoming effective after one year. On April 16, 2018, our board of directors, including a majority of our independent directors, approved of our becoming subject to a minimum asset coverage ratio of 150% under the 1940 Act, which became effective on April 16, 2019. We are required to make certain disclosures on our website and in SEC filings regarding, among other things, the receipt of approval to increase our leverage, our leverage capacity and usage, and risks related to leverage.

 

We are generally permitted to incur indebtedness or issue senior securities in amounts such that our asset coverage, as defined in the 1940 Act, equals at least 150% after each issuance of senior securities. Compliance with these requirements may unfavorably limit our investment opportunities and reduce our ability in comparison to other companies to profit from favorable spreads between the rates at which we can borrow and the rates at which we can lend. As a BDC, therefore, we may need to issue equity more frequently than our privately-owned competitors, which may lead to greater stockholder dilution. With respect to stock that is a senior security, we must make provisions to prohibit any dividend distribution to our stockholders or the repurchase of certain of our securities, unless we meet the applicable asset coverage ratios at the time of the dividend distribution or repurchase. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to liquidate a portion of our investments and repay a portion of our indebtedness at a time when such sales may be disadvantageous in order to make dividend distributions or repurchase certain of our securities.

 

36

 

 

 

Leverage magnifies the potential for loss on investments in our indebtedness and on invested equity capital. As we use leverage to partially finance our investments, our stockholders will experience increased risks of investing in our securities. If the value of our assets increases, then leveraging would cause the NAV attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause NAV to decline more sharply than it otherwise would have had we not leveraged our business. Similarly, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to pay common stock dividends, scheduled debt payments or other payments related to our securities. Increased leverage may also cause a downgrade of our credit rating. Leverage is generally considered a speculative investment technique. See “Risk Factors—Risks Related to Our Business and Structure—We employ leverage, which magnifies the potential for gain or loss on amounts invested and may increase the risk of investing in us.”

 

The agreements governing our Encina Credit Facility and our Live Oak Credit Facility contain various covenants that, among other things, limit our discretion in operating our business and provide for certain minimum financial covenants.

 

The agreements governing the Encina Credit Facility and the Live Oak Credit Facility contain customary default provisions such as the termination or departure of certain “key persons” of Saratoga Investment Advisors, a material adverse change in our business and the failure to maintain certain minimum loan quality and performance standards. An event of default under the Encina Credit Facility or the Live Oak Credit Facility would result, among other things, in termination of the availability of further funds under the Encina Credit Facility or the Live Oak Credit Facility and an accelerated maturity date for all amounts outstanding under the Encina Credit Facility or the Live Oak Credit Facility, which would likely disrupt our business and, potentially, the portfolio companies whose loans we financed through the Encina Credit Facility or the Live Oak Credit Facility. This could reduce our revenues and, by delaying any cash payment allowed to us under the Encina Credit Facility or the Live Oak Credit Facility until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain our status as a RIC.

 

Each loan origination under the respective facility is subject to the satisfaction of certain conditions. We cannot assure you that we will be able to borrow funds under the Encina Credit Facility or Live Oak Credit Facility at any particular time or at all.

 

We will be subject to U.S. federal income tax imposed at corporate rates if we fail to qualify as a RIC.

 

We have elected to be treated, and intend to maintain our qualification annually as a RIC under Subchapter M of the Code; however, no assurance can be given that we will be able to maintain our RIC tax treatment. As a RIC, we are not subject to U.S. federal income tax on our income (including realized gains) that is timely distributed to our stockholders, provided that we satisfy certain source-of-income, annual distribution and asset–diversification requirements. While we are not subject to U.S. federal income tax on the income and gains we timely distribute to our stockholders, our stockholders will be required to include the amounts of such distributions in income and may be subject to U.S. federal income tax on such amounts.

 

The source-of-income requirement is satisfied if we derive at least 90% of our annual gross income from interest, dividends, payments with respect to certain securities loans, gains from the sale or other disposition of securities or options thereon or foreign currencies, or other income derived with respect to our business of investing in such securities or currencies, and net income from interests in “qualified publicly traded partnerships,” as defined in the Code.

 

The annual distribution requirement generally is satisfied if we timely distribute to our stockholders on an annual basis an amount equal to at least 90% of our ordinary net taxable income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, reduced by deductible expenses. We are subject to certain asset coverage ratio requirements under the 1940 Act and covenants under our borrowing agreements that could, under certain circumstances, restrict us from making the required distributions. In such case, if we are unable to obtain cash from other sources or are prohibited from making distributions, we may be subject to U.S. federal income tax at corporate rates.

 

37

 

 

The asset-diversification requirements will be satisfied if we diversify our holdings so that at the end of each quarter of the taxable year: (i) at least 50% of the value of our assets consists of cash, cash equivalents, U.S. government securities, securities of other regulated investment companies, and other securities if such other securities of any one issuer do not represent more than 5% of the value of our assets or more than 10% of the outstanding voting securities of the issuer; and (ii) no more than 25% of the value of our assets is invested in (a) the securities, other than U.S. government securities or securities of other regulated investment companies, of one issuer, (b) the securities, other than securities of other RICs, of two or more issuers that are controlled, as determined under applicable tax rules, by us and that are engaged in the same or similar or related trades or businesses or (c) the securities of one or more “qualified” publicly traded partnerships.

 

Failure to meet these tests may result in our having to (i) dispose of certain investments or (ii) raise additional capital to prevent the loss of our RIC qualification. Because most of our investments will be in private companies, any such dispositions could be made at disadvantageous prices and may result in substantial losses. If we raise additional capital to satisfy the asset- diversification requirements, it could take us time to invest such capital. During this period, we will invest the additional capital in temporary investments, such as cash and cash equivalents, which we expect will earn yields substantially lower than the interest income that we anticipate receiving in respect of investments in leveraged loans and mezzanine debt.

 

If we fail to qualify as a RIC for any reason, all of our taxable income will be subject to U.S. federal income tax at regular corporate rates. The resulting tax liability could substantially reduce our net assets, the amount of income available for distribution to our common stockholders or payment of our outstanding indebtedness including the Notes. Such a failure would have a material adverse effect on our results of operations and financial condition.

 

Because we intend to distribute between 90% and 100% of our income to our stockholders in connection with our election to be treated as a RIC, we will continue to need additional capital to finance our growth. If additional funds are unavailable or not available on favorable terms, our ability to grow will be impaired.

 

In order to qualify for the tax benefits available to RICs and to minimize U.S. federal income taxes at corporate rates, we intend to distribute to our stockholders between 90% and 100% of our annual taxable income and capital gains, except that we may retain certain net capital gains for investment and treat such amounts as deemed distributions to our stockholders. If we elect to treat any amounts as deemed distributions, we must pay U.S. federal income taxes at the corporate rate on such deemed distributions on behalf of our stockholders. As a result of these requirements, we will likely need to raise capital from other sources to grow our business. As a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which includes all of our borrowings and any outstanding preferred stock, of at least 150% as of April 16, 2019. These requirements limit the amount that we may borrow. Because we will continue to need capital to grow our investment portfolio, these limitations may prevent us from incurring debt and require us to raise additional equity at a time when it may be disadvantageous to do so.

 

While we expect to be able to borrow and to issue additional debt and equity securities, we cannot assure you that debt and equity financing will be available to us on favorable terms, or at all. Also, as a BDC, we generally are not permitted to issue equity securities priced below NAV without stockholder approval. If additional funds are not available to us, we could be forced to curtail or cease new investment activities, and our NAV and share price could decline.

 

We may have difficulty paying our required distributions if we recognize income before or without receiving cash in respect of such income.

 

For U.S. federal income tax purposes, we may be required to recognize taxable income in circumstances in which we do not receive a corresponding payment in cash. For example, we may on occasion hold debt obligations that are treated under applicable tax rules as having original issue discount (such as debt instruments with PIK or, in certain cases, increasing interest rates or issued with warrants) and we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. In addition, we may be required to accrue for U.S. federal income tax purposes amounts attributable to our investment in Saratoga CLO, a collateralized loan obligation fund, that may differ from the distributions paid in respect of our investment in the subordinated notes of such collateralized loan obligation fund because of the factors set forth above or because distributions on the subordinated notes are contractually required to be diverted for reinvestment or to pay down outstanding indebtedness.

 

38

 

 

Because original issue discount will be included in the Company’s “investment company taxable income” for the year of the accrual, we may be requested to make distributions to shareholders to satisfy the annual distribution requirement applicable to RICs, even where we have not received any corresponding cash amount. As a result, we may have difficulty meeting the annual distribution requirement necessary to maintain favorable tax treatment. If we are not able to obtain cash from other sources, and choose not to make a qualifying share distribution, we may become subject to U.S federal income tax at corporate rates. Additionally, because investments with a deferred payment feature may have the effect of deferring a portion of the borrower’s payment obligation until maturity of the debt investment, it may be difficult for us to identify and address developing problems with borrowers in terms of their ability to repay us.

 

We operate in a highly competitive market for investment opportunities.

 

A number of entities compete with us to make the types of investments that we make in private middle-market companies. We compete with other BDCs, public and private funds (including SBICs), commercial and investment banks, commercial financing companies, insurance companies, high-yield investors, hedge funds, and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than us. Some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments that could allow them to consider a wider variety of investments and establish more relationships than us. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. As a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we cannot assure you that we will be able to identify and make investments that meet our investment objective.

 

While we do not seek to compete primarily based on the interest rates we offer, we believe that some our competitors may make loans with interest rates that are comparable or lower than the rates we offer.

 

We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. If we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss. As a result of operating in such a competitive environment, we may make investments that are on better terms to our portfolio companies than we originally anticipated, which may impact our return on these investments.

 

We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.

 

We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. Although we seek to maintain a diversified portfolio in accordance with our business strategies, to the extent that we assume large positions in the securities of a small number of issuers, our NAV may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond our RIC asset-diversification requirements, we do not have fixed guidelines for diversification, and our investments could be concentrated in relatively few portfolio companies.

 

Our financial condition and results of operations depend on our ability to manage future investments effectively.

 

Our ability to achieve our investment objective depends on our ability to acquire suitable investments and monitor and administer those investments, which depends, in turn, on Saratoga Investment Advisors’ ability to identify, invest in and monitor companies that meet our investment criteria.

 

39

 

 

Accomplishing this result on a cost-effective basis is largely a function of Saratoga Investment Advisors’ structuring of the investment process and its ability to provide competent, attentive and efficient service to us. Our executive officers and the officers and employees of Saratoga Investment Advisors have substantial responsibilities in connection with their roles at Saratoga Partners as well as responsibilities under the Management Agreement. They may also be called upon to provide managerial assistance to our portfolio companies. These demands on their time, which will increase as the number of investments grow, may distract them or slow the rate of investment. In order to grow, Saratoga Investment Advisors may need to hire, train, supervise and manage new employees. However, we cannot assure you that any such employees will contribute beneficially to the work of Saratoga Investment Advisors. Any failure to manage our future growth effectively could have a material adverse effect on our business and financial condition.

 

We may experience fluctuations in our quarterly and annual results.

 

We could experience fluctuations in our quarterly operating results due to a number of factors, including the interest rate payable on the debt investments we make, the default rate on such investments, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, changes in our portfolio composition, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. In addition, any of these factors could negatively impact our ability to achieve our investment objectives, which may cause the NAV of our common stock to decline.

 

Terrorist attacks, acts of war, or natural disasters may affect any market for our common stock, impact the businesses in which we invest and harm our business, operating results and financial condition.

 

Portfolio investments may be affected by force majeure events (i.e., events beyond the control of the party claiming that the event has occurred, including, without limitation, acts of God, fire, flood, earthquakes, war, terrorism and labor strikes). Some force majeure events may adversely affect the ability of a party (including a portfolio company or a counterparty to us or a portfolio company) to perform its obligations until it is able to remedy the force majeure event. In addition, the cost to a portfolio company of repairing or replacing damaged assets resulting from such force majeure event could be considerable. Additionally, a major governmental intervention into industry, including the nationalization of an industry or the assertion of control over one or more companies or its assets, could result in a loss to us, including if its investment in such issuer is cancelled, unwound or acquired (which could be without what we consider to be adequate compensation). To the extent we are exposed to investments in portfolio companies that as a group are exposed to such force majeure events, the risks and potential losses to us are enhanced.

 

The continued threat of global terrorism and the impact of military and other action will likely continue to cause volatility in the economies of certain countries, contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide and various aspects thereof, including in prices of commodities. Our portfolio investments may involve significant strategic assets having a national or regional profile. The nature of these assets could expose them to a greater risk of being the subject of a terrorist attack than other assets or businesses. Acts of war could similarly lead to such volatility. For example, in response to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. In addition, the recent outbreak of hostilities in the Middle East and escalating tensions in the region may create volatility and disruption of global markets. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on our business, financial condition, cash flows, and results of operations, and could cause the market value of our common stock to decline.

 

Substantially all of our portfolio investments are recorded at fair value as determined in good faith by our board of directors; such valuations are inherently uncertain and may be materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

 

Substantially all of our portfolio is, and we expect will continue to be, comprised of investments that are not publicly traded. The value of investments that are not publicly traded may not be readily determinable. We value these investments quarterly at fair value as determined in good faith by our board of directors. Saratoga Investment Advisors may utilize the services of an independent valuation firm to aid it in determining fair value of investments for which market quotations are not readily available. The types of factors that may be considered in valuing our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, market yield trend analysis, comparison to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private investments and private companies are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our NAV could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

 

40

 

 

Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval, the effects of which may be adverse.

 

Our board of directors has the authority to modify or waive our current investment objective, operating policies and strategies without prior notice and without stockholder approval. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, financial condition, and value of our common stock. However, the effects might be adverse, which could negatively impact our ability to pay dividends and cause you to lose all or part of your investment.

 

Any failure to comply with SBA regulations could have an adverse effect on our operations.

 

Our wholly owned subsidiaries, SBIC II LP and SBIC III LP, received an SBIC license from the SBA on August 14, 2019 and September 29, 2022, respectively.

 

The SBA places certain limitations on the financing terms of investments by SBICs in portfolio companies and prohibits SBICs from providing funds for certain purposes or to businesses in a few prohibited industries. Compliance with SBIC requirements may cause our SBIC subsidiaries to forego attractive investment opportunities that are not permitted under SBA regulations.

 

Further, SBA regulations require that an SBIC be periodically examined and audited by the SBA to determine its compliance with the relevant SBA regulations. The SBA prohibits, without prior SBA approval, a “change of control” of an SBIC or transfers that would result in any person (or a group of persons acting in concert) owning 10% or more of a class of capital stock of an SBIC. If our SBIC Subsidiaries fail to comply with applicable SBA regulations, the SBA could, depending on the severity of the violation, limit or prohibit its use of debentures, declare outstanding debentures immediately due and payable, and/or limit it from making new investments. In addition, the SBA can revoke or suspend a license for willful or repeated violation of, or willful or repeated failure to observe, any provision of the Small Business Investment Act of 1958 or any rule or regulation promulgated thereunder. These actions by the SBA would, in turn, negatively affect us because our SBIC Subsidiaries are our wholly owned subsidiaries. Any failure to comply with SBA regulations may hinder our ability to take advantage of our SBIC subsidiaries’ access to SBA-guaranteed debentures, which could have an adverse effect on our operations.

 

RISKS RELATED TO THE CURRENT ENVIRONMENT

 

Global economic, political and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.

 

The current worldwide financial market situation, as well as various social and political tensions in the United States and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may contribute to increased market volatility, may have long-term effects on the U.S. and worldwide financial markets, and may cause economic uncertainties or deterioration in the United States and worldwide.

 

On January 31, 2020, the United Kingdom ended its membership in the European Union, referred to as “Brexit.” Following the termination of a transition period, the United Kingdom and the European Union entered into a trade and cooperation agreement to govern the future relationship between the parties, which was provisionally applied as of January 1, 2021 and entered into force on May 1, 2021 following ratification by the European Union. With respect to financial services, the agreement leaves decisions on equivalence and adequacy to be determined by each of the United Kingdom and the European Union unilaterally in due course. Such agreement is untested and could lead to ongoing political and economic uncertainty and periods of exacerbated volatility in both the United Kingdom and in wider European and global markets for some time. In addition, on December 24, 2020, the European Union and United Kingdom governments signed a trade deal that became provisionally effective on January 1, 2021 and that now governs the relationship between the United Kingdom and the European Union (the “Trade Agreement”). The Trade Agreement implements significant regulation around trade, transport of goods and travel restrictions between the United Kingdom and the European Union.

 

41

 

 

Notwithstanding the foregoing, the longer term economic, legal, political and social implications of Brexit are unclear at this stage and are likely to continue to lead to ongoing political and economic uncertainty and periods of increased volatility in both the United Kingdom and in wider European markets for some time. In particular, Brexit could lead to calls for similar referendums in other European Union jurisdictions, which could cause increased economic volatility in the European and global markets. This mid- to long-term uncertainty could have adverse effects on the economy generally and on our ability to earn attractive returns. In particular, currency volatility could mean that our returns are adversely affected by market movements and could make it more difficult, or more expensive, for us to execute prudent currency hedging policies.

 

We are currently operating in a period of significant market disruption and economic uncertainty, which may have a negative impact on our business, financial condition and results of operations. An extended disruption in the capital markets and the credit markets could negatively affect our business.

 

From time to time, capital markets may experience periods of disruption and instability. The U.S. capital markets have experienced extreme volatility and disruption following the global outbreak of COVID-19 that began in December 2019, the conflict between Russia and Ukraine that began in late February 2022, and the ongoing war in the Middle East (see “Terrorist attacks, acts of war, or natural disasters may affect any market for our common stock, impact the businesses in which we invest and harm our business, operating results and financial condition” for more information). Even after the COVID-19 pandemic subsided, the U.S. economy, as well as most other major economies, have continued to experience unpredictable economic conditions, and we anticipate our businesses would be materially and adversely affected by any prolonged economic downturn or recession in the United States and other major markets. In addition, disruptions in the capital markets have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets. These types of events have adversely affected and could continue to adversely affect operating results for us and for our portfolio companies.

 

The current economic conditions have resulted in an adverse impact on the ability of lenders to originate loans, the volume and type of loans originated, the ability of borrowers to make payments and the volume and type of amendments and waivers granted to borrowers and remedial actions taken in the event of a borrower default, each of which could negatively impact the amount and quality of loans available for investment by the Company and returns to the Company, among other things. The U.S. credit markets (in particular for middle-market loans) have experienced the following among other things: (i) increased draws by borrowers on revolving lines of credit and other financing instruments; (ii) increased requests by borrowers for amendments and waivers of their credit agreements to avoid default, increased defaults by such borrowers and/or increased difficulty in obtaining refinancing at the maturity dates of their loans and increased uses of PIK features; and (iii) greater volatility in pricing and spreads and difficulty in valuing loans during periods of increased volatility, and liquidity issues.

 

With respect to loans to portfolio companies, the Company will be impacted if, among other things, (i) amendments and waivers are granted (or are required to be granted) to borrowers permitting deferral of loan payments or allowing for PIK interest payments, (ii) borrowers default on their loans, are unable to refinance their loans at maturity, or go out of business, or (iii) the value of loans held by the Company decreases as a result of such events and the uncertainty they cause. Portfolio companies may also be more likely to seek to draw on unfunded commitments we have made, and the risk of being unable to fund such commitments is heightened during such periods. Depending on the duration and extent of the disruption to the business operations of our portfolio companies, we expect some portfolio companies, particularly those in vulnerable industries, to experience financial distress and possibly to default on their financial obligations to us and/or their other capital providers. In addition, if such portfolio companies are subjected to prolonged and severe financial distress, we expect some of them to substantially curtail their operations, defer capital expenditures, and lay off workers. These developments would be likely to permanently impair their businesses and result in a reduction in the value of our investments in them.

 

42

 

 

These conditions and future market disruptions and/or illiquidity could have an adverse effect on our (and our portfolio companies’) business, financial condition, results of operations and cash flows. Ongoing unfavorable economic conditions may increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to our portfolio companies and/or us. These events have limited and could continue to limit our investment originations, limit our ability to grow and have a material negative impact on our operating results and the fair values of our debt and equity investments. We may have to access, if available, alternative markets for debt and equity capital, and a severe disruption in the global financial markets, deterioration in credit and financing conditions, continued increases in interest rates, or uncertainty regarding U.S. government spending and deficit levels or other global economic conditions could have a material adverse effect on our business, financial condition and results of operations.

 

While we intend to continue to source and invest in new loan transactions to U.S. middle-market companies, we cannot be certain that we will be able to do so successfully or consistently. A lack of suitable investment opportunities may impair our ability to make new investments, and may negatively impact our earnings and result in decreased dividends to our shareholders.

 

If current economic conditions continue for an extended period of time, loan delinquencies, loan non-accruals, problem assets, and bankruptcies may increase. In addition, collateral for our loans may decline in value, which could cause loan losses to increase and the net worth and liquidity of loan guarantors could decline, impairing their ability to honor commitments to us. An increase in loan delinquencies and non-accruals or a decrease in loan collateral and guarantor net worth could result in increased costs and reduced income which would have a material adverse effect on our business, financial condition or results of operations. We continue to observe supply chain interruptions, labor difficulties, commodity inflation and elements of economic and financial market instability both globally and in the United States.

 

We will need to raise additional capital in the future in order to continue to make investments in accordance with our business and investing strategy and to pursue new business opportunities. Ongoing disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition.

 

We cannot be certain as to the duration or magnitude of the ongoing economic conditions in the markets in which we and our portfolio companies operate and corresponding declines in economic activity that may negatively impact the U.S. economy and the markets for the various types of goods and services provided by U.S. middle-market companies. Depending on the duration, magnitude and severity of these conditions and their related economic and market impacts, certain of our portfolio companies may suffer declines in earnings and could experience financial distress, which could cause them to default on their financial obligations to us and their other lenders.

 

We will also be negatively affected if our operations and effectiveness or the operations and effectiveness of a portfolio company (or any of the key personnel or service providers of the foregoing) is compromised or if necessary or beneficial systems and processes are disrupted. In consideration of these and related factors, we may downgrade our internal ratings with respect to other portfolio companies in the future as conditions warrant and new information becomes available.

 

Inflation may adversely affect the business, results of operations and financial condition of our portfolio companies, which may, in turn, impact the valuation of such portfolio companies.

 

Certain of our portfolio companies may be impacted by inflation, which may, in turn, impact the valuation of such portfolio companies. If such portfolio companies are unable to pass any increases in their costs along to their customers, it could adversely affect their results and their ability to pay interest and principal on our loans, particularly if interest rates rise in response to inflation. In addition, any projected future decreases in our portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future unrealized losses and therefore reduce our net assets resulting from operations.

 

43

 

 

Further downgrades of the U.S. credit rating, automatic spending cuts, or another government shutdown could negatively impact our liquidity, financial condition and earnings.

 

U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns, or a recession in the United States. U.S. lawmakers have passed legislation to raise the federal debt ceiling on multiple occasions, including, most recently, in June 2023, which suspended the debt ceiling through early 2025 unless Congress takes legislative action to further extend or defer it. Despite taking action to suspend the debt ceiling, ratings agencies have threatened to lower the long-term sovereign credit rating on the United States, including Fitch downgrading the U.S. government’s long-term rating from AAA to AA+ in August 2023 and Moody’s lowering the U.S. government’s credit rating outlook from “stable” to “negative” in November 2023.

 

The impact of the increased debt ceiling and/or downgrades to the U.S. government’s sovereign credit rating or its perceived creditworthiness could adversely affect the U.S. and global financial markets and economic conditions. Absent further quantitative easing by the Federal Reserve, these developments could cause interest rates and borrowing costs to rise, which may negatively impact our ability to access the debt markets on favorable terms. In addition, disagreement over the federal budget has caused the U.S. federal government to shut down for periods of time, and may lead to additional shutdowns in the future. Continued adverse political and economic conditions could have a material adverse effect on our business, financial condition and results of operations.

 

Economic recessions or downturns could impair the ability of our portfolio companies to repay loans and harm our operating results.

 

Many of our portfolio companies are susceptible to economic slowdowns or recessions, including as a result of, among other things, the COVID-19 pandemic, elevated levels of inflation, and a rising interest rate environment, and may be unable to repay our loans during these periods. Therefore, any non-performing assets are likely to increase, and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions also may decrease the value of any collateral securing some of our loans and the value of our equity investments and could lead to financial losses in our portfolio and a corresponding decrease in revenues, net income and assets. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events could prevent us from increasing our investments and harm our operating results.

 

A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of its loans and foreclosure on its assets, which could trigger cross-defaults under other agreements and jeopardize our portfolio company’s ability to meet its obligations under the debt securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company. It is possible that we could become subject to a lender liability claim, including as a result of actions taken if we or Saratoga Investment Advisors renders significant managerial assistance to the borrower. Furthermore, if one of our portfolio companies were to file for bankruptcy protection, even though we may have structured our investment as senior secured debt, depending on the facts and circumstances, including the extent to which we or Saratoga Investment Advisors provided managerial assistance to that portfolio company or otherwise exercise control over it, a bankruptcy court might re-characterize our debt as a form of equity and subordinate all or a portion of our claim to claims of other creditors.

 

RISKS RELATED TO OUR ADVISER AND ITS AFFILIATES

 

We may be obligated to pay Saratoga Investment Advisors incentive fees even if we incur a net loss, or there is a decline in the value of our portfolio.

 

Saratoga Investment Advisors is entitled to incentive fees for each fiscal quarter in an amount equal to a percentage of the excess of our investment income for that quarter (before deducting incentive compensation, but net of operating expenses and certain other items) above a threshold return for that quarter. Our pre-incentive fee net investment income, for incentive compensation purposes, excludes realized and unrealized capital gains or losses that we may incur in the fiscal quarter, even if such capital gains or losses result in a net gain or loss on our consolidated statements of operations for that quarter. Thus, we may be required to pay Saratoga Investment Advisors incentive fees for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter.

 

44

 

 

Under the terms of the Management Agreement, we may have to pay incentive fees to Saratoga Investment Advisors in connection with the sale of an investment that is sold at a price higher than the fair value of such investment on May 31, 2010, even if we incur a loss on the sale of such investment.

 

Incentive fees on capital gains paid to Saratoga Investment Advisors under the Management Agreement equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of any previously paid capital gain incentive fee. Under the Management Agreement, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and Saratoga Investment Advisors will be entitled to 20.0% of the incentive fee capital gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date. See our Form 10-Q for the quarter ended May 31, 2010 that was filed with the SEC on July 15, 2010 for the fair value and other information related to our investments as of such date. As a result, we may be required to pay incentive fees to Saratoga Investment Advisors on the sale of an investment even if we incur a realized loss on such investment, so long as the investment is sold for an amount greater than its fair value as of May 31, 2010.

 

The way in which the base management and incentive fees under the Management Agreement is determined may encourage Saratoga Investment Advisors to take actions that may not be in our best interests.

 

The incentive fee payable by us to our Investment Adviser may create an incentive for it to make investments on our behalf that are risky or more speculative than would be the case in the absence of such compensation arrangement, which could result in higher investment losses, particularly during cyclical economic downturns. The way in which the incentive fee payable to our Investment Adviser is determined, which is calculated separately in two components as a percentage of the income (subject to a hurdle rate) and as a percentage of the realized gain on invested capital, may encourage our Investment Adviser to use leverage to increase the return on our investments or otherwise manipulate our income so as to recognize income in quarters where the hurdle rate is exceeded.

 

Moreover, we pay Saratoga Investment Advisors a base management fee based on our total assets, including any investments made with borrowings, which may create an incentive for it to cause us to incur more leverage than is prudent, or not to repay our outstanding indebtedness when it may be advantageous for us to do so, in order to maximize its compensation. Under certain circumstances, the use of leverage may increase the likelihood of default, which would disfavor the holders of our securities.

 

The incentive fee payable by us to our Investment Adviser also may create an incentive for our Investment Adviser to invest on our behalf in instruments that have a deferred interest feature. Under these investments, we would accrue the interest over the life of the investment but would not receive the cash income from the investment until the end of the investment’s term, if at all. Our net investment income used to calculate the income portion of our incentive fee, however, includes accrued interest. Thus, a portion of the incentive fee would be based on income that we have not yet received in cash and may never receive in cash if the portfolio company is unable to satisfy such interest payment obligation to us. Consequently, while we may make incentive fee payments on income accruals that we may not collect in the future and with respect to which we do not have a “claw back” right against our Investment Adviser per se, the amount of accrued income written off in any period will reduce the income in the period in which such write-off was taken and may thereby reduce such period’s incentive fee payment.

 

In addition, Saratoga Investment Advisors receives a quarterly income incentive fee based, in part, on our pre-incentive fee net investment income, if any, for the immediately preceding calendar quarter. This income incentive fee is subject to a fixed quarterly hurdle rate before providing an income incentive fee return to Saratoga Investment Advisors. This fixed hurdle rate was determined when then current interest rates were relatively low on a historical basis. Thus, if interest rates rise, it would become easier for our investment income to exceed the hurdle rate and, as a result, more likely that Saratoga Investment Advisors will receive an income incentive fee than if interest rates on our investments remained constant or decreased. However, if we repurchase our outstanding debt securities, including the Notes, and such repurchase results in our recording a net gain or loss on the extinguishment of debt for financial reporting and tax purposes, such net gain or loss will not be included in our pre-incentive fee net investment income for purposes of determining the income incentive fee payable to our Investment Adviser under the Management Agreement. Moreover, our Investment Adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike the portion of the incentive fee based on income, there is no performance threshold applicable to the portion of the incentive fee based on net capital gains. As a result, our Investment Adviser may have a tendency to invest more in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns.

 

45

 

 

Our board of directors will seek to ensure that Saratoga Investment Advisors is acting in our best interests and that any conflict of interest faced by Saratoga Investment Advisors in its capacity as our Investment Adviser does not negatively impact us.

 

The base management fee we pay to Saratoga Investment Advisors may induce it to influence our leverage, which may be contrary to our interest.

 

We pay Saratoga Investment Advisors a quarterly base management fee based on the value of our total assets (including any assets acquired with leverage). Accordingly, Saratoga Investment Advisors has an economic incentive to increase our leverage. Our board of directors monitors the conflicts presented by this compensation structure by approving the amount of leverage that we incur. If our leverage is increased, we will be exposed to increased risk of loss, bear the increase cost of issuing and servicing such senior indebtedness, and will be subject to any additional covenant restrictions imposed on us in an indenture or other instrument or by the applicable lender.

 

Saratoga Investment Advisors’ liability is limited under the Management Agreement and we will indemnify Saratoga Investment Advisors against certain liabilities, which may lead it to act in a riskier manner on our behalf than it would when acting for its own account.

 

Saratoga Investment Advisors has not assumed any responsibility to us other than to render the services described in the Management Agreement. Pursuant to the Management Agreement, Saratoga Investment Advisors and its officers and employees are not liable to us for their acts under the Management Agreement absent willful misfeasance, bad faith, gross negligence or reckless disregard in the performance of their duties. We have agreed to indemnify, defend and protect Saratoga Investment Advisors and its officers and employees with respect to all damages, liabilities, costs and expenses resulting from acts of Saratoga Investment Advisors not arising out of willful misfeasance, bad faith, gross negligence or reckless disregard in the performance of their duties under the Management Agreement. These protections may lead Saratoga Investment Advisors to act in a riskier manner when acting on our behalf than it would when acting for its own account.

 

Our ability to enter into transactions with our affiliates is restricted.

 

Because we have elected to be treated as a BDC, we are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates without the prior approval of our independent directors and, in some cases, the SEC. Any person that owns, directly or indirectly, 5.0% or more of our outstanding voting securities is our affiliate for purposes of the 1940 Act and we are generally prohibited from buying or selling any securities (other than any security of which we are the issuer) from or to such affiliate, absent the prior approval of our independent directors. The 1940 Act also prohibits certain “joint” transactions with certain of our affiliates, which could include investments in the same portfolio company, without prior approval of our independent directors and, in some cases, the SEC. If a person acquires more than 25.0% of our voting securities, we are prohibited from buying or selling any security (other than any security of which we are the issuer) from or to such person or certain of that person’s affiliates, or entering into prohibited joint transactions with such person, absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers, directors or Investment Adviser or their affiliates. We rely on the Order granted to us, Saratoga Investment Advisors and certain of its affiliates by the SEC that permits us to participate in negotiated co-investment transactions with certain other funds and accounts managed and controlled by Saratoga Investment Advisors or a control affiliate thereof, subject to the satisfaction of certain conditions. These restrictions may limit the scope of investment opportunities that would otherwise be available to us and there can be no assurance that we will be able to participate in all investment opportunities that are suitable to us.

 

46

 

 

RISKS RELATED TO OUR INVESTMENTS

 

If we make unsecured debt investments, we may lack adequate protection in the event our portfolio companies become distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event our portfolio companies default on their indebtedness.

 

We make unsecured debt investments in portfolio companies. Unsecured debt investments are unsecured and junior to other indebtedness of the portfolio company. As a consequence, the holder of an unsecured debt investment may lack adequate protection in the event the portfolio company becomes distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event the portfolio company defaults on its indebtedness. In addition, unsecured debt investments of middle-market companies are often highly illiquid and in adverse market conditions may experience steep declines in valuation even if they are fully performing.

 

If we invest in the securities and other obligations of distressed or bankrupt companies, such investments may be subject to significant risks, including lack of income, extraordinary expenses, uncertainty with respect to satisfaction of debt, lower-than expected investment values or income potentials and resale restrictions.

 

We are authorized to invest in the securities and other obligations of distressed or bankrupt companies. At times, distressed debt obligations may not produce income and may require us to bear certain extraordinary expenses (including legal, accounting, valuation and transaction expenses) in order to protect and recover our investment. Therefore, to the extent we invest in distressed debt, our ability to achieve current income may be diminished which may affect our ability to make distributions on our common stock or make interest and principal payments of the Notes.

 

We also will be subject to significant uncertainty as to when and in what manner and for what value the distressed debt we invest in will eventually be satisfied (e.g., through a liquidation of the obligor’s assets, an exchange offer or plan of reorganization involving the distressed debt securities or a payment of some amount in satisfaction of the obligation). In addition, even if an exchange offer is made or plan of reorganization is adopted with respect to distressed debt held by us, there can be no assurance that the securities or other assets received by us in connection with such exchange offer or plan of reorganization will not have a lower value or income potential than may have been anticipated when the investment was made.

 

Moreover, any securities received by us upon completion of an exchange offer or plan of reorganization may be restricted as to resale. As a result of our participation in negotiations with respect to any exchange offer or plan of reorganization with respect to an issuer of distressed debt, we may be restricted from disposing of such securities if we are in possession of material non-public information relating to the issuer.

 

Second priority liens on collateral securing loans that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.

 

Certain loans that we make to portfolio companies will be secured on a second priority basis by the same collateral securing senior secured debt of such companies. The first priority liens on the collateral will secure the portfolio company’s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the loans. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the loan obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the loan obligations secured by the second priority liens, then we, to the extent not repaid from the proceeds of the sale of the collateral, will only have an unsecured claim against the company’s remaining assets, if any.

 

The rights we may have with respect to the collateral securing the loans we make to our portfolio companies with senior debt outstanding may also be limited pursuant to the terms of one or more intercreditor agreements that we enter into with the holders of senior debt. Under such an intercreditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken with respect to the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.

 

47

 

 

A majority of our debt investments are not required to make principal payments until the maturity of such debt securities and are generally riskier than other types of loans.

 

As of February 29, 2024, 77.8% of our debt portfolio consisted of “interest-only” loans, which are structured such that the borrower makes only interest payments throughout the life of the loan and makes a large, “balloon payment” at the end of the loan term. The ability of a borrower to make or refinance a balloon payment may be affected by a number of factors, including the financial condition of the borrower, prevailing economic conditions, interest rates, and collateral values. If the interest-only loan borrower is unable to make or refinance a balloon payment, we may experience greater losses than if the loan were structured as amortizing.

 

We may be exposed to higher risks with respect to our investments that include PIK interest, particularly our investments in interest-only loans.

 

To the extent our portfolio investments permit PIK interest and our portfolio companies elect to pay PIK interest, we will be exposed to higher risks, including the following:

 

  because PIK interest results in an increase in the size of the loan balance of the underlying loan, our exposure to potential loss increases when we receive PIK interest;

 

  PIK instruments may have higher yields, which reflect the payment deferral and credit risk associated with these instruments;

 

  PIK accruals may create uncertainty about the source of our distributions to stockholders;

 

  PIK instruments may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of the collateral.

 

To the extent our investments are structured as interest-only loans, PIK interest will increase the size of the balloon payment due at the end of the loan term. PIK interest payments on such loans may increase the probability and magnitude of a loss on our investment, particularly with respect to our interest-only loans. As of February 29, 2024, 19.7% of our interest-only loans provided for contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loan’s term, and 49.6% of such investments elected to pay a portion of interest due in PIK. As of February 29, 2024, 2.3% of the Company’s interest-only loans are loans that pay contractual PIK interest only.

 

The lack of liquidity in our investments may adversely affect our business.

 

We primarily make investments in private companies. A portion of these securities may be subject to legal and other restrictions on resale, transfer, pledge or other disposition or will otherwise be less liquid than publicly traded securities. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. In addition, we may face other restrictions on our ability to liquidate an investment in a business entity to the extent that we or our Investment Adviser has or could be deemed to have material non-public information regarding such business entity.

 

We may not have the funds to make additional investments in our portfolio companies which could impair the value of our portfolio.

 

After our initial investment in a portfolio company, we may be called upon from time to time to provide additional funds to such company or have the opportunity to increase our investment through the exercise of a warrant to purchase common stock. There is no assurance that we will make, or will have sufficient funds to make, follow-on investments. Any decisions not to make a follow-on investment or any inability on our part to make such an investment may have a negative impact on a portfolio company in need of such an investment, may result in a missed opportunity for us to increase our participation in a successful operation or may reduce the expected yield on the investment. Even if we have sufficient capital to make a desired follow-on investment, we may elect not to make a follow-on investment because we may not want to increase our level of risk, because we prefer other opportunities or because we are inhibited by compliance with BDC requirements, SBA regulations or the desire to maintain our RIC tax treatment. Our ability to make follow-on investments may also be limited by our Investment Adviser allocation policy.

 

48

 

 

The debt securities in which we invest are subject to credit risk and prepayment risk.

 

An issuer of a debt security may be unable to make interest payments and repay principal. We could lose money if the issuer of a debt obligation is, or is perceived to be, unable or unwilling to make timely principal and/or interest payments, or to otherwise honor its obligations. Substantially all of the debt investments held in our portfolio hold a non-investment grade rating by one or more rating agencies or, if not rated, would be rated below investment grade if they were rated, which are often referred to as “junk.”

 

Certain debt instruments may contain call or redemption provisions which would allow the issuer thereof to prepay principal prior to the debt instrument’s stated maturity. This is known as prepayment risk. Prepayment risk is greater during a falling interest rate environment as issuers can reduce their cost of capital by refinancing higher interest debt instruments with lower interest debt instruments. An issuer may also elect to refinance their debt instruments with lower interest debt instruments if the credit standing of the issuer improves. To the extent debt securities in our portfolio are called or redeemed, we may receive less than we paid for such security and we may be forced to reinvest in lower yielding securities or debt securities of issuers of lower credit quality.

 

Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of subordinated notes representing the lowest-rated securities issued by a pool of predominantly senior secured first lien term loans and is subject to additional risks and volatility. All losses in the pool of loans will be borne by our subordinated notes and only after the value of our subordinated notes is reduced to zero will the higher-rated notes issued by the pool bear any losses.

 

At February 29, 2024, our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of $9.5 million and constituted 0.8% of our portfolio. This investment constitutes a first loss position in a portfolio that, as of February 29, 2024, was composed of $640.8 million in aggregate principal amount of primarily senior secured first lien term loans and $12.1 million in uninvested cash. In addition, as of February 29, 2024, we also own $9.4 million in aggregate principal of the F-2-R-3 Notes with a fair value of $8.9 million in the Saratoga CLO, that only rank senior to the subordinated notes. A first loss position means that we will suffer the first economic losses if the value of Saratoga CLO decreases. First loss positions typically carry a higher risk and earn a higher yield. Interest payments generated from this portfolio will be used to pay the administrative expenses of Saratoga CLO and interest on the debt issued by Saratoga CLO before paying a return on the subordinated notes.

 

Principal payments will be similarly applied to pay administrative expenses of Saratoga CLO and for reinvestment or repayment of Saratoga CLO debt before paying a return on, or repayment of, the subordinated notes. In addition, 80.0% of our fixed management fee and 100.0% our incentive management fee for acting as the collateral manager of Saratoga CLO is subordinated to the payment of interest and principal on Saratoga CLO debt. Any losses on the portfolio will accordingly reduce the cash flow available to pay these management fees and provide a return on, or repayment of, our investment. Depending on the amount and timing of such losses, we may experience smaller than expected returns and, potentially, the loss of our entire investment.

 

As the manager of the portfolio of Saratoga CLO, we will have some ability to direct the composition of the portfolio, but our discretion is limited by the terms of the debt issued by Saratoga CLO which may limit our ability to make investments that we feel are in the best interests of the subordinated notes, and the availability of suitable investments. The performance of Saratoga CLO’s portfolio is also subject to many of the same risks sets forth in this Annual Report with respect to portfolio investments in leveraged loans.

 

In the event that a bankruptcy court orders the substantive consolidation of us with Saratoga CLO, the creditors of Saratoga CLO, including the holders of $640.8 million aggregate principal amount of debt, as of February 29, 2024 issued by Saratoga CLO, would have claims against the consolidated bankruptcy estate, which would include our assets.

 

We believe that we have observed and will observe certain formalities and operating procedures that are generally recognized requirements for maintaining our separate existence and that our assets and liabilities can be readily identified as distinct from those of Saratoga CLO. However, we cannot assure you that a bankruptcy court would agree in the event that we or Saratoga CLO became a debtor in connection with a bankruptcy proceeding. If a bankruptcy court concludes that substantive consolidation of us with Saratoga CLO is warranted, the creditors of Saratoga CLO would have claims against the consolidated bankruptcy estate.

 

49

 

 

Substantive consolidation means that our assets are placed in a single bankruptcy estate with those of Saratoga CLO, rather than kept separate, and that the creditors of Saratoga CLO have a claim against that single estate (including our assets), as opposed to retaining their claims against only Saratoga CLO.

 

Our investments in Saratoga CLO have a different risk profile than would direct investments made by us, including less information available and fewer rights regarding repayment compared to companies we invest in directly as well as complicated accounting and tax implications.

 

Due to our investments in the Saratoga CLO being primarily broadly syndicated loans, there may be less information available to us on those companies as compared to most investments that we make directly. For example, we will typically have fewer rights relating to how such companies manage their cash flow to repay debt, the inclusion of protective covenants, default penalties, lien protection, change of control provisions and board observation rights in deal terms, and our general ability to oversee the company’s operations. Our investment in Saratoga CLO is also subject to the risk of leverage associated with the debt issued by Saratoga CLO and the repayment priority of senior debt holders in Saratoga CLO.

 

The accounting and tax implications of such investments are complicated. In particular, reported earnings from the equity tranche investment of Saratoga CLO are recorded according to U.S. GAAP based upon an effective yield calculation. Current taxable earnings on these investments, however, will generally not be determinable until after the end of the fiscal year of Saratoga CLO that ends within the Company’s fiscal year, even though the investment is generating cash flow. In general, the U.S. federal income tax treatment of investment in Saratoga CLO may result in higher distributable earnings in the early years and a capital loss at maturity, while for reporting purposes the totality of cash flows are reflected in a constant yield to maturity.

 

The senior loan portfolio of Saratoga CLO may be concentrated in a limited number of industries or borrowers, which may subject Saratoga CLO, and in turn us, to a risk of significant loss if there is a downturn in a particular industry in which Saratoga CLO is concentrated.

 

Saratoga CLO has senior loan portfolios that may be concentrated in a limited number of industries or borrowers. A downturn in any particular industry or borrower in which Saratoga CLO is heavily invested may subject Saratoga CLO, and in turn us, to a risk of significant loss and could significantly impact the aggregate returns we realize. If an industry in which Saratoga CLO is heavily invested suffers from adverse business or economic conditions, a material portion of our investment in Saratoga CLO could be affected adversely, which, in turn, could adversely affect our financial position and results of operations. For example, as of February 29, 2024, Saratoga CLO’s investments in the banking, finance, insurance & real estate industry represented approximately 19.0% of the fair value of Saratoga CLO’s portfolio. Companies in the banking, finance, insurance & real estate industry are subject to general economic downturns and business cycles and will often suffer reduced revenues and rate pressures during periods of economic uncertainty. In addition, investments in business service represented approximately 10.8% of the fair value of Saratoga CLO’s portfolio. Changes in healthcare or other laws and regulations applicable to the businesses of some of the companies in which Saratoga CLO invests may occur that could increase their compliance and other costs of doing business, require significant systems enhancements, or render their products or services less profitable or obsolete, any of which could have a material adverse effect on their results of operations. There has also been an increased political and regulatory focus on healthcare laws in recent years, and new legislation could have a material effect on the business and operations of companies in which Saratoga CLO invests.

 

Failure by Saratoga CLO to satisfy certain debt compliance ratios may entitle senior debtholders to additional payments, which may harm our operating results by reducing payments we would otherwise be entitled to receive from Saratoga CLO.

 

The failure by Saratoga CLO to satisfy certain debt compliance ratios, specifically those with respect to adequate collateralization and/or interest coverage tests, could lead to a reduction in its payments to us. In the event that Saratoga CLO failed these certain tests, senior debt holders may be entitled to additional payments that would, in turn, reduce the payments we would otherwise be entitled to receive. Separately, we may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with Saratoga CLO or any other investment we may make. If any of these occur, it could materially and adversely affect our operating results and cash flows.

 

50

 

 

Downgrades by rating agencies of broadly syndicated loans could adversely impact the financial performance of Saratoga CLO and its ability to pay equity distributions in the future.

 

Ratings agencies have undergone reviews of CLO tranches and their broadly syndicated loans in light of the COVID-19 pandemic’s adverse impact on the economic market. Such reviews have, in some cases, resulted in downgrades of broadly syndicated loans. Such downgrades of broadly syndicated loans, as well as downgrades of broadly syndicated loans in the future, could adversely impact the financial performance of Saratoga CLO, thereby limiting Saratoga CLO’s ability to pay equity distributions and subordinated management fees to the Company in the future. The full extent of downgrades by ratings agencies of broadly syndicated loans is currently unknown, thereby resulting in a high degree of uncertainty with respect to Saratoga CLO’s financial performance and ability to pay equity distributions and subordinated management fees to the Company in the future.

 

We may invest through joint ventures, partnerships or other special purpose vehicles and our investments through these vehicles may entail greater risks, or risks that we otherwise would not incur, if we otherwise made such investments directly.

 

We may make indirect investments in portfolio companies through joint ventures, partnerships or other special purpose vehicles, including SLF JV. In general, the risks associated with indirect investments in portfolio companies through a joint venture, partnership or other special purpose vehicle are similar to those associated with a direct investment in a portfolio company. While we intend to analyze the credit and business of a potential portfolio company in determining whether to make an investment in an investment vehicle, we will nonetheless be exposed to the creditworthiness of the investment vehicle. In the event of a bankruptcy proceeding against the portfolio company, the assets of the portfolio company may be used to satisfy its obligations prior to the satisfaction of our investment in the investment vehicle (i.e., our investment in the investment vehicle could be structurally subordinated to the other obligations of the portfolio company). In addition, if we are to invest in an investment vehicle, we may be required to rely on our partners in the investment vehicle when making decisions regarding such investment vehicle’s investments, accordingly, the value of the investment could be adversely affected if our interests diverge from those of our partners in the investment vehicle.

 

Available information about privately held companies is limited.

 

We invest primarily in privately-held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of our Investment Adviser’s investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. These companies and their financial information are not subject to the Sarbanes-Oxley Act of 2002 and other rules that govern public companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments.

 

When we are a debt or minority equity investor in a portfolio company, we may not be in a position to control the entity, and its management may make decisions that could decrease the value of our investment.

 

We make both debt and minority equity investments; therefore, we are subject to the risk that a portfolio company may make business decisions with which we disagree, and the stockholders and management of such company may take risks or otherwise act in ways that do not serve our interests. As a result, a portfolio company may make decisions that could decrease the value of our portfolio holdings.

 

51

 

 

Our portfolio companies may incur debt or issue equity securities that rank equally with, or senior to, our investments in such companies.

 

Our portfolio companies usually will have, or may be permitted to incur, other debt, or issue other equity securities that rank equally with, or senior to, our investments. By their terms, such instruments may provide that the holders are entitled to receive payment of dividends, interest or principal on or before the dates on which we are entitled to receive payments in respect of our investments. These debt instruments will usually prohibit the portfolio companies from paying interest on or repaying our investments in the event and during the continuance of a default under such debt. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of securities ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such holders, the portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debtor ranking equally with our investments, we would have to share on an equal basis any distributions with other holders in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.

 

There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.

 

If one of our portfolio companies were to go bankrupt, even though we may have structured our interest as senior debt, depending on the facts and circumstances, including the extent to which we actually provided managerial assistance to that portfolio company, a bankruptcy court might re-characterize our debt holding and subordinate all or a portion of our claim to that of other creditors. In addition, lenders can be subject to lender liability claims for actions taken by them where they become too involved in the borrower’s business or exercise control over the borrower. It is possible that we could become subject to a lender’s liability claim, including as a result of actions taken if we actually render significant managerial assistance.

 

Investments in equity securities involve a substantial degree of risk.

 

We purchase common stock and other equity securities. Although equity securities have historically generated higher average total returns than fixed-income securities over the long-term, equity securities also have experienced significantly more volatility in those returns and in recent years have significantly underperformed relative to fixed-income securities. The equity securities we acquire may fail to appreciate and may decline in value or become worthless and our ability to recover our investment will depend on our portfolio company’s success. Investments in equity securities involve a number of significant risks, including:

 

  any equity investment we make in a portfolio company could be subject to further dilution as a result of the issuance of additional equity interests and to serious risks as a junior security that will be subordinate to all indebtedness or senior securities in the event that the issuer is unable to meet its obligations or becomes subject to a bankruptcy process;

 

  to the extent that the portfolio company requires additional capital and is unable to obtain it, we may not recover our investment in equity securities; and

 

  in some cases, equity securities in which we invest will not pay current dividends, and our ability to realize a return on our investment, as well as to recover our investment, will be dependent on the success of our portfolio companies. Even if the portfolio companies are successful, our ability to realize the value of our investment may be dependent on the occurrence of a liquidity event, such as a public offering or the sale of the portfolio company. It is likely to take a significant amount of time before a liquidity event occurs or we can sell our equity investments. In addition, the equity securities we receive or invest in may be subject to restrictions on resale during periods in which it could be advantageous to sell.

 

There are special risks associated with investing in preferred securities, including:

 

  preferred securities may include provisions that permit the issuer, at its discretion, to defer distributions for a stated period without any adverse consequences to the issuer. If we own a preferred security that is deferring its distributions, we may be required to report income for U.S. federal income tax purposes even though we have not received any cash payments in respect of such income;

 

  preferred securities are subordinated with respect to corporate income and liquidation payments, and are therefore subject to greater risk than debt;

 

52

 

 

  preferred securities may be substantially less liquid than many other securities, such as common securities or U.S. government securities; and

 

  preferred security holders generally have no voting rights with respect to the issuing company, subject to limited exceptions.

 

Our investments in foreign debt, including that of emerging market issuers, may involve significant risks in addition to the risks inherent in U.S. investments.

 

Although there are limitations on our ability to invest in foreign debt, we may, from time to time, invest in debt of foreign companies, including the debt of emerging market issuers. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility.

 

Investments in the debt of emerging market issuers may subject us to additional risks such as inflation, wage and price controls, and the imposition of trade barriers. Furthermore, economic conditions in emerging market countries are, to some extent, influenced by economic and securities market conditions in other emerging market countries. Although economic conditions are different in each country, investors’ reaction to developments in one country can have effects on the debt of issuers in other countries.

 

Although most of our investments will be U.S. dollar-denominated, our investments that are denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments.

 

We may employ hedging techniques to minimize these risks, but we cannot assure you that we will fully hedge against these risks or that such strategies will be effective. As a result, a change in currency exchange rates may adversely affect our profitability.

 

We may expose ourselves to risks if we engage in hedging transactions.

 

We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Use of these hedging instruments may expose us to counter-party credit risk. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the portfolio positions should increase. Moreover, it may not be possible to hedge against an exchange rate or interest rate fluctuation that is generally anticipated at an acceptable price.

 

The success of our hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates.

 

Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rates or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities denominated in non-U.S. currencies because the value of those securities is likely to fluctuate as a result of factors not entirely related to currency fluctuations. To the extent we engage in hedging transactions, we also face the risk that counterparties to the derivative instruments we hold may default, which may expose us to unexpected losses from positions where we believed that our risk had been appropriately hedged.

 

53

 

 

Our investments may be risky, and you could lose all or part of your investment.

 

Substantially all of our debt investments hold a non-investment grade rating by one or more rating agencies (which non-investment grade debt is commonly referred to as “high yield” and “junk” debt) or, where not rated by any rating agency, would be below investment grade or “junk”, if rated. A below investment grade or “junk” rating means that, in the rating agency’s view, there is an increased risk that the obligor on such debt will be unable to pay interest and repay principal on its debt in full. We also invest in debt that defers or pays PIK interest. To the extent interest payments associated with such debt are deferred, such debt will be subject to greater fluctuations in value based on changes in interest rates, such debt could produce taxable income without a corresponding cash payment to us, and since we generally do not receive any cash prior to maturity of the debt, the investment will be of greater risk.

 

In addition, private middle-market companies in which we invest are exposed to a number of significant risks, including:

 

  limited financial resources and an inability to meet their obligations, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment;

 

  shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;

 

  dependence on the management talents and efforts of a small group of persons; the death, disability, resignation or termination of one or more of which could have a material adverse impact on the company and, in turn, on us;

 

  less predictable operating results and, possibly, substantial additional capital requirements to support their operations, finance expansion or maintain their competitive position; and

 

  difficulty accessing the capital markets to meet future capital needs.

 

In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies.

 

Our portfolio may continue to be concentrated in a limited number of industries, which may subject us to a risk of significant loss if there is a downturn in a particular industry in which a number of our investments are concentrated.

 

Our portfolio may continue to be concentrated in a limited number of industries. A downturn in any particular industry in which we are invested could significantly impact the aggregate returns we realize.

 

As of February 29, 2024, our investments in the Healthcare Software industry represented approximately 10.6% of the fair value of our portfolio and our investments in the IT Services industry represented approximately 6.9% of the fair value of our portfolio. In addition, we may from time to time invest a relatively significant percentage of our portfolio in industries we do not necessarily target. If an industry in which we have significant investments suffers from adverse business or economic conditions, as these industries have to varying degrees, a material portion of our investment portfolio could be affected adversely, which, in turn, could adversely affect our financial position and results of operations.

 

54

 

 

A number of our portfolio companies are in the Software-as-a-Service industry and such companies are subject to additional risks that are unique to that industry, and the financial results of our portfolio companies in the Software-as-a-Service industry could materially adversely affect our financial results.

 

A number of our portfolio companies are in the Software-as-a-Service (“SAAS”) industry and such companies are subject to additional risks that are unique to the SAAS industry. For example, such portfolio companies may be subject to consumer protection laws that are enforced by regulators such as the Federal Trade Commission (“FTC”) and private parties, and include statutes that regulate the collection and use of information for marketing purposes. Any new legislation or regulations regarding the Internet, mobile devices, software sales or export and/or the cloud or SAAS industry, and/or the application of existing laws and regulations to the Internet, mobile devices, software sales or export and/or the cloud or SAAS industry, could create new legal or regulatory burdens on our portfolio companies that could have a material adverse effect on their respective operations. In addition, our SAAS portfolio companies may incur significant operating losses and negative cash flows during certain times of their respective life cycles, resulting in an adverse impact on their operations and on their ability to repay their debt. Because our SAAS portfolio companies are generally investments that are underwritten and valued on “recurring revenue” rather than EBITDA, the fair value determinations of such companies are inherently uncertain and may fluctuate over short periods of time. They are also subject to the risks that their customers have financial difficulties that make them unable or unwilling to pay for the software and services that drive a portfolio company’s recurring revenue projections. There is often less collateral securing our loans to these companies as compared to our other portfolio companies, which could impair our ability to be repaid if the portfolio companies default on their obligations or otherwise encounter financial difficulties. For these reasons, our financial results could be materially adversely affected if our portfolio companies in the SAAS industry encounter financial difficulty and fail to repay their obligations. As of February 29, 2024, our current total investments in SAAS companies were $664.7 million, or 58.4% of total investments.

 

If our primary investments are deemed not to be qualifying assets, we could be precluded from investing in our desired manner or deemed to be in violation of the 1940 Act.

 

In order to maintain our status as a BDC, we may not acquire any assets other than “qualifying assets” unless, at the time of and after giving effect to such acquisition, at least 70.0% of our total assets are qualifying assets. We believe that most of the investments that we may acquire in the future will constitute qualifying assets. However, we may be precluded from investing in what we believe are attractive investments if such investments are not qualifying assets for purposes of the 1940 Act. If we do not invest a sufficient portion of our assets in qualifying assets, we could violate the 1940 Act provisions applicable to BDCs and be precluded from making follow-on investments in existing portfolio companies (which could result in the dilution of our position) or required to dispose of investments at inappropriate times in order to come into compliance with the 1940 Act. If we need to dispose of such investments quickly, it could be difficult to dispose of such investments on favorable terms. We may not be able to find a buyer for such investments and, even if we do find a buyer, we may have to sell the investments at a substantial loss. Any such outcomes would have a material adverse effect on our business, financial condition, results of operations and cash flows. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. If we do not maintain our status as a BDC, we would be subject to regulation as a registered closed-end investment company under the 1940 Act. As a registered closed-end investment company, we would be subject to substantially more regulatory restrictions under the 1940 Act, which would significantly decrease our operating flexibility.

 

RISKS RELATED TO OUR COMMON STOCK

 

Investing in our common stock may involve an above average degree of risk.

 

The investments we make in accordance with our investment objective may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive, and therefore, an investment in our common stock may not be suitable for someone with lower risk tolerance.

 

55

 

 

We may choose to pay dividends in our own stock, in which case you may be required to pay tax in excess of the cash you receive.

 

We have in the past, and may in the future, distribute taxable dividends that are payable to our stockholders in part through the issuance of shares of our common stock. For example, on October 30, 2013, our board of directors declared a dividend of $2.65 per share to shareholders payable in cash or shares of our common stock. Under certain applicable provisions of the Code and the Treasury regulations and a revenue procedure issued by the IRS, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC, subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. If too many stockholders elect to receive their distributions in cash, we must allocate the cash available for distribution among the shareholders electing to receive cash (with the balance of the distribution paid in shares of our common stock). If we qualify as a publicly offered RIC and we decide to make any distributions consistent with this revenue procedure that are payable in part in our stock, taxable stockholders receiving such dividends will be required to include the full amount of the dividend (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain dividend) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. The value of the shares received by a stockholder is treated as income for U.S. federal income tax purposes. A U.S. stockholder may have income from such a dividend in excess of the amount of cash received, and thus may be required to obtain cash from other sources to pay any applicable U.S. federal income tax. If a U.S. stockholder sells the stock it receives as a dividend in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the dividend, depending on the market price of our stock at the time of the sale.

 

Furthermore, with respect to non-U.S. stockholders, we may be required to withhold U.S. tax with respect to such dividends, including in respect of all or a portion of such dividend that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on dividends, it may put downward pressure on the trading price of our stock.

 

Due to the current market conditions, we may defer our dividends and choose to incur U.S. federal excise tax in order preserve cash and maintain flexibility.

 

As a BDC, we are not required to make any distributions to shareholders other than in connection with our election to be treated a RIC for U.S. federal income tax purposes as under Subchapter M of the Code. In order to maintain our tax treatment as a RIC, we generally must distribute to shareholders for each taxable year at least 90% of our investment company taxable income (i.e., net ordinary income plus realized net short-term capital gains in excess of realized net long-term capital losses). If we qualify for taxation as a RIC, we generally will not be subject to U.S. federal income tax on our investment company taxable income and net capital gains (i.e., realized net long- term capital gains in excess of realized net short-term capital losses) that we timely distribute to shareholders. We will be subject to U.S. federal income tax on our investment company taxable income and net capital gains that we do not timely distribute to shareholders. In addition, we will be subject to a nondeductible 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98% of our net ordinary income for the calendar year, (ii) 98.2% of our capital gain net income for the one-year period ending on October 31 of the calendar year, and (iii) any net ordinary income and capital gain net income that we recognized for preceding years, but were not distributed during such years, and on which we paid no U.S. federal income tax.

 

Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current calendar year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to shareholders of record in the current year, the dividend will be treated for all U.S. federal tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as “spillover dividends,” that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for U.S. federal income tax at corporate rates. Under these spillover dividend procedures, because our taxable year ends on February 28 or 29, we may defer distribution of income earned during the current taxable year until February of the following taxable year. For example, we may defer distributions of income earned during the year ended February 29, 2024 until as late as February 28, 2025. If we choose to carry-over this distribution of income in the form of a spillover dividend, we will incur the 4% U.S. federal excise tax on some or all of the distribution.

 

Due to current market conditions (as described herein) it is possible that we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer our dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillover dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock. (see “We may choose to pay dividends in our own stock, in which case you may be required to pay tax in excess of the cash you receive” for more information).

 

56

 

 

The market price of our common stock may fluctuate significantly.

 

The market price and liquidity of the market for our common stock may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include, but are not limited to:

 

  significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies;

 

  changes in regulatory policies, accounting pronouncements or tax guidelines, particularly with respect to RICs, BDCs or SBICs;

 

  failure to qualify for RIC tax treatment;

 

  changes in the value of our portfolio of investments;

 

  any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;

 

  departure of any of Saratoga Investment Advisors’ key personnel;

 

  operating performance of companies comparable to us;

 

  general economic trends and other external factors; or

 

  loss of a major funding source.

 

Our business and operation could be negatively affected if we become subject to any securities litigation or shareholder activism, which could cause us to incur significant expense, hinder execution of investment strategy and impact our stock price.

 

In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been brought against that company. Shareholder activism, which could take many forms or arise in a variety of situations, has been increasing in the BDC space recently. While we are currently not subject to any securities litigation or shareholder activism, due to the potential volatility of our stock price and for a variety of other reasons, we may in the future become the target of securities litigation or shareholder activism. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert management’s and our board of directors’ attention and resources from our business.

 

Additionally, such securities litigation and shareholder activism could give rise to perceived uncertainties as to our future, adversely affect our relationships with service providers and make it more difficult to attract and retain qualified personnel. Also, we may be required to incur significant legal fees and other expenses related to any securities litigation and activist shareholder matters. Further, our stock price could be subject to significant fluctuation or otherwise be adversely affected by the events, risks and uncertainties of any securities litigation and shareholder activism.

 

There is a risk that you may not receive distributions or that our distributions may not grow over time.

 

As a BDC for 1940 Act purposes and a RIC for U.S. federal income tax purposes, we intend to make distributions out of assets legally available for distribution to our stockholders once such distributions are authorized by our board of directors and declared by us. We cannot assure you that we will achieve investment results that will allow us to make a specified level of cash distributions or periodically increase our dividend rate. In addition, due to the asset coverage test that is applicable to us as a BDC, and provisions contained in the agreements governing our borrowings, we may be limited in our ability to make distributions. Further, if we invest a greater amount of assets in equity securities that do not pay current dividends, it could reduce the amount available for distribution.

 

57

 

 

Provisions of our governing documents and the Maryland General Corporation Law could deter future takeover attempts and have an adverse impact on the price of our common stock.

 

We are governed by our charter and bylaws, which we refer to as our “governing documents.”

 

Our governing documents and the Maryland General Corporation Law contain provisions that may have the effect of delaying, deferring or preventing a future transaction or change in control of us that might involve a premium price for our stockholders or otherwise be in their best interest.

 

Our charter provides for the classification of our board of directors into three classes of directors, serving staggered three-year terms, which may render a change of control of us or removal of our incumbent management more difficult. Furthermore, any and all vacancies on our board of directors will be filled generally only by the affirmative vote of a majority of the remaining directors in office, even if the remaining directors do not constitute a quorum, and any director elected to fill a vacancy will serve for the remainder of the full term until a successor is elected and qualifies.

 

Our board of directors is authorized to create and issue new series of shares, to classify or reclassify any unissued shares of stock into one or more classes or series, including preferred stock and, without stockholder approval, to amend our charter to increase or decrease the number of shares of stock that we have authority to issue, which could have the effect of diluting a stockholder’s ownership interest. Prior to the issuance of shares of stock of each class or series, including any reclassified series, our board of directors is required by our governing documents to set the terms, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications and terms or conditions of redemption for each class or series of shares of stock.

 

Our governing documents also provide that our board of directors has the exclusive power to adopt, alter or repeal any provision of our bylaws, and to make new bylaws. The Maryland General Corporation Law also contains certain provisions that may limit the ability of a third party to acquire control of us, such as:

 

  the Maryland Business Combination Act, which, subject to certain limitations, prohibits certain business combinations between us and an “interested stockholder” (defined generally as any person who beneficially owns 10% or more of the voting power of the common stock or an affiliate thereof) for five years after the most recent date on which the stockholder becomes an interested stockholder and, thereafter, imposes special minimum price provisions and special stockholder voting requirements on these combinations; and

 

  the Maryland Control Share Acquisition Act, which provides that “control shares” of a Maryland corporation (defined as shares of common stock which, when aggregated with other shares of common stock controlled by the stockholder, entitles the stockholder to exercise one of three increasing ranges of voting power in electing directors) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of “control shares”) have no voting rights except to the extent approved by stockholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares of common stock.

 

In addition, the provisions of the Maryland Business Combination Act will not apply, however, if our board of directors adopts a resolution that any business combination between us and any other person will be exempt from the provisions of the Maryland Business Combination Act. Although our board of directors has adopted such a resolution, there can be no assurance that this resolution will not be altered or repealed in whole or in part at any time. If the resolution is altered or repealed, the provisions of the Maryland Business Combination Act may discourage others from trying to acquire control of us.

 

As permitted by Maryland law, our bylaws contain a provision exempting from the Maryland Control Share Acquisition Act any and all acquisitions by any person of our common stock. Although our bylaws include such a provision, such a provision may also be amended or eliminated by our board of directors at any time in the future, subject to obtaining confirmation from the SEC that it does not object to us being subject to the Maryland Control Share Acquisition Act.

 

Our common stock may trade at a discount to our NAV per share.

 

Common stock of BDCs, as closed-end investment companies, frequently trade at a discount to NAV. Our common stock has traded at a discount to our NAV since shortly after our initial public offering. The risk that our common stock may continue to trade at a discount to our NAV is separate and distinct from the risk that our NAV per share may decline.

 

58

 

 

Stockholders may incur dilution if we sell shares of our common stock in one or more offerings at prices below the then current NAV per share of our common stock.

 

The 1940 Act prohibits us from selling shares of our common stock at a price below the current NAV per share of such stock, with certain exceptions. One such exception is prior stockholder approval of issuances below NAV provided that our board of directors makes certain determinations. We do not currently have stockholder approval of issuances below NAV.

 

If we were to sell shares of our common stock below NAV per share, such sales would result in an immediate dilution to the NAV per share. This dilution would occur as a result of the sale of shares at a price below the then current NAV per share of our common stock and a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance.

 

Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.

 

The issuance of subscription rights, warrants or convertible debt that are exchangeable for our common stock, will cause your economic interest and voting power in us to be diluted as a result of our offering of any such securities.

 

Stockholders who do not fully exercise rights, warrants or convertible debt issued to them in any offering of subscription rights, warrants or convertible debt to purchase our common stock should expect that they will, at the completion of the offering, own a smaller proportional economic interest and have diminished voting power in us than would otherwise be the case if they fully exercised their rights, warrants or convertible debt. We cannot state precisely the amount of any such dilution in share ownership or voting power because we do not know what proportion of the common stock would be purchased as a result of any such offering.

 

In addition, if the subscription price, warrant price or convertible debt price is less than our NAV per share of common stock at the time of such offering, then our stockholders would experience an immediate dilution of the aggregate NAV of their shares as a result of the offering. The amount of any such decrease in NAV is not predictable because it is not known at this time what the subscription price, warrant price, convertible debt price or NAV per share will be on the expiration date of such offering or what proportion of our common stock will be purchased as a result of any such offering. The risk of dilution is greater if there are multiple rights offerings. However, our board of directors will make a good faith determination that any offering of subscription rights, warrants or convertible debt would result in a net benefit to existing stockholders.

 

Finally, our common stockholders will bear all costs and expenses incurred by us in connection with any proposed offering of subscription rights, warrants or convertible debt that are exchangeable for our common stock, whether or not such offering is actually completed by us.

 

RISKS RELATED TO OUR NOTES

 

The Notes are unsecured and therefore are effectively subordinated to any existing and future secured indebtedness, including indebtedness under our Encina Credit Facility and our Live Oak Credit Facility.

 

The Notes are not secured by any of our assets or any of the assets of any of our subsidiaries, including our wholly owned subsidiaries. As a result, the Notes are effectively subordinated to any existing and future secured indebtedness we or our subsidiaries have outstanding (including our Encina Credit Facility and our Live Oak Credit Facility) or that we or our subsidiaries may incur in the future (or any indebtedness that is initially unsecured as to which we have granted or subsequently grant a security interest) to the extent of the value of the assets securing such indebtedness, including, without limitation, borrowings under our Encina Credit Facility and our Live Oak Credit Facility. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our secured indebtedness or secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the Notes. As of February 29, 2024, there was $35.0 million outstanding borrowings under the Encina Credit Facility and we had the ability to borrow up to $65.0 million under the Encina Credit Facility, subject to certain conditions. The Encina Credit Facility and the Live Oak Credit Facility is secured by substantially all of the assets of SIF II and SIF III, respectively, wholly owned subsidiaries.

 

59

 

 

The Notes are structurally subordinated to the indebtedness and other liabilities of our subsidiaries.

 

The Notes are obligations exclusively of Saratoga Investment Corp., and not of any of our subsidiaries. None of our subsidiaries is a guarantor of the Notes and the Notes are not required to be guaranteed by any subsidiary we may acquire or create in the future. Any assets of our subsidiaries are not directly available to satisfy the claims of our creditors, including holders of the Notes. Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors of our subsidiaries will have priority over our equity interests in such entities (and therefore the claims of our creditors, including holders of the Notes) with respect to the assets of such entities. Even if we are recognized as a creditor of one or more of these entities, our claims would still be effectively subordinated to any security interests in the assets of any such entity and to any indebtedness or other liabilities of any such entity senior to our claims. Consequently, the Notes are structurally subordinated to all indebtedness and other liabilities of any of our existing or future indebtedness of our subsidiaries, including the SBA-guaranteed debentures. These entities may incur substantial indebtedness in the future, all of which would be structurally senior to the Notes. As of February 29, 2024, we had $214.0 million in SBA-guaranteed debentures outstanding. The indebtedness under the SBA-guaranteed debentures is structurally senior to the Notes.

 

The indenture under which the Notes are issued contains limited protection for holders of the Notes.

 

The indenture under which the Notes are issued offers limited protection to holders of the Notes.

 

The terms of the indenture and the Notes do not restrict our or any of our subsidiaries’ ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have a material adverse impact on your investment in the Notes. In particular, the terms of the indenture and the Notes do not place any restrictions on our or our subsidiaries’ ability to:

 

  issue securities or otherwise incur additional indebtedness or other obligations, including (1) any indebtedness or other obligations that would be equal in right of payment to the Notes, (2) any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the Notes to the extent of the values of the assets securing such debt, (3) indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore is structurally senior to the Notes and (4) securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to the Notes with respect to the assets of these entities, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section 18(a)(1)(A) as modified by Section 61(a)(2) of the 1940 Act or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act), but giving effect, in each case, to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from incurring additional borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 150% after such borrowings;

 

  sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);

 

  enter into transactions with affiliates;

 

  create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;

 

  make investments; or

 

  create restrictions on the payment of dividends or other amounts to us from our subsidiaries.

 

Furthermore, the terms of the indenture and the Notes do not protect holders of the Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, if any, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow, or liquidity.

 

60

 

 

Our ability to recapitalize, incur additional debt (including additional debt that matures prior to the maturity of the Notes), and take a number of other actions that are not limited by the terms of the Notes may have important consequences for you as a holder of the Notes, including making it more difficult for us to satisfy our obligations with respect to the Notes or negatively affecting the market value of the Notes.

 

Other debt we issue or incur in the future could contain more protections for its holders than the indenture and the Notes, including additional covenants and events of default. For example, the indenture under which the Notes is issued do not contain cross-default provisions that are contained in the agreement relating to the Encina Credit Facility and the Live Oak Credit Facility. The issuance or incurrence of any such debt with incremental protections could affect the market for, trading levels and prices of the Notes.

 

We may not be able to repurchase the 4.375% 2026 Notes and the 4.35% 2027 Notes upon a Change of Control Repurchase Event.

 

Upon a Change of Control Repurchase Event (as defined in the relevant indenture), holders of the 4.375% 2026 Notes and the 4.35% 2027 Notes may require us to repurchase for cash some or all of the 4.375% 2026 Notes and the 4.35% 2027 Notes, respectively, at a repurchase price equal to 100% of the aggregate principal amount of the 4.375% 2026 Notes and the 4.35% 2027 Notes, respectively, being repurchased, plus their respective accrued and unpaid interest to, but not including, the repurchase date. We may not be able to repurchase the 4.375% 2026 Notes and the 4.35% 2027 Notes upon a Change of Control Repurchase Event because we may not have sufficient funds. Our and our subsidiaries’ future financing facilities may contain similar restrictions and provisions. Our failure to purchase such tendered 4.375% 2026 Notes and the 4.35% 2027 Notes upon the occurrence of such Change of Control Repurchase Event would cause an event of default under the respective indenture governing the 4.375% 2026 Notes and the 4.35% 2027 Notes, respectively, which may result in the acceleration of such indebtedness requiring us to repay that indebtedness immediately. If the holders of the 4.375% 2026 Notes and the 4.35% 2027 Notes exercise their respective right to require us to repurchase the 4.375% 2026 Notes and the 4.35% 2027 Notes, respectively, upon a Change of Control Repurchase Event, the financial effect of any such repurchase could cause a default under our current and future debt instruments, even if the Change of Control Repurchase Event itself would not cause a default. If a Change of Control Repurchase Event were to occur, we may not have sufficient funds to repay any such accelerated indebtedness.

 

An active trading market for the Public Notes may not develop or be sustained, which could limit the market price of the Public Notes or the ability to sell them.

 

Although each of the 6.00% 2027 Notes, 8.00% 2027 Notes, 8.125% 2027 Notes, and 8.50% 2028 Notes are listed on the NYSE under the symbol “SAT”, “SAJ”, “SAY”, and “SAZ”, respectively, we cannot provide any assurances that an active trading market will develop or be maintained for the Public Notes or that the Public Notes will be able to be sold. At various times, the Public Notes may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. Accordingly, we cannot provide any assurance that a liquid trading market will develop for the Public Notes, or that the Public Notes will be able to be sold at a particular time or at a favorable price. To the extent an active trading market does not develop, the liquidity and trading price for the Public Notes may be harmed. At the same time, the trading market for the Public Notes may also be very volatile, and many of the risk factors related to our common stock and outlined above in “Risks Related to Our Common Stock” could also be applicable to the Public Notes.

 

Terms relating to redemption may materially adversely affect the return on our Notes.

 

Subject to their terms, we may redeem the Notes from time to time, especially when prevailing interest rates are lower than the rate borne by the Notes. If prevailing rates are lower at the time of redemption, you would not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the interest rate on the Notes being redeemed. Our redemption right also may adversely impact your ability to sell the Notes as the optional redemption date or period approaches.

 

61

 

 

The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option.   The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The 8.50% 2028 Notes mature on April 15, 2028 and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at our option.

 

The 4.375% 2026 Notes are redeemable, in whole or in part, at any time at our option prior to November 28. 2025, at par plus a “make-whole” premium, and thereafter at par. The 4.35% 2027 Notes are redeemable, in whole or in part, at any time at our option prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par.

 

The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at our option, at par plus a “make-whole” premium, and thereafter at par. The 7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option, subject to a fee depending on the date of repayment, at par plus a “make-whole” premium, and thereafter at par.  The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at our option, on or after December 29, 2024, at par plus a “make-whole” premium, and thereafter at par.

 

If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the Notes.

 

Any default under the agreements governing our indebtedness, including a default under the Encina Credit Facility or the Live Oak Credit Facility, indenture governing each of the Notes or other indebtedness to which we may be a party that is not waived by the required lenders or the holders, and the remedies sought by the lenders or the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the Notes and substantially decrease the market value of the Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, as applicable, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness (including the Encina Credit Facility, the Live Oak Credit Facility and the Notes). In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lenders under the Encina Credit Facility, the Live Oak Credit Facility, or other debt we may incur in the future could elect to terminate their commitment, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. In addition, any such default may constitute a default under the Notes, which could further limit our ability to repay our debt, including the Notes.

 

Our ability to generate sufficient cash flow in the future is, to some extent, subject to general economic, financial, competitive, legislative and regulatory factors as well as other factors that are beyond our control. We cannot assure you that our business will generate cash flow from operations, or that future borrowings will be available to us under the Encina Credit Facility, the Live Oak Credit Facility, or otherwise, in an amount sufficient to enable us to meet our payment obligations under the Notes, the Encina Credit Facility, and the Live Oak Credit Facility, and to fund other liquidity needs.

 

If our operating performance declines and we are not able to generate sufficient cash flow to service our debt obligations, we may, in the future, need to refinance or restructure our debt, including any Notes sold, sell assets, reduce or delay capital investments, seek to raise additional capital or seek to obtain waivers from the required lenders under the Encina Credit Facility or the Live Oak Credit Facility, the holders of the respective Notes, or other debt that we may incur in the future to avoid being in default. If we are unable to implement one or more of these alternatives, we may not be able to meet our payment obligations under the Notes and our other debt. If we breach our covenants under the Encina Credit Facility, the Live Oak Credit Facility, the Notes or other debt and seek a waiver, we may not be able to obtain a waiver from the required lenders or the holders thereof. If this occurs, we would be in default under the Encina Credit Facility, the Live Oak Credit Facility, the Notes or other debt, the lenders or holders could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations could proceed against the collateral securing the debt.

 

62

 

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 1C. CYBERSECURITY

 

The Company’s cybersecurity program is designed to identify, assess, and manage material risks from cybersecurity threats. The Company relies on Saratoga Investment Advisors to implement the cybersecurity program. The cyber risk management program involves risk assessments relating to the information systems of Saratoga Investment Advisors, incident response training and testing, implementation of security measures, identification of sensitive information assets (“Critical Information”) and ongoing monitoring of systems and networks and assessment of the associated risks on an annual basis, including networks on which the Company relies on. The Chief Compliance Officer, along with the Company’s external information technology consultant (the “IT Consultant”), actively monitors the current threat landscape in an effort to identify material risks arising from new and evolving cybersecurity threats. The Company and Saratoga Investment Advisors have engaged external experts, including consultants, such as the IT Consultant, to evaluate cybersecurity measures and risk management processes, and depends on and engages various third parties, including suppliers, vendors, and service providers. The compliance team of the Company and Saratoga Investment Advisors will conduct ongoing due diligence of its significant service providers to determine whether the cybersecurity programs of service providers include, among other things, procedures and safeguards designed to ensure the protection of Critical Information and the information of the Company’s stockholders and portfolio companies, as well as adequate responses in the case of a cybersecurity incident.

 

Board Oversight of Cybersecurity Risks

 

The Board has the primary responsibility for overseeing and reviewing the guidelines and policies with respect to the Company’s risk management, including risks associated with cybersecurity threats. The Chief Compliance Officer will periodically report to the Board on cybersecurity matters, such as the overall state of the Company’s cybersecurity program, information on the current threat landscape, and risks from cybersecurity threats and material cybersecurity incidents.

 

Management's Role in Cybersecurity Risk Management

 

The Company’s management is responsible for assessing and managing material risks from cybersecurity threats, in consultations with cybersecurity consultants. The compliance team of the Company will maintain effective disclosure controls and procedures to ensure timely identification, consideration, and disclosure of material cybersecurity incidents, including through timely reporting to management and the Board. The Chief Compliance Officer, in consultation with the IT Consultant, will periodically determine whether the Company requires additional information technology or cybersecurity support.

 

Assessment of Cybersecurity Risk

 

The potential impact of risks from cybersecurity threats are assessed on an ongoing basis, and how such risks could materially affect the Company’s business strategy, operational results, and financial condition are regularly evaluated. During the reporting period, the Company has not identified any risks from cybersecurity threats, including as a result of previous cybersecurity incidents, that the Company believes has materially affected, or are reasonably likely to materially affect, the Company, including the Company’s business strategy, operational results, and financial condition.

 

ITEM 2. PROPERTIES

 

We do not own any real estate or other physical properties important to our operations, however, an affiliate of our Investment Adviser leases office space for our executive offices at 535 Madison Avenue, New York, New York 10022.

 

ITEM 3. LEGAL PROCEEDINGS

 

Neither we nor our wholly owned subsidiaries are currently subject to any material legal proceedings. From time to time, we, our consolidated subsidiaries and/or Saratoga Investment Advisors may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business also is subject to extensive regulation, which may result in regulatory proceedings against us.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

63

 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Price range of common stock

 

Our common stock is traded on the NYSE under the symbol “SAR.” The following table lists the high and low closing sale price for our common stock, and the closing sale price as a percentage of NAV for each fiscal quarter during the last two most recently completed fiscal years and any subsequent interim period.

 

       Price Range   Percentage of High Closing Sales Price as a Premium (Discount)   Percentage of Low Closing Sales Price as a Premium (Discount) 
   NAV(1)   High   Low   to NAV(2)    to NAV(2) 
Fiscal Year Ending February 28, 2025                    
First Quarter through May 1, 2024  $*   $

24.09

   $

22.52

    *    *. 
Fiscal Year Ended February 29, 2024                         
First Quarter  $28.48   $28.10   $22.82    (1.3)%   (19.9)%
Second Quarter  $28.44   $28.64   $25.70    0.7%   (9.6)%
Third Quarter  $27.42   $26.60   $23.05    (3.0)%   (15.9)%
Fourth Quarter  $27.12   $26.73   $22.77    (1.4)%   (16.0)%
Fiscal Year Ended February 28, 2023                         
First Quarter  $28.69   $28.31   $24.98    (1.3)%   (12.9)%
Second Quarter  $28.27   $26.95   $22.70    (4.7)%   (19.7)%
Third Quarter  $28.25   $27.16   $20.36    (3.9)%   (27.9)%
Fourth Quarter  $29.18   $27.77   $25.02    (4.8)%   (14.3)%

 

 

*Net asset value has not yet been calculated for this period.

 

(1)Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low sales prices.

 

(2)Calculated as the respective high or low closing sales price divided by the quarter end net asset value and subtracting 1.

 

Shares of BDCs may trade at a market price that is less than the NAV of those shares. The possibilities that our shares of common stock will trade at a discount from NAV or at premiums that are unsustainable over the long term are separate and distinct from the risk that our NAV will decrease. The last reported closing sale price of our common stock on May 3, 2024 was $23.57 per share, which represents a discount of approximately 13.1% to the NAV of $27.12 as of February 29, 2024. 

 

64

 

 

Summarized Financial Highlights

 

The following table summarizes ten years of financial highlights:

 

   For the year ended 
Per share data  February 29,
2024
   February 28,
2023
   February 28,
2022
   February 28,
2021
   February 29,
2020
 
Net asset value at beginning of period  $29.18   $29.33   $27.25   $27.13   $23.62 
Net investment income(1)   4.49    2.94    1.74    2.07    1.59 
Net realized and unrealized gains (losses) on investments(1)   (3.77)   (0.75)   2.46    (0.74)   4.56 
Realized losses on extinguishment of debt*   (0.01)   (0.13)   (0.21)   (0.01)   (0.17)
Net increase in net assets resulting from operations   0.71    2.06    3.99    1.32    5.98 
Distributions declared from net investment income   (2.82)   (2.28)   (1.93)   (1.23)   (2.21)
Total distributions to stockholders   (2.82)   (2.28)   (1.93)   (1.23)   (2.21)
Issuance of common stock at net asset value (2)   (0.40)   -    -    -    - 
Capital contribution from manager for the issuance of common stock (8)   0.48    -    -    -    - 
Repurchases of common stock(3)   0.03    0.17    0.01    0.13    - 
Dilution(4)   (0.06)   (0.10)   -    (0.10)   (0.26)
Net asset value at end of period  $27.12   $29.18   $29.33   $27.25   $27.13 
                          
Per share market value at end of period  $23.61   $27.55   $27.47   $23.08   $22.91 
Total return based on market value(5)   -3.92%   10.35%   28.19%   7.63%   9.28%
Total return based on net asset value(5)(6)   4.20%   9.46%   15.88%   7.31%   26.22%
Shares outstanding at end of period   13,653,476    11,890,500    12,131,350    11,161,416    11,217,545 
                          
Ratio/Supplemental data:                         
Net assets at end of period   370,224,108    346,958,042    355,780,523    304,185,770    304,286,853 
Ratio of total expenses to average net assets*   24.70%   18.91%   16.09%   13.11%   18.34%
Ratio of net investment income to average net assets*   16.01%   10.23%   6.05%   7.77%   6.31%
Portfolio turnover rate(7)   2.80%   24.05%   33.59%   25.26%   36.82%

 

   For the year ended 
Per share data  February 28,
2019
   February 28,
2018
   February 28,
2017
   February 29,
2016
   February 28,
2015
 
Net asset value at beginning of period  $22.96   $21.97   $22.06   $22.70   $21.08 
Adoption of ASC 606   (0.01)   -    -    -    - 
Net asset value at beginning of period, as adjusted   22.95    21.97    22.06    22.70    21.08 
Net investment income(1)   2.60    2.11    1.94    1.91    1.80 
Net realized and unrealized gains (losses) on investments(1)   0.03    0.82    0.30    0.18    0.24 
Realized losses on extinguishment of debt*   -    -    (0.26)   -    - 
Net increase in net assets resulting from operations   2.63    2.93    2.24    2.09    2.04 
Distributions declared from net investment income   (2.06)   (1.90)   (1.93)   (2.36)   (0.40)
Total distributions to stockholders   (2.06)   (1.90)   (1.93)   (2.36)   (0.40)
Issuance of common stock above net asset value(2)   0.15    -    -    -    - 
Repurchases of common stock(3)   -    -    -    -    - 
Dilution(4)   (0.05)   (0.04)   (0.14)   (0.37)   (0.02)
Net asset value at end of period  $23.62   $22.96   $21.97   $22.06   $22.70 
                          
Per share market value at end of period  $23.04   $21.86   $22.74   $14.22   $15.76 
Total return based on market value(5)   16.11%   5.28%   80.83%   4.27%   1.63%
Total return based on net asset value(5)(6)   13.33%   14.45%   12.62%   11.10%   10.09%
Shares outstanding at end of period   7,657,156    6,257,029    5,794,600    5,672,227    5,401,899 
                          
Ratio/Supplemental data:                         
Net assets at end of period   180,875,187    143,691,367    127,294,777    125,149,875    122,598,742 
Ratio of total expenses to average net assets*   19.12%   19.05%   17.27%   15.46%   14.85%
Ratio of net investment income to average net assets*   11.22%   9.37%   8.71%   8.52%   8.11%
Portfolio turnover rate(7)   35.26%   19.73%   43.76%   26.22%   31.28%

 

 

* Certain prior period amounts have been reclassified to conform to current period presentation.
   
(1) Per share amounts are calculated using the weighted average shares outstanding during the period.

 

65

 

 

(2) The continuous issuance of common stock may cause an incremental decrease in NAV per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company less than NAV per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date multiplied by (B) the differences between the net proceeds per share and the NAV per share on each share transaction date, divided by (ii) the total shares outstanding during the period.
   
(3) Represents the anti-dilutive impact on the NAV per share of the Company due to the repurchase of common shares.  See Note 11, Stockholders’ Equity.
   
(4) Represents the dilutive effect of issuing common stock below NAV per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement and may include the impact of the different share amounts used for different items (weighted average basic common shares outstanding for the corresponding year and actual common shares outstanding at the end of the year) in the per common share data calculation and rounding impacts. See Note 13, Dividend.
   
(5) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.
   
(6) Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.
   
(7) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.
   
(8) The Manager agreed to reimburse the Company to the extent the per share price of the shares to the public, less underwriting fees, was less than net asset value per share.

  

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, which, most recently, was increased to 1.7 million shares of common stock. Most recently, on January 8, 2024, the Company’s board of directors extended the Share Repurchase Plan for another year to January 15, 2025. As shown in the table below, as of February 29, 2024, the Company purchased an aggregate of 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three months ended February 29, 2024, the Company did not purchase any shares of common stock pursuant to the Share Repurchase Plan. During the year ended February 29, 2024, the Company purchased 88,576 shares of common stock, at the average price $24.36 for approximately $2.2 million pursuant to the Share Repurchase Plan.

 

66

 

 

Period  Total Number of Shares
(or Units)
Purchased
   Average Price per Share
(or Unit)
   Total Number of Shares
(or Units)
Purchased as Part of Publicly
Announced Plans or
Programs
   Maximum Number (or Approximate Dollar Value) of Shares
(or Units)
that May Yet Be Purchased Under the Plans or Programs
 
March 1, 2015 through November 30, 2015   2,500   $15.59    2,500    397,500 
December 1, 2015 through December 31, 2015   -   $-    2,500    397,500 
January 1, 2016 through January 31, 2016   4,200   $13.86    6,700    393,300 
February 1, 2016 through February 29, 2016   18,717   $13.86    25,417    374,583 
March 1, 2016 through March 31, 2016   16,282   $14.57    41,699    358,301 
April 1, 2016 through April 30, 2016   7,858   $16.22    49,557    350,443 
May 1, 2016 through May 31, 2016   21,357   $16.29    70,914    329,086 
June 1, 2016 through June 30, 2016   8,310   $16.50    79,224    320,776 
July 1, 2016 through July 31, 2016   19,212   $17.31    98,436    301,564 
August 1, 2016 through August 31, 2016   40,058   $17.44    138,494    261,506 
September 1, 2016 through September 30, 2016   40,221   $18.04    178,715    221,285 
October 1, 2016 through October 31, 2016   27,076   $18.10    205,791    394,209 
November 1, 2016 through November 30, 2016   8,600   $18.24    214,391    385,609 
December 1, 2016 through December 31, 2016   4,100   $18.57    218,491    381,509 
January 1, 2017 through February 29, 2020   -    -    218,491    381,509 
March 1, 2020 through February 28, 2021   190,321   $18.96    408,812    891,188 
March 1, 2021 through February 28, 2022   99,623   $25.55    508,435    791,565 
March 1, 2022 through February 28, 2023   438,192   $24.70    946,627    353,373 
March 1, 2023 through February 29, 2024   88,576   $24.36    1,035,203    664,797 
Total   1,035,203   $22.05           

 

Holders

 

As of May 3, 2024, there were 11 holders of record of our common stock.

 

67

 

 

Performance Graph

 

The following graph compares the return on our common stock with that of the Standard & Poor’s 500 Stock Index, the NASDAQ Financial 100 index and the Standard & Poor’s BDC Index, for the period from March 23, 2007, the date our common stock began trading, through February 29, 2024. The graph assumes that, on March 23, 2007, a person invested $100 in each of our common stock, the Standard & Poor’s 500 Stock Index, the NASDAQ Financial 100 index and the Standard & Poor’s BDC Index. The graph measures total shareholder return, which takes into account both changes in stock price and dividends. It assumes that dividends paid are reinvested in like securities.

 

  

Outstanding Securities and Debt

 

The following table shows our outstanding classes of securities and debt as of February 29, 2024.

 

(a)
Title of Class
  (b)
Amount Authorized
   (c)
Amount Held by us or for Our Account
   (d)
Amount Outstanding Exclusive of Amounts Shown Under (c)
 
Securities:            
Common Stock   100,000,000    11,890,500   $88,109,500 
Debt:               
Encina credit facility  $65,000,000   $35,000,000   $49,965,000 
SBA Debentures  $325,000,000   $214,000,000   $47,000,000 
7.00% 2025 Notes  $12,000,000   $12,000,000   $- 
7.75% 2025 Notes  $5,000,000   $5,000,000   $- 
8.75% 2025 Notes  $20,000,000   $20,000,000   $- 
4.375% 2026 Notes  $175,000,000   $175,000,000   $- 
4.35% 2027 Notes  $75,000,000   $75,000,000   $- 
6.00% 2027 Notes  $105,500,000   $105,500,000   $- 
6.25% 2027 Notes  $15,000,000   $15,000,000   $- 
8.00% 2027 Notes  $46,000,000   $46,000,000   $- 
8.125% 2027 Notes  $60,375,000   $60,375,000   $- 
8.50% 2028 Notes  $57,500,000   $57,500,000   $- 

 

68

 

 

FEES AND EXPENSES

 

The following table is intended to assist you in understanding the costs and expenses that an investor will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this report contains a reference to fees or expenses paid by “you,” “us” or “Saratoga Investment Corp.,” or that “we” will pay fees or expenses, stockholders will indirectly bear such fees or expenses as investors in Saratoga Investment Corp.

 

Stockholder transaction expenses (as a percentage of offering price):    
Sales load paid  -%(1)
Offering expenses borne by us  -%(2)
Dividend reinvestment plan expenses   None(3)
Total stockholder transaction expenses paid   -%
Annual estimated expenses (as a percentage of average net assets attributable to common stock):     

Base management fees

   5.4%(4)
Incentive fees payable under the Management Agreement   2.3%(5)
Interest payments on borrowed funds   13.8%(6)
Other expenses   3.2%(7)
Total annual expenses   24.7%(8)

 

 

(1) In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load.

 

(2) The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses.

 

(3) The expenses associated with the administration of our dividend reinvestment plan are included in “Other expenses.” The participants in the dividend reinvestment plan will pay a pro rata share of brokerage commissions incurred with respect to open market purchases, if any, made by the administrator under the dividend reinvestment plan.

 

(4) Our base management fee under the Management Agreement with Saratoga Investment Advisors is based on our gross assets, which is defined as our total assets, including those acquired using borrowings for investment purposes, but excluding cash and cash equivalents. See “Investment Advisory and Management Agreement” in Part I, Item 1 of this Annual Report. The fact that our base management fee is payable based upon our gross assets, rather than our net assets (i.e., total assets after deduction of any liabilities, including borrowings) means that our base management fee as a percentage of net assets attributable to common stock will increase when we utilize leverage.

 

(5) The incentive fee consists of two parts. The first part is calculated and payable quarterly in arrears and equals 20% of our “pre-incentive fee net investment income” for the immediately preceding quarter, subject to a preferred return, or “hurdle,” and a “catch up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees, such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees that we receive from portfolio companies) accrued by us during the fiscal quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the administration agreement described below, and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Under the Management Agreement, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and Saratoga Investment Advisors will be entitled to 20% of incentive fee capital gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date. See “Investment Advisory and Management Agreement.”

 

69

 

 

(6) We may borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The 13.8% figure in the table includes all expected borrowing costs that we expect to incur over the next twelve months in connection with Encina Credit Facility. The costs associated with our outstanding borrowings are indirectly borne by our stockholders. We do not expect to issue any preferred stock during the next twelve months and, therefore, have not included the cost of issuing and servicing preferred stock in the table. In addition, all of the commitment fees, interest expense, amortized financing costs of our Credit Facility, SBA debentures and the 7.00% 2025 Notes, 7.75% 2025 Notes, 4.375% 2026 Notes, the 4.35% 2027 Notes,  6.00% 2027 Notes, the 6.25% 2027 Notes, the 8.00% 2027 Notes, the 8.125% 2027 Notes, and the 8.50% 2028 Notes, and the fees and expenses of issuing and servicing any other borrowings or leverage that we expect to incur during the next twelve months are included in the table and expense example presentation below. On April 16, 2018, our board of directors, including a majority of our independent directors, approved the Company becoming subject to a minimum asset coverage ratio of 150%, which became effective on April 16, 2019. See “Business Development Company Regulations” in Part I, Item 1 of this Annual Report and “Risk Factors—Risks Related to Our Business and Structure—Effective April 16, 2019, our asset coverage requirement was reduced from 200% to 150%, which may increase the risk of investing in the Company” in Part I, Item 1A of this Annual Report.

 

(7) “Other expenses” are based on estimated amounts for the current fiscal year and include our overhead expenses, including payments under our administration agreement based on our allocable portion of overhead and other expenses incurred by Saratoga Investment Advisors in performing its obligations under the administration agreement. See “Administration Agreement.”

 

(8) This figure includes all of the fees and expenses of our wholly owned subsidiaries, Saratoga Investment Corp SBIC LP, Saratoga Investment Corp SBIC II LP, Saratoga Investment Corp SBIC III LP, Saratoga Investment Funding LLC and Saratoga Investment Funding II LLC, except SLF JV.  As SLF JV is structured as a private joint venture, with control and management shared equally between us and TJHA, no management fees are paid by SLF JV.  Furthermore, this table reflects all of the fees and expenses borne by us with respect to our investment in Saratoga CLO.  

 

Example

 

The following example demonstrates the projected dollar amount of total cumulative expenses over various periods with respect to a hypothetical $1,000 investment in our common stock, assuming an asset coverage ratio of 161.1% (the Company’s actual asset coverage as of February 29, 2024) and total annual expenses of 24.7% of net assets attributable to common stock as set forth in the fees and expenses table above, and (x) a 5.0% annual return resulting entirely from net realized capital gains (none of which is subject to the incentive fee) and (y) a 5.0% annual return resulting entirely from net realized capital gains (all of which is subject to the incentive fee based on capital gains). Transaction expenses are included in the following example. This example and the expenses in the table above should not be considered a representation of our future expenses, and actual expenses (including cost of debt, if any, and other expenses) may be greater or less than those shown.

 

   1 Year   3 Years   5 years   10 years 
Assuming a 5% annual return on portfolio resulting entirely from net realized capital gains (none of which is subject to the capital gains incentive fee)(1)  $253   $798   $1,399   $3,184 
Assuming a 5% annual return resulting entirely from net realized capital gains (all of which is subject to incentive fee based on capital gains)(2)  $263   $830   $1,454   $3,310 

 

 

(1) Assumes that we will not realize any capital gains computed net of all realized capital losses and unrealized capital depreciation.

 

(2) Assumes no unrealized capital depreciation and a 5% annual return resulting entirely from net realized capital gains and therefore subject to the incentive fee based on capital gains. Because our investment strategy involves investments that generate primarily current income, we believe that a 5% annual return resulting entirely from net realized capital gains is unlikely.

 

70

 

 

This example and the expenses in the table above should not be considered a representation of our future expenses, and actual expenses (including the cost of debt, if any, and other expenses) may be greater or less than those shown.

 

The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5% annual return, our performance will vary and may result in a return greater or less than 5%. Both examples assume that the 5% annual return will be generated entirely through net realized capital gains and, as a result, will trigger the payment of the capital gains portion of the incentive fee under the investment advisory agreement. Any potential income portion of the incentive fee under the investment advisory agreement is not included in the example. If we achieve sufficient returns on our investments, including through net realized capital gains, to trigger an incentive fee of a material amount, our expenses, and returns to our investors, would be higher. In addition, while the example assumes reinvestment of all dividends and distributions at NAV, under certain circumstances, reinvestment of dividends and other distributions under our dividend reinvestment plan may occur at a price per share that differs from NAV.

 

Sales of unregistered securities

 

All sales of unregistered securities during the year ended February 29, 2024 were reported in a Form 8-K or Quarterly Report on Form 10-Q filed with the SEC.

 

Issuer purchases of equity securities

 

During the year ended February 29, 2024, February 28, 2023 and February 28, 2022, we purchased 88,576, 438,192 and 99,623 shares, respectfully of our common stock in the open market.

 

The following table summarizes the purchased common stock on a month to month basis for the year ended February 29, 2024:

 

Period  Quantity 
March 1, 2023 through March 31, 2023   60,000 
April 1, 2023 through April 30, 2023   15,000 
May 1, 2023 through May 31, 2023   13,576 
June 1, 2023 through June 30, 2023   - 
July 1, 2023 through July 31, 2023   - 
August 1, 2023 through August 31, 2023   - 
September 1, 2023 through September 30, 2023   - 
October 1, 2023 through October 31, 2023   - 
November 1, 2023 through November 30, 2023   - 
December 1, 2023 through December 31, 2023   - 
January 1, 2024 through January 31, 2024   - 
February 1, 2024 through February 29, 2024   - 
Total   88,576 

 

ITEM 6. - Reserved

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Annual Report on Form 10-K. In addition to historical information, the following discussion and other parts of this Annual Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under Part I. Item 1A. “Risk Factors” and “Note about Forward-Looking Statements” appearing elsewhere herein.

 

71

 

 

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

 

The forward-looking statements contained in this Annual Report on Form 10-K involve risks and uncertainties, including statements as to:

 

  our future operating results;

 

  the introduction, withdrawal, success and timing of business initiatives and strategies;

 

  changes in political, economic or industry conditions, the interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

 

  the relative and absolute investment performance and operations of our Manager;

 

  the impact of increased competition;

 

  our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

 

  the unfavorable resolution of any future legal proceedings;

 

  our business prospects and the operational and financial performance of our portfolio companies, including their ability to achieve our respective objectives as a result of the current economic conditions caused by, among other things, the COVID-19 pandemic, elevated levels of inflation, and a rising interest rate environment, and the effects of the disruptions caused thereby on our ability to continue to effectively manage our business;

 

interest rate volatility, including the replacement of LIBOR with alternate reference rates and the high interest rate environment, could adversely affect our results, particularly if we elect to use leverage as part of our investment strategy;

 

  the impact of investments that we expect to make and future acquisitions and divestitures;

 

  our contractual arrangements and relationships with third parties;

 

  the dependence of our future success on the general economy and its impact on the industries in which we invest;

 

  the ability of our portfolio companies to achieve their objectives;

 

  our expected financings and investments;

 

  our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiaries, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

 

72

 

 

  the adequacy of our cash resources and working capital;

 

  the timing of cash flows, if any, from the operations of our portfolio companies;

 

  the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;
     
  the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

 

  the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;

 

  the impact of changes to tax legislation and, generally, our tax position;

 

  our ability to access capital and any future financings by us;

 

  the ability of our Manager to attract and retain highly talented professionals; and

 

  the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments.

 

Such forward-looking statements may include statements preceded by, followed by or that otherwise include terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “will” and “would” or the negative of these terms or other comparable terminology.

 

We have based the forward-looking statements included in this Annual Report on Form 10-K on information available to us on the date of this Annual Report on Form 10-K, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the U.S. Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

 

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this annual report on Form 10-K.

 

OVERVIEW

 

We are a Maryland corporation that has elected to be treated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Our investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from our investments. We invest primarily in senior and unitranche leveraged loans and mezzanine debt issued by private U.S. middle-market companies, which we define as companies having earnings before interest, tax, depreciation and amortization (“EBITDA”) of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of our net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

 

73

 

 

Corporate History

 

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

 

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC LP (“SBIC LP”), Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), and Saratoga Investment Corp. SBIC III LP (“SBIC III LP”, and together with SBIC LP and SBIC II LP, the “SBIC Subsidiaries”), received SBIC licenses from the SBA on March 28, 2012, August 14, 2019, and September 29, 2022, respectively. SBIC LP’s license provided up to $150.0 million in additional long-term capital in the form of SBA debentures, while SBIC II LP’s and SBIC III LP’s SBIC licenses each provide up to $175.0 million. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital. With all debentures repaid to the SBA, SBIC LP’s license was surrendered on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP.

 

 On February 26, 2021, we completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, and extended its legal maturity to April 2033, and added a non-call period ending February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, we invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. We also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid.

 

We have formed a wholly owned special purpose entity, Saratoga Investment Funding II LLC, a Delaware limited liability company (“SIF II”), for the purpose of entering into a $50.0 million senior secured revolving credit facility with Encina Lender Finance, LLC (the “Lender”), supported by loans held by SIF II and pledged to the Lender under the credit facility (the “Encina Credit Facility). The Encina Credit Facility closed on October 4, 2021. During the first two years following the closing date, SIF II may request an increase in the commitment amount under the Encina Credit Facility to up to $75.0 million. The terms of the Encina Credit Facility require a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increases to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. The term of the Encina Credit Facility is three years. Advances under the Encina Credit Facility bear interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to our and the Lender’s selection of a replacement benchmark rate. Concurrently with the closing of the Encina Credit Facility, all remaining amounts outstanding on our existing revolving credit facility with Madison Capital Funding, LLC were repaid and the facility was terminated. On January 27, 2023, among other things, the borrowings available under the Encina Credit Facility was increased from up to $50.0 million to up to $65.0 million, the underlying benchmark rate used to compute interest changed from LIBOR to Term SOFR for one-month tenor plus a 0.10% credit spread adjustment; the applicable effective margin rate on borrowings increased from 4.00% to 4.25% and the maturity date was extended from October 4, 2024 to January 27, 2026.

 

On October 26, 2021, we entered into a Limited Liability Company Agreement with TJHA JV I LLC (“TJHA”) to co-manage Saratoga Senior Loan Fund I JV LLC (“SLF JV”). SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2021-1 Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

 

74

 

 

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. (“SLF 2022”).

 

We and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

 

We and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, where we provided $43.75 million and TJHA provides $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note will pay a fixed rate of 10.0% per annum and is due and payable in full on October 20, 2033. As of February 29, 2024, our and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 28, 2023, the Company and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 29, 2024, and February 28, 2023, the Company’s investment in the unsecured note of SLF JV had a fair value of $15.8 million and $17.6 million, respectively, and the Company’s investment in the membership interests of SLF JV had a fair value of $9.4 million and $13.1 million, respectively.

 

SLF JV’s initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00% per annum and was paid in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing.

 

We have determined that SLF JV is an investment company under (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies; however, in accordance with such guidance we will generally not consolidate our investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as we and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, Consolidation, concludes that in a joint venture where both members have equal decision making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, we do not consolidate SLF JV.

 

On October 28, 2022, SLF 2022 issued $402.1 million of debt through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, we purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million. As of February 29, 2024 and February 28, 2023, the fair value of these Class E Notes were $12.3 million and $11.4 million, respectively.

  

Critical Accounting Policies and Estimates

 

Basis of Presentation

 

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in our consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies and estimates follows.

 

75

 

 

Investment Valuation

 

We account for investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. Under ASC 820 we are required to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

 

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisors, the audit committee of our board of directors and a third party independent valuation firm. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which we determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

 

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

  each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

  an independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. We use a third-party independent valuation firm to value our investment in the subordinated notes of Saratoga CLO and the Class F-2-R-3 Notes tranche of the Saratoga CLO every quarter.

 

In addition, all our investments are subject to the following valuation process:

 

  the audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

 

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flows that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and market comparables for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by Saratoga Investment Advisors and recommended to our board of directors. Specifically, we use Intex cash flows, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

 

76

 

 

Rule 2a-5 under the 1940 Act (“Rule 2a-5”) establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides the recordkeeping requirements associated with fair value determinations. While our board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, we has adopted certain revisions to its valuation policies and procedures in order comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

    

Revenue Recognition

 

Income Recognition

 

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

  

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

 

Payment-in-Kind Interest

 

We hold debt and preferred equity investments in our portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

 

Revenues

 

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt or preferred equity investments may provide for a portion or all of the interest to be PIK. To the extent interest is PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring, amendment, redemption or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity or common equity securities that pay dividends on a current basis.

 

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 with its reinvestment period extended to October 2016. On November 15, 2016, we completed a second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018.

 

77

 

 

On December 14, 2018, we completed a third refinancing and upsize of the Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030, and added a non-call period of January 2020. Following this refinancing, the Saratoga CLO portfolio increased from approximately $300.0 million in aggregate principal amount to approximately $500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased $2.5 million in aggregate principal amount of the Class F-R-2 and $7.5 million aggregate principal amount of the Class G-R-2 notes tranches at par, with a coupon of 3M USD LIBOR plus 8.75% and 3M USD LIBOR plus 10.00%, respectively. As part of this refinancing, we also redeemed our existing $4.5 million aggregate amount of the Class F notes tranche at par and the $20.0 million CLO 2013-1 Warehouse Loan was repaid.

 

On February 11, 2020, we entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO, pursuant to which CLO 2013-1 Warehouse 2 may borrow from time to time up to $20.0 million from the Company in order to provide capital necessary to support warehouse activities. On October 23, 2020, the availability under the CLO 2013-1 Warehouse 2 Loan was increased to $25.0 million, which was immediately fully drawn and, which expires on August 20, 2021. The interest rate was also amended to be based on a pricing grid, starting at an annual rate of 3M USD LIBOR + 4.46%. During the fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd was repaid in full.

 

On February 26, 2021, we completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. We also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.

 

On August 9, 2021, we exchanged our existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, we sold our Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

 

The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Prior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, we received a base management fee of 0.25% per annum and a subordinated management fee of 0.25% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds.

 

Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

 

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of FASB ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

 

78

 

 

Expenses

 

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act) of the Company (“independent directors”) and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our Manager for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

 

  organization;

 

  calculating our net asset value (“NAV”) (including the cost and expenses of any independent valuation firm);

 

  expenses incurred by our Manager payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

  expenses incurred by our Manager payable for travel and due diligence on our prospective portfolio companies;

 

  interest payable on debt, if any, incurred to finance our investments;

 

  offerings of our common stock and other securities;

 

  investment advisory and management fees;

 

  fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

  transfer agent and custodial fees;

 

  federal and state registration fees;

 

  all costs of registration and listing our common stock on any securities exchange;

 

  U.S. federal, state and local taxes;

 

  independent directors’ fees and expenses;

 

  costs of preparing and filing reports or other documents required by governmental bodies (including the Securities and Exchange Commission (the “SEC”) and the SBA);

 

  costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

  our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

  direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

  administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

 

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters and an incentive fee.

 

79

 

 

The incentive fee had two parts:

 

  A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

 

  A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis on each investment in our portfolio, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

 

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007 and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Annual Report.

 

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

 

  The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

 

  Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

 

  We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

 

80

 

 

Capital Gains Incentive Fee

 

We record an expense accrual relating to the capital gains incentive fee payable by us to the Manager when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if we were to liquidate our investment portfolio at such time. The actual incentive fee payable to the Company’s Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

 

Recent Accounting Pronouncements

 

In June 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820) (“ASU 2022-03”), which clarifies that a contractual sale restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security and is not included in the equity security’s unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value. In addition, ASU 2022-03 prohibits an entity from recognizing a contractual sale restriction as a separate unit of account. ASU 2022-03’s amendments are effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently evaluating the impact of the adoption of ASU 2022-03 on our consolidated financial statements.

 

In March 2020, the FASB issued Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) to provide optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. ASU 2020-04 established Topic 848 to provide relief during the temporary transition period and includes a sunset provision based on expectations of when the London Interbank Offered Rate (“LIBOR”) would cease being published. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which deferred the sunset day of this guidance to December 31, 2024. With the adoption of ASU 2022-06, there was no significant impact to our consolidated financial position.

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. The amendments in this update require more disaggregated information on income taxes paid. ASU 2023-09 is effective for years beginning after December 15, 2024. Early adoption is permitted, however the Company has not elected to adopt this provision as of the date of the financial statements contained in this report. The Company is still assessing the impact of the new guidance. However, it does not expect ASU 2023-09 to have a material impact on the consolidated financial statements and the notes thereto.

 

Portfolio and investment activity

 

Investment Portfolio Overview

 

   February 29,
2024
   February 28,
2023
   February 28,
2022
 
   ($ in millions) 
Number of investments(1)   139    115    94 
Number of portfolio companies(2)   55    49    45 
Average investment per portfolio company(2)  $20.1   $19.0   $17.3 
Average investment size(1)  $8.1   $8.3   $8.4 
Weighted average maturity(3)   2.5 yrs    2.9 yrs    2.9 yrs 
Number of industries(5)   43    40    38 
Non-performing or delinquent investments (fair value)  $18.9   $9.8   $- 
Fixed rate debt (% of interest earning portfolio)(3)  $5.5(0.5)%  $8.2(1.0)%  $16.9(2.5)%
Fixed rate debt (weighted average current coupon)(3)   15.0%   12.2%   10.0%
Floating rate debt (% of interest earning portfolio)(3)  $997.9(99.5)%  $817.1(99.0)%  $671.2(97.5)%
Floating rate debt (weighted average current spread over SOFR)(3)(4)   7.5%   7.0%   7.1%

 

 

(1)Excludes our investment in the subordinated notes of Saratoga CLO.

 

(2)At February 29, 2024, excludes our investment in the subordinated notes of Saratoga CLO and Class F-2-R-3 Notes tranche, as well as the unsecured notes and equity interests in the SLF JV and the Class E Note tranche of the SLF 2022. At February 28, 2023, excludes our investment in the subordinated notes of Saratoga CLO and Class F-2-R-3 Notes tranche, as well as the unsecured notes and equity interests in the SLF JV and the Class E Note tranche of the SLF 2022. At February 28, 2022, excludes our investment in the subordinated notes of Saratoga CLO, Class F-2-R-3 Note tranche, as well as the unsecured notes and equity interests in the SLF JV.

 

81

 

 

(3)Excludes our investment in the subordinated notes of Saratoga CLO and equity interests, as well as the unsecured notes and equity interests in SLF JV and the Class E Note tranche of the SLF 2022.

 

(4)Calculation uses either 1-month or 3-month SOFR, depending on the contractual terms, and after factoring in any existing SOFR floors.

 

(5)Our investment in the subordinated notes of Saratoga CLO and Class F-R-3 Note tranche, as well as the unsecured notes and equity interests in the SLF JV and the Class E note tranche of the SLF 2022 are included in Structured Finance Securities industry.

 

During the fiscal year ended February 29, 2024, we invested $246.1 million in new and existing portfolio companies and had $30.3 million in aggregate amount of exits and repayments resulting in net investments of $215.8 million for the year.

 

During the fiscal year ended February 28, 2023, we invested $385.1 million in new and existing portfolio companies and had $222.2 million in aggregate amount of exits and repayments resulting in net investments of $162.9 million for the year.

 

During the fiscal year ended February 28, 2022, we invested $458.1 million in new and existing portfolio companies and had $226.9 million in aggregate amount of exits and repayments resulting in net investments of $231.1 million for the year.

 

Portfolio Composition

 

Our portfolio composition at February 29, 2024, February 28, 2023 and February 28, 2022 at fair value was as follows:

 

   February 29, 2024   February 28, 2023   February 28, 2022 
   Percentage of Total Portfolio   Weighted Average Current Yield   Percentage of Total Portfolio   Weighted Average Current Yield   Percentage of Total Portfolio   Weighted Average Current Yield 
First lien term loans   85.7%   12.6%   82.1%   12.3%   77.3%   8.3%
Second lien term loans   1.6    5.1    1.5    5.3    5.4    11.1 
Unsecured loans   1.4    11.1    2.1    9.8    1.9    9.7 
Structured finance securities   2.7    10.3    4.3    7.4    4.7    10.5 
Equity interests   8.6    -    10.0    -    10.7    - 
Total   100.0%   11.4%   100.0%   10.7%   100.0%   7.7%

 

At February 29, 2024, our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of $9.5 million and constituted 0.8% of our portfolio. This investment constitutes a first loss position in a portfolio that, as of February 29, 2024 and February 28, 2023, was composed of $640.8 million and $658.0 million, respectively, in aggregate principal amount of primarily senior secured first lien term loans. In addition, as of February 29, 2024, we also own $9.4 million in aggregate principal of the F-2-R-3 Notes in the Saratoga CLO, which only rank senior to the subordinated notes.

 

82

 

 

This investment is subject to unique risks. (See “Part 1. Item 1A. Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of subordinated notes representing the lowest-rated securities issued by a pool of predominantly senior secured first lien term loans and is subject to additional risks and volatility. All losses in the pool of loans will be borne by our subordinated notes and only after the value of our subordinated notes is reduced to zero will the higher-rated notes issued by the pool bear any losses”). We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at February 29, 2024, $603.0 million or 99.2% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and two of the Saratoga CLO portfolio investments were in default with a fair value of $0.3 million. At February 28, 2023, $544.4 million or 89.8% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and two Saratoga CLO portfolio investments were in default with a fair value of $2.8 million. For more information relating to Saratoga CLO, see the audited financial statements for Saratoga CLO included elsewhere herein.

 

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—performing credit; (Yellow)—underperforming credit; (Red)—in principal payment default and/or expected loss of principal.

 

Portfolio CMR distribution

 

The CMR distribution of our investments at February 29, 2024 and February 28, 2023 was as follows:

 

Saratoga Investment Corp.

 

   February 29, 2024   February 28, 2023 
Color Score  Investments
at
Fair Value
   Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Green  $1,000,298    87.8%  $808,791    83.2%
Yellow   12,643    1.1    34,172    3.5 
Red   6,273    0.6    -    0.0 
N/A(1)   119,580    10.5    129,627    13.3 
Total  $1,138,794    100.0%  $972,590    100.0%

 

 

(1)Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

 

The change in reserve from $2.2 million as of February 28, 2023 to $9.5 million as of February 29, 2024 was primarily related to the non-accrual of interest income related to our investments in Knowland Group, Pepper Palace and Zollege.

 

The CMR distribution of Saratoga CLO investments at February 29, 2024 and February 28, 2023 was as follows:

 

Saratoga CLO

 

   February 29, 2024   February 28, 2023 
Color Score  Investments
at
Fair Value
   Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Green  $560,384    92.2%  $544,424    89.9%
Yellow   42,580    7.0    40,812    6.7 
Red   3,568    0.6    20,718    3.4 
N/A(1)   1,020    0.2    0    0.0 
Total  $607,552    100.0%  $605,954    100.0%

 

 

(1)Comprised of Saratoga CLO’s equity interests.

 

83

 

 

Portfolio composition by industry grouping at fair value

 

The following table shows our portfolio composition by industry grouping at fair value at February 29, 2024 and February 28, 2023:

 

Saratoga Investment Corp.

 

   February 29, 2024   February 28, 2023 
  Investments
At
Fair Value
   Percentage
of Total
Portfolio
   Investments
At
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Healthcare Software  $120,500    10.8%  $119,124    12.2%
IT Services   78,422    6.9    87,167    9.0 
Consumer Services   64,689    5.7    63,642    6.6 
HVAC Services and Sales   59,208    5.2    54,450    5.6 
Real Estate Services   52,350    4.6    53,406    5.5 
Healthcare Services   51,094    4.5    26,286    2.7 
Education Software   45,579    4.0    44,955    4.6 
Hospitality/Hotel   41,447    3.6    37,972    3.9 
Dental Practice Management   40,235    3.5    1,000    0.1 
Mental Healthcare Services   37,377    3.3    16,922    1.7 
Health/Fitness Franchisor   32,032    2.8    -    0.0 
Structured Finance Securities(1)   30,626    2.7    41,363    4.4 
Sports Management   27,000    2.4    26,711    2.7 
Talent Acquisition Software   26,896    2.4    25,999    2.7 
Financial Services   26,276    2.3    26,218    2.7 
Research Software   26,255    2.3    10,677    1.1 
Education Services   25,819    2.3    34,489    3.5 
Architecture & Engineering Software   25,247    2.2    -    0.0 
Investment Fund   25,222    2.2    30,726    3.2 
Association Management Software   24,089    2.1    -    0.0 
Direct Selling Software   24,073    2.1    25,771    2.7 
Restaurant   22,580    2.0    24,826    2.6 
Mentoring Software   22,069    1.9    21,359    2.2 
Legal Software   20,709    1.8    20,699    2.1 
Insurance Software   19,821    1.7    16,761    1.7 
Roofing Contractor Software   19,014    1.7    -    0.0 
Marketing Orchestration Software   18,420    1.6    18,715    1.9 
Corporate Education Software   18,026    1.6    15,254    1.6 
Non-profit Services   16,267    1.4    13,095    1.3 
Employee Collaboration Software   14,150    1.2    13,052    1.3 
Lead Management Software   12,120    1.1    12,090    1.2 
Alternative Investment Management Software   10,779    0.9    10,459    1.1 
Field Service Management   10,708    0.9    9,958    1.0 
Financial Services Software   9,916    0.9    9,096    0.9 
Fire Inspection Business Software   9,916    0.9    -    0.0 
Industrial Products   9,095    0.8    9,608    1.0 
Office Supplies   7,181    0.6    6,373    0.7 
Veterinary Services   4,753    0.4    -    0.0 
Staffing Services   3,288    0.3    2,079    0.2 
Cyber Security   2,826    0.2    2,509    0.3 
Specialty Food Retailer   2,489    0.2    -    0.0 
Facilities Maintenance   231    0.0    408    0.0 
Specialty Food Retailer   -    0.0    24,411    2.5 
Dental Practice Management   -    0.0    11,151    1.1 
Corporate Education Software   -    0.0    3,809    0.4 
Healthcare Supply   -    0.0    -    0.0 
Total  $1,138,794    100.0%  $972,590    100.0%

 

 

(1)As of February 29, 2024, comprised of our investment in the subordinated notes and F-2-R-3 Notes of Saratoga CLO, as well as the unsecured notes and equity interests in the SLF JV and E-Notes of SLF 2022. As of February 28, 2023, comprised of our investment in the subordinated notes and Class F-2-R-3 Notes of Saratoga CLO, as well as the unsecured notes and equity interests in the SLF JV.

84

 

 

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at February 29, 2024 and February 28, 2023:

 

Saratoga CLO

 

   February 29, 2024   February 28, 2023 
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Banking, Finance, Insurance & Real Estate  $116,253    19.0%  $114,570    18.9%
Services: Business   65,524    10.8    65,947    10.9 
High Tech Industries   50,996    8.4    52,636    8.7 
Healthcare & Pharmaceuticals   40,453    6.7    38,952    6.4 
Services: Consumer   30,433    5.0    34,544    5.7 
Chemicals, Plastics, & Rubber   30,219    5.0    23,857    3.9 
Retail   26,339    4.3    24,049    4.0 
Telecommunications   22,718    3.7    22,514    3.7 
Media: Advertising, Printing & Publishing   20,265    3.3    20,309    3.4 
Hotel, Gaming & Leisure   20,217    3.3    14,315    2.4 
Automotive   20,007    3.3    20,410    3.4 
Consumer goods: Durable   17,555    2.9    24,887    4.1 
Containers, Packaging & Glass   17,138    2.8    18,239    3.0 
Construction & Building   16,663    2.7    13,875    2.3 
Beverage, Food & Tobacco   13,150    2.2    14,501    2.4 
Aerospace & Defense   13,068    2.2    13,688    2.3 
Media: Broadcasting & Subscription   10,778    1.8    11,143    1.8 
Consumer goods: Non-durable   10,698    1.8    13,734    2.3 
Media: Diversified & Production   10,390    1.7    9,279    1.5 
Transportation: Cargo   8,890    1.5    8,236    1.4 
Utilities: Oil & Gas   8,046    1.3    7,246    1.2 
Wholesale   7,255    1.2    8,011    1.3 
Capital Equipment   5,694    0.9    8,450    1.4 
Transportation: Consumer   4,720    0.8    6,844    1.1 
Metals & Mining   4,256    0.7    3,239    0.5 
Energy: Oil & Gas   4,024    0.7    2,676    0.4 
Forest Products & Paper   3,592    0.6    3,190    0.5 
Environmental Industries   3,120    0.5    2,155    0.4 
Energy: Electricity   2,855    0.5    2,105    0.3 
Utilities: Electric   2,234    0.4    2,353    0.4 
Total  $607,550    100.0%  $605,954    100.0%

 

85

 

 

Portfolio composition by geographic location at fair value

 

The following table shows our portfolio composition by geographic location at fair value at February 29, 2024 and February 28, 2023. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

   February 29, 2024   February 28, 2023 
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 
Southeast  $308,590    27.1%  $247,192    25.4%
Midwest   264,966    23.3    199,944    20.6 
West   233,791    20.5    173,283    17.8 
Northeast   144,562    12.7    133,158    13.7 
Southwest   111,911    9.8    123,744    12.7 
Other(1)   74,974    6.6    92,760    9.5 
Northwest   -    -    2,509    0.3 
Total  $1,138,794    100.0%  $972,590    100.0%

 

 

(1)As of February 29, 2024, comprised of our investments in the subordinated notes, F-2-R-3 Notes of Saratoga CLO, as well as the unsecured notes and equity interests in the SLF JV, and the Class E Note tranche of the SLF 2022 and foreign investments. As of February 28, 2023, comprised of our investments in the subordinated notes, F-2-R-3 Notes of Saratoga CLO, as well as the unsecured notes and equity interests in the SLF JV, and the Class E Note tranche of the SLF 2022 and foreign investments.

 

Results of operations

 

Operating results for the fiscal years ended February 29, 2024, February 28, 2023 and February 28, 2022 were as follows:

 

   For the Year Ended 
   February 29,
2024
   February 28,
2023
   February 28,
2022
 
   ($ in thousands) 
Total investment income  $143,720   $99,104   $70,740 
Total operating expenses   86,846    63,903    50,797 
Net investment income   56,874    35,201    19,943 
Net realized gains (losses) from investments   154    7,446    13,398 
Income tax (provision) benefit from realized gain on investments   -    549    (2,886)
Net change in unrealized appreciation (depreciation) on investments   (47,091)   (15,218)   17,020 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   (893)   (1,715)   695 
Loss on extinguishment of debt*   (110)   (1,587)   (2,434)
Net increase in net assets resulting from operations  $8,934   $24,676   $45,735 

 

 

*Certain prior period amounts have been reclassified to conform to current period presentation.

 

86

 

 

Investment income

 

The composition of our investment income for the fiscal years ended February 29, 2024, February 28, 2023 and February 28, 2022 were as follows:

 

   For the Year Ended 
   February 29,
2024
   February 28,
2023
   February 28,
2022
 
   ($ in thousands) 
Interest from investments  $127,785   $85,217   $58,502 
Interest from cash and cash equivalents   2,512    1,368    4 
Management fee income   3,270    3,270    3,263 
Incentive fee income   -    -    - 
Dividend Income*   6,533    2,720    1,926 
Structuring and advisory fee income   2,150    3,585    4,308 
Other income*   1,470    2,944    2,739 
Total investment income  $143,720   $99,104   $70,740 

 

 

*Certain prior period amounts have been reclassified to conform to current period presentation.

 

For the fiscal year ended February 29, 2024, total investment income increased $44.6 million, or 45.0%, to $143.7 million for the fiscal year ended February 29, 2024 compared to $99.1 million for the fiscal year ended February 28, 2023. Interest income from investments increased $42.6 million, or 50.0%, to $127.8 million for the year ended February 29, 2024 from $85.2 million for the fiscal year ended February 28, 2023. The increase in interest income for the fiscal year ended February 29, 2024 is primarily attributable to an increase of 17.1% in total investments to $1,138.8 million from $972.6 million in the prior period, as well as the increase in the weighted average current yield on investments of 11.4% compared to 10.7% in the prior period.

 

For the fiscal year ended February 28, 2023, total investment income increased $28.4 million, or 40.1%, to $99.1 million for the fiscal year ended February 28, 2023 compared to $13.1 million for the fiscal year ended February 28, 2022. Interest income from investments increased $26.7 million, or 45.7%, to $85.2 million for the year ended February 28, 2023 from $58.5 million for the fiscal year ended February 28, 2022. The increase in interest income for the fiscal year ended February 28, 2023 is primarily attributable to an increase of 19.0% in total investments to $972.6 million from $817.6 million in the prior period, as well as the increase in the weighted average current yield on investments of 10.7% compared to 7.7% in the prior period.

 

For the fiscal year ended February 29, 2024 and February 28, 2023, total PIK income was $2.5 million and $1.2 million, respectively. This increase was due to investment growth and amended terms of debt securities that elected to pay a portion of their interest in PIK.

 

For the fiscal year ended February 28, 2023 and February 28, 2022, total PIK income was $1.2 million and $1.5 million, respectively. This decrease was primarily due to the repayment of debt securities that elected to pay a portion of their interest in PIK.

 

Management fee income reflects the fee income received for managing the Saratoga CLO. For the years ended February 29, 2024, 2023 and 2022, total management fee income was $3.3 million, $3.3 million and $3.3 million, respectively.

 

For the fiscal year ended February 29, 2024, February 28, 2023 and February 28, 2022, total dividend income was $6.5 million, $2.7 million and $1.9 million, respectively. Dividends received is recorded in the consolidated statements of operations when earned, and the increase primarily reflects $5.9 million of dividend income received on the SLF JV.

 

For the fiscal year ended February 29, 2024, February 28, 2023 and February 28, 2022, total structuring and advisory fee income was $2.1 million, $3.6 million and $4.3 million, respectively. Structuring and advisory fee income represents fee income earned and received performing certain investment and advisory activities during the closing of new investments, with the changes year-over-year primarily reflecting the increased or decreased originations during the period.

 

For the fiscal year ended February 29, 2024, February 28, 2023 and February 28, 2022, other income was $1.5 million, $2.9 million and $2.7 million, respectively. Other income primarily includes prepayment, amendment and redemption fees and is recorded in the consolidated statements of operations when earned.

 

87

 

 

Operating expenses

 

The composition of our operating expenses for the years ended February 29, 2024, February 28, 2023 and February 28, 2022 were as follows:

 

   For the Year Ended 
   February 29,
2024
   February 28,
2023
   February 28,
2022
 
   ($ in thousands) 
Interest and debt financing expenses  $49,180   $33,499   $19,880 
Base management fees   19,212    16,424    11,902 
Incentive management fees   8,025    5,057    11,794 
Professional fees   1,767    1,812    1,378 
Administrator expenses   3,873    3,160    2,906 
Insurance   322    347    349 
Directors fees and expenses   351    360    336 
General and administrative and other expenses   2,243    2,329    1,662 
Income tax expense (benefit)   43    (153)   (40)
Excise tax expense (benefit)   1,830    1,068    630 
Total operating expenses  $86,846   $63,903   $50,797 

 

For the year ended February 29, 2024, total operating expenses increased $22.9 million, or 35.9%, to $86.8 million compared to $63.9 million for the year ended February 28, 2023. For the year ended February 28, 2023, total operating expenses increased $13.1 million, or 25.8%, to $63.9 compared to $50.8 million for the year ended February 28, 2022.

 

For the year ended February 29, 2024, interest and debt financing expenses increased $15.7 million, or 46.8% compared to the year ended February 28, 2023. The increase is attributable to both the total average outstanding debt increasing from $663.0 million for the year ended February 28, 2023 to $798.9 million for the year ended February 29, 2024, as well as the weighted average interest rate on our outstanding indebtedness increasing from 4.48% to 5.46% for the same periods. The increase in total average outstanding debt and the weighted average interest rate was primarily due to the issuance during the year ended February 29, 2024 of the higher-cost 8.75% 2025 Notes and 8.50% 2028 Notes. At February 29, 2024 and February 28, 2023, the lower-cost SBA debentures represented 26.1% and 27.7% of overall debt, respectively. 

 

For the year ended February 28, 2023, interest and debt financing expenses increased $13.6 million, or 68.5% compared to the year ended February 28, 2022. The increase is attributable to both the total average outstanding debt increasing from $417.4 million for the year ended February 28, 2022 to $663.0 million for the year ended February 28, 2023, as well as the weighted average interest rate on our outstanding indebtedness increasing from 4.15% to 4.48% for the same periods. The increase in total average outstanding debt and the weighted average interest rate was primarily due to the issuance during the year ended February 28, 2023 of the higher-cost 6.00% 2027 Notes, 7.00% 2025 Notes, 8.00% 2027 Notes and 8.125% 2027 Notes. At February 28, 2023 and February 28, 2022, the lower-cost SBA debentures represented 27.7% and 36.2% of overall

debt, respectively. 

 

For the year ended February 29, 2024, base management fees increased $2.8 million, or 17.0% compared to the fiscal year ended February 28, 2023. The increase in base management fees is due to the 17.0% increase in the average value of our total assets, less cash and cash equivalents, from $938.5 million as of February 28, 2023 to $1,097.8 million as of February 29, 2024.

 

88

 

 

For the year ended February 28, 2023, base management fees increased $4.5 million, or 38.0% compared to the fiscal year ended February 28, 2022. The increase in base management fees is due to the 38.0% increase in the average value of our total assets, less cash and cash equivalents, from $680.1 million as of February 28, 2022 to $938.5 million as of February 28, 2023.

 

For the year ended February 29, 2024, incentive fees increased $3.0 million, or 58.7% compared to the fiscal year ended February 28, 2023. The incentive fee on income increased this year from $6.8 million for the year ended February 28, 2023 to $13.0 million for the year ended February 29, 2024, reflecting the increased operating performance of our debt investments during this period. The incentive fees on capital gains decreased from ($1.8) million benefit for the fiscal year ended February 28, 2023 to ($8.3) million benefit for the fiscal year ended February 29, 2024, both reflecting the incentive fee income and expense on net unrealized appreciation and depreciation recognized during both these periods.

 

For the year ended February 28, 2023, incentive fees decreased $6.7 million, or 57.1% compared to the fiscal year ended February 28, 2022. The incentive fee on income increased this year from $6.4 million for the year ended February 28, 2022 to $6.8 million for the year ended February 28, 2023, reflecting the increased operating performance of our debt investments during this period. The incentive fees on capital gains decreased from $5.5 million expense for the fiscal year ended February 28, 2022 to ($1.7) million benefit for the fiscal year ended February 28, 2023, both reflecting the incentive fee income and expense on net unrealized appreciation and depreciation recognized during both these periods.

 

For the year ended February 29, 2024, professional fees decreased $0.05 million, or 2.5% compared to the fiscal year ended February 28, 2023. This decrease primarily reflects the benefit of scale and optimization of costs and vendors across accounting, legal and consulting fees across the Company.

 

For the year ended February 28, 2023, professional fees increased $0.4 million, or 31.5% compared to the fiscal year ended February 28, 2022. This increase primarily reflects growth across accounting, legal and consulting fees in connection with an increase in our assets and legal entities, as well as the increased rates across vendors in the current inflation environment.

 

For the year ended February 29, 2024, administrator expenses increased $0.7 million, or 22.5% compared to the fiscal year ended February 28, 2023, which reflects an increase to the cap on the payment or reimbursement of expenses by the Company from $3.275 million last year to $ 4.3 million, effective August 1, 2023.

 

For the year ended February 28, 2023, administrator expenses increased $0.3 million, or 8.7% compared to the fiscal year ended February 28, 2022, which reflects an increase to the cap on the payment or reimbursement of expenses by the Company from $3.0 million to 3.275 million, effective August 1, 2022.

  

For the fiscal years ended February 29, 2024, February 28, 2023 and February 28, 2022, the average borrowings outstanding under the Credit Facilities was approximately $37.9 million, $26.3 million and $8.7 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Credit Facilities was 9.66%, 6.72% and 5.22%, respectively.

 

For the fiscal years ended February 29, 2024, February 28, 2023 and February 28, 2022, the average borrowings outstanding of SBA debentures was $202.5 million, $230.0 million and $180.4 million, respectively. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.08%, 2.78% and 2.60%, respectively.

 

The weighted average dollar amount of our unsecured notes for the fiscal years ended February 29, 2024 and February 28, 2023 were as follows:

   Fiscal Year Ended 
(in millions)  February 29,
2024
   February 28,
2023
 
7.25% 2025 Notes  $-   $13.6 
7.75% 2025 Notes   5.0    5.0 
6.25% 2027 Notes   15.0    15.0 
4.375% 2026 Notes   175.0    175.0 
4.35% 2027 Notes   75.0    75.0 
6.00% 2027 Notes   105.5    88.2 
7.00% 2025 Notes   12.0    5.7 
8.00% 2027 Notes   46.0    15.6 
8.125% 2027 Notes   60.4    13.2 
8.75% 2025 Notes   17.5    - 
8.50% 2028 Notes   50.2    - 

 

89

 

 

For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, we recognized income tax expense (benefit) of $0.04 million, ($0.15) million and ($0.04) million, respectively. This relates to net deferred federal and state income tax expense (benefit) with respect to operating gains and losses and income derived from equity investments held in entities that are treated as corporations for U.S. federal income tax purposes, as well as current U.S. federal and state income taxes on those operating gains and losses when realized.

 

For the year ended February 29, 2024, we accrued excise taxes of $1.8 million on undistributed taxable income as of December 31, 2023. For the year ended February 28, 2023, we accrued excise taxes of $1.1 million on undistributed taxable income as of December 31, 2022.

 

Net realized gains (losses) on sales of investments

 

For the fiscal year ended February 29, 2024, we had $30.3 million of sales, repayments, exits or restructurings resulting in $0.2 million of net realized gains. The most significant realized gains and losses during the year ended February 29, 2024 were as follows (dollars in thousands):

 

Fiscal year ended February 29, 2024

 

Issuer  Asset Type  Gross
Proceeds
   Cost   Net
Realized
Gain (Loss)
 
PDDS Buyer, LLC  Equity Interests  $      -   $     -   $41,350 
Censis Technologies, Inc.  Equity Interests   -    -    6,773 
GreyHeller LLC  Equity Interests   -    -    42,568 
Ohio Medical, LLC  Equity Interests   -    -    60,565 
Targus Holdings, Inc  Equity Interests   -    -    2,327 

 

We received escrow payments from the prior sales of our investments in PPDS Buyer, LLC, Censis Technologies, Inc., Ohio Medical, LLC, GreyHeller LLC and Targus Holdings, Inc.

 

For the fiscal year ended February 28, 2023, we had $222.2 million of sales, repayments, exits or restructurings resulting in $7.4 million of net realized loss. The most significant realized gains and losses during the year ended February 28, 2023 were as follows (dollars in thousands):

 

Fiscal year ended February 28, 2023

 

Issuer  Asset Type  Gross
Proceeds
   Cost   Net
Realized
Gain (Loss)
 
PDDS Buyer, LLC  Equity Interests  $9,943,838   $2,000,000   $7,943,838 
Ohio Medical, LLC  Equity Interests   770,161    380,353    389,808 
Targus Holdings, Inc.  Equity Interests   540,075    1,589,630    (1,049,555)
Censis Technologies, Inc.  Equity Interests   -    -    68,731 
Texas Teachers of Tomorrow, LLC  Equity Interests   -    -    24,977 
V Rental Holdings LLC  Equity Interests   -    -    68,800 

 

The $7.9 million of net realized gains was from the sales of the equity position in our investment in PDDS Buyer, LLC.

 

The $0.4 million of net realized gains was from the sales of the equity position in our investment in Ohio Medical, LLC.

 

The $1.0 million of net realized loss was from the sales of the equity position in our investment in Targus Holding, Inc.

 

90

 

 

We received escrow payments from the prior sales of our investments in Censis Technologies, Inc., Texas Teachers of Tomorrow, LLC and V Rental Holdings LLC. 

 

For the fiscal year ended February 28, 2022, we had $226.9 million of sales, repayments, exits or restructurings resulting in $13.4 million of net realized loss. The most significant realized gains and losses during the year ended February 28, 2022 were as follows (dollars in thousands):

 

Fiscal year ended February 28, 2022

 

Issuer  Asset Type  Gross
Proceeds
   Cost   Net
Realized
Gain
 
GreyHeller LLC  Equity Interests  $8,178   $850   $7,328 
Lexipol, LLC  Equity Interests   10,792    10,792    - 
My Alarm Center, LLC  Equity Interests   -    4,867    (4,867)
Passageways, Inc.  Equity Interests   7,440    1,000    6,476 
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-1-R-3 Note  Structured Finance Securities   8,360    8,500    (140)
Texas Teachers of Tomorrow, LLC  Equity Interests   3,339    750    2,589 
V Rental Holdings LLC  Equity Interests   2,345    366    1,979 

 

The $7.3 million of net realized gains was from the sales of the equity position in our investment in GreyHeller LLC.

 

The $0.1 million of net realized loss was from the sales of the equity position in our investment in Lexipol, LLC.

 

The $4.9 million of net realized loss was from our investment in My Alarm Center, LLC that was deemed worthless during this period.

 

The $6.4 million of net realized gains was from the sales of the equity position in our investment in Passageways Inc.

 

The $0.1 million of net realized loss was from the repayment of the structured finance securities in the Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-1-R-3 Note.

 

The $2.6 million of net realized gains was from the sales of the equity position in our investment in Texas Teachers of Tomorrow, LLC .

 

The $1.9 million of net realized gains was from the sales of the equity position in our investment in V Rental Holdings LLC.

 

91

 

 

Net change in unrealized appreciation (depreciation) on investments

 

For the year ended February 29, 2024, our investments had a net change in unrealized depreciation of $47.1 million compared to a net change in unrealized depreciation of $15.2 million for the year ended February 28, 2023. The most significant cumulative changes in unrealized appreciation (depreciation) for the year ended February 29, 2024, were the following (dollars in thousands):

 

Fiscal year ended February 29, 2024

 

Issuer  Asset Type  Cost   Fair Value   Total
Unrealized
Appreciation
(Depreciation)
   YTD Change in Unrealized
Appreciation
(Depreciation)
 
Pepper Palace, Inc.  First Lien Term Loan & Equity Interests  $35,438   $2,489   $(32,949)  $(23,104)
Zollege PBC  First Lien Term Loan & Equity Interests   17,949    3,784    (14,165)   (12,845)
Netreo Holdings, LLC  First Lien Term Loan & Equity Interests   39,225    35,422    (3,803)   (12,083)
Saratoga Senior Loan Fund I JV, LLC  Equity Interests   35,202    25,222    (9,980)   (5,504)
Saratoga Investment Corp. CLO 2013-1, Ltd.  Structured Finance Securities   22,002    9,501    (12,501)   (4,734)
Knowland Group, LLC  Second Lien Term Loan   15,879    12,643    (3,236)   2,882 
ETU Holdings, Inc.  First Lien Term Loan, Second Lien Term Loan & Equity Interests   16,034    13,600    (2,434)   (2,518)
Vector Controls Holding Co., LLC  First Lien Term Loan & Equity Interests   924    9,095    8,171    1,653 
Chronus LLC  First Lien Term Loan & Equity Interests   22,875    22,069    (806)   (1,304)
Avionte Holdings, LLC  Equity Interests   100    3,288    3,188    1,209 
Buildout, Inc.  First Lien Term Loan, Second Lien Term Loan & Equity Interests   53,666    52,350    (1,316)   (1,167)

 

The $23.1 million net change in unrealized depreciation in our investment in Pepper Palace, Inc. was driven by further declines in company performance during the year ended February 29, 2024.

 

The $12.8 million net change in unrealized depreciation in our investment in Zollege PBC was driven by further declines in company performance during the year ended February 29, 2024.

 

The $12.1 million net change in unrealized depreciation in our investment in Netreo Holdings, LLC was driven by increased company leverage and declines in company performance.

 

The $5.5 million net change in unrealized depreciation in our investment in Saratoga Senior Loan Fund I JV, LLC was primarily driven by overall market conditions.

 

The $4.7 million net change in unrealized depreciation in our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. was driven by overall market conditions as well as the mark-down of specific investments.

 

The $2.9 million net change in unrealized appreciation in our investment in Knowland Group, LLC was driven by overall improved company performance and valuation.

 

The $2.5 million net change in unrealized depreciation in our investment in ETU Holdings, Inc. was driven by declining company performance.

 

The $1.7 million net change in unrealized appreciation in our investment in Vector Controls Holding Co., LLC was driven by overall company performance.

 

The $1.3 million net change in unrealized depreciation in our investment in Chronus LLC was driven by overall company performance.

 

The $1.2 million net change in unrealized appreciation in our investment in Avionte Holdings, Inc. was driven by overall company performance.

 

The $1.2 million net change in unrealized depreciation in our investment in Buildout, Inc. was driven by overall company performance.

 

92

 

 

For the year ended February 28, 2023, our investments had a net change in unrealized depreciation of $15.2 million compared to a net change in unrealized appreciation of $17.0 million for the year ended February 28, 2022. The most significant cumulative changes in unrealized appreciation (depreciation) for the year ended February 28, 2023, were the following (dollars in thousands):

 

Fiscal year ended February 28, 2023

 

Issuer  Asset Type  Cost   Fair Value   Total
Unrealized
Appreciation
(Depreciation)
   YTD Change in Unrealized
Appreciation
(Depreciation)
 
Pepper Palace, Inc.  First Lien Term Loan & Equity Interests  $34,256   $24,411   $(9,845)  $(9,327)
Artemis Wax Corp.  First Lien Term Loan & Equity Interests   60,059    63,642    3,583    1,460 
Vector Controls Holding Co., LLC  First Lien Term Loan & Equity Interests   3,090    9,608    6,518    3,099 
Axero Holdings, LLC  First Lien Term Loan & Equity Interests   10,551    13,052    2,500    1,952 
Destiny Solutions Inc.  First Lien Term Loan & Equity Interests   3,969    8,941    4,972    1,309 
Zollege PBC  First Lien Term Loan & Equity Interests   16,652    15,333    (1,319)   (1,185)
Netreo Holdings, LLC  First Lien Term Loan & Equity Interests   35,887    44,167    8,280    (2,363)
PDDS Buyer, LLC  First Lien Term Loan & Equity Interests   -    -    -    (5,094)
Saratoga Investment Corp. CLO 2013-1, Ltd.  Structured Finance Securities   28,944    21,177    (7,767)   (4,149)
Saratoga Senior Loan Fund I JV, LLC  Equity Interests   35,202    30,726    (4,476)   (3,368)

 

The $9.3 million net change in unrealized depreciation in our investment in Pepper Palace, Inc. was driven by overall company performance.

 

The $2.1 million net change in unrealized appreciation in our investment in Artemis Wax Corp. was driven by improved financial performance.

 

The $3.1 million net change in unrealized appreciation in our investment in Vector Controls Holding Co., LLC was driven by improved financial performance.

 

The $2.0 million net change in unrealized appreciation in our investment in Axero Holdings, LLC was driven by growth and overall strong financial performance.

 

The $1.3 million net change in unrealized appreciation in our investment in Destiny Solutions Inc. was driven by growth and overall strong financial performance.

 

The $1.2 million net change in unrealized depreciation in our investment in Zollege PBC was driven by weakened financial performance.

 

93

 

 

 

The $2.4 million net change in unrealized depreciation in our investment in Netreo Holdings, LLC was driven by increased leverage and slowing top line growth.

 

The $5.1 million net change in unrealized depreciation in our investment in PDDS Buyer, LLC was driven by the sale of that investment, resulting in a reversal of previously recognized unrealized appreciation reclassified to realized gains.

 

The $4.1 million net change in unrealized depreciation in our investment in Saratoga Investment Corp. CLO 2013-1 Ltd. was driven by the increase in discount rates and overall market conditions.

 

The $3.4 million net change in unrealized depreciation in our investment in Saratoga Senior Loan Fund I JV, LLC was driven by the increase in discount rates and overall market conditions. 

 

For the year ended February 28, 2022, our investments had a net change in unrealized appreciation of $17.0 million compared to a net change in unrealized appreciation of $5.0 million for the year ended February 28, 2021. The most significant cumulative changes in unrealized appreciation (depreciation) for the year ended February 28, 2022, were the following (dollars in thousands):

 

Fiscal year ended February 28, 2022

 

Issuer  Asset Type  Cost   Fair Value   Total
Unrealized
Appreciation
(Depreciation)
   YTD Change in Unrealized
Appreciation
(Depreciation)
 
ArbiterSports, LLC  First Term Lien Loan  $26,846   $26,654   $(192)  $1,140 
Artemis Wax  First Term Lien Loan & Equity Interests   36,774    38,234    1,460    1,460 
C2 Educational Systems  First Term Lien Loan & Equity Interests   18,985    18,820    (165)   2,334 
Destiny Solutions Inc.  First Term Lien Loan & Equity Interests   3,969    7,632    3,663    2,636 
GreyHeller LLC  First Term Lien Loan & Equity Interests   1,636    1,636    -    (3,103)
My Alarm Center, LLC  Equity Interests   -    -    -    4,686 
Netreo Holdings, LLC  First Term Lien Loan & Equity Interests   27,160    37,804    10,644    5,056 
Passageways, Inc.  First Term Lien Loan & Equity Interests   -    -    -    (2,311)
PDDS  First Term Lien Loan & Equity Interests   29,944    35,038    5,094    4,270 
Saratoga Investment Corp. CLO 2013-1, Ltd.  Structured Finance Securities   41,648    38,030    (3,618)   (1,675)
Saratoga Senior Loan Fund I JV, LLC  Unsecrued & Equity Interest   26,250    25,141    (1,109)   (1,109)
SCHOOX INVESTMENTS LLC  Equity Interests   476    3,306    2,830    2,830 
TG Pressure Washing Holdings  First Term Lien Loan & Equity Interests   488    482    (6)   1,060 
Village Realty Holdings LLC  First Term Lien Loan & Equity Interests   -    -    -    (2,183)
Vector Controls  First Term Lien Loan & Equity Interests   5,008    8,427    3,419    1,393 

 

94

 

 

The $1.1 million net change in unrealized appreciation in our investment in ArbiterSports, LLC was driven by improved financial performance.

 

The $1.5 million net change in unrealized appreciation in our investment in Artemis Wax was driven by improved financial performance.

 

The $2.3 million net change in unrealized appreciation in our investment in C2 Education Systems was driven by improved financial performance.

  

The $2.6 million net change in unrealized appreciation in our investment in Destiny Solutions Inc. was driven by growth and overall strong financial performance.

 

The $3.1 million net change in unrealized depreciation in our investment in GreyHeller LLC. was driven by the sale of that investment, resulting in a reversal of previously recognized unrealized appreciation reclassified to realized gains.

 

The $4.7 million net change in unrealized appreciation in our investment in My Alarm Center, LLC was driven by the reversal of previously recognized unrealized depreciation reclassified to realized losses.

 

The $5.1 million net change in unrealized appreciation in our investment in Netreo Holdings, LLC was driven by growth and improved financial performance.

 

The $2.3 million net change in unrealized depreciation in our investment in Passageways, Inc. was driven by the sale of that investment, resulting in a reversal of previously recognized unrealized appreciation reclassified to realized gains.

 

The $4.3 million net change in unrealized appreciation in our investment in PDDS Buyer, LLC was driven by overall strong company performance.

 

The $1.7 million net change in unrealized depreciation in our investment in Saratoga Investment Corp. CLO 2013-1 Ltd. was driven by the increase in discount rates, impact of LIBOR changes and overall market conditions. 

 

The $1.1 million net change in unrealized depreciation in our investment in Saratoga Senior Loan Fund I JV, LLC was driven by market volatility of the underlying investments of the fund.

 

The $2.8 million net change in unrealized appreciation in our investment in Schoox, Inc. was driven by overall strong company performance.

 

The $1.1 million net change in unrealized appreciation in our investment in Top Gun Pressure Washing, LLC was driven by growth, improved financial performance, and a reduced leverage profile.

 

The $2.2 million net change in unrealized depreciation in our investment in Village Realty Holdings, LLC was driven by the sale of that investment, resulting in a reversal of previously recognized unrealized appreciation reclassified to realized gains.

 

The $1.4 million net change in unrealized appreciation in our investment in Vector Controls. was driven by growth and overall strong financial performance.

 

95

 

 

Changes in net assets resulting from operations

 

For the fiscal years ended February 29, 2024, February 28, 2023 and February 28, 2022, we recorded a net increase in net assets resulting from operations of $8.9 million, $24.7 million and $45.7 million, respectively. Based on 12,670,939 weighted average common shares outstanding as of February 29, 2024, our per share net increase in net assets resulting from operations was $0.71 for the fiscal year ended February 29, 2024. This compares to a per share net increase in net assets resulting from operations of $2.06 for the fiscal year ended February 28, 2023 (based on 11,963,533 weighted average common shares outstanding as of February 28, 2023), and a per share net increase in net assets resulting from operations of $3.99 for the fiscal year ended February 28, 2022 (based on 11,456,631 weighted average common shares outstanding as of February 28, 2022).

 

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

 

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle-market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, the Encina Credit Facility and the Live Oak Credit Facility, our continued access to the SBA debentures future borrowings and future offerings of debt and equity securities.

 

Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan (“DRIP”), our equity ATM program, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current NAV per share and we are limited in our ability to sell our common stock at a price below NAV per share, we have been and may continue to be limited in our ability to raise equity capital.

 

In addition, we intend to distribute to our stockholders substantially all of our operating taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, in accordance with certain applicable provisions of the Code and the Treasury regulations and a revenue procedure issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. We may rely on the revenue procedure in future periods to satisfy our RIC distribution requirement.

 

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%, reduced to 150% effective April 16, 2019 following the approval received from our board of directors, including a majority of our independent directors, on April 16, 2018. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 161.1% as of February 29, 2024 and 165.9% as of February 28, 2023. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

 

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies, to pay dividends or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

 

Due to the diverse capital sources available to us at this time, we believe we have adequate liquidity to support our near term capital requirements.

 

96

 

 

Encina Credit Facility

 

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Encina Lender Finance, LLC on October 4, 2021 (the “Encina Credit Facility”).

 

Commitment. We entered into the Credit and Security Agreement (the “Encina Credit Agreement”) relating to the Encina Credit Facility in the initial facility amount of $50.0 million (the “Facility Amount”). 

 

Availability. We can draw up to the lesser of (i) the Facility Amount and (ii) the Borrowing Base. The Borrowing Base is an amount equal to (i) the difference of (A) the product of the applicable advance rate which varies from 50.0% to 75.0% depending on the type of loan asset (Defaulted Loans being excluded in that they carry an advance rate of 0%) and the value, determined in accordance with the Encina Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base Value”) and (B) the Excess Concentration Amount, as calculated in accordance with the Encina Credit Facility, plus (ii) any amounts held in the Prefunding Account and, without duplication, Excess Cash held in the Collection Account, less (iii) the product of (a) the amount of any undrawn funding commitments we have under any loan asset and (b) the Unfunded Exposure Haircut Percentage, and less (iv) $100,000. Each loan asset we held as of the date on which the Encina Credit Facility was closed was valued as of that date and each loan asset that we acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things and under certain circumstances, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

 

The Encina Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, we may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

 

The Encina Credit Facility requires certain minimum drawn amounts. For the period beginning on the closing date and ended April 4, 2022, the minimum funding amount was $12.5 million. For the period beginning on April 5, 2022 through maturity, the minimum funding amount is the greater of $25.0 million and 50% of the Facility Amount in effect from time to time.

 

Collateral. The Encina Credit Facility is secured by assets of Saratoga Investment Funding II LLC (“SIF II”) and pledged to the lender under the credit facility. SIF II is a wholly owned special purpose entity formed for the purpose of entering into the Encina Credit Facility.

 

Interest Rate and Fees. Under the Encina Credit Facility, funds were borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 0.75%, plus an applicable margin of 4.00%. The Encina Credit Agreement includes benchmark replacement provisions which permit the Administrative Agent and the borrower to select a replacement rate upon the unavailability of LIBOR. In addition, we pay the lenders a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility for the duration of the term of the Encina Credit Facility. Accrued interest and commitment fees are payable monthly in arrears. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Encina Credit Facility.

 

Collateral Tests. It is a condition precedent to any borrowing under the Encina Credit Facility that the principal amount outstanding under the Encina Credit Facility, after giving effect to the proposed borrowings, not exceed the Borrowing Base (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

 

  o Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Encina Credit Facility, to accrued interest and commitment fees payable to the lenders under the Encina Credit Facility for the last 6 payment periods must equal at least 175.0%.

 

  o Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets (in each case, subject to certain adjustments) to outstanding borrowings under the Encina Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

 

97

 

 

The Encina Credit Facility also may require payment of outstanding borrowings or replacement of pledged loan assets upon our breach of our representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such ineligible collateral loans will be excluded from the calculation of the Borrowing Base and may lead to a Borrowing Base Deficiency, which may be cured by effecting one or more (or any combination thereof) of the following actions: (A) deposit into or credit to the collection account cash and eligible investments, (B) repay outstanding borrowings (together with certain costs and expenses), (C) sell or substitute loan assets in accordance with the Encina Credit Facility, or (D) pledge additional loan assets as collateral. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by us.

 

Priority of Payments. The priority of payments provisions of the Encina Credit Facility require, after payment of specified fees and expenses, that collections of interest from the loan assets and, to the extent that these are insufficient, collections of principal from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met.

 

Operating Expenses. The priority of payments provision of the Encina Credit Facility provides for the payment of certain of our operating expenses out of collections on interest and principal in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $200,000 per annum.

  

Covenants; Representations and Warranties; Events of Default. The Encina Credit Agreement contains customary representations and warranties, affirmative covenants, negative covenants and events of default. The Encina Credit Agreement does not contain grace periods for breach by us of any negative covenants or of certain of the affirmative covenants, including, without limitation, those related to preservation of the existence and separateness of the Company. Other events of default under the Encina Credit Agreement include, among other things, the following:

 

  o our failure to maintain an Interest Coverage Ratio of less than 175%;

 

  o our failure to maintain an Overcollateralization Ratio of less than 200%;

 

  o the filing of certain ERISA or tax liens on our assets or the Equity holder;

 

  o failure by Specified Holders to collectively, directly or indirectly, own and control at least 51% of the outstanding equity interests of Saratoga Investment Advisor, or (y) possess the right to elect (through contract, ownership of voting securities or otherwise) at all times a majority of the board of directors (or similar governing body) of Saratoga Investment Advisor and to direct the management policies and decisions of Saratoga Investment Advisor, or (ii) the dissolution, termination or liquidation in whole or in part, transfer or other disposition, in each case, of all or substantially all of the assets of, Saratoga Investment Advisor;

 

  o indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed to replace such key person within 30 days;

 

  o resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed within 30 days.

 

98

 

 

Fees and Expenses. We paid certain fees and reimbursed Encina Lender Finance, LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Encina Lender Finance, LLC in connection with the Encina Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing. These amounts totaled $1.4 million.

 

On January 27, 2023, we entered into the first amendment to the Encina Credit Agreement to, among other things:

 

  increase the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

 

  change the underlying benchmark used to compute interest under the Encina Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

 

  increase the applicable effective margin rate on borrowings from 4.00% to 4.25%;

 

  extend the revolving period from October 4, 2024 to January 27, 2026;

 

  extend the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a “Facility Increase”) from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to the Encina Facility Increase from $75.0 million to $150.0 million;

 

  revised the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

 

  amended the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Encina Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

  

As of February 29, 2024, we had $35.0 million outstanding borrowings under the Credit Facility and $214.0 million of SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2023, we had $32.5 million outstanding borrowings under the Credit Facility and $202.0 million of SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at February 29, 2024 and February 28, 2023 was $65.0 million and $65.0 million, respectively.

 

Our asset coverage ratio, as defined in the 1940 Act, was 161.1% as of February 29, 2024 and 165.9% as of February 28, 2023.

 

SBA-guaranteed debentures

 

In addition, we, through three wholly owned subsidiaries, sought and obtained licenses from the SBA to operate an SBIC. In this regard, our wholly owned subsidiaries, SBIC LP, SBIC II LP, and SBIC III LP, received an SBIC license from the SBA on March 28, 2012, August 14, 2019, and September 29, 2022, respectively. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Following the debentures being fully repaid to the SBA, SBIC LP surrendered its license on January 3, 2023, and SBIC LP subsequently merged with and into the Company.

 

The SBIC license allows our SBIC Subsidiaries to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

 

99

 

 

The SBIC Subsidiaries are regulated by the SBA. SBA regulations currently limit the amount that our SBIC Subsidiaries may borrow to a maximum of $175.0 million of SBA debentures when it has at least $87.5 million in regulatory capital, subject to the SBA’s approval. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million. Our wholly owned SBIC Subsidiaries are able to borrow funds from the SBA against regulatory capital (which generally approximates equity capital in the respective SBIC) and is subject to customary regulatory requirements, including, but not limited to, periodic examination by the SBA.

 

We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC Subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows us increased flexibility under the asset coverage test by permitting us to borrow up to $350.0 million more than we would otherwise be able to absent the receipt of this exemptive relief. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our independent directors, approved of our becoming subject to a minimum asset coverage ratio of 150% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150% asset coverage ratio became effective on April 16, 2019.

 

As of February 29, 2024, SBIC LP had $0.0 million in regulatory capital and $0.0 million SBA-guaranteed debentures outstanding. SBIC II LP had $87.5 million in regulatory capital and $175.0 million SBA-guaranteed debentures outstanding. SBIC III LP had $66.7 million in regulatory capital and $39.0 million SBA-guaranteed debentures outstanding.

 

Unsecured notes

 

7.25% 2025 Notes

 

On June 24, 2020, we issued $37.5 million aggregate principal amount of our 7.25% 2025 Notes for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.3 million. On July 6, 2020, the underwriters exercised their option in full to purchase an additional $5.625 million in aggregate principal amount of its 7.25% 2025 Notes. Net proceeds to the Company were $5.4 million after deducting underwriting commissions of approximately $0.2 million. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and were amortized over the term of the 7.25% 2025 Notes.

 

On July 14, 2022, we redeemed $43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes. The 7.25% 2025 Notes were listed on the NYSE under the trading symbol of “SAK” and have been delisted following the full redemption on July 14, 2022.

 

At February 29, 2024, the total 7.25% 2025 Notes outstanding was $0.0 million.

 

7.75% 2025 Notes

 

On July 9, 2020, we issued $5.0 million aggregate principal amount of our 7.75% fixed-rate notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option, subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the Notes. The 7.75% 2025 Notes are not listed and have a par value of $25.00 per note.

 

At February 29, 2024, the total 7.75% 2025 Notes outstanding was $5.0 million.

 

100

 

 

6.25% 2027 Notes

 

On December 29, 2020, we issued $5.0 million in aggregate principal amount of our 6.25% fixed-rate notes due in 2027 (the “6.25% 2027 Notes”).  Offering costs incurred were approximately $0.1 million.  Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at our option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

 

On January 28, 2021, we issued an additional $10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million (the “Additional 6.25% 2027 Notes”). The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at our option on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.

 

At February 29, 2024, the total 6.25% 2025 Notes outstanding was $15.0 million.

 

4.375% 2026 Notes

 

On March 10, 2021, we issued $50.0 million in aggregate principal amount of the 4.375% fixed rate notes due 2026 (the “4.375% 2026 Notes”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million.  Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.2 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

 

On July 15, 2021, we issued an additional $125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the “Additional 4.375% 2026 Notes”) for net proceeds for approximately $123.5 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting discount of $2.5 million and the offering expenses of approximately $0.2 million payable by the Company. The net proceeds from the offering were used to redeem all of the outstanding 6.25% 2025 Notes (as described above), and for general corporate purposes in accordance with our investment objective and strategies. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes.

 

At February 29, 2024 the total 4.375% Notes outstanding was $175.0 million.

 

4.35% 2027 Notes

 

On January 19, 2022, we issued $75.0 million in aggregate principal amount of our 4.35% fixed-rate Notes due in 2027 (the “4.35% 2027 Notes”) for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million.  Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at our option at any time prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes.

 

At February 29, 2024 the total 4.35% Notes outstanding was $75.0 million.

 

101

 

 

6.00% 2027 Notes

 

On April 27, 2022, we issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the “6.00% 2027 Notes”) for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds were $9.7 million after deducting underwriting commissions of approximately $0.3 million. Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAT” with a par value of $25.00 per note.

 

On August 15, 2022, we issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the “Additional 6.00% 2027 Notes”) for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Additional offering costs incurred were approximately $0.03 million. Additional financing costs of $0.03 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.

 

At February 29, 2024 the total 6.00% 2027 Notes outstanding was $105.5 million.

 

7.00% 2025 Notes

 

On September 8, 2022, we issued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the “7.00% 2025 Notes”) for net proceeds of $11.6 million after deducting customary fees and offering expenses of approximately $0.4 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.05 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

 

At February 29, 2024 the total 7.00% 2025 Notes outstanding was $12.0 million.

 

8.00% 2027 Notes

 

On October 27, 2022, we issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.1 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.73 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol “SAJ” with a par value of $25.00 per note.

 

 At February 29, 2024 the total 8.00% 2027 Notes outstanding was $46.0 million.

 

102

 

 

8.125% 2027 Notes

 

On December 13, 2022, we issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.875 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $25.00 per note.

 

At February 29, 2024, the total 8.125% 2027 Notes outstanding was $60.4 million.

 

8.75% 2025 Notes

 

On March 31, 2023, we issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the “8.75% 2025 Notes”) for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, we issued an additional $10.0 million in aggregate principal amount of the 8.75% 2024 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year.  On February 2, 2024, pursuant to the terms of the indenture governing the 8.75% 2025 Notes, we elected to exercise our option to extend the maturity date of the 8.75% 2025 Notes from March 31, 2024 to March 31, 2025. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2025 Notes have been capitalized and are being amortized over the term of the 8.75% 2025 Notes.

 

At February 29, 2024, the total 8.75% 2025 Notes outstanding was $20.0 million.

 

8.50% 2028 Notes

 

On April 14, 2023, we issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year.  The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at our option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $25.00 per note.

 

At February 29, 2024, the total 8.50% 2028 Notes outstanding was $57.5 million.

 

At February 29, 2024 and February 28, 2023, the fair value of total cash and cash equivalents, cash and cash equivalents in reserve accounts and total investments by major category are as follows:

 

   February 29, 2024    February 28, 2023 
   Fair Value   Percentage
of Total
   Fair Value   Percentage
of Total
 
   ($ in thousands) 
Cash and cash equivalents  $8,693    0.8%  $65,746    6.2%
Cash and cash equivalents, reserve accounts   31,814    2.7    30,330    2.8 
First lien term loans   976,423    82.8    798,534    74.7 
Second lien term loans   18,097    1.5    14,936    1.4 
Structured finance securities   30,626    2.6    41,362    3.9 
Unsecured loan   15,818    1.3    20,661    1.9 
Equity interests   97,830    8.3    97,097    9.1 
Total  $1,179,301    100.0%  $1,068,666    100.0%

 

103

 

 

Equity Capital Activities

 

Share Repurchases

 

On September 24, 2014, we announced the approval of the Share Repurchase Plan. Since September 24, 2014, the Share Repurchase Plan has been extended annually, and we have periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan. Most recently, on January 9, 2023, our board of directors extended the Share Repurchase Plan for another year to January 15, 2024, increasing the number of shares that may be repurchased under the Share Repurchase Plan to 1.7 million shares of common stock. As of February 29, 2024, we purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three months ended February 29, 2024 we did not purchased shares of common stock pursuant to the Share Repurchase Plan. During the year ended February 29, 2024 we purchased 88,576 shares of common stock, at the average price $24.36 for approximately $2.2 million pursuant to the Share Repurchase Plan.

 

Public Equity Offering

 

On July 13, 2018, we issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. We also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.

 

Equity ATM Program

 

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, we amended our equity distribution agreement to add BB&T Capital Markets and B. Riley FBR, Inc. as sales agents in our ATM offering. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, we had sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs).

 

On July 30, 2021, we entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Ladenburg Thalmann & Co. Inc. and Compass Point Research and Trading, LLC, each as agents (the “Agents”), through which we may offer for sale, from time to time, up to $150.0 million of our common stock through the Agents, or to them, as principal for their account (the “ATM Program”).

 

On July 6, 2023, we amended the Equity Distribution Agreement to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $300.0 million from $150.0 million, and on July 19, 2023, we amended the Equity Distribution Agreement to add an additional distribution agent, Raymond James & Associates. The sales price per share of our common stock offered under the ATM Program, less the Agents’ commission, will not be less than the NAV per share of our common stock at the time of such sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

 

As of February 29, 2024 we sold 6,543,878 shares for gross proceeds of $172.5 million at an average price of $26.37 for aggregate net proceeds of $171.0 million (net of transaction costs). During the three months ended February 29, 2024, we sold 501,105 shares for gross proceeds of $14.3 million at an average price of $28.44 for aggregate net proceeds of $14.3 million (net of transaction costs). During the year ended February 29, 2024, we sold 1,703,517 shares for gross proceeds of $49.0 million at an average price of $28.51 for aggregate net proceeds of $49.0 million (net of transaction costs). The Manager agreed to reimburse the Company to the extent the per share price of the shares to the public, less underwriting fees, was less than net asset value per share. For the three months ended February 29, 2024, the Manager reimbursed the Company $1.4 million. For the year ended February 29, 2024, the Manager reimbursed the Company $4.5 million. 

 

104

 

 

Dividend Distributions

 

We have distributed or intend to distribute sufficient dividends to eliminate taxable income for our completed tax years. If we fail to satisfy the 90% distribution requirement or otherwise fail to qualify as a RIC in any tax year, we would be subject to U.S. federal income tax in that year on all of our taxable income imposed at corporate rates, regardless of whether we made any distributions to our shareholders. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Our distributions for the tax years ended February 29, 2024 to inception were as follows:

 

Payment date  Cash Dividend   
Tax Year Ended February 28, 2025     
March 28, 2024  $0.73(45) 
   $0.73  
Tax Year Ended February 29, 2024      
December 28, 2023  $0.72(44) 
September 28, 2023   0.71(43) 
June 29, 2023   0.70(42) 
March 30, 2023   0.69(1) 
   $2.82  
Tax Year Ended February 28, 2023      
January 4, 2023  $0.68(2) 
September 29, 2022   0.54(3) 
June 29, 2022   0.53(4) 
March 28, 2022   0.53(5) 
   $2.28  
Tax Year Ended February 28, 2022      
January 19, 2022  $0.53(6) 
September 28, 2021   0.52(7) 
June 29, 2021   0.44(8) 
April 22, 2021   0.43(9) 
   $1.92  
Tax Year Ended February 28, 2021      
February 10, 2021  $0.42(10) 
November 10, 2020   0.41(11) 
August 12, 2020   0.40(12) 
   $1.03  
Tax Year Ended February 29, 2020      
February 6, 2020  $0.56(13) 
September 26, 2019   0.56(14) 
June 27, 2019   0.55(15) 
March 28, 2019   0.54(16) 
   $2.21  
Tax Year Ended February 28, 2019      
January 2, 2019  $0.53(17) 
September 27, 2018   0.52(18) 
June 27, 2018   0.51(19) 
March 26, 2018   0.50(20) 
   $2.06  
Tax Year Ended February 28, 2018      
December 27, 2017  $0.49(21) 
September 26, 2017   0.48(22) 
June 27, 2017   0.47(23) 
March 28, 2017   0.46(24) 
   $1.90  
Tax Year Ended February 28, 2017      
February 9, 2017  $0.45(25) 
November 9, 2016   0.44(26) 
September 5, 2016   0.20(27) 
August 9, 2016   0.43(28) 
April 27, 2016   0.41(29) 
   $1.93  
Tax Year Ended February 29, 2016      
February 29, 2016  $0.40(30) 
November 30, 2015   0.36(31) 
August 31, 2015   0.33(32) 
June 5, 2015   1.00(33) 
May 29. 2015   0.27(34) 
   $2.36  
Tax Year Ended February 28, 2015      
February 27, 2015  $0.22(35) 
November 28, 2014   0.18(36) 
   $0.40  
Tax Year Ended February 28. 2014      
December 27, 2013  $2.65(37) 
   $2.65  
Tax Year Ended February 28, 2013      
December 31, 2012  $4.25(38) 
   $4.25  
Tax Year Ended February 29, 2012      
December 30, 2011  $3.00(39) 
   $3.00  
Tax Year Ended February 28, 2011      
December 29, 2010  $4.40(40) 
   $4.40  
Tax Year Ended February 28, 2010      
December 31, 2009  $18.25(41) 
   $18.25  

 

105

 

 

(1) Based on shareholder elections, the dividend consisted of approximately $7.1 million in cash and 45,818 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 17, 20, 21, 22, 23, 24, 27, 28, 29, and 30, 2023.

 

(2) Based on shareholder elections, the dividend consisted of approximately $6.8 million in cash and 53,615 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.26 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21, 22, 23, 27, 28, 29 and 30 2022 and January 3 and 4, 2023.
   
(3) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 52,312 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.00 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 16, 19, 20, 21, 22, 23, 26, 27, 28 and 29, 2022.
   
(4) Based on shareholder elections, the dividend consisted of approximately $5.1 million in cash and 48,590 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.40 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 17, 21, 22, 23, 24, 27, 28 and 29, 2022.
   
(5) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 42,825 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.89 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 18, 21, 22, 23, 24, 25 and 28, 2022.
   
(6) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 41,520 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 5, 6, 7, 10, 11, 12, 13, 14, 18 and 19, 2022.
   
(7) Based on shareholder elections, the dividend consisted of approximately $4.9 million in cash and 38,016 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.77 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2021.
   
(8) Based on shareholder elections, the dividend consisted of approximately $4.1 million in cash and 33,100 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.03 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 16, 17, 18, 21, 22, 23, 24, 25, 28 and 29, 2021.

 

106

 

 

(9) Based on shareholder elections, the dividend consisted of approximately $3.9 million in cash and 38,580 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.69 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 9,12, 13, 14, 15, 16, 19, 20, 21 and 22, 2021.
   
(10) Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 41,388 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.75 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 28, 29 and February 1, 2, 3, 4, 5, 8, 9 and 10, 2021.

 

(11) Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9 and 10, 2020.
   
(12) Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.

 

(13) Based on shareholder elections, the dividend consisted of approximately $5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3, 4, 5 and 6, 2020.
   
(14) Based on shareholder elections, the dividend consisted of approximately $4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25 and 26, 2019.

 

(15) Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.65 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2019.
   
(16) Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.

 

107

 

 

(17) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018 and January 2, 2019.
   
(18) Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2018.
   
(19) Based on shareholder elections, the dividend consisted of approximately $2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2018.
   
(20) Based on shareholder elections, the dividend consisted of approximately $2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $19.91 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26, 2018.

 

(21) Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.
   
(22) Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.
   
(23) Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

 

(24) Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

 

108

 

 

(25) Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.
   
(26) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.
   
(27) Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.
   
(28) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.

 

(29) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.
   
(30) Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.

 

(31) Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.
   
(32) Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.
   
(33) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5, 2015.

 

109

 

 

(34)Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.

 

(35) Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.
   
(36) Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.
   
(37) Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.
   
(38) Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.
   
(39) Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.
   
(40) Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.
   
(41) Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

 

110

 

 

(42) Based on shareholder elections, the dividend consisted of approximately $7.6 million in cash and 29,627 newly issued shares of common stock, or 0.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.29 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 20, 21, 22, 23, 26, 27, 28, and 29, 2023.
   
(43) Based on shareholder elections, the dividend consisted of approximately $8.4 million in cash and 35,196 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.41 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2023.
   
(44) Based on shareholder elections, the dividend consisted of approximately $8.9 million in cash and 37,394 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 14, 15, 18, 19, 20, 21, 22, 26, 27, and 28, 2023.
   
(45) Based on shareholder elections, the dividend consisted of approximately $9.0 million in cash and 45,490 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2024.

 

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

 

Subsequent Events

 

Live Oak Facility

 

On March 27, 2024, we and our wholly owned special purpose subsidiary, Saratoga Investment Funding III LLC (“SIF III”), entered into a credit and security agreement (the “Live Oak Credit Agreement”), by and among SIF III, as borrower, us, as collateral manager and equity holder, the lenders from time to time parties thereto, Live Oak Banking Company (“Live Oak”), as administrative agent and collateral agent, U.S. Bank National Association, as custodian, and U.S. Bank Trust Company, National Association, as collateral administrator, relating to a special purpose vehicle financing credit facility (the “Live Oak Credit Facility”).

 

The Live Oak Credit Facility provides for borrowings in U.S. dollars in an aggregate amount of up to $50.0 million. During the first two years following the closing date, SIF III may request one or more increases in the commitment amount from $50.0 million to an amount not to exceed $150.0 million, subject to certain terms and conditions and a customary fee. The terms of the Live Oak Credit Agreement require a minimum drawn amount of $12.5 million at all times during the period ending March 27, 2025 and, thereafter, the greater of: (i) $25.0 million and (ii) 50% of the facility amount in effect at such time. The Live Oak Credit Facility matures on March 27, 2027. Advances are available during the term of the Live Oak Credit Facility and must be repaid in full at maturity. SIF III may request an extension of the maturity date by an additional one year, subject to the agreement of the lenders and an extension fee.

 

111

 

 

Advances under the Live Oak Credit Facility are subject to a borrowing base calculation, and the Live Oak Credit Facility has various eligibility criteria for loans to be included in the borrowing base. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to Adjusted Term SOFR plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility’s utilization. The Live Oak Credit Agreement also provides for an unused fee of 0.50% on the unused commitments. SIF III’s obligations to the lenders under the Live Oak Credit Facility are secured by a first priority security interest in substantially all of SIF III’s assets. In addition, SIF III’s obligations to the lenders under the Live Oak Credit Facility are secured by a pledge by us of our equity interests in SIF III, which is evidenced by the equity pledge agreement, dated as of March 27, 2024, by and between us, as pledgor, and Live Oak, as collateral agent for the benefit of the secured parties.

 

In connection with the Live Oak Credit Agreement, we entered into a loan sale and contribution agreement with SIF III, dated as of March 27, 2024, by and between us, as seller, and SIF III, as purchaser, pursuant to which we will sell or contribute certain loans held by us to SIF III to be used to support the borrowing base under the Live Oak Credit Facility. The Live Oak Credit Facility permits loan proceeds and excess cash in SIF III’s collection accounts to be distributed to us at any time based on three business days advance notice, subject to compliance with various conditions, including the absence of a default or event of default, the absence of an over-advance against the borrowing base and the absence of a violation of the financial covenants.

 

Contractual obligations

 

The following table shows our payment obligations for repayment of debt and other contractual obligations at February 29, 2024:

 

       Payment Due by Period 
Long-Term Debt Obligations  Total   Less Than
1 Year
   1 - 3
Years
   3 - 5
Years
   More Than
5 Years
 
       ($ in thousands) 
Encina credit facility    $35,000   $-   $35,000   $-   $- 
SBA debentures   214,000    -    -    -    214,000 
8.75% 2025 Notes     20,000    -    20,000    -    - 
7.00% 2025 Notes   12,000    -    12,000    -    - 
7.75% 2025 Notes     5,000    -    5,000    -    - 
4.375% 2026 Notes   175,000    -    175,000    -    - 
4.35% 2027 Notes     75,000    -    75,000    -    - 
6.00% 2027 Notes   105,500    -    -    105,500    - 
6.25% 2027 Notes     15,000    -    -    15,000    - 
8.00% 2027 Notes   46,000    -    -    46,000    - 
8.125% 2027 Notes     60,375    -    -    60,375    - 
8.50% 2028 Notes   57,500    -    -    57,500    - 
Total Long-Term Debt Obligations  $820,375   $-   $322,000   $284,375   $214,000 

 

Off-balance sheet arrangements

 

At February 29, 2024 and February 28, 2023, our off-balance sheet arrangements consisted of $132.4 million and $108.8 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to our discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in our consolidated statements of assets and liabilities.

 

112

 

 

A summary of the unfunded commitments outstanding as of February 29, 2024 and February 28, 2023 is shown in the table below (dollars in thousands):

 

   February 29,
2024
   February 28,
2023
 
At Company’s discretion        
ActiveProspect, Inc.  $10,000   $10,000 
Artemis Wax Corp.    23,500    - 
Ascend Software, LLC   5,000    5,000 
Granite Comfort, LP    750    15,000 
JDXpert   5,000    5,000 
LFR Chicken LLC    -    4,000 
Pepper Palace, Inc.   1,898    3,000 
Procurement Partners, LLC    4,250    4,250 
Saratoga Senior Loan Fund I JV, LLC   8,548    8,548 
Sceptre Hospitality Resources, LLC    5,000    5,000 
Stretch Zone Franchising, LLC   3,750    - 
VetnCare MSO, LLC    10,000    - 
Total  $77,696   $59,798 
           
At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required          
Alpha Aesthetics Partners OpCo, LLC  $6,500   $- 
ARC Health OpCo LLC    2,585    10,773 
Artemis Wax Corp.   -    8,500 
Ascend Software, LLC    -    3,200 
Axero Holdings, LLC - Revolver   500    500 
Axiom Medical Consulting, LLC    2,000    - 
BQE Software, Inc.   3,250    - 
C2 Educational Systems    3,000    - 
Davisware, LLC   750    - 
Exigo, LLC    -    4,167 
Exigo, LLC - Revolver   1,042    833 
Gen4 Dental Partners Holdings, LLC    -    11,000 
GoReact   2,500    2,500 
Granite Comfort, LP    11,637    - 
JDXpert   -    1,000 
Inspect Point Holding, LLC    1,500    - 
Pepper Palace, Inc. - Delayed Draw Term Loan   -    2,000 
Pepper Palace, Inc. - Revolver    2,500    2,500 
Procurement Partners, LLC   -    1,000 
Stretch Zone Franchising, LLC    1,500    - 
VetnCare MSO, LLC   15,319    - 
Zollege PBC    150    1,000 
    54,733    48,973 
Total   $132,429   $108,771 

 

We believe our assets will provide adequate coverage to satisfy these unfunded commitments. As of February 29, 2024, we had cash and cash equivalents of $8.7 million and $31.8 million in available borrowings under the Encina Credit Facility.

 

113

 

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK SUTHERLAND TO UPDATE

 

Our business activities contain elements of market risk. We consider the fluctuation in interest rates to be our principal market risk. Managing this risk is essential to our business. Accordingly, we have systems and procedures designed to identify and analyze our risks, to establish appropriate policies and thresholds and to continually monitor this risk and thresholds by means of administrative and information technology systems and other policies and processes.

 

Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, including relative changes in different interest rates, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest-bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire leveraged loans, high yield bonds and other debt investments and the value of our investment portfolio.

 

Our investment income is affected by fluctuations in various interest rates, including SOFR and the prime rate. Substantially all of our portfolio is, and we expect will continue to be, comprised of floating rate investments that utilize SOFR or an alternate rate. Since March 2022, the Federal Reserve has been rapidly raising interest rates in response to ongoing inflation concerns. Although the Federal Reserve left its benchmark rates steady in the fourth quarter of 2023, it has indicated that additional rate increases in the future may be necessary to mitigate inflationary pressures and there can be no assurance that the Federal Reserve will not make upwards adjustments to the federal funds rate in the future. However, there are reports that the Federal Reserve may begin to cut the benchmark rates in 2024. In a rising interest rate environment, our cost of funds would increase, which could reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve’s tightening cycle could result in a recession in the United States, which would likely decrease interest rates. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR, are not offset by corresponding increases in the spread over such base rates that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities. Our interest expense is affected by fluctuations in SOFR on our Encina Credit Facility. In addition, all of our assets have been transitioned from LIBOR to an acceptable replacement rate, such as SOFR.

 

At February 29, 2024, we had $785.4 million of borrowings outstanding. There were $35.0 million borrowings outstanding under the Encina Credit Facility as of February 29, 2024. As of February 29, 2024, on a fair value basis, approximately 0.5% of our debt investments bear interest at a fixed-rate and approximately 99.5% of our debt investments bear interest at a floating rate. As of February 29, 2024, 0% of our floating rate debt investments are subject to interest rate floors.  Additionally, the Encina Credit Facility also is subject to a floating interest rate and is currently paid based on floating Term SOFR rate.

 

We have analyzed the potential impact of changes in interest rates on interest income from investments. Assuming that our investments as of February 29, 2024 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately $10.4 million to our interest income. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately $10.4 million to our interest income.

 

Changes in interest rates would have no impact to our current interest and debt financing expense, as all our borrowings except for our credit facility are fixed rate, and our credit facility is currently undrawn.

 

Although management believes that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the statements of assets and liabilities and other business developments that could magnify or diminish our sensitivity to interest rate changes, nor does it account for divergences in SOFR and the commercial paper rate, which have historically moved in tandem but, in times of unusual credit dislocations, have experienced periods of divergence. Accordingly, no assurances can be given that actual results would not materially differ from the potential outcome simulated by this estimate.

 

114

 

 

For further information, the following table shows the approximate annualized increase or decrease in the components of net investment income due to hypothetical base rate changes in interest rates, assuming no changes in our investments and borrowings as of February 29, 2024.

 

    Increase   (Increase)   Increase   Increase   Increase 
Basis   (Decrease)   Decrease   (Decrease) in Net   (Decrease) in Net   (Decrease) in Net 
Point   in Interest   in Interest   Investment   Investment   Investment 
Change   Income   Expense   Income   Income*   Income per Share 
    ($ in thousands)     
 -100   $(10,431)  $350   $(10,081)  $(8,065)  $(0.59)
 -50    (5,215)   175    (5,040)   (4,032)   (0.30)
 -25    (2,608)   88    (2,520)   (2,016)   (0.15)
 25    2,608    (88)   2,520    2,016    0.15 
 50    5,215    (175)   5,040    4,032    0.30 
 100    10,431    (350)   10,081    8,065    0.59 
 200    20,862    (700)   20,162    16,130    1.18 
 300    31,448    (1,050)   30,398    24,318    1.78 
 400    42,079    (1,400)   40,679    32,543    2.38 

 

 

*Adjusts Net Interest Income for the impact of the first incentive fee on Net Investment Income

 

The table above assumes no defaults or prepayments by portfolio companies over the next twelve months. The hypothetical results would also be impacted by the changes in the amount of debt outstanding under our Encina Credit Facility, with an increase (decrease) in the debt outstanding under the Encina Credit Facility resulting in an (increase) decrease in the hypothetical interest expense.

 

ITEM 8. CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

Our consolidated financial statements are annexed to this Annual Report beginning on page F-1. In addition, the Financial Statements of Saratoga Investment Corp. CLO 2013-1, Ltd. are annexed to this Annual Report beginning on page S-1.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Evaluation of disclosure controls and procedures

 

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Exchange Act. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

115

 

 

Management’s annual report on internal control over financial reporting

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with U.S. GAAP. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that the receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with polices or procedures may deteriorate.

 

Under the supervision and with participation of our Chief Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of internal control over financial reporting based on the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on the Company’s evaluation under the framework in Internal Control—Integrated Framework (2013), management concluded that the Company’s internal control over financial reporting was effective as of February 29, 2024.

 

Changes in internal controls over financial reporting

 

There have been no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) of Exchange Act) that occurred during our most recently completed fiscal year that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

a)None.

 

b)During the fiscal quarter ended February 29, 2024, no director or officer of the Company has entered into (i) any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

 

The Company has adopted insider trading policies and procedures governing the purchase, sale, and disposition of the Company’s securities by officers and directors of the Company that are reasonably designed to promote compliance with insider trading laws, rules and regulations.

 

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

116

 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE PLEASE HAVE ROCHELLE REVIEW THIS SECTION

 

Director and Executive Officer Information

 

Directors and Executive Officers

 

The following table sets forth the names, ages and positions held by each of our directors, followed by a brief biography of each individual, including the business experience of each individual during the past five years and the specific qualifications that led to the conclusion that each individual should serve as a director.

 

Name   Age   Position   Director Since   Term Expires
Interested Directors                
Christian L. Oberbeck   64   Chairman of the Board, Chief Executive Officer and President   2010   2024
Henri J. Steenkamp   48   Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary   2020   2026
Independent Directors                
Steven M. Looney   74   Director   2007   2025
Charles S. Whitman III   82   Director   2007   2025
G. Cabell Williams   70   Director   2007   2026

 

Christian L. Oberbeck— Mr. Oberbeck has over 37 years of experience in leveraged finance, including acquisition financing, distressed investing, and private equity, and has been involved in originating, structuring, negotiating, consummating, managing, operating, and monitoring minority and control investments in a broad array of businesses. Mr. Oberbeck is the Founder and Managing Member of Saratoga Investment Advisors, LLC, the Company’s investment adviser, and has served as the Chairman of the Board, Chief Executive Officer, and President of the Company since 2010. Mr. Oberbeck is also the Managing Partner of Saratoga Partners, a middle-market private equity investment firm. Prior to assuming full management responsibility for Saratoga Partners in 2008, Mr. Oberbeck had co-managed Saratoga Partners since 1995. Mr. Oberbeck joined Dillon Read and Saratoga Partners from Castle Harlan, Inc., a corporate buyout firm which he had joined at its founding in 1987 and was a Managing Director, leading successful investments in manufacturing and financial services companies. Prior to that, he worked in the Corporate Development Group of Arthur Young and in corporate finance at Blyth Eastman Paine Webber. Mr. Oberbeck has been a director of numerous middle-market companies. Mr. Oberbeck graduated from Brown University in 1982 with a BS in Physics and a BA in Mathematics. In 1985, he earned an MBA from Columbia University. Mr. Oberbeck’s qualifications as a director include his extensive experience in the investment and finance industry, as well as his intimate knowledge of the Company’s operations gained through his service as an executive officer.

 

Steven M. Looney — Mr. Looney has served as member of our Board since 2007. Mr. Looney is a Managing Director of Peale Davies & Co. Inc., a strategic advisory firm specializing in change management and revenue enhancement for middle-market enterprises, and is a CPA and an attorney. Mr. Looney has served as a consultant and director to numerous companies in the healthcare, manufacturing and services industries. Between 2000 and 2005, he served as Senior Vice President and Chief Financial Officer of PCCI, Inc., a private IT staffing and outsourcing firm. Between 1992 and 2000, Mr. Looney worked at WH Industries as Chief Financial and Administrative Officer. Mr. Looney is a trustee of Excellent Education for Everyone, a nonprofit organization and founder of its affiliate, TradePrep and a director of ICG Loan Funding Ltd., a manager of and investor in collateralized loan portfolios in Europe and the United States. Mr. Looney graduated summa cum laude from the University of Washington with a B.A. degree in accounting and received a J.D. from the University of Washington School of Law where he was a member of the law review. He began his career at the SEC. Mr. Looney’s qualifications as director include his experience as a Managing Director of Peale Davies & Co., as Chief Financial and Administrative Officer of WH Industries and as General Counsel and Chief Compliance Officer of A.G. Becker-Warburg Paribas Becker, as well as his financial, accounting and legal expertise. 

 

Charles S. Whitman III—Mr. Whitman has served as member of our Board since 2007. Mr. Whitman is senior counsel (retired) at Davis Polk & Wardwell LLP. Mr. Whitman was a partner in Davis Polk’s Corporate Department for 28 years, representing clients in a broad range of corporate finance matters, including shelf registrations, securities compliance for financial institutions, foreign asset privatizations, and mergers and acquisitions. From 1971 to 1973, Mr. Whitman served as Executive Assistant to three successive Chairmen of the SEC. Mr. Whitman graduated from Harvard College and graduated magna cum laude from Harvard Law School with a LL.B. Mr. Whitman also received an LL.M. from Cambridge University in England. Mr. Whitman’s qualifications as director include his 28 years of experience representing clients, including AT&T, Exxon Mobil, General Motors and BP, in securities matters as a partner in Davis Polk’s corporate department. 

 

117

 

 

Henri J. Steenkamp— Mr. Steenkamp has served as the Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary of the Company, the Company’s investment adviser, Saratoga Investment Advisors, since 2014. Mr. Steenkamp has also served as a director of the Company since 2020. Mr. Steenkamp has served as the Chief Financial Officer of MF Global Holdings Ltd., a broker in commodities and derivatives, from April 2011. Prior to that, Mr. Steenkamp held the position of Chief Accounting Officer and Global Controller at MF Global for four years. He joined MF Global, then Man Financial, in 2006 as Vice President of External Reporting and Accounting Policy. After MF Global filed for bankruptcy protection in October 2011, he continued to serve as Chief Financial Officer through January 2013. Before joining MF Global, Mr. Steenkamp spent eight years with PricewaterhouseCoopers (“PwC”), including four years in Transaction Services in its New York office, managing a variety of capital-raising transactions on a global basis. His focus was also on the SEC registration and public company filing process, including technical accounting. He spent four years with PwC in South Africa, where he served as an auditor primarily for SEC registrants and assisted South African companies as they went public in the United States Mr. Steenkamp is a chartered accountant and holds an honors degree in Finance. Mr. Steenkamp’s qualifications as a director include his extensive experience in the investment and finance industry, as well as his intimate knowledge of the Company’s operations gained through his service as an executive officer.

 

G. Cabell Williams— Mr. Williams has served as member of our Board since 2007. Mr. Williams has served as the Managing General Partner of Williams and Gallagher, a private equity partnership located in Chevy Chase, Maryland since 2004. Mr. Williams is a Partner, Senior Manager and Director of Farragut Capital Partners, which is a Mezzanine Fund based out of Chevy Chase, Maryland. In 2004, Mr. Williams concluded a 23-year career at Allied Capital Corporation, a business development company based in Washington, DC, which was acquired by Ares Capital Corporation in 2010. While at Allied, Mr. Williams held a variety of positions, including President, CIO and finally Managing Director following Allied’s merger with its affiliates in 1998. From 1991 to 2004, Mr. Williams either led or co-managed the firm’s Private Equity Group. For the nine years prior to 1999, Mr. Williams led Allied’s Mezzanine investment activities. For 15 years, Mr. Williams served on Allied’s Investment Committee where he was responsible for reviewing and approving all of the firm’s investments. Prior to 1991, Mr. Williams ran Allied’s Minority Small Business Investment Company. He also founded Allied Capital Commercial Corporation, a real estate investment vehicle. Mr. Williams has served on the board of directors of various public and private companies. Mr. Williams attended The Landon School, and graduated from Mercersburg Academy and Rollins College, receiving a B.S. in Business Administration from the latter. Mr. Williams’ qualifications as director include his 28 years of experience managing investment activities at Allied Capital, where he served in a variety of positions, including President, CIO and Managing Director.

  

Code of Business Conduct and Ethics

 

We have adopted a Code of Business Conduct and Ethics which applies to, among others, our executive officers, including our principal executive officer and principal financial officer, as well as every officer, director and employee of the Company. Requests for copies should be sent in writing to Saratoga Investment Corp., 535 Madison Avenue, New York, New York 10022. The Company’s Code of Business Conduct and Ethics is also available on our website at www.saratogainvestmentcorp.com.

 

If we make any substantive amendment to, or grant a waiver from, a provision of our Code of Business Conduct and Ethics, we will promptly disclose the nature of the amendment or waiver on our website at www.saratogainvestmentcorp.com.

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Exchange Act requires the Company’s officers and directors, and persons who own more than 10% of our shares, to file reports of securities ownership and changes in such ownership with the SEC. Officers, directors, and greater than 10% shareholders also are required by SEC rules to furnish the Company with copies of all Section 16(a) forms they file.

 

Based solely on the Company’s review of Forms 3, 4 and 5 filed by such persons and information provided by the Company’s directors and officers, the Company believes that during the year ended February 29, 2024, all Section 16(a) filing requirements applicable to such persons were met in a timely manner, with the following inadvertent exceptions: Christian L. Oberbeck filed late a Form 4 with respect to one transaction in our shares during the reporting period.

 

Practices and Policies Regarding Hedging, Speculative Trading and Pledging of Securities  

 

Our insider trading policy generally prohibits the Company’s and our Investment Adviser’s directors, officers and employees from engaging in any short-term trading, short sales and other speculative transactions involving our securities, including buying or selling puts or calls or other derivative securities based on our securities. In addition, such persons are generally prohibited under our insider trading policy from entering into hedging or monetization transactions or similar arrangements, as well as pledging our securities in a margin account or as collateral for a loan, except in limited circumstances that are pre-approved by our chief compliance officer.  

 

118

 

 

Insider Trading Arrangements and Policies

 

We have adopted insider trading policies and procedures governing the purchase, sale, and disposition of our securities by our officers and directors of that are reasonably designed to promote compliance with insider trading laws, rules and regulations.

 

Nomination of Directors

 

There have been no material changes to the procedures by which stockholders may recommend nominees to our board of directors implemented since the filing of our Proxy Statement for our 2018 Annual Meeting of Stockholders.

 

Audit Committee

 

The current members of the audit committee are Steven M. Looney (Chairman), Charles S. Whitman III and G. Cabell Williams. The board of directors has determined that Mr. Looney is an “audit committee financial expert” as defined under Item 407 of Regulation S-K of the Exchange Act and that each of Messrs. Whitman and Williams are “financially literate” as required by NYSE corporate governance standards. All of these members are independent directors.

 

ITEM 11. EXECUTIVE COMPENSATION

 

Executive Compensation

 

Currently, none of our executive officers are compensated by us. We currently have no employees, and each of our executive officers is also an employee of Saratoga Investment Advisors. Services necessary for our business are provided by individuals who are employees of Saratoga Investment Advisors, pursuant to the terms of the Management Agreement and the Administration Agreement.

 

Director Compensation

 

Our independent directors receive an annual fee of $70,000. They also receive $3,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the audit committee receives an annual fee of $12,500 and the chairman of each other committee receives an annual fee of $6,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of NAV or the market price at the time of payment. No compensation is paid to directors who are “interested persons.”

  

The following table sets forth information concerning total compensation earned by or paid to each of our directors during the fiscal year ended February 29, 2024:

 

   Fees Earned
or Paid in
Cash
   Total 
Interested Directors        
Christian L. Oberbeck(1)  $-   $- 
Henri J. Steenkamp(1)   -    - 
Independent Directors          
Steven M. Looney  $102,500   $102,500 
Charles S. Whitman III   96,000    96,000 
G. Cabell Williams   96,000    96,000 

 

 

(1)No compensation was paid to directors who are interested persons of us as defined in the 1940 Act.

 

Compensation Committee Interlocks and Insider Participation

 

The current members of the compensation committee are G. Cabell Williams (Chairman), Steven M. Looney and Charles S. Whitman III. All of these members are independent directors. The compensation committee is responsible for overseeing the Company’s compensation policies generally and making recommendations to the board of directors with respect to incentive compensation and equity-based plans of the Company that are subject to board of directors approval, evaluating executive officer performance and reviewing the Company’s management succession plan, overseeing and setting compensation for the Company’s directors and, as applicable, its executive officers and, as applicable, preparing the report on executive officer compensation that SEC rules require to be included in our Annual Report on Form 10-K. Currently, none of our executive officers are compensated by the Company and as such the compensation committee is not required to produce a report on executive officer compensation for inclusion in our Annual Report on Form 10-K.

 

119

 

 

During fiscal year ended February 29, 2024 none of the Company’s executive officers served on the board of directors (or a compensation committee thereof or other board committee performing equivalent functions) of any entities that had one or more executive officers serve on the compensation committee or on the board of directors. No current or past executive officers or employees of the Company or its affiliates serve on the compensation committee.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The following table sets forth, as of May 3, 2024, the beneficial ownership of each current director, the nominees for director, the Company’s executive officers, each person known to us to beneficially own 5.0% or more of the outstanding shares of our common stock, and the executive officers and directors as a group.

 

The percentage ownership is based on 13,698,966 shares of common stock outstanding as of May 3, 2024. Shares of common stock that are subject to warrants or other convertible securities currently exercisable or exercisable within 60 days thereof, are deemed outstanding for the purposes of computing the percentage ownership of the person holding these options or convertible securities, but are not deemed outstanding for computing the percentage ownership of any other person. Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. To our knowledge, unless otherwise indicated in the footnotes to this table, the persons and entities named in the table have sole voting and sole investment power with respect to all shares beneficially owned. Unless otherwise indicated by footnote, the address for each listed individual is Saratoga Investment Corp., 535 Madison Avenue, New York, New York 10022.

 

Name of Beneficial Owners  Number of
Shares of
Common
Stock
Beneficially
Owned
   Percent of
Class
 
Interested Directors        
Christian L. Oberbeck   1,520,712(1)   11.1%
Henri J. Steenkamp   28,459    * 
Independent Directors          
Steven M. Looney   4,258    * 
Charles S. Whitman III   4,518    * 
G. Cabell Williams   88,773    * 
All Directors as a Group   1,646,720    12.0%
Owners of 5% or more of our common stock          
Elizabeth Oberbeck(2)   549,183    4.0%
Thomas V. Inglesby   352,236    2.6%
Michael J. Grisius   167,216    1.2%

 

 

* Less than 1.0%

 

Mr. Oberbeck, Mr. Grisius and Mr. Inglesby are affiliates who make up 17.2% of the ownership of SAR.

 

(1)Includes 644,248 shares of common stock directly held by Mr. Oberbeck, 217,774 shares of common stock held by CLO Partners LLC, an entity wholly owned by Mr. Oberbeck, 67,465 shares of common stock directly held by Mr. Oberbeck’s children, for which Mr. Oberbeck retains the voting rights, 1,318 shares of common stock directly held by Mr. Oberbeck’s wife, for which Mr. Oberbeck retains the voting rights, and 549,183 shares of common stock directly held by Elizabeth Oberbeck. See footnote 2 below.

 

(2)Based on information included in Amendment No. 2 to Schedule 13D filed on January 16, 2020, which amends and supplements the statements on Schedule 13D originally filed with the Securities and Exchange filed jointly by Christian L. Oberbeck, Elizabeth Oberbeck, Saratoga Investment Advisors and CLO Partners LLC on November 4, 2014. Pursuant to an Agreement Relating to Shares of Common Stock of Saratoga Investment Corp. (the “Transfer Agreement”), Christian L. Oberbeck transferred 744,183 shares of common stock beneficially owned by him to Elizabeth Oberbeck. Elizabeth Oberbeck has full ownership rights with respect to the shares, including without limitation, the right to (A) receive any cash and/or stock dividends and distributions paid on or with respect to the shares and (B) sell the shares in accordance with the provisions of the Transfer Agreement and receive all proceeds therefrom. However, pursuant to the terms of the Transfer Agreement, Christian L. Oberbeck has retained the right to vote the shares, except that Elizabeth Oberbeck has retained the right to vote the shares on all matters submitted to shareholders with respect to any matter that could give rise to dissenters or other rights of an objecting shareholder under Maryland General Corporation Law. The Transfer Agreement also contains a right of first refusal that requires Elizabeth Oberbeck to offer Christian L. Oberbeck the opportunity to purchase any shares of Common Stock owned by her prior to her intended sale of the shares. Any such purchases may be made either directly by Mr. Oberbeck or through entities affiliated with him.

 

120

 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

Transactions with Related Persons

 

We have entered into a Management Agreement with Saratoga Investment Advisors, LLC. We have also entered into a license agreement with Saratoga Investment Advisors, LLC, pursuant to which Saratoga Investment Advisors has agreed to grant us a non-exclusive, royalty-free license to use the name “Saratoga.” In addition, pursuant to the terms of the Administration Agreement, Saratoga Investment Advisors, LLC provides us with the office facilities and administrative services necessary to conduct our day-to-day operations. Mr. Oberbeck, our chief executive officer, is the primary investor in and controls Saratoga Investment Advisors, LLC.

 

Review, Approval or Ratification of Transactions with Related Persons

 

The Audit Committee of our board is required to review and approve any transactions with related persons (as such term is defined in Item 404 of Regulation S-K).

 

Director Independence

 

In accordance with rules of the NYSE, the board of directors annually determines the independence of each director. No director is considered independent unless the board of directors has determined that he or she has no material relationship with the Company. The Company monitors the status of its directors and officers through the activities of the Company’s Nominating and Corporate Governance Committee and through a questionnaire to be completed by each director no less frequently than annually, with updates periodically if information provided in the most recent questionnaire has changed.

 

In order to evaluate the materiality of any such relationship, the board of directors uses the definition of director independence set forth in the NYSE Listed Company Manual. Section 303A.00 of the NYSE Listed Company Manual provides that business development companies, or BDCs, such as the Company, are required to comply with all of the provisions of Section 303A applicable to domestic issuers other than Sections 303A.02, the section that defines director independence.

 

Section 303A.00 provides that a director of a BDC shall be considered to be independent if he or she is not an “interested person” of the Company, as defined in Section 2(a)(19) of the 1940 Act. Section 2(a)(19) of the 1940 Act defines an “interested person” to include, among other things, any person who has, or within the last two years had, a material business or professional relationship with the Company.

 

The board of directors has determined that each of the directors is independent and has no relationship with the Company, except as a director and stockholder of the Company, with the exception of Messrs. Oberbeck and Grisius who are interested persons of the Company due to their positions as officers of the Company and its Investment Adviser.

 

121

 

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Independent Registered Public Accounting Firm

 

For the years ended February 29, 2024 and February 28, 2023, the Company incurred the following fees for services provided by Ernst & Young LLP, including expenses:

 

   Fiscal Year
Ended
February 29,
2024
  

Fiscal Year
Ended
February 28,

2023

 
Audit Fees  $642,300   $584,500 
Tax Fees   50,350    46,200 
Total Fees  $692,650   $630,700 

 

In addition to the services listed above, Ernst & Young LLP provided audit services to the Company’s subsidiaries. The following are the related fees:

 

   Fiscal Year
Ended
February 29,
2024
   Fiscal Year
Ended
February 28,
2023
 
CLO Audit Fees  $—     $—   
Tax Services for Company’s Subsidiaries   —      —   
All Other Fees   84,925    97,750 
Total Fees  $84,925   $97,750 

 

Audit Fees. Audit fees include fees for services that normally would be provided by the accountant in connection with statutory and regulatory filings or engagements and that generally only the independent accountant can provide. In addition to fees for the audit of our annual consolidated financial statements, the audit of the effectiveness of our internal control over financial reporting and the review of our quarterly consolidated financial statements in accordance with generally accepted auditing standards, this category contains fees for comfort letters, statutory audits, consents, and assistance with and review of documents filed with the SEC.

 

Tax Fees. Tax fees include services in conjunction with preparation of the Company’s tax return.

 

All Other Fees. Fees for other services would include fees for products and services other than the services reported above.

 

It is the policy of the audit committee to pre-approve all audit, review or attest engagements and permissible non-audit services to be performed by our independent registered public accounting firm.

 

122

 

 

PART IV

 

ITEM 15. EXHIBITS, CONSOLIDATED FINANCIAL STATEMENT SCHEDULES

 

The following documents are filed or incorporated by reference as part of this Annual Report:

 

1. Consolidated Financial Statements

 

The following consolidated financial statements of the Company are filed herewith: Report of Independent Registered Public Accounting Firm

 

Consolidated Statements of Assets and Liabilities as of February 29, 2024 and February 28, 2023

 

Consolidated Statements of Operations for the years ended February 29, 2024, February 28, 2023 and February 28, 2022

 

Consolidated Schedules of Investments as of February 29, 2024 and February 28, 2023

 

Consolidated Statements of Changes in Net Assets for the years ended February 29, 2024, February 28, 2023 and February 28, 2022

 

Consolidated Statements of Cash Flows for the years ended February 29, 2024, February 28, 2023 and February 28, 2022

 

Notes to Consolidated Financial Statements

 

2. Financial Statement Schedules

 

Reference is made to the Index to Other Financial Statements on page S-1.

 

123

 

 

3. Exhibits required to be filed by Item 601 of Regulation S-K

 

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

 

EXHIBIT INDEX

 

Exhibit
Number
  Description
     
3.1(a)   Articles of Incorporation of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007).
     
3.1(b)   Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 3, 2010).
     
3.1(c)   Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 13, 2010).
     
3.2   Third Amended and Restated Bylaws of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 10-Q filed January 6, 2021)
     
4.1   Specimen certificate of Saratoga Investment Corp.’s common stock, par value $0.001 per share. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010).
     
4.2   Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
     
4.3   Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 24, 2014).
     
4.4   Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-186323 filed April 30, 2013).
     
4.5   Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 1, File No. 333-196526, filed on December 5, 2014).
     
4.6   Fifth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 7.75% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report  on Form 10-Q, filed on January 10, 2023).
     
4.7   Seventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 6.25% Notes due 2027 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).   
     
4.8   Eighth Supplemental Indenture between the Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2026 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on March 10, 2021).
     
4.9   Ninth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2027 (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on January 19, 2022).
     
4.10   Tenth  Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 6.00% Note due 2027 (incorporated by reference to the Registrant’s Current Report on Form 8-K (File No. 814-00732) filed on April 27, 2022).
     
4.11   Eleventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 7.00% Notes due 2025 (incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q, filed on January 10, 2023).   
     
4.12   Twelfth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association, as trustee, relating to the 8.00% Notes due 2027 (incorporated by reference to the Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 813-00732) filed on October 27, 2022).
     
4.13   Thirteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.125% Notes due 2027 (incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on December 13, 2022).

 

124

 

 

4.14   Fifteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.50% Notes due 2028 (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on April 14, 2023).
     
4.15   Form of 7.75% Notes due 2025 (incorporated by reference to Exhibit 4.6 hereto).
     
4.16   Form of 6.25% Notes due 2027 (incorporated by reference to Exhibit 4.7 hereto).
     
4.17   Form of 4.375% Notes due 2026 (incorporated by reference to Exhibit 4.8 hereto).
     
4.18   Form of 4.35% Notes due 2027 (incorporated by reference to Exhibit 4.9 hereto).
     
4.19   Form of 6.00% Notes due 2027 (incorporated by reference to Exhibit 4.10 hereto).
     
4.20   Form of 7.00% Notes due 2027 (incorporated by reference to Exhibit 4.11 hereto).
     
4.21   Form of 8.00% Notes due 2027 (incorporated by reference to Exhibit 4.12 hereto).
     
4.22   Form of 8.125% Notes due 2027 (incorporated by reference to Exhibit 4.13 hereto).
     
4.23   Form of 8.50% Notes due 2028 (incorporated by reference to Exhibit 4.14 hereto).
     
4.24   Description of Securities (incorporated by reference to Saratoga Investment Corp.’s Annual Report on Form 10-K filed on May 2, 2023).
     
10.1   Investment Advisory and Management Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
     
10.2   Custodian Agreement dated March 21, 2007 between GSC Investment LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007).
     
10.3   Administration Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
     
10.4   Trademark License Agreement dated July 30, 2010 between Saratoga Investment Advisors, LLC and GSC Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
     
10.5   Form of Indemnification Agreement between Saratoga Investment Corp. and each officer and director of Saratoga Investment Corp. (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2 filed on January 12, 2007).
     
10.6   Amended and Restated Indenture, dated as of November 15, 2016, among Saratoga Investment Corp. CLO 2013-1, Ltd., Saratoga Investment Corp. CLO 2013-1, Inc. and U.S. Bank National Association. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-216344, filed on February 28, 2017).
     
10.7   Amended and Restated Collateral Management Agreement, dated February 26, 2021, by and between Saratoga Investment Corp. and Saratoga Investment Corp. CLO 2013-1, Ltd. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on March 4, 2021).
     
10.8   Amended and Restated Collateral Administration Agreement, dated February 26, 2021, by and between Saratoga Investment Corp., Saratoga Investment Corp. CLO 2013-1, Ltd. and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on March 4, 2021).
     
10.9   Equity Distribution Agreement, dated July 30, 2021, by and among Saratoga Investment Corp. and Saratoga Investment Advisors, LLC, on the one hand, and Ladenburg Thalmann & Co. Inc. and Compass Point Research & Trading, LLC, on the other hand (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 2, 2021).

 

125

 

 

10.10   Amendment No. 2 to the Equity Distribution Agreement, dated July 30, 2021, by and among Saratoga Investment Corp. and Saratoga Investment Advisors, LLC, on the one hand, and Ladenburg Thalmann & Co. Inc. and Compass Point Research & Trading, LLC, on the other hand (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on July 10, 2023).
     
10.11   Amendment No. 3 to the Equity Distribution Agreement, dated July 30, 2021, by and among Saratoga Investment Corp. and Saratoga Investment Advisors, LLC, on the one hand, and Ladenburg Thalmann & Co. Inc., Compass Point Research and Trading, LLC, and Raymond James & Associates, Inc. on the other hand (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on July 19, 2023).
     
10.12   Credit and Security Agreement, dated as of October 4, 2021, by and among Saratoga Investment Funding II, LLC, Saratoga Investment Corp., as collateral manager and equityholder, the lenders party thereto, Encina Lender Finance, LLC, as administrative agent for the secured parties and the collateral agent, and U.S. Bank National Association, as collateral custodian for the secured parties thereto and as collateral administrator (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 7, 2021).
     
10.13   First Amendment to the Credit and Security Agreement, dated as of January 27, 2023, by and among Saratoga Investment Fund II LLC, as borrower, Saratoga Investment Corp., as equityholder and as collateral manager, the lenders party thereto, Encina Lender Finance, LLC, as administrative agent and as collateral agent, U.S. Bank National Association, as custodian, and U.S. Bank Trust Company, National Association (successor in interest to U.S. Bank National Association), as collateral administrator (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K, filed on February 2, 2023).
     
10.14   Equity Pledge Agreement, dated as of October 4, 2021, by and between Saratoga Investment Corp. and Encina Lender Finance, LLC, as collateral agent for the secured parties thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 7, 2021).
     
10.15   Loan Sale and Contribution Agreement, dated as of October 4, 2021, by and between Saratoga Investment Corp., as seller, and Saratoga Investment Funding II LLC, as purchaser (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 7, 2021).
     
10.16   Credit and Security Agreement, dated as of March 27, 2024, by and among Saratoga Investment Funding III, LLC, as borrower, Saratoga Investment Corp., as collateral manager and equityholder, the lenders from time to time party thereto, Live Oak Banking Company, as administrative agent and collateral agent, U.S. Bank National Association, as custodian, and U.S. Bank Trust Company, National Association, as collateral administrator (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on March 28, 2024). 
     
10.17   Equity Pledge Agreement, dated as of March 27, 2024, by and between Saratoga Investment Corp., as pledgor, and Live Oak Banking Company, as collateral agent for the benefit of the secured parties (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on March 28, 2024). 
     
10.18   Loan Sale and Contribution Agreement, dated as of March 27, 2024, by and between Saratoga Investment Corp., as seller, and Saratoga Investment Funding III LLC, as purchaser (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on March 28, 2024). 
     
10.19   Saratoga Senior Loan Fund I JV LLC Limited Liability Company Agreement, dated October 26, 2021, by and between Saratoga Investment Corp. and TJHA JV I LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on October 27, 2021).
     
10.20   Note Purchase Agreement by and between Saratoga Investment Corp. and the purchaser party thereto, dated July 9, 2020 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q filed on October 4, 2022).
     
10.21   First Supplemental Note Purchase Agreement by and between Saratoga Investment Corp. and the purchaser party thereto, dated January 28, 2021 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q filed on October 4, 2022).

 

126

 

 

10.22   Second Supplemental Note Purchase Agreement by and between Saratoga Investment Corp. and the purchaser party thereto, dated September 8, 2022 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q filed on October 4, 2022).
     
14   Code of Ethics of the Company adopted under Rule 17j-1 (incorporated by reference to Amendment No.7 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-138051, filed on March 22, 2007).
     
19*   Insider Trading Policies and Procedures.
     
21*   List of Subsidiaries.
     
23.1*   Consent of Ernst & Young LLP for Saratoga Investment Corp. 
     
23.2*   Consent of CohnReznick LLP for Saratoga Investment Corp. CLO 2013-1, Ltd.
     
31.1*   Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
     
31.2*   Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
     
32.1*   Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.1350)
     
32.2*   Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
     
97.1*   Compensation Recoupment Policy.
     
101.INS   Inline XBRL Instance Document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 

*Filed herewith

 

ITEM 16. FORM 10-K SUMMARY

 

None.

127

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SARATOGA INVESTMENT CORP.
     
Date: May 6, 2024 By: /s/ CHRISTIAN L. OBERBECK
    Christian L. Oberbeck
    Chief Executive Officer
     
  By: /s/ HENRI J. STEENKAMP
    Henri J. Steenkamp
    Chief Financial Officer and Chief Compliance Officer

 

KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below hereby constitutes and appoints Christian L. Oberbeck and Henri J. Steenkamp, and each of them (with full power to each of them to act alone), his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign this report and any and all amendments thereto, and to file the same, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ CHRISTIAN L. OBERBECK   Chairman of the Board of Directors, Chief Executive Officer   May 6, 2024
Christian L. Oberbeck   (Principal Executive Officer)    
         
/s/ HENRI J. STEENKAMP   Chief Financial Officer (Principal Accounting Officer and   May 6, 2024
Henri J. Steenkamp   Principal Financial Officer), Member of the Board of Directors    
         
/s/ STEVEN M. LOONEY   Member of the Board of Directors   May 6, 2024
Steven M. Looney        
         
/s/ CHARLES S. WHITMAN III   Member of the Board of Directors   May 6, 2024
Charles  S. Whitman III        
         
/s/ G. CABELL WILLIAMS   Member of the Board of Directors   May 6, 2024
Cabell Williams        

 

128

 

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

    PAGE
Reports of Independent Registered Public Accounting Firm (PCAOB No. 00042)   F-2
Consolidated Statements of Assets and Liabilities as of February 29, 2024 and February 28, 2023   F-4
Consolidated Statements of Operations for the years ended February 29, 2024, February 28, 2023 and February 28, 2022   F-5
Consolidated Statements of Changes in Net Assets for the years ended February 29, 2024, February 28, 2023 and February 28, 2022   F-6
Consolidated Statements of Cash Flows for the years ended February 29, 2024, February 28, 2023 and February 28, 2022   F-7
Consolidated Schedules of Investments for the year ended February 29, 2024 and February 28, 2023   F-8
Notes to Consolidated Financial Statements   F-32

 

F-1

 

 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and the Board of Directors of Saratoga Investment Corp.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated statements of assets and liabilities of Saratoga Investment Corp. (the “Company”), including the consolidated schedules of investments, as of February 29, 2024 and February 28, 2023, the related consolidated statements of operations, changes in net assets, and cash flows for each of the three years in the period ended February 29, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at February 29, 2024 and February 28, 2023, and the results of its operations, changes in its net assets and its cash flows for each of the three years in the period ended February 29, 2024, in conformity with U.S. generally accepted accounting principles.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of investments owned as of February 29, 2024 and February 28, 2023 by correspondence with the portfolio companies, custodians and debt agents. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosure to which is relates.

 

F-2

 

 

Valuation of investments using significant unobservable inputs

 

Description of the Matter   At February 29, 2024, the fair value of the Company's investments categorized in Level 3 of the fair value hierarchy (Level 3 investments) totaled $1,129,390 (in thousands). Management determines the fair value of these investments by applying the valuation techniques described in Notes 2 and 3 to the consolidated financial statements and using significant unobservable inputs and assumptions. The selection of the valuation techniques and the significant unobservable inputs and assumptions used by management requires subjective judgments and estimates. The valuation techniques used by the Company include market comparables, discounted cash flows and enterprise value waterfalls. The significant unobservable inputs used to measure fair value include market yields, EBITDA multiples, revenue multiples, third-party bids, discount rates, recovery rates and prepayment rates.

 

Auditing the fair value of the Company's Level 3 investments was complex and involved auditor judgment, as the valuation techniques selected and the significant unobservable inputs and assumptions used by the Company are highly judgmental and require estimation, and the selection of such techniques, inputs and assumptions has a significant effect on the fair value measurement of such investments.

     
How We Addressed the Matter in Our Audit   To test the valuation of the Company’s Level 3 investments, we gained an understanding of the valuation techniques, significant unobservable inputs and assumptions used by the Company to value the Level 3 investments and reviewed the information considered by the Board of Directors relating to the fair value of each investment. For a sample of Level 3 investments, we evaluated the valuation techniques used, tested the significant unobservable inputs and assumptions, and tested the mathematical accuracy of the related valuation models. For this sample of Level 3 investments, we agreed the significant inputs and underlying data used in the Company’s valuations (for example, deal terms, portfolio company operating results, market yields, third-party bids) to transaction agreements, most recently available portfolio company financial statements or other financial information, information available from third-party sources and market data, as applicable. We involved our valuation specialists to assist in developing independent estimates of fair value for a sample of investments by using portfolio company and market information, and we compared such estimates to the Company’s fair value of these investments. We also searched for and evaluated information that corroborated or contradicted the Company’s valuations of Level 3 investments.

 

/s/ Ernst & Young LLP

 

We have served as the Company’s auditor since 2006.

 

New York, New York

May 6, 2024

 

F-3

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Consolidated Financial Statements

 

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

   February 29,
2024
   February 28,
2023
 
ASSETS        
Investments at fair value        
Non-control/Non-affiliate investments (amortized cost of $1,035,879,751 and $819,966,208, respectively)  $1,019,774,616   $828,028,800 
Affiliate investments (amortized cost of $26,707,415 and $25,722,320, respectively)   27,749,137    28,305,871 
Control investments (amortized cost of $117,196,571 and $120,800,829, respectively)   91,270,036    116,255,582 
Total investments at fair value (amortized cost of $1,179,783,737 and $966,489,357, respectively)   1,138,793,789    972,590,253 
Cash and cash equivalents   8,692,846    65,746,494 
Cash and cash equivalents, reserve accounts   31,814,278    30,329,779 
Interest receivable (net of reserve of $9,490,340 and $2,217,300, respectively)   10,298,998    8,159,951 
Management fee receivable   343,023    363,809 
Other assets   1,163,225    531,337 
Current tax receivable   99,676    436,551 
Total assets  $1,191,205,835   $1,078,158,174 
           
LIABILITIES          
Revolving credit facility  $35,000,000   $32,500,000 
Deferred debt financing costs, revolving credit facility   (882,122)   (1,344,005)
SBA debentures payable   214,000,000    202,000,000 
Deferred debt financing costs, SBA debentures payable   (5,779,892)   (4,923,488)
8.75% Notes Payable 2025   20,000,000    
-
 
Discount on 8.75% notes payable 2025   (112,894)   
-
 
Deferred debt financing costs, 8.75% notes payable 2025   (4,777)   
-
 
7.00% Notes Payable 2025   12,000,000    12,000,000 
Discount on 7.00% notes payable 2025   (193,175)   (304,946)
Deferred debt financing costs, 7.00% notes payable 2025   (24,210)   (40,118)
7.75% Notes Payable 2025   5,000,000    5,000,000 
Deferred debt financing costs, 7.75% notes payable 2025   (74,531)   (129,528)
4.375% Notes Payable 2026   175,000,000    175,000,000 
Premium on 4.375% notes payable 2026   564,260    830,824 
Deferred debt financing costs, 4.375% notes payable 2026   (1,708,104)   (2,552,924)
4.35% Notes Payable 2027   75,000,000    75,000,000 
Discount on 4.35% notes payable 2027   (313,010)   (408,932)
Deferred debt financing costs, 4.35% notes payable 2027   (1,033,178)   (1,378,515)
6.25% Notes Payable 2027   15,000,000    15,000,000 
Deferred debt financing costs, 6.25% notes payable 2027   (273,449)   (344,949)
6.00% Notes Payable 2027   105,500,000    105,500,000 
Discount on 6.00% notes payable 2027   (123,782)   (159,334)
Deferred debt financing costs, 6.00% notes payable 2027   (2,224,403)   (2,926,637)
8.00% Notes Payable 2027   46,000,000    46,000,000 
Deferred debt financing costs, 8.00% notes payable 2027   (1,274,455)   (1,622,376)
8.125% Notes Payable 2027   60,375,000    60,375,000 
Deferred debt financing costs, 8.125% notes payable 2027   (1,563,594)   (1,944,536)
8.50% Notes Payable 2028   57,500,000    
-
 
Deferred debt financing costs, 8.50% notes payable 2028   (1,680,039)   
-
 
Base management and incentive fees payable   8,147,217    12,114,878 
Deferred tax liability   3,791,150    2,816,572 
Accounts payable and accrued expenses   1,337,542    1,464,343 
Interest and debt fees payable   3,582,173    3,652,936 
Directors fees payable   
-
    14,932 
Due to Manager   450,000    10,935 
Total liabilities   820,981,727    731,200,132 
           
Commitments and contingencies (See Note 9)   
 
    
 
 
           
NET ASSETS          
Common stock, par value $0.001, 100,000,000 common shares authorized, 13,653,476 and 11,890,500 common shares issued and outstanding, respectively   13,654    11,891 
Capital in excess of par value   371,081,199    321,893,806 
Total distributable earnings (deficit)   (870,745)   25,052,345 
Total net assets   370,224,108    346,958,042 
Total liabilities and net assets  $1,191,205,835   $1,078,158,174 
NET ASSET VALUE PER SHARE  $27.12   $29.18 

 

See accompanying notes to consolidated financial statements.

F-4

 

 

Saratoga Investment Corp.

Consolidated Statements of Operations

 

   For the year ended 
   February 29,
2024
   February 28,
2023
   February 28,
2022
 
INVESTMENT INCOME            
Interest from investments            
Interest income:            
Non-control/Non-affiliate investments  $113,521,652   $72,677,237   $46,369,544 
Affiliate investments   3,299,816    4,773,527    3,308,471 
Control investments   8,507,909    6,602,594    7,345,691 
Payment-in-kind interest income:               
Non-control/Non-affiliate investments   766,697    359,910    1,150,695 
Affiliate investments   874,226    416,711    
-
 
Control investments   814,925    386,889    327,171 
Total interest from investments   127,785,225    85,216,868    58,501,572 
Interest from cash and cash equivalents   2,512,416    1,368,489    3,584 
Management fee income   3,270,232    3,269,820    3,262,591 
Dividend income(*):               
Non-control/Non-affiliate investments   621,398    2,104,355    1,379,182 
Affiliate investments   
-
    615,917    546,609 
Control investments   5,911,564    
-
    
-
 
Total dividend from investments   6,532,962    2,720,272    1,925,791 
Structuring and advisory fee income   2,149,751    3,585,061    4,307,647 
Other income   1,469,320    2,943,610    2,739,372 
Total investment income   143,719,906    99,104,120    70,740,557 
                
OPERATING EXPENSES               
Interest and debt financing expenses   49,179,899    33,498,489    19,880,693 
Base management fees   19,212,337    16,423,960    11,901,729 
Incentive management fees expense (benefit)   8,025,468    5,057,117    11,794,208 
Professional fees   1,767,015    1,812,259    1,378,134 
Administrator expenses   3,872,917    3,160,417    2,906,250 
Insurance   322,323    347,483    348,671 
Directors fees and expenses   351,297    360,000    335,596 
General and administrative   2,241,579    2,328,672    1,661,932 
Income tax expense (benefit)   42,926    (152,956)   (39,649)
Excise tax expense (benefit)   1,829,837    1,067,532    630,183 
Total operating expenses   86,845,598    63,902,973    50,797,747 
NET INVESTMENT INCOME   56,874,308    35,201,147    19,942,810 
                
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS               
Net realized gain (loss) from investments:               
Non-control/Non-affiliate investments   153,583    7,446,596    6,209,737 
Affiliate investments   
-
    
-
    7,328,457 
Control investments   
-
    
-
    (139,867)
Net realized gain (loss) from investments   153,583    7,446,596    13,398,327 
Income tax (provision) benefit from realized gain on investments   
-
    548,568    (2,886,444)
Net change in unrealized appreciation (depreciation) on investments:               
Non-control/Non-affiliate investments   (24,167,727)   (5,330,880)   14,775,190 
Affiliate investments   (1,541,829)   574,354    (26,836)
Control investments   (21,381,288)   (10,461,606)   2,271,639 
Net change in unrealized appreciation (depreciation) on investments   (47,090,844)   (15,218,132)   17,019,993 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   (893,166)   (1,715,333)   694,908 
Net realized and unrealized gain (loss) on investments   (47,830,427)   (8,938,301)   28,226,784 
Realized losses on extinguishment of debt   (110,056)   (1,587,083)   (2,434,410)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  $8,933,825   $24,675,763   $45,735,184 
                
WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE
  $0.71   $2.06   $3.99 
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED
   12,670,939    11,963,533    11,456,631 

 

 

*Certain prior period amounts have been reclassified to conform to current year presentation.

 

See accompanying notes to consolidated financial statements.

F-5

 

 

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

 

   For the year ended 
   February 29,
2024
   February 28,
2023
   February 28,
2022
 
INCREASE (DECREASE) FROM OPERATIONS:            
Net investment income  $56,874,308   $35,201,147   $19,942,810 
Net realized gain from investments   153,583    7,446,596    13,398,327 
Realized losses on extinguishment of debt   (110,056)   (1,587,083)   (2,434,410)
Income tax (provision) benefit from realized gain on investments   
-
    548,568    (2,886,444)
Net change in unrealized appreciation (depreciation) on investments   (47,090,844)   (15,218,132)   17,019,993 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   (893,166)   (1,715,333)   694,908 
Net increase in net assets resulting from operations   8,933,825    24,675,763    45,735,184 
                
DECREASE FROM SHAREHOLDER DISTRIBUTIONS:               
Total distributions to shareholders   (35,635,955)   (27,313,402)   (22,033,235)
Net decrease in net assets from shareholder distributions   (35,635,955)   (27,313,402)   (22,033,235)
                
CAPITAL SHARE TRANSACTIONS:               
Proceeds from issuance of common stock(1)   44,539,387    
-
    26,835,203 
Capital contribution from Manager   

4,475,297

    
-
    
-
 
Stock dividend distribution   3,582,345    4,648,262    3,875,206 
Repurchases of common stock   (2,157,605)   (10,824,340)   (2,545,037)
Repurchase fees   (1,772)   (8,764)   (1,992)
Offering costs   (469,456)   
-
    (270,576)
Net increase (decrease) in net assets from capital share transactions   49,968,196    (6,184,842)   27,892,804 
Total increase (decrease) in net assets   23,266,066    (8,822,481)   51,594,753 
Net assets at beginning of year   346,958,042    355,780,523    304,185,770 
Net assets at end of year  $370,224,108   $346,958,042   $355,780,523 

 

 

(1)See Note 11 to the Consolidated Financial Statements contained herein for more information on share issuance.

 

See accompanying notes to consolidated financial statements.

 

F-6

 

 

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

 

   For the year ended 
   February 29,
2024
   February 28,
2023
   February 28,
2022
 
Operating activities            
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  $8,933,825   $24,675,763   $45,735,184 
ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS RESULTING               
FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:               
Payment-in-kind and other adjustments to cost   4,910,320    1,882,734    349,292 
Net accretion of discount on investments   (2,221,257)   (1,816,934)   (2,043,088)
Amortization of deferred debt financing costs   5,171,249    3,587,139    2,164,761 
Realized losses on extinguishment of debt   110,056    1,587,083    2,434,410 
Income tax expense (benefit)   42,926    (152,956)   21,260 
Net realized (gain) loss from investments   (153,583)   (7,446,596)   (13,398,327)
Net change in unrealized (appreciation) depreciation on investments   47,090,844    15,218,132    (17,019,993)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   893,166    1,715,333    (694,908)
Proceeds from sales and repayments of investments   30,271,047    222,215,062    226,931,104 
Purchases of investments   (246,100,906)   (385,075,296)   (458,073,629)
(Increase) decrease in operating assets:               
Interest receivable   (2,139,047)   (3,066,390)   (869,931)
Due from affiliate   
-
    90,968    2,628,032 
Management fee receivable   20,786    (1,260)   (327,905)
Other assets   (631,887)   (276,357)   692,335 
Current income tax receivable   336,875    (436,551)   - 
Increase (decrease) in operating liabilities:               
Base management and incentive fees payable   (3,967,661)   (832,147)   6,390,351 
Accounts payable and accrued expenses   (126,801)   665,285    (951,208)
Current tax payable   
-
    (2,820,036)   2,820,036 
Interest and debt fees payable   (70,763)   851,315    155,837 
Directors fees payable   (14,932)   (55,068)   (500)
Excise tax payable   
-
    (630,183)   (61,489)
Due to Manager   439,065    (252,879)   (15,251)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES   (157,206,679)   (130,373,839)   (203,133,627)
                
Financing activities               
Borrowings on debt   71,500,000    113,000,000    135,000,000 
Paydowns on debt   (57,000,000)   (76,000,000)   (95,500,000)
Issuance of notes   77,500,000    223,875,000    250,000,000 
Repayments of notes   
-
    (43,125,000)   (60,000,000)
Payments of deferred debt financing costs   (4,694,711)   (10,135,986)   (10,008,424)
Discount on debt issuance, 6.00% notes 2027   
-
    (176,000)   
-
 
Discount on debt issuance, 7.00% notes 2025   
-
    (360,000)   
-
 
Premium on debt issuance, 4.375% notes 2026   
-
    
-
    1,250,000 
Discount on debt issuance, 4.35% notes 2027   
-
    
-
    (512,250)
Proceeds from issuance of common stock   44,539,387    
-
    26,835,203 
Capital contribution from Manager   4,475,297    
-
    
-
 
Payments of cash dividends   (32,053,610)   (22,665,140)   (18,158,029)
Repurchases of common stock   (2,157,605)   (10,824,340)   (2,545,037)
Repurchases fees   (1,772)   (8,764)   (1,992)
Payments of offering costs   (469,456)   
-
    (270,576)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES   101,637,530    173,579,770    226,088,895 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS   (55,569,149)   43,205,931    22,955,268 
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF YEAR   96,076,273    52,870,342    29,915,074 
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF YEAR (See Note 2)  $40,507,124   $96,076,273   $52,870,342 
                
Supplemental information:               
Interest paid during the year  $44,079,413   $28,904,198   $17,560,094 
Cash paid for taxes   748,721    2,770,984    1,355,083 
Supplemental non-cash information:               
Payment-in-kind interest income and other adjustments to cost   (4,910,319)   (1,882,734)   (349,292)
Net accretion of discount on investments   2,221,257    1,816,934    2,043,088 
Amortization of deferred debt financing costs   5,171,249    3,587,139    2,164,761 
Stock dividend distribution   3,582,345    4,648,262    3,875,206 

 

See accompanying notes to consolidated financial statements.

F-7

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Non-control/Non-affiliate investments - 276.5% (b)                             
Altvia MidCo, LLC.  Alternative Investment Management Software  First Lien Term Loan
(3M USD TERM SOFR+8.50%), 13.83% Cash, 7/18/2027
  7/18/2022  $7,900,000   $7,840,328   $7,884,990    2.1%
Altvia MidCo, LLC. (h)  Alternative Investment Management Software  Series A-1 Preferred Shares  7/18/2022   2,000,000    2,000,000    2,894,346    0.8%
      Total Alternative Investment Management Software           9,840,328    10,779,336    2.9%
BQE Software, Inc.  Architecture & Engineering Software  First Lien Term Loan
(3M USD TERM SOFR+6.75%), 12.08% Cash, 4/13/2028
  4/13/2023  $24,500,000    24,285,669    24,497,550    6.6%
BQE Software, Inc. (j)  Architecture & Engineering Software  Delayed Draw Term Loan
(3M USD TERM SOFR+6.75%), 12.08% Cash, 4/13/2028
  4/13/2023  $750,000    743,481    749,925    0.2%
      Total Architecture & Engineering Software           25,029,150    25,247,475    6.8%
GrowthZone, LLC  Association Management Software  First Lien Term Loan
(3M USD TERM SOFR+8.25%), 13.58% Cash, 5/10/2028
  5/10/2023  $22,649,425    22,292,083    22,934,808    6.2%
Golden TopCo LP (h)  Association Management Software  Class A-2 Common Units  5/10/2023   1,072,394    1,072,394    1,154,132    0.3%
      Total Association Management Software           23,364,477    24,088,940    6.5%

  

F-8

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Artemis Wax Corp. (d)(j)  Consumer Services  Delayed Draw Term Loan
(1M USD TERM SOFR+6.75%), 12.07% Cash, 5/20/2026
  5/20/2021  $57,500,000    57,208,255    58,149,750    15.7%
Artemis Wax Corp. (h)  Consumer Services  Series B-1 Preferred Stock  5/20/2021   934,463    1,500,000    4,822,941    1.3%
Artemis Wax Corp. (h)  Consumer Services  Series D Preferred Stock  12/22/2022   290,595    1,500,000    1,716,380    0.5%
      Total Consumer Services           60,208,255    64,689,071    17.5%
Schoox, Inc. (h), (i)  Corporate Education Software  Series 1 Membership Interest  12/8/2020   1,050    475,698    4,426,630    1.2%
      Total Corporate Education Software           475,698    4,426,630    1.2%
GreyHeller LLC (h)  Cyber Security  Common Stock  11/10/2021   7,857,689    1,906,275    2,826,009    0.8%
      Total Cyber Security           1,906,275    2,826,009    0.8%
Gen4 Dental Partners Holdings, LLC  Dental Practice Management  Delayed Draw Term Loan
(3M USD TERM SOFR+10.22%), 15.55% Cash, 4/29/2026
  2/8/2023  $11,000,000    10,979,958    11,110,000    3.0%
Gen4 Dental Partners Holdings, LLC (h)(i)  Dental Practice Management  Series A Preferred Units  2/8/2023   493,999    1,027,519    1,111,499    0.3%
Modis Dental Partners OpCo, LLC  Dental Practice Management  First Lien Term Loan
(1M USD TERM SOFR+9.48%), 14.80% Cash, 4/18/2028
  4/18/2023  $7,000,000    6,906,453    7,113,400    1.9%
Modis Dental Partners OpCo, LLC  Dental Practice Management  Delayed Draw Term Loan
(1M USD TERM SOFR+9.48%), 14.80% Cash, 4/18/2028
  4/18/2023  $7,500,000    7,392,367    7,621,500    2.1%
Modis Dental Partners OpCo, LLC (h)  Dental Practice Management  Class A Preferred Units  4/18/2023   2,950,000    2,950,000    2,682,996    0.7%
New England Dental Partners  Dental Practice Management  First Lien Term Loan
(3M USD TERM SOFR+8.00%), 13.48% Cash, 11/25/2025
  11/25/2020  $6,555,000    6,526,643    6,198,408    1.7%
New England Dental Partners  Dental Practice Management  Delayed Draw Term Loan
(3M USD TERM SOFR+8.00%), 13.48% Cash, 11/25/2025
  11/25/2020  $4,650,000    4,635,903    4,397,040    1.2%
      Total Dental Practice Management           40,418,843    40,234,843    10.9%

 

F-9

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Exigo, LLC (d)  Direct Selling Software  First Lien Term Loan
(1M USD TERM SOFR+5.75%), 11.17% Cash, 3/16/2027
  3/16/2022  $24,313,135    24,167,354    23,165,555    6.3%
Exigo, LLC (j)  Direct Selling Software  Revolving Credit Facility
(1M USD TERM SOFR+5.75%), 11.17% Cash, 3/16/2027
  3/16/2022  $
-
    
-
    (49,167)   0.0%
Exigo, LLC (h), (i)  Direct Selling Software  Common Units  3/16/2022   1,041,667    1,041,667    957,067    0.3%
      Total Direct Selling Software           25,209,021    24,073,455    6.6%
C2 Educational Systems, Inc. (d)  Education Services  First Lien Term Loan
(3M USD TERM SOFR+8.50%), 13.83% Cash, 5/31/2025
  5/31/2017  $21,500,000    21,478,821    21,459,150    5.8%
C2 Educational Systems, Inc. (j)  Education Services  Delayed Draw Term Loan
(3M USD TERM SOFR+8.50%), 13.83% Cash, 5/31/2025
  4/28/2023  $
-
    
-
    
-
    0.0%
C2 Education Systems, Inc. (h)  Education Services  Series A-1 Preferred Stock  5/18/2021   3,127    499,904    576,118    0.2%
Zollege PBC (k)  Education Services  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash/2.00% PIK, 5/11/2026
  5/11/2021  $16,409,153    16,340,466    3,493,509    0.9%
Zollege PBC (j)(k)  Education Services  Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash/2.00% PIK, 5/11/2026
  5/11/2021  $1,364,109    1,358,200    290,419    0.1%
Zollege PBC (h)  Education Services  Class A Units  5/11/2021   250,000    250,000    
-
    0.0%
      Total Education Services           39,927,391    25,819,196    7.0%
Destiny Solutions Inc. (h)(i)  Education Software  Limited Partner Interests  5/16/2018   3,068    3,969,291    9,894,736    2.7%
GoReact  Education Software  First Lien Term Loan
(3M USD TERM SOFR+7.50%), 13.03% Cash/1.00% PIK, 1/17/2025
  1/17/2020  $8,087,775    8,060,498    8,087,775    2.2%
GoReact (j)  Education Software  Delayed Draw Term Loan
(3M USD TERM SOFR+7.50%), 13.03% Cash/1.00% PIK, 1/17/2025
  1/18/2022  $
-
    
-
    
-
    0.0%
Identity Automation Systems (h)  Education Software  Common Stock Class A-2 Units  8/25/2014   232,616    232,616    569,355    0.2%
Identity Automation Systems (h)  Education Software  Common Stock Class A-1 Units  3/6/2020   43,715    171,571    235,296    0.1%
Ready Education  Education Software  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash, 8/5/2027
  8/5/2022  $27,000,000    26,797,063    26,792,100    7.2%
      Total Education Software           39,231,039    45,579,262    12.4%
TG Pressure Washing Holdings, LLC (h)  Facilities Maintenance  Preferred Equity  8/12/2019   488,148    488,148    231,181    0.1%
      Total Facilities Maintenance           488,148    231,181    0.1%

 

F-10

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Davisware, LLC  Field Service Management  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash, 7/31/2024
  9/6/2019  $6,000,000    5,991,382    5,989,200    1.6%
Davisware, LLC (j)  Field Service Management  Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash, 7/31/2024
  9/6/2019  $4,727,790    4,714,256    4,719,280    1.3%
      Total Field Service Management           10,705,638    10,708,480    2.9%
GDS Software Holdings, LLC  Financial Services  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2026
  12/30/2021  $22,713,926    22,624,322    22,545,843    6.1%
GDS Software Holdings, LLC  Financial Services  Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2026
  12/30/2021  $3,286,074    3,262,111    3,261,757    0.9%
GDS Software Holdings, LLC (h)  Financial Services  Common Stock Class A Units  8/23/2018   250,000    250,000    468,204    0.1%
      Total Financial Services           26,136,433    26,275,804    7.1%
Ascend Software, LLC  Financial Services Software  First Lien Term Loan
(3M USD TERM SOFR+7.50%), 13.10% Cash, 12/15/2026
  12/15/2021  $6,000,000    5,961,680    5,920,200    1.6%
Ascend Software, LLC (j)  Financial Services Software  Delayed Draw Term Loan
(3M USD TERM SOFR+7.50%), 13.10% Cash, 12/15/2026
  12/15/2021  $4,050,000    4,029,154    3,996,135    1.1%
      Total Financial Services Software           9,990,834    9,916,335    2.7%
Inspect Point Holdings, LLC  Fire Inspection Business Software  First Lien Term Loan
(1M USD TERM SOFR+6.50%), 11.82% Cash, 07/19/2028
  7/19/2023  $10,000,000    9,908,861    9,916,000    2.7%
Inspect Point Holdings, LLC (j)  Fire Inspection Business Software  Delayed Draw Term Loan
(1M USD TERM SOFR+6.50%), 11.82% Cash, 07/19/2028
  7/19/2023  $
-
    
-
    
-
    0.0%
      Total Fire Inspection Business Software           9,908,861    9,916,000    2.7%

 

F-11

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Stretch Zone Franchising, LLC  Health/Fitness Franchisor  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash, 3/31/2028
  3/31/2023  $30,000,000    29,740,931    29,970,000    8.1%
Stretch Zone Franchising, LLC (j)  Health/Fitness Franchisor  Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash, 3/31/2028
  3/31/2023  $
-
    
-
    
-
    0.0%
Stretch Zone Franchising, LLC (h)  Health/Fitness Franchisor  Class A Units  3/31/2023   20,000    2,000,000    2,062,331    0.6%
      Total Health/Fitness Franchisor           31,740,931    32,032,331    8.7%
Alpha Aesthetics Partners OpCo, LLC  Healthcare Services  First Lien Term Loan
(1M USD TERM SOFR+9.98%), 15.30% Cash, 3/20/2028
  3/20/2023  $3,900,000    3,847,845    3,959,670    1.2%
Alpha Aesthetics Partners OpCo, LLC (j)  Healthcare Services  Delayed Draw Term Loan
(1M USD TERM SOFR+9.98%), 15.30% Cash, 3/20/2028
  3/20/2023  $8,600,000    8,482,841    8,731,580    2.4%
Alpha Aesthetics Partners OpCo, LLC (h)  Healthcare Services  Class A Preferred Units  3/20/2023   2,850,000    2,850,000    2,859,121    0.8%
Axiom Medical Consulting, LLC  Healthcare Services  First Lien Term Loan
(3M USD TERM SOFR+6.00%), 11.33% Cash, 9/11/2028
  9/11/2023  $10,000,000    9,917,367    9,913,000    2.7%
Axiom Medical Consulting, LLC (j)  Healthcare Services  Delayed Draw Term Loan
(3M USD TERM SOFR+6.00%), 11.33% Cash, 9/11/2028
  9/11/2023  $
-
    
-
    
-
    0.0%
Axiom Parent Holdings, LLC (h)  Healthcare Services  Class A Preferred Units  6/19/2018   400,000    258,389    630,740    0.2%
ComForCare Health Care (d)  Healthcare Services  First Lien Term Loan
(3M USD TERM SOFR+6.25%), 11.58% Cash, 1/31/2025
  1/31/2017  $25,000,000    24,973,000    25,000,000    6.8%
      Total Healthcare Services           50,329,442    51,094,111    14.1%
HemaTerra Holding Company, LLC (d)  Healthcare Software  First Lien Term Loan
(1M USD TERM SOFR+8.25%), 13.57% Cash, 1/31/2027
  4/15/2019  $54,927,713    54,624,303    55,087,003    14.9%
HemaTerra Holding Company, LLC  Healthcare Software  Delayed Draw Term Loan
(1M USD TERM SOFR+8.25%), 13.57% Cash, 1/31/2027
  4/15/2019  $13,755,875    13,710,513    13,795,767    3.7%
TRC HemaTerra, LLC (h)  Healthcare Software  Class D Membership Interests  4/15/2019   2,487    2,816,693    5,362,439    1.4%
Procurement Partners, LLC  Healthcare Software  First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.83% Cash, 5/12/2026
  11/12/2020  $35,125,000    34,965,458    35,125,000    9.5%
Procurement Partners, LLC (j)  Healthcare Software  Delayed Draw Term Loan
(3M USD TERM SOFR+6.50%), 11.83% Cash, 5/12/2026
  11/12/2020  $10,300,000    10,230,001    10,300,000    2.8%
Procurement Partners Holdings LLC (h)  Healthcare Software  Class A Units  11/12/2020   571,219    571,219    826,280    0.2%
      Total Healthcare Software           116,918,187    120,496,489    32.5%
Roscoe Medical, Inc. (h)  Healthcare Supply  Common Stock  3/26/2014   5,081    508,077    
-
    0.0%
      Total Healthcare Supply           508,077    
-
    0.0%

 

F-12

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Book4Time, Inc. (a)(d)  Hospitality/Hotel  First Lien Term Loan
(3M USD TERM SOFR+7.50%), 12.83%, 12/22/2025
  12/22/2020  $3,136,517    3,122,542    3,136,517    0.8%
Book4Time, Inc. (a)  Hospitality/Hotel  Delayed Draw Term Loan
(3M USD TERM SOFR+7.50%), 12.83%, 12/22/2025
  12/22/2020  $2,000,000    1,989,839    2,000,000    0.5%
Book4Time, Inc. (a)(h)(i)  Hospitality/Hotel  Class A Preferred Shares  12/22/2020   200,000    156,826    389,531    0.1%
Knowland Group, LLC (k)  Hospitality/Hotel  Second Lien Term Loan
(3M USD TERM SOFR+8.00%), 13.48% Cash/3.00% PIK, 12/31/2024
  11/9/2018  $15,878,989    15,878,989    12,642,851    3.4%
Sceptre Hospitality Resources, LLC  Hospitality/Hotel  First Lien Term Loan
(3M USD TERM SOFR+7.25%), 12.58% Cash, 11/15/2027
  4/27/2020  $23,000,000    22,835,500    23,278,300    6.3%
Sceptre Hospitality Resources, LLC (j)  Hospitality/Hotel  Delayed Draw Term Loan
(3M USD TERM SOFR+7.25%), 12.58% Cash, 11/15/2027
  9/2/2021  $
-
    
-
    
-
    0.0%
      Total Hospitality/Hotel           43,983,696    41,447,199    11.1%
Granite Comfort, LP (d)  HVAC Services and Sales  First Lien Term Loan
(3M USD TERM SOFR+7.46%), 12.79% Cash, 5/16/2027
  11/16/2020  $43,000,000    42,781,757    43,000,000    11.6%
Granite Comfort, LP (j)  HVAC Services and Sales  Delayed Draw Term Loan
(3M USD TERM SOFR+7.46%), 12.79% Cash, 5/16/2027
  11/16/2020  $16,207,805    16,059,588    16,207,805    4.4%
      Total HVAC Services and Sales           58,841,345    59,207,805    16.0%
Vector Controls Holding Co., LLC (d)  Industrial Products  First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.75% Cash, 3/6/2025
  3/6/2013  $923,886    923,886    923,886    0.2%
Vector Controls Holding Co., LLC (h)  Industrial Products  Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027  5/31/2015   343    
-
    8,171,235    2.2%
      Total Industrial Products           923,886    9,095,121    2.4%

 

F-13

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
AgencyBloc, LLC  Insurance Software  First Lien Term Loan
(1M USD TERM SOFR+7.76%), 13.09% Cash, 10/1/2026
  10/1/2021  $15,788,864    15,686,250    15,806,231    4.3%
Panther ParentCo LLC (h)  Insurance Software  Class A Units  10/1/2021   2,500,000    2,500,000    4,014,869    1.1%
      Total Insurance Software           18,186,250    19,821,100    5.4%
LogicMonitor, Inc. (d)  IT Services  First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.83% Cash, 5/17/2026
  3/20/2020  $43,000,000    42,967,165    43,000,000    11.6%
      Total IT Services           42,967,165    43,000,000    11.6%
ActiveProspect, Inc. (d)  Lead Management Software  First Lien Term Loan
(3M USD TERM SOFR+6.00%), 11.53% Cash, 8/8/2027
  8/8/2022  $12,000,000    11,920,834    12,120,000    3.3%
ActiveProspect, Inc. (j)  Lead Management Software  Delayed Draw Term Loan
(3M USD TERM SOFR+6.00%), 11.53% Cash, 8/8/2027
  8/8/2022  $
-
    
-
    
-
    0.0%
      Total Lead Management Software           11,920,834    12,120,000    3.3%
Centerbase, LLC  Legal Software  First Lien Term Loan
(3M USD TERM SOFR+7.75%), 13.08% Cash, 1/18/2027
  1/18/2022  $21,033,360    20,882,496    20,709,446    5.6%
      Total Legal Software           20,882,496    20,709,446    5.6%
Madison Logic, Inc. (d)  Marketing Orchestration Software  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2028
  12/30/2022  $18,857,500    18,544,720    18,420,006    5.0%
      Total Marketing Orchestration Software           18,544,720    18,420,006    5.0%

  

F-14

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
ARC Health OpCo LLC (d)  Mental Healthcare Services  First Lien Term Loan
(3M USD TERM SOFR+8.47%), 13.81% Cash, 8/5/2027
  8/5/2022  $6,500,000    6,438,832    6,490,900    1.8%
ARC Health OpCo LLC (d)(j)  Mental Healthcare Services  Delayed Draw Term Loan
(3M USD TERM SOFR+8.47%), 13.81% Cash, 8/5/2027
  8/5/2022  $26,914,577    26,903,916    26,876,897    7.3%
ARC Health OpCo LLC (h)  Mental Healthcare Services  Class A Preferred Units  8/5/2022   3,818,400    4,169,599    4,009,323    1.1%
      Total Mental Healthcare Services           37,512,347    37,377,120    10.2%
Chronus LLC  Mentoring Software  First Lien Term Loan
(3M USD TERM SOFR+5.25%), 10.73% Cash, 8/26/2026
  8/26/2021  $15,000,000    14,911,921    14,841,000    4.0%
Chronus LLC  Mentoring Software  First Lien Term Loan
(3M USD TERM SOFR+6.00%), 11.48% Cash, 8/26/2026
  8/26/2021  $5,000,000    4,962,938    4,947,000    1.3%
Chronus LLC (h)  Mentoring Software  Series A Preferred Stock  8/26/2021   3,000    3,000,000    2,280,881    0.6%
      Total Mentoring Software           22,874,859    22,068,881    5.9%
Omatic Software, LLC  Non-profit Services  First Lien Term Loan
(3M USD TERM SOFR+8.00%), 13.59% Cash/1.00% PIK, 6/30/2025
  5/29/2018  $16,270,192    16,239,922    16,266,938    4.4%
      Total Non-profit Services           16,239,922    16,266,938    4.4%
Emily Street Enterprises, L.L.C.  Office Supplies  Senior Secured Note
(3M USD TERM SOFR+7.50%), 12.83% Cash, 12/31/2025
  12/28/2012  $6,000,000    5,992,437    6,027,000    1.6%
Emily Street Enterprises, L.L.C. (h)  Office Supplies  Warrant Membership Interests,
 Expires 12/31/2025
  12/28/2012   49,318    400,000    1,153,874    0.3%
      Total Office Supplies           6,392,437    7,180,874    1.9%

 

F-15

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Buildout, Inc. (d)  Real Estate Services  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 12.43% Cash, 7/9/2025
  7/9/2020  $14,000,000    13,950,236    13,631,800    3.7%
Buildout, Inc.  Real Estate Services  Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 12.47% Cash, 7/9/2025
  2/12/2021  $38,500,000    38,342,798    37,487,450    10.1%
Buildout, Inc. (h)(i)  Real Estate Services  Limited Partner Interests  7/9/2020   1,250    1,372,557    1,231,195    0.3%
      Total Real Estate Services           53,665,591    52,350,445    14.1%
Wellspring Worldwide Inc.  Research Software  First Lien Term Loan
(1M USD TERM SOFR+6.00%), 11.32% Cash, 12/22/2028
  6/27/2022  $9,552,000    9,474,084    9,483,226    2.6%
Wellspring Worldwide Inc.  Research Software  Delayed DrawTerm Loan
(1M USD TERM SOFR+6.00%), 11.32% Cash, 12/22/2028
  6/27/2022  $14,400,000    14,227,504    14,296,320    3.9%
Archimedes Parent LLC (h)  Research Software  Class A Common Units  6/27/2022   2,475,160    2,475,160    2,475,160    0.7%
      Total Research Software           26,176,748    26,254,706    7.2%
LFR Chicken LLC  Restaurant  First Lien Term Loan
(1M USD TERM SOFR+7.00%), 12.32% Cash, 11/19/2026
  11/19/2021  $12,000,000    11,926,272    12,104,400    3.3%
LFR Chicken LLC  Restaurant  Delayed Draw Term Loan
(1M USD TERM SOFR+7.00%), 12.32% Cash, 11/19/2026
  11/19/2021  $9,000,000    8,935,545    9,078,300    2.5%
LFR Chicken LLC (h)  Restaurant  Series B Preferred Units  11/19/2021   497,183    1,000,000    1,397,572    0.4%
      Total Restaurant           21,861,817    22,580,272    6.2%
JobNimbus LLC  Roofing Contractor Software  First Lien Term Loan
(1M USD TERM SOFR+8.75%), 14.17% Cash, 9/20/2026
  3/28/2023  $18,777,459    18,624,294    19,014,055    5.1%
      Total Roofing Contractor Software           18,624,294    19,014,055    5.1%

 

F-16

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Pepper Palace, Inc. (d)(k)  Specialty Food Retailer  First Lien Term Loan
(3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026
  6/30/2021  $33,320,000    33,148,332    2,409,036    0.7%
Pepper Palace, Inc. (j)(k)  Specialty Food Retailer  Delayed Draw Term Loan
(3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026
  6/30/2021  $1,101,600    1,092,422    79,646    0.0%
Pepper Palace, Inc. (j)(k)  Specialty Food Retailer  Revolving Credit Facility
(3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026
  6/30/2021  $
-
    
-
    
-
    0.0%
Pepper Palace, Inc. (h)  Specialty Food Retailer  Membership Interest (Series A)  6/30/2021   1,000,000    1,000,000    
-
    0.0%
Pepper Palace, Inc. (h)  Specialty Food Retailer  Membership Interest (Series B)  6/30/2021   197,035    197,035    
-
    0.0%
      Total Specialty Food Retailer           35,437,789    2,488,682    0.7%
ArbiterSports, LLC (d)  Sports Management  First Lien Term Loan
(3M USD TERM SOFR+6.00%), 11.33% Cash, 2/21/2025
  2/21/2020  $26,000,000    25,945,071    26,000,000    7.0%
ArbiterSports, LLC  Sports Management  Delayed Draw Term Loan
(3M USD TERM SOFR+6.00%), 11.33% Cash, 2/21/2025
  2/21/2020  $1,000,000    1,000,000    1,000,000    0.3%
      Total Sports Management           26,945,071    27,000,000    7.3%
Avionte Holdings, LLC (h)  Staffing Services  Class A Units
  1/8/2014   100,000    100,000    3,287,970    0.9%
      Total Staffing Services           100,000    3,287,970    0.9%
JDXpert  Talent Acquisition Software  First Lien Term Loan
(3M USD TERM SOFR+8.50%), 14.10% Cash, 5/2/2027
  5/2/2022  $6,000,000    5,955,935    6,060,000    1.6%
JDXpert (j)  Talent Acquisition Software  Delayed Draw Term Loan
(3M USD TERM SOFR+8.50%), 14.10% Cash, 5/2/2027
  5/2/2022  $1,000,000    991,649    1,010,000    0.3%
Jobvite, Inc. (d)  Talent Acquisition Software  First Lien Term Loan
(6M USD TERM SOFR+8.00%), 13.27% Cash, 8/5/2028
  8/5/2022  $20,000,000    19,875,273    19,826,000    5.6%
      Total Talent Acquisition Software           26,822,857    26,896,000    7.5%

 

F-17

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
VetnCare MSO, LLC (j)  Veterinary Services  Delayed Draw Term Loan
(3M USD TERM SOFR+5.75%), 11.08% Cash, 5/12/2028
  5/12/2023  $4,680,505    4,638,599    4,753,048    1.3%
      Total Veterinary Services           4,638,599    4,753,048    1.3%
Sub Total Non-control/Non-affiliate investments                 1,035,879,751    1,019,774,616    276.5%
Affiliate investments - 7.5% (b)                             
ETU Holdings, Inc. (f)  Corporate Education Software  First Lien Term Loan
(3M USD TERM SOFR+9.00%), 14.48% Cash, 8/18/2027
  8/18/2022  $7,000,000    6,945,060    6,983,200    1.9%
ETU Holdings, Inc. (f)  Corporate Education Software  Second Lien Term Loan
15.00% PIK, 2/18/2028
  8/18/2022  $6,130,483    6,089,408    5,454,290    1.5%
ETU Holdings, Inc. (f)(h)  Corporate Education Software  Series A Preferred Units  8/18/2022   3,000,000    3,000,000    1,162,040    0.3%
      Total Corporate Education Software           16,034,468    13,599,530    3.7%
Axero Holdings, LLC (f)  Employee Collaboration Software  First Lien Term Loan
(3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026
  6/30/2021  $5,500,000    5,468,859    5,555,000    1.5%
Axero Holdings, LLC (f)  Employee Collaboration Software  Delayed Draw Term Loan
(3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026
  6/30/2021  $1,100,000    1,092,870    1,111,000    0.3%
Axero Holdings, LLC (f)(j)  Employee Collaboration Software  Revolving Credit Facility
(3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026
  2/3/2022  $
-
    
-
    
-
    0.0%
Axero Holdings, LLC (f)(h)  Employee Collaboration Software  Series A Preferred Units  6/30/2021   2,055,609    2,055,609    2,877,000    0.8%
Axero Holdings, LLC (f)(h)  Employee Collaboration Software  Series B Preferred Units  6/30/2021   2,055,609    2,055,609    4,606,607    1.2%
      Total Employee Collaboration Software           10,672,947    14,149,607    3.8%
Sub Total Affiliate investments                 26,707,415    27,749,137    7.5%
Control investments - 24.7% (b)                             

 

F-18

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

Company(1)  Industry  Investment Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Netreo Holdings, LLC (g)  IT Services  First Lien Term Loan
(3M USD TERM SOFR +6.50%), 11.98% Cash/3.50% PIK
12/31/2025
  7/3/2018  $5,693,748    5,686,791    5,582,719    1.5%
Netreo Holdings, LLC (d)(g)  IT Services  Delayed Draw Term Loan
(3M USD TERM SOFR +6.50%), 11.98% Cash/3.50% PIK,
12/31/2025
  5/26/2020  $25,271,214    25,193,452    24,778,425    6.7%
Netreo Holdings, LLC (g)(h)  IT Services  Common Stock Class A Units  7/3/2018   4,600,677    8,344,500    5,060,745    1.4%
      Total IT Services           39,224,743    35,421,889    9.6%
Saratoga Investment Corp. CLO 2013-1, Ltd. (a)(e)(g)  Structured Finance Securities  Other/Structured Finance Securities
0.00%, 4/20/2033
  1/22/2008  $111,000,000    22,001,887    9,500,627    2.6%
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a)(g)  Structured Finance Securities  Other/Structured Finance Securities
(3M USD TERM SOFR+10.00%), 15.60%, 4/20/2033
  8/9/2021  $9,375,000    9,375,000    8,875,227    2.4%
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a)(g)  Structured Finance Securities  Other/Structured Finance Securities
(3M USD TERM SOFR+8.55%), 13.88%, 10/20/2033
  10/28/2022  $12,250,000    11,392,500    12,250,000    3.3%
      Total Structured Finance Securities           42,769,387    30,625,854    8.3%
Saratoga Senior Loan Fund I JV, LLC (a)(g)(j)  Investment Fund  Unsecured Loan
10.00%, 10/20/2033
  12/17/2021  $17,618,954    17,618,954    15,818,297    4.3%
Saratoga Senior Loan Fund I JV, LLC (a)(g)  Investment Fund  Membership Interest  12/17/2021   17,583,486    17,583,487    9,403,996    2.5%
      Total Investment Fund           35,202,441    25,222,293    6.8%
Sub Total Control investments                 117,196,571    91,270,036    24.7%
TOTAL INVESTMENTS - 308.7% (b)                $1,179,783,737   $1,138,793,789    308.7%

 

F-19

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

   Number of Shares   Cost   Fair Value   of
Net Assets
 
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 10.9% (b)                
U.S. Bank Money Market (l)   40,507,124   $40,507,124   $40,507,124    10.9%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts   40,507,124   $40,507,124   $40,507,124    10.9%

 

(1)Securities are exempt from registration under Rule 144A of the Securities Act of 1933, as amended, and are restricted securities. Money market funds are valued at net asset value and are considered level 1 investments within the fair value hierarchy.

 

(a)Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of February 29, 2024, non-qualifying assets represent 6.2% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets.

 

(b)Percentages are based on net assets of $370,224,108 as of February 29, 2024.

 

(c)Because there is no “readily available market quotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).

 

(d)These securities are either fully or partially pledged as collateral under the Company’s senior secured revolving credit facility (see Note 8 to the consolidated financial statements).

 

(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 0.00% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.

 

F-20

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

 

(f)As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Modis Dental Partners OpCo, LLC and Alpha Aesthetics Partners OpCo, LLC are no longer affiliates as of February 29, 2024. Transactions during the year ended February 29, 2024 in which the issuer was an affiliate are as follows:

 

Company  Purchases   Sales   Total Interest from Investments   Management Fee Income   Net Realized Gain (Loss) from Investments   Net Change in Unrealized Appreciation (Depreciation) 
Axero Holdings, LLC  $
-
   $
-
   $931,008   $
        -
   $
-
   $976,251 
ETU Holdings, Inc.   
-
    
-
    1,915,718    
-
    
-
    (2,518,080)
Modis Dental Partners OpCo, LLC   8,845,000    
-
    656,579    
-
    
-
    
-
 
Alpha Aesthetics Partners OpCo, LLC   10,498,789    
-
    670,737    
-
    
-
    
-
 
Total  $19,343,789   $
-
   $4,174,042   $
-
   $
-
   $(1,541,829)

 

(g)As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the year ended February 29, 2024 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

 

Company  Purchases   Sales   Total Interest from Investments   Total Dividends from Investments   Management Fee Income   Net Realized
Gain (Loss) from Investments
   Net Change in Unrealized Appreciation (Depreciation) 
Netreo Holdings, LLC  $2,475,000   $
-
   $4,374,804   $
-
   $
-
   $
-
   $(12,083,067)
Saratoga Investment Corp. CLO 2013-1, Ltd.   
-
    
-
    
-
    
-
    3,270,232    
-
    (4,733,934)
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note   
-
    
-
    1,696,890    
-
    
-
    
-
    895,505 
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note   
-
    
-
    1,469,668    
-
    
-
    
-
    43,821 
Saratoga Senior Loan Fund I JV, LLC   
-
    
-
    1,781,472    
-
    
-
    
-
    (1,800,657)
Saratoga Senior Loan Fund I JV, LLC   
-
    
-
    
-
    5,911,564    
-
    
-
    (3,702,956)
Total  $2,475,000   $
-
   $9,322,834   $5,911,564   $3,270,232   $
-
   $(21,381,288)

 

(h)Non-income producing at February 29, 2024.

 

(i)Includes securities issued by an affiliate of the company.

 

(j)All or a portion of this investment has an unfunded commitment as of February 29, 2024. (See Note 9 to the consolidated financial statements).
  
(k)As of February 29, 2024, the investment was on non-accrual status. The fair value of these investments was approximately $18.9 million, which represented 1.7% of the Company’s portfolio (see Note 2 to the consolidated financial statements).

 

(l)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of February 29, 2024.

 

SOFR - Secured Overnight Financing Rate

 

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of February 29, 2024 was 5.32%.

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of February 29, 2024 was 5.33%.

6M USD TERM SOFR - The 6 month USD TERM SOFR rate as of February 29, 2024 was 5.27%.

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

 

See accompanying notes to consolidated financial statements.

 

F-21

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

Company(1)  Industry  Investment
Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Non-control/Non-affiliate investments - 238.6% (b)                         
Altvia MidCo, LLC.  Alternative Investment Management Software  First Lien Term Loan
(3M USD TERM SOFR+8.50%), 13.39% Cash, 7/18/2027
  7/18/2022  $7,980,000   $7,907,457   $7,911,372    2.3%
Altvia MidCo, LLC. (h)  Alternative Investment Management Software  Series A-1 Preferred Shares  7/18/2022   2,000,000    2,000,000    2,548,000    0.7%
      Total Alternative Investment Management Software           9,907,457    10,459,372    3.0%
Artemis Wax Corp. (d)(j)  Consumer Services  Delayed Draw Term Loan
(1M USD TERM SOFR+6.75%), 11.41% Cash, 5/20/2026
  5/20/2021  $57,500,000    57,059,057    57,500,000    16.6%
Artemis Wax Corp. (h)  Consumer Services  Series B-1 Preferred Stock  5/20/2021   934,463    1,500,000    4,642,322    1.3%
Artemis Wax Corp. (h)  Consumer Services  Series D Preferred Stock  12/22/2022   278,769    1,500,000    1,500,005    0.4%
      Total Consumer Services           60,059,057    63,642,327    18.3%
Schoox, Inc. (h), (i)  Corporate Education Software  Series 1 Membership Interest  12/8/2020   1,050    475,698    3,809,091    1.1%
      Total Corporate Education Software           475,698    3,809,091    1.1%
GreyHeller LLC (h)  Cyber Security  Common Stock  11/10/2021   7,857,689    1,906,275    2,509,210    0.7%
      Total Cyber Security           1,906,275    2,509,210    0.7%
New England Dental Partners  Dental Practice Management  First Lien Term Loan
(3M USD LIBOR+8.00%), 12.97% Cash, 11/25/2025
  11/25/2020  $6,555,000    6,514,437    6,523,536    1.9%
New England Dental Partners  Dental Practice Management  Delayed Draw Term Loan
(3M USD LIBOR+8.00%), 12.97% Cash, 11/25/2025
  11/25/2020  $4,650,000    4,627,032    4,627,680    1.3%
Gen4 Dental Partners Holdings, LLC (j)  Dental Practice Management  Delayed Draw Term Loan
(3M USD TERM SOFR+10.35%), 15.24% Cash, 4/29/2026
  2/8/2023  $-    (94,504)   -    0.0%
Gen4 Dental Partners Holdings, LLC (i)  Dental Practice Management  Series A Preferred Units  2/8/2023   480,769    1,000,000    1,000,000    0.3%
      Total Dental Practice Management           12,046,965    12,151,216    3.5%
Exigo, LLC (d)  Direct Selling Software  First Lien Term Loan
(1M USD LIBOR+5.75%), 10.42% Cash, 3/16/2027
  3/16/2022  $24,812,500    24,632,494    24,504,825    7.1%
Exigo, LLC (j)  Direct Selling Software  Delayed Draw Term Loan
(1M USD LIBOR+5.75%), 10.42% Cash, 3/16/2027
  3/16/2022  $-    -    (51,667)   0.0%
Exigo, LLC (j)  Direct Selling Software  Revolving Credit Facility
(1M USD LIBOR+5.75%), 10.42% Cash, 3/16/2027
  3/16/2022  $208,334    208,333    195,417    0.1%
Exigo, LLC (h), (i)  Direct Selling Software  Common Units  3/16/2022   1,041,667    1,041,667    1,121,575    0.3%
      Total Direct Selling Software           25,882,494    25,770,150    7.5%
C2 Educational Systems (d)  Education Services  First Lien Term Loan
(3M USD LIBOR+8.50%), 13.47% Cash, 5/31/2023
  5/31/2017  $18,500,000    18,497,146    18,525,900    5.3%
C2 Education Systems, Inc. (h)  Education Services  Series A-1 Preferred Stock  5/18/2021   3,127    499,904    629,892    0.2%
Zollege PBC  Education Services  First Lien Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 5/11/2026
  5/11/2021  $16,000,000    15,905,830    14,827,200    4.3%
Zollege PBC (j)  Education Services  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 5/11/2026
  5/11/2021  $500,000    496,809    390,050    0.1%
Zollege PBC (h)  Education Services  Class A Units  5/11/2021   250,000    250,000    115,676    0.0%
      Total Education Services           35,649,689    34,488,718    9.9%

 

F-22

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

Company(1)  Industry  Investment
Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Destiny Solutions Inc. (h), (i)  Education Software  Limited Partner Interests  5/16/2018   3,068    3,969,291    8,941,350    2.6%
GoReact  Education Software  First Lien Term Loan
(3M USD TERM SOFR+7.50%), 13.59% Cash, 1/17/2025
  1/17/2020  $8,006,000    7,952,042    7,982,783    2.3%
GoReact (j)  Education Software  Delayed Draw Term Loan
(3M USD TERM SOFR+7.50%), 13.59% Cash, 1/17/2025
  1/18/2022  $1,000,750    1,000,750    997,848    0.3%
Identity Automation Systems (h)  Education Software  Common Stock Class A-2 Units  8/25/2014   232,616    232,616    218,168    0.1%
Identity Automation Systems (h)  Education Software  Common Stock Class A-1 Units  3/6/2020   43,715    171,571    217,370    0.1%
Ready Education  Education Software  First Lien Term Loan
(3M USD TERM SOFR+6.00%), 10.89% Cash, 8/5/2027
  8/5/2022  $27,000,000    26,751,573    26,597,700    7.7%
      Total Education Software           40,077,843    44,955,219    13.1%
TG Pressure Washing Holdings, LLC (h)  Facilities Maintenance  Preferred Equity  8/12/2019   488,148    488,148    407,760    0.1%
      Total Facilities Maintenance           488,148    407,760    0.1%
Davisware, LLC  Field Service Management  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 11.89% Cash, 7/31/2024
  9/6/2019  $6,000,000    5,972,735    5,988,000    1.7%
Davisware, LLC  Field Service Management  Delayed Draw Term Loan
(3M USD TERM SOFR+7.00%), 11.89% Cash, 7/31/2024
  9/6/2019  $3,977,790    3,950,992    3,969,834    1.1%
      Total Field Service Management           9,923,727    9,957,834    2.8%
B. Riley Financial, Inc. (a)  Financial Services  Senior Unsecured Loan
6.75% Cash, 5/31/2024
  10/18/2022  $165,301    165,301    160,077    0.0%
GDS Software Holdings, LLC  Financial Services  First Lien Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 12/30/2026
  12/30/2021  $22,713,926    22,603,970    22,311,890    6.4%
GDS Software Holdings, LLC  Financial Services  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 12/30/2026
  12/30/2021  $3,286,074    3,257,297    3,227,910    0.9%
GDS Software Holdings, LLC  (h)  Financial Services  Common Stock Class A Units  8/23/2018   250,000    250,000    518,413    0.1%
      Total Financial Services           26,276,568    26,218,290    7.4%
Ascend Software, LLC  Financial Services Software  First Lien Term Loan
(3M USD LIBOR+7.50%), 12.47% Cash, 12/15/2026
  12/15/2021  $6,000,000    5,952,354    5,902,200    1.7%
Ascend Software, LLC (j)  Financial Services Software  Delayed Draw Term Loan
(3M USD LIBOR+7.50%), 12.47% Cash, 12/15/2026
  12/15/2021  $3,300,000    3,269,283    3,194,050    0.9%
      Total Financial Services Software           9,221,637    9,096,250    2.6%
Axiom Parent Holdings, LLC (h)  Healthcare Services  Common Stock Class A Units  6/19/2018  $400,000    400,000    1,286,156    0.4%
ComForCare Health Care (d)  Healthcare Services  First Lien Term Loan
(3M USD LIBOR+6.25%), 11.22% Cash, 1/31/2025
  1/31/2017  $25,000,000    24,938,666    25,000,000    7.2%
      Total Healthcare Services           25,338,666    26,286,156    7.6%

 

F-23

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

Company(1)  Industry  Investment
Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
HemaTerra Holding Company, LLC (d)  Healthcare Software  First Lien Term Loan
(1M USD TERM SOFR+8.25%), 12.91% Cash, 1/31/2027
  4/15/2019  $55,483,943    55,105,372    55,445,104    16.0%
HemaTerra Holding Company, LLC  Healthcare Software  Delayed Draw Term Loan
(1M USD TERM SOFR+8.25%), 12.91% Cash, 1/31/2027
  4/15/2019  $13,895,175    13,829,142    13,885,448    4.0%
TRC HemaTerra, LLC (h)  Healthcare Software  Class D Membership Interests  4/15/2019   2,487    2,816,693    4,606,741    1.3%
Procurement Partners, LLC  Healthcare Software  First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.39% Cash, 5/12/2026
  11/12/2020  $35,125,000    34,906,981    35,103,925    10.1%
Procurement Partners, LLC (j)  Healthcare Software  Delayed Draw Term Loan
(3M USD TERM SOFR+6.50%), 11.39% Cash, 5/12/2026
  11/12/2020  $9,300,000    9,219,412    9,294,420    2.7%
Procurement Partners Holdings LLC (h)  Healthcare Software  Class A Units  11/12/2020   571,219    571,219    788,283    0.2%
      Total Healthcare Software           116,448,819    119,123,921    34.3%
Roscoe Medical, Inc. (h)  Healthcare Supply  Common Stock  3/26/2014   5,081    508,077    -    0.0%
      Total Healthcare Supply           508,077    -    0.0%
Book4Time, Inc. (a), (d)  Hospitality/Hotel  First Lien Term Loan
(3M USD LIBOR+7.50%), 12.47%, 12/22/2025
  12/22/2020  $3,136,517    3,116,896    3,136,517    0.9%
Book4Time, Inc. (a)  Hospitality/Hotel  Delayed Draw Term Loan
(3M USD LIBOR+7.50%), 12.47%, 12/22/2025
  12/22/2020  $2,000,000    1,984,212    2,000,000    0.6%
Book4Time, Inc. (a), (h), (i)  Hospitality/Hotel  Class A Preferred Shares  12/22/2020   200,000    156,826    281,778    0.1%
Knowland Group, LLC (h), (k)  Hospitality/Hotel  Second Lien Term Loan
(3M USD LIBOR+8.00%), 13.97% Cash/1.00% PIK, 5/9/2024
  11/9/2018  $15,878,989    15,878,989    9,760,821    2.8%
Sceptre Hospitality Resources, LLC  Hospitality/Hotel  First Lien Term Loan
(3M USD TERM SOFR+7.25%), 12.14% Cash, 11/15/2027
  4/27/2020  $23,000,000    22,806,316    22,793,000    6.6%
Sceptre Hospitality Resources, LLC (j)  Hospitality/Hotel  Delayed Draw Term Loan
(3M USD TERM SOFR+7.25%), 12.14% Cash, 11/15/2027
  9/2/2021  $-    -    -    0.0%
      Total Hospitality/Hotel           43,943,239    37,972,116    11.0%
Granite Comfort, LP (d)  HVAC Services and Sales  First Lien Term Loan
(3M USD TERM SOFR+7.86%), 12.75% Cash, 11/16/2025
  11/16/2020  $43,000,000    42,694,831    42,570,000    12.3%
Granite Comfort, LP (j)  HVAC Services and Sales  Delayed Draw Term Loan
(3M USD TERM SOFR+7.86%), 12.75% Cash, 11/16/2025
  11/16/2020  $12,000,000    11,894,177    11,880,000    3.4%
      Total HVAC Services and Sales           54,589,008    54,450,000    15.7%
Vector Controls Holding Co., LLC (d)  Industrial Products  First Lien Term Loan
(3M USD LIBOR+6.50%), 11.47% Cash, 3/6/2025
  3/6/2013  $3,089,986    3,089,986    3,089,986    0.9%
Vector Controls Holding Co., LLC (h)  Industrial Products  Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027  5/31/2015   343    -    6,517,923    1.9%
      Total Industrial Products           3,089,986    9,607,909    2.8%

 

F-24

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

Company(1)  Industry  Investment
Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
AgencyBloc, LLC  Insurance Software  First Lien Term Loan
(1M USD BSBY+8.00%), 12.58% Cash, 10/1/2026
  10/1/2021  $13,469,318    13,376,121    13,449,114    3.9%
Panther ParentCo LLC (h)  Insurance Software  Class A Units  10/1/2021   2,500,000    2,500,000    3,311,442    1.0%
      Total Insurance Software           15,876,121    16,760,556    4.9%
LogicMonitor, Inc. (d)  IT Services  First Lien Term Loan
(3M USD TERM SOFR+6.50%), 11.39% Cash, 5/17/2026
  3/20/2020  $43,000,000    42,953,087    43,000,000    12.4%
        Total IT Services           42,953,087    43,000,000    12.4%
ActiveProspect, Inc. (d)  Lead Management Software  First Lien Term Loan
(3M USD LIBOR+6.00%), 10.97% Cash, 8/8/2027
  8/8/2022  $12,000,000    11,906,362    12,090,000    3.5%
ActiveProspect, Inc. (j)  Lead Management Software  Delayed Draw Term Loan
(3M USD LIBOR+6.00%), 10.97% Cash, 8/8/2027
  8/8/2022  $-    -    -    0.0%
      Total Lead Management Software           11,906,362    12,090,000    3.5%
Centerbase, LLC  Legal Software  First Lien Term Loan
(1M USD TERM SOFR+7.75%), 12.41% Cash, 1/18/2027
  1/18/2022  $21,247,440    21,055,931    20,699,256    6.0%
      Total Legal Software           21,055,931    20,699,256    6.0%
Madison Logic, Inc. (d)  Marketing Orchestration Software  First Lien Term Loan
(3M USD TERM SOFR+7.00%), 11.89% Cash, 12/30/2028
  12/10/2021  $19,000,000    18,626,777    18,715,000    5.4%
      Total Marketing Orchestration Software           18,626,777    18,715,000    5.4%
ARC Health OpCo LLC (d)  Mental Healthcare Services  First Lien Term Loan
(3M USD TERM SOFR+8.48%), 13.37% Cash, 8/5/2027
  8/5/2022  $6,500,000    6,427,296    6,461,000    1.9%
ARC Health OpCo LLC (d), (j)  Mental Healthcare Services  Delayed Draw Term Loan
(3M USD TERM SOFR+8.48%), 13.37% Cash, 8/5/2027
  8/5/2022  $7,726,978    7,634,711    7,680,616    2.2%
ARC Health OpCo LLC (h)  Mental Healthcare Services  Class A Preferred Shares  8/5/2022   2,808,236    3,035,108    2,780,153    0.8%
      Total Mental Healthcare Services           17,097,115    16,921,769    4.9%
Chronus LLC  Mentoring Software  First Lien Term Loan
(3M USD LIBOR+5.25), 10.22% Cash, 8/26/2026
  8/26/2021  $15,000,000    14,887,780    14,890,500    4.3%
Chronus LLC  Mentoring Software  First Lien Term Loan
(3M USD LIBOR+6.00), 10.97% Cash, 8/26/2026
  8/26/2021  $3,000,000    2,973,634    2,978,100    0.9%
Chronus LLC (h)  Mentoring Software  Series A Preferred Stock  8/26/2021   3,000    3,000,000    3,490,403    1.0%
      Total Mentoring Software           20,861,414    21,359,003    6.2%
Omatic Software, LLC  Non-profit Services  First Lien Term Loan
(3M USD TERM SOFR+8.00%), 14.15% Cash/1.00% PIK, 1/31/2024
  5/29/2018  $13,122,781    13,091,197    13,095,223    3.8%
      Total Non-profit Services           13,091,197    13,095,223    3.8%
Emily Street Enterprises, L.L.C.  Office Supplies  Senior Secured Note
(3M USD TERM SOFR+7.50%), 12.39% Cash, 12/31/2025
  12/28/2012  $6,000,000    5,974,379    5,965,800    1.7%
Emily Street Enterprises, L.L.C. (h)  Office Supplies  Warrant Membership Interests,                          
Expires 12/31/2025
  12/28/2012   49,318    400,000    406,755    0.1%
      Total Office Supplies           6,374,379    6,372,555    1.8%

 

F-25

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

Company(1)  Industry  Investment
Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Buildout, Inc.  Real Estate Services  First Lien Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 7/9/2025
  7/9/2020  $14,000,000    13,924,435    13,855,800    4.0%
Buildout, Inc.  Real Estate Services  Delayed Draw Term Loan
(3M USD LIBOR+7.00%), 11.97% Cash, 7/9/2025
  2/12/2021  $38,500,000    38,257,589    38,103,450    11.0%
Buildout, Inc. (h), (i)  Real Estate Services  Limited Partner Interests  7/9/2020   1,250    1,372,557    1,447,219    0.4%
      Total Real Estate Services           53,554,581    53,406,469    15.4%
Archimedes Parent LLC (h)  Research Software  Class A Common Units  6/27/2022   1,125,160    1,125,160    1,136,503    0.3%
Wellspring Worldwide Inc.  Research Software  First Lien Term Loan
(1M USD BSBY+7.25%), 11.83% Cash, 6/27/2027
  6/27/2022  $9,600,000    9,503,123    9,540,480    2.7%
      Total Research Software           10,628,283    10,676,983    3.0%
LFR Chicken LLC  Restaurant  First Lien Term Loan
(1M USD LIBOR+7.00%), 11.67% Cash, 11/19/2026
  11/19/2021  $12,000,000    11,906,864    11,866,800    3.4%
LFR Chicken LLC (j)  Restaurant  Delayed Draw Term Loan
(1M USD LIBOR+7.00%), 11.67% Cash, 11/19/2026
  11/19/2021  $9,000,000    8,927,326    8,900,100    2.6%
LFR Chicken LLC (h)  Restaurant  Series B Preferred Units  11/19/2021   497,183    1,000,000    1,177,373    0.3%
TMAC Acquisition Co., LLC  Restaurant  Unsecured Term Loan
8.00% PIK, 3/1/2024
  3/1/2018  $3,217,657    3,217,657    2,881,888    0.8%
      Total Restaurant           25,051,847    24,826,161    7.1%
Pepper Palace, Inc. (d)  Specialty Food Retailer  First Lien Term Loan
(3M USD LIBOR+6.25%), 11.22% Cash, 6/30/2026
  6/30/2021  $33,490,000    33,255,863    24,410,861    7.0%
Pepper Palace, Inc. (j)  Specialty Food Retailer  Delayed Draw Term Loan
(3M USD LIBOR+6.25%), 11.22% Cash, 6/30/2026
  6/30/2021  $-    -    -    0.0%
Pepper Palace, Inc. (j)  Specialty Food Retailer  Revolving Credit Facility
(3M USD LIBOR+6.25%), 11.22% Cash, 6/30/2026
  6/30/2021  $-    -    -    0.0%
Pepper Palace, Inc. (h)  Specialty Food Retailer  Membership Interest  6/30/2021   1,000,000    1,000,000    -    0.0%
      Total Specialty Food Retailer           34,255,863    24,410,861    7.0%

 

F-26

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

Company(1)  Industry  Investment
Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
ArbiterSports, LLC (d)  Sports Management  First Lien Term Loan
(3M USD LIBOR+6.50%), 11.47% Cash, 2/21/2025
  2/21/2020  $26,000,000    25,894,505    25,721,800    7.4%
ArbiterSports, LLC  Sports Management  Delayed Draw Term Loan
(3M USD LIBOR+6.50%), 11.47% Cash, 2/21/2025
  2/21/2020  $1,000,000    1,000,000    989,300    0.3%
      Total Sports Management           26,894,505    26,711,100    7.7%
Avionte Holdings, LLC (h)  Staffing Services  Class A Units  1/8/2014   100,000    100,000    2,079,325    0.6%
      Total Staffing Services           100,000    2,079,325    0.6%
JDXpert  Talent Acquisition Software  First Lien Term Loan
(3M USD LIBOR+8.50%), 13.47% Cash, 5/2/2027
  5/2/2022  $6,000,000    5,947,780    6,045,000    1.7%
JDXpert (j)  Talent Acquisition Software  Delayed Draw Term Loan
(3M USD LIBOR+8.50%), 13.47% Cash, 5/2/2027
  5/2/2022  $-    -    -    0.0%
Jobvite, Inc. (d)  Talent Acquisition Software  First Lien Term Loan
(3M USD TERM SOFR+8.00%), 12.89% Cash, 8/5/2028
  8/5/2022  $20,000,000    19,857,613    19,954,000    5.8%
      Total Talent Acquisition Software           25,805,393    25,999,000    7.5%
Sub Total Non-control/Non-affiliate investments                 

819,966,208

    

828,028,800

    

238.6

% 

 

F-27

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

Company(1)  Industry  Investment
Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Affiliate investments - 8.1% (b)                         
ETU Holdings, Inc. (f)  Corporate Education Software  First Lien Term Loan
(3M USD LIBOR+9.00%), 13.97% Cash, 8/18/2027
  8/18/2022  $7,000,000    6,935,556    7,006,300    2.0%
ETU Holdings, Inc. (f)  Corporate Education Software  Second Lien Term Loan
15.00% PIK, 2/18/2028
  8/18/2022  $5,282,563    5,235,433    5,175,327    1.5%
ETU Holdings, Inc. (f), (h)  Corporate Education Software  Series A-1 Preferred Stock  8/18/2022   3,000,000    3,000,000    3,072,504    0.9%
      Total Corporate Education Software           15,170,989    15,254,131    4.4%
Axero Holdings, LLC (f)  Employee Collaboration Software  First Lien Term Loan
(3M USD TERM SOFR+8.00%), 13.04% Cash, 6/30/2026
  6/30/2021  $5,500,000    5,460,448    5,513,200    1.6%
Axero Holdings, LLC (f)  Employee Collaboration Software  Delayed Draw Term Loan
(3M USD TERM SOFR+8.00%), 13.04% Cash, 6/30/2026
  6/30/2021  $1,100,000    1,090,883    1,102,640    0.3%
Axero Holdings, LLC (f), (j)  Employee Collaboration Software  Revolving Credit Facility
(3M USD TERM SOFR+8.00%), 13.04% Cash, 6/30/2026
  2/3/2022  $-    -    -    0.0%
Axero Holdings, LLC (f), (h)  Employee Collaboration Software  Series A Preferred Units  6/30/2021   2,000,000    2,000,000    2,498,000    0.7%
Axero Holdings, LLC (f), (h)  Employee Collaboration Software  Series B Preferred Units  6/30/2021   2,000,000    2,000,000    3,937,900    1.1%
      Total Employee Collaboration Software           10,551,331    13,051,740    3.7%
Sub Total Affiliate investments                 25,722,320    28,305,871    8.1%

 

F-28

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

Company(1)  Industry  Investment
Interest Rate/
Maturity
  Original
Acquisition
Date
  Principal/
Number of Shares
   Cost   Fair
Value (c)
   % of
Net Assets
 
Control investments - 33.6% (b)                             
Netreo Holdings, LLC (g)  IT Services  First Lien Term Loan
(3M USD LIBOR +6.50%), 13.47% Cash/2.00% PIK
12/31/2025
  7/3/2018  $5,539,029    5,522,608    5,443,757    1.6%
Netreo Holdings, LLC (d), (g)  IT Services  Delayed Draw Term Loan
(3M USD LIBOR +6.50%), 13.47% Cash/2.00% PIK,
12/31/2025
  5/26/2020  $22,111,008    22,019,877    21,730,699    6.3%
Netreo Holdings, LLC (g), (h)  IT Services  Common Stock Class A Unit  7/3/2018   4,600,677    8,344,500    16,992,742    4.9%
      Total IT Services           35,886,985    44,167,198    12.8%
Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (e), (g)  Structured Finance Securities  Other/Structured Finance Securities
0.00%, 4/20/2033
  1/22/2008  $111,000,000    28,943,904    21,176,578    6.1%
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a), (g)  Structured Finance Securities  Other/Structured Finance Securities
(3M USD LIBOR+10.00%), 14.97%, 4/20/2033
  8/9/2021  $9,375,000    9,375,000    8,831,406    2.5%
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a), (g)  Structured Finance Securities  Other/Structured Finance Securities
(3M USD TERM SOFR+8.55%), 13.44%, 10/20/2033
  10/28/2022  $12,250,000    11,392,500    11,354,495    3.3%
      Total Structured Finance Securities           49,711,404    41,362,479    11.9%
Saratoga Senior Loan Fund I JV, LLC (a), (g), (j)  Investment Fund  Unsecured Loan
10.00%, 6/15/2023
  2/17/2022  $17,618,954    17,618,954    17,618,954    5.1%
Saratoga Senior Loan Fund I JV, LLC (a), (g), (h)  Investment Fund  Membership Interest  2/17/2022   17,583,486    17,583,486    13,106,951    3.8%
      Total Investment Fund           35,202,440    30,725,905    8.9%
Sub Total Control investments                 120,800,829    116,255,582    33.6%
TOTAL INVESTMENTS - 280.3% (b)                $966,489,357   $972,590,253    280.3%

 

F-29

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

   Number of
Shares
   Cost   Fair Value   % of
Net Assets
 
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 27.7% (b)                
U.S. Bank Money Market (l)   96,076,273   $96,076,273   $96,076,273    27.7%
Total cash and cash equivalents and cash and cash equivalents, reserve accounts   96,076,273   $96,076,273   $96,076,273    27.7%

 

(1)Securities are exempt from registration under Rule 144A of the Securities Act of 1933, as amended, and are restricted securities. Money market funds are valued at net asset value and are considered level 1 investments within the fair value hierarchy.

 

(a)Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of February 28, 2023, non-qualifying assets represent 8.6% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets.

 

(b)Percentages are based on net assets of $346,958,042 as of February 28, 2023.

 

(c)Because there is no “readily available market quotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).

 

(d)These securities are either fully or partially pledged as collateral under the Company’s senior secured revolving credit facility (see Note 8 to the consolidated financial statements).

 

(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 0.00% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.

 

(f)As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Artemis Wax Corp. is no longer an affiliate as of February 28, 2023. Transactions during the nine monthsyear ended February 28, 2023 in which the issuer was an affiliate are as follows:

 

Company  Purchases   Sales   Total
Interest from
Investments
   Management
Fee Income
   Net Realized
Gain (Loss)
from Investments
   Net Change
in Unrealized
Appreciation
(Depreciation)
 
Artemis Wax Corp  $27,440,000   $6,162,526   $3,418,378   $
          -
   $
         -
   $(1,460,287)
Axero Holdings, LLC   1,089,000    
-
    848,422    
-
    
-
    1,951,499 
ETU Holdings, Inc.   14,880,000    
-
    923,437    
-
    
-
    83,142 
Total  $43,409,000   $6,162,526   $5,190,237   $
-
   $
-
   $574,354 

 

F-30

 

 

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2023

 

(g)As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the year ended February 28, 2023 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

 

Company  Purchases   Sales   Total
Interest from
Investments
   Management
Fee Income
   Net Realized
Gain (Loss)
from Investments
   Net Change
in Unrealized
Appreciation
(Depreciation)
 
Netreo Holdings, LLC  $8,290,000   $
     -
   $2,529,483   $
-
   $
        -
   $(2,363,302)
Saratoga Investment Corp. CLO 2013-1, Ltd.   
-
    
-
    1,228,486    3,269,820    
-
    (4,149,106)
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note   11,392,500    
-
    552,330    
-
    
-
    (38,005)
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note   
-
    
-
    1,195,662    
-
    
-
    (543,594)
Saratoga Senior Loan Fund I JV, LLC   4,493,954    
-
    1,483,522    
-
    
-
    
-
 
Saratoga Senior Loan Fund I JV, LLC   4,458,486    
-
    
-
    
-
    
-
    (3,367,599)
Total  $28,634,940   $
-
   $6,989,483   $3,269,820   $
-
   $(10,461,606)

 

(h)Non-income producing at February 28, 2023.

 

(i)Includes securities issued by an affiliate of the company.

 

(j)All or a portion of this investment has an unfunded commitment as of February 28, 2023. (See Note 9 to the consolidated financial statements).

 

(k)As of February 28, 2023, the investment was on non-accrual status. The fair value of these investments was approximately $9.8 million, which represented 2.8% of the Company’s portfolio (see Note 2 to the consolidated financial statements).

 

(l)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of February 28, 2023.

 

BSBY - Bloomberg Short-Term Bank Yield

LIBOR - London Interbank Offered Rate

SOFR - Secured Overnight Financing Rate

 

1M USD BSBY - The 1 month USD BSBY rate as of February 28, 2023 was 4.58%.

3M USD BSBY - The 3 month USD BSBY rate as of February 28, 2023 was 4.87%.

1M USD LIBOR - The 1 month USD LIBOR rate as of February 28, 2023 was 4.67%.

3M USD LIBOR - The 3 month USD LIBOR rate as of February 28, 2023 was 4.97%.

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of February 28, 2023 was 4.66%

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of February 28, 2023 was 4.89%

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

 

See accompanying notes to consolidated financial statements.

 

F-31

 

 

SARATOGA INVESTMENT CORP.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

February 29, 2024

 

Note 1. Organization

 

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed the initial public offering (“IPO”) on March 28, 2007. The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

 

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

 

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in connection with the consummation of a recapitalization transaction.

 

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the “Manager” or “Saratoga Investment Advisors”), pursuant to an investment advisory and management agreement (the “Management Agreement”).

 

The Company has established wholly owned subsidiaries, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MAC, Inc., SIA-MDP, Inc., SIA-PP Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT, Inc., SIA-Vector, Inc. and SIA-VR, Inc., which are structured as Delaware entities that are treated as corporations for U.S. federal income tax purposes and are intended to facilitate its compliance with the requirements to be treated as a RIC under the Code by holding equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). These entities are consolidated for accounting purposes, but are not consolidated for U.S. federal income tax purposes and may incur U.S. federal income tax expenses as a result of their ownership of portfolio companies. In February 2022, SIA-GH, Inc., SIA-TT Inc. and SIA-VR, Inc. received an approved plan of liquidation following the sale of equity held by each of the portfolio companies.  

 

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC LP (“SBIC LP”), Saratoga Investment Corp. SBIC II LP (“SBIC II LP”), and Saratoga Investment Corp. SBIC III LP (“SBIC III LP”, and together with SBIC LP and SBIC II LP, the “SBIC Subsidiaries”), received SBIC licenses from the SBA on March 28, 2012, August 14, 2019, and September 29, 2022, respectively. SBIC LP’s license provided up to $150.0 million in additional long-term capital in the form of SBA debentures, while SBIC II LP’s and SBIC III LP’s SBIC licenses provide up to $175.0 million each. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital. Following the debentures being fully repaid to the SBA, SBIC LP surrendered its license on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. 

 

F-32

 

 

The Company has formed a wholly owned special purpose entity, Saratoga Investment Funding II LLC (“SIF II”), a Delaware limited liability company, for the purpose of entering into the senior secured revolving credit facility with Encina Lender Finance, LLC (the “Lender”), supported by loans held by SIF II and pledged to the Lender under the credit facility (the “Encina Credit Facility”).

 

On October 26, 2021, the Company and TJHA JV I LLC (“TJHA”) entered into a Limited Liability Company Agreement to co-manage Saratoga Senior Loan Fund I JV LLC (“SLF JV”). SLF JV is under joint control and is not consolidated. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1 Ltd. (“SLF 2022”), which is a wholly owned subsidiary of SLF JV. SLF 2022 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets. On October 28, 2022, SLF 2022 issued $402.1 million of debt (the “2022 JV CLO Notes”) through a collateralized loan obligation trust (the “JV CLO trust”). The 2022 JV CLO Notes were issued pursuant to an indenture, dated October 28, 2022 (the “JV Indenture”), with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) (the “Trustee”) servicing as the trustee.

 

Note 2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), are stated in U.S. Dollars and include the accounts of the Company and its wholly owned special purpose financing subsidiaries, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC), SIF II, SBIC LP, SBIC II LP, SBIC III LP, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc., SIA-MAC, Inc., SIA-PP, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., SIA-Vector, Inc. and SIA-VR, Inc. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

 

The Company, SBIC LP, SBIC II LP, and SBIC III LP are all considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services — Investment Companies (“ASC 946”). There have been no changes to the Company, SBIC LP, SBIC II LP, or SBIC III LP’s status as investment companies during the year ended February 29, 2024.

 

Principles of Consolidation

 

Under the investment company rules and regulations pursuant to ASC 946, the Company is precluded from consolidating any entity other than another investment company or controlled operating company whose business consists of providing services to the Company.  As a result, the consolidated financial statements of the Company include only the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

 

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, Consolidation, concludes that in a joint venture where both members have equal decision making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate its investment in SLF JV.

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

 

F-33

 

 

Operating Segment

 

The Company invests in various industries. The Company separately evaluates the performance of each of its investment relationships. However, because each of these investment relationships has similar business and economic characteristics, they have been aggregated into a single investment segment. All applicable segment disclosures are included in or can be derived from the Company’s consolidated financial statements (See “Note 3. Investments”).

 

Cash and Cash Equivalents

 

Cash and cash equivalents include short-term, liquid investments in a money market fund. The Company places its cash in financial institutions and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits. Cash and cash equivalents are carried at cost which approximates fair value. Pursuant to Section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another investment company, such as a money market fund, if such investment would cause the Company to:

 

own more than 3.0% of the investment company’s total outstanding voting stock;

 

hold securities in the investment company having an aggregate value in excess of 5.0% of the value of the Company’s total assets; or

 

hold securities in investment companies having an aggregate value in excess of 10.0% of the value of the Company’s total assets.

 

As of February 29, 2024, the Company did not exceed any of these limitations.

 

Cash and Cash Equivalents, Reserve Accounts

 

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds, and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits, representing payments received on secured investments or other reserved amounts associated with the Encina Credit Facility held by the Company’s wholly owned subsidiary, SIF II. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the Encina Credit Facility.

 

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within the Company’s wholly owned subsidiaries, SBIC LP, SBIC II LP and SBIC III LP.

 

The statements of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents when reconciling the beginning-of-period and end-of-period total amounts.

 

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:

 

   February 29,
2024
   February 28,
2023
   February 28,
2022
 
Cash and cash equivalents  $8,692,846   $65,746,494   $47,257,801 
Cash and cash equivalents, reserve accounts   31,814,278    30,329,779    5,612,541 
Total cash and cash equivalents and cash and cash equivalents, reserve accounts  $40,507,124   $96,076,273   $52,870,342 

 

Investment Classification

 

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “control investments” are defined as investments in companies in which the Company owns more than 25.0% of the voting securities or maintains greater than 50.0% of the board representation. Under the 1940 Act, “affiliated investments” are defined as those non-control investments in companies in which the Company owns between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “non-affiliated investments” are defined as investments that are neither control investments nor affiliated investments.

 

F-34

 

 

Investment Valuation

 

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the measurement date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

 

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by the Company’s board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. The Company values investments for which market quotations are not readily available at fair value as approved, in good faith, by the Company’s board of directors based on input from the Manager, the audit committee of the board of directors and a third-party independent valuation firm.

 

The Company undertakes a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

Each investment is initially valued by the responsible investment professionals of the Manager and preliminary valuation conclusions are documented, reviewed and discussed with our senior management; and

 

An independent valuation firm engaged by the Company’s board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. The Company uses a third-party independent valuation firm to value its investment in the subordinated notes of Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), the Class F-2-R-3 Notes of the Saratoga CLO, and the Class E Notes of the SLF 2022 every quarter.

 

In addition, all investments are subject to the following valuation process:

 

The audit committee of the Company’s board of directors reviews and approves each preliminary valuation and the Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

The Company’s board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of the Manager, independent valuation firm (to the extent applicable) and the audit committee of the board of directors.

 

The Company uses multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of the Company’s investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

 

F-35

 

 

 

The Company’s investments in the subordinated notes of Saratoga CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022 are carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds, when available, as determined by the Manager and recommended to the Company’s board of directors. Specifically, the Company uses Intex cash flows, or an appropriate substitute, to form the basis for the valuation of its investment in the subordinated notes of Saratoga CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine the valuation for our investment in Saratoga CLO. 

 

The Company’s equity investment in SLF JV is measured using the proportionate share of the net asset value (“NAV”), or equivalent, of SLF JV as a practical expedient for fair value, provided by ASC 820. The Company’s unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

 

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. The Company’s NAV could be materially affected if the determinations regarding the fair value of its investments were materially higher or lower than the values that the Company ultimately realizes upon the disposal of such investments.

 

Rule 2a-5 under the 1940 Act (“Rule 2a-5”) establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards of directors, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides for certain recordkeeping requirements associated with fair value determinations. Finally, the Securities and Exchange Commission (the “SEC”) rescinded previously issued guidance on related issues, including the role of the board in determining fair value and the accounting and auditing of fund investments. While the Company’s board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, the Company has established policies and procedures in compliance with the applicable requirements of Rule 2a-5 and Rule 31a-4.

 

Derivative Financial Instruments

 

The Company accounts for derivative financial instruments in accordance with FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

 

Investment Transactions and Income Recognition

 

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments up to the earliest call date.

 

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At February 29, 2024 our investment in three portfolio companies were on non-accrual status with a fair value of approximately $18.9 million, or 1.7% of the fair value of our portfolio. At February 28, 2023, our investment in one portfolio company was on non-accrual status with a fair value of approximately $9.8 million, or 1.0% of the fair value of our portfolio.

 

F-36

 

 

Interest income on our investment in the subordinated note of Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

 

Payment-in-Kind Interest

 

The Company holds debt and preferred equity investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company stops accruing PIK interest if it is expected that the issuer will not be able to pay all principal and interest when due. The Company restores to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

 

Dividend Income

 

Dividend income is recorded in the consolidated statements of operations when earned.

 

Structuring and Advisory Fee Income

 

Structuring and advisory fee income represents various fee income earned and received for performing certain investment structuring and advisory activities during the closing of new investments.

 

Other Income

 

Other income includes prepayment income fees, and monitoring, administration, redemption and amendment fees and is recorded in the consolidated statements of operations when earned.

 

Deferred Debt Financing Costs

 

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight-line method over the life of the respective facility and debt securities. Financing costs incurred in connection with the SBA debentures of SBIC LP, SBIC II LP, and SBIC III LP are deferred and amortized using the straight-line method over the life of the debentures. Any discount or premium on the issuance of any debt is accreted and amortized using the effective interest method over the life of the respective debt security.

 

The Company presents deferred debt financing costs on the balance sheet as a contra-liability, which is a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.

 

Realized Loss on Extinguishment of Debt 

 

Upon the repayment of debt obligations that are deemed to be extinguishments, the difference between the principal amount due at maturity adjusted for any unamortized debt issuance costs is recognized as a loss (i.e., the unamortized debt issuance costs are recognized as a loss upon extinguishment of the underlying debt obligation).

 

F-37

 

 

Contingencies

 

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management reasonably believes that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

 

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

 

Income Taxes

 

The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. By meeting these requirements, the Company generally will not be subject to U.S. federal income tax on ordinary income or capital gains timely distributed to stockholders. Therefore, no provision has been recorded for federal income taxes, except as related to the Corporate Blockers (as defined below) and long-term capital gains, when applicable.

 

In order to qualify as a RIC, among other requirements, the Company generally is required to timely distribute to its stockholders at least 90% of its “investment company taxable income”, as defined by the Code, for each fiscal tax year. The Company will be subject to U.S. federal income tax imposed at corporate rates on its investment company taxable income and net capital gains that it does not timely distribute to shareholders. The Company will be subject to a non-deductible U.S. federal excise tax of 4% on undistributed income if it does not distribute at least (1) 98% of its net ordinary income in any calendar year, (2) 98.2% of its capital gain net income for each one-year period ending on October 31and (3) any net ordinary income and capital gain net income that it recognized for preceding years, but were not distributed during such year, and on which the Company paid no U.S federal income tax.

  

Depending on the level of investment company taxable income earned in a tax year and the amount of net capital gains recognized in such tax year, the Company may choose to carry forward investment company taxable income and net capital gains in excess of current year dividend distributions into the next tax year and pay U.S. federal income tax, and possibly the 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual investment company taxable income will be in excess of estimated current year dividend distributions for U.S. federal excise tax purposes, the Company accrues the U.S. federal excise tax, if any, on estimated excess taxable income as taxable income is earned. For the years ended February 29, 2024, 2023 and 2022, the excise tax accrual on estimated excess taxable income was $1.8 million, $1.1 million and $0.6 million, respectively.

 

In accordance with U.S. Treasury regulations and published guidance issued by the Internal Revenue Service (“IRS”), a publicly offered RIC may treat a distribution of its own stock as counting toward its RIC distribution requirements if each stockholder may elect to receive his, her, or its entire distribution in either cash or stock of the RIC. This published guidance indicates that the rule will apply where the aggregate amount of cash to be distributed to all stockholders is not at least 20% of the aggregate declared distribution. Under the published guidance, if too many stockholders elect to receive cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S. federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

 

The Company may utilize wholly owned holding companies that are treated as corporations for U.S. federal income tax purposes when making equity investments in portfolio companies taxed as pass-through entities to meet its source-of-income requirements as a RIC (“Corporate Blockers”). Corporate Blockers are consolidated in the Company’s U.S. GAAP financial statements and may result in current and deferred U.S. federal and state income tax expense with respect to income derived from those investments. Such income, net of applicable income taxes, is not included in the Company’s tax-basis net investment income until distributed by the Corporate Blocker, which may result in timing and character differences between the Company’s U.S. GAAP and tax-basis net investment income and realized gains and losses. Income tax expense or benefit from Corporate Blockers related to net investment income are included in total operating expenses, while any expense or benefit related to federal or state income tax originated for capital gains and losses are included together with the applicable net realized or unrealized gain or loss line item. Deferred tax assets of the Corporate Blockers are reduced by a valuation allowance when, in the opinion of management, it is more-likely than-not that some portion or all of the deferred tax assets will not be realized.

  

F-38

 

 

FASB ASC Topic 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 29, 2024, February 28, 2023 and February 28, 2022 the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2020, 2021, 2022 and 2023 federal tax years for the Company remain subject to examination by the IRS. At February 29, 2024, and February 28, 2023, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

 

Dividends

 

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain some or all of our net capital gains for reinvestment.

 

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

 

Capital Gains Incentive Fee

 

The Company records an expense accrual on the consolidated statements of operations relating to the capital gains incentive fee payable to the Manager, as recorded on the consolidated statements of assets and liabilities when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments, as a capital gains incentive fee would be owed to the Manager if the Company were to liquidate its investment portfolio at such time.

 

The actual incentive fee payable to the Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and only reflect those realized capital gains net of realized and unrealized losses for the period.

 

Recent Accounting Pronouncements

 

In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820) (“ASU 2022-03”), which clarifies that a contractual sale restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security and is not included in the equity security’s unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value. In addition, ASU 2022-03 prohibits an entity from recognizing a contractual sale restriction as a separate unit of account. ASU 2022-03 amendments are effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of the adoption of ASU 2022-03 on its consolidated financial statements.

 

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) to provide optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. ASU 2020-04 established Topic 848 to provide relief during the temporary transition period and includes a sunset provision based on expectations of when the London Interbank Offered Rate (“LIBOR”) would cease being published. With the adoption of ASU 2020-04, there was no significant impact to the Company’s financial position.

 

F-39

 

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. The amendments in this update require more disaggregated information on income taxes paid. ASU 2023-09 is effective for years beginning after December 15, 2024. Early adoption is permitted, however the Company has not elected to adopt this provision as of the date of the financial statements contained in this report. The Company is still assessing the impact of the new guidance. However, it does not expect ASU 2023-09 to have a material impact on the consolidated financial statements and the notes thereto.

 

Risk Management

 

In the ordinary course of its business, the Company manages a variety of risks, including market and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

 

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

 

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

  

Note 3. Investments

 

As noted above, the Company values all investments in accordance with ASC 820. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between independent market participants at the measurement date.

 

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

 

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

  Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

  Level 2— Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. Such inputs may be quoted prices for similar assets or liabilities, quoted markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full character of the financial instrument, or inputs that are derived principally from, or corroborated by, observable market information. Investments that are generally included in this category include illiquid debt securities and less liquid, privately held or restricted equity securities, for which some level of recent trading activity has been observed.

 

F-40

 

 

  Level 3—Pricing inputs are unobservable for the investment and includes situations where there is little, if any, market activity for the investment. The inputs may be based on the Company’s own assumptions about how market participants would price the asset or liability or may use Level 2 inputs, as adjusted, to reflect specific investment attributes relative to a broader market assumption. Even if observable market data for comparable performance or valuation measures (earnings multiples, discount rates, other financial/valuation ratios, etc.) are available, such investments are grouped as Level 3 if any significant data point that is not also market observable (private company earnings, cash flows, etc.) is used in the valuation technique. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

 

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our valuation policy, the Company evaluates the source of inputs, including any markets in which its investments are trading, in determining fair value.

 

The following table presents fair value measurements of investments, by major class, as of February 29, 2024 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements   Valued Using Net Asset      
   Level 1   Level 2   Level 3   Value*   Total 
First lien term loans  $
          -
   $
     -
   $976,423   $
-
   $976,423 
Second lien term loans   
-
    
-
    18,097    
-
    18,097 
Unsecured loans   
-
    
-
    15,818    
-
    15,818 
Structured finance securities   
-
    
-
    30,626    
-
    30,626 
Equity interests   
-
    
-
    88,426    9,404    97,830 
Total  $
-
   $
-
   $1,129,390   $9,404   $1,138,794 

 

 

*The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy. The Company’s unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2023 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements   Valued Using Net Asset     
   Level 1   Level 2   Level 3   Value*   Total 
First lien term loans  $
      -
   $
       -
   $798,534   $
-
   $798,534 
Second lien term loans   
-
    
-
    14,936    
-
    14,936 
Unsecured loans   
-
    
-
    20,661    
-
    20,661 
Structured finance securities   
-
    
-
    41,362    
-
    41,362 
Equity interests   
-
    
-
    83,990    13,107    97,097 
Total  $
-
   $
-
   $959,483   $13,107   $972,590 

 

 

*The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy. The Company’s unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

 

F-41

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 29, 2024 (dollars in thousands):

 

   First lien
term loans
   Second lien
term loans
   Unsecured
term loans
   Structured
finance
securities
   Equity
interests
   Total 
Balance as of February 28, 2023  $798,534   $14,936   $20,661   $41,362   $83,990   $959,483 
Payment-in-kind and other adjustments to cost   1,479    848    
-
    (6,941)   (296)   (4,910)
Net accretion of discount on investments   2,215    6    
-
    
-
    
-
    2,221 
Net change in unrealized appreciation (depreciation) on investments   (33,325)   2,307    (1,460)   (3,795)   (7,115)   (43,388)
Purchases   234,408    
-
    
-
    
-
    11,693    246,101 
Sales and repayments   (26,888)   
-
    (3,383)   
-
    
-
    (30,271)
Net realized gain (loss) from investments   
-
    
-
    
-
    
-
    154    154 
Balance as of February 29, 2024  $976,423   $18,097   $15,818   $30,626   $88,426   $1,129,390 
Net change in unrealized appreciation (depreciation) for the year relating to those Level 3 assets that  were still held by the Company at the end of the year  $(33,307)  $2,307   $1,801   $(3,795)  $(7,115)  $(40,109)

 

Purchases, PIK and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK interests.

 

Sales and repayments represent net proceeds received from investments sold and principal paydowns received during the period.

 

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2, or 3 during the year ended February 29, 2024.

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2023 (dollars in thousands):

 

   First lien
term loans
   Second lien
term loans
   Unsecured
term loans
   Structured
finance
securities
   Equity
interests
   Total 
Balance as of February 28, 2022  $631,572   $44,386   $15,931   $38,030   $75,632   $805,551 
Payment-in-kind and other adjustments to cost   391    283    238    (3,329)   535    (1,882)
Net accretion of discount on investments   1,831    (14)   
-
    
-
    
-
    1,817 
Net change in unrealized appreciation (depreciation) on investments   (10,465)   (703)   (167)   (4,731)   4,215    (11,851)
Purchases   345,955    4,950    4,659    11,392    13,660    380,616 
Sales and repayments   (170,913)   (33,966)   
-
    -    (17,336)   (222,215)
Net realized gain (loss) from investments   163    
-
    
-
    
-
    7,284    7,447 
Balance as of February 28, 2023  $798,534   $14,936   $20,661   $41,362   $83,990   $959,483 
Net change in unrealized appreciation (depreciation) for the year relating to those Level 3 assets that  were still held by the Company at the end of the year  $(10,575)  $(892)  $(167)  $(4,731)  $6,111   $(10,254)

 

F-42

 

 

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2, or 3 during the year ended February 28, 2023

 

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 29, 2024 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range  Weighted
Average*
First lien term loans  $976,423   Market Comparables  Market Yield (%)  10.6%  - 17.2%  13.0%
           Revenue Multiples (x)  4.6x - 9.4x  6.6x
           EBITDA Multiples (x)  5.0x - 6.0x  5.6x
           Third-party bid (x)  3.9x - 4.2x  4.0x
Second lien term loans   18,097   Market Comparables  Market Yield (%)  19.0% - 28.3%  25.5%
           EBITDA Multiples (x)  7.0x  7.0x
           Third-party bid (x)  29.7x  29.7x
Unsecured term loans   15,818   Discounted Cash Flow  Discount Rate (%)  10.5%  10.5%
Structured finance securities   30,626   Discounted Cash Flow  Discount Rate (%)  8.5% - 22.0%  15.1%
           Recovery Rate (%)  35.0% - 70.0%  70.0%
           Prepayment Rate (%)  20.0%  20.0%
Equity interests   88,426   Enterprise Value Waterfall  EBITDA Multiples (x)  4.7x - 20.4x  10.4x
           Revenue Multiples (x)  1.3x - 10.4x  6.3x
           Third-party bid (x)  3.9x  3.9x
Total  $1,129,390             

 

 

*The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input, excluding the recovery rate for Structured finance securities.

 

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2023 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range  Weighted
Average*
First lien term loans  $798,534   Market Comparables  Market Yield (%)  10.5%  - 23.1%  12.8%
           Revenue Multiples (x)  4.1x  4.1x
           EBITDA Multiples (x)  8.0x  8.0x
Second lien term loans   14,936   Market Comparables  Market Yield (%)  15.6% - 61.8%  45.8%
Unsecured term loans   20,661   Market Comparables  Market Yield (%)  10.0% - 28.8%  12.6%
        Market Comparables  Market Quote (%)  100.0%  100%
        Collateral Value Coverage  Net Asset Value (%)  100.0%  100%
Structured finance securities   41,362   Discounted Cash Flow  Discount Rate (%)  12.0% - 22.0%  17.6%
           Recovery Rate (%)  35.0% - 70.0%  70.0%
           Prepayment Rate (%)  20.0%  20.0%
Equity interests   83,990   Enterprise Value Waterfall  EBITDA Multiples (x)  5.5x - 28.6x  11.0x
           Revenue Multiples (x)  1.3x - 11.2x  6.4x
Total  $959,483             

 

 

*The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input, excluding the recovery rate for Structured finance securities.

 

F-43

 

 

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the earnings before interest, tax, depreciation and amortization (“EBITDA”) or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, and prepayment rate, in isolation, would result in a significantly lower (higher) fair value measurement while a significant increase (decrease) in recovery rate, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a market quote, third party bid or net asset value in deriving a value, a significant increase (decrease) in the market quote, bid or net asset value in isolation, would result in a significantly higher (lower) fair value measurement.

 

The composition of our investments as of February 29, 2024 at amortized cost and fair value was as follows (dollars in thousands):

 

   Investments at
Amortized
Cost
   Amortized
Cost
Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Fair Value
Percentage
of Total
Portfolio
 
First lien term loans  $1,019,678    86.4%  $976,423    85.7%
Second lien term loans   21,968    1.9    18,097    1.6 
Unsecured loans   17,619    1.5    15,818    1.4 
Structured finance securities   42,769    3.6    30,626    2.7 
Equity interests   77,750    6.6    97,830    8.6 
Total  $1,179,784    100.0%  $1,138,794    100.0%

 

The composition of our investments as of February 28, 2023 at amortized cost and fair value was as follows (dollars in thousands):

 

   Investments at
Amortized
Cost
   Amortized
Cost
Percentage
of Total
Portfolio
   Investments
at
Fair Value
   Fair Value
Percentage
of Total
Portfolio
 
First lien term loans  $808,464    83.7%  $798,534    82.1%
Second lien term loans   21,114    2.2    14,936    1.5 
Unsecured loans   21,001    2.2    20,661    2.1 
Structured finance securities   49,711    5.1    41,362    4.3 
Equity interests   66,199    6.8    97,097    10.0 
Total  $966,489    100.0%  $972,590    100.0%

 

For loans and debt securities for which market quotations are not readily available, the Company determines their fair value based on third party indicative broker quotes, where available, or the inputs that a hypothetical market participant would use to value the security in a current hypothetical sale using a market comparables valuation technique. In applying the market comparables valuation technique, the Company determines the fair value based on such factors as market participant inputs including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in the Company’s judgment, the market comparables technique is not sufficient or appropriate, the Company may use additional techniques such as an asset liquidation or expected recovery model.

 

For equity securities of portfolio companies and partnership interests, the Company determines the fair value using an enterprise value waterfall valuation technique. Under the enterprise value waterfall valuation technique, the Company determines the enterprise fair value of the portfolio company and then waterfalls the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, the Company weighs some or all of the traditional market valuation techniques and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The techniques for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, the Company may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. The Company also takes into account historical and anticipated financial results. 

 

F-44

 

 

The Company’s investments in Saratoga CLO and SLF 2022 are carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO and SLF 2022, when available, as determined by the Manager and recommended to the Company’s board of directors. Specifically, the Company uses Intex cash flows, or an appropriate substitute, to form the basis for the valuation of the investment in Saratoga CLO and SLF 2022. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company ran Intex models based on inputs about the refinanced Saratoga CLO’s structure and the SLF 2022 structure, including capital structure, cost of liabilities and reinvestment period. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investments in Saratoga CLO and SLF 2022 at February 29, 2024. The inputs at February 29, 2024 for the valuation model include:

 

  Default rate: 2.0%

 

  Recovery rate: 35%-70%

 

  Discount rate: 8.5%-22.0%

 

  Prepayment rate: 20.0%

 

  Reinvestment rate / price: S+365bps / $99.00

 

Investment Concentration

 

Set forth is a brief description of each portfolio company in which the fair value of the Company’s investment represents greater than 5% of the Company’s total assets as of February 29, 2024, excluding Saratoga CLO, SLF JV and SLF 2022 (see Note 4 and Note 5 for more information on Saratoga CLO, SLF JV and SLF 2022, respectively).

 

HemaTerra Holdings Company, LLC

 

HemaTerra Holding Company, LLC (“HemaTerra”) provides SaaS-based software solutions addressing complex supply chain issues across a variety of medical environments, including blood, plasma, tissue, implants and DNA sample management, to customers in blood centers, hospitals, pharmaceuticals, and law enforcement settings.

 

Artemis Wax Corp.

 

Artemis Wax Corporation is a U.S. based retail aggregator of European Wax Center (“EWC”) franchise locations with a concentration in the northeast. Founded in 2004, EWC is the largest U.S. body waxing national chain with more than 800 locations across the country.

 

Granite Comfort, LP

 

Granite Comfort, LP is a U.S. based heating, ventilation and air conditioning (“HVAC”) company. The company provides traditional service and replacement of HVAC / plumbing systems, as well as a rental model that is in the early stages of implementation.

 

Note 4. Investment in Saratoga CLO

 

On January 22, 2008, the Company entered into a collateral management agreement with Saratoga CLO, pursuant to which the Company acts as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 with its reinvestment period extended to October 2016. On November 15, 2016, the Company completed a second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018.

 

On December 14, 2018, the Company completed a third refinancing and upsize of the Saratoga CLO (the “2013-1 Reset CLO Notes”). The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030. Following this refinancing, the Saratoga CLO portfolio increased its aggregate principal amount from approximately $300.0 million to approximately $500.0 million of predominantly senior secured first lien term loans.

 

F-45

 

 

On February 11, 2020, the Company entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO. During the fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd. was repaid in full.

 

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.

 

On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Note for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

 

The Saratoga CLO remains effectively 100.0% owned and managed by the Company. The Company receives a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

 

For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, we accrued management fee income of $3.3 million, $3.3 million and $3.3 million, respectively, and interest income of $0.0 million, $1.2 million and $4.9 million, respectively, from the Saratoga CLO.

 

As of February 29, 2024, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $9.5 million. As of February 29, 2024, the fair value of its investment in the Class F-R-3 Notes of Saratoga CLO was $8.9 million. As of February 29, 2024, Saratoga CLO had investments with a principal balance of $640.8 million and a weighted average spread over LIBOR of 3.8% and had debt with a principal balance of $611.0 million with a weighted average spread over LIBOR of 2.2%. As of February 29, 2024, the present value of the projected future cash flows of the subordinated notes, was approximately $9.5 million, using a 22.0% discount rate. The Company’s total investment in the subordinate notes of Saratoga CLO is $57.8 which consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021. To date the Company has since received distributions of $84.6 million, management fees of $35.1 million and incentive fees of $1.2 million.

 

As of February 28, 2023, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $21.2 million. As of February 28, 2023, the fair value of its investment in the Class F-R-3 Notes of Saratoga CLO was $8.8 million. As of February 28, 2023, Saratoga CLO had investments with a principal balance of $645.6 million and a weighted average spread over LIBOR of 3.8% and had debt with a principal balance of $611.0 million with a weighted average spread over LIBOR of 2.2%. As of February 28, 2023, the present value of the projected future cash flows of the subordinated notes, was approximately $21.2 million, using a 22.0% discount rate. The Company’s total investment in the subordinate notes of Saratoga CLO is $57.8 million, which consists of additional investments of $30 million in January 2008, $13.8 million in December 2018 and $14.0 million in February 2021. As of February 28, 2023, the Company has received distributions of $77.7 million, management fees of $31.9 million and incentive fees of $1.2 million.

 

The separate audited financial statements of the Saratoga CLO as of February 29, 2024 and February 28, 2023, pursuant to Rule 3-09 of SEC rules Regulation S-X, and for the years ended February 29, 2024, February 28, 2023 and February 28, 2022, are presented on page S-1.

 

F-46

 

 

Note 5. Investment in SLF JV

 

On October 26, 2021, the Company and TJHA entered into the LLC Agreement to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

 

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. (“SLF 2022”).

 

The Company and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

 

The Company and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, with the Company providing $43.75 million and TJHA providing $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note pays a fixed rate of 10% per annum and is due and payable in full on October 20, 2033. As of February 29, 2024, the Company and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 28, 2023, the Company and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 29, 2024, and February 28, 2023, the Company’s investment in the unsecured note of SLF JV had a fair value of $15.8 million and $17.6 million, respectively, and the Company’s investment in the membership interests of SLF JV had a fair value of $9.4 million and $13.1 million, respectively.

  

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, ASC 810 concludes that in a joint venture where both members have equal decision making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate SLF JV.

 

For the year ended February 29, 2024, the Company earned approximately $1.8 million of interest income related to SLF JV, which is included in interest income on the Statement of Operations. As of February 29, 2024, approximately $0.2 million of interest income related to SLF JV was included in interest receivable on the Statements of Assets and Liabilities.

 

For the year ended February 28, 2023 the Company earned approximately $1.5 million of interest income related to SLF JV, which is included in interest income on the Statements of Operations. As of February 28, 2023, approximately $0.4 million of interest income related to SLF JV was included in interest receivable on the Statements of Assets and Liabilities.

 

For the period from October 26, 2021, through February 28, 2022, the Company earned approximately $0.1 million of interest income related to SLF JV, which is included in interest income on the Statement of Operations. As of February 28, 2022, approximately $0.1 million of interest income related to SLF JV was included in interest receivable.

 

For the years ended February 29, 2024, and February 28, 2023 and 2022, the Company earned approximately $5.9 million, $0.0 million and $0.0 million of dividend related to SLF JV, which is included in dividend income on control investments.

 

SLF JV’s initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00% per annum and was paid in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing.

 

On October 28, 2022, SLF 2022 issued $402.1 million of the 2022 JV CLO Notes through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, the Company purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million. As of February 29, 2024 and February 28, 2023, the fair value of these Class E Notes were $12.3 million and $11.4 million, respectively.

 

F-47

 

 

Note 6. Income Taxes

 

The Company has elected and intends to operate so as to qualify annually to be taxed as a RIC under Subchapter M of the Code and, as such, will not be subject to U.S. federal income tax on the portion of taxable income and gains timely distributed to stockholders.

 

The Company owns 100% of Saratoga CLO, an exempted company incorporated in the Cayman Islands. For financial reporting purposes, the Saratoga CLO is not included as part of the consolidated financial statements. For U.S. federal income tax purposes, the Company has requested and received approval from the IRS to treat the Saratoga CLO as a disregarded entity. As such, for U.S. federal income tax purposes and for purposes of meeting the RIC qualification and diversification tests, the results of operations of the Saratoga CLO are included with those of the Company to qualify as a RIC. Generally, the Company is required to meet certain income and asset diversification tests in addition to timely distributing at least 90% of its investment company taxable income, as defined by the Code. Because U.S. federal income tax regulations differ from U.S. GAAP, distributions as required in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences between these distributions and U.S. GAAP financial results may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the consolidated financial statements to reflect their tax character. Differences in classification may also result from the treatment of short-term gains as ordinary income for U.S. federal income tax purposes. As of February 29, 2024 and February 28, 2023, the Company reclassified for book purposes amounts arising from permanent book/tax differences primarily related to nondeductible U.S. federal excise and capital gains tax and worthless securities losses (dollars in thousands):

 

   February 29,
2024
   February 28,
2023
 
Capital in excess of par value  $(779)  $16 
Total distributable earnings (loss)   779    (16)

 

For U.S federal income tax purposes, distributions paid to shareholders are reported as ordinary income, return of capital, long term capital gains or a combination thereof. The tax character of distributions paid for the years ended February 29, 2024, February 28, 2023 and February 28, 2022 was as follows (dollars in thousands):

 

   February 29,
2024
   February 28,
2023
   February 28,
2022
 
Ordinary income  $35,636   $27,313   $22,033 
Capital gains   
-
    
-
    
-
 
Total  $35,636   $27,313   $22,033 

 

For U.S. federal income tax purposes, as of February 29, 2024, the aggregate net unrealized depreciation for all securities was $39.7 million. The aggregate cost of securities for U.S. federal income tax purposes was $1.8 billion.

 

For U.S. federal income tax purposes, as of February 28, 2023, the aggregate net unrealized depreciation for all securities was $15.5 million. The aggregate cost of securities for U.S. federal income tax purposes was $1.6 billion.

 

F-48

 

 

As of February 29, 2024 and February 28, 2023, the components of accumulated losses on a tax basis as detailed below differ from the amounts reflected per the Company’s consolidated statements of assets and liabilities by temporary book/tax differences primarily arising from the consolidation of the Saratoga CLO for U.S federal tax purposes, market discount and original issue discount income, interest income accrual on defaulted bonds, write-off of investments, and amortization of organizational expenditures and partnership interests (dollars in thousands).

 

   February 29,
2024
   February 28,
2023
 
Post October loss deferred  $
        -
   $
-
 
Accumulated capital losses   (19,900)   (1,580)
Other temporary differences   6,855    1,971 
Undistributed Long Term Gain   
-
    
-
 
Undistributed ordinary income   46,215    19,771 
Unrealized appreciation (depreciation)   (39,685)   (15,500)
Total components of accumulated losses  $(6,515)  $4,662 

 

At February 29, 2024, the Company had a short-term capital loss of $0.0 million and a long-term capital loss of $19.9 million, available to offset future capital gains. At February 29, 2024 the company did not utilize any short-term capital losses or long-term capital losses. Post RIC-modernization act losses are deemed to arise on the first day of the fund’s following fiscal year and there is no expiration for these losses. As of February 28, 2023, the Company had net long-term capital losses of $1.6 million.

 

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. For the calendar years ended December 31, 2023 and December 31, 2022, the Company did not distribute at least 98% of its ordinary income and 98.2% of its capital gains and accrued $1.8 million and $1.1 million in U.S. federal excise taxes on undistributed taxable income for the years ended February 29, 2024 and February 28, 2023, respectively.

 

Management has analyzed the Company’s tax positions taken on U.S. federal income tax returns for all open years (fiscal years 2020- 2023) and has concluded that no provision for uncertain income tax positions is required in the Company’s consolidated financial statements.

 

SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MAC, Inc., SIA-MDP, Inc., SIA-PP Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., SIA-Vector, Inc., and SIA-VR, Inc., each 100% owned by the Company, are each filing standalone C Corporation tax returns for U.S. federal and state tax purposes. As separately regarded entities for tax purposes, these entities are subject to U.S. federal income tax at corporate rates. For tax purposes, any distributions by the entities to the parent company would generally need to be distributed to the Company’s shareholders. Generally, such distributions of the entities’ income to the Company’s shareholders will be considered as qualified dividends for tax purposes. The entities’ taxable net income will differ from U.S. GAAP net income because of deferred tax temporary differences arising from net operating losses and unrealized appreciation and deprecation of securities held. Deferred tax assets and liabilities are measured using enacted corporate federal and state tax rates expected to apply to taxable income in the years in which those net operating losses are utilized and the unrealized gains and losses are realized. Deferred tax assets and deferred tax liabilities are netted off by entity, as allowed. The recoverability of deferred tax assets is assessed and a valuation allowance is recorded to the extent that it is more likely than not that any portion of the deferred tax asset will not be realized on the basis of a history of operating losses combined with insufficient projected taxable income or other taxable events in the Corporate Blockers. In February 2022, SIA-GH, Inc., SIA-TT Inc. and SIA-VR, Inc. received an approved plan of liquidation following the sale of equity held by each of the portfolio companies.

  

The Company’s V Rental Holdings LLC Class A-1 membership units were sold during the year ended February 28, 2022. The entity which held this investment, SIA-VR, Inc. will remain in existence for a period of time until all ongoing indemnification obligations are settled, after which it will be dissolved. For purposes of tax accounting, the Company had an $0.0 million current tax receivable as of February 29, 2024.

 

The Company’s Texas Teachers of Tomorrow, LLC common stock was sold during the year ended February 28, 2022. The entity which held this investment, SIA-TT, Inc. will remain in existence for a period of time until all ongoing indemnification obligations are settled, after which it will be dissolved. For purposes of tax accounting, the Company had an $0.01 million current tax receivable as of February 29, 2024.

 

F-49

 

 

The Company’s GreyHeller LLC Series A preferred units was sold during the year ended February 28, 2022. The entity which held this investment, SIA-TT, Inc. will remain in existence for a period of time until all ongoing indemnification obligations are settled, after which it will be dissolved. For purposes of tax accounting, the Company had an $0.09 million current tax receivable as of February 29, 2024.

 

The Company may distribute a portion of its realized net long term capital gains in excess of realized net short term capital losses to its stockholders, but may also decide to retain a portion, or all, of its net capital gains and elect to pay the 21% U.S. federal tax on the net capital gain, potentially in the form of a “deemed distribution” to its stockholders.  Income tax (provision) relating to an election to retain its net capital gains, including in the form of a deemed distribution, is included as a component of income tax (provision) benefit from realized gains on investments, depending on the character of the underlying taxable income (ordinary or capital gains), on the consolidated statements of operations. 

  

Deferred tax assets and liabilities, and related valuation allowances, as of February 29, 2024 and February 28, 2023, were as follows:

 

   February 29,
2024
   February 28,
2023
 
Total deferred tax assets  $2,650,580   $2,542,373 
Total deferred tax liabilities   (3,901,995)   (3,008,829)
Valuation allowance on net deferred tax assets   (2,539,735)   (2,350,116)
Net deferred tax liability  $(3,791,150)  $(2,816,572)

 

As of February 29, 2024, the valuation allowance on deferred tax assets was $2.5 million, which represents the federal and state tax effect of net operating losses and unrealized losses that we do not believe we will realize through future taxable income. Any adjustments to the Company’s valuation allowance will depend on estimates of future taxable income and will be made in the period such determination is made.

 

Net deferred tax expense (benefit) for the year ended February 29, 2024 includes $0.9 million net change in unrealized appreciation (depreciation) on investments and $0.04 million net change in total operating expense (benefit), in the consolidated statement of operations, respectively.

 

Net deferred tax expense (benefit) for the year ended February 28, 2023 includes $1.7 million net change in unrealized appreciation (depreciation) on investments and $(0.2) million net change in total operating expense, in the consolidated statement of operations, respectively.

 

Net deferred tax expense (benefit) for the year ended February 28, 2022 includes $(0.7) million net change in unrealized appreciation (depreciation) on investments and $0.0 million net change in total operating expense, in the consolidated statement of operations, respectively.

 

Deferred tax temporary differences may include differences for state taxes and joint venture interests.

 

Federal and state income tax provisions (benefits) on investments are as follows:

 

   February 29,
2024
   February 28,
2023
   February 28,
2022
 
Current            
Federal  $
-
   $(473,475)  $2,498,515 
State   
-
    (80,273)   327,021 
Net current expense   
-
    (553,748)   2,825,536 
Deferred               
Federal   990,920    1,467,975    (444,628)
State   (16,343)   99,582    (227,737)
Net deferred expense   974,577    1,567,557    (672,365)
Net tax provision  $974,577   $1,013,809   $2,153,171 

 

The Company has remaining federal net operating loss carryforwards of $0.03 million which will expire starting in 2037, with the remaining net operating loss carryforwards of $6.2 million having an indefinite life. In addition, the Company has state net operating loss carryforwards of $2.5 million, which begin to expire in fiscal year 2029.

 

Income tax expense was computed by applying the U.S. federal statutory rate of 21% combined with the weighted average state tax rate applicable to each Corporate Blocker based on the states they operate in.

 

F-50

 

 

Note 7. Agreements and Related Party Transactions

 

Investment Advisory and Management Agreement

 

On July 30, 2010, the Company entered into the Management Agreement with the Manager. The initial term of the Management Agreement was two years from its effective date, with one-year renewals thereafter subject to certain approvals by the Company’s board of directors and/or the Company’s stockholders. Most recently, on July 6, 2023, the Company’s board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, the Manager implements the Company’s business strategy on a day-to-day basis and performs certain services for the Company, subject to oversight by the board of directors. The Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, the Company pays the Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive management fee.

 

Base Management Fee and Incentive Management Fee

 

The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters. The base management fee is paid quarterly following the filing of the most recent quarterly report on Form 10-Q.

 

The incentive management fee consists of the following two parts:

 

The first, payable quarterly in arrears, equals 20% of the Company’s pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, the Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. The Manager will receive 100% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

 

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20% of the Company’s “incentive fee capital gains,” which equals the Company’s realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and the Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

 

For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, the Company incurred $19.2 million, $16.4 million and $11.9 million in base management fees, respectively. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, the Company incurred $13.0 million, $6.8 million and $6.4 million in incentive fees related to pre-incentive fee net investment income. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, the Company accrued $(8.3) million, $(1.8) million and $5.5 million, respectively, in incentive fees related to capital gains.

 

The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of February 29, 2024, the base management fees accrual was $5.0 million and the incentive fees accrual was $3.2 million and are included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2023, the base management fees accrual was $4.3 million and the incentive fees accrual was $7.9 million and are included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

 

F-51

 

 

Administration Agreement

 

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with the Manager, pursuant to which the Manager, as the Company’s administrator, has agreed to furnish the Company with the facilities and administrative services necessary to conduct day-to-day operations and provide managerial assistance on the Company’s behalf to those portfolio companies to which the Company is required to provide such assistance. The initial term of the Administration Agreement was two years from its effective date, with one-year renewals thereafter subject to certain approvals by the Company’s board of directors and/or the Company’s stockholders. The amount of expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two-year term of the Administration Agreement and subsequent renewals. Most recently, on July 6, 2023, the Company’s board of directors approved the renewal of the Administration Agreement for an additional one-year term and subsequently increased the cap on the payment or reimbursement of expenses by the Company from $3.275 million to $4.3 million, effective August 1, 2023.

 

For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, we recognized $3.9 million, $3.2 million and $2.9 million in administrator expenses, respectively, pertaining to bookkeeping, recordkeeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of February 29, 2024, $0.5 million of administrator expenses were accrued and included in due to Manager in the accompanying consolidated statements of assets and liabilities. As of February 28, 2023, $0.001 million of administrator expenses were accrued and included in due to Manager in the accompanying consolidated statements of assets and liabilities.

 

Saratoga CLO

 

On December 14, 2018, the Company completed the third refinancing and issuance of the 2013-1 Reset CLO Notes. This refinancing, among other things, extended the Saratoga CLO reinvestment period to January 2021, and extended its legal maturity to January 2030. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $300 million in assets to approximately $500 million.

 

In conjunction with the third refinancing and issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to receive an incentive management fee from Saratoga CLO. See Note 4 for additional information.

 

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and extended the non-call period to February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At November 30, 2021, the outstanding receivable of 2.6 million was repaid in full.

 

On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

  

As of February 29, 2024, and February 28, 2023, the Company’s investment in the Class F-2-R-3 Note of the Saratoga CLO had a fair value of $8.9 million and $8.8 million, respectively. In addition, the Company has no outstanding receivable balance from the Class F-2-R-3 Note of the Saratoga CLO, as of February 29, 2024.

 

For the years ended February 29, 2024, February 28, 2023, and February 28, 2022, we recognized $1.5 million, $1.2 million and $0.5 million in interest income, respectively, related to the Class F-2-R-3 Note of the Saratoga CLO.

 

As of February 29, 2024, and February 28, 2023, the Company’s investment in the Subordinated Note of the Saratoga CLO had a fair value of $9.5 million and $21.2 million, respectively. In addition, the Company has no outstanding receivable balance from the Subordinated Note of the Saratoga CLO, as of February 29, 2024.

 

For the years ended February 29, 2024, February 28, 2023, and February 28, 2022, we recognized $3.3 million, $3.3 million and $3.3 million in management fee income, respectively, related to the Subordinated Note of the Saratoga CLO.

 

For the years ended February 29, 2024, February 28, 2023, and February 28, 2022, we recognized $0.0 million, $1.2 million and $4.4 million in interest income, respectively, related to the Subordinated Note of the Saratoga CLO.

 

For the years ended February 29, 2024, February 28, 2023, and February 28, 2022, the Company neither bought nor sold any investments from the Saratoga CLO.

 

F-52

 

 

SLF JV

 

On October 26, 2021, the Company and TJHA entered into an LLC Agreement to co-manage the SLF JV. SLF JV is a joint venture that invests in the debt or equity interests of collateralized loan obligations, loan, notes and other debt instruments. The Company records interest income from its investment in an unsecured loan with SLF JV on an accrual basis and records dividend income from its membership interest when earned.  All operating decisions are shared with a 50% voting interest in SLF JV.

 

On October 28, 2022, SLF 2022 issued $402.1 million of the 2022 JV CLO Notes through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee.

 

As of February 29, 2024 and February 28, 2023 respectively, the Company’s investment in the SLF JV had a fair value of $25.2 million and $30.7 million, consisting of an unsecured loan of $15.8 million and $17.6 million, and membership interest of $9.4 million and $13.1 million. In addition, approximately $0.3 million and $0.4 million of interest income related to SLF JV was included in interest receivable on the Statement of Assets and Liabilities.

 

For the years ended February 29, 2024, February 28, 2023, and February 28, 2022, we recognized $1.8 million, $1.5 million and $0.1 million in interest income on the consolidated statement of operations, respectively, related to the SLF JV.

 

For the years ended February 29, 2024, and February 28, 2023 and 2022, the we recognized $5.9 million, $0.0 million and $0.0 million of dividend income on the consolidated statement of operations, respectively, related to the SLF JV.

 

As part of the JV CLO trust transaction, the Company purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million.

 

Note 8. Borrowings

 

Credit Facility

 

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200% after giving effect to such leverage, or, 150% if certain requirements under the 1940 Act are met. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act”) of the Company (“independent directors”), approved a minimum asset coverage ratio of 150%. The 150% asset coverage ratio became effective on April 16, 2019. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing. Our asset coverage ratio, as defined in the 1940 Act, was 161.1% as of February 29, 2024 and 165.9% as of February 28, 2023.

 

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral were used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

 

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC (the “Madison Credit Facility”), in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, SBIC II LP and SBIC III LP, were pledged under the Madison Credit Facility to secure our obligations thereunder.

 

On October 4, 2021, all outstanding amounts on the Madison Credit Facility were repaid and the Madison Credit Facility was terminated. The repayment and termination of the Madison Credit Facility resulted in a realized loss on the extinguishment of debt of $0.8 million. 

 

F-53

 

 

Encina Credit Facility

 

On October 4, 2021, the Company entered into the Credit and Security Agreement (the “Encina Credit Agreement”) relating to a $50.0 million senior secured revolving credit facility with the Lender, supported by loans held by SIF II and pledged to the Encina Credit Facility. The terms of the Encina Credit Facility required a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increased to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. Advances under the Encina Credit Facility originally bore interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to the selection by the Lender and the Company of a replacement benchmark rate. 

 

On January 27, 2023, we entered into the first amendment to the Encina Credit Agreement to, among other things:

 

  increase the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

 

  change the underlying benchmark used to compute interest under the Encina Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

 

  increase the applicable effective margin rate on borrowings from 4.00% to 4.25%;

 

  extend the revolving period from October 4, 2024 to January 27, 2026;

 

  extend the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a “Facility Increase”) from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to the Encina Facility Increase from $75.0 million to $150.0 million;

 

  revise the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

 

  amend the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Encina Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

 

In addition to any fees or other amounts payable under the terms of the Encina Credit Facility, an administrative agent fee per annum equal to $0.1 million is payable in equal monthly installments in arrears.

 

As of February 29, 2024 and February 28, 2023, there were $35.0 million and $32.5 million outstanding borrowings under the Encina Credit Facility. During the applicable periods, the Company was in compliance with all of the limitations and requirements under the Encina Credit Agreement. Financing costs of $2.0 million related to the Encina Credit Facility have been capitalized and are being amortized over the term of the facility, with all existing financing costs amortized through January 27, 2026 from the date of the amendment and extension. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, we recorded $3.9 million, $2.0 million and $0.8 million of interest expense related to the Encina Credit Facility and the Madison Credit Facility, respectively, which includes commitment and administrative agent fees.

 

For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, we recorded $0.5 million, $0.5 million and $0.3 million of amortization of deferred financing costs related to the Encina Credit Facility and Madison Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expenses on the consolidated statements of operations. For the fiscal year ended February 29, 2024, the average borrowings outstanding and the weighted average interest rate on outstanding borrowings under the Encina Credit Facility was approximately $37.9 million and 9.66%, respectively. For the fiscal year ended February 28, 2023, the average borrowings outstanding and the weighted average interest rate on outstanding borrowings under the Encina Credit Facility and the Madison Credit Facility were approximately $26.3 million and 6.72%, respectively. For the fiscal year ended February 28, 2022, the average borrowings outstanding and the weighted average interest rate on outstanding borrowings under the Encina Credit Facility and the Madison Credit Facility were approximately $8.7 million and 5.22%, respectively.

 

F-54

 

 

The Encina Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Encina Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. Availability on the Encina Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the borrowing base. Funds may be borrowed at the greater of the prevailing one-month SOFR rate, plus an applicable effective margin of 4.25%. In addition, the Company will pay the lender a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility.

 

Our borrowing base under the Encina Credit Facility was $35.0 million subject to the Encina Credit Facility cap of $65.0 million at February 29, 2024. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”). Accordingly, the February 29, 2024 borrowing base relies upon the valuations set forth in the Quarterly Report on Form 10-Q for the period ended November 30, 2023. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Annual Report on Form 10-K is filed with the SEC.

 

SBA Debentures

 

The Company’s wholly owned subsidiaries, SBIC LP, SBIC II LP, and SBIC III LP, received SBIC licenses from the SBA on March 28, 2012, August 14, 2019, and September 29, 2022, respectively. SBIC LP’s license provides up to $150.0 million in additional long-term capital in the form of SBA debentures, while SBIC II LP’s and SBIC III LP’s SBIC licenses each provide up to $175.0 million. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million. Following the debentures being fully repaid to the SBA, SBIC LP surrendered its license on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP.

 

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $24.0 million and have average annual fully taxed net income not exceeding $8.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to “smaller enterprises” as defined by the SBA. A smaller enterprise is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

 

The Company’s wholly owned SBIC Subsidiaries are able to borrow funds from the SBA against each SBIC’s regulatory capital (which generally approximates equity capital in the respective SBIC). The SBIC Subsidiaries are subject to customary regulatory requirements including but not limited to, a periodic examination by the SBA and requirements to maintain certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that the SBIC Subsidiaries will receive SBA-guaranteed debenture funding, which is dependent upon the SBIC Subsidiaries complying with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to each SBIC Subsidiaries’ assets over the Company’s stockholders and debtholders in the event that the Company liquidates such SBIC Subsidiary or the SBA exercises its remedies under the SBA-guaranteed debentures issued by the SBIC Subsidiary upon an event of default.

 

The Company received exemptive relief from the SEC to permit it to exclude the debt of the SBIC subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows the Company increased flexibility under the asset coverage requirement by permitting it to borrow up to $350.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

 

F-55

 

 

As of February 29, 2024, we have funded SBIC II LP and SBIC III LP with an aggregate total of equity capital of $87.5 million and $66.7 million, respectively, and have $214.0 million in SBA-guaranteed debentures outstanding, of which $175.0 million was held by SBIC II LP and $39.0 million held in SBIC III LP.

 

At February 29, 2024 and February 28, 2023, there was $214.0 million and $202.0 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy. Financing costs of $5.0 million, $6.0, and $0.4 million related to the SBA debentures issued by SBIC LP, SBIC II LP and SBIC III LP, respectively, have been capitalized and are being amortized over the term of the commitment and drawdown. During the year ended February 29, 2024, the Company repaid $27.0 million of SBA debentures, resulting in a realized loss on extinguishment of $0.1 million related to the acceleration of deferred debt financing costs.

 

For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, we recorded $6.2 million, $6.4 million and $4.7 million of interest expense related to the SBA debentures, respectively. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, we recorded $1.0 million, $1.0 million and $0.7 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the years ended February 29, 2024, February 28, 2023 and February 28, 2022 on the outstanding borrowings of the SBA debentures was 3.08%, 2.78% and 2.60%, respectively. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of SBA debentures outstanding was $202.5 million and $229.9 million, respectively.

 

Notes

 

6.25% 2025 Notes

 

On August 28, 2018, the Company issued $40.0 million in aggregate principal amount of 6.25% fixed-rate notes due 2025 (the “6.25% 2025 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.3 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $5.0 million in aggregate principal amount of 6.25% 2025 Notes within 30 days. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes have been capitalized and were amortized over the term of the 6.25% 2025 Notes.

 

On February 5, 2019, the Company issued an additional $20.0 million in aggregate principal amount of the 6.25% 2025 Notes for net proceeds of $19.2 million after deducting underwriting commissions of approximately $0.6 million and discount of $0.2 million. Offering costs incurred were approximately $0.2 million. The issuance included the full exercise of the underwriters’ option to purchase an additional $2.5 million in aggregate principal amount of 6.25% 2025 Notes within 30 days. The additional 6.25% 2025 Notes were treated as a single series with the existing 6.25% 2025 Notes under the indenture and have the same terms as the existing 6.25% 2025 Notes. The net proceeds from this offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. The financing costs and discount of $1.0 million related to the 6.25% 2025 Notes have been capitalized and were amortized over the term of the 6.25% 2025 Notes.

 

On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of issued and outstanding 6.25% 2025 Notes. The 6.25% 2025 Notes were listed on the NYSE under the trading symbol of “SAF” and have been delisted following the full redemption on August 31, 2021. As such, it was not fair valued with market quotes and is not fair value leveled. The repayment of the 6.25% 2025 Notes resulted in a realized loss on the extinguishment of debt of $1.5 million. 

 

F-56

 

 

7.25% 2025 Notes

 

On June 24, 2020, the Company issued $37.5 million in aggregate principal amount of 7.25% fixed-rate notes due 2025 (the “7.25% 2025 Notes”) for net proceeds of $36.3 million after deducting underwriting commissions of approximately $1.2 million. Offering costs incurred were approximately $0.3 million. On July 6, 2020, the underwriters exercised their option in full to purchase an additional $5.625 million in aggregate principal amount of its 7.25% 2025 Notes. Net proceeds to the Company were $5.4 million after deducting underwriting commissions of approximately $0.2 million. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.6 million related to the 7.25% 2025 Notes have been capitalized and were amortized over the term of the 7.25% 2025 Notes.

 

On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes. The 7.25% 2025 Notes were listed on the NYSE under the trading symbol of “SAK” and have been delisted following the full redemption on July 14, 2022. As such, it was not fair valued with market quotes and is not fair value leveled. The repayment of the 7.25% 2025 Notes resulted in a realized loss on the extinguishment of debt of $1.0 million.

  

For the years ended February 29, 2024 and February 28, 2023, we recorded $0.0 million and $1.2 million, respectively, of interest expense and $0.0 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 7.25% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. For the year ended February 29, 2024 and February 28, 2023, the average dollar amount of 7.25% 2025 Notes outstanding was $0.0 million and $13.5 million, respectively.

 

7.75% 2025 Notes

 

On July 9, 2020, the Company issued $5.0 million in aggregate principal amount of 7.75% fixed-rate notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company’s option subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the 7.75% 2025 Notes.

 

As of February 29, 2024, the total 7.75% 2025 Notes outstanding was $5.0 million. The 7.75% 2025 Notes are not listed and have a par value of $25.00 per note. The carrying amount of the outstanding 7.75% 2025 Notes had a fair value of $5.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the total 7.75% 2025 Notes outstanding was $5.0 million, and they had a fair value of $5.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy.

 

For the years ended February 29, 2024 and February 28, 2023, we recorded $0.4 million and $0.4 million, respectively, of interest expense and $0.05 million and $0.05 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. For the year ended February 29, 2024 and February 28, 2023, the average dollar amount of 7.75% 2025 Notes outstanding was $5.0 million and $5.0 million, respectively.

 

F-57

 

 

6.25% 2027 Notes

 

On December 29, 2020, the Company issued $5.0 million in aggregate principal amount of 6.25% fixed-rate notes due in 2027 (the “6.25% 2027 Notes”). Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company’s option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

 

On January 28, 2021, the Company issued an additional $10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million (the “Additional 6.25% 2027 Notes”). Offering costs incurred were approximately $0.1 million. The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.

 

As of February 29, 2024, the total 6.25% 2027 Notes outstanding was $15.0 million. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note. The carrying amount of the outstanding 6.25% 2027 Notes had a fair value of $14.2 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the total 6.25% 2027 Notes outstanding was $15.0 million, and they had a fair value of $13.7 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy.

 

For the years ended February 29, 2024 and February 28, 2023, we recorded $0.9 million and $0.9 million, respectively, of interest expense and $0.07 million and $0.07 million, respectively, of amortization of deferred financing costs related to the 6.25% 2027 Notes. Interest expense and amortization of deferred financing cost are reported as interest and debt financing expense on the consolidated statements of operations. For the year ended February 29, 2024 and February 28, 2023, the average dollar amount of 6.25% 2027 Notes outstanding was $15.0 million and $15.0 million, respectively.

 

4.375% 2026 Notes

 

On March 10, 2021, the Company issued $50.0 million in aggregate principal amount of 4.375% fixed-rate notes due in 2026 (the “4.375% 2026 Notes”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million.  Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.3 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

 

On July 15, 2021, the Company issued an additional $125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the “Additional 4.375% 2026 Notes”) for net proceeds for approximately $123.8 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting commissions of $2.5 million. Offering costs incurred were approximately $0.2 million. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes. The net proceeds from the offering were used to redeem all of the outstanding 6.25% 2025 Notes (as described above), and for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $2.7 million have been capitalized and are being amortized over the term of the additional 4.375% 2026 Notes. 

 

As of February 29, 2024, the total 4.375% 2026 Notes outstanding was $175.0 million. The 4.375% 2026 Notes are not listed and are issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. The carrying amount of the outstanding 4.375% 2026 Notes had a fair value of $163.4 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the total 4.375% 2026 Notes outstanding was $175.0 million, and they had a fair value of $156.1 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, there was $175.0 million outstanding.

 

F-58

 

 

 

For the years ended February 29, 2024 and February 28, 2023, we recorded $7.7 million and $7.7 million, respectively, of interest expense, $0.8 million and $0.8 million, respectively, of amortization of deferred financing costs and $0.3 million and $0.3 million, respectively, of amortization of premium on issuance of 4.375% Notes due 2026 (inclusive of the issuance of the Additional 4.375% 2026 Notes). Interest expense, amortization of deferred financing costs and amortization of premium on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of 4.375% 2026 Notes outstanding was $175.0 million and $175.0 million respectively.

 

4.35% 2027 Notes

 

On January 19, 2022, the Company issued $75.0 million in aggregate principal amount of 4.35% fixed-rate notes due in 2027 (the “4.35% 2027 Notes”) for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million. Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at the Company’s option at any time prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes.

 

As of February 29, 2024, the total 4.35% 2027 Notes outstanding was $75.0 million. The 4.35% 2027 Notes are not listed. The carrying amount of the outstanding 4.35% 2027 Notes had a fair value of $67.8 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the total 4.35% 2027 Notes outstanding was $75.0 million, and they had a fair value of $64.5 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, there was $75.0 million outstanding.

 

For the years ended February 29, 2024 and February 28, 2023, we recorded $3.3 million and $3.3 million, respectively, of interest expense, $0.3 million and $0.3 million, respectively, of amortization of deferred financing costs and $0.10 million and $0.09 million, respectively, of amortization of discount on issuance of 4.35% Notes due 2027 (inclusive of the issuance of the Additional 4.35% 2027 Notes). Interest expense, amortization of deferred financing costs and amortization of discount on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of 4.35% 2027 Notes outstanding was $75.0 million and $75.0 million respectively.

 

6.00% 2027 Notes

 

On April 27, 2022, the Company issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the “6.00% 2027 Notes”) for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds to the Company were $9.7 million after deducting underwriting commissions of approximately $0.3 million. Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAT” with a par value of $25.00 per note.

 

On August 15, 2022, the Company issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the “Additional 6.00% 2027 Notes”) for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. Additional offering costs incurred were approximately $0.2 million. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Additional financing costs of $0.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. 

 

F-59

 

 

As of February 29, 2024, the total 6.00% 2027 Notes outstanding was $105.5 million. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAT” with a par value of $25.00 per note. As of February 29, 2024, the carrying amount and fair value of the 6.00% 2027 Notes was $105.5 million and $100.7 million, respectively. The fair value of the 6.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 6.00% 2027 Notes was $105.5 million and $100.4 million, respectively.

 

For the years ended February 29, 2024 and February 28, 2023, we recorded $6.3 million and $5.3 million, respectively, of interest expense, $0.7 million and $0.6 million, respectively, of amortization of deferred financing costs related to the 6.00% Notes due 2027. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of 6.00% 2027 Notes outstanding was $105.5 million and $100.4 million respectively.

 

7.00% 2025 Notes 

 

On September 8, 2022, the Company issued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the “7.00% 2025 Notes”) for net proceeds of $11.6 million after deducting underwriting discounts of approximately $0.4 million. Additional offering costs incurred were approximately $0.05 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $0.04 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

 

As of February 29, 2024, the total 7.00% 2025 Notes outstanding was $12.0 million. The 7.00% 2025 Notes are not listed. The carrying amount of the outstanding 7.00% 2025 Notes had a fair value of $11.8 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the total 7.00% 2025 Notes outstanding was $12.0 million, and they had a fair value of $11.5 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, there was $12.0 million outstanding.

 

For the years ended February 29, 2024 and February 28, 2023, we recorded $0.8 million and $0.4 million, respectively, of interest expense, $0.01 million and $0.01 million, respectively, of amortization of deferred financing costs and $0.1 million and $0.06 million, respectively, of amortization of discount on issuance of 7.00% Notes due 2025. Interest expense, amortization of deferred financing costs and amortization of discount on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of 7.00% 2025 Notes outstanding was $12.0 million and $5.8 million respectively.

 

8.00% 2027 Notes

 

On October 27, 2022, the Company issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.2 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds to the Company were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $1.7 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes.

 

F-60

 

 

As of February 29, 2024, the total 8.00% 2027 Notes outstanding was $46.0 million. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol “SAJ” with a par value of $25.00 per note. As of February 29, 2024, the carrying amount and fair value of the 8.00% 2027 Notes was $46.0 million and $46.2 million, respectively. The fair value of the 8.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 8.00% 2027 Notes was $46.0 million and $46.4 million, respectively.

 

For the years ended February 29, 2024 and February 28, 2023, the Company recorded $3.7 million and $1.3 million, respectively, of interest expense and $0.3 million and $0.1 million, respectively, of amortization of deferred financing costs related to the 8.00% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of 8.00% 2027 Notes outstanding was $46.0 million and $15.7 million, respectively.

 

8.125% 2027 Notes

 

On December 13, 2022, the Company issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.9 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds to the Company were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes.

 

As of February 29, 2024, the total 8.125% 2027 Notes outstanding was $60.4 million. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $25.00 per note. As of February 29, 2024, the carrying amount and fair value of the 8.125% 2027 Notes was $60.4 million and $60.8 million, respectively. The fair value of the 8.125% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 8.125% 2027 Notes was $60.4 million and $61.1 million, respectively.

 

For the years ended February 29, 2024 and February 28, 2023, the Company recorded $4.9 million and $1.1 million, respectively, of interest expense and $0.4 million and $0.09 million, respectively, of amortization of deferred financing costs related to the 8.125% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of 8.125% 2027 Notes outstanding was $60.4 million and $13.2 million, respectively.

 

8.75% 2025 Notes

 

On March 31, 2023, the Company issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the “8.75% 2025 Notes”) for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, the Company issued an additional $10.0 million in aggregate principal amount of the 8.75% 2025 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year. On February 2, 2024, pursuant to the terms of the indenture governing the 8.75% 2025 Notes, the Company elected to exercise its option to extend the maturity date of the 8.75% 2025 Notes from March 31, 2024 to March 31, 2025. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through the SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2025 Notes have been capitalized and are being amortized over the term of the 8.75% 2025 Notes.

 

F-61

 

 

As of February 29, 2024, the total 8.75% 2025 Notes outstanding was $20.0 million. The 8.75% 2025 Notes are not listed. The carrying amount of the outstanding 8.75% 2025 Notes had a fair value of $20.1 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 28, 2023, the total 8.75% 2025 Notes outstanding was $0.0 million, and they had a fair value of $0.0 million. As of February 28, 2023, there was $0.0 million outstanding.

 

For the years ended February 29, 2024 and February 28, 2023, we recorded $1.5 million and $0.0 million, respectively, of interest expense, $0.02 million and $0.0 million, respectively, of amortization of deferred financing costs and $0.6 million and $0.0 million, respectively, of amortization of discount on issuance of 8.75% Notes due 2025. Interest expense, amortization of deferred financing costs and amortization of discount on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of 8.75% 2025 Notes outstanding was $17.5 million and $0.0 million respectively.

 

8.50% 2028 Notes

 

On April 14, 2023, the Company issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds to the Company were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year.  The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at the Company’s option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes.

 

As of February 29, 2024, the total 8.50% 2028 Notes outstanding was $57.5 million. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $25.00 per note. As of February 29, 2024, the carrying amount and fair value of the 8.50% 2028 Notes was $57.5 million and $58.3 million, respectively. The fair value of the 8.50% 2028 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 28, 2023, the carrying amount and fair value of the 8.50% 2028 Notes was $0.0 million and $0.0 million, respectively.

 

For the years ended February 29, 2024 and February 28, 2023, we recorded $4.3 million and $0.0 million, respectively, of interest expense and $0.4 million and $0.0 million, respectively, of amortization of deferred financing costs of 8.50% 2028 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the years ended February 29, 2024 and February 28, 2023, the average dollar amount of 8.50% 2028 Notes outstanding was $50.2 million and $0.0 million respectively.

 

Senior Securities

 

Information about our senior securities is shown in the following table as of February 28/29 for the fiscal years indicated in the table, unless otherwise noted. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Financial condition, liquidity and capital resources” for more detailed information regarding the senior securities.

 

F-62

 

 

SENIOR SECURITIES

(dollar amounts in thousands, except per share data)

 

Class and Year (1)(2)  Total Amount Outstanding Exclusive of Treasury Securities(3)   Asset Coverage per Unit(4)   Involuntary Liquidating Preference per Share(5)   Average Market Value per Share(6) 
   (in thousands) 
Credit Facility with Encina Lender Finance, LLC                
Fiscal year 2024 (as of February 29, 2024)  $35,000   $1,610    
    -
    N/A 
Fiscal year 2023 (as of February 28, 2023)  $32,500   $1,659    
-
    N/A 
Fiscal year 2022 (as of February 28, 2022)  $12,500   $2,093    
-
    N/A 
Credit Facility with Madison Capital Funding(14)                    
Fiscal year 2021 (as of February 28, 2021)  $
-
   $3,471    
-
    N/A 
Fiscal year 2020 (as of February 29, 2020)  $
-
   $6,071    
-
    N/A 
Fiscal year 2019 (as of February 28, 2019)  $
-
   $2,345    
-
    N/A 
Fiscal year 2018 (as of February 28, 2018)  $
-
   $2,930    
-
    N/A 
Fiscal year 2017 (as of February 28, 2017)  $
-
   $2,710    
-
    N/A 
Fiscal year 2016 (as of February 29, 2016)  $
-
   $3,025    
-
    N/A 
Fiscal year 2015 (as of February 28, 2015)  $9,600   $3,117    
-
    N/A 
Fiscal year 2014 (as of February 28, 2014)  $
-
   $3,348    
-
    N/A 
Fiscal year 2013 (as of February 28, 2013)  $24,300   $5,421    
-
    N/A 
Fiscal year 2012 (as of February 29, 2012)  $20,000   $5,834    
-
    N/A 
Fiscal year 2011 (as of February 28, 2011)  $4,500   $20,077    
-
    N/A 
7.50% Notes due 2020(7)                    
Fiscal year 2017 (as of February 28, 2017)  $
-
   $
-
    
-
    N/A 
Fiscal year 2016 (as of February 29, 2016)  $61,793   $3,025    
-
   $25.24(8)
Fiscal year 2015 (as of February 28, 2015)  $48,300   $3,117    
-
   $25.46(8)
Fiscal year 2014 (as of February 28, 2014)  $48,300   $3,348    
-
   $25.18(8)
6.75% Notes due 2023(9)                    
Fiscal year 2020 (as of February 29, 2020)  $
-
   $
-
    
-
    N/A 
Fiscal year 2019 (as of February 28, 2019)  $74,451   $2,345    
-
   $25.74(10)
Fiscal year 2018 (as of February 28, 2018)  $74,451   $2,930    
-
   $26.05(10)
Fiscal year 2017 (as of February 28, 2017)  $74,451   $2,710    
-
   $25.89(10)
8.75% Notes due 2025                    
Fiscal year 2024 (as of February 29, 2024)  $20,000   $1,610    
-
   $25.00(12)
6.25% Notes due 2025(13)                    
Fiscal year 2022 (as of February 28, 2022)   
-
    
-
    
-
     N/A  
Fiscal year 2021 (as of February 28, 2021)  $60,000   $3,471    
-
   $24.24(11)
Fiscal year 2020 (as of February 29, 2020)  $60,000   $6,071    
-
   $25.75(11)
Fiscal year 2019 (as of February 28, 2019)  $60,000   $2,345    
-
   $24.97(11)

 

F-63

 

 

SENIOR SECURITIES

(dollar amounts in thousands, except per share data)

 

Class and Year (1)(2)  Total Amount Outstanding Exclusive of Treasury Securities(3)   Asset Coverage per Unit(4)   Involuntary Liquidating Preference per Share(5)   Average Market Value per Share(6) 
   (in thousands) 
7.00% Notes due 2025                    
Fiscal year 2024 (as of February 29, 2024)  $12,000   $1,610    
-
   $25.00(12)
Fiscal year 2023 (as of February 28, 2023)  $12,000   $1,659    
-
   $25.00(12)
7.25% Notes due 2025(16)                    
Fiscal year 2023 (as of February 28, 2023)   
-
    
-
    
-
     N/A  
Fiscal year 2022 (as of February 28, 2022)  $43,125   $2,093    
-
   $25.46(11)
Fiscal year 2021 (as of February 28, 2021)  $43,125   $3,471    
-
   $25.77(11)
7.75% Notes due 2025                    
Fiscal year 2024 (as of February 29, 2024)  $5,000   $1,610    
-
   $25.00(12)
Fiscal year 2023 (as of February 28, 2023)  $5,000   $1,659    
-
   $25.00(12)
Fiscal year 2022 (as of February 28, 2022)  $5,000   $2,093    
-
   $25.00(12)
Fiscal year 2021 (as of February 28, 2021)  $5,000   $3,471    
-
   $25.00(12)
4.375% Notes due 2026                    
Fiscal year 2024 (as of February 29, 2024)  $175,000   $1,610    
-
   $25.00(12)
Fiscal year 2023 (as of February 28, 2023)  $175,000   $1,659    
-
   $25.00(12)
Fiscal year 2022 (as of February 28, 2022)  $175,000   $2,093    
-
   $25.00(12)
4.35% Notes due 2027                    
Fiscal year 2024 (as of February 29, 2024)  $75,000   $1,610    
-
   $25.00(12)
Fiscal year 2023 (as of February 28, 2023)  $75,000   $1,659    
-
   $25.00(12)
Fiscal year 2022 (as of February 28, 2022)  $75,000   $2,093    
-
   $25.00(12)
6.00% Notes due 2027                    
Fiscal year 2024 (as of February 29, 2024)  $105,500   $1,610    
-
   $23.51(15)
Fiscal year 2023 (as of February 28, 2023)  $105,500   $1,659    
-
   $23.97(15)
6.25% Notes due 2027                    
Fiscal year 2024 (as of February 29, 2024)  $15,000   $1,610    
-
   $25.00(12)
Fiscal year 2023 (as of February 28, 2023)  $15,000   $1,659    
-
   $25.00(12)
Fiscal year 2022 (as of February 28, 2022)  $15,000   $2,093    
-
   $25.00(12)
Fiscal year 2021 (as of February 28, 2021)  $15,000   $3,471    
-
   $25.00(12)
8.00% Notes due 2027                    
Fiscal year 2024 (as of February 29, 2024)  $46,000   $1,610    
-
   $25.00(15)
8.125% Notes due 2027                    
Fiscal year 2024 (as of February 29, 2024)  $60,375   $1,610    
-
   $25.05(15)
Fiscal year 2023 (as of February 28, 2023)  $60,375   $1,659    
-
   $25.10(15)
8.50% Notes due 2028                    
Fiscal year 2024 (as of February 29, 2024)  $57,500   $1,610    
-
   $25.17(17)

 

 

(1)We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the 150% asset coverage ratio we are required to maintain under the 1940 Act.

 

(2)This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.

 

(3)Total amount of senior securities outstanding at the end of the period presented.

 

(4)Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness, calculated on a total basis.

 

F-64

 

 

(5)The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “—” indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.

 

(6)Not applicable for credit facility because not registered for public trading.

 

(7)On January 13, 2017, the Company redeemed in full its 2020 Notes. The Company used a portion of the net proceeds from the 2023 Notes offering, which was completed in December 2016, to redeem the 2020 Notes in full.

 

(8)Based on the average daily trading price of the 2020 Notes on the NYSE.

 

(9)On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.45 million, respectively, in aggregate principal amount of the $74.45 million in aggregate principal amount of issued and outstanding 2023 Notes.

 

(10)Based on the average daily trading price of the 2023 Notes on the NYSE.

 

(11)Based on the average daily trading price of the 2025 Notes on the NYSE.

 

(12)The carrying value of this unlisted security approximates its fair value, based on a waterfall analysis showing adequate collateral coverage.

 

(13)On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes. The Company used a portion of the net proceeds from the 4.375% 2026 Notes offering, which was completed in July 2021, to redeem the 6.25% 2025 Notes in full.

 

(14)On October 4, 2021, the Company repaid all remaining amounts outstanding under the Madison Credit Facility and the credit agreement relating to the Madison Credit Facility was terminated.

 

(15)Based on the average daily trading price of the 2027 Notes on the NYSE.

 

(16)On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes.

 

(17)Based on the average daily trading price of the 2028 Notes on the NYSE.

 

Note 9. Commitments and Contingencies

 

Contractual Obligations

 

The following table shows our payment obligations for repayment of debt and other contractual obligations at February 29, 2024:

 

       Payment Due by Period 
Long-Term Debt Obligations  Total   Less Than
1 Year
   1 - 3
Years
   3 - 5
Years
   More Than
5 Years
 
   ($ in thousands) 
Encina credit facility  $35,000   $
       -
   $35,000   $
-
   $
-
 
SBA debentures   214,000    
-
    
-
    
-
    214,000 
8.75% 2025 Notes   20,000    
-
    20,000    
-
    
-
 
7.00% 2025 Notes   12,000    
-
    12,000    
-
    
-
 
7.75% 2025 Notes   5,000    
-
    5,000    
-
    
-
 
4.375% 2026 Notes   175,000    
-
    175,000    
-
    
-
 
4.35% 2027 Notes   75,000    
-
    75,000    
-
    
-
 
6.00% 2027 Notes   105,500    
-
    
-
    105,500    
-
 
6.25% 2027 Notes   15,000    
-
    
-
    15,000    
-
 
8.00% 2027 Notes   46,000    
-
    
-
    46,000    
-
 
8.125% 2027 Notes   60,375    
-
    
-
    60,375    
-
 
8.50% 2028 Notes   57,500    
-
    
-
    57,500    
-
 
Total Long-Term Debt Obligations  $820,375   $
-
   $322,000   $284,375   $214,000 

 

F-65

 

 

Off-balance Sheet Arrangements

 

At February 29, 2024 and February 28, 2023, the Company’s off-balance sheet arrangements consisted of $132.4 million and $108.8 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

 

A summary of the unfunded commitments outstanding as of February 29, 2024 and February 28, 2023 is shown in the table below (dollars in thousands):

         

   February 29,
2024
   February 28,
2023
 
At Company’s discretion        
ActiveProspect, Inc.  $10,000   $10,000 
Artemis Wax Corp.   23,500    
-
 
Ascend Software, LLC   5,000    5,000 
Granite Comfort, LP   750    15,000 
JDXpert   5,000    5,000 
LFR Chicken LLC   
-
    4,000 
Pepper Palace, Inc.   1,898    3,000 
Procurement Partners, LLC   4,250    4,250 
Saratoga Senior Loan Fund I JV, LLC   8,548    8,548 
Sceptre Hospitality Resources, LLC   5,000    5,000 
Stretch Zone Franchising, LLC   3,750    
-
 
VetnCare MSO, LLC   10,000    
-
 
Total  $77,696   $59,798 
           
At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required          
Alpha Aesthetics Partners OpCo, LLC  $6,500   $
-
 
ARC Health OpCo LLC   2,585    10,773 
Artemis Wax Corp.   
-
    8,500 
Ascend Software, LLC   
-
    3,200 
Axero Holdings, LLC - Revolver   500    500 
Axiom Medical Consulting, LLC   2,000    
-
 
BQE Software, Inc.   3,250    
-
 
C2 Educational Systems   3,000    
-
 
Davisware, LLC   750    
-
 
Exigo, LLC   
-
    4,167 
Exigo, LLC - Revolver   1,042    833 
Gen4 Dental Partners Holdings, LLC   
-
    11,000 
GoReact   2,500    2,500 
Granite Comfort, LP   11,637    - 
JDXpert   
-
    1,000 
Inspect Point Holding, LLC   1,500    
-
 
Pepper Palace, Inc. - Delayed Draw Term Loan   
-
    2,000 
Pepper Palace, Inc. - Revolver   2,500    2,500 
Procurement Partners, LLC   
-
    1,000 
Stretch Zone Franchising, LLC   1,500    
-
 
VetnCare MSO, LLC   15,319    
-
 
Zollege PBC   150    1,000 
    54,733    48,973 
Total  $132,429   $108,771 

 

The Company believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of February 29, 2024, the Company had cash and cash equivalents of $8.7 million and $31.8 million in available borrowings under the Encina Credit Facility.

 

F-66

 

 

Note 10. Directors Fees

 

The independent directors each receive an annual fee of $70,000. They also receive $3,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $12,500 and the chairman of each other committee of the board of directors receives an annual fee of $6,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of NAV or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as defined in Section 2(a)(19) of the 1940 Act). No compensation is paid to directors who are “interested persons” of the Company (as defined in Section 2(a)(19) of the 1940 Act). For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, we incurred $0.4 million, $0.4 million and $0.3 million for directors’ fees and expenses, respectively. As of February 29, 2024 and February 28, 2023, $0.0 million and $0.01 million in directors’ fees and expenses were accrued and unpaid, respectively. As of February 29, 2024, we had not issued any common stock to our directors as compensation for their services.

 

Note 11. Stockholders’ Equity

 

Share Repurchases

 

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that originally allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 8, 2024, the Company’s board of directors extended the Share Repurchase Plan for another year to January 15, 2025. As of February 29, 2024, the Company purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three months ended February 29, 2024, the Company did not purchase any shares of common stock pursuant to the Share Repurchase Plan. During the year ended February 29, 2024, the Company purchased 88,576 shares of common stock, at the average price $24.36 for approximately $2.2 million pursuant to the Share Repurchase Plan.

  

 Public Equity Offering

 

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised. 

 

Equity ATM Program

 

On March 16, 2017, the Company entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which the Company offered for sale, from time to time, up to $30.0 million of the Company’s common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, the Company had sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs).

 

On July 30, 2021, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Ladenburg Thalmann & Co. Inc. and Compass Point Research and Trading, LLC (collectively the “Agents”), through which the Company may offer for sale, from time to time, up to $150.0 million of the Company’s common stock through the Agents, or to them, as principal for their account (the “ATM Program”).

 

On July 6, 2023, the Equity Distribution Agreement was amended to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $300.0 million from $150.0 million, and on July 19, 2023, the Equity Distribution Agreement was amended to add an additional distribution agent, Raymond James & Associates. The sales price per share of the Company’s common stock offered under the ATM Program, less the Agents’ commission, will not be less than the NAV per share of the Company’s common stock at the time of such sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

 

F-67

 

 

As of February 29, 2024 the Company sold 6,543,878 shares for gross proceeds of $172.5 million at an average price of $26.37 for aggregate net proceeds of $171.0 million (net of transaction costs). During the three months ended February 29, 2024, the Company sold 501,105 shares for gross proceeds of $14.3 million at an average price of $28.44 for aggregate net proceeds of $14.3 million (net of transaction costs). During the year ended February 29, 2024, the Company sold 1,703,517 shares for gross proceeds of $49.0 million at an average price of $28.51 for aggregate net proceeds of $49.0 million (net of transaction costs). The Manager agreed to reimburse the Company to the extent the per share price of the shares to the public, less underwriting fees, was less than net asset value per share. For the three months ended February 29, 2024, the Manager reimbursed the Company $1.4 million. For the year ended February 29, 2024, the Manager reimbursed the Company $4.5 million.

 

The Company adopted Rule 3-04/Rule 8-03(a)(5) under Regulation S-X (Note 2). Pursuant to Regulation S-X, the Company has presented a reconciliation of the changes in each significant caption of stockholders’ equity as shown in the tables below:

 

               Total     
   Common Stock   Capital
in Excess
   Distributable
Earnings
     
   Shares   Amount   of Par Value   (Loss)   Net Assets 
Balance at February 28, 2022   12,131,350   $12,131   $328,062,246   $27,706,146   $355,780,523 
Increase (Decrease) from Operations:                         
Net investment income   -    
-
    
-
    7,976,222    7,976,222 
Net realized gain (loss) from investments   -    
-
    
-
    162,509    162,509 
Income tax (provision) benefit from realized gain on investments   -    
-
    
-
    69,250    69,250 
Net change in unrealized appreciation (depreciation) on investments   -    
-
    
-
    (9,333,449)   (9,333,449)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    
-
    
-
    (361,951)   (361,951)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    
-
    
-
    (6,428,817)   (6,428,817)
Capital Share Transactions:                         
Stock dividend distribution   42,825    43    1,108,637    
-
    1,108,680 
Repurchases of common stock   (142,177)   (142)   (3,734,174)   
-
    (3,734,316)
Repurchase fees   -    
-
    (2,840)   
-
    (2,840)
Balance at May 31, 2022   12,031,998   $12,032   $325,433,869   $19,789,910   $345,235,811 
Increase (Decrease) from Operations:                         
Net investment income   -    
-
    
-
    7,698,014    7,698,014 
Net realized gain (loss) from investments   -    
-
    
-
    7,943,838    7,943,838 
Realized losses on extinguishment of debt   -    
-
    
-
    (1,204,809)   (1,204,809)
Net change in unrealized appreciation (depreciation) on investments   -    
-
    
-
    (13,258,456)   (13,258,456)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    
-
    
-
    (230,154)   (230,154)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    
-
    
-
    (6,369,981)   (6,369,981)
Capital Share Transactions:                         
Stock dividend distribution   48,590    49    1,088,139    
-
    1,088,188 
Repurchases of common stock   (153,350)   (154)   (3,685,951)   
-
    (3,686,105)
Repurchase fees   -    
-
    (3,071)   
-
    (3,071)
Balance at August 31, 2022   11,927,238   $11,927   $322,832,986   $14,368,362   $337,213,275 

 

F-68

 

 

               Total     
   Common Stock   Capital
in Excess
   Distributable
Earnings
     
   Shares   Amount   of Par Value   (Loss)   Net Assets 
Increase (Decrease) from Operations:                         
Net investment income   -    
-
    
-
    9,877,437    9,877,437 
Net realized gain (loss) from investments   -    
-
    
-
    (740,434)   (740,434)
Income tax (provision) benefit from realized gain on investments   -    
-
    
-
    479,318    479,318 
Net change in unrealized appreciation (depreciation) on investments   -    
-
    
-
    (3,176,208)   (3,176,208)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    
-
    
-
    (425,848)   (425,848)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    
-
    
-
    (6,433,298)   (6,433,298)
Capital Share Transactions:                         
Stock dividend distribution   52,312    53    1,150,881    
-
    1,150,934 
Repurchases of common stock   (94,071)   (95)   (2,179,600)   
-
    (2,179,695)
Repurchase fees   -    
-
    (1,881)   
-
    (1,881)
Balance at November 30, 2022   11,885,479   $11,885   $321,802,386   $13,949,329   $335,763,600 
                          
Increase (Decrease) from Operations:                         
Net investment income   -    
-
    
-
    9,649,474    9,649,474 
Net realized gain (loss) from investments   -    
-
    
-
    80,683    80,683 
Realized losses on extinguishment of debt   -    
-
    
-
    (382,274)   (382,274)
Net change in unrealized appreciation (depreciation) on investments   -    
-
    
-
    10,549,981    10,549,981 
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    
-
    
-
    (697,380)   (697,380)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    
-
    
-
    (8,081,306)   (8,081,306)
Capital Share Transactions:                         
Stock dividend distribution   53,615    55    1,300,405    
-
    1,300,460 
Repurchases of common stock   (48,594)   (49)   (1,224,175)   
-
    (1,224,224)
Repurchase fees   -    
-
    (972)   
-
    (972)
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles   -    
-
    16,162    (16,162)   
-
 
Balance at February 28, 2023   11,890,500   $11,891   $321,893,806   $25,052,345   $346,958,042 

 

F-69

 

 

               Total     
   Common Stock   Capital
in Excess
   Distributable
Earnings
     
   Shares   Amount   of Par Value   (Loss)   Net Assets 
Increase (Decrease) from Operations:                         
Net investment income   -    
-
    
-
    15,958,950    15,958,950 
Net realized gain (loss) from investments   -    
-
    
-
    90,691    90,691 
Net change in unrealized appreciation (depreciation) on investments   -    
-
    
-
    (16,322,307)   (16,322,307)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    
-
    
-
    59,407    59,407 
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    
-
    
-
    (8,193,402)   (8,193,402)
Capital Share Transactions:                         
Stock dividend distribution   45,818    47    1,058,797    
-
    1,058,844 
Repurchases of common stock   (88,576)   (90)   (2,157,515)   
-
    (2,157,605)
Repurchase fees   -    
-
    (1,772)   
-
    (1,772)
Balance at May 31, 2023   11,847,742   $11,848   $320,793,316   $16,645,684   $337,450,848 
Increase (Decrease) from Operations:                         
Net investment income   -    
-
    
-
    13,964,784    13,964,784 
Realized losses on extinguishment of debt   -    
-
    
-
    (110,056)   (110,056)
Net change in unrealized appreciation (depreciation) on investments   -    
-
    
-
    (5,737,571)   (5,737,571)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    
-
    
-
    (221,206)   (221,206)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    
-
    
-
    (8,352,335)   (8,352,335)
Capital Share Transactions:                         
Proceeds from issuance of common stock   852,412    852    22,497,265    
-
    22,498,117 
Capital contribution from Manager   -    
-
    2,050,288    
-
    2,050,288 
Stock dividend distribution   29,627    30    749,283    
-
    749,313 
Offfering costs   -    
-
    (213,427)   
-
    (213,427)
Balance at August 31, 2023   12,729,781   $12,730   $345,876,725   $16,189,300   $362,078,755 
Increase (Decrease) from Operations:                         
Net investment income   -    
-
    
-
    14,166,063    14,166,063 
Net realized gain (loss) from investments   -    
-
    
-
    60,565    60,565 
Net change in unrealized appreciation (depreciation) on investments   -    
-
    
-
    (17,866,353)   (17,866,353)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    
-
    
-
    (415,894)   (415,894)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    
-
    
-
    (9,286,642)   (9,286,642)
Capital Share Transactions:                         
Proceeds from issuance of common stock   350,000    350    9,012,150    
-
    9,012,500 
Capital contribution from Manager   -    
-
    1,043,000    
-
    1,043,000 
Stock dividend distribution   35,196    35    858,960    
-
    858,995 
Offering costs   -    
-
    (92,240)   
-
    (92,240)
Balance at November 30, 2023   13,114,977   $13,115   $356,698,595   $2,847,039   $359,558,749 
Increase (Decrease) from Operations:                         
Net investment income   -    
-
    
-
    12,784,511    12,784,511 
Net realized gain (loss) from investments   -    
-
    
-
    2,328    2,328 
Net change in unrealized appreciation (depreciation) on investments   -    
-
    
-
    (7,164,613)   (7,164,613)
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments   -    
-
    
-
    (315,473)   (315,473)
Decrease from Shareholder Distributions:                         
Distributions of investment income – net   -    
-
    
-
    (9,803,576)   (9,803,576)
Capital Share Transactions:                         
Proceeds from issuance of common stock   501,105    501    13,028,269    
-
    13,028,770 
Capital contribution from Manager   -    
-
    1,382,009    
-
    1,382,009 
Stock dividend distribution   37,394    38    915,155    
-
    915,193 
Offering costs   -    
-
    (163,789)   
-
    (163,789)
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles   -    -    

(779

)   

779

    - 
Balance at February 29, 2024   13,653,476   $13,654   $371,081,199   $(870,745)  $370,224,108 

 

F-70

 

Note 12. Earnings Per Share

 

In accordance with the provisions of FASB ASC Topic 260, Earnings per Share, basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

 

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets resulting from operations per share for the years ended February 29, 2024, February 28, 2023 and February 28, 2022 (dollars in thousands except share and per share amounts):

 

Basic and Diluted  February 29,
2024
   February 28,
2023
   February 28,
2022
 
Net increase in net assets resulting from operations  $8,934   $24,676   $45,735 
Weighted average common shares outstanding   12,670,939    11,963,533    11,456,631 
Weighted average earnings per common share  $0.71   $2.06   $3.99 

 

Note 13. Dividend

 

We have distributed or intend to distribute sufficient dividends to eliminate our U.S. federal taxable income for our completed tax years. If we fail to satisfy the 90% distribution requirement or otherwise fail to qualify as a RIC in any tax year, we would be subject to U.S. federal income tax in that year on all of our taxable income, regardless of whether we made any distributions to our shareholders. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock. Our distributions for the tax years ended February 29, 2024 to inception were as follows:

 

Payment date  Cash Dividend 
Tax Year Ended February 28, 2025    
March 28, 2024  $0.73(45) 
   $0.73 
Tax Year Ended February 29, 2024     
December 28, 2023  $0.72(44) 
September 28, 2023   0.71(43) 
June 29, 2023   0.70(42) 
March 30, 2023   0.69(1) 
   $2.82 
Tax Year Ended February 28, 2023     
January 4, 2023  $0.68(2) 
September 29, 2022   0.54(3) 
June 29, 2022   0.53(4) 
March 28, 2022   0.53(5) 
   $2.28 
Tax Year Ended February 28, 2022     
January 19, 2022  $0.53(6) 
September 28, 2021   0.52(7) 
June 29, 2021   0.44(8) 
April 22, 2021   0.43(9) 
   $1.92 
Tax Year Ended February 28, 2021     
February 10, 2021  $0.42(10) 
November 10, 2020   0.41(11) 
August 12, 2020   0.40(12) 
   $1.03 
Tax Year Ended February 29, 2020     
February 6, 2020  $0.56(13) 
September 26, 2019   0.56(14) 
June 27, 2019   0.55(15) 
March 28, 2019   0.54(16) 
   $2.21 
Tax Year Ended February 28, 2019     
January 2, 2019  $0.53(17) 
September 27, 2018   0.52(18) 
June 27, 2018   0.51(19) 
March 26, 2018   0.50(20) 
   $2.06 
Tax Year Ended February 28, 2018     
December 27, 2017  $0.49(21) 
September 26, 2017   0.48(22) 
June 27, 2017   0.47(23) 
March 28, 2017   0.46(24) 
   $1.90 

F-71

 

Payment date  Cash Dividend 
Tax Year Ended February 28, 2017    
February 9, 2017  $0.45(25) 
November 9, 2016   0.44(26) 
September 5, 2016   0.20(27) 
August 9, 2016   0.43(28) 
April 27, 2016   0.41(29) 
   $1.93 
      
Tax Year Ended February 29, 2016     
February 29, 2016  $0.40(30) 
November 30, 2015   0.36(31) 
August 31, 2015   0.33(32) 
June 5, 2015   1.00(33) 
May 29. 2015   0.27(34) 
   $2.36 
Tax Year Ended February 28, 2015     
February 27, 2015  $0.22(35) 
November 28, 2014   0.18(36) 
   $0.40 
Tax Year Ended February 28. 2014     
December 27, 2013  $2.65(37) 
   $2.65 
Tax Year Ended February 28, 2013     
December 31, 2012  $4.25(38) 
   $4.25 
Tax Year Ended February 29, 2012     
December 30, 2011  $3.00(39) 
   $3.00 
Tax Year Ended February 28, 2011     
December 29, 2010  $4.40(40) 
   $4.40 
Tax Year Ended February 28, 2010     
December 31, 2009  $18.25(41) 
   $18.25 

 

 

(1) Based on shareholder elections, the dividend consisted of approximately $7.1 million in cash and 45,818 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 17, 20, 21, 22, 23, 24, 27, 28, 29, and 30, 2023.
   
(2) Based on shareholder elections, the dividend consisted of approximately $6.8 million in cash and 53,615 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.26 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21, 22, 23, 27, 28, 29 and 30 2022 and January 3 and 4, 2023.
   
(3) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 52,312 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.00 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 16, 19, 20, 21, 22, 23, 26, 27, 28 and 29, 2022.
   
(4) Based on shareholder elections, the dividend consisted of approximately $5.1 million in cash and 48,590 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.40 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 17, 21, 22, 23, 24, 27, 28 and 29, 2022.
   
(5) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 42,825 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.89 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 18, 21, 22, 23, 24, 25 and 28, 2022.

F-72

 

 

(6) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 41,520 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 5, 6, 7, 10, 11, 12, 13, 14, 18 and 19, 2022.
   
(7) Based on shareholder elections, the dividend consisted of approximately $4.9 million in cash and 38,016 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.77 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2021.
   
(8) Based on shareholder elections, the dividend consisted of approximately $4.1 million in cash and 33,100 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.03 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 16, 17, 18, 21, 22, 23, 24, 25, 28 and 29, 2021.
   
(9) Based on shareholder elections, the dividend consisted of approximately $3.9 million in cash and 38,580 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.69 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 9,12, 13, 14, 15, 16, 19, 20, 21 and 22, 2021.
   
(10) Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 41,388 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.75 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 28, 29 and February 1, 2, 3, 4, 5, 8, 9 and 10, 2021.
   
(11) Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9 and 10, 2020.
   
(12) Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.

 

(13) Based on shareholder elections, the dividend consisted of approximately $5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3, 4, 5 and 6, 2020.
   
(14) Based on shareholder elections, the dividend consisted of approximately $4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25 and 26, 2019.
   
(15) Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.65 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2019.

 

F-73

 

 

(16) Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.
   
(17) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018 and January 2, 2019.
   
(18) Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2018.
   
(19) Based on shareholder elections, the dividend consisted of approximately $2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2018.
   
(20) Based on shareholder elections, the dividend consisted of approximately $2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $19.91 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26, 2018.
   
(21) Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.
   
(22) Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.
   
(23) Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

 

(24) Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.
   
(25) Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.

 

F-74

 

 

(26) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.
   
(27) Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.
   
(28) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.
   
(29) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.
   
(30) Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.
   
(31) Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.
   
(32) Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.
   
(33) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5, 2015.
   
(34) Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.

 

(35) Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

 

F-75

 

 

(36) Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.
   
(37) Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.
   
(38) Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.
   
(39) Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.
   
(40) Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.
   
(41) Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.
   
(42) Based on shareholder elections, the dividend consisted of approximately $7.6 million in cash and 29,627 newly issued shares of common stock, or 0.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.29 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 20, 21, 22, 23, 26, 27, 28, and 29, 2023.
   
(43) Based on shareholder elections, the dividend consisted of approximately $8.4 million in cash and 35,196 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.41 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2023.
   
(44) Based on shareholder elections, the dividend consisted of approximately $8.9 million in cash and 37,394 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 14, 15, 18, 19, 20, 21, 22, 26, 27, and 28, 2023.
   
(45) Based on shareholder elections, the dividend consisted of approximately $9.0 million in cash and 45,490 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2024.

 

F-76

 

 

The following tables summarize dividends declared for the years ended February 29, 2024, February 28, 2023, February 28, 2022, February 28, 2021 and February 29, 2020 (dollars in thousands except for share amounts):

 

Date Declared  Record Date  Payment Date  Amount per Share   Total Amount* 
February 15, 2024  March 13, 2024  March 28, 2024  $0.73   $9,967 
November 15, 2023  December 11, 2023  December 28, 2023   0.72    9,803 
August 14, 2023  September 14, 2023  September 28, 2023   0.71    9,287 
May 22, 2023  June 13, 2023  June 29, 2023   0.70    8,352 
Total dividends declared        $2.86   $37,409 

 

Date Declared  Record Date  Payment Date  Amount per Share   Total Amount* 
February 28, 2023  March 14, 2023  March 28, 2023  $0.69   $8,193 
November 15, 2022  December 15, 2022  January 4, 2023   0.68    8,081 
August 29, 2022  September 14, 2022  September 29, 2022   0.54    6,433 
May 26, 2022  June 14, 2022  June 29, 2022   0.53    6,370 
Total dividends declared        $2.44   $29,077 

 

Date Declared  Record Date  Payment Date  Amount per Share   Total Amount* 
February 24, 2022  March 14, 2022  March 28, 2022  $0.53   $6,434 
August 26, 2021  September 14, 2021  September 28, 2021   0.52    5,889 
May 27, 2021  June 15, 2021  June 29, 2021   0.44    4,910 
March 22, 2021  April 8, 2021  April 22, 2021   0.43    4,799 
Total dividends declared        $1.92   $22,032 

 

Date Declared  Record Date  Payment Date  Amount per Share   Total Amount* 
January 5, 2021  January 26, 2021  February 10, 2021  $0.42   $4,679 
October 7, 2020  October 26, 2020  November 10, 2020   0.41    4,581 
July 7, 2020  July 27, 2020  August 12, 2020   0.40    4,487 
Total dividends declared        $1.23   $13,747 

 

Date Declared  Record Date  Payment Date  Amount per Share   Total Amount* 
January 7, 2020  January 24, 2020  February 6, 2020  $0.56   $6,262 
August 27, 2019  September 13, 2019  September 26, 2019   0.56    5,323 
May 28, 2019  June 13, 2019  June 27, 2019   0.55    4,336 
February 26, 2019  March 14, 2019  March 28, 2019   0.54    4,176 
Total dividends declared        $2.21   $20,097 

 

 

*Total amount is calculated based on the number of shares outstanding at the date of record.

 

F-77

 

 

Note 14. Financial Highlights

 

The following is a schedule of financial highlights as of and for the years ended February 29, 2024, February 28, 2023, February 28, 2022, February 28, 2021 and February 29, 2020:                         

 

Per share data  February 29,
2024
   February 28,
2023
   February 28,
2022
   February 28,
2021
   February 29,
2020
 
Net asset value at beginning of period  $29.18   $29.33   $27.25   $27.13   $23.62 
Net investment income(1)   4.49    2.94    1.74    2.07    1.59 
Net realized and unrealized gain and losses on investments(1)   (3.77)   (0.75)   2.46    (0.74)   4.56 
Realized losses on extinguishment of debt*   (0.01)   (0.13)   (0.21)   (0.01)   (0.17)
Net increase in net assets resulting from operations   0.71    2.06    3.99    1.32    5.98 
Distributions declared from net investment income   (2.82)   (2.28)   (1.93)   (1.23)   (2.21)
Total distributions to stockholders   (2.82)   (2.28)   (1.93)   (1.23)   (2.21)
Issuance of common stock above net asset value(2)   (0.40)   (2.28)   (1.93)   (1.23)   (2.21)
Capital contribution from Manager for the issuance of common stock(8)   0.48    
-
    
-
    
-
    
-
 
Repurchases of common stock(3)   0.03    0.17    0.01    0.13    
-
 
Dilution(4)   (0.06)   (0.10)   
-
    (0.10)   (0.26)
Net asset value at end of period  $27.12   $29.18   $29.33   $27.25   $27.13 
Net assets at end of period  $370,224,108   $346,958,042   $355,780,523   $304,185,770   $304,286,853 
Shares outstanding at end of period   13,653,476    11,890,500    12,131,350    11,161,416    11,217,545 
Per share market value at end of period  $23.61   $27.55   $27.47   $23.08   $22.91 
Total return based on market value(5)   -3.92%   10.35%   28.19%   7.63%   9.28%
Total return based on net asset value(6)   4.20%   9.46%   15.88%   7.31%   26.22%
Ratio/Supplemental data:                         
Ratio of net investment income to average net assets   16.01%   10.23%   6.05%   7.77%   6.31%
Ratio of loss on extinguishment of debt to average net assets   0.03%   0.46%   0.74%   0.04%   0.67%
Expenses:                         
Ratios of operating expenses and income taxes to average net assets*   8.59%   7.71%   6.48%   6.90%   6.10%
Ratio of incentive management fees to average net assets   2.26%   1.47%   3.58%   1.65%   6.01%
Ratio of interest and debt financing expenses to average net assets   13.84%   9.73%   6.03%   4.56%   6.23%
Ratio of total expenses and income taxes to average net assets*   24.70%   18.91%   16.09%   13.11%   18.34%
Portfolio turnover rate(7)   2.80%   24.05%   33.59%   25.26%   36.82%
Asset coverage ratio per unit(8)   1,610    1,659    2,092    3,471    6,071 
Average market value per unit                         
Revolving Credit Facility(9)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
SBA Debentures Payable(9)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
6.75% Notes Payable 2023(10)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
8.75% Notes Payable 2025(9)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
6.25% Notes Payable 2025(11)   
N/A
    
N/A
    
N/A
   $24.24   $25.75 
7.00% Notes Payable 2025(9)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
7.25% Notes Payable 2025(12)   
N/A
    
N/A
   $26.18    25.77    
N/A
 
7.75% Notes Payable 2025(9)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
4.375% Notes Payable 2026(9)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
4.35% Notes Payable 2027(9)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
6.00% Notes Payable 2027  $23.51   $23.97    
N/A
    
N/A
    
N/A
 
6.25% Notes Payable 2027(9)   
N/A
    
N/A
    
N/A
    
N/A
    
N/A
 
8.00% Notes Payable 2027  $25.00   $25.08    
N/A
    
N/A
    
N/A
 
8.125% Notes Payable 2027  $25.05   $25.10    
N/A
    
N/A
    
N/A
 
8.50% Notes Payable 2028  $25.17    
N/A
    
N/A
    
N/A
    
N/A
 

 

 

* Certain prior period amounts have been reclassified to conform to current period presentation.
   
(1) Per share amounts are calculated using the weighted average shares outstanding during the period.

 

F-78

 

 

(2) The continuous issuance of common stock may cause an incremental increase in NAV per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of NAV per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date multiplied by (B) the differences between the net proceeds per share and the NAV per share on each share transaction date, divided by (ii) the total shares outstanding during the period.

 

(3) Represents the anti-dilutive impact on the NAV of the Company due to the repurchase of common shares.
   
(4) Represents the dilutive effect of issuing common stock below NAV per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement and may include the impact of the different share amounts used for different items (weighted average basic common shares outstanding for the corresponding year and actual common shares outstanding at the end of the year) in the per common share data calculation and rounding impacts. See Note 13, Dividend.             
   
(5) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the DRIP. Total investment return does not reflect brokerage commissions.
   
(6) Total investment return is calculated assuming a purchase of common shares at the current NAV on the first day and a sale at the current NAV on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the DRIP. Total investment return does not reflect brokerage commissions.
   
(7) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.
   
(8) Asset coverage ratio per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage ratio per unit is expressed in terms of dollar amounts per $1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause us to be below the required amount of regulatory coverage.
   
(9) The Revolving Credit Facility, SBA Debentures, 8.75 Notes Payable 2025, 7.75% Notes Payable 2025, 4.375% Notes Payable 2026, 4.35% Notes Payable 2026, 7.00% Notes Payable 2025 and 6.25% Notes Payable 2027 are not registered for public trading.
   
(10) On December 21, 2019 and February 7, 2020, the Company redeemed $50.0 million and $24.5 million, respectively, in aggregate principal amount of the $74.5 million in aggregate principal amount of issued and outstanding 2023 Notes and are no longer listed on the NYSE.
   
(11) On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes and, as a result of the full redemption, the 6.25% 2025 Notes are no longer listed on the NYSE.
   
(12) On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the $43.1 million in aggregate principal amount of issued and outstanding 7.25% 2025 Notes and are no longer listed on the NYSE.

 

F-79

 

 

Note 15. Selected Quarterly Data (Unaudited)

 

   2024 
($ in thousands, except per share numbers)  Qtr 4   Qtr 3   Qtr 2   Qtr 1 
Total investment income  $37,233   $36,340   $35,514   $34,632 
Net investment income  $12,785   $14,166   $13,965   $15,959 
Net realized and unrealized gain (loss)  $(7,478)  $(18,222)  $(5,959)  $(16,172)
Realized losses on extinguishment of debt*  $
-
   $
-
   $(110)  $
-
 
Net increase in net assets resulting from operations  $5,307   $(4,056)  $7,896   $(213)
Net investment income per common share  $0.94   $1.09   $1.15   $1.35 
Net realized and unrealized gain (loss) per common share  $(0.55)  $(1.40)  $(0.49)  $(1.36)
Dividends declared per common share  $0.72   $0.71   $0.70   $0.69 
Net asset value per common share  $27.12   $27.42   $28.44   $28.48 

 

   2023 
($ in thousands, except per share numbers)  Qtr 4   Qtr 3   Qtr 2   Qtr 1 
Total investment income  $32,315   $26,257   $21,853   $18,679 
Net investment income  $9,650   $9,877   $7,698   $7,976 
Net realized and unrealized gain (loss)  $9,934   $(3,863)  $(5,545)  $(9,464)
Realized losses on extinguishment of debt*  $(382)  $
-
   $(1,205)  $
-
 
Net increase in net assets resulting from operations  $19,202   $6,014   $948   $(1,488)
Net investment income per common share  $0.81   $0.83   $0.64   $0.66 
Net realized and unrealized gain (loss) per common share  $0.81   $(0.32)  $(0.46)  $(0.78)
Dividends declared per common share  $0.68   $0.54   $0.53   $0.53 
Net asset value per common share  $29.18   $28.25   $28.27   $28.69 

 

   2022 
($ in thousands, except per share numbers)  Qtr 4   Qtr 3   Qtr 2   Qtr 1 
Total investment income  $18,980   $16,502   $18,442   $16,816 
Net investment income  $5,796   $5,197   $6,393   $2,556 
Net realized and unrealized gain (loss)  $2,725   $3,908   $3,101   $18,493 
Realized losses on extinguishment of debt*  $(2,434)  $(118)  $(1,552)  $
-
 
Net increase in net assets resulting from operations  $8,404   $8,340   $7,942   $21,049 
Net investment income per common share  $0.48   $0.45   $0.57   $0.23 
Net realized and unrealized gain (loss) per common share  $0.23   $0.34   $0.29   $1.66 
Dividends declared per common share  $0.53   $0.52   $0.44   $0.43 
Net asset value per common share  $29.33   $29.17   $28.97   $28.70 

 

 

*Certain prior period amounts have been reclassified to conform to current period presentation.

 

F-80

 

 

Note 16. Subsequent Events

 

The Company has evaluated subsequent events through the filing of this Form 10-K and determined that there have been no events that have occurred that would require adjustments to the Company’s consolidated financial statements and disclosures in the consolidated financial statements except for the following:

 

Live Oak Facility

 

On March 27, 2024, the Company and its wholly owned special purpose subsidiary, Saratoga Investment Funding III LLC (“SIF III”), entered into a credit and security agreement (the “Live Oak Credit Agreement”), by and among SIF III, as borrower, the Company, as collateral manager and equityholder, the lenders from time to time parties thereto, Live Oak Banking Company (“Live Oak”), as administrative agent and collateral agent, U.S. Bank National Association, as custodian, and U.S. Bank Trust Company, National Association, as collateral administrator, relating to a special purpose vehicle financing credit facility (the “Live Oak Credit Facility”).

 

The Live Oak Credit Facility provides for borrowings in U.S. dollars in an aggregate amount of up to $50.0 million. During the first two years following the closing date, SIF III may request one or more increases in the commitment amount from $50.0 million to an amount not to exceed $150.0 million, subject to certain terms and conditions and a customary fee. The terms of the Live Oak Credit Agreement require a minimum drawn amount of $12.5 million at all times during the period ending March 27, 2025 and, thereafter, the greater of: (i) $25.0 million and (ii) 50% of the facility amount in effect at such time. The Live Oak Credit Facility matures on March 27, 2027. Advances are available during the term of the Live Oak Credit Facility and must be repaid in full at maturity. SIF III may request an extension of the maturity date by an additional one year, subject to the agreement of the lenders and an extension fee.

 

Advances under the Live Oak Credit Facility are subject to a borrowing base calculation, and the Live Oak Credit Facility has various eligibility criteria for loans to be included in the borrowing base. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to Adjusted Term SOFR plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility’s utilization. The Live Oak Credit Agreement also provides for an unused fee of 0.50% on the unused commitments. SIF III’s obligations to the lenders under the Live Oak Credit Facility are secured by a first priority security interest in substantially all of SIF III’s assets. In addition, SIF III’s obligations to the lenders under the Live Oak Credit Facility are secured by a pledge by the Company of its equity interests in SIF III, which is evidenced by the equity pledge agreement, dated as of March 27, 2024, by and between the Company, as pledgor, and Live Oak, as collateral agent for the benefit of the secured parties.

 

In connection with the Live Oak Credit Agreement, the Company entered into a loan sale and contribution agreement with SIF III, dated as of March 27, 2024, by and between the Company, as seller, and SIF III, as purchaser, pursuant to which the Company will sell or contribute certain loans held by the Company to SIF III to be used to support the borrowing base under the Live Oak Credit Facility. The Live Oak Credit Facility permits loan proceeds and excess cash in SIF III’s collection accounts to be distributed to us at any time based on three business days advance notice, subject to compliance with various conditions, including the absence of a default or event of default, the absence of an over-advance against the borrowing base and the absence of a violation of the financial covenants.

 

F-81

 

 

INDEX TO OTHER FINANCIAL STATEMENTS

Saratoga Investment Corp. CLO 2013-1, Ltd.

 

  PAGE
Independent Auditor’s Report S-2
Statements of Assets and Liabilities as of February 29, 2024 and February 28, 2023 S-3
Statements of Operations for the years ended February 29, 2024, February 28, 2023 and February 28, 2022 S-4
Statements of Changes in Net Assets for the years ended February 29, 2024, February 28, 2023 and February 28, 2022 S-5
Statements of Cash Flows for the years ended February 29, 2024, February 28, 2023 and February 28, 2022 S-6
Schedules of Investments as of February 29, 2024 and February 28, 2023 S-7
Notes to Financial Statements S-42

 

IMPORTANT NOTE

 

In accordance with certain SEC rules, Saratoga Investment Corp. (the “Company”) is providing additional information regarding one of its portfolio companies, Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”). The Company owns 100% of the subordinated notes of Saratoga CLO. The additional financial information regarding Saratoga CLO does not directly impact the Company’s financial position, results of operations or cash flows.

 

S-1

 

 

 

Independent Auditor’s Report

 

To the Board of Directors

Saratoga Investment Corp. CLO 2013-1, Ltd.

 

Opinion

 

We have audited the financial statements of Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), which comprise the statements of assets and liabilities as of February 29, 2024 and February 28, 2023, including the schedule of investments, as of February 29, 2024 and February 28, 2023, and the related statements of operations, changes in net assets, and cash flows for the years ended February 29, 2024, February 28, 2023, and February 28, 2022, and the related notes to the financial statements.

 

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of Saratoga Investment Corp. CLO 2013-1, Ltd. as of February 29, 2024 and February 28, 2023, and the results of its operations, changes in its net assets, and its cash flows for the years ended February 29, 2024, February 28, 2023, and February 28, 2022, in accordance with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

We conducted our audits in accordance with auditing standards generally accepted in the United States of America ("GAAS"). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of Saratoga CLO and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

 

Responsibilities of Management for the Financial Statements

 

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Saratoga CLO's ability to continue as a going concern for one year after the date that the financial statements are available to be issued.

 

Auditor's Responsibilities for the Audit of the Financial Statements

 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

 

In performing an audit in accordance with GAAS, we:

 

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

 

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of Saratoga CLO's internal control. Accordingly, no such opinion is expressed.

 

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

 

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about Saratoga CLO's ability to continue as a going concern for a reasonable period of time.

 

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

 

/s/ CohnReznick LLP

 

Parsippany, New Jersey

May 6, 2024

 

S-2

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd. 

Statements of Assets and Liabilities

 

   February 29,
2024
   February 28,
2023
 
         
ASSETS        
Investments at fair value        
Loans at fair value (amortized cost of $629,345,724 and $645,599,001, respectively)  $606,531,189   $605,954,468 
Equities at fair value  (amortized cost of $1,649,986 and $0, respectively)   1,020,585    - 
Total investments at fair value (amortized cost of $630,995,710 and $645,599,001, respectively)   607,551,774    605,954,468 
Cash and cash equivalents   12,104,832    23,776,950 
Receivable from open trades   2,865,174    1,827,460 
Interest receivable (net of reserve of $615,604 and $234,690, respectively)   3,402,471    3,026,720 
Due from affiliate (See Note 7)   3,953    119,150 
Prepaid expenses and other assets   205,400    152,760 
Total assets  $626,133,604   $634,857,508 
           
LIABILITIES          
Interest payable  $5,043,712   $4,662,695 
Payable from open trades   10,519,573    23,184,337 
Accrued base management fee   68,605    72,762 
Accrued subordinated management fee   274,418    291,047 
Accounts payable and accrued expenses   84,199    82,565 
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:          
Class A-1-R-3 Senior Secured Floating Rate Notes   357,500,000    357,500,000 
Class A-2-R-3 Senior Secured Floating Rate Notes   65,000,000    65,000,000 
Class B-FL-R-3 Senior Secured Floating Rate Notes   60,500,000    60,500,000 
Class B-FXD-R-3 Senior Secured Fixed Rate Notes   11,000,000    11,000,000 
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes   26,000,000    26,000,000 
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes   6,500,000    6,500,000 
Class D-R-3 Deferrable Mezzanine Floating Rate Notes   39,000,000    39,000,000 
Discount on Class D-R-3 Notes   (220,100)   (244,234)
Class E-R-3 Deferrable Mezzanine Floating Rate Notes   27,625,000    27,625,000 
Discount on Class E-R-3 Notes   (2,286,598)   (2,537,315)
Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes   8,500,000    8,500,000 
Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes   9,375,000    9,375,000 
Deferred debt financing costs   (1,707,224)   (1,897,076)
Subordinated Notes   111,000,000    111,000,000 
Discount on Subordinated Notes   (36,164,988)   (40,130,353)
Total liabilities   697,611,597    705,484,428 
           
Commitments and contingencies          
           
NET ASSETS          
Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 common shares issued and outstanding, respectively   250    250 
Total distributable earnings (loss)   (71,478,243)   (70,627,170)
Total net deficit   (71,477,993)   (70,626,920)
Total liabilities and net assets  $626,133,604   $634,857,508 

 

See accompanying notes to financial statements.

 

S-3

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

 

   For the years ended 
   February 29,
2024
   February 28,
2023
   February 28,
2022
 
INVESTMENT INCOME            
Interest from investments  $61,667,773   $42,505,427   $30,767,008 
Interest from cash and cash equivalents   719,268    39,754    691 
Other income   929,392    551,174    710,708 
Total investment income   63,316,433    43,096,355    31,478,407 
                
EXPENSES               
Interest and debt financing expenses   57,706,205    38,425,261    24,220,477 
Base management fee   654,046    653,964    652,517 
Subordinated management fee   2,616,185    2,615,856    2,610,073 
Professional fees   307,340    252,196    255,521 
Trustee expenses   262,197    276,689    262,632 
Other expense   241,181    303,371    243,511 
Total expenses   61,787,154    42,527,337    28,244,731 
NET INVESTMENT INCOME (LOSS)   1,529,279    569,018    3,233,676 
                
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS               
Net realized loss from investments   (18,580,949)   (8,412,837)   (1,063,813)
Net change in unrealized appreciation (depreciation) on investments   16,200,597    (25,585,618)   (10,829,482)
Net realized and unrealized gain (loss) on investments   (2,380,352)   (33,998,455)   (11,893,295)
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  $(851,073)  $(33,429,437)  $(8,659,619)

 

See accompanying notes to financial statements.

 

S-4

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Changes in Net Assets

 

   For the years ended 
   February 29,
2024
   February 28,
2023
   February 28,
2022
 
INCREASE (DECREASE) FROM OPERATIONS:            
Net investment income (loss)  $1,529,279   $569,018   $3,233,676 
Net realized gain (loss) from investments   (18,580,949)   (8,412,837)   (1,063,813)
Realized losses on extinguishment of debt   -    -    - 
Net change in unrealized appreciation (depreciation) on investments   16,200,597    (25,585,618)   (10,829,482)
Net increase (decrease) in net assets resulting from operations   (851,073)   (33,429,437)   (8,659,619)
Total increase (decrease) in net assets   (851,073)   (33,429,437)   (8,659,619)
Net assets at beginning of period   (70,626,920)   (37,197,483)   (28,537,864)
Net assets at end of period  $(71,477,993)  $(70,626,920)  $(37,197,483)

 

See accompanying notes to financial statements.

 

S-5

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Cash Flows

 

   For the years ended 
   February 29,
2024
   February 28, 2023   February 28, 2022 
Operating activities            
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  $(851,073)  $(33,429,437)  $(8,659,618)
ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:               
Payment-in-kind and other adjustments to cost   (960,409)   (764,255)   (609,083)
Net accretion of discount on investments   (3,123,995)   (2,470,677)   (3,151,234)
Amortization of discount and deferred debt financing costs   4,430,068    4,418,481    4,418,481 
Realized loss on extinguishment of debt   -    -    - 
Net realized (gain) loss from investments   18,580,949    8,412,837    1,063,812 
Net change in unrealized (appreciation) depreciation on investments   (16,200,597)   25,585,618    10,829,482 
Proceeds from sales and repayments of investments   121,049,971    124,326,428    247,233,353 
Purchases of investments   (120,943,225)   (122,081,068)   (302,309,641)
(Increase) decrease in operating assets:               
Interest receivable, net   (375,751)   (963,864)   (565,523)
Receivable from open trades   (1,037,714)   7,325,200    (7,250,906)
Due from affiliate   115,197    (119,150)   - 
Prepaid expenses and other assets   (52,640)   (52,693)   18,801 
Increase (decrease) in operating liabilities:               
Interest and debt fees payable   381,017    3,002,919    1,535,543 
Payable for open trades   (12,664,764)   4,389,710    (47,503,941)
Accrued base management fee   (4,157)   252    65,580 
Accrued subordinated management fee   (16,629)   1,007    262,325 
Accounts payable and accrued expenses   1,634    23,849    (751,044)
Due to affiliate   -    -    (2,600,000)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES   (11,672,118)   17,605,157    (107,973,613)
                
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   (11,672,118)   17,605,157    (107,973,613)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR   23,776,950    6,171,793    114,145,406 
CASH AND CASH EQUIVALENTS, END OF YEAR  $12,104,832   $23,776,950   $6,171,793 
                
Supplemental Information:               
Interest paid during the year  $52,895,120   $31,003,861   $18,266,452 
                
Supplemental non-cash information:               
Paid-in-kind interest income and other adjustments to cost  $960,409   $764,255   $609,083 
 Net accretion of discount on investments   3,123,995    2,470,677    3,151,234 
Amortization of deferred debt financing costs and discount on notes   4,430,068    4,418,481    4,418,481 

 

See accompanying notes to financial statements.

 

S-6

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Altisource Solutions S.a r.l.  Banking, Finance, Insurance & Real Estate  Common Stock  Equity                   15,981   $-   $44,587 
Envision Parent Inc  Healthcare & Pharmaceuticals  Common Stock  Equity                   92,837    -    - 
Envision Parent Inc  Healthcare & Pharmaceuticals  Warrants  Equity                   4,410    175,000    42,998 
Isagenix International, LLC  Beverage, Food & Tobacco  Common Stock  Equity                   86,398    -    - 
Resolute Investment Managers (American Beacon), Inc.  Banking, Finance, Insurance & Real Estate  Common Stock  Equity                   24,320    1,034,581    468,000 
URS TOPCO LLC  Transportation: Cargo  Common Stock  Equity                   25,330    440,405    465,000 
1011778 B.C Unltd Liability Co  Beverage, Food & Tobacco  Term Loan B (09/23)  Loan  1M USD SOFR+ 2.25 %   0.00%   7.58%  9/12/2030  $1,447,500    1,427,292    1,440,002 
19TH HOLDINGS GOLF, LLC  Consumer goods: Durable  Term Loan  Loan  1M USD SOFR+ 3.25 %   0.50%   8.67%  2/7/2029   2,473,646    2,383,742    2,416,950 
888 Acquisitions Limited  Hotel, Gaming & Leisure  Term Loan B  Loan  6M USD SOFR+ 5.25 %   0.00%   10.82%  7/8/2028   2,472,826    2,173,473    2,418,745 
Adtalem Global Education Inc.  Services: Business  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.75%   8.83%  8/12/2028   582,329    578,482    583,423 
Aegis Sciences Corporation  Healthcare & Pharmaceuticals  Term Loan  Loan  3M USD SOFR+ 5.50 %   1.00%   11.08%  5/9/2025   2,308,370    2,303,734    2,206,410 
Agiliti Health Inc.  Healthcare & Pharmaceuticals  Term Loan B (03/23)  Loan  3M USD SOFR+ 3.00 %   0.00%   8.33%  5/1/2030   1,674,704    1,662,945    1,668,424 
AHEAD DB Holdings, LLC  Services: Business  Term Loan (04/21)  Loan  3M USD SOFR+ 3.75 %   0.75%   9.20%  10/18/2027   2,925,000    2,856,780    2,914,031 
Air Canada  Transportation: Consumer  Term Loan B (07/21)  Loan  1M USD SOFR+ 3.50 %   0.75%   8.93%  8/11/2028   1,970,000    1,853,394    1,970,276 
AIS HoldCo, LLC  Services: Business  Term Loan  Loan  3M USD SOFR+ 5.00 %   0.00%   10.57%  8/15/2025   4,551,925    4,499,117    4,392,607 
AIT Worldwide Logistics Holdings, Inc.  Transportation: Cargo  Term Loan (04/21)  Loan  1M USD SOFR+ 4.75 %   0.75%   10.17%  4/6/2028   2,474,684    2,334,728    2,471,590 
Alchemy US Holdco 1, LLC  Metals & Mining  Term Loan  Loan  1M USD LIBOR+ 7.32 %   0.00%   7.42%  10/10/2025   1,654,803    1,647,646    1,646,943 
AlixPartners, LLP  Banking, Finance, Insurance & Real Estate  Term Loan B (01/21)  Loan  1M USD SOFR+ 2.50 %   0.50%   7.94%  2/4/2028   243,125    242,907    243,064 
Alkermes, Inc.  Healthcare & Pharmaceuticals  Term Loan B (3/21)  Loan  1M USD SOFR+ 2.50 %   0.50%   7.93%  3/12/2026   2,104,577    2,095,205    2,101,947 
Allen Media, LLC  Media: Diversified & Production  Term Loan (7/21)  Loan  3M USD SOFR+ 5.50 %   0.00%   11.00%  2/10/2027   4,349,069    4,329,175    3,803,870 
Alliant Holdings Intermediate, LLC  Banking, Finance, Insurance & Real Estate  Term Loan (12/23)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.82%  11/6/2030   803,044    802,787    803,197 
Allied Universal Holdco LLC  Services: Business  Term Loan 4/21  Loan  1M USD SOFR+ 3.75 %   0.50%   9.18%  5/12/2028   1,955,000    1,948,856    1,945,948 
Alterra Mountain Company (Intrawest Resort Holdings)  Hotel, Gaming & Leisure  Term Loan B Add-on  Loan  1M USD SOFR+ 3.75 %   0.00%   9.07%  5/31/2030   250,000    250,000    250,000 

 

S-7

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Altisource Solutions S.a r.l.(c)  Banking, Finance, Insurance & Real Estate  Term Loan B (03/18)  Loan  3M USD SOFR+ 5.00 %   1.00%   10.45%  4/30/2025   1,110,821    1,110,656    877,549 
Altium Packaging LLC  Containers, Packaging & Glass  Term Loan (01/21)  Loan  1M USD SOFR+ 2.75 %   0.50%   8.19%  1/29/2028   486,250    484,910    483,819 
Amer Sports Oyj (MASCOT BIDCO OY)  Consumer goods: Durable  USD Term Loan B (01/24)  Loan  3M USD SOFR+ 3.25 %   0.00%   8.58%  2/7/2031   500,000    497,525    499,375 
American Axle & Manufacturing Inc.  Automotive  Term Loan (12/22)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.92%  12/13/2029   480,000    467,515    479,798 
American Greetings Corporation  Media: Advertising, Printing & Publishing  Term Loan (01/23)  Loan  1M USD SOFR+ 6.00 %   1.00%   11.33%  4/5/2028   2,982,733    2,981,076    2,983,478 
American Trailer World Corp  Automotive  Term Loan  Loan  1M USD SOFR+ 3.75 %   0.75%   9.18%  3/3/2028   1,357,439    1,355,695    1,323,788 
AmWINS Group, LLC  Banking, Finance, Insurance & Real Estate  Term Loan 2/21  Loan  1M USD SOFR+ 2.25 %   0.75%   7.69%  2/17/2028   1,940,029    1,924,089    1,930,484 
Anastasia Parent LLC  Consumer goods: Non-durable  Term Loan  Loan  3M USD SOFR+ 3.75 %   0.00%   9.36%  8/11/2025   947,500    946,257    681,859 
Anchor Packaging, LLC  Containers, Packaging & Glass  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.00%   8.93%  7/18/2026   1,959,296    1,939,016    1,955,632 
ANI Pharmaceuticals, Inc.  Healthcare & Pharmaceuticals  Term Loan B  Loan  1M USD SOFR+ 6.00 %   0.75%   11.44%  11/19/2027   2,940,000    2,901,304    2,940,000 
AP Core Holdings II LLC  High Tech Industries  Term Loan B1  Loan  1M USD SOFR+ 5.50 %   0.75%   10.94%  9/1/2027   1,775,000    1,757,513    1,734,317 
AP Core Holdings II LLC  High Tech Industries  Term Loan B2  Loan  1M USD SOFR+ 5.50 %   0.75%   10.94%  9/1/2027   500,000    495,081    487,320 
APEX GROUP TREASURY LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  3M USD SOFR+ 5.00 %   0.50%   10.32%  7/26/2028   495,000    468,246    494,381 
Apollo Commercial Real Estate Finance, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD SOFR+ 2.75 %   0.00%   8.19%  5/15/2026   2,908,629    2,890,508    2,857,728 
Apollo Commercial Real Estate Finance, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B1 (2/21)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  3/6/2028   972,500    966,275    943,325 
AppLovin Corporation  High Tech Industries  Term Loan (10/21)  Loan  1M USD SOFR+ 3.00 %   0.50%   8.43%  10/21/2028   1,473,750    1,471,272    1,474,207 
AppLovin Corporation  High Tech Industries  Term Loan (08/23)  Loan  1M USD SOFR+ 3.00 %   0.50%   8.43%  8/15/2030   969,617    969,617    970,374 
AqGen Ascensus, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  8/2/2028   500,000    496,312    496,375 
Aramark Services, Inc.  Services: Consumer  Term Loan B (4/21)  Loan  1M USD SOFR+ 2.50 %   0.00%   7.94%  4/1/2028   1,753,715    1,748,558    1,750,436 
Aramark Services, Inc.  Services: Consumer  Term Loan  Loan  1M USD SOFR+ 1.75 %   0.00%   7.19%  1/15/2027   2,331,250    2,292,785    2,324,699 

 

S-8

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
ARC FALCON I INC.  Chemicals, Plastics, & Rubber  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.50%   8.93%  9/23/2028   981,274    978,810    972,550 
Arches Buyer Inc.  Services: Consumer  Term Loan B  Loan  1M USD SOFR+ 3.25 %   0.50%   8.68%  12/6/2027   1,469,697    1,463,299    1,405,398 
ARCIS GOLF LLC  Services: Consumer  Term Loan B  Loan  1M USD SOFR+ 3.75 %   0.50%   9.19%  11/24/2028   497,980    493,335    498,602 
Aretec Group, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD SOFR+ 4.50 %   0.00%   9.93%  8/9/2030   2,642,718    2,627,451    2,651,650 
Aspire Bakeries Holdings, LLC  Beverage, Food & Tobacco  Term loan  Loan  1M USD SOFR+ 4.25 %   0.00%   9.57%  12/13/2030   900,000    891,160    900,000 
Asplundh Tree Expert, LLC  Services: Business  Term Loan 2/21  Loan  1M USD SOFR+ 1.75 %   0.00%   7.18%  9/7/2027   967,500    965,030    966,068 
AssuredPartners Capital, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B (2/20)  Loan  1M USD SOFR+ 3.50 %   0.00%   8.94%  2/12/2027   979,592    977,377    979,866 
Assuredpartners Inc.  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.50%   8.83%  2/12/2027   491,250    490,654    491,250 
Assuredpartners Inc.  Banking, Finance, Insurance & Real Estate  Incremental Term Loan (7/21)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  2/12/2027   975,000    975,000    975,000 
Asurion, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B10  Loan  1M USD SOFR+ 4.00 %   0.00%   9.43%  8/19/2028   1,975,000    1,895,414    1,957,719 
Asurion, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B8  Loan  1M USD SOFR+ 3.25 %   0.00%   8.69%  12/18/2026   2,934,604    2,928,879    2,915,442 
ATHENAHEALTH GROUP INC.  Healthcare & Pharmaceuticals  Term Loan B (2/22)  Loan  1M USD SOFR+ 3.25 %   0.50%   8.58%  2/15/2029   1,317,171    1,313,077    1,304,619 
Avolon TLB Borrower 1 (US) LLC  Capital Equipment  Term Loan B6  Loan  1M USD SOFR+ 2.00 %   0.00%   7.32%  6/22/2028   1,483,750    1,429,872    1,483,038 
Axalta Coating Systems US Holdings  Chemicals, Plastics, & Rubber  Term Loan B (08/23)  Loan  3M USD SOFR+ 2.50 %   0.50%   7.85%  12/20/2029   867,888    860,595    868,183 
AZURITY PHARMACEUTICALS, INC.  Healthcare & Pharmaceuticals  Term Loan B  Loan  1M USD SOFR+ 6.62 %   0.75%   12.06%  9/20/2027   450,000    440,909    445,500 
B&G Foods, Inc.  Beverage, Food & Tobacco  Term Loan  Loan  1M USD SOFR+ 2.50 %   0.00%   7.83%  10/10/2026   556,042    553,804    553,540 
BAKELITE UK INTERMEDIATE LTD.  Chemicals, Plastics, & Rubber  Term Loan  Loan  3M USD SOFR+ 4.00 %   0.50%   9.50%  5/29/2029   985,000    981,238    980,075 
Baldwin Risk Partners, LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  10/14/2027   1,960,048    1,946,212    1,946,171 

  

S-9

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Barnes Group Inc.  Aerospace & Defense  Term Loan B  Loan  1M USD SOFR+ 3.00 %   0.00%   8.43%  8/9/2030   249,375    247,649    249,500 
Bausch Health Companies Inc.  Healthcare & Pharmaceuticals  Term Loan B (1/22)  Loan  1M USD SOFR+ 5.25 %   0.50%   10.67%  2/1/2027   1,850,000    1,710,365    1,465,552 
Belfor Holdings Inc.  Services: Consumer  Term Loan B-1 (11/23)  Loan  1M USD SOFR+ 3.75 %   0.50%   9.08%  10/25/2030   1,600,000    1,584,928    1,602,000 
Belron Finance US LLC  Automotive  Term Loan B  Loan  3M USD SOFR+ 2.00 %   0.50%   7.58%  4/13/2028   1,945,000    1,945,000    1,943,172 
Belron Finance US LLC  Automotive  Term Loan B  Loan  3M USD SOFR+ 2.25 %   0.50%   7.66%  4/18/2029   248,750    248,750    248,544 
Bengal Debt Merger Sub LLC  Beverage, Food & Tobacco  Term Loan  Loan  3M USD SOFR+ 3.25 %   0.50%   8.70%  1/24/2029   1,970,000    1,969,251    1,852,785 
Blackstone Mortgage Trust, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (6/21)  Loan  1M USD SOFR+ 2.75 %   0.50%   8.19%  4/23/2026   1,450,228    1,444,650    1,439,352 
Blackstone Mortgage Trust, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD SOFR+ 2.25 %   0.00%   7.69%  4/23/2026   969,620    966,168    962,348 
Blue Tree Holdings, Inc.  Chemicals, Plastics, & Rubber  Term Loan (2/21)  Loan  3M USD SOFR+ 2.50 %   0.00%   8.11%  3/4/2028   972,500    971,083    967,229 
Bombardier Recreational Products, Inc.  Consumer goods: Durable  Term Loan  Loan  1M USD SOFR+ 2.75 %   0.00%   8.08%  1/22/2031   1,440,189    1,436,033    1,437,942 
Bombardier Recreational Products, Inc.  Consumer goods: Durable  Term Loan B3  Loan  1M USD SOFR+ 2.75 %   0.50%   8.18%  12/13/2029   493,769    482,991    493,833 
Boost Newco Borrower, LLC (Worldpay)  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD SOFR+ 3.00 %   0.50%   8.33%  1/31/2031   500,000    497,629    501,460 
Boxer Parent Company, Inc.  High Tech Industries  Term Loan USD (11/23)  Loan  1M USD SOFR+ 4.25 %   0.00%   9.58%  12/29/2028   1,012,255    1,007,334    1,015,018 
BrightSpring Health Services (Phoenix Guarantor)  Healthcare & Pharmaceuticals  Term Loan (02/24)  Loan  1M USD SOFR+ 3.25 %   0.00%   8.58%  2/21/2031   972,500    972,500    961,355 
BroadStreet Partners, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B3  Loan  1M USD SOFR+ 3.00 %   0.00%   8.44%  1/22/2027   2,918,464    2,915,588    2,913,007 
Brookfield WEC Holdings Inc.  Energy: Electricity  Term Loan B  Loan  1M USD SOFR+ 2.75 %   0.00%   8.08%  1/17/2031   1,447,688    1,447,688    1,442,028 
BROWN GROUP HOLDING, LLC  Aerospace & Defense  Term Loan B-2  Loan  1M USD SOFR+ 3.00 %   0.00%   8.33%  7/1/2029   493,750    483,706    492,856 
Buckeye Partners, L.P.  Utilities: Oil & Gas  Term Loan B2  Loan  1M USD SOFR+ 2.50 %   0.00%   7.83%  11/15/2030   333,333    332,779    333,393 
Buckeye Partners, L.P.  Utilities: Oil & Gas  Term Loan  B 3  Loan  1M USD SOFR+ 2.00 %   0.00%   7.33%  11/1/2026   1,595,639    1,589,524    1,595,910 
BW Gas & Convenience Holdings LLC  Beverage, Food & Tobacco  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  3/31/2028   2,437,500    2,421,791    2,400,938 

 

S-10

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Callaway Golf Company  Retail  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.00%   8.93%  3/16/2030   496,250    491,660    496,200 
Calpine Corporation  Utilities: Electric  Term Loan B-10 (01/20)  Loan  3M USD LIBOR+ 2.00 %   0.00%   3.87%  8/12/2026   2,000,000    1,990,000    1,983,760 
Camping World, Inc.  Retail  Term Loan B (5/21)  Loan  1M USD SOFR+ 2.50 %   0.75%   7.94%  6/5/2028   2,462,025    2,277,630    2,401,238 
CAPSTONE BORROWER INC  Services: Business  Term Loan (06/23)  Loan  3M USD SOFR+ 3.75 %   0.00%   9.10%  6/15/2030   998,077    984,312    993,396 
CareerBuilder, LLC  Services: Business  Term Loan B3  Loan  3M USD SOFR+ 6.75 %   0.00%   12.36%  7/31/2026   3,930,582    3,912,784    589,587 
Castle US Holding Corporation  Media: Advertising, Printing & Publishing  Term Loan B (USD)  Loan  3M USD SOFR+ 3.75 %   0.00%   9.35%  1/27/2027   1,946,639    1,939,553    1,354,627 
CASTLELAKE AVIATION LLC  Aerospace & Defense  Term Loan B  Loan  3M USD SOFR+ 2.75 %   0.50%   8.40%  10/21/2027   990,000    983,747    989,228 
Catalent Pharma Solutions, Inc.  Healthcare & Pharmaceuticals  Term Loan B4  Loan  1M USD SOFR+ 3.00 %   0.50%   8.32%  2/22/2028   600,000    595,597    601,500 
Catalent Pharma Solutions, Inc.  Healthcare & Pharmaceuticals  Term Loan B3 (2/21)  Loan  1M USD SOFR+ 2.00 %   0.50%   7.43%  2/22/2028   598,462    587,525    597,588 
CBL & Associates Limited Partnership  Retail  Term Loan 11/21  Loan  1M USD SOFR+ 2.75 %   1.00%   8.19%  11/1/2025   2,464,605    2,167,043    2,214,029 
CCC Intelligent Solutions Inc.  Services: Business  Term Loan B  Loan  1M USD SOFR+ 2.25 %   0.50%   7.69%  9/16/2028   245,000    244,633    244,030 
CCI Buyer, Inc  Telecommunications  Term Loan  Loan  3M USD SOFR+ 4.00 %   0.75%   9.35%  12/17/2027   243,125    241,678    241,195 
CCRR Parent, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD SOFR+ 4.25 %   0.50%   9.68%  3/5/2028   990,000    949,452    920,700 
CCRR Parent, Inc.  Healthcare & Pharmaceuticals  Term Loan B  Loan  1M USD SOFR+ 3.75 %   0.75%   9.19%  3/5/2028   972,500    969,580    866,741 
CCS-CMGC Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD SOFR+ 5.50 %   0.00%   10.83%  9/25/2025   2,375,000    2,368,777    1,863,520 
CDK GLOBAL, INC.  High Tech Industries  Term Loan B (10/23)  Loan  3M USD SOFR+ 4.00 %   0.00%   9.35%  7/6/2029   992,500    967,482    994,406 
Cengage Learning, Inc.  Media: Advertising, Printing & Publishing  Term Loan B (6/21)  Loan  3M USD SOFR+ 4.75 %   1.00%   10.33%  7/14/2026   2,932,500    2,917,832    2,930,682 
CENTURI GROUP, INC.  Construction & Building  Term Loan B  Loan  1M USD SOFR+ 2.50 %   0.50%   7.94%  8/27/2028   868,330    862,415    868,191 

 

S-11

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
CenturyLink, Inc.  Telecommunications  Term Loan B (1/20)  Loan  1M USD SOFR+ 2.25 %   0.00%   7.69%  3/15/2027   3,838,165    3,835,627    2,781,480 
Charlotte Buyer, Inc.  Services: Business  Term Loan B  Loan  1M USD SOFR+ 5.25 %   0.50%   10.57%  2/11/2028   1,485,000    1,404,122    1,487,866 
Chemours Company, (The)  Chemicals, Plastics, & Rubber  Term Loan B2  Loan  1M USD SOFR+ 3.50 %   0.50%   8.83%  8/10/2028   2,393,717    2,355,365    2,345,842 
Churchill Downs Incorporated  Hotel, Gaming & Leisure  Term Loan B1 (3/21)  Loan  1M USD SOFR+ 2.00 %   0.00%   7.43%  3/17/2028   486,250    485,591    485,642 
CIMPRESS PUBLIC LIMITED COMPANY  Media: Advertising, Printing & Publishing  USD Term Loan  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  5/17/2028   1,959,849    1,885,810    1,951,676 
CITADEL SECURITIES LP  Banking, Finance, Insurance & Real Estate  Term Loan B (01/24)  Loan  1M USD SOFR+ 2.25 %   0.00%   7.58%  7/29/2030   4,863,365    4,862,868    4,857,286 
Citco Funding LLC  Banking, Finance, Insurance & Real Estate  Term Loa 1st Lien Incremental  Loan  3M USD SOFR+ 3.25 %   0.50%   8.57%  4/27/2028   997,500    992,828    997,919 
Clarios Global LP  Automotive  Term Loan (12/23)  Loan  1M USD SOFR+ 3.00 %   0.00%   8.33%  5/6/2030   1,197,000    1,191,616    1,196,629 
Claros Mortgage Trust, Inc  Banking, Finance, Insurance & Real Estate  Term Loan B-1 (11/21)  Loan  1M USD SOFR+ 4.50 %   0.50%   9.92%  8/9/2026   3,404,430    3,390,583    3,132,076 
CLYDESDALE ACQUISITION HOLDINGS, INC.  Containers, Packaging & Glass  Term Loan B  Loan  1M USD SOFR+ 3.68 %   0.50%   9.10%  4/13/2029   1,477,500    1,448,088    1,475,343 
Columbus McKinnon Corporation  Capital Equipment  Term Loan (4/21)  Loan  3M USD SOFR+ 2.75 %   0.50%   8.39%  5/14/2028   406,951    406,326    407,207 
Conduent, Inc.  Services: Business  Term Loan B  Loan  1M USD SOFR+ 4.25 %   0.50%   9.69%  10/16/2028   2,762,330    2,701,073    2,702,470 
Connect Finco SARL  Telecommunications  Term Loan (1/21)  Loan  1M USD SOFR+ 3.50 %   1.00%   8.83%  12/11/2026   2,887,500    2,809,993    2,882,678 
Consolidated Communications, Inc.  Telecommunications  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.75%   8.94%  10/2/2027   2,714,005    2,553,865    2,544,379 
CORAL-US CO-BORROWER LLC  Telecommunications  Term Loan B-5  Loan  1M USD SOFR+ 2.25 %   0.00%   7.68%  1/31/2028   4,000,000    3,990,860    3,950,000 
Corelogic, Inc.  Services: Business  Term Loan (4/21)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  6/2/2028   2,443,750    2,436,006    2,372,344 
Cortes NP Acquisition Corp (Vertiv)  Capital Equipment  Term Loan B (12/23)  Loan  1M USD SOFR+ 2.50 %   0.00%   7.94%  3/2/2027   1,940,138    1,940,138    1,941,903 
Creative Artists Agency, LLC  Media: Diversified & Production  Term Loan B (02/23)  Loan  1M USD SOFR+ 3.50 %   0.00%   8.83%  11/27/2028   1,588,004    1,577,748    1,588,449 
CROCS INC  Consumer goods: Durable  Term Loan B (01/24)  Loan  1M USD SOFR+ 2.25 %   0.50%   7.58%  2/19/2029   1,230,000    1,190,854    1,230,923 
Cross Financial Corp  Banking, Finance, Insurance & Real Estate  Term Loan B2  Loan  1M USD SOFR+ 3.50 %   0.75%   8.83%  9/15/2027   487,500    487,355    486,891 

 

S-12

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Crown Subsea Communications Holding, Inc.  Construction & Building  Term Loan B (01/24)  Loan  3M USD SOFR+ 4.75 %   0.75%   10.07%  1/30/2031   2,400,000    2,376,371    2,409,000 
CSC Holdings LLC (Neptune Finco Corp.)  Media: Broadcasting & Subscription  Term Loan B-5  Loan  1M USD LIBOR+ 2.50 %   0.00%   7.93%  4/15/2027   480,000    480,000    448,277 
CSC Holdings LLC (Neptune Finco Corp.)  Media: Broadcasting & Subscription  Term Loan 12/22  Loan  1M USD SOFR+ 4.50 %   0.00%   9.82%  4/15/2027   2,376,032    2,368,120    2,307,222 
CTC Holdings, LP  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  3M USD SOFR+ 5.00 %   0.50%   10.48%  2/15/2029   2,210,625    2,165,966    2,194,045 
CTS Midco, LLC  High Tech Industries  Term Loan B  Loan  3M USD SOFR+ 6.00 %   1.00%   11.57%  11/2/2027   1,937,017    1,903,074    1,830,481 
Daseke Inc  Transportation: Cargo  Term Loan 2/21  Loan  1M USD SOFR+ 4.00 %   0.75%   9.44%  3/5/2028   1,162,500    1,159,080    1,162,860 
Dave & Buster’s Inc.  Hotel, Gaming & Leisure  Term Loan B (1/24)  Loan  1M USD SOFR+ 3.25 %   0.50%   8.63%  6/29/2029   990,019    949,041    990,791 
DCert Buyer, Inc.  High Tech Industries  Term Loan  Loan  1M USD SOFR+ 4.00 %   0.00%   9.33%  10/16/2026   1,454,660    1,454,660    1,442,426 
Delek US Holdings, Inc.  Utilities: Oil & Gas  Term Loan B (11/22)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.93%  11/16/2029   5,346,000    5,244,974    5,325,952 
Delos Aircraft DAC  Transportation: Consumer  Term Loan B  Loan  3M USD SOFR+ 2.00 %   0.00%   7.35%  10/31/2027   250,000    250,000    250,438 
Delta 2 Lux Sarl  Hotel, Gaming & Leisure  Term Loan B  Loan  3M USD SOFR+ 2.25 %   0.50%   7.60%  1/15/2030   2,000,000    1,991,389    1,997,000 
Derby Buyer LLC  Chemicals, Plastics, & Rubber  Term Loan (09/23)  Loan  1M USD SOFR+ 4.25 %   0.50%   9.58%  11/1/2030   625,000    616,061    625,394 
DexKo Global, Inc. (Dragon Merger)  Automotive  Term Loan (9/21)  Loan  3M USD SOFR+ 3.75 %   0.50%   9.36%  10/4/2028   982,500    979,722    978,206 
DG Investment Intermediate Holdings 2, Inc.  Aerospace & Defense  Incremental Term Loan (3/22)  Loan  1M USD SOFR+ 4.75 %   0.75%   10.08%  3/31/2028   493,750    477,680    492,051 
Diamond Sports Group, LLC  Media: Broadcasting & Subscription  1st Priority Term Loan  Loan  1M USD SOFR+ 10.00 %   1.00%   15.43%  5/25/2026   152,224    149,462    146,896 
DIRECTV FINANCING, LLC  Media: Broadcasting & Subscription  Term Loan  Loan  3M USD SOFR+ 5.25 %   0.75%   10.83%  8/2/2029   3,190,000    3,169,423    3,181,036 
DISCOVERY PURCHASER CORPORATION  Chemicals, Plastics, & Rubber  Term Loan  Loan  3M USD SOFR+ 4.38 %   0.50%   9.71%  10/4/2029   1,485,028    1,383,712    1,476,207 
Dispatch Acquisition Holdings, LLC  Environmental Industries  Term Loan B (3/21)  Loan  3M USD SOFR+ 4.25 %   0.75%   9.75%  3/25/2028   487,500    484,443    452,463 
DOMTAR CORPORATION  Forest Products & Paper  Term Loan 9/21  Loan  1M USD SOFR+ 5.50 %   0.75%   10.94%  11/30/2028   3,243,968    3,187,785    3,163,874 
DOTDASH MEREDITH, INC.  Media: Advertising, Printing & Publishing  Term Loan B  Loan  1M USD SOFR+ 4.00 %   0.50%   9.43%  11/30/2028   1,974,747    1,809,468    1,955,000 
DRI HOLDING INC.  Media: Advertising, Printing & Publishing  Term Loan (12/21)  Loan  1M USD SOFR+ 5.25 %   0.50%   10.68%  12/15/2028   3,932,462    3,808,999    3,605,596 
DRW Holdings, LLC  Banking, Finance, Insurance & Real Estate  Term Loan (2/21)  Loan  1M USD SOFR+ 3.75 %   0.00%   9.19%  3/1/2028   6,370,000    6,338,820    6,354,075 

 

S-13

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
DTZ U.S. Borrower, LLC  Construction & Building  Term Loan  Loan  1M USD SOFR+ 2.75 %   0.00%   8.19%  8/21/2025   198,929    198,685    198,432 
DTZ U.S. Borrower, LLC  Construction & Building  Term Loan (01/23)  Loan  1M USD SOFR+ 3.25 %   0.50%   8.68%  1/31/2030   2,024,241    2,022,091    1,999,788 
DTZ U.S. Borrower, LLC  Construction & Building  Term Loan (08/23)  Loan  1M USD SOFR+ 4.00 %   0.50%   9.33%  1/31/2030   1,100,000    1,074,202    1,097,250 
EAB Global, Inc.  Services: Business  Term Loan (08/21)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  8/16/2028   980,000    976,771    977,344 
Echo Global Logistics, Inc.  Services: Business  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.50%   8.93%  11/23/2028   1,965,000    1,962,209    1,926,761 
Edelman Financial Group Inc., The  Banking, Finance, Insurance & Real Estate  Term Loan B (3/21)  Loan  1M USD SOFR+ 3.50 %   0.75%   8.94%  4/7/2028   2,166,328    2,161,731    2,158,616 
Electrical Components Inter., Inc.  Capital Equipment  Term Loan (6/18)  Loan  1M USD SOFR+ 4.25 %   0.00%   9.68%  6/26/2025   1,868,421    1,868,421    1,861,415 
ELECTRON BIDCO INC.  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD SOFR+ 3.00 %   0.50%   8.44%  11/1/2028   491,250    489,769    490,253 
ELO Touch Solutions, Inc.  Media: Diversified & Production  Term Loan (12/18)  Loan  1M USD SOFR+ 6.50 %   0.00%   11.94%  12/14/2025   2,522,373    2,488,308    2,485,798 
Embecta Corp  Healthcare & Pharmaceuticals  Term Loan B  Loan  1M USD SOFR+ 3.00 %   0.50%   8.33%  3/30/2029   2,598,596    2,581,552    2,366,360 
Emerson Climate Technologies Inc  Services: Business  Term Loan B (04/23)  Loan  1M USD SOFR+ 2.50 %   0.00%   7.79%  5/31/2030   1,000,000    995,376    997,250 
Endo Luxembourg Finance Company I S.a.r.l.  Healthcare & Pharmaceuticals  Term Loan (3/21)  Loan  Prime 6.00 %   0.75%   14.50%  3/27/2028   2,335,285    2,330,451    1,522,606 
Endure Digital, Inc.  High Tech Industries  Term Loan B  Loan  6M USD SOFR+ 3.50 %   0.75%   9.42%  2/10/2028   2,437,500    2,430,093    2,380,048 
Entain Holdings (Gibraltar) Limited  Hotel, Gaming & Leisure  Term Loan B (10/22)  Loan  3M USD SOFR+ 3.50 %   0.50%   8.95%  10/30/2029   1,487,496    1,472,128    1,489,355 
EOS U.S. FINCO LLC  Transportation: Cargo  Term Loan  Loan  3M USD SOFR+ 5.75 %   0.50%   11.10%  10/6/2029   975,000    908,088    871,104 
Equiniti Group PLC  Services: Business  Term Loan B  Loan  6M USD SOFR+ 4.50 %   0.50%   9.93%  12/11/2028   980,000    973,017    981,470 
Evertec Group LLC  Banking, Finance, Insurance & Real Estate  Term Loan B (09/23)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.83%  10/30/2030   1,125,000    1,108,675    1,123,594 
EyeCare Partners, LLC  Healthcare & Pharmaceuticals  Term Loan  Loan  3M USD SOFR+ 3.75 %   0.00%   9.39%  2/18/2027   -    1,951    - 
Fiesta Purchaser, Inc.  Beverage, Food & Tobacco  First Lien TLB  Loan  1M USD SOFR+ 4.00 %   0.00%   9.32%  2/12/2031   500,000    495,088    499,315 
Finco I LLC  Banking, Finance, Insurance & Real Estate  Term Loan B (08/23)  Loan  3M USD SOFR+ 3.00 %   0.00%   8.31%  6/27/2029   2,816,795    2,813,980    2,815,386 

 

S-14

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
First Brands Group, LLC  Automotive  1st Lien Term Loan (3/21)  Loan  3M USD SOFR+ 5.00 %   1.00%   10.57%  3/30/2027   4,862,500    4,816,997    4,868,578 
First Eagle Investment Management  Banking, Finance, Insurance & Real Estate  Refinancing Term Loan  Loan  3M USD SOFR+ 2.50 %   0.00%   7.95%  2/1/2027   5,091,652    5,082,259    5,068,332 
First Student Bidco Inc.  Transportation: Consumer  Term Loan B  Loan  3M USD SOFR+ 3.00 %   0.50%   8.61%  7/21/2028   715,360    711,800    709,694 
First Student Bidco Inc.  Transportation: Consumer  Term Loan C  Loan  3M USD SOFR+ 3.00 %   0.50%   8.61%  7/21/2028   216,966    215,877    215,248 
Fitness International, LLC (LA Fitness)  Services: Consumer  Term Loan  B (1/24)  Loan  1M USD SOFR+ 5.25 %   1.00%   10.58%  2/5/2029   1,200,000    1,164,361    1,165,500 
Flutter Financing B.V.  Hotel, Gaming & Leisure  Third Amendment 2028-B Term Loan  Loan  3M USD SOFR+ 3.25 %   0.50%   8.86%  7/21/2028   309,759    304,101    310,103 
Flutter Financing B.V.  Hotel, Gaming & Leisure  Term Loan B3 (11/23)  Loan  3M USD SOFR+ 2.25 %   0.50%   7.70%  11/25/2030   3,000,000    2,992,850    2,984,370 
FOCUS FINANCIAL PARTNERS, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B7  Loan  1M USD SOFR+ 2.75 %   0.50%   8.08%  6/30/2028   1,472,388    1,458,275    1,461,345 
Franchise Group, Inc.  Services: Consumer  First Out Term Loan  Loan  6M USD SOFR+ 4.75 %   0.75%   10.36%  3/10/2026   799,104    795,310    703,211 
Franchise Group, Inc.  Services: Consumer  Term Loan B  Loan  3M USD SOFR+ 4.75 %   0.75%   10.33%  3/10/2026   2,977,500    2,874,281    2,612,756 
Franklin Square Holdings, L.P.  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD SOFR+ 2.25 %   0.00%   7.68%  8/1/2025   4,263,723    4,255,884    4,258,394 
Froneri International (R&R Ice Cream)  Beverage, Food & Tobacco  Term Loan B-2  Loan  1M USD SOFR+ 2.25 %   0.00%   7.68%  1/29/2027   1,930,000    1,928,989    1,928,340 
Garrett LX III S.a r.l.  Automotive  Dollar Term Loan  Loan  3M USD SOFR+ 3.25 %   0.50%   8.82%  4/30/2028   1,466,250    1,461,820    1,465,634 
Gemini HDPE LLC  Chemicals, Plastics, & Rubber  Term Loan B (12/20)  Loan  3M USD SOFR+ 3.00 %   0.50%   8.57%  12/31/2027   2,183,488    2,172,849    2,163,466 
Genesee & Wyoming, Inc.  Transportation: Cargo  Term Loan (11/19)  Loan  3M USD SOFR+ 2.00 %   0.00%   7.45%  12/30/2026   1,443,750    1,440,683    1,443,577 
GGP Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  1M USD LIBOR+ 2.50 %   0.00%   2.96%  8/27/2025   2,781,634    2,604,347    2,766,864 
GIP Pilot Acquisition Partners, L.P.  Energy: Oil & Gas  Term Loan  Loan  3M USD SOFR+ 3.00 %   0.00%   8.33%  10/4/2030   500,000    497,577    499,585 
Global Tel*Link Corporation  Telecommunications  Term Loan B  Loan  1M USD SOFR+ 4.25 %   0.00%   9.68%  11/29/2025   4,846,612    4,750,154    4,708,290 
Go Daddy Operating Company, LLC  High Tech Industries  Term Loan 2/21  Loan  1M USD SOFR+ 2.00 %   0.00%   7.44%  8/10/2027   947,411    947,411    946,984 
GOLDEN WEST PACKAGING GROUP LLC  Forest Products & Paper  Term Loan (11/21)  Loan  1M USD SOFR+ 5.25 %   0.75%   10.69%  12/1/2027   1,875,000    1,862,167    1,556,250 

 

S-15

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
GOTO GROUP, INC.  High Tech Industries  First Lien Term Loan  Loan  1M USD SOFR+ 4.75 %   0.00%   10.17%  4/30/2028   1,254,792    730,596    1,198,326 
GOTO GROUP, INC.  High Tech Industries  Second-Out Term Loan (02/24)  Loan  1M USD SOFR+ 4.75 %   0.00%   10.17%  4/30/2028   1,732,808    1,646,943    1,199,970 
Graham Packaging Co Inc  Containers, Packaging & Glass  Term Loan (2/21)  Loan  1M USD SOFR+ 3.00 %   0.75%   8.44%  8/7/2027   945,831    942,144    944,554 
Great Outdoors Group, LLC  Retail  Term Loan B2  Loan  1M USD SOFR+ 3.75 %   0.75%   9.19%  3/6/2028   970,169    967,400    969,994 
Griffon Corporation  Consumer goods: Durable  Term Loan B  Loan  3M USD SOFR+ 2.25 %   0.50%   7.75%  1/24/2029   144,063    143,842    143,838 
Grosvenor Capital Management Holdings, LLLP  Banking, Finance, Insurance & Real Estate  Amendment 5 Term Loan  Loan  1M USD SOFR+ 2.50 %   0.50%   7.94%  2/24/2028   2,807,931    2,806,739    2,807,061 
Groupe Solmax Inc.  Environmental Industries  Term Loan (6/21)  Loan  3M USD SOFR+ 4.75 %   0.75%   10.36%  5/27/2028   2,473,405    2,125,105    2,402,740 
GYP HOLDINGS III CORP.  Construction & Building  Term Loan  (1/24)  Loan  1M USD SOFR+ 2.25 %   0.00%   7.58%  5/12/2030   249,375    248,230    249,375 
Harbor Freight Tools USA, Inc.  Retail  Term Loan B (06/21)  Loan  1M USD SOFR+ 2.75 %   0.50%   8.19%  10/19/2027   3,344,665    3,330,419    3,319,212 
Helix Gen Funding, LLc  Energy: Electricity  Term Loan  Loan  3M USD SOFR+ 4.75 %   1.00%   10.10%  12/31/2027   932,597    915,944    933,763 
Hertz Corporation (The)  Transportation: Consumer  Term Loan B  Loan  1M USD SOFR+ 3.75 %   0.00%   9.07%  6/30/2028   500,000    490,436    481,875 
Hillman Group Inc. (The) (New)  Consumer goods: Durable  Term Loan B-1 (2/21)  Loan  1M USD SOFR+ 2.75 %   0.50%   8.19%  7/14/2028   3,172,373    3,168,887    3,167,266 
Hilton Domestic Operating Company Inc.  Hotel, Gaming & Leisure  Term Loan B 4  Loan  1M USD SOFR+ 2.00 %   0.00%   7.42%  11/8/2030   1,500,000    1,496,471    1,501,020 
Hilton Grand Vacations Borrower LLC  Hotel, Gaming & Leisure  Term Loan (3/21)  Loan  1M USD SOFR+ 2.75 %   0.50%   8.19%  8/2/2028   497,455    497,455    496,834 
Hilton Grand Vacations Borrower LLC  Hotel, Gaming & Leisure  Term Loan B  Loan  1M USD SOFR+ 2.75 %   0.00%   8.18%  8/2/2028   500,000    500,000    499,375 
HLF Financing SARL (Herbalife)  Consumer goods: Non-durable  Term Loan B (08/18)  Loan  1M USD SOFR+ 2.50 %   0.00%   7.94%  8/18/2025   3,116,400    3,113,557    3,044,598 
Holley Purchaser, Inc  Automotive  Term Loan (11/21)  Loan  1M USD SOFR+ 3.75 %   0.75%   9.19%  11/17/2028   2,254,003    2,247,557    2,188,795 
Hudson River Trading LLC  Banking, Finance, Insurance & Real Estate  Term Loan (3/21)  Loan  1M USD SOFR+ 3.00 %   0.00%   8.44%  3/17/2028   5,835,000    5,798,864    5,792,171 
Hunter Douglas Inc  Consumer goods: Durable  Term Loan B-1  Loan  3M USD SOFR+ 3.50 %   0.50%   8.82%  2/26/2029   2,474,937    2,235,702    2,442,466 
Hyperion Refinance S.a.r.l.  Banking, Finance, Insurance & Real Estate  Term Loan B  Loan  3M USD SOFR+ 3.50 %   0.50%   8.81%  2/15/2031   3,000,000    2,985,024    2,983,440 

 

S-16

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Idera, Inc.  High Tech Industries  Term Loan (02/21)  Loan  3M USD SOFR+ 3.75 %   0.75%   9.21%  3/2/2028   4,762,143    4,756,197    4,730,379 
IMA Financial Group, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (10/21)  Loan  1M USD SOFR+ 3.75 %   0.50%   9.19%  11/1/2028   2,458,728    2,449,919    2,452,581 
INDY US BIDCO, LLC  Services: Business  Term Loan (11/21)  Loan  1M USD SOFR+ 3.75 %   0.00%   9.08%  3/6/2028   2,193,266    2,192,568    2,119,243 
INEOS 226 Ltd.  Chemicals, Plastics, & Rubber  Term Loan 3/23  Loan  1M USD SOFR+ 3.75 %   0.00%   9.18%  3/13/2030   497,500    492,907    490,450 
Ineos US Finance LLC  Chemicals, Plastics, & Rubber  Term Loan C  Loan  1M USD SOFR+ 3.50 %   0.00%   8.93%  2/18/2030   995,000    985,838    985,259 
INEOS US PETROCHEM LLC  Chemicals, Plastics, & Rubber  Term Loan B  Loan  1M USD SOFR+ 4.25 %   0.00%   9.68%  4/2/2029   2,714,874    2,657,733    2,667,363 
Informatica Inc.  High Tech Industries  Term Loan B (10/21)  Loan  1M USD SOFR+ 2.75 %   0.00%   8.19%  10/27/2028   491,250    491,064    491,250 
Ingram Micro Inc.  Wholesale  Term Loan (09/23)  Loan  3M USD SOFR+ 3.00 %   0.50%   8.61%  6/30/2028   1,095,000    1,087,525    1,093,631 
Inmar, Inc.  Services: Business  Term Loan (06/23)  Loan  1M USD SOFR+ 5.50 %   1.00%   10.83%  5/1/2026   3,333,250    3,240,468    3,305,117 
Innophos, Inc.  Chemicals, Plastics, & Rubber  Term Loan B  Loan  1M USD SOFR+ 3.25 %   0.00%   8.58%  2/4/2027   481,250    480,346    475,475 
INSTANT BRANDS HOLDINGS INC.  Consumer goods: Durable  Instant Brands TL  Loan  Prime 4.00 %   0.75%   14.50%  4/7/2028   10,085    10,085    10,085 
INSTANT BRANDS HOLDINGS INC. (b)  Consumer goods: Durable  Term Loan 4/21  Loan  Prime 4.00 %   0.75%   14.50%  4/7/2028   3,942,576    3,929,234    256,267 
INSTANT BRANDS HOLDINGS INC. (c)  Consumer goods: Durable  PIK DIP Term Loan  Loan  1M USD SOFR+ 3.00 %   1.00%   15.45%  1/31/2024   1,523,653    1,523,115    1,557,935 
IRB Holding Corporation  Beverage, Food & Tobacco  Term Loan B  Loan  1M USD SOFR+ 2.75 %   0.75%   8.18%  12/15/2027   494,962    490,830    494,101 
Isagenix International, LLC (c)  Beverage, Food & Tobacco  Term Loan  Loan  6M USD SOFR+ 2.50 %   0.00%   2.50%  4/13/2028   1,258,790    838,779    1,082,559 
Isolved Inc.  Services: Business  Term Loan  Loan  6M USD SOFR+ 4.00 %   0.50%   9.48%  10/5/2030   625,000    618,886    626,563 
Jane Street Group  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD SOFR+ 2.50 %   0.00%   7.94%  1/26/2028   3,880,000    3,878,565    3,869,602 
Journey Personal Care Corp.  Consumer goods: Non-durable  Term Loan B  Loan  1M USD SOFR+ 4.25 %   0.75%   9.69%  3/1/2028   2,925,000    2,876,836    2,850,647 
JP Intermediate B, LLC  Consumer goods: Non-durable  Term Loan 7/23  Loan  3M USD SOFR+ 5.50 %   1.00%   11.07%  11/20/2027   3,456,884    3,442,560    276,551 
Kleopatra Finco S.a r.l.  Containers, Packaging & Glass  Term Loan (1/21) (USD)  Loan  6M USD SOFR+ 4.73 %   0.50%   10.27%  2/12/2026   1,458,750    1,456,824    1,400,400 

 

S-17

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Kodiak BP, LLC  Construction & Building  Term Loan  Loan  3M USD SOFR+ 3.25 %   0.75%   8.86%  3/13/2028   486,159    485,291    485,211 
Koppers Inc  Chemicals, Plastics, & Rubber  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.50%   8.93%  4/10/2030   995,006    967,558    998,121 
KREF Holdings X LLC  Banking, Finance, Insurance & Real Estate  Term Loan (11/21)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.93%  9/1/2027   486,325    479,475    464,440 
Lakeland Tours, LLC (c)  Hotel, Gaming & Leisure  Holdco Fixed Term Loan  Loan  Fixed 0.00 %   0.00%   8.00%  9/27/2027   1,127,568    568,253    761,108 
Lealand Finance Company B.V. (c)  Energy: Oil & Gas  Exit Term Loan  Loan  1M USD SOFR+ 1.00 %   0.00%   6.44%  6/30/2025   355,751    355,751    138,149 
LHS BORROWER, LLC  Construction & Building  Term Loan (02/22)  Loan  1M USD SOFR+ 4.75 %   0.50%   10.18%  2/16/2029   2,475,771    2,084,045    2,310,216 
Lifetime Brands, Inc  Consumer goods: Non-durable  Term Loan  Loan  1M USD SOFR+ 5.50 %   1.00%   10.94%  8/26/2027   1,659,313    1,653,207    1,595,015 
Liquid Tech Solutions Holdings, LLC  Services: Business  Term Loan  Loan  1M USD SOFR+ 4.75 %   0.75%   10.19%  3/17/2028   975,000    972,922    957,938 
LOYALTY VENTURES INC. (b)  Services: Business  Term Loan B  Loan  Prime 5.50 %   0.50%   14.00%  11/3/2027   2,913,525    2,902,171    25,493 
LPL Holdings, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B1  Loan  1M USD SOFR+ 1.75 %   0.00%   7.18%  11/11/2026   1,195,404    1,194,671    1,194,125 
LSF11 A5 HOLDCO LLC  Chemicals, Plastics, & Rubber  Term Loan (01/23)  Loan  1M USD SOFR+ 4.25 %   0.50%   9.68%  10/14/2028   1,492,500    1,473,942    1,491,754 
LSF11 A5 HOLDCO LLC  Chemicals, Plastics, & Rubber  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.50%   8.94%  10/16/2028   245,625    244,848    244,473 
LSF11 TRINITY BIDCO INC  Aerospace & Defense  Term Loan B  Loan  1M USD SOFR+ 4.00 %   0.00%   9.32%  6/14/2030   980,756    967,038    980,756 
LSF9 Atlantis Holdings, LLC (A Wireless)  Retail  Term Loan  (2/24)  Loan  1M USD SOFR+ 6.50 %   0.75%   11.83%  3/31/2029   2,775,000    2,700,276    2,775,860 
MAGNITE, INC.  Services: Business  Term Loan B (01/24)  Loan  1M USD SOFR+ 4.50 %   0.00%   9.82%  2/6/2031   3,250,000    3,218,266    3,241,875 
Marriott Ownership Resorts, Inc.  Hotel, Gaming & Leisure  Term Loan (11/19)  Loan  1M USD SOFR+ 1.75 %   0.00%   7.18%  8/29/2025   1,317,074    1,317,074    1,312,543 
Match Group, Inc, The  Services: Consumer  Term Loan (1/20)  Loan  3M USD SOFR+ 1.75 %   0.00%   7.27%  2/15/2027   250,000    249,741    249,063 
Max US Bidco Inc.  Beverage, Food & Tobacco  Term Loan B  Loan  3M USD SOFR+ 5.00 %   0.50%   10.35%  10/3/2030   2,000,000    1,870,298    1,832,500 
Mayfield Agency Borrower Inc. (FeeCo)  Banking, Finance, Insurance & Real Estate  First Lien Term Loan B (12/23)  Loan  1M USD SOFR+ 4.25 %   0.00%   9.58%  2/28/2028   3,432,772    3,346,276    3,432,772 
McGraw-Hill Education, Inc.  Media: Advertising, Printing & Publishing  Term Loan (07/21)  Loan  1M USD SOFR+ 4.75 %   0.50%   10.19%  7/28/2028   1,955,000    1,940,387    1,946,281 

 

S-18

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
MedAssets Software Inter Hldg, Inc.  High Tech Industries  Term Loan (11/21) (USD)  Loan  1M USD SOFR+ 4.00 %   0.50%   9.44%  12/18/2028   491,250    488,835    409,275 
Mermaid Bidco Inc.  High Tech Industries  Term Loan B2  Loan  3M USD SOFR+ 4.50 %   0.75%   9.88%  12/22/2027   1,966,412    1,947,595    1,968,870 
Michaels Companies Inc  Retail  Term Loan B (Magic Mergeco)  Loan  3M USD SOFR+ 4.25 %   0.75%   9.86%  4/8/2028   2,442,400    2,429,364    1,996,417 
MKS Instruments, Inc.  High Tech Industries  Term Loan B  Loan  1M USD SOFR+ 2.50 %   0.50%   7.82%  8/17/2029   1,971,537    1,967,675    1,966,253 
Momentive Performance Materials Inc.  Chemicals, Plastics, & Rubber  Term Loan (03/23)  Loan  1M USD SOFR+ 4.50 %   0.00%   9.83%  3/28/2028   496,250    479,007    485,084 
Moneygram International, Inc.  Services: Business  Term Loan  Loan  3M USD SOFR+ 5.50 %   0.50%   10.88%  5/31/2030   2,993,750    2,617,290    2,936,989 
Mosel Bidco SE  High Tech Industries  Term Loan B  Loan  3M USD SOFR+ 4.75 %   0.50%   10.10%  9/16/2030   500,000    495,262    500,625 
MPH Acquisition Holdings LLC (Multiplan)  Services: Business  Term Loan B (08/21)  Loan  3M USD SOFR+ 4.25 %   0.50%   9.85%  9/1/2028   2,962,121    2,734,973    2,861,320 
NAB Holdings, LLC (North American Bancard)  Banking, Finance, Insurance & Real Estate  Term Loan (11/21)  Loan  3M USD SOFR+ 2.75 %   0.50%   8.25%  11/23/2028   2,940,000    2,935,048    2,929,504 
Napa Management Services Corp  Healthcare & Pharmaceuticals  Term Loan B (02/22)  Loan  1M USD SOFR+ 5.25 %   0.75%   10.68%  2/22/2029   2,969,773    2,447,043    2,806,436 
Natgasoline LLC  Chemicals, Plastics, & Rubber  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.00%   8.94%  11/14/2025   3,305,649    3,294,914    3,289,120 
National Mentor Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan 2/21  Loan  1M USD SOFR+ 3.75 %   0.75%   9.18%  3/2/2028   2,708,195    2,701,639    2,522,007 
National Mentor Holdings, Inc.  Healthcare & Pharmaceuticals  Term Loan C 2/21  Loan  3M USD SOFR+ 3.75 %   0.75%   9.20%  3/2/2028   87,464    87,200    81,450 
New Trojan Parent, Inc. (c)  Consumer goods: Durable  Term Loan  Loan  1M USD SOFR+ 5.25 %   0.50%   10.69%  1/6/2028   -    40,239    - 
Nexstar Broadcasting, Inc. (Mission Broadcasting)  Media: Broadcasting & Subscription  Term Loan  Loan  1M USD SOFR+ 2.50 %   0.00%   7.94%  9/18/2026   657,625    654,056    655,705 
Next Level Apparel, Inc.  Retail  Term Loan  Loan  1M USD SOFR+ 7.50 %   1.00%   12.92%  8/9/2026   2,605,709    2,579,219    2,019,425 
NortonLifeLock Inc.  High Tech Industries  Term Loan B  Loan  1M USD SOFR+ 2.00 %   0.50%   7.43%  9/12/2029   997,195    993,475    994,014 
Nouryon Finance B.V.  Chemicals, Plastics, & Rubber  Term Loan B  Loan  1M USD SOFR+ 4.00 %   0.00%   9.42%  4/3/2028   497,500    492,525    497,192 
Nouryon Finance B.V.  Chemicals, Plastics, & Rubber  Term Loan (05/23)  Loan  3M USD SOFR+ 4.00 %   0.00%   9.42%  4/3/2028   498,747    494,084    498,228 
Novae LLC  Automotive  Term Loan B  Loan  3M USD SOFR+ 5.00 %   0.75%   10.52%  12/22/2028   1,965,000    1,954,113    1,948,632 

 

S-19

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Nuvei Technologies Corp.  High Tech Industries  Term Loan B  Loan  1M USD SOFR+ 3.00 %   0.50%   8.43%  12/19/2030   2,100,000    2,084,250    2,100,336 
Olaplex, Inc.  Consumer goods: Non-durable  Term Loan (2/22)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.93%  2/23/2029   2,467,387    2,376,707    2,249,442 
Open Text Corporation  High Tech Industries  Term Loan B (08/23)  Loan  1M USD SOFR+ 2.75 %   0.50%   8.18%  1/31/2030   1,380,397    1,343,151    1,381,267 
Organon & Co.  Healthcare & Pharmaceuticals  Term Loan USD  Loan  1M USD SOFR+ 3.00 %   0.50%   8.43%  6/2/2028   2,118,750    2,112,577    2,120,085 
Oxbow Carbon, LLC  Metals & Mining  Term Loan B (04/23)  Loan  1M USD SOFR+ 4.00 %   0.50%   9.43%  5/2/2030   497,500    488,294    496,669 
PACIFIC DENTAL SERVICES, LLC  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.75%   8.94%  4/21/2028   895,408    894,474    893,734 
Pacific Gas & Electric  Utilities: Electric  Term Loan  Loan  1M USD SOFR+ 2.50 %   0.50%   7.83%  6/23/2027   250,000    248,893    249,923 
PACTIV EVERGREEN GROUP HOLDINGS INC.  Containers, Packaging & Glass  Term Loan B  Loan  1M USD SOFR+ 3.25 %   0.50%   8.69%  9/20/2028   975,000    971,827    975,994 
Padagis LLC  Healthcare & Pharmaceuticals  Term Loan  Loan  3M USD SOFR+ 4.75 %   0.50%   10.34%  7/6/2028   941,176    934,588    896,471 
PAR PETROLEUM LLC  Energy: Oil & Gas  Term Loan 2/23  Loan  3M USD SOFR+ 4.25 %   0.50%   9.69%  2/27/2030   2,483,737    2,460,184    2,482,198 
PATAGONIA HOLDCO LLC  Telecommunications  Term Loan B  Loan  3M USD SOFR+ 5.75 %   0.50%   11.06%  8/1/2029   1,975,000    1,671,950    1,816,013 
Pathway Partners Vet Management Company LLC  Services: Business  Term Loan  Loan  1M USD SOFR+ 3.75 %   0.00%   9.19%  3/30/2027   481,544    475,840    411,321 
PCI Gaming Authority  Hotel, Gaming & Leisure  Term Loan  Loan  1M USD SOFR+ 2.50 %   0.00%   7.94%  5/29/2026   794,490    793,022    794,156 
PEARLS (Netherlands) Bidco B.V.  Chemicals, Plastics, & Rubber  USD Term Loan (02/22)  Loan  3M USD SOFR+ 3.75 %   0.50%   9.06%  2/28/2029   982,500    981,042    972,066 
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC  Healthcare & Pharmaceuticals  Term Loan (12/22)  Loan  1M USD SOFR+ 3.25 %   0.50%   8.69%  12/29/2028   1,474,639    1,470,327    1,325,332 
Penn National Gaming, Inc  Hotel, Gaming & Leisure  Term Loan B  Loan  1M USD SOFR+ 2.75 %   0.50%   8.18%  5/3/2029   985,000    981,209    979,720 
Peraton Corp.  Aerospace & Defense  Term Loan B  Loan  1M USD SOFR+ 3.75 %   0.75%   9.18%  2/1/2028   5,236,340    5,225,013    5,236,340 
PHYSICIAN PARTNERS, LLC  Healthcare & Pharmaceuticals  Term Loan  Loan  3M USD SOFR+ 4.00 %   0.50%   9.46%  12/23/2028   2,958,680    2,899,926    2,608,254 

 

S-20

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Pitney Bowes Inc  Services: Business  Term Loan B  Loan  1M USD SOFR+ 4.00 %   0.00%   9.44%  3/17/2028   3,899,823    3,878,054    3,880,324 
Plastipak Holdings Inc.  Containers, Packaging & Glass  Term Loan B (11/21)  Loan  1M USD SOFR+ 2.50 %   0.50%   7.93%  12/1/2028   1,795,294    1,789,191    1,791,309 
Playtika Holding Corp.  High Tech Industries  Term Loan B (3/21)  Loan  1M USD SOFR+ 2.75 %   0.00%   8.19%  3/13/2028   4,376,250    4,370,414    4,362,377 
PMHC II, INC.  Chemicals, Plastics, & Rubber  Term Loan (02/22)  Loan  3M USD SOFR+ 4.25 %   0.50%   9.72%  4/21/2029   1,975,000    1,967,432    1,926,968 
PointClickCare Technologies, Inc.  High Tech Industries  Term Loan B  Loan  3M USD SOFR+ 3.00 %   0.75%   8.61%  12/29/2027   486,250    484,831    485,642 
Polymer Process Holdings, Inc.  Containers, Packaging & Glass  Term Loan  Loan  1M USD SOFR+ 4.75 %   0.75%   10.19%  2/12/2028   5,348,750    5,313,507    5,071,310 
Pre-Paid Legal Services, Inc.  Services: Consumer  Term Loan (12/21)  Loan  1M USD SOFR+ 3.75 %   0.50%   9.19%  12/15/2028   2,947,500    2,929,343    2,939,512 
Presidio, Inc.  Services: Business  Term Loan B (1/20)  Loan  3M USD SOFR+ 3.50 %   0.00%   8.91%  1/22/2027   482,500    482,164    483,103 
Prime Security Services Borrower, LLC (ADT)  Services: Consumer  Term Loan B (10/23)  Loan  3M USD SOFR+ 2.50 %   0.00%   7.83%  10/11/2030   2,000,000    1,980,728    1,998,300 
PRIORITY HOLDINGS, LLC  Services: Consumer  Term Loan  Loan  1M USD SOFR+ 5.75 %   1.00%   11.19%  4/27/2027   2,925,000    2,906,770    2,921,344 
PriSo Acquisition Corporation  Construction & Building  Term Loan (01/21)  Loan  3M USD SOFR+ 3.25 %   0.75%   8.84%  12/28/2027   486,242    484,862    472,311 
Project Leopard Holdings, Inc. (NEW)  High Tech Industries  Term Loan B (06/22)  Loan  3M USD SOFR+ 5.25 %   0.50%   10.66%  7/20/2029   990,000    931,883    907,711 
Propulsion (BC) Finco  Aerospace & Defense  Term Loan  Loan  3M USD SOFR+ 3.75 %   0.50%   9.10%  9/14/2029   750,000    742,504    748,748 
PUG LLC  Services: Consumer  Term Loan B (02/20)  Loan  1M USD SOFR+ 3.50 %   0.00%   8.94%  2/12/2027   475,176    474,168    466,010 
Quartz AcquireCo, LLC  High Tech Industries  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.00%   8.83%  6/28/2030   997,500    988,167    996,253 
QUEST BORROWER LIMITED  High Tech Industries  Term Loan (1/22)  Loan  3M USD SOFR+ 4.25 %   0.50%   9.71%  2/1/2029   1,970,000    1,954,941    1,552,734 
R1 RCM INC.  Healthcare & Pharmaceuticals  Term Loan (12/23)  Loan  1M USD SOFR+ 3.00 %   0.00%   8.36%  6/21/2029   1,200,000    1,185,480    1,200,000 
R1 RCM INC.  Healthcare & Pharmaceuticals  Term Loan  Loan  1M USD SOFR+ 3.00 %   0.50%   8.33%  6/21/2029   1,200,000    1,185,733    1,200,000 
Rackspace Technology Global, Inc.  High Tech Industries  Term Loan (1/21)  Loan  1M USD SOFR+ 2.75 %   0.75%   8.19%  2/15/2028   2,944,353    2,869,199    1,278,173 
RAND PARENT LLC  Transportation: Cargo  Term Loan B  Loan  3M USD SOFR+ 4.25 %   0.00%   9.60%  3/16/2030   2,481,250    2,400,653    2,476,213 

 

S-21

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
RealPage, Inc.  High Tech Industries  Term Loan (04/21)  Loan  1M USD SOFR+ 3.00 %   0.50%   8.44%  4/24/2028   977,500    976,326    950,501 
Rent-A-Center, Inc.  Retail  Term Loan B2 (9/21)  Loan  6M USD SOFR+ 3.25 %   0.50%   9.12%  2/17/2028   1,860,192    1,827,856    1,856,323 
Research Now Group, Inc  Media: Advertising, Printing & Publishing  Term Loan  Loan  3M USD SOFR+ 5.50 %   1.00%   11.07%  12/20/2024   4,252,891    4,231,426    2,426,275 
Resideo Funding Inc.  Services: Consumer  Term Loan (1/21)  Loan  1M USD SOFR+ 2.25 %   0.50%   7.69%  2/11/2028   1,458,750    1,457,581    1,454,651 
Resolute Investment Managers (American Beacon), Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (12/23)  Loan  3M USD SOFR+ 6.50 %   1.00%   12.11%  4/30/2027   1,968,154    1,968,154    1,936,172 
Restoration Hardware, Inc.  Retail  Term Loan (9/21)  Loan  1M USD SOFR+ 2.50 %   0.50%   7.94%  10/20/2028   3,427,375    3,422,882    3,328,838 
Reynolds Consumer Products LLC  Containers, Packaging & Glass  Term Loan  Loan  1M USD SOFR+ 1.75 %   0.00%   7.18%  1/29/2027   1,117,917    1,117,917    1,117,078 
Reynolds Group Holdings Inc.  Containers, Packaging & Glass  Term Loan B2  Loan  1M USD SOFR+ 3.25 %   0.00%   8.69%  2/5/2026   1,933,578    1,929,763    1,936,692 
Russell Investments US Inst’l Holdco, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (10/20)  Loan  1M USD SOFR+ 3.50 %   1.00%   8.93%  6/2/2025   5,503,217    5,487,956    5,313,356 
RV Retailer LLC  Automotive  Term Loan  Loan  1M USD SOFR+ 3.75 %   0.75%   9.17%  2/8/2028   2,927,756    2,890,768    2,728,317 
Ryan Specialty Group LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD SOFR+ 2.75 %   0.75%   8.08%  9/1/2027   1,463,497    1,454,416    1,463,497 
S&S HOLDINGS LLC  Services: Business  Term Loan  Loan  3M USD SOFR+ 5.00 %   0.50%   10.42%  3/10/2028   2,433,693    2,393,141    2,405,560 
Sally Holdings LLC  Retail  Term Loan B  Loan  1M USD SOFR+ 2.25 %   0.00%   7.58%  2/28/2030   496,250    492,943    495,421 
Schweitzer-Mauduit International, Inc.  High Tech Industries  Term Loan B  Loan  1M USD SOFR+ 3.75 %   0.75%   9.19%  4/20/2028   1,297,546    1,293,069    1,294,847 
Scientific Games Holdings LP  Hotel, Gaming & Leisure  Term Loan B  Loan  3M USD SOFR+ 3.25 %   0.50%   8.58%  4/4/2029   493,750    492,933    492,516 
Sedgwick Claims Management Services, Inc.  Services: Business  Term Loan B 2/23  Loan  1M USD SOFR+ 3.75 %   0.00%   9.08%  2/17/2028   992,500    984,017    993,294 
SETANTA AIRCRAFT LEASING DAC  Aerospace & Defense  Term Loan  Loan  3M USD SOFR+ 2.00 %   0.00%   7.61%  11/2/2028   1,000,000    998,338    1,000,560 
Sitel Worldwide Corporation  Services: Business  USD Term Loan (7/21)  Loan  1M USD SOFR+ 3.75 %   0.50%   9.19%  8/28/2028   1,955,000    1,948,734    1,873,144 

 

S-22

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
SiteOne Landscape Supply, LLC  Services: Business  Term Loan (3/21)  Loan  1M USD SOFR+ 2.00 %   0.50%   7.44%  3/18/2028   1,267,378    1,261,906    1,267,378 
SMG US Midco 2, Inc.  Services: Business  Term Loan (01/20)  Loan  3M USD SOFR+ 2.50 %   0.00%   8.07%  1/23/2025   480,000    480,000    479,702 
Smyrna Ready Mix Concrete, LLC  Construction & Building  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.00%   8.82%  4/1/2029   514,217    510,811    514,860 
Sotheby’s  Services: Business  Term Loan (7/21)  Loan  3M USD SOFR+ 4.50 %   0.50%   10.08%  1/15/2027   3,191,015    3,159,783    3,159,903 
Sparta U.S. HoldCo LLC  Chemicals, Plastics, & Rubber  Term Loan (04/21)  Loan  1M USD SOFR+ 3.25 %   0.75%   8.69%  8/2/2028   1,960,000    1,953,602    1,955,453 
Specialty Pharma III Inc.  Services: Business  Term Loan  Loan  1M USD SOFR+ 4.25 %   0.75%   9.68%  3/31/2028   1,955,000    1,942,520    1,857,250 
Spin Holdco, Inc.  Services: Consumer  Term Loan 3/21  Loan  3M USD SOFR+ 4.00 %   0.75%   9.62%  3/4/2028   2,917,500    2,907,433    2,644,510 
SRAM, LLC  Consumer goods: Durable  Term Loan (05/21)  Loan  1M USD SOFR+ 2.75 %   0.50%   8.19%  5/12/2028   2,523,636    2,521,215    2,517,327 
STANDARD INDUSTRIES INC.  Construction & Building  Term Loan B  Loan  1M USD SOFR+ 2.25 %   0.50%   7.68%  9/22/2028   620,250    616,132    619,785 
Staples, Inc.  Wholesale  Term Loan (03/19)  Loan  1M USD SOFR+ 5.00 %   0.00%   10.44%  4/16/2026   4,296,252    4,227,884    4,185,881 
Star Parent, Inc.  Services: Business  Term Loan B (09/23)  Loan  3M USD SOFR+ 4.00 %   0.00%   9.35%  9/19/2030   1,250,000    1,232,293    1,233,600 
Storable, Inc  High Tech Industries  Term Loan B  Loan  1M USD SOFR+ 3.50 %   0.50%   8.83%  4/17/2028   490,000    489,451    489,084 
Superannuation & Investments US LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD SOFR+ 3.75 %   0.50%   9.19%  12/1/2028   980,000    972,893    979,510 
Sweetwater Borrower, LLC  Retail  Term Loan (8/21)  Loan  1M USD SOFR+ 4.25 %   0.75%   9.69%  8/2/2028   2,197,331    2,118,286    2,186,345 
Syncsort Incorporated  High Tech Industries  Term Loan B (10/21)  Loan  3M USD SOFR+ 4.00 %   0.75%   9.59%  4/24/2028   2,444,975    2,444,257    2,421,748 
Ta TT Buyer LLC  Media: Broadcasting & Subscription  Term Loan 3/22  Loan  3M USD SOFR+ 5.00 %   0.50%   10.35%  4/2/2029   987,475    979,563    987,060 
Tenable Holdings, Inc.  Services: Business  Term Loan B (6/21)  Loan  1M USD SOFR+ 2.75 %   0.50%   8.19%  7/7/2028   980,000    978,620    977,962 
Teneo Holdings LLC  Banking, Finance, Insurance & Real Estate  Term Loan  Loan  1M USD SOFR+ 5.25 %   1.00%   10.68%  7/15/2025   4,337,912    4,305,238    4,332,490 
Ten-X, LLC  Banking, Finance, Insurance & Real Estate  Term Loan 5/23  Loan  1M USD SOFR+ 6.00 %   0.00%   11.33%  5/25/2028   1,880,000    1,879,762    1,809,030 
The Dun & Bradstreet Corporation  Services: Business  Term Loan (01/24)  Loan  1M USD SOFR+ 2.75 %   0.00%   8.07%  1/18/2029   1,148,788    1,146,995    1,145,629 

 

S-23

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Thor Industries, Inc.  Automotive  Term Loan B2  Loan  1M USD SOFR+ 2.75 %   0.00%   8.07%  11/15/2030   847,276    839,124    847,276 
Torrid LLC  Wholesale  Term Loan 5/21  Loan  3M USD SOFR+ 5.50 %   0.75%   11.11%  6/14/2028   3,293,297    2,885,799    2,766,369 
TORY BURCH LLC  Retail  Term Loan  Loan  1M USD SOFR+ 3.25 %   0.50%   8.69%  4/15/2028   2,308,083    2,173,521    2,279,878 
Tosca Services, LLC  Containers, Packaging & Glass  Term Loan (2/21)  Loan  3M USD SOFR+ 3.50 %   0.75%   9.07%  8/18/2027   485,000    481,026    403,360 
Trans Union LLC  Banking, Finance, Insurance & Real Estate  Term Loan B7 (02/24)  Loan  1M USD SOFR+ 2.00 %   0.50%   7.33%  12/1/2028   609,032    608,154    608,161 
Transdigm, Inc.  Aerospace & Defense  Term Loan H  Loan  3M USD SOFR+ 3.25 %   0.00%   8.60%  2/22/2027   1,973,436    1,970,279    1,977,580 
TRITON WATER HOLDINGS, INC.  Beverage, Food & Tobacco  Term Loan (03/21)  Loan  3M USD SOFR+ 3.25 %   0.50%   8.86%  3/31/2028   1,462,504    1,457,793    1,435,389 
Tronox Finance LLC  Chemicals, Plastics, & Rubber  Term Loan  Loan  1M USD SOFR+ 2.50 %   0.00%   7.94%  3/10/2028   346,923    346,548    345,584 
Tronox Finance LLC  Chemicals, Plastics, & Rubber  Incremental Term Loan  Loan  3M USD SOFR+ 3.50 %   0.50%   8.85%  8/11/2028   2,000,000    1,981,659    1,997,500 
TruGreen Limited Partnership  Services: Consumer  Term Loan  Loan  1M USD SOFR+ 4.00 %   0.75%   9.43%  10/29/2027   944,761    940,433    912,034 
Uber Technologies, Inc.  Transportation: Consumer  Term Loan 2/23  Loan  3M USD SOFR+ 2.75 %   0.00%   8.13%  3/3/2030   395,438    394,559    396,284 
Ultra Clean Holdings, Inc.  High Tech Industries  Incremental Term Loan 3/21  Loan  1M USD SOFR+ 3.75 %   0.00%   9.19%  8/27/2025   763,480    761,941    764,755 
Unimin Corporation  Metals & Mining  Term Loan (12/20)  Loan  3M USD SOFR+ 4.00 %   1.00%   9.59%  7/31/2026   496,815    481,603    494,207 
United Natural Foods, Inc  Beverage, Food & Tobacco  Term Loan B  Loan  1M USD SOFR+ 3.25 %   0.00%   8.69%  10/22/2025   1,241,834    1,218,443    1,239,922 
Univision Communications Inc.  Media: Broadcasting & Subscription  Term Loan B (6/21)  Loan  1M USD SOFR+ 3.25 %   0.75%   8.69%  3/15/2026   2,421,809    2,418,336    2,418,031 
Univision Communications Inc.  Media: Broadcasting & Subscription  Term Loan B (6/22)  Loan  3M USD SOFR+ 4.25 %   0.50%   9.60%  6/25/2029   246,250    240,243    246,250 
Utz Quality Foods, LLC  Beverage, Food & Tobacco  Term Loan B  Loan  1M USD SOFR+ 3.00 %   0.00%   8.44%  1/20/2028   1,478,977    1,478,749    1,478,252 
Vaco Holdings, LLC  Services: Business  Term Loan (01/22)  Loan  6M USD SOFR+ 5.00 %   0.75%   10.43%  1/19/2029   2,318,552    2,260,590    2,287,251 

 

S-24

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Vericast Corp. (c)  Media: Advertising, Printing & Publishing  Term Loan (12/23)  Loan  3M USD SOFR+ 7.75 %   0.00%   13.36%  6/16/2026   1,208,512    1,207,739    1,111,831 
Verifone Systems, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan (7/18)  Loan  3M USD SOFR+ 4.00 %   0.00%   9.59%  8/20/2025   1,353,744    1,351,272    1,170,988 
Vertex Aerospace Services Corp  Aerospace & Defense  Term Loan (10/21)  Loan  1M USD SOFR+ 3.25 %   0.75%   8.68%  12/6/2028   982,538    979,566    982,459 
VFH Parent LLC  Banking, Finance, Insurance & Real Estate  Term Loan (01/22)  Loan  1M USD SOFR+ 3.00 %   0.50%   8.43%  1/12/2029   2,975,130    2,970,557    2,970,667 
Viasat Inc  Telecommunications  Term Loan (2/22)  Loan  1M USD SOFR+ 4.50 %   0.50%   9.83%  3/5/2029   2,967,381    2,908,179    2,909,903 
Virtus Investment Partners, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B (9/21)  Loan  1M USD SOFR+ 2.25 %   0.00%   7.69%  9/28/2028   2,823,409    2,817,201    2,819,880 
Vistra Operations Company LLC  Energy: Electricity  2018 Incremental Term Loan  Loan  1M USD SOFR+ 2.00 %   0.00%   7.33%  12/20/2030   1,889,393    1,880,083    1,880,135 
Vizient, Inc  Healthcare & Pharmaceuticals  Term Loan 4/22  Loan  1M USD SOFR+ 2.25 %   0.50%   7.68%  5/16/2029   492,500    488,534    492,731 
VM Consolidated, Inc.  Construction & Building  Term Loan B (01/24)  Loan  1M USD SOFR+ 2.75 %   0.00%   8.08%  3/24/2028   1,841,374    1,840,186    1,843,676 
Vouvray US Finance LLC  High Tech Industries  Term Loan  Loan  1M USD SOFR+ 6.00 %   1.00%   11.33%  9/30/2025   466,250    466,250    472,078 
Walker & Dunlop, Inc.  Banking, Finance, Insurance & Real Estate  Term Loan B (12/22)  Loan  1M USD SOFR+ 3.00 %   0.50%   8.43%  12/15/2028   496,250    487,839    495,009 
Warner Music Group Corp. (WMG Acquisition Corp.)  Hotel, Gaming & Leisure  First Lien TL I (01/24)  Loan  1M USD SOFR+ 2.00 %   0.00%   7.33%  1/24/2031   1,250,000    1,249,906    1,247,463 
Watlow Electric Manufacturing Company  High Tech Industries  Term Loan B  Loan  3M USD SOFR+ 3.75 %   0.50%   9.33%  3/2/2028   2,831,632    2,822,010    2,826,337 
WeddingWire, Inc.  Services: Consumer  Term Loan (09/23)  Loan  1M USD SOFR+ 4.50 %   0.00%   9.82%  1/29/2028   4,808,923    4,806,669    4,784,879 
WEX Inc.  Services: Business  Term Loan  Loan  1M USD SOFR+ 2.00 %   0.00%   7.33%  3/31/2028   2,924,849    2,918,448    2,919,379 
WildBrain Ltd.  Media: Diversified & Production  Term Loan  Loan  1M USD SOFR+ 4.25 %   0.75%   9.69%  3/27/2028   3,005,025    2,952,048    2,899,849 
Windsor Holdings III, LLC  Chemicals, Plastics, & Rubber  Term Loan  Loan  1M USD SOFR+ 4.50 %   0.00%   9.82%  8/1/2030   500,000    500,000    500,390 
Wyndham Hotels & Resorts, Inc.  Hotel, Gaming & Leisure  Term Loan  5/23  Loan  1M USD SOFR+ 2.25 %   0.00%   7.68%  5/24/2030   995,000    990,380    996,124 

 

S-25

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/
Spread
  SOFR/
LIBOR Floor
   Current Rate
(All In)
   Maturity Date  Principal/
Number
of Shares
   Cost   Fair Value 
Xperi Corporation  High Tech Industries  Term Loan  Loan  1M USD SOFR+ 3.50 %   0.00%   8.94%  6/8/2028   1,983,094    1,979,717    1,977,303 
Zayo Group, LLC  Telecommunications  Term Loan 4/22  Loan  1M USD SOFR+ 4.25 %   0.50%   9.65%  3/9/2027   982,500    965,514    884,555 
ZEBRA BUYER (Allspring) LLC  Banking, Finance, Insurance & Real Estate  Term Loan 4/21  Loan  3M USD SOFR+ 3.25 %   0.50%   8.89%  11/1/2028   1,866,509    1,857,862    1,862,142 
Zekelman Industries, Inc.  Metals & Mining  Term Loan (01/20)  Loan  1M USD SOFR+ 2.00 %   0.00%   7.44%  1/25/2027   954,029    954,029    953,733 
Zest Acquisition Corp.  Healthcare & Pharmaceuticals  Term Loan (1/23)  Loan  1M USD SOFR+ 5.50 %   0.00%   10.83%  2/8/2028   1,980,000    1,897,656    1,940,400 
Zodiac Pool Solutions  Consumer goods: Durable  Term Loan (1/22)  Loan  1M USD SOFR+ 1.93 %   0.50%   7.35%  1/29/2029   490,000    489,237    488,772 
TOTAL INVESTMENTS                                $630,995,710   $607,551,774 

 

   Number of Shares   Cost   Fair Value 
Cash and cash equivalents            
U.S. Bank Money Market (a)   12,104,832   $12,104,832   $12,104,832 
Total cash and cash equivalents   12,104,832   $12,104,832   $12,104,832 

 

 

(a)Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 29, 2024.
(b)

As of February 29, 2024, the investment was in default and on non-accrual status.

(c)Investments include Payment-in-Kind Interest.

 

LIBOR - London Interbank Offered Rate

SOFR - Secured Overnight Financing Rate

 

1M USD LIBOR - The 1-month USD LIBOR rate as of February 29, 2024 was 5.44%.

3M USD LIBOR - The 3-month USD LIBOR rate as of February 29, 2024 was 5.60%.

1M SOFR - The 1-month SOFR rate as of February 29, 2024 was 5.32%.

3M SOFR - The 3-month SOFR rate as of February 29, 2024 was 5.33%.

6M SOFR - The 6-month SOFR rate as of February 29, 2024 was 5.27%.

 

Prime - The Prime Rate as of February 29, 2024 was 8.50%.

 

See accompanying notes to financial statements.

 

S-26

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name  Industry  Asset Name  Asset
Type
  Reference Rate/Spread  SOFR/
LIBOR
Floor
   Current
Rate (All In)
   Maturity
Date
  Principal/
Number of Shares
   Cost   Fair Value 
19TH HOLDINGS GOLF, LLC  Consumer goods: Durable  Term Loan  Loan  1M USD SOFR+ 3.00 %   0.50%   7.67%  2/7/2029  $1,997,500   $1,924,905   $1,901,380 
888 Acquisitions Limited  Hotel, Gaming & Leisure  Term Loan B  Loan  3M USD SOFR+ 5.25 %   0.00%   9.93%  7/8/2028   2,494,565    2,143,085    2,126,617 
ADMI Corp.  Healthcare & Pharmaceuticals  Term Loan B  Loan  1M USD LIBOR+ 3.00 %   0.00%   7.63%  4/30/2025   1,910,276    1,907,516    1,825,517 
Adtalem Global Education Inc.  Services: Business  Term Loan B (02/21)  Loan  1M USD LIBOR+ 4.00 %   0.75%   8.63%  8/11/2028   691,846    686,475    689,992 
Aegis Sciences Corporation  Healthcare & Pharmaceuticals  Term Loan  Loan  3M USD LIBOR+ 5.50 %   1.00%   10.36%  5/9/2025   2,349,601    2,341,307    2,268,540 
Agiliti Health Inc.  Healthcare & Pharmaceuticals  Term Loan (09/20)  Loan  1M USD LIBOR+ 2.75 %   0.75%   7.38%  1/4/2026   214,286    213,103    212,946 
Agiliti Health Inc.  Healthcare & Pharmaceuticals  Term Loan (1/19)  Loan  1M USD LIBOR+ 2.75 %   0.00%   7.38%  1/4/2026   1,468,430    1,463,378    1,457,416 
AHEAD DB Holdings, LLC  Services: Business  Term Loan (04/21)  Loan  3M USD LIBOR+ 3.75 %   0.75%   8.48%  10/18/2027   2,955,000    2,871,299    2,915,285 
AI Convoy (Luxembourg) S.a.r.l.  Aerospace & Defense  Term Loan B (USD)  Loan  6M USD LIBOR+ 3.50 %   1.00%   8.17%  1/18/2027   -    -    - 
Air Canada  Transportation: Consumer  Term Loan B (07/21)  Loan  3M USD LIBOR+ 3.50 %   0.75%   8.37%  8/11/2028   1,990,000    1,851,613    1,984,408 
AIS HoldCo, LLC  Services: Business  Term Loan  Loan  3M USD LIBOR+ 5.00 %   0.00%   9.83%  8/15/2025   4,789,642    4,700,517    4,622,004 
AIT Worldwide Logistics Holdings, Inc.  Transportation: Cargo  Term Loan (04/21)  Loan  1M USD LIBOR+ 4.75 %   0.75%   9.33%  4/6/2028   2,500,000    2,333,827    2,407,300 
AL GCX Holdings (Arclight) T/L B  Energy: Oil & Gas  Term Loan B  Loan  3M USD SOFR+ 3.50 %   0.50%   8.28%  5/17/2029   976,802    971,918    975,581 
Alchemy US Holdco 1, LLC  Metals & Mining  Term Loan  Loan  1M USD LIBOR+ 5.50 %   0.00%   5.60%  10/10/2025   1,654,803    1,644,633    1,551,378 
AlixPartners, LLP  Banking, Finance, Insurance & Real Estate  Term Loan B (01/21)  Loan  1M USD LIBOR+ 2.75 %   0.50%   7.38%  2/4/2028   245,625    245,275    245,050 
Alkermes, Inc.  Healthcare & Pharmaceuticals  Term Loan B (3/21)  Loan  1M USD LIBOR+ 2.50 %   0.50%   7.11%  3/12/2026   2,126,218    2,112,914    2,062,432 
Allen Media, LLC  Media: Diversified & Production  Term Loan (7/21)  Loan  3M USD SOFR+ 5.50 %   0.00%   10.23%  2/10/2027   4,394,261    4,368,566    3,649,434 
Alliant Holdings Intermediate, LLC  Banking, Finance, Insurance & Real Estate  Term Loan B4  Loan  1M USD LIBOR+ 3.50 %   0.50%   8.09%  11/5/2027   987,500    986,800    974,781 
Allied Universal Holdco LLC  Services: Business  Term Loan 4/21  Loan  1M USD SOFR+ 3.75 %   0.50%   8.47%  5/12/2028   1,975,000    1,967,474    1,900,404 
Altisource Solutions S.a r.l.  Banking, Finance, Insurance & Real Estate  Term Loan B (03/18)  Loan  3M USD LIBOR+ 4.00 %   1.00%   8.73%  4/3/2024   1,126,283    1,124,635    893,142 
Altium Packaging LLC  Containers, Packaging & Glass  Term Loan (01/21)  Loan  1M USD LIBOR+ 2.75 %   0.50%   7.38%  1/29/2028   491,250    489,554    480,506 
American Airlines T/L (2/23)  Transportation: Consumer  Term Loan  Loan  N/A N/A   N/A    N/A   N/A   -    27    - 
American Axle & Manufacturing Inc.  Automotive  Term Loan (12/22)  Loan  1M USD SOFR+ 3.50 %   0.50%   8.16%  12/5/2029   500,000    485,367    499,000 
American Greetings Corporation  Media: Advertising, Printing & Publishing  Term Loan  Loan  1M USD LIBOR+ 4.50 %   1.00%   9.07%  4/6/2024   3,012,861    3,011,462    3,011,596 
American Trailer World Corp  Automotive  Term Loan  Loan  1M USD SOFR+ 3.75 %   0.75%   8.47%  3/3/2028   1,357,439    1,354,762    1,194,967 
AmWINS Group, LLC  Banking, Finance, Insurance & Real Estate  Term Loan 2/21  Loan  1M USD LIBOR+ 2.25 %   0.75%   6.88%  2/17/2028   1,960,017    1,940,778    1,926,462 

 

S-27

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
Anastasia Parent LLC   Consumer goods: Non-durable   Term Loan   Loan   3M USD LIBOR+ 3.75 %     0.00 %     8.48 %   8/11/2025     957,500       955,643       791,134  
Anchor Glass Container Corporation   Containers, Packaging & Glass   Term Loan (07/17)   Loan   3M USD LIBOR+ 2.75 %     1.00 %     7.48 %   12/7/2023     470,138       469,901       333,915  
Anchor Packaging, LLC   Containers, Packaging & Glass   Term Loan B   Loan   1M USD LIBOR+ 4.00 %     0.00 %     8.63 %   7/18/2026     977,215       971,052       952,785  
ANI Pharmaceuticals, Inc.   Healthcare & Pharmaceuticals   Term Loan B   Loan   1M USD LIBOR+ 6.00 %     0.75 %     10.63 %   11/19/2027     2,970,000       2,922,446       2,866,050  
AP Core Holdings II LLC   High Tech Industries   Term Loan B1   Loan   1M USD LIBOR+ 5.50 %     0.75 %     10.13 %   9/1/2027     1,875,000       1,852,824       1,802,344  
AP Core Holdings II LLC   High Tech Industries   Term Loan B2   Loan   1M USD LIBOR+ 5.50 %     0.75 %     10.13 %   9/1/2027     500,000       494,095       480,415  
APEX GROUP TREASURY LLC   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   3M USD SOFR+ 5.00 %     0.50 %     9.66 %   7/26/2028     500,000       468,464       497,500  
APi Group DE, Inc. (J2 Acquisition)   Services: Business   Term Loan B   Loan   1M USD LIBOR+ 2.50 %     0.00 %     7.13 %   10/1/2026     1,757,184       1,751,429       1,754,548  
APLP Holdings Limited Partnership   Energy: Electricity   Term Loan B (3/21)   Loan   3M USD LIBOR+ 3.75 %     1.00 %     8.48 %   5/14/2027     440,541       437,327       440,726  
Apollo Commercial Real Estate Finance, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B   Loan   1M USD LIBOR+ 2.75 %     0.00 %     7.38 %   5/15/2026     2,939,086       2,914,348       2,850,914  
Apollo Commercial Real Estate Finance, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B1 (2/21)   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   3/6/2028     982,500       975,109       928,463  
AppLovin Corporation   High Tech Industries   Term Loan (10/21)   Loan   3M USD SOFR+ 3.10 %     0.50 %     7.70 %   10/21/2028     1,488,750       1,485,729       1,472,002  
AppLovin Corporation   High Tech Industries   Term Loan B   Loan   3M USD SOFR+ 3.35 %     0.00 %     7.94 %   8/15/2025     979,592       979,592       972,245  
Aramark Corporation   Services: Consumer   Term Loan B (4/21)   Loan   1M USD LIBOR+ 2.50 %     0.00 %     7.13 %   4/1/2028     1,753,715       1,747,448       1,747,139  
Aramark Corporation   Services: Consumer   Term Loan   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.38 %   1/15/2027     2,331,250       2,280,733       2,305,023  
ARC FALCON I INC.   Chemicals, Plastics, & Rubber   Term Loan   Loan   1M USD LIBOR+ 3.75 %     0.50 %     8.38 %   9/23/2028     863,885       860,682       811,836  
ARC FALCON I INC. (a)   Chemicals, Plastics, & Rubber   Delayed Draw Term Loan   Loan   3M USD LIBOR+ 1.00 %     0.50 %     1.00 %   9/29/2028     -       (512 )     (7,675 )
Arches Buyer Inc.   Services: Consumer   Term Loan B   Loan   1M USD SOFR+ 3.25 %     0.50 %     7.97 %   12/6/2027     1,484,848       1,477,106       1,395,758  
Aretec Group, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan (10/18)   Loan   1M USD SOFR+ 4.25 %     0.00 %     8.97 %   10/1/2025     1,916,203       1,913,228       1,887,460  
ASP BLADE HOLDINGS, INC.   Capital Equipment   Term Loan   Loan   3M USD LIBOR+ 4.00 %     0.50 %     8.73 %   10/7/2028     99,059       98,658       82,491  
Asplundh Tree Expert, LLC   Services: Business   Term Loan 2/21   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.38 %   9/7/2027     977,500       974,396       974,010  
AssuredPartners Capital, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B (2/20)   Loan   1M USD LIBOR+ 3.50 %     0.00 %     8.13 %   2/12/2027     989,796       986,847       967,773  
AssuredPartners Inc.   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   1M USD SOFR+ 3.50 %     0.50 %     8.12 %   2/12/2027     496,250       495,400       485,084  
AssuredPartners Inc.   Banking, Finance, Insurance & Real Estate   Incremental Term Loan (7/21)   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   2/12/2027     985,000       985,000       962,838  
ASTRO ONE ACQUISITION CORPORATION   Consumer goods: Durable   Term Loan   Loan   3M USD LIBOR+ 5.50 %     0.75 %     10.23 %   9/15/2028     2,970,000       2,946,187       1,767,150  
Asurion, LLC   Banking, Finance, Insurance & Real Estate   Term Loan B10   Loan   3M USD SOFR+ 4.00 %     0.00 %     8.68 %   8/19/2028     1,995,000       1,901,937       1,866,741  

 

S-28

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
Asurion, LLC   Banking, Finance, Insurance & Real Estate   Term Loan B8   Loan   1M USD LIBOR+ 3.25 %     0.00 %     7.88 %   12/18/2026     2,964,858       2,956,667       2,817,683  
ATHENAHEALTH GROUP INC.   Healthcare & Pharmaceuticals   Term Loan B (2/22)   Loan   1M USD SOFR+ 3.50 %     0.50 %     8.06 %   2/15/2029     1,330,543       1,325,206       1,227,426  
ATHENAHEALTH GROUP INC. (a)   Healthcare & Pharmaceuticals   Delayed Draw Term Loan (02/22)   Loan   3M USD LIBOR+ 3.50 %     0.50 %     3.50 %   2/15/2029     -       -       (12,636 )
Avison Young (Canada) Inc   Services: Business   Term Loan (08/22)   Loan   1M USD SOFR+ 7.00 %     0.00 %     11.73 %   1/31/2026     748,125       708,918       635,906  
Avison Young (Canada) Inc   Services: Business   Term Loan   Loan   1M USD SOFR+ 5.75 %     0.00 %     10.48 %   1/31/2026     3,370,882       3,344,831       2,646,142  
Avolon TLB Borrower 1 (US) LLC   Capital Equipment   Term Loan B5 (7/21)   Loan   1M USD LIBOR+ 2.25 %     0.50 %     6.85 %   12/1/2027     490,000       486,530       489,539  
Avolon TLB Borrower 1 (US) LLC   Capital Equipment   Term Loan B3   Loan   1M USD LIBOR+ 1.75 %     0.75 %     6.35 %   1/15/2025     1,000,000       932,184       998,440  
Axalta Coating Systems Dutch Holding B B.V.   Chemicals, Plastics, & Rubber   Term Loan B-4 Dollar   Loan   3M USD SOFR+ 3.00 %     0.50 %     7.51 %   12/7/2029     1,000,000       990,447       1,003,570  
AZURITY PHARMACEUTICALS, INC.   Healthcare & Pharmaceuticals   Term Loan B   Loan   3M USD LIBOR+ 6.00 %     0.75 %     10.75 %   9/20/2027     475,000       463,094       457,188  
B&G Foods, Inc.   Beverage, Food & Tobacco   Term Loan   Loan   1M USD LIBOR+ 2.50 %     0.00 %     7.13 %   10/10/2026     642,295       638,890       613,391  
B.C. Unlimited Liability Co (Burger King)   Beverage, Food & Tobacco   Term Loan B4   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.38 %   11/19/2026     1,455,000       1,430,342       1,440,712  
BAKELITE UK INTERMEDIATE LTD.   Chemicals, Plastics, & Rubber   Term Loan   Loan   3M USD SOFR+ 4.00 %     0.50 %     8.73 %   5/29/2029     995,000       990,609       940,275  
Baldwin Risk Partners, LLC   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.10 %   10/14/2027     1,226,325       1,215,617       1,205,637  
Bausch Health Companies Inc.   Healthcare & Pharmaceuticals   Term Loan B (1/22)   Loan   1M USD SOFR+ 5.25 %     0.50 %     9.91 %   2/1/2027     1,950,000       1,764,574       1,534,299  
Belfor Holdings Inc.   Services: Consumer   Term Loan B-2 (3/22)   Loan   1M USD SOFR+ 4.25 %     0.50 %     8.87 %   4/6/2026     994,911       971,026       992,424  
Belfor Holdings Inc.   Services: Consumer   Term Loan   Loan   1M USD LIBOR+ 4.00 %     0.00 %     8.63 %   4/6/2026     245,547       245,547       244,995  
Belron Finance US LLC   Automotive   Term Loan B (3/21)   Loan   3M USD LIBOR+ 2.50 %     0.50 %     7.38 %   4/13/2028     1,965,000       1,950,181       1,960,913  
Bengal Debt Merger Sub LLC   Beverage, Food & Tobacco   Term Loan   Loan   3M USD SOFR+ 3.25 %     0.50 %     7.93 %   1/24/2029     1,990,000       1,988,811       1,804,273  
Blackstone Mortgage Trust, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan (6/21)   Loan   1M USD LIBOR+ 2.75 %     0.50 %     7.38 %   4/23/2026     1,465,141       1,457,842       1,441,332  
Blackstone Mortgage Trust, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.88 %   4/23/2026     979,747       975,006       952,804  
Blue Tree Holdings, Inc.   Chemicals, Plastics, & Rubber   Term Loan (2/21)   Loan   3M USD LIBOR+ 2.50 %     0.00 %     7.23 %   3/4/2028     982,500       980,692       967,763  
Bombardier Recreational Products, Inc.   Consumer goods: Durable   Term Loan  12/22   Loan   1M USD SOFR+ 3.50 %     0.50 %     8.12 %   12/12/2029     498,750       486,572       496,007  
Bombardier Recreational Products, Inc.   Consumer goods: Durable   Term Loan (1/20)   Loan   1M USD LIBOR+ 2.00 %     0.00 %     6.63 %   5/24/2027     1,455,049       1,449,140       1,416,854  
Boxer Parent Company, Inc.   High Tech Industries   Term Loan (2/21)   Loan   1M USD LIBOR+ 3.75 %     0.00 %     8.38 %   10/2/2025     516,794       516,794       509,827  
Bracket Intermediate Holding Corp   Healthcare & Pharmaceuticals   Term Loan   Loan   3M USD LIBOR+ 4.25 %     0.00 %     9.04 %   9/5/2025     957,500       955,597       929,378  
BrightSpring Health Services (Phoenix Guarantor)   Healthcare & Pharmaceuticals   Term Loan B-3   Loan   1M USD LIBOR+ 3.50 %     0.00 %     8.13 %   3/5/2026     982,500       982,500       967,556  

 

S-29

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
BroadStreet Partners, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B3   Loan   1M USD LIBOR+ 3.00 %     0.00 %     7.63 %   1/22/2027     2,948,786       2,944,577       2,906,412  
Brookfield WEC Holdings Inc.   Energy: Electricity   Term Loan (1/21)   Loan   1M USD LIBOR+ 2.75 %     0.50 %     7.38 %   8/1/2025     1,462,613       1,464,152       1,456,090  
BROWN GROUP HOLDING, LLC   Aerospace & Defense   Term Loan B-2   Loan   1M USD SOFR+ 3.75 %     0.00 %     8.37 %   6/8/2029     498,750       487,209       498,336  
Buckeye Partners, L.P.   Utilities: Oil & Gas   Term Loan (1/21)   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.82 %   11/1/2026     1,950,188       1,941,198       1,946,931  
BW Gas & Convenience Holdings LLC   Beverage, Food & Tobacco   Term Loan B   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   3/31/2028     2,462,500       2,443,814       2,437,875  
Callaway Golf Company   Retail   Term Loan B   Loan   1M USD LIBOR+ 4.50 %     0.00 %     9.13 %   1/4/2026     675,000       668,575       674,582  
Camping World, Inc.   Retail   Term Loan B (5/21)   Loan   1M USD LIBOR+ 2.50 %     0.75 %     7.09 %   6/5/2028     2,487,342       2,268,038       2,208,560  
CareerBuilder, LLC   Services: Business   Term Loan   Loan   3M USD LIBOR+ 6.75 %     1.00 %     11.48 %   7/31/2023     5,393,388       5,347,671       3,513,792  
Castle US Holding Corporation   Media: Advertising, Printing & Publishing   Term Loan B (USD)   Loan   1M USD LIBOR+ 3.75 %     0.00 %     8.38 %   1/27/2027     1,963,384       1,954,023       1,375,469  
CASTLELAKE AVIATION LLC   Aerospace & Defense   Term Loan B   Loan   1M USD SOFR+ 2.75 %     0.50 %     7.31 %   10/21/2027     1,000,000       992,500       987,080  
CBI BUYER, INC.   Consumer goods: Durable   Term Loan   Loan   1M USD LIBOR+ 3.25 %     0.50 %     7.88 %   1/6/2028     2,969,887       2,814,181       2,026,948  
CCC Intelligent Solutions Inc.   Services: Business   Term Loan B   Loan   1M USD LIBOR+ 2.25 %     0.50 %     6.88 %   9/16/2028     247,500       247,017       244,612  
CCI Buyer, Inc   Telecommunications   Term Loan   Loan   3M USD SOFR+ 4.00 %     0.75 %     8.58 %   12/17/2027     245,625       243,880       241,223  
CCRR Parent, Inc.   Healthcare & Pharmaceuticals   Term Loan   Loan   1M USD SOFR+ 4.25 %     0.50 %     8.97 %   3/5/2028     1,000,000       951,484       975,000  
CCRR Parent, Inc.   Healthcare & Pharmaceuticals   Term Loan B   Loan   1M USD LIBOR+ 3.75 %     0.75 %     8.39 %   3/5/2028     982,500       978,899       957,938  
CCS-CMGC Holdings, Inc.   Healthcare & Pharmaceuticals   Term Loan   Loan   1M USD LIBOR+ 5.50 %     0.00 %     10.13 %   9/25/2025     2,400,000       2,390,330       1,605,504  
CDK GLOBAL, INC.   High Tech Industries   Term Loan B   Loan   3M USD SOFR+ 4.50 %     0.50 %     9.08 %   7/6/2029     1,000,000       971,508       996,150  
Cengage Learning, Inc.   Media: Advertising, Printing & Publishing   Term Loan B (6/21)   Loan   6M USD LIBOR+ 4.75 %     1.00 %     9.88 %   7/14/2026     2,962,500       2,942,124       2,794,171  
CENTURI GROUP, INC.   Construction & Building   Term Loan B   Loan   3M USD LIBOR+ 2.50 %     0.50 %     7.45 %   8/27/2028     878,330       871,190       870,100  
CenturyLink, Inc.   Telecommunications   Term Loan B (1/20)   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.88 %   3/15/2027     3,887,492       3,883,600       3,208,269  
Charlotte Buyer, Inc.   Services: Business   Term Loan B   Loan   1M USD SOFR+ 5.25 %     0.00 %     9.81 %   2/11/2028     1,500,000       1,403,100       1,455,945  
Chemours Company, (The)   Chemicals, Plastics, & Rubber   Term Loan   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.39 %   4/3/2025     905,031       880,859       898,406  
Churchill Downs Incorporated   Hotel, Gaming & Leisure   Term Loan B1 (3/21)   Loan   1M USD LIBOR+ 2.00 %     0.00 %     6.64 %   3/17/2028     491,250       490,382       486,952  
CIMPRESS PUBLIC LIMITED COMPANY   Media: Advertising, Printing & Publishing   USD Term Loan   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   5/17/2028     1,979,950       1,892,607       1,785,419  
CITADEL SECURITIES LP   Banking, Finance, Insurance & Real Estate   Term Loan B (01/21)   Loan   1M USD SOFR+ 2.50 %     0.00 %     7.23 %   2/2/2028     4,912,500       4,910,914       4,865,684  
Clarios Global LP   Automotive   Term Loan B1   Loan   1M USD LIBOR+ 3.25 %     0.00 %     7.88 %   4/30/2026     1,267,812       1,261,524       1,260,091  
Claros Mortgage Trust, Inc   Banking, Finance, Insurance & Real Estate   Term Loan B-1 (11/21)   Loan   1M USD SOFR+ 4.50 %     0.50 %     9.16 %   8/9/2026     3,439,962       3,421,651       3,401,262  
CLYDESDALE ACQUISITION HOLDINGS, INC.   Containers, Packaging & Glass   Term Loan B   Loan   1M USD SOFR+ 4.18 %     0.50 %     8.89 %   4/13/2029     1,492,500       1,458,949       1,469,993  
Cole Haan   Consumer goods: Non-durable   Term Loan B   Loan   3M USD LIBOR+ 5.50 %     0.00 %     10.23 %   2/7/2025     875,000       871,486       841,461  
Columbus McKinnon Corporation   Capital Equipment   Term Loan (4/21)   Loan   3M USD LIBOR+ 2.75 %     0.50 %     7.50 %   5/14/2028     449,172       448,339       446,926  

 

S-30

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
Conduent, Inc.   Services: Business   Term Loan B   Loan   1M USD LIBOR+ 4.25 %     0.50 %     8.88 %   10/16/2028     1,787,985       1,755,247       1,742,177  
Connect Finco SARL   Telecommunications   Term Loan (1/21)   Loan   1M USD SOFR+ 3.50 %     1.00 %     8.14 %   12/11/2026     2,917,500       2,816,917       2,863,526  
Consolidated Communications, Inc.   Telecommunications   Term Loan B   Loan   1M USD LIBOR+ 3.50 %     0.75 %     8.19 %   10/2/2027     2,714,005       2,520,099       2,435,819  
CORAL-US CO-BORROWER LLC   Telecommunications   Term Loan B-5   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.84 %   1/31/2028     4,000,000       3,988,733       3,867,160  
Corelogic, Inc.   Services: Business   Term Loan (4/21)   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.19 %   6/2/2028     2,468,750       2,459,383       2,110,164  
Cortes NP Acquisition Corp (Vertiv)   Capital Equipment   Term Loan 2/21   Loan   1M USD LIBOR+ 2.75 %     0.00 %     7.32 %   3/2/2027     1,960,000       1,960,000       1,934,579  
COWEN INC.   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   6M USD LIBOR+ 3.25 %     0.00 %     7.43 %   3/24/2028     3,927,406       3,907,308       3,922,496  
Creative Artists Agency, LLC   Media: Diversified & Production   Term Loan B (02/23)   Loan   1M USD SOFR+ 3.50 %     0.00 %     8.06 %   11/1/2028     1,600,000       1,588,000       1,595,008  
CROCS INC   Consumer goods: Durable   Term Loan   Loan   6M USD SOFR+ 3.50 %     0.50 %     7.73 %   2/20/2029     2,512,500       2,421,039       2,504,133  
Cross Financial Corp   Banking, Finance, Insurance & Real Estate   Term Loan B (3/21)   Loan   1M USD LIBOR+ 4.00 %     0.75 %     8.69 %   9/15/2027     492,500       492,174       489,422  
Crown Subsea Communications Holding, Inc.   Construction & Building   Term Loan (4/21)   Loan   1M USD LIBOR+ 4.75 %     0.75 %     9.32 %   4/27/2027     3,404,110       3,377,740       3,340,283  
CSC Holdings LLC (Neptune Finco Corp.)   Media: Broadcasting & Subscription   Term Loan B-5   Loan   1M USD LIBOR+ 2.50 %     0.00 %     7.09 %   4/15/2027     485,000       485,000       435,894  
CSC Holdings LLC (Neptune Finco Corp.)   Media: Broadcasting & Subscription   Term Loan 12/22   Loan   1M USD SOFR+ 4.50 %     0.00 %     9.06 %   4/15/2027     2,400,032       2,389,363       2,244,030  
CTS Midco, LLC   High Tech Industries   Term Loan B   Loan   3M USD LIBOR+ 6.00 %     1.00 %     10.83 %   11/2/2027     1,960,000       1,917,602       1,666,000  
Daseke Inc   Transportation: Cargo   Term Loan 2/21   Loan   1M USD LIBOR+ 4.00 %     0.75 %     8.64 %   3/5/2028     1,473,750       1,468,500       1,468,223  
Dave & Buster’s Inc.   Hotel, Gaming & Leisure   Term Loan B (04/22)   Loan   1M USD SOFR+ 5.00 %     0.50 %     9.75 %   6/29/2029     995,000       948,574       997,736  
DCert Buyer, Inc.   High Tech Industries   Term Loan   Loan   6M USD SOFR+ 4.00 %     0.00 %     8.70 %   10/16/2026     1,469,773       1,469,773       1,446,257  
Delek US Holdings, Inc.   Utilities: Oil & Gas   Term Loan B (11/22)   Loan   1M USD SOFR+ 3.50 %     0.50 %     8.22 %   11/16/2029     5,400,000       5,285,256       5,298,750  
Delta 2 Lux Sarl   Hotel, Gaming & Leisure   Term Loan B   Loan   1M USD SOFR+ 3.25 %     0.50 %     7.87 %   1/15/2030     1,000,000       990,424       1,001,750  
DexKo Global, Inc. (Dragon Merger)   Automotive   Term Loan (9/21)   Loan   3M USD LIBOR+ 3.75 %     0.50 %     8.48 %   10/4/2028     992,500       989,236       928,980  
DG Investment Intermediate Holdings 2, Inc.   Aerospace & Defense   Incremental Term Loan (3/22)   Loan   1M USD SOFR+ 4.75 %     0.75 %     9.37 %   3/31/2028     498,750       479,659       488,152  
Diamond Sports Group, LLC (b)   Media: Broadcasting & Subscription   Second Lien Term Loan   Loan   3M USD SOFR+ 3.40 %     0.00 %     8.03 %   8/24/2026     3,374,880       3,017,273       382,306  
Diamond Sports Group, LLC (b)   Media: Broadcasting & Subscription   1st Priority Term Loan   Loan   6M USD SOFR+ 8.00 %     1.00 %     13.06 %   5/25/2026     342,343       333,975       318,951  
DIRECTV FINANCING, LLC   Media: Broadcasting & Subscription   Term Loan   Loan   1M USD LIBOR+ 5.00 %     0.75 %     9.63 %   8/2/2027     3,550,000       3,523,794       3,448,754  
DISCOVERY PURCHASER CORPORATION   Chemicals, Plastics, & Rubber   Term Loan   Loan   3M USD SOFR+ 4.38 %     0.50 %     8.96 %   10/4/2029     1,500,000       1,385,334       1,433,310  
Dispatch Acquisition Holdings, LLC   Environmental Industries   Term Loan B (3/21)   Loan   3M USD LIBOR+ 4.25 %     0.75 %     8.98 %   3/25/2028     492,500       488,806       434,631  

 

S-31

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
DOMTAR CORPORATION   Forest Products & Paper   Term Loan 9/21   Loan   1M USD LIBOR+ 5.50 %     0.75 %     10.10 %   11/30/2028     1,310,136       1,272,492       1,286,121  
DOTDASH MEREDITH, INC.   Media: Advertising, Printing & Publishing   Term Loan B   Loan   1M USD SOFR+ 4.00 %     0.50 %     8.67 %   11/30/2028     1,994,949       1,803,027       1,755,556  
DRI HOLDING INC.   Media: Advertising, Printing & Publishing   Term Loan (12/21)   Loan   1M USD LIBOR+ 5.25 %     0.50 %     9.88 %   12/15/2028     3,972,487       3,830,439       3,552,913  
DRW Holdings, LLC   Banking, Finance, Insurance & Real Estate   Term Loan (2/21)   Loan   1M USD LIBOR+ 3.75 %     0.00 %     8.38 %   3/1/2028     6,435,000       6,396,896       6,284,164  
DTZ U.S. Borrower, LLC   Construction & Building   Term Loan   Loan   1M USD LIBOR+ 2.75 %     0.00 %     7.38 %   8/21/2025     1,612,878       1,609,665       1,602,798  
DTZ U.S. Borrower, LLC   Construction & Building   Term Loan (01/23)   Loan   1M USD SOFR+ 3.25 %     0.00 %     7.97 %   1/31/2030     2,034,413       2,031,025       2,021,698  
EAB Global, Inc.   Services: Business   Term Loan (08/21)   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   8/16/2028     990,000       985,965       969,586  
Echo Global Logistics, Inc.   Services: Business   Term Loan   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   11/23/2028     1,985,000       1,981,077       1,916,776  
Edelman Financial Group Inc., The   Banking, Finance, Insurance & Real Estate   Term Loan B (3/21)   Loan   1M USD LIBOR+ 3.50 %     0.75 %     8.13 %   4/7/2028     2,188,547       2,182,686       2,129,281  
Electrical Components Inter., Inc.   Capital Equipment   Term Loan (6/18)   Loan   1M USD LIBOR+ 4.25 %     0.00 %     8.88 %   6/26/2025     1,888,404       1,888,404       1,719,638  
ELECTRON BIDCO INC.   Healthcare & Pharmaceuticals   Term Loan   Loan   1M USD LIBOR+ 3.00 %     0.50 %     7.63 %   11/1/2028     496,250       494,396       491,208  
ELO Touch Solutions, Inc.   Media: Diversified & Production   Term Loan (12/18)   Loan   1M USD LIBOR+ 6.50 %     0.00 %     11.13 %   12/14/2025     2,175,269       2,121,627       2,169,831  
Embecta Corp   Healthcare & Pharmaceuticals   Term Loan B   Loan   6M USD SOFR+ 3.00 %     0.50 %     7.79 %   3/30/2029     614,918       611,634       604,735  
Endo Luxembourg Finance Company I S.a.r.l.   Healthcare & Pharmaceuticals   Term Loan (3/21)   Loan    Prime 6.00 %     0.75 %     13.75 %   3/27/2028     2,335,285       2,328,380       1,839,037  
Endure Digital, Inc.   High Tech Industries   Term Loan B   Loan   1M USD LIBOR+ 3.50 %     0.75 %     8.07 %   2/10/2028     2,462,500       2,453,593       2,276,581  
Entain Holdings (Gibraltar) Limited   Hotel, Gaming & Leisure   Term Loan B (10/22)   Loan   3M USD SOFR+ 3.50 %     0.50 %     8.18 %   10/30/2029     1,000,000       987,635       999,060  
Envision Healthcare Corporation   Healthcare & Pharmaceuticals   Term Loan B (06/18)   Loan   3M USD LIBOR+ 3.75 %     0.00 %     8.48 %   10/10/2025     4,784,383       4,782,311       1,202,076  
EOS U.S. FINCO LLC   Transportation: Cargo   Term Loan   Loan   3M USD SOFR+ 6.00 %     0.50 %     10.60 %   8/3/2029     1,000,000       923,495       986,250  
Equiniti Group PLC   Services: Business   Term Loan B   Loan   6M USD SOFR+ 4.50 %     0.50 %     9.54 %   12/11/2028     990,000       981,797       990,624  
EyeCare Partners, LLC   Healthcare & Pharmaceuticals   Term Loan   Loan   3M USD LIBOR+ 3.75 %     0.00 %     8.48 %   2/18/2027     1,948,081       1,948,081       1,621,174  
Finco I LLC   Banking, Finance, Insurance & Real Estate   Term Loan B (9/20)   Loan   1M USD LIBOR+ 2.50 %     0.00 %     7.13 %   6/27/2025     2,830,950       2,826,805       2,830,950  
First Brands Group, LLC   Automotive   1st Lien Term Loan (3/21)   Loan   6M USD SOFR+ 5.00 %     1.00 %     10.25 %   3/30/2027     4,912,500       4,854,265       4,754,367  
First Eagle Investment Management   Banking, Finance, Insurance & Real Estate   Refinancing Term Loan   Loan   3M USD LIBOR+ 2.50 %     0.00 %     7.23 %   2/1/2027     5,146,145       5,133,892       5,055,007  
First Student Bidco Inc.   Transportation: Consumer   Term Loan B   Loan   3M USD LIBOR+ 3.00 %     0.50 %     7.73 %   7/21/2028     723,088       718,928       689,255  

 

S-32

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
First Student Bidco Inc.   Transportation: Consumer   Term Loan C   Loan   3M USD LIBOR+ 3.00 %     0.50 %     7.73 %   7/21/2028     269,608       268,052       256,993  
Fitness International, LLC (LA Fitness)   Services: Consumer   Term Loan B (4/18)   Loan   3M USD SOFR+ 3.25 %     1.00 %     8.08 %   4/18/2025     1,330,058       1,326,810       1,268,211  
Flutter Financing B.V.   Hotel, Gaming & Leisure   Term Loan   Loan   3M USD LIBOR+ 2.25 %     0.00 %     6.98 %   7/21/2026     1,975,000       1,972,044       1,971,643  
Flutter Financing B.V.   Hotel, Gaming & Leisure   Third Amendment 2028-B Term Loan   Loan   3M USD SOFR+ 3.25 %     0.50 %     8.09 %   7/21/2028     748,125       732,248       747,848  
FOCUS FINANCIAL PARTNERS, LLC   Banking, Finance, Insurance & Real Estate   Term Loan B   Loan   1M USD SOFR+ 3.25 %     0.50 %     7.87 %   6/30/2028     1,487,298       1,470,684       1,477,765  
Franchise Group, Inc.   Services: Consumer   First Out Term Loan   Loan   3M USD LIBOR+ 4.75 %     0.75 %     9.56 %   3/10/2026     799,104       793,938       760,148  
Franchise Group, Inc.   Services: Consumer   Term Loan B   Loan   3M USD SOFR+ 4.75 %     0.75 %     9.70 %   3/10/2026     3,000,000       2,852,614       2,857,500  
Franklin Square Holdings, L.P.   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.94 %   8/1/2025     4,308,730       4,296,025       4,303,344  
Froneri International (R&R Ice Cream)   Beverage, Food & Tobacco   Term Loan B-2   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.88 %   1/29/2027     1,950,000       1,948,124       1,915,524  
Garrett LX III S.a r.l.   Automotive   Dollar Term Loan   Loan   3M USD LIBOR+ 3.25 %     0.50 %     8.08 %   4/30/2028     1,481,250       1,475,822       1,460,261  
Gates Global LLC   Automotive   Term Loan (11/22)   Loan   1M USD SOFR+ 3.50 %     0.50 %     8.12 %   11/15/2029     249,375       242,119       249,121  
Gemini HDPE LLC   Chemicals, Plastics, & Rubber   Term Loan B (12/20)   Loan   3M USD LIBOR+ 3.00 %     0.50 %     7.83 %   12/31/2027     2,289,884       2,276,592       2,281,297  
Genesee & Wyoming, Inc.   Transportation: Cargo   Term Loan (11/19)   Loan   3M USD LIBOR+ 2.00 %     0.00 %     6.73 %   12/30/2026     1,458,750       1,454,820       1,453,892  
GGP Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B   Loan   1M USD LIBOR+ 2.50 %     0.00 %     2.96 %   8/27/2025     3,072,992       2,734,560       3,053,141  
Global Tel*Link Corporation   Telecommunications   Term Loan B   Loan   3M USD SOFR+ 4.25 %     0.00 %     9.08 %   11/29/2025     4,897,634       4,753,219       4,342,830  
Go Daddy Operating Company, LLC   High Tech Industries   Term Loan 2/21   Loan   1M USD LIBOR+ 2.00 %     0.00 %     6.63 %   8/10/2027     1,959,799       1,959,799       1,950,255  
GOLDEN WEST PACKAGING GROUP LLC   Forest Products & Paper   Term Loan (11/21)   Loan   1M USD LIBOR+ 5.25 %     0.75 %     9.88 %   12/1/2027     1,962,500       1,946,411       1,903,625  
Graham Packaging Co Inc   Containers, Packaging & Glass   Term Loan (2/21)   Loan   1M USD LIBOR+ 3.00 %     0.75 %     7.63 %   8/7/2027     962,517       957,931       956,501  
Great Outdoors Group, LLC   Retail   Term Loan B2   Loan   1M USD LIBOR+ 3.75 %     0.75 %     8.38 %   3/6/2028     980,094       976,551       964,471  
Greenhill & Co., Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B   Loan   3M USD LIBOR+ 3.25 %     0.00 %     8.20 %   4/12/2024     2,844,231       2,836,329       2,789,707  
Griffon Corporation   Consumer goods: Durable   Term Loan B   Loan   1M USD SOFR+ 2.50 %     0.50 %     7.20 %   1/24/2029     154,375       154,051       152,959  
Grosvenor Capital Management Holdings, LLLP   Banking, Finance, Insurance & Real Estate   Amendment 5 Term Loan   Loan   1M USD LIBOR+ 2.50 %     0.50 %     7.13 %   2/24/2028     2,836,805       2,834,453       2,808,437  
Groupe Solmax Inc.   Environmental Industries   Term Loan (6/21)   Loan   3M USD LIBOR+ 4.75 %     0.75 %     9.48 %   5/27/2028     1,994,937       1,625,873       1,720,633  
Harbor Freight Tools USA, Inc.   Retail   Term Loan B (06/21)   Loan   1M USD LIBOR+ 2.75 %     0.50 %     7.38 %   10/19/2027     3,438,442       3,420,645       3,324,355  
Helix Gen Funding, LLc   Energy: Electricity   Term Loan B (02/17)   Loan   1M USD LIBOR+ 3.75 %     1.00 %     8.38 %   6/3/2024     209,702       209,702       208,332  
Hillman Group Inc. (The) (New)   Consumer goods: Durable   Term Loan B-1 (2/21)   Loan   1M USD LIBOR+ 2.75 %     0.50 %     7.38 %   7/14/2028     3,479,167       3,473,274       3,441,105  
Hillman Group Inc. (The) (New) (a)   Consumer goods: Durable   Delayed Draw Term Loan (2/21)   Loan   1M USD LIBOR+ 2.75 %     0.50 %     7.38 %   7/14/2028     66,667       66,667       57,444  
HLF Financing SARL (Herbalife)   Consumer goods: Non-durable   Term Loan B (08/18)   Loan   1M USD LIBOR+ 2.50 %     0.00 %     7.13 %   8/18/2025     3,510,000       3,504,423       3,452,225  

 

S-33

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
Holley Purchaser, Inc   Automotive   Term Loan (11/21)   Loan   3M USD LIBOR+ 3.75 %     0.75 %     8.48 %   11/17/2028     2,317,577       2,309,047       1,888,825  
Howden Group Holdings   Banking, Finance, Insurance & Real Estate   Term Loan (1/21)   Loan   1M USD LIBOR+ 3.25 %     0.75 %     7.94 %   11/12/2027     2,152,191       2,144,311       2,117,218  
Hudson River Trading LLC   Banking, Finance, Insurance & Real Estate   Term Loan (3/21)   Loan   1M USD SOFR+ 3.00 %     0.00 %     7.73 %   3/17/2028     5,895,000       5,850,826       5,619,173  
Idera, Inc.   High Tech Industries   Term Loan (02/21)   Loan   3M USD LIBOR+ 3.75 %     0.75 %     8.51 %   3/2/2028     4,811,111       4,802,585       4,635,698  
IMA Financial Group, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan (10/21)   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   11/1/2028     1,980,000       1,972,160       1,947,825  
INDY US BIDCO, LLC   Services: Business   Term Loan (11/21)   Loan   1M USD LIBOR+ 3.75 %     0.00 %     8.38 %   3/6/2028     2,215,703       2,215,226       1,888,200  
Ineos US Finance LLC   Chemicals, Plastics, & Rubber   Term Loan C   Loan   1M USD SOFR+ 3.75 %     0.00 %     8.42 %   2/9/2030     1,000,000       990,000       991,560  
INEOS US PETROCHEM LLC   Chemicals, Plastics, & Rubber   Term Loan (1/21)   Loan   1M USD LIBOR+ 2.75 %     0.50 %     7.38 %   1/29/2026     1,979,950       1,929,143       1,967,080  
Informatica Inc.   High Tech Industries   Term Loan B (10/21)   Loan   1M USD LIBOR+ 2.75 %     0.00 %     7.44 %   10/27/2028     496,250       495,896       494,761  
Ingram Micro Inc.   Wholesale   Term Loan   Loan   3M USD LIBOR+ 3.50 %     0.50 %     8.23 %   6/30/2028     1,477,500       1,465,872       1,468,266  
Inmar Acquisition Sub, Inc.   Services: Business   Term Loan B   Loan   1M USD LIBOR+ 4.00 %     1.00 %     8.63 %   5/1/2024     3,350,673       3,327,770       3,270,055  
Innophos, Inc.   Chemicals, Plastics, & Rubber   Term Loan B   Loan   1M USD LIBOR+ 3.25 %     0.00 %     7.88 %   2/4/2027     486,250       484,966       483,007  
INSTANT BRANDS HOLDINGS INC.   Consumer goods: Durable   Term Loan 4/21   Loan   3M USD LIBOR+ 5.00 %     0.75 %     9.95 %   4/7/2028     4,027,667       4,010,741       2,154,802  
IRB Holding Corporation   Beverage, Food & Tobacco   Term Loan B3   Loan   1M USD SOFR+ 3.00 %     0.75 %     7.57 %   12/14/2027     500,000       495,150       493,125  
IRB Holding T/L B (1/22)   Beverage, Food & Tobacco   Term Loan B   Loan   1M USD SOFR+ 3.00 %     0.75 %     7.69 %   12/15/2027     500,000       495,150       493,125  
Isagenix International, LLC (b)   Beverage, Food & Tobacco   Term Loan   Loan   3M USD LIBOR+ 7.75 %     1.00 %     11.35 %   6/14/2025     2,330,036       2,311,947       814,068  
J Jill Group, Inc   Retail   Priming Term Loan   Loan   3M USD LIBOR+ 5.00 %     1.00 %     9.83 %   5/8/2024     1,553,698       1,553,299       1,464,361  
Jane Street Group   Banking, Finance, Insurance & Real Estate   Term Loan (1/21)   Loan   1M USD LIBOR+ 2.75 %     0.00 %     7.38 %   1/31/2028     3,920,000       3,917,671       3,897,970  
Journey Personal Care Corp.   Consumer goods: Non-durable   Term Loan B   Loan   3M USD LIBOR+ 4.25 %     0.75 %     8.98 %   3/1/2028     985,000       981,310       731,569  
JP Intermediate B, LLC   Consumer goods: Non-durable   Term Loan   Loan   3M USD LIBOR+ 5.50 %     1.00 %     10.33 %   11/15/2025     3,884,160       3,863,896       2,469,199  
Klockner-Pentaplast of America, Inc.   Containers, Packaging & Glass   Term Loan (1/21) (USD)   Loan   6M USD SOFR+ 4.75 %     0.50 %     10.13 %   2/12/2026     1,473,750       1,469,605       1,354,936  
Kodiak BP, LLC   Construction & Building   Term Loan   Loan   3M USD LIBOR+ 3.25 %     0.75 %     7.98 %   3/13/2028     491,242       490,111       472,083  
KREF Holdings X LLC   Banking, Finance, Insurance & Real Estate   Term Loan (11/21)   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   9/1/2027     491,288       482,835       482,690  
Lakeland Tours, LLC   Hotel, Gaming & Leisure   Holdco Fixed Term Loan   Loan   Fixed 0.00 %     0.00 %     13.25 %   9/27/2027     990,775       383,373       644,004  
Lealand Finance Company B.V.   Energy: Oil & Gas   Exit Term Loan   Loan   1M USD LIBOR+ 1.00 %     0.00 %     5.63 %   6/30/2025     345,078       345,078       221,426  
LHS BORROWER, LLC   Construction & Building   Term Loan (02/22)   Loan   1M USD SOFR+ 4.75 %     0.50 %     9.47 %   2/16/2029     997,487       815,989       817,940  
Lifetime Brands, Inc   Consumer goods: Non-durable   Term Loan B   Loan   1M USD SOFR+ 3.50 %     1.00 %     8.23 %   2/28/2025     2,616,496       2,602,628       2,295,975  
Liquid Tech Solutions Holdings, LLC   Services: Business   Term Loan   Loan   6M USD LIBOR+ 4.75 %     0.00 %     8.92 %   3/17/2028     985,000       982,312       940,675  

 

S-34

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
LogMeIn, Inc.   High Tech Industries   Term Loan (8/20)   Loan   1M USD LIBOR+ 4.75 %     0.00 %     9.38 %   8/31/2027     3,920,000       3,868,809       2,137,145  
LOYALTY VENTURES INC. (b)   Services: Business   Term Loan B   Loan   Prime 3.50 %     0.50 %     11.25 %   11/3/2027     3,089,630       3,074,278       926,889  
LPL Holdings, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B1   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.32 %   11/11/2026     1,207,856       1,206,501       1,203,701  
LSF11 A5 HOLDCO LLC   Chemicals, Plastics, & Rubber   Term Loan (01/23)   Loan   1M USD SOFR+ 4.25 %     0.50 %     8.97 %   10/14/2028     500,000       486,534       489,165  
LSF11 A5 HOLDCO LLC   Chemicals, Plastics, & Rubber   Term Loan   Loan   1M USD SOFR+ 3.50 %     0.50 %     8.23 %   10/16/2028     248,125       247,170       241,508  
LSF9 Atlantis Holdings, LLC (A Wireless)   Retail   Term Loan B   Loan   3M USD SOFR+ 7.25 %     0.75 %     11.83 %   3/29/2029     2,962,500       2,872,908       2,888,438  
MAGNITE, INC.   Services: Business   Term Loan   Loan   1M USD LIBOR+ 5.00 %     0.75 %     9.63 %   4/28/2028     2,964,950       2,901,156       2,826,575  
Marriott Ownership Resorts, Inc.   Hotel, Gaming & Leisure   Term Loan (11/19)   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.38 %   8/29/2025     1,317,074       1,317,074       1,308,842  
Match Group, Inc, The   Services: Consumer   Term Loan (1/20)   Loan   3M USD LIBOR+ 1.75 %     0.00 %     6.49 %   2/15/2027     250,000       249,658       247,500  
Maxar Technologies Inc   Aerospace & Defense   Term Loan (6/22)   Loan   1M USD SOFR+ 4.25 %     0.50 %     8.97 %   6/14/2029     1,994,987       1,926,722       1,997,641  
Mayfield Agency Borrower Inc. (FeeCo)   Banking, Finance, Insurance & Real Estate   Term Loan B (02/23)   Loan   3M USD SOFR+ 5.00 %     0.00 %     8.81 %   2/27/2028     3,450,000       3,346,500       3,363,750  
McGraw-Hill Education, Inc.   Media: Advertising, Printing & Publishing   Term Loan (07/21)   Loan   3M USD LIBOR+ 4.75 %     0.50 %     9.70 %   7/28/2028     1,975,000       1,957,770       1,894,025  
MedAssets Software Inter Hldg, Inc.   High Tech Industries   Term Loan (11/21) (USD)   Loan   1M USD LIBOR+ 4.00 %     0.50 %     8.63 %   12/18/2028     496,250       493,413       462,753  
Mermaid Bidco Inc.   High Tech Industries   Term Loan B2   Loan   3M USD LIBOR+ 3.50 %     0.75 %     8.30 %   12/22/2027     983,769       981,224       964,093  
Messer Industries, LLC   Chemicals, Plastics, & Rubber   Term Loan B   Loan   3M USD LIBOR+ 2.50 %     0.00 %     7.23 %   3/1/2026     2,980,405       2,970,477       2,968,871  
Michaels Companies Inc   Retail   Term Loan B (Magic Mergeco)   Loan   3M USD LIBOR+ 4.25 %     0.75 %     8.98 %   4/8/2028     2,467,450       2,452,022       2,254,632  
MPH Acquisition Holdings LLC (Multiplan)   Services: Business   Term Loan B (08/21)   Loan   3M USD LIBOR+ 4.25 %     0.50 %     9.20 %   9/1/2028     2,992,424       2,725,679       2,509,148  
MW Industries, Inc. (Helix Acquisition Holdings)   Capital Equipment   Term Loan (2019 Incremental)   Loan   3M USD LIBOR+ 3.75 %     0.00 %     8.48 %   9/30/2024     2,842,097       2,823,791       2,778,150  
NAB Holdings, LLC (North American Bancard)   Banking, Finance, Insurance & Real Estate   Term Loan (11/21)   Loan   3M USD SOFR+ 3.00 %     0.50 %     7.73 %   11/23/2028     2,970,000       2,963,897       2,927,678  
Napa Management Services Corp   Healthcare & Pharmaceuticals   Term Loan B (02/22)   Loan   1M USD SOFR+ 5.25 %     0.75 %     9.95 %   2/22/2029     3,000,000       2,407,500       2,285,640  
Natgasoline LLC   Chemicals, Plastics, & Rubber   Term Loan   Loan   1M USD LIBOR+ 3.50 %     0.00 %     8.19 %   11/14/2025     3,436,481       3,419,311       3,395,690  
National Mentor Holdings, Inc.   Healthcare & Pharmaceuticals   Term Loan 2/21   Loan   1M USD SOFR+ 3.75 %     0.75 %     8.47 %   3/2/2028     2,736,043       2,727,702       2,108,477  
National Mentor Holdings, Inc.   Healthcare & Pharmaceuticals   Term Loan C 2/21   Loan   3M USD LIBOR+ 3.75 %     0.75 %     8.48 %   3/2/2028     87,464       87,137       67,402  
NEW ERA CAP, LLC   Consumer goods: Durable   Term Loan (01/22)   Loan   3M USD LIBOR+ 6.00 %     0.75 %     10.82 %   7/13/2027     3,628,164       3,627,422       3,483,037  
Nexstar Broadcasting, Inc. (Mission Broadcasting)   Media: Broadcasting & Subscription   Term Loan   Loan   1M USD LIBOR+ 2.50 %     0.00 %     7.13 %   9/18/2026     657,625       652,850       655,745  
Next Level Apparel, Inc.   Retail   Term Loan   Loan   3M USD LIBOR+ 5.50 %     1.00 %     10.33 %   8/9/2024     1,675,340       1,670,519       1,373,779  

 

S-35

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
NortonLifeLock Inc.   High Tech Industries   Term Loan B   Loan   1M USD SOFR+ 2.00 %     0.50 %     6.72 %   9/12/2029     1,398,374       1,392,077       1,382,391  
Novae LLC   Automotive   Term Loan B   Loan   3M USD SOFR+ 5.00 %     0.75 %     9.82 %   12/22/2028     1,985,000       1,972,048       1,692,213  
Nuvei Technologies Corp.   High Tech Industries   US Term Loan   Loan   1M USD LIBOR+ 2.50 %     0.50 %     7.13 %   9/29/2025     2,216,250       2,213,211       2,210,709  
Olaplex, Inc.   Consumer goods: Non-durable   Term Loan (2/22)   Loan   1M USD SOFR+ 3.50 %     0.50 %     8.20 %   2/23/2029     2,492,500       2,386,817       2,224,556  
Open Text Corporation   High Tech Industries   Term Loan B   Loan   1M USD SOFR+ 3.50 %     0.50 %     8.22 %   8/24/2029     1,500,000       1,455,000       1,496,955  
Organon & Co.   Healthcare & Pharmaceuticals   Term Loan USD   Loan   3M USD LIBOR+ 3.00 %     0.50 %     7.75 %   6/2/2028     2,327,083       2,318,310       2,297,995  
Pacific Gas & Electric   Utilities: Electric   Term Loan   Loan   1M USD LIBOR+ 3.00 %     0.50 %     7.69 %   6/18/2025     1,464,944       1,460,891       1,457,619  
PACTIV EVERGREEN GROUP HOLDINGS INC.   Containers, Packaging & Glass   Term Loan B   Loan   1M USD LIBOR+ 3.25 %     0.50 %     7.88 %   9/20/2028     987,500       983,571       981,950  
Padagis LLC   Healthcare & Pharmaceuticals   Term Loan   Loan   3M USD LIBOR+ 4.75 %     0.50 %     9.54 %   7/6/2028     941,176       933,570       864,122  
Panther Guarantor II, L.P. (Forcepoint)   High Tech Industries   Term Loan 1/21   Loan   3M USD LIBOR+ 4.25 %     0.50 %     9.08 %   1/7/2028     492,500       489,882       461,719  
PAR PETROLEUM LLC   Energy: Oil & Gas   Term Loan 2/23   Loan   1M USD SOFR+ 4.25 %     0.50 %     8.92 %   2/13/2030     1,500,000       1,477,500       1,479,375  
PATAGONIA HOLDCO LLC   Telecommunications   Term Loan B   Loan   3M USD SOFR+ 5.75 %     0.50 %     10.47 %   8/1/2029     1,995,000       1,653,635       1,700,738  
Pathway Partners Vet Management Company LLC   Services: Business   Term Loan   Loan   1M USD LIBOR+ 3.75 %     0.00 %     8.38 %   3/30/2027     486,509       479,333       424,630  
PCI Gaming Authority   Hotel, Gaming & Leisure   Term Loan   Loan   1M USD LIBOR+ 2.50 %     0.00 %     7.13 %   5/29/2026     809,038       806,994       807,396  
PEARLS (Netherlands) Bidco B.V.   Chemicals, Plastics, & Rubber   USD Term Loan (02/22)   Loan   3M USD SOFR+ 3.75 %     0.50 %     8.43 %   2/28/2029     992,500       990,539       975,131  
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC   Healthcare & Pharmaceuticals   Term Loan (12/22)   Loan   1M USD LIBOR+ 3.25 %     0.50 %     7.88 %   12/29/2028     1,292,862       1,287,663       1,272,396  
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC (a)   Healthcare & Pharmaceuticals   Delayed Draw Term Loan (12/21)   Loan   1M USD LIBOR+ 3.25 %     0.50 %     7.88 %   12/29/2028     147,287       147,287       144,174  
Penn National Gaming, Inc   Hotel, Gaming & Leisure   Term Loan B   Loan   1M USD SOFR+ 2.75 %     0.50 %     7.47 %   5/3/2029     995,000       990,530       990,851  
Peraton Corp.   Aerospace & Defense   Term Loan B   Loan   1M USD LIBOR+ 3.75 %     0.75 %     8.38 %   2/1/2028     5,306,577       5,291,284       5,249,372  
PHYSICIAN PARTNERS, LLC   Healthcare & Pharmaceuticals   Term Loan   Loan   1M USD SOFR+ 4.00 %     0.50 %     8.72 %   12/23/2028     1,985,000       1,967,896       1,900,638  
Pike Corporation   Construction & Building   Term Loan (8/22)   Loan   1M USD SOFR+ 3.50 %     0.00 %     8.12 %   1/21/2028     498,750       487,274       497,294  
Pitney Bowes Inc   Services: Business   Term Loan B   Loan   1M USD SOFR+ 4.00 %     0.00 %     8.73 %   3/17/2028     3,939,924       3,914,651       3,789,734  
Plastipak Holdings Inc.   Containers, Packaging & Glass   Term Loan B (11/21)   Loan   1M USD LIBOR+ 2.50 %     0.50 %     7.13 %   12/1/2028     1,921,176       1,913,386       1,911,974  
Playtika Holding Corp.   High Tech Industries   Term Loan B (3/21)   Loan   1M USD LIBOR+ 2.75 %     0.00 %     7.38 %   3/13/2028     4,421,250       4,414,119       4,370,804  
PMHC II, INC.   Chemicals, Plastics, & Rubber   Term Loan (02/22)   Loan   3M USD SOFR+ 4.25 %     0.50 %     9.08 %   4/21/2029     1,995,000       1,986,056       1,710,912  
PointClickCare Technologies, Inc.   High Tech Industries   Term Loan B   Loan   3M USD LIBOR+ 3.00 %     0.75 %     7.75 %   12/29/2027     491,250       489,531       487,566  

 

S-36

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
Polymer Process Holdings, Inc.   Containers, Packaging & Glass   Term Loan   Loan   1M USD LIBOR+ 4.75 %     0.75 %     9.38 %   2/12/2028     5,403,750       5,359,857       5,025,488  
Pre-Paid Legal Services, Inc.   Services: Consumer   Term Loan (12/21)   Loan   1M USD LIBOR+ 3.75 %     0.50 %     8.38 %   12/15/2028     2,977,500       2,956,393       2,929,116  
Presidio, Inc.   Services: Business   Term Loan B (1/20)   Loan   3M USD SOFR+ 3.50 %     0.00 %     8.28 %   1/22/2027     487,500       486,909       485,267  
Prime Security Services Borrower, LLC (ADT)   Services: Consumer   Term Loan (1/21)   Loan   3M USD LIBOR+ 2.75 %     0.75 %     7.52 %   9/23/2026     3,520,468       3,520,468       3,511,667  
PRIORITY HOLDINGS, LLC   Services: Consumer   Term Loan   Loan   3M USD LIBOR+ 5.75 %     1.00 %     10.70 %   4/27/2027     2,955,000       2,932,371       2,936,531  
PriSo Acquisition Corporation   Construction & Building   Term Loan (01/21)   Loan   3M USD LIBOR+ 3.25 %     0.75 %     8.00 %   12/28/2027     491,245       489,458       450,310  
Project Leopard Holdings, Inc. (NEW)   High Tech Industries   Term Loan B (06/22)   Loan   6M USD SOFR+ 5.25 %     0.50 %     9.80 %   7/20/2029     1,000,000       933,902       924,690  
Prometric Inc. (Sarbacane Bidco)   Services: Consumer   Term Loan   Loan   1M USD LIBOR+ 3.00 %     1.00 %     7.64 %   1/29/2025     476,438       475,777       444,278  
PUG LLC   Services: Consumer   Term Loan B (02/20)   Loan   1M USD LIBOR+ 3.50 %     0.00 %     8.13 %   2/12/2027     480,126       478,777       378,099  
QUEST BORROWER LIMITED   High Tech Industries   Term Loan (1/22)   Loan   3M USD SOFR+ 4.25 %     0.50 %     9.08 %   2/1/2029     1,990,000       1,972,710       1,707,539  
Rackspace Technology Global, Inc.   High Tech Industries   Term Loan (1/21)   Loan   3M USD LIBOR+ 2.75 %     0.75 %     7.60 %   2/15/2028     2,974,823       2,882,889       1,863,310  
RAND PARENT LLC   Transportation: Cargo   Term Loan B   Loan   1M USD SOFR+ 4.25 %     0.00 %     8.80 %   2/7/2030     1,500,000       1,462,500       1,455,000  
RealPage, Inc.   High Tech Industries   Term Loan (04/21)   Loan   1M USD LIBOR+ 3.00 %     0.50 %     7.63 %   4/24/2028     987,500       985,860       955,159  
Renaissance Learning, Inc.   Services: Consumer   Term Loan (5/18)   Loan   1M USD LIBOR+ 3.25 %     0.00 %     7.88 %   5/30/2025     2,938,373       2,922,432       2,871,025  
Rent-A-Center, Inc.   Retail   Term Loan B2 (9/21)   Loan   3M USD LIBOR+ 3.25 %     0.50 %     8.13 %   2/17/2028     1,976,155       1,934,422       1,927,997  
Research Now Group, Inc   Media: Advertising, Printing & Publishing   Term Loan   Loan   3M USD LIBOR+ 5.50 %     1.00 %     10.31 %   12/20/2024     4,298,135       4,249,328       3,200,305  
Resideo Funding Inc.   Services: Consumer   Term Loan (1/21)   Loan   3M USD LIBOR+ 2.25 %     0.50 %     7.12 %   2/11/2028     1,473,750       1,471,623       1,471,908  
Resolute Investment Managers (American Beacon), Inc.   Banking, Finance, Insurance & Real Estate   Term Loan (10/20)   Loan   3M USD LIBOR+ 4.25 %     1.00 %     8.98 %   4/30/2024     3,038,616       3,035,050       2,385,313  
Restoration Hardware, Inc.   Retail   Term Loan (9/21)   Loan   1M USD LIBOR+ 2.50 %     0.50 %     7.13 %   10/20/2028     3,462,437       3,456,353       3,320,477  
Reynolds Consumer Products LLC   Containers, Packaging & Glass   Term Loan   Loan   1M USD SOFR+ 1.75 %     0.00 %     6.47 %   1/29/2027     1,276,932       1,276,737       1,273,880  
Reynolds Group Holdings Inc.   Containers, Packaging & Glass   Term Loan B2   Loan   1M USD LIBOR+ 3.25 %     0.00 %     7.88 %   2/5/2026     3,124,551       3,114,804       3,114,302  
Rocket Software, Inc.   High Tech Industries   Term Loan (11/18)   Loan   1M USD LIBOR+ 4.25 %     0.00 %     8.88 %   11/28/2025     2,875,317       2,870,016       2,818,414  
Russell Investments US Inst’l Holdco, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan (10/20)   Loan   1M USD LIBOR+ 3.50 %     1.00 %     8.13 %   6/2/2025     5,590,662       5,565,048       5,499,813  
RV Retailer LLC   Automotive   Term Loan   Loan   3M USD SOFR+ 3.75 %     0.75 %     8.55 %   2/8/2028     2,957,631       2,912,519       2,516,441  
Ryan Specialty Group LLC   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   1M USD SOFR+ 3.00 %     0.75 %     7.72 %   9/1/2027     1,478,623       1,467,543       1,474,010  
S&S HOLDINGS LLC   Services: Business   Term Loan   Loan   3M USD LIBOR+ 5.00 %     0.50 %     9.83 %   3/10/2028     2,458,719       2,409,819       2,349,625  

 

S-37

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
Sally Holdings LLC   Retail   Term Loan B   Loan   1M USD SOFR+ 2.50 %     0.00 %     7.06 %   3/24/2030     500,000       496,250       498,750  
Samsonite International S.A.   Consumer goods: Non-durable   Term Loan B2   Loan   1M USD LIBOR+ 3.00 %     0.75 %     7.63 %   4/25/2025     927,537       914,134       927,537  
Schweitzer-Mauduit International, Inc.   High Tech Industries   Term Loan B   Loan   1M USD LIBOR+ 3.75 %     0.75 %     8.44 %   4/20/2028     2,955,000       2,942,014       2,895,900  
Scientific Games Holdings LP   Hotel, Gaming & Leisure   Term Loan B   Loan   3M USD SOFR+ 3.50 %     0.50 %     8.10 %   4/4/2029     498,750       497,703       489,942  
Sedgwick Claims Management Services, Inc.   Services: Business   Term Loan B 2/23   Loan   1M USD SOFR+ 3.75 %     0.00 %     8.32 %   2/17/2028     1,000,000       990,000       987,500  
SETANTA AIRCRAFT LEASING DAC   Aerospace & Defense   Term Loan   Loan   3M USD LIBOR+ 2.00 %     0.00 %     6.73 %   11/2/2028     1,000,000       998,000       991,250  
Signify Health, LLC   Healthcare & Pharmaceuticals   Term Loan B (6/21)   Loan   3M USD LIBOR+ 3.00 %     0.50 %     7.73 %   6/16/2028     493,750       491,846       493,750  
Sitel Worldwide Corporation   Services: Business   USD Term Loan (7/21)   Loan   1M USD LIBOR+ 3.75 %     0.50 %     8.39 %   8/28/2028     1,975,000       1,967,031       1,966,982  
SiteOne Landscape Supply, LLC   Services: Business   Term Loan (3/21)   Loan   1M USD LIBOR+ 2.00 %     0.50 %     6.64 %   3/18/2028     777,852       776,450       774,609  
SMG US Midco 2, Inc.   Services: Business   Term Loan (01/20)   Loan   3M USD LIBOR+ 2.50 %     0.00 %     7.33 %   1/23/2025     485,000       485,000       479,243  
Smyrna Ready Mix Concrete, LLC   Construction & Building   Term Loan   Loan   1M USD SOFR+ 4.25 %     0.50 %     8.97 %   4/2/2029     1,000,000       992,500       995,000  
Solis IV B.V.   Consumer goods: Durable   Term Loan B-1   Loan   3M USD SOFR+ 3.50 %     0.50 %     8.37 %   2/26/2029     1,994,987       1,724,963       1,826,132  
Sotheby’s   Services: Business   Term Loan (7/21)   Loan   3M USD LIBOR+ 4.50 %     0.50 %     9.33 %   1/15/2027     3,223,744       3,183,482       3,209,237  
Sparta U.S. HoldCo LLC   Chemicals, Plastics, & Rubber   Term Loan (04/21)   Loan   1M USD LIBOR+ 3.25 %     0.75 %     7.82 %   8/2/2028     1,980,000       1,972,123       1,964,160  
Specialty Pharma III Inc.   Services: Business   Term Loan   Loan   1M USD LIBOR+ 4.25 %     0.75 %     8.88 %   3/31/2028     1,975,000       1,959,930       1,821,938  
Spectrum Brands, Inc.   Consumer goods: Durable   Term Loan (2/21)   Loan   3M USD LIBOR+ 2.00 %     0.50 %     6.96 %   3/3/2028     491,250       490,363       487,158  
Spin Holdco, Inc.   Services: Consumer   Term Loan 3/21   Loan   3M USD LIBOR+ 4.00 %     0.75 %     8.77 %   3/4/2028     2,947,500       2,935,211       2,475,487  
Spirit Aerosystems Inc.   Aerospace & Defense   Term Loan (11/22)   Loan   3M USD SOFR+ 4.50 %     0.50 %     9.18 %   1/14/2027     498,750       484,414       498,541  
SRAM, LLC   Consumer goods: Durable   Term Loan (05/21)   Loan   1M USD LIBOR+ 2.75 %     0.50 %     7.38 %   5/12/2028     2,709,091       2,705,948       2,682,000  
SS&C Technologies, Inc.   Services: Business   Term Loan B3   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.38 %   4/16/2025     167,061       166,987       166,678  
SS&C Technologies, Inc.   Services: Business   Term Loan B4   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.38 %   4/16/2025     148,146       148,083       147,807  
SS&C Technologies, Inc.   Services: Business   Term Loan B-5   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.38 %   4/16/2025     458,152       457,773       457,199  
STANDARD INDUSTRIES INC.   Construction & Building   Term Loan B   Loan   6M USD LIBOR+ 2.25 %     0.50 %     6.43 %   9/22/2028     630,250       625,240       628,032  
Staples, Inc.   Wholesale   Term Loan (03/19)   Loan   3M USD LIBOR+ 5.00 %     0.00 %     9.81 %   4/16/2026     4,341,357       4,246,081       4,013,802  
Storable, Inc   High Tech Industries   Term Loan B   Loan   3M USD SOFR+ 3.50 %     0.50 %     8.08 %   4/17/2028     495,000       494,153       482,318  
Summit Materials, LLC   Metals & Mining   Term Loan B (12/22)   Loan   3M USD SOFR+ 3.00 %     0.00 %     7.61 %   12/13/2027     250,000       247,640       249,583  
Superannuation & Investments US LLC   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   1M USD LIBOR+ 3.75 %     0.50 %     8.38 %   12/1/2028     990,000       981,648       984,515  
Sweetwater Borrower, LLC   Retail   Term Loan (8/21)   Loan   1M USD LIBOR+ 4.25 %     0.75 %     8.94 %   8/2/2028     2,000,000       1,905,968       1,880,000  

 

S-38

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
Syncsort Incorporated   High Tech Industries   Term Loan B (10/21)   Loan   3M USD LIBOR+ 4.00 %     0.75 %     8.82 %   4/24/2028     2,469,987       2,468,993       2,243,984  
Ta TT Buyer LLC   Media: Broadcasting & Subscription   Term Loan 3/22   Loan   6M USD SOFR+ 5.00 %     0.50 %     8.98 %   4/2/2029     997,500       988,507       982,538  
Tenable Holdings, Inc.   Services: Business   Term Loan B (6/21)   Loan   3M USD LIBOR+ 2.75 %     0.50 %     7.58 %   7/7/2028     990,000       988,026       980,922  
Teneo Holdings LLC   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   1M USD SOFR+ 5.25 %     1.00 %     9.97 %   7/15/2025     4,383,217       4,330,652       4,322,948  
Ten-X, LLC   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   1M USD LIBOR+ 4.00 %     1.00 %     8.63 %   9/27/2024     1,900,000       1,899,296       1,819,250  
The Dun & Bradstreet Corporation   Services: Business   Term Loan B   Loan   1M USD SOFR+ 3.25 %     0.00 %     7.85 %   1/18/2029     248,125       246,554       246,636  
The Dun & Bradstreet Corporation   Services: Business   Term Loan   Loan   1M USD LIBOR+ 3.25 %     0.00 %     7.87 %   2/6/2026     962,949       962,285       960,021  
THE KNOT WORLDWIDE INC.   Services: Consumer   Term Loan (1/22)   Loan   1M USD SOFR+ 4.50 %     0.00 %     9.22 %   12/19/2025     4,845,447       4,840,970       4,833,333  
Thor Industries, Inc.   Automotive   USD Term Loan (3/21)   Loan   1M USD LIBOR+ 3.00 %     0.00 %     7.69 %   2/1/2026     2,015,823       1,990,264       2,004,494  
Torrid LLC   Wholesale   Term Loan 5/21   Loan   3M USD LIBOR+ 5.50 %     0.75 %     10.31 %   6/14/2028     2,978,835       2,540,024       2,529,031  
TORY BURCH LLC   Retail   Term Loan   Loan   1M USD LIBOR+ 3.50 %     0.50 %     8.13 %   4/15/2028     1,329,211       1,232,469       1,268,147  
Tosca Services, LLC   Containers, Packaging & Glass   Term Loan (2/21)   Loan   1M USD SOFR+ 3.50 %     0.75 %     8.23 %   8/18/2027     490,000       485,078       383,180  
Trans Union LLC   Banking, Finance, Insurance & Real Estate   Term Loan   Loan   1M USD LIBOR+ 2.25 %     0.50 %     6.88 %   12/1/2028     796,452       794,928       791,203  
Transdigm, Inc.   Aerospace & Defense   Term Loan H   Loan   3M USD SOFR+ 3.25 %     0.00 %     7.83 %   2/21/2027     1,993,370       1,990,666       1,989,941  
TRITON WATER HOLDINGS, INC.   Beverage, Food & Tobacco   Term Loan (03/21)   Loan   3M USD LIBOR+ 3.50 %     0.50 %     8.23 %   3/31/2028     1,477,502       1,471,933       1,372,422  
Tronox Finance LLC   Chemicals, Plastics, & Rubber   Term Loan   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.88 %   3/10/2028     346,923       346,338       340,907  
TruGreen Limited Partnership   Services: Consumer   Term Loan   Loan   1M USD LIBOR+ 4.00 %     0.75 %     8.63 %   10/29/2027     954,501       949,189       873,368  
Uber Technologies, Inc.   Transportation: Consumer   Term Loan B (2/21)   Loan   3M USD LIBOR+ 3.50 %     0.00 %     8.45 %   2/25/2027     3,906,277       3,874,854       3,913,620  
Ultra Clean Holdings, Inc.   High Tech Industries   Incremental Term Loan 3/21   Loan   1M USD LIBOR+ 3.75 %     0.00 %     8.38 %   8/27/2025     820,338       817,776       819,928  
Unimin Corporation   Metals & Mining   Term Loan (12/20)   Loan   3M USD LIBOR+ 4.00 %     1.00 %     8.78 %   7/31/2026     496,815       476,431       489,984  
United Natural Foods, Inc   Beverage, Food & Tobacco   Term Loan B   Loan   1M USD SOFR+ 3.25 %     0.00 %     7.98 %   10/22/2025     1,289,967       1,252,901       1,291,309  
United Road Services Inc.   Transportation: Cargo   Term Loan (10/17)   Loan   3M USD LIBOR+ 5.75 %     1.00 %     10.70 %   9/1/2024     889,180       886,242       465,335  
Univision Communications Inc.   Media: Broadcasting & Subscription   Term Loan B (6/21)   Loan   1M USD LIBOR+ 3.25 %     0.75 %     7.88 %   3/15/2026     2,446,648       2,441,783       2,426,610  
Univision Communications Inc.   Media: Broadcasting & Subscription   Term Loan B (6/22)   Loan   3M USD SOFR+ 4.25 %     0.50 %     8.83 %   6/25/2029     248,750       241,881       248,233  
Utz Quality Foods, LLC   Beverage, Food & Tobacco   Term Loan B   Loan   1M USD SOFR+ 3.00 %     0.00 %     7.73 %   1/20/2028     1,828,465       1,827,288       1,825,046  
Vaco Holdings, LLC   Services: Business   Term Loan (01/22)   Loan   3M USD SOFR+ 5.00 %     0.75 %     9.73 %   1/19/2029     2,342,210       2,275,198       2,310,989  

 

S-39

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

Issuer Name   Industry   Asset Name   Asset
Type
  Reference Rate/Spread   SOFR/
LIBOR Floor
    Current
Rate (All In)
    Maturity
Date
  Principal/
Number of Shares
    Cost     Fair Value  
Vericast Corp.   Media: Advertising, Printing & Publishing   Term Loan   Loan   3M USD SOFR+ 7.75 %     1.00 %     12.33 %   6/15/2026     1,201,006       1,199,817       939,787  
Verifone Systems, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan (7/18)   Loan   3M USD LIBOR+ 4.00 %     0.00 %     8.96 %   8/20/2025     1,368,031       1,364,137       1,269,875  
Vertex Aerospace Services Corp   Aerospace & Defense   Term Loan (10/21)   Loan   1M USD LIBOR+ 3.50 %     0.75 %     8.13 %   12/6/2028     992,500       988,789       987,895  
VFH Parent LLC   Banking, Finance, Insurance & Real Estate   Term Loan (01/22)   Loan   1M USD SOFR+ 3.00 %     0.50 %     7.66 %   1/12/2029     3,069,879       3,063,097       3,036,111  
Viasat Inc   Telecommunications   Term Loan (2/22)   Loan   1M USD SOFR+ 4.50 %     0.50 %     9.23 %   3/2/2029     1,994,987       1,948,951       1,967,137  
Virtus Investment Partners, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B (9/21)   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.85 %   9/28/2028     2,853,409       2,845,646       2,834,377  
Vistra Energy Corp   Utilities: Electric   2018 Incremental Term Loan   Loan   1M USD LIBOR+ 1.75 %     0.00 %     6.38 %   12/31/2025     897,014       896,802       895,023  
Vizient, Inc   Healthcare & Pharmaceuticals   Term Loan 4/22   Loan   1M USD SOFR+ 2.25 %     0.50 %     6.91 %   5/16/2029     497,500       492,868       496,525  
VM Consolidated, Inc.   Construction & Building   Term Loan B (3/21)   Loan   1M USD LIBOR+ 3.25 %     0.00 %     7.88 %   3/24/2028     2,185,087       2,183,095       2,180,170  
Vouvray US Finance LLC   High Tech Industries   Term Loan   Loan   1M USD SOFR+ 6.00 %     1.00 %     10.62 %   9/9/2025     471,250       471,250       442,386  
Walker & Dunlop, Inc.   Banking, Finance, Insurance & Real Estate   Term Loan B (12/22)   Loan   1M USD SOFR+ 3.00 %     0.50 %     7.72 %   12/15/2028     500,000       490,249       496,250  
Warner Music Group Corp. (WMG Acquisition Corp.)   Hotel, Gaming & Leisure   Term Loan Incremental (11/22)   Loan   1M USD SOFR+ 3.00 %     0.50 %     7.62 %   1/19/2028     500,000       490,562       498,960  
Warner Music Group Corp. (WMG Acquisition Corp.)   Hotel, Gaming & Leisure   Term Loan G   Loan   1M USD LIBOR+ 2.13 %     0.00 %     6.76 %   1/20/2028     1,250,000       1,249,851       1,243,750  
Watlow Electric Manufacturing Company   High Tech Industries   Term Loan B   Loan   3M USD SOFR+ 3.75 %     0.50 %     8.69 %   3/2/2028     2,456,250       2,447,468       2,417,368  
West Corporation   Telecommunications   Term Loan B-3   Loan   3M USD SOFR+ 4.00 %     1.00 %     8.93 %   4/9/2027     1,189,119       1,172,865       1,044,939  
WEX Inc.   Services: Business   Term Loan B (3/21)   Loan   1M USD LIBOR+ 2.25 %     0.00 %     6.88 %   3/31/2028     2,954,924       2,946,492       2,944,582  
WildBrain Ltd.   Media: Diversified & Production   Term Loan   Loan   1M USD SOFR+ 4.25 %     0.75 %     8.98 %   3/27/2028     1,965,000       1,935,307       1,864,903  
Xperi Corporation   High Tech Industries   Term Loan   Loan   1M USD LIBOR+ 3.50 %     0.00 %     8.13 %   6/8/2028     2,427,446       2,420,580       2,388,752  
Zayo Group, LLC   Telecommunications   Term Loan 4/22   Loan   1M USD SOFR+ 4.25 %     0.50 %     8.87 %   3/9/2027     992,500       971,029       842,027  
ZEBRA BUYER (Allspring) LLC   Banking, Finance, Insurance & Real Estate   Term Loan 4/21   Loan   3M USD LIBOR+ 3.00 %     0.50 %     7.75 %   11/1/2028     880,444       876,985       874,941  
Zekelman Industries, Inc.   Metals & Mining   Term Loan (01/20)   Loan   3M USD LIBOR+ 2.00 %     0.00 %     6.73 %   1/25/2027     961,471       961,471       948,251  
Zest Acquisition Corp.   Healthcare & Pharmaceuticals   Term Loan (1/23)   Loan   1M USD SOFR+ 5.50 %     0.00 %     10.07 %   1/31/2028     2,000,000       1,901,512       1,928,340  
Zodiac Pool Solutions   Consumer goods: Durable   Term Loan (1/22)   Loan   1M USD SOFR+ 2.00 %     0.50 %     6.72 %   1/29/2029     495,000       494,015       490,192  
TOTAL INVESTMENTS                                                $ 645,599,001     $ 605,954,468  

 

S-40

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2023

 

   Number of Shares   Cost   Fair Value 
Cash and cash equivalents               
U.S. Bank Money Market (c)   23,776,950   $23,776,950   $23,776,950 
Total cash and cash equivalents   23,776,950   $23,776,950   $23,776,950 

 

 

 

(a)All or a portion of this investment has an unfunded commitment as of February 28, 2023.
(b)As of February 28, 2023, the investment was in default and on non-accrual status.
(c)Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 28, 2023.
(d)Investments include Payment-in-Kind Interest.

 

LIBOR - London Interbank Offered Rate

SOFR - Secured Overnight Financing Rate

 

1M USD LIBOR - The 1-month USD LIBOR rate as of February 28, 2023 was 4.67%.

3M USD LIBOR - The 3-month USD LIBOR rate as of February 28, 2023 was 4.97%.

6M USD LIBOR - The 6-month USD LIBOR rate as of February 28, 2023 was 5.26%.

1M SOFR - The 1-month SOFR rate as of February 28, 2023 was 4.66%.

3M SOFR - The 3-month SOFR rate as of February 28, 2023 was 4.89%.

6M SOFR - The 6-month SOFR rate as of February 28, 2023 was 5.15%.

 

Prime—The Prime Rate as of February 28, 2023 was 7.75%.

 

See accompanying notes to financial statements.

 

S-41

 

 

SARATOGA INVESTMENT CORP. CLO 2013-1, LTD.

 

NOTES TO FINANCIAL STATEMENTS

 

1. Organization and Purpose

 

Saratoga Investment Corp. CLO 2013-1, Ltd. (the “Issuer”, “we”, “our”, “us”, “CLO” or “Saratoga CLO”), an exempted company with limited liability incorporated under the laws of the Cayman Islands was formed on November 28, 2007 and commenced operations on January 22, 2008. The Issuer was established to acquire or participate in U.S. dollar-denominated corporate debt obligations. The “Company” refers to Saratoga Investment Corp.

 

On January 22, 2008, the Issuer issued $400.0 million of notes, consisting of Class A Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes (collectively the “Secured Notes”), and Subordinated Notes. The notes were issued pursuant to an indenture, dated January 22, 2008 (the “Indenture”), with U.S. Bank National Association (the “Trustee”) servicing as the Trustee thereunder.

 

On October 17, 2013, in a refinancing transaction, the Issuer issued $284.9 million of notes (the “2013-1 CLO Notes”), consisting of Class X Floating Rate Senior Notes, Class A-1 Floating Rate Senior Notes, Class A-2 Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes, and Class F Deferrable Floating Rate Notes. The 2013-1 CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 CLO Notes were used, along with existing assets held by the Trustee, to redeem all of the Secured Notes issued in 2008.

 

On November 15, 2016, in a refinancing transaction, the Issuer issued $282.4 million of notes (the “2013-1 Amended CLO Notes”), consisting of Class A-1 Floating Rate Senior Notes, Class A-2 Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes, and Class F Deferrable Floating Rate Notes. The 2013-1 Amended CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 Amended CLO Notes were used, along with existing assets held by the Trustee, to redeem all of the 2013-1 CLO Notes issued in 2013. 

 

On December 14, 2018, in a refinancing transaction, the Issuer issued $509.5 million of notes (the “2013-1 Reset CLO Notes”), consisting of Class A-1FL-R-2 Floating Rate Senior Notes, Class A-1FXD-R-2 Fixed Rate Senior Notes, Class A-2-R-2 Floating Rate Senior Notes, Class B-R-2 Floating Rate Senior Notes, Class C-R-2 Deferrable Mezzanine Floating Rate Notes, Class D-R-2 Deferrable Mezzanine Floating Rate Notes, Class E-1-R-2 Deferrable Mezzanine Floating Rate Notes, Class F-R-2 Deferrable Junior Floating Rate Notes, Class G-R-2 Deferrable Junior Floating Rate Notes, and Subordinated Notes. The 2013-1 Reset CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 Reset CLO Notes were used along with existing assets held by the Trustee to redeem all of the Secured Notes issued in 2016.

 

On February 26, 2021, in a refinancing transaction, the Issuer issued $722.0 million of notes consisting of Class A-1-R-3 Senior Secured Floating Rate Notes (“Class A-1-R-3 Notes”), Class A-2-R-3 Senior Secured Floating Rate Notes (“Class A-2-R-3 Notes”), Class B-FL-R-3 Senior Secured Floating Rate Notes (“Class B-FL-R-3 Notes”), Class B-FXD-R-3 Senior Secured Fixed Rate Notes (“Class B-FXD-R-3 Notes”), Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes (“Class C-FL-R-3 Notes”), Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes (“Class C-FXD-R-3 Notes”), Class D-R-3 Deferrable Mezzanine Floating Rate Notes (“Class D-R-3 Notes”), Class E-R-3 Deferrable Mezzanine Floating Rate Notes (Class E-R-3 Notes”), Class F-R-3 Deferrable Junior Floating Rate Notes (Class F-R-3 Notes”), and Subordinated Notes. The Class D-R-3 Notes, Class E-R-c Notes and Subordinated Notes were issued at a discount, which is being amortized over the term of the notes. Proceeds net of issue discounts were used along with existing trust assets to redeem all of the rated note classes of the 2013-1 Reset CLO Notes. $69.5 million of Subordinated Notes issued in connection with the 2008 CLO Notes, 2013-1 CLO Notes, 2013-1 Amended CLO Notes and 2013-1 CLO Reset Notes were not redeemed and remained outstanding.

 

S-42

 

 

On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par as a non cash transaction. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

 

Pursuant to an investment management agreement (the “Investment Management Agreement”), Saratoga Investment Corp. (the “Investment Manager”), provides investment management services to the Issuer, and makes day-to-day investment decisions concerning the assets of the Issuer. The Investment Manager also performs certain administrative services on behalf of the Issuer under the Investment Management Agreement. The CLO is both managed by and a wholly owned subsidiary of Saratoga Investment Corp.

 

2. Significant Accounting Policies

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and are stated in U.S. dollars. The following is a summary of the significant accounting policies followed by the Issuer in the preparation of its financial statements.

 

The Issuer is considered to be an investment company for financial reporting purposes and has applied the guidance in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies. There has been no change to the Issuer’s status as an investment company during the year ended February 29, 2024.

 

Use of Estimates

 

The preparation of the financial statements in conformity with U.S. GAAP requires the Investment Manager to make estimates and assumptions that affect the amounts of assets and liabilities reported and disclosed at the date of the financial statements, including the fair value of investments, and the amounts of income and expenses during the reporting period. Actual results could differ from these estimates and such differences could be material.

 

Cash and Cash Equivalents

 

The Issuer defines cash and cash equivalents as highly-liquid financial instruments with original maturities of three months or less. Cash and cash equivalents may include investments in money market mutual funds, which are carried at fair value. At February 29, 2024 and February 28, 2023, cash and cash equivalents amounted to $12.1 million and $23.8 million, respectively, and are swept on an overnight basis into a U.S. Bank money market deposit account held at the Trustee.

 

Valuation of Investments

 

The Issuer accounts for its investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Issuer to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

 

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by the Investment Manager to approve a fair value determination to reflect significant events affecting the value of these investments. The Investment Manager values investments for which market quotations are not readily available at fair value. Determinations of fair value may involve significant judgments and estimates. The types of factors that may be considered in determining the fair value of investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

 

S-43

 

 

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that are ultimately realized upon the disposal of such investments.

 

Investment Transactions and Income Recognition

 

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

 

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. The Issuer stops accruing interest on its investments when it is determined that interest is no longer collectible, with all outstanding accrued interest reserved immediately. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon the Investment Manager’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. The Issuer elected not to measure an allowance for credit losses for accrued interest receivables. At February 29, 2024 and February 28, 2023 we had two and three investments that were on non-accrual status, which we established a reserve of $0.6 million and $0.2 million, respectively, against interest receivable related to portfolio companies that were on non-accrual status and will be written off in a timely manner.

 

Payment-in-Kind Interest

 

The Issuer holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022 we recorded $0.3 million, $0.2 million and $0.6 in PIK interest.

 

Deferred Debt Financing Costs, net

 

The Issuer presents deferred debt financing costs on the balance sheet as a contra-liability as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.

 

As of February 29, 2020, included in deferred debt financing costs of $2.3 million, are structuring fees of the investment bank, rating agency and legal fees, and other various closing costs associated with the issuance of the 2013-1 Reset CLO Notes on December 14, 2018. Such costs have been capitalized and amortized using an effective yield method, as appropriate, over the life of the related notes.

 

New debt financing costs of $2.3 million were incurred with the issuance of the 2013-1 2021 Reset CLO Notes on February 26, 2021. These costs consist of structuring fees of the investment bank, rating agency and legal fees, and other various closing costs. Of that amount, $1.8 million has been capitalized and amortized using an effective yield method, as appropriate, over the life of the related notes.

 

S-44

 

 

Management Fees

 

The Issuer is externally managed by the Investment Manager pursuant to the Investment Management Agreement. As compensation for the performance of its obligations under the Investment Management Agreement, the Investment Manager is entitled to receive from the Issuer a base management fee (the “Base Management Fee”), a subordinated management fee (the “Subordinated Management Fee”) and an incentive management fee (the “Incentive Management Fee”). The Base Management Fee is payable in arrears quarterly (subject to availability of funds and to the satisfaction of payment obligations on the debt obligations of the Issuer (the “Priority of Payments”)) and prior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, was payable in an amount equal to 0.25% per annum of the fee basis amount at the beginning of the Collection Period. The Subordinated Management Fee is payable in arrears quarterly (subject to availability of funds and to the Priority of Payments) and prior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, was payable in an amount equal to 0.25% per annum of the fee basis amount at the beginning of the Collection Period. Subsequent to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, the Base Management Fee was changed to be payable in an amount equal to 0.10% per annum of the fee basis amount at the beginning of the Collection Period, and the Subordinated Management Fees was changed to be payable in an amount equal to 0.40% per annum of the fee basis amount at the beginning of the Collection Period. This remained unchanged during the third refinancing and the issuance of the 2013-1 Reset CLO Notes, as well as the fourth refinancing and issuance of the 2013-1 2021 Reset CLO Notes.

 

Prior to the third refinancing of the CLO, the Incentive Management Fee equaled 20.0% of the remaining interest proceeds and principal proceeds, if any, after the Subordinated Notes have realized the Incentive Management Fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. The Investment Manager is no longer eligible to receive the Incentive Management Fee following the third refinancing of the CLO on December 14, 2018.

 

Expenses

 

The Issuer bears its own organizational and offering expenses, all expenses related to its investment program and expenses incurred in connection with its operations including, but not limited to, external legal, administrative, trustee, accounting, tax and audit expenses, costs related to trading, acquiring, monitoring or disposing of investments of the Issuer, and interest and other borrowing expenses, expenses of preparing and distributing reports, financial statements, and litigation or other extraordinary expenses. The Issuer has retained the Trustee to provide trustee services. Additionally, the Trustee performs loan administration, debt covenant compliance calculations, and monitoring and reporting services. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, the Issuer paid $0.3 million, $0.3 million and $0.3 million, respectively, for trustee services provided and is included on the statements of operations.

 

Interest Expense

 

The Issuer has issued rated and unrated notes to finance its operations. Interest on debt is calculated by the Trustee for the Issuer. Interest is accrued and generally paid quarterly. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, $6.9 million, $4.9 million and $5.2 million of payments to the Subordinated Notes were included in interest and debt financing expenses on the statements of operations, respectively. For the years ended February 29, 2024 and February 28, 2023 and February 28, 2022, $4.4 million, $4.4 million and $4.4 million, respectively, in discount amortization related to the Subordinated Notes is also included in interest and debt financing expenses on the Issuer’s statements of operations and statements of cash flows.

 

Risk Management

 

In the ordinary course of its business, the Issuer manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

 

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

 

The Issuer is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution.

 

The Issuer has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

 

S-45

 

 

New Accounting Pronouncements

 

In June 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820) (“ASU 2022-03”), which clarifies that a contractual sale restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security and is not included in the equity security’s unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value. In addition, ASU 2022-03 prohibits an entity from recognizing a contractual sale restriction as a separate unit of account. ASU 2022-03’s amendments are effective for fiscal years beginning after December 15, 2023, with early adoption permitted. We are currently evaluating the impact of the adoption of ASU 2022-03 on our consolidated financial statements.

 

In March 2020, the FASB issued Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) to provide optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. ASU 2020-04 established Topic 848 to provide relief during the temporary transition period and includes a sunset provision based on expectations of when the London Interbank Offered Rate (“LIBOR”) would cease being published. In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which deferred the sunset day of this guidance to December 31, 2024. With the adoption of ASU 2022-06, there was no significant impact to our consolidated financial position.

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. The amendments in this update require more disaggregated information on income taxes paid. ASU 2023-09 is effective for years beginning after December 15, 2024. Early adoption is permitted, however the Company has not elected to adopt this provision as of the date of the financial statements contained in this report. The Company is still assessing the impact of the new guidance. However, it does not expect ASU 2023-09 to have a material impact on the consolidated financial statements and the notes thereto.

 

3. Fair Value Measurements

 

As noted above, the Issuer values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

 

Based on the observability of the inputs used in the valuation techniques, the Issuer is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

  Level 1— Valuations based on quoted prices in active markets for identical assets or liabilities that the Issuer has the ability to access.

 

  Level 2— Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. Such inputs may be quoted prices for similar assets or liabilities, quoted markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full character of the financial instrument, or inputs that are derived principally from, or corroborated by, observable market information. Investments which are generally included in this category include illiquid debt securities and less liquid, privately held or restricted equity securities, for which some level of recent trading activity has been observed.

 

  Level 3— Pricing inputs are unobservable for the investment and include situations where there is little, if any, market activity for the investment. The inputs may be based on the Company’s own assumptions about how market participants would price the asset or liability or may use Level 2 inputs, as adjusted, to reflect specific investment attributes relative to a broader market assumption. These inputs into the determination of fair value may require significant management judgment or estimation. Even if observable market data for comparable performance or valuation measures (earnings multiples, discount rates, other financial/valuation ratios, etc.) are available, such investments are grouped as Level 3 if any significant data point that is not also market observable (private company earnings, cash flows, etc.) is used in the valuation methodology.

 

S-46

 

 

In addition to using the above inputs in investment valuations, the Issuer continues to employ the valuation policy that is consistent with ASC 820 and the Investment Company Act of 1940, as amended (“1940 Act”).

 

The following table presents fair value measurements of investments, by major class, as of February 29, 2024, according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 
Term loans  $     -   $544,194,304   $62,336,885   $606,531,189 
Equity interests   -    44,587    975,998    1,020,585 
Total  $-   $544,238,891   $63,312,883   $607,551,774 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2023, according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 
Term loans  $        -   $541,492,510   $64,461,958   $605,954,468 
Total  $-   $541,492,510   $64,461,958   $605,954,468 

 

 

Transfers into or out of Level 1, 2 or 3 are recognized at the reporting date.                

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 29, 2024:

 

   First Lien Term Loan   Equity Interests   Total 
Balance as of February 28, 2023  $64,461,958   $-   $64,461,958 
Payment-in-kind and other adjustments to cost   -    -    - 
Net accretion of discount on investments   76,065    -    76,065 
Net change in unrealized appreciation (depreciation) on investments   851,630    (673,988)   177,642 
Purchases   16,586,078    1,649,986    18,236,064 
Sales and repayments   (8,762,524)   -    (8,762,524)
Net realized loss from investments   (361,041)   -    (361,041)
Transfers in (1)   29,342,250    -    29,342,250 
Transfers out (2)   (39,857,531)   -    (39,857,531)
Balance as of February 29, 2024  $62,336,885   $975,998   $63,312,883 
Net change in unrealized depreciation for the year relating to those Level 3 assets that were still held by the Issuer at the end of the year  $(145,844)  $(673,988)  $(819,832)

 

 

(1)The Issuer’s investment in Level 3 investments were classified as such during the year ended February 29, 2024, as market quotes for these investments are only provided by one trading desk.
(2)The Issuer’s investment in Level 2 investments were classified as such during the year ended February 29, 2024, as the number of observable market quotes for these investments increased.

 

S-47

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2023:

 

   Term Loans   Equity Interests   Total 
Balance as of February 28, 2022  $69,474,664   $          -   $69,474,664 
Payment-in-kind and other adjustments to cost   -    -    - 
Net accretion of discount on investments   97,816    -    97,816 
Net change in unrealized depreciation on investments   (633,895)   -    (633,895)
Purchases   15,870,770    -    15,870,770 
Sales and repayments   (9,192,436)   -    (9,192,436)
Net realized loss from investments   (38,093)   -    (38,093)
Transfers in (1)   19,263,898    -    19,263,898 
Transfers out (2)   (30,380,766)   -    (30,380,766)
Balance as of February 28, 2023  $64,461,958   $-   $64,461,958 
Net change in unrealized depreciation for the year relating to those Level 3 assets that were still held by the Issuer at the end of the year  $(975,369)  $-   $(975,369)

 

 

(1)The Issuer’s investment in Level 3 investments were classified as such during the year ended February 28, 2023, as market quotes for these investments are only provided by one trading desk.
(2)The Issuer’s investment in Level 2 investments were classified as such during the year ended February 28, 2023, as the number of observable market quotes for these investments increased.

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

 

Sales and repayments represent net proceeds received from investments sold and principal paydowns received, during the period.

 

Significant unobservable inputs used in the fair value measurement of the Level 3 term loans and equity include market quotations available from multiple dealers. A significant increase (decrease) in the market quote, in isolation, would result in a significantly lower (higher) fair value measurement.

 

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 29, 2024 were as follows:

 

   Fair Value   Valuation Technique  Unobservable Inputs  Range
(Weighted Average)*
Term loans  $62,336,885   Market Comparables  Third-Party Bid  67.50 - 101.25 (96.49)
Equity interests   975,998   Market Comparables  Third-Party Bid  9.75% - 19.24% (15.78%)
Total  $63,312,883          

 

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2023 were as follows:

 

   Fair Value   Valuation Technique  Unobservable Inputs  Range
(Weighted Average)*
 
Term loans  $64,461,958   Market Comparables  Third-Party Bid   82.00 - 100.00 (96.68)  
Total  $64,461,958            

 

 

*Weighted average represents the arithmetic average of the inputs and is not weighted by the relative fair value or notional amount.

 

S-48

 

 

4. Financing

 

On January 22, 2008, the Issuer issued $400.0 million of notes, consisting of Class A Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes (collectively the “Secured Notes”), and Subordinated Notes. The notes were issued pursuant to the Indenture.

 

The Secured Notes are limited recourse obligations of the Issuer. The Subordinated Notes are unsecured, limited recourse debt obligations of the Issuer.

 

On February 26, 2021, in a refinancing transaction, the Issuer issued $722.0 million of notes consisting of Class A-1-R-3 Senior Secured Floating Rate Notes, Class A-2-R-3 Senior Secured Floating Rate Notes, Class B-FL-R-3 Senior Secured Floating Rate Notes, Class B-FXD-R-3 Senior Secured Fixed Rate Notes, Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes, Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes, Class D-R-3 Deferrable Mezzanine Floating Rate Notes, Class E-R-3 Deferrable Mezzanine Floating Rate Notes, Class F-R-3 Deferrable Junior Floating Rate Notes, and Subordinated Notes. Proceeds net of issue discounts were used along with existing trust assets to redeem all of the rated note classes of the 2013-1 Reset CLO Notes. $69.5 million of Subordinated Notes issued in connection with the 2008 CLO Notes, 2013-1 CLO Notes, 2013-1 Amended CLO Notes and 2013-1 CLO Reset Notes were not redeemed and remained outstanding. On August 9, 2021, the Company exchanged its existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par.

 

The 2013-1 2021 Reset CLO Notes are limited recourse obligations of the Issuer. The Subordinated Notes are unsecured, limited recourse debt obligations of the Issuer.

 

The relative order of seniority of payment of each class of securities is as follows: first, Class A-1-R- 3 Notes, second, Class A-2-R-3 Notes, third Class B-FL-R-3 Notes, fourth, Class B-FXD-R-3 Notes, fifth, Class C-FL-R-3 Notes, sixth, Class C-FXD-R-3 Notes, seventh, Class D-R-3 Notes, eighth, Class E-R-3 Notes, ninth, Class F-1-R-3 Notes, Class F-2-R-3 Notes, and tenth the Subordinated Notes, with (a) each class of securities (other than the Subordinated Notes) in such list being senior to each other class of securities that follows such class of securities in such list and (b) each class of securities in such list being subordinate to each other class of securities that precedes such class of securities in such list. The Subordinated Notes are subordinated to the 2013-1 2021 Reset CLO Notes and are entitled to periodic payments from interest proceeds available in accordance with the Priority of Payments.

 

The table below sets forth certain information for each outstanding class of notes issued, pursuant to the loan agreements and Indenture at February 29, 2024.

 

Description   Interest Rate   Maturity   Principal Amount     Amount
Outstanding
    Weighted Average
Interest Rate
 
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:                          
Class A-1-R-3 Senior Secured Floating Rate Notes   3M SOFR + 1.32%   April 20, 2033   $ 357,500,000     $ 357,500,000       6.82 %
Class A-2-R-3 Senior Secured Floating Rate Notes   3M SOFR + 1.65%   April 20, 2033     65,000,000       65,000,000       7.05 %
Class B-FL-R-3 Senior Secured Floating Rate Notes   3M SOFR + 1.80%   April 20, 2033     60,500,000       60,500,000       7.19 %
Class B-FXD-R-3 Senior Secured Fixed Rate Notes   2.54%   April 20, 2033     11,000,000       11,000,000       2.60 %
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes   3M SOFR + 2.40%   April 20, 2033     26,000,000       26,000,000       7.78 %
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes   3.31%   April 20, 2033     6,500,000       6,500,000       3.39 %
Class D-R-3 Deferrable Mezzanine Floating Rate Notes   3M SOFR + 4.00%   April 20, 2033     39,000,000       39,000,000       9.34 %
Class E-R-3 Deferrable Mezzanine Floating Rate Notes   3M SOFR + 7.50%   April 20, 2033     27,625,000       27,625,000       12.75 %
Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes   3M SOFR + 10.00%   April 20, 2033     8,500,000       8,500,000       15.19 %
Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes   3M SOFR + 10.00%   April 20, 2033     9,375,000       9,375,000       15.19 %
Subordinated Notes   N/A   April 20, 2033     111,000,000       111,000,000       N/A  
            $ 722,000,000     $ 722,000,000          

 

S-49

 

 

The table below sets forth certain information for each outstanding class of notes issued, pursuant to the loan agreements and Indenture at February 28, 2023.

 

Description  Interest Rate   Maturity  Principal Amount   Amount
Outstanding
   Weighted Average
Interest Rate
 
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:                   
Class A-1-R-3 Senior Secured Floating Rate Notes   LIBOR + 1.32%  April 20, 2033  $357,500,000   $357,500,000    1.61%
Class A-2-R-3 Senior Secured Floating Rate Notes   LIBOR + 1.65%  April 20, 2033   65,000,000    65,000,000    1.95%
Class B-FL-R-3 Senior Secured Floating Rate Notes   LIBOR + 1.80%  April 20, 2033   60,500,000    60,500,000    2.11%
Class B-FXD-R-3 Senior Secured Fixed Rate Notes   2.54%  April 20, 2033   11,000,000    11,000,000    2.67%
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes   LIBOR + 2.40%  April 20, 2033   26,000,000    26,000,000    2.72%
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes   3.31%  April 20, 2033   6,500,000    6,500,000    3.48%
Class D-R-3 Deferrable Mezzanine Floating Rate Notes   LIBOR + 4.00%  April 20, 2033   39,000,000    39,000,000    4.36%
Class E-R-3 Deferrable Mezzanine Floating Rate Notes   LIBOR + 7.50%  April 20, 2033   27,625,000    27,625,000    7.95%
Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes   LIBOR + 10.00%  April 20, 2033   8,500,000    8,500,000    10.52%
Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes   LIBOR + 10.00%  April 20, 2033   9,375,000    9,375,000    10.52%
Subordinated Notes   N/A   April 20, 2033   111,000,000    111,000,000    N/A 
           $722,000,000   $722,000,000      

 

The following table shows the fair value of the Issuer’s debt outstanding as of February 29, 2024(a):

 

Debt Security  February 29,
2024
 
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:    
Class A-1-R-3 Senior Secured Floating Rate Notes  $359,983,909 
Class A-2-R-3 Senior Secured Floating Rate Notes   65,676,594 
Class B-FL-R-3 Senior Secured Floating Rate Notes   61,141,020 
Class B-FXD-R-3 Senior Secured Fixed Rate Notes   11,006,154 
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes   26,295,629 
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes   6,505,936 
Class D-R-3 Deferrable Mezzanine Floating Rate Notes   39,532,812 
Class E-R-3 Deferrable Mezzanine Floating Rate Notes   28,169,374 
Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes   8,564,667 
Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes   8,875,227 
Subordinated Notes   9,500,627 
   $625,251,949 

 

 

(a) These notes are fair valued based on a discounted cash flow model, specifically using Intex cash flow models, to form the basis for the valuation and would be classified as Level 3 liabilities within the fair value hierarchy.

 

S-50

 

 

The following table shows each outstanding class of notes issued, pursuant to the Indenture, at fair value at February 28, 2023(a):

 

Debt Security  February 28,
2023
 
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:    
Class A-1-R-3 Senior Secured Floating Rate Notes  $359,565,649 
Class A-2-R-3 Senior Secured Floating Rate Notes   65,537,373 
Class B-FL-R-3 Senior Secured Floating Rate Notes   61,017,654 
Class B-FXD-R-3 Senior Secured Fixed Rate Notes   11,009,371 
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes   26,253,490 
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes   6,508,929 
Class D-R-3 Deferrable Mezzanine Floating Rate Notes   39,515,127 
Class E-R-3 Deferrable Mezzanine Floating Rate Notes   28,232,871 
Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes   8,749,793 
Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes   8,831,406 
Subordinated Notes   21,176,578 
   $636,398,241 

 

 

 

(a)These notes are fair valued based on a discounted cash flow model, specifically using Intex cash flow models, to form the basis for the valuation and would be classified as Level 3 liabilities within the fair value hierarchy.

 

The Indenture provides that payments on the Subordinated Notes shall rank subordinate in priority of payment to payments due on all classes of 2013-1 2021 Reset CLO Notes and subordinate in priority of payment to the payment of fees and expenses. Distributions on the Subordinated Notes are limited to the assets of the Issuer remaining after payment of all of the liabilities of the Issuer that rank senior in priority of payment to the Subordinated Notes. To the extent that the proceeds from the collateral are not sufficient to make distributions on the Subordinated Notes the Issuer will have no further obligation in respect of the Subordinated Notes.

 

Interest proceeds and, after the 2013-1 2021 Reset CLO Notes have been paid in full, principal proceeds in each case will be distributed to the holders of the Subordinated Notes in accordance with the Indenture.

 

Distributions, if any, on the Subordinated Notes will be payable quarterly on the 20th day of each January, April, July and October of each calendar year or, if any such day is not a business day, on the next succeeding business day (each, a “Payment Date”), commencing on the first Payment Date, and on April 20, 2033 (or if any such day is not a business day, the next succeeding business day) (the “Stated Redemption Date”) (if not redeemed prior to such date) sequentially in order of seniority. At the Stated Redemption Date, the Subordinated Notes will be redeemed after payment in full of all of the 2013-1 2021 Reset CLO Notes and the payment of all administrative and other fees and expenses. The failure to pay interest proceeds or principal proceeds to the holders of the Subordinated Notes will not be an event of default under the Indenture.

 

As of February 29, 2024, the remaining unamortized discount on Class A-1-R-3 Notes, Class A-2-R- 3 Notes, Class B-FL-R-3 Notes, Class B-FXD-R-3 Notes, Class C-FL-R-3 Notes, Class C-FXD-R-3 Notes, Class D-R-3 Notes, Class E-R-3 Notes, Class F-1-R-3 Notes and F-2-R-3 were $0.0 million, $0.0 million, $0.0 million, $0.0 million, $0.0 million, $0.0 million, $0.2 million, $2.3 million, $0.0 million and $0.0 million, respectively.

 

As of February 28, 2023, the remaining unamortized discount on Class A-1-R-3 Notes, Class A-2-R- 3 Notes, Class B-FL-R-3 Notes, Class B-FXD-R-3 Notes, Class C-FL-R-3 Notes, Class C-FXD-R-3 Notes, Class D-R-3 Notes, Class E-R-3 Notes, Class F-1-R-3 Notes and F-2-R-3 were $0.0 million, $0.0 million, $0.0 million, $0.0 million, $0.0 million, $0.0 million, $0.2 million, $2.5 million, $0.0 million and $0.0 million, respectively.

 

As of February 29, 2024 and February 28, 2023, remaining capitalized financing costs of $1.7 million and $1.9 million, respectively, related to the 2013-1 2021 Reset CLO Notes are being amortized over the term of the 2013-1 2021 Reset CLO Notes.

 

S-51

 

 

5. Income Tax

 

Under the current laws, the Issuer is not subject to net income taxation in the United States or the Cayman Islands. Accordingly, no provision for income taxes has been made in the accompanying financial statements.

 

Pursuant to ASC Topic 740, Accounting for Uncertainty in Income Taxes, the Issuer adopted the provisions of the FASB relating to accounting for uncertainty in income taxes which clarifies the accounting for income taxes by prescribing the minimum recognition threshold a tax position must meet before being recognized in the financial statements and applies to all open tax years as of the effective date. The Investment Manager has analyzed such tax positions for uncertain tax positions for tax years that may be open (2019—2022). The Issuer identifies its major tax jurisdictions as U.S. Federal, state and foreign jurisdictions where the Issuer makes investments. As of February 29, 2024 and February 28, 2023, there was no impact to the financial statements as a result of the Issuer’s accounting for uncertainty in income taxes. The Issuer does not have any unrecognized tax benefits or liabilities for the years ended February 29, 2024, February 28, 2023 and February 28, 2022. Also, the Issuer recognizes interest and, if applicable, penalties for any uncertain tax positions, as a component of income tax expense. No interest or penalty expense was recorded by the Issuer for the years ended February 29, 2024, February 28, 2023 and February 28, 2022.

 

6. Commitments and Contingencies

 

In the ordinary course of its business, the Issuer may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Issuer. Based on its history and experience, the Investment Manager feels that the likelihood of such an event is remote. Therefore, the Issuer has not accrued any liabilities in connection with such indemnifications.

 

In the ordinary course of business, the Issuer may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Issuer. As of February 29, 2024 and February 28, 2023, the Issuer is not subject to any material legal proceedings. Therefore, the Issuer has not accrued any liabilities in connection with such indemnifications.

 

The terms of Collateralized Debt Investments may require the Issuer to provide funding for any unfunded portion of a Collateralized Debt Investment at the request of the borrower. At February 29, 2024 and February 28, 2023, the Issuer had $0.0 million and $1.9 million of unfunded commitments outstanding, respectively.

 

7. Related Party Transactions

 

In the ordinary course of business and as permitted per the terms of the Indenture, the Issuer may acquire or sell investments to or from related parties at the fair value at such time. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, the Issuer neither bought nor sold investments from related parties.

 

The Subordinated Notes are wholly owned by the Investment Manager. The Subordinated Notes do not have a stated coupon rate but are entitled to residual cash flows from the CLO’s investments after all of the other tranches of debt and certain other fees and expenses are paid. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, $6.9 million, $4.9 million and $5.2 million of payments to the Subordinated Notes were included in interest and debt financing expenses in the statements of operations, respectively. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, $4.4 million, $4.4 million and $4.4 million, respectively, in discount amortization related to the Subordinated Notes is also included in interest and debt financing expenses on the Issuer’s statements of operations and statements of cash flows.

 

The Investment Manager holds aggregate principal amounts of $9.4 million in Class F-2-R-3 Notes of the CLO tranches with a coupon of LIBOR plus 10.00% at February 29, 2024 and February 28, 2023. For the years ended February 29, 2024, February 28, 2023 and February 28, 2022, payments for the Class F-2-R-3 Notes totaling $1.5 million, $1.2 million and $0.5 million, respectively, are included in interest and debt financing expenses in the Issuer’s statements of operations. Expenses relating to the refinancing were paid for by the Company on behalf of Saratoga CLO and are included in due to affiliate on the statements of assets and liabilities at February 28, 2021 and were subsequently repaid during fiscal year 2022.

 

In addition, as of February 29, 2024 and February 28, 2023, $0.01 million and $0.0 million, respectively, is included in due from affiliate are amounts reimbursable to Saratoga CLO for shared operating expenses with a related party.

 

S-52

 

 

8. Shareholders’ Capital

 

Capital contributions and distributions shall be made at such time and in such amounts as determined by the Investment Manager and the Indenture.

 

The majority holder of the Subordinated Notes has various control rights over the CLO, including the ability to call the CLO prior to its legal maturity, replace the Investment Manager under certain circumstances, and refinance any of the outstanding debt tranches. The voting structure of the Subordinated Notes may require either majority or unanimous approval depending upon the issue.

 

The authorized share capital of the Issuer consists of 50,000 ordinary shares, 250 of which are owned by Maples Finance Limited and are held under the terms of a declaration of trust.

 

As of February 29, 2024 and February 28, 2023, net assets (deficit) were $(71.5) million and $(70.6) million, respectively. These amounts include accumulated losses of $71.5 million and $70.6 million, respectively, which include cumulative net investment income or loss, cumulative amounts of gains and losses realized from investment transactions, net unrealized appreciation or depreciation of investments, as well as the cumulative effect of accounting mismatches between investments accounted for at fair value and amortized cost or accrual-basis assets and liabilities as discussed in Significant Accounting Policies, above. The Issuer’s investments continue to generate sufficient liquidity to satisfy its obligations on periodic payment dates as well as comply with all performance criteria as of the statements of assets and liabilities date.

 

The Issuer adopted Rule 3-04/Rule 8-03(a)(5) under Regulation S-X. Pursuant to the regulation, the Issuer has presented a reconciliation of the changes in each significant caption of stockholders’ equity for each of the three fiscal years ended February 29, 2024, February 28, 2023 and February 28, 2022, as shown in the tables below:

 

   For the Year Ended February 29, 2024 
              Total     
       Capital
in Excess
   Distributable
Earnings
   Net Assets 
   Common Stock   of Par Value   (Loss)   (Deficit) 
Balance at February 28, 2023   250   $250   $       -   $(70,627,170)  $(70,626,920)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    502,662    502,662 
Net realized gain (loss) from investments   -    -    -    (2,108,567)   (2,108,567)
Net change in unrealized depreciation on investments   -    -    -    (10,337,238)   (10,337,238)
Balance at May 31, 2023   250    250    -    (82,570,313)   (82,570,063)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    168,515    168,515 
Net realized gain (loss) from investments   -    -    -    (641,267)   (641,267)
Net change in unrealized appreciation on investments   -    -    -    13,352,743    13,352,743 
Balance at August 31, 2023   250    250    -    (69,690,322)   (69,690,072)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    359,637    359,637 
Net realized gain (loss) from investments   -    -    -    (6,298,909)   (6,298,909)
Net change in unrealized depreciation on investments   -    -    -    (313,230)   (313,230)
Balance at November 30, 2023   250    250    -    (75,942,824)   (75,942,574)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    498,467    498,467 
Net realized gain (loss) from investments   -    -    -    (9,532,208)   (9,532,208)
Net change in unrealized appreciation on investments   -    -    -    13,498,322    13,498,322 
Balance at February 29, 2024   250   $250    -   $(71,478,243)  $(71,477,993)

 

S-53

 

 

   For the Year Ended February 28, 2023 
              Total     
   Common Stock   Capital
in Excess
   Distributable
Earnings
   Net Assets 
   Shares   Amount   of Par Value   (Loss)   (Deficit) 
Balance at February 28, 2022   250   $250   $       -   $(37,197,733)  $(37,197,483)
Increase (Decrease) from Operations:                         
Net investment loss   -    -    -    (286,724)   (286,724)
Net realized gain (loss) from investments   -    -    -    77,656    77,656 
Net change in unrealized depreciation on investments   -    -    -    (24,681,988)   (24,681,988)
Balance at May 31, 2022   250    250    -    (62,088,789)   (62,088,539)
Increase (Decrease) from Operations:                         
Net investment loss   -    -    -    (507,279)   (507,279)
Net realized gain (loss) from investments   -    -    -    (1,144,858)   (1,144,858)
Net change in unrealized depreciation on investments   -    -    -    (1,544,463)   (1,544,463)
Balance at August 31, 2022   250    250    -    (65,285,389)   (65,285,139)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    586,193    586,193 
Net realized gain (loss) from investments   -    -    -    (532,640)   (532,640)
Net change in unrealized depreciation on investments   -    -    -    (10,640,311)   (10,640,311)
Balance at November 30, 2022   250    250    -    (75,872,147)   (75,871,897)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    1,031,538    1,031,538 
Net realized gain (loss) from investments   -    -    -    (7,086,473)   (7,086,473)
Net change in unrealized appreciation on investments   -    -    -    11,299,912    11,299,912 
Balance at February 28, 2023   250   $250   -   $(70,627,170)  $(70,626,920)

 

   For the Year Ended February 28, 2022 
              Total     
   Common Stock   Capital
in Excess
   Distributable
Earnings
   Net Assets 
   Shares   Amount   of Par Value   (Loss)   (Deficit) 
Balance at February 28, 2021   250   $250   $       -   $(28,538,114)  $(28,537,864)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    2,315,511    2,315,511 
Net realized gain (loss) from investments   -    -    -    (565,094)   (565,094)
Net change in unrealized depreciation on investments   -    -    -    (481,097)   (481,097)
Balance at May 31, 2021   250    250    -    (27,268,794)   (27,268,544)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    1,397,282    1,397,282 
Net realized gain (loss) from investments   -    -    -    175,669    175,669 
Net change in unrealized depreciation on investments   -    -    -    (662,095)   (662,095)
Balance at August 31, 2021   250    250    -    (26,357,938)   (26,357,688)
Increase (Decrease) from Operations:                         
Net investment loss   -    -    -    (647,430)   (647,430)
Net realized gain (loss) from investments   -    -    -    (662,289)   (662,289)
Net change in unrealized depreciation on investments   -    -    -    (4,277,923)   (4,277,923)
Balance at November 30, 2021   250    250    -    (31,945,580)   (31,945,330)
Increase (Decrease) from Operations:                         
Net investment income   -    -    -    168,313    168,313 
Net realized gain (loss) from investments   -    -    -    (12,099)   (12,099)
Net change in unrealized depreciation on investments   -    -    -    (5,408,367)   (5,408,367)
Balance at February 28, 2022   250   $250   $-   $(37,197,733)  $(37,197,483)

 

S-54

 

 

9. Financial Highlights

 

The following is a schedule of financial highlights for the years ended February 29, 2024, February 28, 2023, February 28, 2022, February 28, 2021 and February 29, 2020:

 

      February 29,
2024(4)
  February 28,
2023
  February 28,
2022
  February 28,
2021
  February 29,
2020
 
Year-end subordinated notes’ capital balance(1)     $ 3,356,769   $ 242,477   $ 28,742,295   $ 34,422,474   $ 11,498,257  
Ratio and supplemental data:                                  
Total return(2)       NM     (94.53) %   (9.75 %   150.86 %   (46.85) %
Net investment income (loss)(3)       NM     8.77 %   9.38 %   (17.12 )%   0.01 %
Total expenses(3)       NM     655.20 %   81.89 %   383.67 %   156.62 %
Base management fee(3)       NM     10.08 %   1.89 %   6.60 %   2.48 %
Subordinated management fee(3)       NM     40.30 %   7.57 %   26.42 %   9.93 %

 

 

(1)Subordinated notes’ capital balance is calculated based on the sum of the subordinated notes outstanding amount and total net assets, net of ordinary equity.
(2)Total return is calculated based on a time-weighted rate of return methodology, in which quarterly rates of return are compounded to derive the total return reflected above. Total return is calculated for the subordinated notes’ capital taken as a whole and assumes the purchase of the subordinated notes’ capital on the first day of the period and the sale of the last day of the period.
(3)Calculated based on the average subordinated notes’ capital balance.
(4)

The Investment Manager has deemed the total return and other ratios to be not meaningful (“NM”) for the year ended February 29, 2024. As the total of the subordinated notes and retained earnings balance was negative at certain times during the year, the time-weighted rate of return methodology can result in misleading returns. With average capital balances during the year being negative, the other ratios can be misleading as well and therefore not meaningful.

 

10. Subsequent Events

 

The Investment Manager has evaluated events or transactions that have occurred since February 29, 2024 through May 6, 2024, the date the financial statements were available for issuance. The Investment Manager has determined that there are no material events that would require the disclosure in the financial statements.

 

S-55

 

 

42 0.71 2.06 3.99 11456631 11963533 12670939 false --02-28 FY 0001377936 10.6% 0001377936 2023-03-01 2024-02-29 0001377936 us-gaap:CommonStockMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableOneMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableTwoMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableThreeMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableFourMember 2023-03-01 2024-02-29 0001377936 2023-08-31 0001377936 2024-05-03 0001377936 2024-02-29 0001377936 2023-02-28 0001377936 sar:NoncontrolNonaffiliateInvestmentsMember 2024-02-29 0001377936 sar:NoncontrolNonaffiliateInvestmentsMember 2023-02-28 0001377936 sar:AffiliatedInvestmentsMember 2024-02-29 0001377936 sar:AffiliatedInvestmentsMember 2023-02-28 0001377936 sar:ControlInvestmentsMember 2024-02-29 0001377936 sar:ControlInvestmentsMember 2023-02-28 0001377936 us-gaap:RevolvingCreditFacilityMember 2024-02-29 0001377936 us-gaap:RevolvingCreditFacilityMember 2023-02-28 0001377936 sar:DebenturesPayableMember 2024-02-29 0001377936 sar:DebenturesPayableMember 2023-02-28 0001377936 sar:NotesPayableMember 2024-02-29 0001377936 sar:NotesPayableMember 2023-02-28 0001377936 sar:NotesPayableOneMember 2024-02-29 0001377936 sar:NotesPayableOneMember 2023-02-28 0001377936 sar:NotesPayableTwoMember 2024-02-29 0001377936 sar:NotesPayableTwoMember 2023-02-28 0001377936 sar:NotesPayableThreeMember 2024-02-29 0001377936 sar:NotesPayableThreeMember 2023-02-28 0001377936 sar:NotesPayableFourMember 2024-02-29 0001377936 sar:NotesPayableFourMember 2023-02-28 0001377936 sar:NotesPayableFiveMember 2024-02-29 0001377936 sar:NotesPayableFiveMember 2023-02-28 0001377936 sar:NotesPayableSixMember 2024-02-29 0001377936 sar:NotesPayableSixMember 2023-02-28 0001377936 sar:NotesPayableSevenMember 2024-02-29 0001377936 sar:NotesPayableSevenMember 2023-02-28 0001377936 sar:NotesPayableEightMember 2024-02-29 0001377936 sar:NotesPayableEightMember 2023-02-28 0001377936 sar:NotesPayableNineMember 2024-02-29 0001377936 sar:NotesPayableNineMember 2023-02-28 0001377936 2022-03-01 2023-02-28 0001377936 2021-03-01 2022-02-28 0001377936 2022-02-28 0001377936 2021-02-28 0001377936 sar:NotesTwoThousandAndTwentySevenMember 2023-03-01 2024-02-29 0001377936 sar:NotesTwoThousandAndTwentySevenMember 2022-03-01 2023-02-28 0001377936 sar:NotesTwoThousandAndTwentySevenMember 2021-03-01 2022-02-28 0001377936 sar:Notes2025Member 2023-03-01 2024-02-29 0001377936 sar:Notes2025Member 2022-03-01 2023-02-28 0001377936 sar:Notes2025Member 2021-03-01 2022-02-28 0001377936 sar:Notes2026Member 2023-03-01 2024-02-29 0001377936 sar:Notes2026Member 2022-03-01 2023-02-28 0001377936 sar:Notes2026Member 2021-03-01 2022-02-28 0001377936 sar:Notes2027OneMember 2023-03-01 2024-02-29 0001377936 sar:Notes2027OneMember 2022-03-01 2023-02-28 0001377936 sar:Notes2027OneMember 2021-03-01 2022-02-28 0001377936 sar:AltviaMidCoLLCMember sar:TotalAlternativeInvestmentManagementSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:AltviaMidCoLLCMember sar:TotalAlternativeInvestmentManagementSoftwareMember 2024-02-29 0001377936 sar:AltviaMidCoLLCOneMember sar:TotalAlternativeInvestmentManagementSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:AltviaMidCoLLCOneMember sar:TotalAlternativeInvestmentManagementSoftwareMember 2024-02-29 0001377936 sar:TotalAlternativeInvestmentManagementSoftwareMember 2024-02-29 0001377936 sar:BQESoftwareIncMember sar:TotalArchitectureEngineeringSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:BQESoftwareIncMember sar:TotalArchitectureEngineeringSoftwareMember 2024-02-29 0001377936 sar:BQESoftwareIncOneMember sar:TotalArchitectureEngineeringSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:BQESoftwareIncOneMember sar:TotalArchitectureEngineeringSoftwareMember 2024-02-29 0001377936 sar:TotalArchitectureEngineeringSoftwareMember 2024-02-29 0001377936 sar:GrowthZoneLLCMember sar:TotalAssociationManagementSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:GrowthZoneLLCMember sar:TotalAssociationManagementSoftwareMember 2024-02-29 0001377936 sar:GoldenTopCoLPMember sar:TotalAssociationManagementSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:GoldenTopCoLPMember sar:TotalAssociationManagementSoftwareMember 2024-02-29 0001377936 sar:TotalAssociationManagementSoftwareMember 2024-02-29 0001377936 sar:ArtemisWaxCorpMember sar:TotalConsumerServices1Member 2023-03-01 2024-02-29 0001377936 sar:ArtemisWaxCorpMember sar:TotalConsumerServices1Member 2024-02-29 0001377936 sar:ArtemisWaxCorpOneMember sar:TotalConsumerServices1Member 2023-03-01 2024-02-29 0001377936 sar:ArtemisWaxCorpOneMember sar:TotalConsumerServices1Member 2024-02-29 0001377936 sar:ArtemisWaxCorpTwoMember sar:TotalConsumerServices1Member 2023-03-01 2024-02-29 0001377936 sar:ArtemisWaxCorpTwoMember sar:TotalConsumerServices1Member 2024-02-29 0001377936 sar:TotalConsumerServices1Member 2024-02-29 0001377936 sar:SchooxIncsMember sar:TotalCorporateEducationSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:SchooxIncsMember sar:TotalCorporateEducationSoftwareMember 2024-02-29 0001377936 sar:TotalCorporateEducationSoftwareMember 2024-02-29 0001377936 sar:GreyHellerLLCMember sar:TotalCyberSecurityMember 2023-03-01 2024-02-29 0001377936 sar:GreyHellerLLCMember sar:TotalCyberSecurityMember 2024-02-29 0001377936 sar:TotalCyberSecurityMember 2024-02-29 0001377936 sar:Gen4DentalPartnersHoldingsLLCMember sar:TotalDentalPracticeManagementMember 2023-03-01 2024-02-29 0001377936 sar:Gen4DentalPartnersHoldingsLLCMember sar:TotalDentalPracticeManagementMember 2024-02-29 0001377936 sar:Gen4DentalPartnersHoldingsLLCOneMember sar:TotalDentalPracticeManagementMember 2023-03-01 2024-02-29 0001377936 sar:Gen4DentalPartnersHoldingsLLCOneMember sar:TotalDentalPracticeManagementMember 2024-02-29 0001377936 sar:ModisDentalPartnersOpCoLLCMember sar:TotalDentalPracticeManagementOneMember 2023-03-01 2024-02-29 0001377936 sar:ModisDentalPartnersOpCoLLCMember sar:TotalDentalPracticeManagementOneMember 2024-02-29 0001377936 sar:ModisDentalPartnersOpCoLLCOneMember sar:TotalDentalPracticeManagementOneMember 2023-03-01 2024-02-29 0001377936 sar:ModisDentalPartnersOpCoLLCOneMember sar:TotalDentalPracticeManagementOneMember 2024-02-29 0001377936 sar:ModisDentalPartnersOpCoLLCTwoMember sar:TotalDentalPracticeManagementOneMember 2023-03-01 2024-02-29 0001377936 sar:ModisDentalPartnersOpCoLLCTwoMember sar:TotalDentalPracticeManagementOneMember 2024-02-29 0001377936 sar:NewEnglandDentalPartnersMember sar:TotalDentalPracticeManagementMember 2023-03-01 2024-02-29 0001377936 sar:NewEnglandDentalPartnersMember sar:TotalDentalPracticeManagementMember 2024-02-29 0001377936 sar:NewEnglandDentalPartnersOneMember sar:TotalDentalPracticeManagementMember 2023-03-01 2024-02-29 0001377936 sar:NewEnglandDentalPartnersOneMember sar:TotalDentalPracticeManagementMember 2024-02-29 0001377936 sar:TotalDentalPracticeManagementMember 2024-02-29 0001377936 sar:ExigoLLCMember sar:TotalDirectSellingSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ExigoLLCMember sar:TotalDirectSellingSoftwareMember 2024-02-29 0001377936 sar:ExigoLLCOneMember sar:TotalDirectSellingSoftwareMember 2024-02-29 0001377936 sar:ExigoLLCOneMember sar:TotalDirectSellingSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ExigoLLCTwoMember sar:TotalDirectSellingSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ExigoLLCTwoMember sar:TotalDirectSellingSoftwareMember 2024-02-29 0001377936 sar:TotalDirectSellingSoftwareMember 2024-02-29 0001377936 sar:C2EducationalSystemsIncMember sar:TotalEducationServicesMember 2023-03-01 2024-02-29 0001377936 sar:C2EducationalSystemsIncMember sar:TotalEducationServicesMember 2024-02-29 0001377936 sar:C2EducationalSystemsIncOneMember sar:TotalEducationServicesMember 2024-02-29 0001377936 sar:C2EducationalSystemsIncOneMember sar:TotalEducationServicesMember 2023-03-01 2024-02-29 0001377936 sar:C2EducationSystemsIncMember sar:TotalEducationServicesMember 2023-03-01 2024-02-29 0001377936 sar:C2EducationSystemsIncMember sar:TotalEducationServicesMember 2024-02-29 0001377936 sar:ZollegePBCMember sar:TotalEducationServicesMember 2023-03-01 2024-02-29 0001377936 sar:ZollegePBCMember sar:TotalEducationServicesMember 2024-02-29 0001377936 sar:ZollegePBCOneMember sar:TotalEducationServicesMember 2023-03-01 2024-02-29 0001377936 sar:ZollegePBCOneMember sar:TotalEducationServicesMember 2024-02-29 0001377936 sar:ZollegePBCTwoMember sar:TotalEducationServicesMember 2023-03-01 2024-02-29 0001377936 sar:ZollegePBCTwoMember sar:TotalEducationServicesMember 2024-02-29 0001377936 sar:TotalEducationServicesMember 2024-02-29 0001377936 sar:DestinySolutionsIncMember sar:TotalConsumerServices1Member 2023-03-01 2024-02-29 0001377936 sar:DestinySolutionsIncMember sar:TotalConsumerServices1Member 2024-02-29 0001377936 sar:GoReactMember sar:TotalEducationSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:GoReactMember sar:TotalEducationSoftwareMember 2024-02-29 0001377936 sar:GoReactOneMember sar:TotalEducationServicesMember 2023-03-01 2024-02-29 0001377936 sar:GoReactOneMember sar:TotalEducationServicesMember 2024-02-29 0001377936 sar:GoReactOneMember sar:TotalEducationSoftwareMember 2024-02-29 0001377936 sar:IdentityAutomationSystemsOneMember sar:TotalEducationSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:IdentityAutomationSystemsOneMember sar:TotalEducationSoftwareMember 2024-02-29 0001377936 sar:IdentityAutomationSystemsTwoMember sar:TotalEducationSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:IdentityAutomationSystemsTwoMember sar:TotalEducationSoftwareMember 2024-02-29 0001377936 sar:ReadyEducationMember sar:TotalEducationSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ReadyEducationMember sar:TotalEducationSoftwareMember 2024-02-29 0001377936 sar:TotalEducationSoftwareMember 2024-02-29 0001377936 sar:TGPressureWashingHoldingsLLCMember sar:TotalFacilitiesMaintenanceMember 2023-03-01 2024-02-29 0001377936 sar:TGPressureWashingHoldingsLLCMember sar:TotalFacilitiesMaintenanceMember 2024-02-29 0001377936 sar:TotalFacilitiesMaintenanceMember 2024-02-29 0001377936 sar:DaviswareLLCMember sar:TotalFieldServiceManagementMember 2023-03-01 2024-02-29 0001377936 sar:DaviswareLLCMember sar:TotalFieldServiceManagementMember 2024-02-29 0001377936 sar:DaviswareLLCOneMember sar:TotalFieldServiceManagementMember 2023-03-01 2024-02-29 0001377936 sar:DaviswareLLCOneMember sar:TotalFieldServiceManagementMember 2024-02-29 0001377936 sar:TotalFieldServiceManagementMember 2024-02-29 0001377936 sar:GDSSoftwareHoldingsLLCMember sar:TotalFinancialServicesMember 2023-03-01 2024-02-29 0001377936 sar:GDSSoftwareHoldingsLLCMember sar:TotalFinancialServicesMember 2024-02-29 0001377936 sar:GDSSoftwareHoldingsLLCOneMember sar:TotalFinancialServicesMember 2023-03-01 2024-02-29 0001377936 sar:GDSSoftwareHoldingsLLCOneMember sar:TotalFinancialServicesMember 2024-02-29 0001377936 sar:GDSSoftwareHoldingsLLCTwoMember sar:TotalFinancialServicesMember 2023-03-01 2024-02-29 0001377936 sar:GDSSoftwareHoldingsLLCTwoMember sar:TotalFinancialServicesMember 2024-02-29 0001377936 sar:TotalFinancialServicesMember 2024-02-29 0001377936 sar:AscendSoftwareLLCMember sar:TotalFinancialServicesSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:AscendSoftwareLLCMember sar:TotalFinancialServicesSoftwareMember 2024-02-29 0001377936 sar:AscendSoftwareLLCOneMember sar:TotalFinancialServicesSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:AscendSoftwareLLCOneMember sar:TotalFinancialServicesSoftwareMember 2024-02-29 0001377936 sar:TotalFinancialServicesSoftwareMember 2024-02-29 0001377936 sar:InspectPointHoldingsLLCMember sar:TotalFireInspectionBusinessSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:InspectPointHoldingsLLCMember sar:TotalFireInspectionBusinessSoftwareMember 2024-02-29 0001377936 sar:InspectPointHoldingsLLCOneMember sar:TotalFireInspectionBusinessSoftwareMember 2024-02-29 0001377936 sar:InspectPointHoldingsLLCOneMember sar:TotalFireInspectionBusinessSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:TotalFireInspectionBusinessSoftwareMember 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCMember sar:TotalHealthFitnessFranchisorMember 2023-03-01 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCMember sar:TotalHealthFitnessFranchisorMember 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCOneMember sar:TotalHealthFitnessFranchisorMember 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCOneMember sar:TotalHealthFitnessFranchisorMember 2023-03-01 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCTwoMember sar:TotalHealthFitnessFranchisorMember 2023-03-01 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCTwoMember sar:TotalHealthFitnessFranchisorMember 2024-02-29 0001377936 sar:TotalHealthFitnessFranchisorMember 2024-02-29 0001377936 sar:AlphaAestheticsPartnersOpCoLLCMember sar:TotalHealthcareServicesOneMember 2023-03-01 2024-02-29 0001377936 sar:AlphaAestheticsPartnersOpCoLLCMember sar:TotalHealthcareServicesOneMember 2024-02-29 0001377936 sar:AlphaAestheticsPartnersOpCoLLCOneMember sar:TotalHealthcareServicesOneMember 2023-03-01 2024-02-29 0001377936 sar:AlphaAestheticsPartnersOpCoLLCOneMember sar:TotalHealthcareServicesOneMember 2024-02-29 0001377936 sar:AlphaAestheticsPartnersOpCoLLCTwoMember sar:TotalHealthcareServicesOneMember 2023-03-01 2024-02-29 0001377936 sar:AlphaAestheticsPartnersOpCoLLCTwoMember sar:TotalHealthcareServicesOneMember 2024-02-29 0001377936 sar:AxiomMedicalsConsultingLLCMember sar:TotalHealthcareServicesthreeMember 2023-03-01 2024-02-29 0001377936 sar:AxiomMedicalsConsultingLLCMember sar:TotalHealthcareServicesthreeMember 2024-02-29 0001377936 sar:AxiomMedicalsConsultingLLCMember sar:TotalHealthcareServicesMember 2024-02-29 0001377936 sar:AxiomMedicalsConsultingLLCOneMember sar:TotalHealthcareServicesMember 2023-03-01 2024-02-29 0001377936 sar:AxiomMedicalsConsultingLLCOneMember sar:TotalHealthcareServicesMember 2024-02-29 0001377936 sar:AxiomMedicalsConsultingLLCOneMember sar:TotalHealthcareServicesthreeMember 2024-02-29 0001377936 sar:AxiomMedicalsConsultingLLCOneMember sar:TotalHealthcareServicestwoMember 2024-02-29 0001377936 sar:AxiomParentHoldingsLLCMember sar:TotalHealthcareServicesMember 2023-03-01 2024-02-29 0001377936 sar:AxiomParentHoldingsLLCMember sar:TotalHealthcareServicesMember 2024-02-29 0001377936 sar:ComForCareHealthCareMember sar:TotalHealthcareServicesMember 2023-03-01 2024-02-29 0001377936 sar:ComForCareHealthCareMember sar:TotalHealthcareServicesMember 2024-02-29 0001377936 sar:TotalHealthcareServicestwoMember 2024-02-29 0001377936 sar:HemaTerraHoldingCompanyLLCMember sar:TotalHealthcareSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:HemaTerraHoldingCompanyLLCMember sar:TotalHealthcareSoftwareMember 2024-02-29 0001377936 sar:HemaTerraHoldingCompanyLLCOneMember sar:TotalHealthcareSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:HemaTerraHoldingCompanyLLCOneMember sar:TotalHealthcareSoftwareMember 2024-02-29 0001377936 sar:TRCHemaTerraLLCMember sar:TotalHealthcareSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:TRCHemaTerraLLCMember sar:TotalHealthcareSoftwareMember 2024-02-29 0001377936 sar:ProcurementPartnersLLCMember sar:TotalHealthcareSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ProcurementPartnersLLCMember sar:TotalHealthcareSoftwareMember 2024-02-29 0001377936 sar:ProcurementPartnersLLCOneMember sar:TotalHealthcareSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ProcurementPartnersLLCOneMember sar:TotalHealthcareSoftwareMember 2024-02-29 0001377936 sar:ProcurementPartnersHoldingsLLCMember sar:TotalHealthcareSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ProcurementPartnersHoldingsLLCMember sar:TotalHealthcareSoftwareMember 2024-02-29 0001377936 sar:TotalHealthcareSoftwareMember 2024-02-29 0001377936 sar:RoscoeMedicalIncMember sar:TotalHealthcareSupplyMember 2024-02-29 0001377936 sar:RoscoeMedicalIncMember sar:TotalHealthcareSupplyMember 2023-03-01 2024-02-29 0001377936 sar:TotalHealthcareSupplyMember 2024-02-29 0001377936 sar:Book4TimeIncMember sar:TotalHospitalityHotelMember 2023-03-01 2024-02-29 0001377936 sar:Book4TimeIncMember sar:TotalHospitalityHotelMember 2024-02-29 0001377936 sar:Book4TimeIncOneMember sar:TotalHospitalityHotelMember 2023-03-01 2024-02-29 0001377936 sar:Book4TimeIncOneMember sar:TotalHospitalityHotelMember 2024-02-29 0001377936 sar:Book4TimeIncTwoMember sar:TotalHospitalityHotelMember 2023-03-01 2024-02-29 0001377936 sar:Book4TimeIncTwoMember sar:TotalHospitalityHotelMember 2024-02-29 0001377936 sar:KnowlandGroupLLCMember sar:TotalHospitalityHotelMember 2023-03-01 2024-02-29 0001377936 sar:KnowlandGroupLLCMember sar:TotalHospitalityHotelMember 2024-02-29 0001377936 sar:SceptreHospitalityResourcesLLCMember sar:TotalHospitalityHotelMember 2023-03-01 2024-02-29 0001377936 sar:SceptreHospitalityResourcesLLCMember sar:TotalHospitalityHotelMember 2024-02-29 0001377936 sar:SceptreHospitalityResourcesLLCOneMember sar:TotalHospitalityHotelMember 2024-02-29 0001377936 sar:SceptreHospitalityResourcesLLCOneMember sar:TotalHospitalityHotelMember 2023-03-01 2024-02-29 0001377936 sar:TotalHospitalityHotelMember 2024-02-29 0001377936 sar:GraniteComfortLPMember sar:TotalHVACServicesAndSalesMember 2023-03-01 2024-02-29 0001377936 sar:GraniteComfortLPMember sar:TotalHVACServicesAndSalesMember 2024-02-29 0001377936 sar:GraniteComfortLPOneMember sar:TotalHVACServicesAndSalesMember 2023-03-01 2024-02-29 0001377936 sar:GraniteComfortLPOneMember sar:TotalHVACServicesAndSalesMember 2024-02-29 0001377936 sar:TotalHVACServicesAndSalesMember 2024-02-29 0001377936 sar:VectorControlsHoldingCoLLCMember sar:TotalIndustrialProductsMember 2023-03-01 2024-02-29 0001377936 sar:VectorControlsHoldingCoLLCMember sar:TotalIndustrialProductsMember 2024-02-29 0001377936 sar:VectorControlsHoldingCoLLCOneMember sar:TotalIndustrialProductsMember 2024-02-29 0001377936 sar:VectorControlsHoldingCoLLCOneMember sar:TotalIndustrialProductsMember 2023-03-01 2024-02-29 0001377936 sar:TotalIndustrialProductsMember 2024-02-29 0001377936 sar:AgencyBlocLLCMember sar:TotalInsuranceSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:AgencyBlocLLCMember sar:TotalInsuranceSoftwareMember 2024-02-29 0001377936 sar:PantherParentCoLLCOneMember sar:TotalInsuranceSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:PantherParentCoLLCOneMember sar:TotalInsuranceSoftwareMember 2024-02-29 0001377936 sar:TotalInsuranceSoftwareMember 2024-02-29 0001377936 sar:LogicMonitorIncMember sar:TotalITServicesMember 2023-03-01 2024-02-29 0001377936 sar:LogicMonitorIncMember sar:TotalITServicesMember 2024-02-29 0001377936 sar:TotalITServicesMember 2024-02-29 0001377936 sar:ActiveProspectIncMember sar:TotalLeadManagementSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ActiveProspectIncMember sar:TotalLeadManagementSoftwareMember 2024-02-29 0001377936 sar:ActiveProspectInc1Member sar:TotalLeadManagementSoftwareMember 2024-02-29 0001377936 sar:ActiveProspectIncOneMember sar:TotalLeadManagementSoftwareMember 2024-02-29 0001377936 sar:ActiveProspectIncOneMember sar:TotalLeadManagementSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:TotalLeadManagementSoftwareMember 2024-02-29 0001377936 sar:CenterbaseLLCMember sar:TotalLegalSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:CenterbaseLLCMember sar:TotalLegalSoftwareMember 2024-02-29 0001377936 sar:TotalLegalSoftwareMember 2024-02-29 0001377936 sar:MadisonLogicIncMember sar:TotalMarketingOrchestrationSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:MadisonLogicIncMember sar:TotalMarketingOrchestrationSoftwareMember 2024-02-29 0001377936 sar:TotalMarketingOrchestrationSoftwareMember 2024-02-29 0001377936 sar:ARCHealthOpCoLLC1Member sar:TotalMentalHealthcareServicesMember 2023-03-01 2024-02-29 0001377936 sar:ARCHealthOpCoLLC1Member sar:TotalMentalHealthcareServicesMember 2024-02-29 0001377936 sar:ARCHealthOpCoLLCOneMember sar:TotalMentalHealthcareServicesMember 2023-03-01 2024-02-29 0001377936 sar:ARCHealthOpCoLLCOneMember sar:TotalMentalHealthcareServicesMember 2024-02-29 0001377936 sar:ARCHealthOpCoLLCTwoMember sar:TotalMentalHealthcareServicesMember 2023-03-01 2024-02-29 0001377936 sar:ARCHealthOpCoLLCTwoMember sar:TotalMentalHealthcareServicesMember 2024-02-29 0001377936 sar:TotalMentalHealthcareServicesMember 2024-02-29 0001377936 sar:ChronusLLCMember sar:TotalMentoringSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ChronusLLCMember sar:TotalMentoringSoftwareMember 2024-02-29 0001377936 sar:ChronusLLC2Member sar:TotalMentoringSoftwareMember 2024-02-29 0001377936 sar:ChronusLLCOneMember sar:TotalMentoringSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ChronusLLCOneMember sar:TotalMentoringSoftwareMember 2024-02-29 0001377936 sar:ChronusLLCTwoMember sar:TotalMentoringSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ChronusLLCTwoMember sar:TotalMentoringSoftwareMember 2024-02-29 0001377936 sar:TotalMentoringSoftwareMember 2024-02-29 0001377936 sar:OmaticSoftwareLLCMember sar:TotalNonprofitServicesMember 2023-03-01 2024-02-29 0001377936 sar:OmaticSoftwareLLCMember sar:TotalNonprofitServicesMember 2024-02-29 0001377936 sar:TotalNonprofitServicesMember 2024-02-29 0001377936 sar:EmilyStreetEnterprisesLLCMember sar:TotalOfficeSuppliesMember 2023-03-01 2024-02-29 0001377936 sar:EmilyStreetEnterprisesLLCMember sar:TotalOfficeSuppliesMember 2024-02-29 0001377936 sar:EmilyStreetEnterprisesLLCOneMember sar:TotalOfficeSuppliesMember 2023-03-01 2024-02-29 0001377936 sar:EmilyStreetEnterprisesLLCOneMember sar:TotalOfficeSuppliesMember 2024-02-29 0001377936 sar:TotalOfficeSuppliesMember 2024-02-29 0001377936 sar:BuildoutIncMember sar:TotalRealEstateServicesMember 2023-03-01 2024-02-29 0001377936 sar:BuildoutIncMember sar:TotalRealEstateServicesMember 2024-02-29 0001377936 sar:BuildoutIncOneMember sar:TotalRealEstateServicesMember 2023-03-01 2024-02-29 0001377936 sar:BuildoutIncOneMember sar:TotalRealEstateServicesMember 2024-02-29 0001377936 sar:BuildoutIncTwoMember sar:TotalRealEstateServicesMember 2023-03-01 2024-02-29 0001377936 sar:BuildoutIncTwoMember sar:TotalRealEstateServicesMember 2024-02-29 0001377936 sar:TotalRealEstateServicesMember 2024-02-29 0001377936 sar:WellspringWorldwideIncMember sar:TotalResearchSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:WellspringWorldwideIncMember sar:TotalResearchSoftwareMember 2024-02-29 0001377936 sar:WellspringWorldwideIncOneMember sar:TotalResearchSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:WellspringWorldwideIncOneMember sar:TotalResearchSoftwareMember 2024-02-29 0001377936 sar:ArchimedesParentLLCMember sar:TotalResearchSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:ArchimedesParentLLCMember sar:TotalResearchSoftwareMember 2024-02-29 0001377936 sar:TotalResearchSoftwareMember 2024-02-29 0001377936 sar:LFRChickenLLCMember sar:TotalRestaurantMember 2023-03-01 2024-02-29 0001377936 sar:LFRChickenLLCMember sar:TotalRestaurantMember 2024-02-29 0001377936 sar:LFRChickenLLCOneMember sar:TotalRestaurantMember 2023-03-01 2024-02-29 0001377936 sar:LFRChickenLLCOneMember sar:TotalRestaurantMember 2024-02-29 0001377936 sar:LFRChickenLLCTwoMember sar:TotalRestaurantMember 2023-03-01 2024-02-29 0001377936 sar:LFRChickenLLCTwoMember sar:TotalRestaurantMember 2024-02-29 0001377936 sar:TotalRestaurantMember 2024-02-29 0001377936 sar:JobNimbusLLCMember sar:TotalRoofingContractorSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:JobNimbusLLCMember sar:TotalRoofingContractorSoftwareMember 2024-02-29 0001377936 sar:TotalRoofingContractorSoftwareMember 2024-02-29 0001377936 sar:PepperPalaceIncMember sar:TotalSpecialtyFoodRetailer1Member 2023-03-01 2024-02-29 0001377936 sar:PepperPalaceIncMember sar:TotalSpecialtyFoodRetailer1Member 2024-02-29 0001377936 sar:PepperPalaceIncOneMember sar:TotalSpecialtyFoodRetailer1Member 2023-03-01 2024-02-29 0001377936 sar:PepperPalaceIncOneMember sar:TotalSpecialtyFoodRetailer1Member 2024-02-29 0001377936 sar:PepperPalaceIncTwoMember sar:TotalSpecialtyFoodRetailer1Member 2024-02-29 0001377936 sar:PepperPalaceIncTwoMember sar:TotalSpecialtyFoodRetailer1Member 2023-03-01 2024-02-29 0001377936 sar:PepperPalaceIncThreeMember sar:TotalSpecialtyFoodRetailer1Member 2024-02-29 0001377936 sar:PepperPalaceIncThreeMember sar:TotalSpecialtyFoodRetailer1Member 2023-03-01 2024-02-29 0001377936 sar:PepperPalaceIncFourMember sar:TotalSpecialtyFoodRetailer1Member 2024-02-29 0001377936 sar:PepperPalaceIncFourMember sar:TotalSpecialtyFoodRetailer1Member 2023-03-01 2024-02-29 0001377936 sar:TotalSpecialtyFoodRetailer1Member 2024-02-29 0001377936 sar:ArbiterSportsLLCMember sar:TotalSportsManagement1Member 2023-03-01 2024-02-29 0001377936 sar:ArbiterSportsLLCMember sar:TotalSportsManagement1Member 2024-02-29 0001377936 sar:ArbiterSportsLLCOneMember sar:TotalSportsManagement1Member 2023-03-01 2024-02-29 0001377936 sar:ArbiterSportsLLCOneMember sar:TotalSportsManagement1Member 2024-02-29 0001377936 sar:TotalSportsManagement1Member 2024-02-29 0001377936 sar:AvionteHoldingsLLCMember sar:TotalStaffingServicesMember 2023-03-01 2024-02-29 0001377936 sar:AvionteHoldingsLLCMember sar:TotalStaffingServicesMember 2024-02-29 0001377936 sar:TotalStaffingServicesMember 2024-02-29 0001377936 sar:JDXpertMember sar:TotalTalentAcquisitionSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:JDXpertMember sar:TotalTalentAcquisitionSoftwareMember 2024-02-29 0001377936 sar:JDXpertOneMember sar:TotalTalentAcquisitionSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:JDXpertOneMember sar:TotalTalentAcquisitionSoftwareMember 2024-02-29 0001377936 sar:JobviteIncMember sar:TotalTalentAcquisitionSoftwareMember 2023-03-01 2024-02-29 0001377936 sar:JobviteIncMember sar:TotalTalentAcquisitionSoftwareMember 2024-02-29 0001377936 sar:TotalTalentAcquisitionSoftwareMember 2024-02-29 0001377936 sar:VetnCareMSOLLCMember sar:TotalVeterinaryServicesMember 2023-03-01 2024-02-29 0001377936 sar:VetnCareMSOLLCMember sar:TotalVeterinaryServicesMember 2024-02-29 0001377936 sar:TotalVeterinaryServicesMember 2024-02-29 0001377936 sar:VetnCareMSOLLCMember sar:SubTotalNoncontrolNonaffiliateInvestmentsMember 2024-02-29 0001377936 sar:ETUHoldingsInc1Member sar:TotalCorporateEducationSoftware1Member 2023-03-01 2024-02-29 0001377936 sar:ETUHoldingsInc1Member sar:TotalCorporateEducationSoftware1Member 2024-02-29 0001377936 sar:ETUHoldingsIncOneMember sar:TotalCorporateEducationSoftware1Member 2023-03-01 2024-02-29 0001377936 sar:ETUHoldingsIncOneMember sar:TotalCorporateEducationSoftware1Member 2024-02-29 0001377936 sar:ETUHoldingsIncTwoMember sar:TotalCorporateEducationSoftware1Member 2023-03-01 2024-02-29 0001377936 sar:ETUHoldingsIncTwoMember sar:TotalCorporateEducationSoftware1Member 2024-02-29 0001377936 sar:TotalCorporateEducationSoftwareOneMember 2024-02-29 0001377936 sar:AxeroHoldingsLLCMember sar:TotalEmployeeCollaborationSoftware1Member 2023-03-01 2024-02-29 0001377936 sar:AxeroHoldingsLLCMember sar:TotalEmployeeCollaborationSoftware1Member 2024-02-29 0001377936 sar:AxeroHoldingsLLCOneMember sar:TotalEmployeeCollaborationSoftware1Member 2023-03-01 2024-02-29 0001377936 sar:AxeroHoldingsLLCOneMember sar:TotalEmployeeCollaborationSoftware1Member 2024-02-29 0001377936 sar:AxeroHoldingsLLCTwoMember sar:TotalEmployeeCollaborationSoftware1Member 2023-03-01 2024-02-29 0001377936 sar:AxeroHoldingsLLCTwoMember sar:TotalEmployeeCollaborationSoftware1Member 2024-02-29 0001377936 sar:AxeroHoldingsLLCThreeMember sar:TotalEmployeeCollaborationSoftware1Member 2023-03-01 2024-02-29 0001377936 sar:AxeroHoldingsLLCThreeMember sar:TotalEmployeeCollaborationSoftware1Member 2024-02-29 0001377936 sar:AxeroHoldingsLLCFourMember sar:TotalEmployeeCollaborationSoftware1Member 2023-03-01 2024-02-29 0001377936 sar:AxeroHoldingsLLCFourMember sar:TotalEmployeeCollaborationSoftware1Member 2024-02-29 0001377936 sar:TotalEmployeeCollaborationSoftware1Member 2024-02-29 0001377936 sar:SubTotalAffiliateInvestmentsMember 2024-02-29 0001377936 sar:NetreoHoldingsLLCMember sar:TotalITServicesOneMember 2023-03-01 2024-02-29 0001377936 sar:NetreoHoldingsLLCMember sar:TotalITServicesOneMember 2024-02-29 0001377936 sar:NetreoHoldingsLLCOneMember sar:TotalITServicesOneMember 2023-03-01 2024-02-29 0001377936 sar:NetreoHoldingsLLCOneMember sar:TotalITServicesOneMember 2024-02-29 0001377936 sar:NetreoHoldingsLLCTwoMember us-gaap:CommercialAndIndustrialSectorMember 2023-03-01 2024-02-29 0001377936 sar:NetreoHoldingsLLCTwoMember us-gaap:CommercialAndIndustrialSectorMember 2024-02-29 0001377936 sar:TotalITServicesOneMember 2024-02-29 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdMember sar:StructuredFinanceSecuritiesMember 2023-03-01 2024-02-29 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdMember sar:StructuredFinanceSecuritiesMember 2024-02-29 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember sar:StructuredFinanceSecuritiesOneMember 2023-03-01 2024-02-29 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember sar:StructuredFinanceSecuritiesOneMember 2024-02-29 0001377936 sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember sar:StructuredFinanceSecuritiesTwoMember 2023-03-01 2024-02-29 0001377936 sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember sar:StructuredFinanceSecuritiesTwoMember 2024-02-29 0001377936 sar:TotalStructuredFinanceSecurities1Member 2024-02-29 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:TotalInvestmentFundMember 2023-03-01 2024-02-29 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:TotalInvestmentFundMember 2024-02-29 0001377936 sar:SaratogaSeniorLoanFundIJVLLCOneMember sar:TotalInvestmentFund1Member 2023-03-01 2024-02-29 0001377936 sar:SaratogaSeniorLoanFundIJVLLCOneMember sar:TotalInvestmentFund1Member 2024-02-29 0001377936 sar:TotalInvestmentFund1Member 2024-02-29 0001377936 sar:SubTotalControlInvestmentsMember 2024-02-29 0001377936 sar:TotalInvestmentsMember 2024-02-29 0001377936 sar:AltviaMidCoLLCMember sar:TotalAlternativeInvestmentManagementSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:AltviaMidCoLLCMember sar:TotalAlternativeInvestmentManagementSoftwareMember 2023-02-28 0001377936 sar:AltviaMidCoLLCOneMember sar:TotalAlternativeInvestmentManagementSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:AltviaMidCoLLCOneMember sar:TotalAlternativeInvestmentManagementSoftwareMember 2023-02-28 0001377936 sar:TotalAlternativeInvestmentManagementSoftwareMember 2023-02-28 0001377936 sar:ArtemisWaxCorpMember sar:TotalConsumerServices1Member 2022-03-01 2023-02-28 0001377936 sar:ArtemisWaxCorpMember sar:TotalConsumerServices1Member 2023-02-28 0001377936 sar:ArtemisWaxCorpOneMember sar:TotalConsumerServices1Member 2022-03-01 2023-02-28 0001377936 sar:ArtemisWaxCorpOneMember sar:TotalConsumerServices1Member 2023-02-28 0001377936 sar:ArtemisWaxCorpTwoMember sar:TotalConsumerServices1Member 2022-03-01 2023-02-28 0001377936 sar:ArtemisWaxCorpTwoMember sar:TotalConsumerServices1Member 2023-02-28 0001377936 sar:TotalConsumerServices1Member 2023-02-28 0001377936 sar:SchooxIncsMember sar:TotalCorporateEducationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:SchooxIncsMember sar:TotalCorporateEducationSoftwareMember 2023-02-28 0001377936 sar:TotalCorporateEducationSoftwareMember 2023-02-28 0001377936 sar:GreyHellerLLCMember sar:TotalCyberSecurityMember 2022-03-01 2023-02-28 0001377936 sar:GreyHellerLLCMember sar:TotalCyberSecurityMember 2023-02-28 0001377936 sar:TotalCyberSecurityMember 2023-02-28 0001377936 sar:NewEnglandDentalPartnersMember sar:TotalDentalPracticeManagementMember 2022-03-01 2023-02-28 0001377936 sar:NewEnglandDentalPartnersMember sar:TotalDentalPracticeManagementMember 2023-02-28 0001377936 sar:NewEnglandDentalPartnersOneMember sar:TotalDentalPracticeManagementMember 2022-03-01 2023-02-28 0001377936 sar:NewEnglandDentalPartnersOneMember sar:TotalDentalPracticeManagementMember 2023-02-28 0001377936 sar:Gen4DentalPartnersHoldingsLLCMember sar:TotalDentalPracticeManagementMember 2023-02-28 0001377936 sar:Gen4DentalPartnersHoldingsLLCMember sar:TotalDentalPracticeManagementMember 2022-03-01 2023-02-28 0001377936 sar:Gen4DentalPartnersHoldingsLLCOneMember sar:TotalDentalPracticeManagementMember 2022-03-01 2023-02-28 0001377936 sar:Gen4DentalPartnersHoldingsLLCOneMember sar:TotalDentalPracticeManagementMember 2023-02-28 0001377936 sar:TotalDentalPracticeManagementMember 2023-02-28 0001377936 sar:ExigoLLCMember sar:TotalDirectSellingSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ExigoLLCMember sar:TotalDirectSellingSoftwareMember 2023-02-28 0001377936 sar:ExigoLLCOneMember sar:TotalDirectSellingSoftwareMember 2023-02-28 0001377936 sar:ExigoLLCOneMember sar:TotalDirectSellingSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ExigoLLCTwoMember sar:TotalDirectSellingSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ExigoLLCTwoMember sar:TotalDirectSellingSoftwareMember 2023-02-28 0001377936 sar:ExigoLLCThreeMember sar:TotalDirectSellingSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ExigoLLCThreeMember sar:TotalDirectSellingSoftwareMember 2023-02-28 0001377936 sar:TotalDirectSellingSoftwareMember 2023-02-28 0001377936 sar:C2EducationalSystemsMember sar:TotalEducationServicesMember 2022-03-01 2023-02-28 0001377936 sar:C2EducationalSystemsMember sar:TotalEducationServicesMember 2023-02-28 0001377936 sar:C2EducationSystemsIncMember sar:TotalEducationServicesMember 2022-03-01 2023-02-28 0001377936 sar:C2EducationSystemsIncMember sar:TotalEducationServicesMember 2023-02-28 0001377936 sar:ZollegePBCMember sar:TotalEducationServicesMember 2022-03-01 2023-02-28 0001377936 sar:ZollegePBCMember sar:TotalEducationServicesMember 2023-02-28 0001377936 sar:ZollegePBCOneMember sar:TotalEducationServicesMember 2022-03-01 2023-02-28 0001377936 sar:ZollegePBCOneMember sar:TotalEducationServicesMember 2023-02-28 0001377936 sar:ZollegePBCTwoMember sar:TotalEducationServicesMember 2022-03-01 2023-02-28 0001377936 sar:ZollegePBCTwoMember sar:TotalEducationServicesMember 2023-02-28 0001377936 sar:TotalEducationServicesMember 2023-02-28 0001377936 sar:DestinySolutionsIncMember sar:TotalEducationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:DestinySolutionsIncMember sar:TotalEducationSoftwareMember 2023-02-28 0001377936 sar:GoReactMember sar:TotalEducationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:GoReactMember sar:TotalEducationSoftwareMember 2023-02-28 0001377936 sar:GoReactOneMember sar:TotalEducationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:GoReactOneMember sar:TotalEducationSoftwareMember 2023-02-28 0001377936 sar:IdentityAutomationSystemsOneMember sar:TotalEducationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:IdentityAutomationSystemsOneMember sar:TotalEducationSoftwareMember 2023-02-28 0001377936 sar:IdentityAutomationSystemsTwoMember sar:TotalEducationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:IdentityAutomationSystemsTwoMember sar:TotalEducationSoftwareMember 2023-02-28 0001377936 sar:ReadyEducationMember sar:TotalEducationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ReadyEducationMember sar:TotalEducationSoftwareMember 2023-02-28 0001377936 sar:TotalEducationSoftwareMember 2023-02-28 0001377936 sar:TGPressureWashingHoldingsLLCMember sar:TotalFacilitiesMaintenanceMember 2022-03-01 2023-02-28 0001377936 sar:TGPressureWashingHoldingsLLCMember sar:TotalFacilitiesMaintenanceMember 2023-02-28 0001377936 sar:TotalFacilitiesMaintenanceMember 2023-02-28 0001377936 sar:DaviswareLLCMember sar:TotalFieldServiceManagementMember 2022-03-01 2023-02-28 0001377936 sar:DaviswareLLCMember sar:TotalFieldServiceManagementMember 2023-02-28 0001377936 sar:DaviswareLLCOneMember sar:TotalFieldServiceManagementMember 2022-03-01 2023-02-28 0001377936 sar:DaviswareLLCOneMember sar:TotalFieldServiceManagementMember 2023-02-28 0001377936 sar:TotalFieldServiceManagementMember 2023-02-28 0001377936 sar:BRileyFinancialIncMember sar:TotalFinancialServicesMember 2022-03-01 2023-02-28 0001377936 sar:BRileyFinancialIncMember sar:TotalFinancialServicesMember 2023-02-28 0001377936 sar:GDSSoftwareHoldingsLLCMember sar:TotalFinancialServicesMember 2022-03-01 2023-02-28 0001377936 sar:GDSSoftwareHoldingsLLCMember sar:TotalFinancialServicesMember 2023-02-28 0001377936 sar:GDSSoftwareHoldingsLLCOneMember sar:TotalFinancialServicesMember 2022-03-01 2023-02-28 0001377936 sar:GDSSoftwareHoldingsLLCOneMember sar:TotalFinancialServicesMember 2023-02-28 0001377936 sar:GDSSoftwareHoldingsLLCTwoMember sar:TotalFinancialServicesMember 2022-03-01 2023-02-28 0001377936 sar:GDSSoftwareHoldingsLLCTwoMember sar:TotalFinancialServicesMember 2023-02-28 0001377936 sar:TotalFinancialServicesMember 2023-02-28 0001377936 sar:AscendSoftwareLLCMember sar:TotalFinancialServicesSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:AscendSoftwareLLCMember sar:TotalFinancialServicesSoftwareMember 2023-02-28 0001377936 sar:AscendSoftwareLLCOneMember sar:TotalFinancialServicesSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:AscendSoftwareLLCOneMember sar:TotalFinancialServicesSoftwareMember 2023-02-28 0001377936 sar:TotalFinancialServicesSoftwareMember 2023-02-28 0001377936 sar:AxiomParentHoldingsLLCMember sar:TotalHealthcareServicesMember 2022-03-01 2023-02-28 0001377936 sar:AxiomParentHoldingsLLCMember sar:TotalHealthcareServicesMember 2023-02-28 0001377936 sar:ComForCareHealthCareOneMember sar:TotalHealthcareServicesMember 2022-03-01 2023-02-28 0001377936 sar:ComForCareHealthCareOneMember sar:TotalHealthcareServicesMember 2023-02-28 0001377936 sar:TotalHealthcareServicesMember 2023-02-28 0001377936 sar:HemaTerraHoldingCompanyLLCMember sar:TotalHealthcareSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:HemaTerraHoldingCompanyLLCMember sar:TotalHealthcareSoftwareMember 2023-02-28 0001377936 sar:HemaTerraHoldingCompanyLLCOneMember sar:TotalHealthcareSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:HemaTerraHoldingCompanyLLCOneMember sar:TotalHealthcareSoftwareMember 2023-02-28 0001377936 sar:TRCHemaTerraLLCMember sar:TotalHealthcareSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:TRCHemaTerraLLCMember sar:TotalHealthcareSoftwareMember 2023-02-28 0001377936 sar:ProcurementPartnersLLCMember sar:TotalHealthcareSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ProcurementPartnersLLCMember sar:TotalHealthcareSoftwareMember 2023-02-28 0001377936 sar:ProcurementPartnersLLCOneMember sar:TotalHealthcareSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ProcurementPartnersLLCOneMember sar:TotalHealthcareSoftwareMember 2023-02-28 0001377936 sar:ProcurementPartnersHoldingsLLCMember sar:TotalHealthcareSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ProcurementPartnersHoldingsLLCMember sar:TotalHealthcareSoftwareMember 2023-02-28 0001377936 sar:TotalHealthcareSoftwareMember 2023-02-28 0001377936 sar:RoscoeMedicalIncOneMember sar:TotalHealthcareSupplyMember 2023-02-28 0001377936 sar:RoscoeMedicalIncOneMember sar:TotalHealthcareSupplyMember 2022-03-01 2023-02-28 0001377936 sar:TotalHealthcareSupplyMember 2023-02-28 0001377936 sar:Book4TimeIncMember sar:TotalHospitalityHotelMember 2022-03-01 2023-02-28 0001377936 sar:Book4TimeIncMember sar:TotalHospitalityHotelMember 2023-02-28 0001377936 sar:Book4TimeIncOneMember sar:TotalHospitalityHotelMember 2022-03-01 2023-02-28 0001377936 sar:Book4TimeIncOneMember sar:TotalHospitalityHotelMember 2023-02-28 0001377936 sar:Book4TimeIncTwoMember sar:TotalHospitalityHotelMember 2022-03-01 2023-02-28 0001377936 sar:Book4TimeIncTwoMember sar:TotalHospitalityHotelMember 2023-02-28 0001377936 sar:KnowlandGroupLLCMember sar:TotalHospitalityHotelMember 2022-03-01 2023-02-28 0001377936 sar:KnowlandGroupLLCMember sar:TotalHospitalityHotelMember 2023-02-28 0001377936 sar:SceptreHospitalityResourcesLLCMember sar:TotalHospitalityHotelMember 2022-03-01 2023-02-28 0001377936 sar:SceptreHospitalityResourcesLLCMember sar:TotalHospitalityHotelMember 2023-02-28 0001377936 sar:SceptreHospitalityResourcesLLCOneMember sar:TotalHospitalityHotelMember 2023-02-28 0001377936 sar:SceptreHospitalityResourcesLLCOneMember sar:TotalHospitalityHotelMember 2022-03-01 2023-02-28 0001377936 sar:TotalHospitalityHotelMember 2023-02-28 0001377936 sar:GraniteComfortLPMember sar:TotalHVACServicesAndSalesMember 2022-03-01 2023-02-28 0001377936 sar:GraniteComfortLPMember sar:TotalHVACServicesAndSalesMember 2023-02-28 0001377936 sar:GraniteComfortLPOneMember sar:TotalHVACServicesAndSalesMember 2022-03-01 2023-02-28 0001377936 sar:GraniteComfortLPOneMember sar:TotalHVACServicesAndSalesMember 2023-02-28 0001377936 sar:TotalHVACServicesAndSalesMember 2023-02-28 0001377936 sar:VectorControlsHoldingCoLLCMember sar:TotalIndustrialProductsMember 2022-03-01 2023-02-28 0001377936 sar:VectorControlsHoldingCoLLCMember sar:TotalIndustrialProductsMember 2023-02-28 0001377936 sar:VectorControlsHoldingCoLLCOneMember sar:TotalIndustrialProductsMember 2023-02-28 0001377936 sar:VectorControlsHoldingCoLLCOneMember sar:TotalIndustrialProductsMember 2022-03-01 2023-02-28 0001377936 sar:TotalIndustrialProductsMember 2023-02-28 0001377936 sar:AgencyBlocLLCMember sar:TotalInsuranceSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:AgencyBlocLLCMember sar:TotalInsuranceSoftwareMember 2023-02-28 0001377936 sar:PantherParentCoLLCMember sar:TotalInsuranceSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:PantherParentCoLLCMember sar:TotalInsuranceSoftwareMember 2023-02-28 0001377936 sar:TotalInsuranceSoftwareMember 2023-02-28 0001377936 sar:LogicMonitorIncMember sar:TotalITServicesMember 2022-03-01 2023-02-28 0001377936 sar:LogicMonitorIncMember sar:TotalITServicesMember 2023-02-28 0001377936 sar:TotalITServicesMember 2023-02-28 0001377936 sar:ActiveProspectIncTwoMember sar:TotalLeadManagementSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ActiveProspectIncTwoMember sar:TotalLeadManagementSoftwareMember 2023-02-28 0001377936 sar:ActiveProspectIncThreeMember sar:TotalLeadManagementSoftwareMember 2023-02-28 0001377936 sar:ActiveProspectIncThreeMember sar:TotalLeadManagementSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:TotalLeadManagementSoftwareMember 2023-02-28 0001377936 sar:CenterbaseLLCMember sar:TotalLegalSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:CenterbaseLLCMember sar:TotalLegalSoftwareMember 2023-02-28 0001377936 sar:TotalLegalSoftwareMember 2023-02-28 0001377936 sar:MadisonLogicIncMember sar:TotalMarketingOrchestrationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:MadisonLogicIncMember sar:TotalMarketingOrchestrationSoftwareMember 2023-02-28 0001377936 sar:TotalMarketingOrchestrationSoftwareMember 2023-02-28 0001377936 sar:ARCHealthOpCoLLC1Member sar:TotalMentalHealthcareServicesMember 2022-03-01 2023-02-28 0001377936 sar:ARCHealthOpCoLLC1Member sar:TotalMentalHealthcareServicesMember 2023-02-28 0001377936 sar:ARCHealthOpCoLLCOneMember sar:TotalMentalHealthcareServicesMember 2022-03-01 2023-02-28 0001377936 sar:ARCHealthOpCoLLCOneMember sar:TotalMentalHealthcareServicesMember 2023-02-28 0001377936 sar:ARCHealthOpCoLLCTwoMember sar:TotalMentalHealthcareServicesMember 2022-03-01 2023-02-28 0001377936 sar:ARCHealthOpCoLLCTwoMember sar:TotalMentalHealthcareServicesMember 2023-02-28 0001377936 sar:TotalMentalHealthcareServicesMember 2023-02-28 0001377936 sar:ChronusLLCMember sar:TotalMentoringSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ChronusLLCMember sar:TotalMentoringSoftwareMember 2023-02-28 0001377936 sar:ChronusLLCOneMember sar:TotalMentoringSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ChronusLLCOneMember sar:TotalMentoringSoftwareMember 2023-02-28 0001377936 sar:ChronusLLCTwoMember sar:TotalMentoringSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ChronusLLCTwoMember sar:TotalMentoringSoftwareMember 2023-02-28 0001377936 sar:TotalMentoringSoftwareMember 2023-02-28 0001377936 sar:OmaticSoftwareLLCMember sar:TotalNonprofitServicesMember 2022-03-01 2023-02-28 0001377936 sar:OmaticSoftwareLLCMember sar:TotalNonprofitServicesMember 2023-02-28 0001377936 sar:TotalNonprofitServicesMember 2023-02-28 0001377936 sar:EmilyStreetEnterprisesLLCMember sar:TotalOfficeSuppliesMember 2022-03-01 2023-02-28 0001377936 sar:EmilyStreetEnterprisesLLCMember sar:TotalOfficeSuppliesMember 2023-02-28 0001377936 sar:EmilyStreetEnterprisesLLCOneMember sar:TotalOfficeSuppliesMember 2022-03-01 2023-02-28 0001377936 sar:EmilyStreetEnterprisesLLCOneMember sar:TotalOfficeSuppliesMember 2023-02-28 0001377936 sar:TotalOfficeSuppliesMember 2023-02-28 0001377936 sar:BuildoutIncMember sar:TotalRealEstateServicesMember 2022-03-01 2023-02-28 0001377936 sar:BuildoutIncMember sar:TotalRealEstateServicesMember 2023-02-28 0001377936 sar:BuildoutIncOneMember sar:TotalRealEstateServicesMember 2022-03-01 2023-02-28 0001377936 sar:BuildoutIncOneMember sar:TotalRealEstateServicesMember 2023-02-28 0001377936 sar:BuildoutIncTwoMember sar:TotalRealEstateServicesMember 2022-03-01 2023-02-28 0001377936 sar:BuildoutIncTwoMember sar:TotalRealEstateServicesMember 2023-02-28 0001377936 sar:TotalRealEstateServicesMember 2023-02-28 0001377936 sar:ArchimedesParentLLCMember sar:TotalResearchSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ArchimedesParentLLCMember sar:TotalResearchSoftwareMember 2023-02-28 0001377936 sar:WellspringWorldwideIncMember sar:TotalResearchSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:WellspringWorldwideIncMember sar:TotalResearchSoftwareMember 2023-02-28 0001377936 sar:TotalResearchSoftwareMember 2023-02-28 0001377936 sar:LFRChickenLLCMember sar:TotalRestaurantMember 2022-03-01 2023-02-28 0001377936 sar:LFRChickenLLCMember sar:TotalRestaurantMember 2023-02-28 0001377936 sar:LFRChickenLLCOneMember sar:TotalRestaurantMember 2022-03-01 2023-02-28 0001377936 sar:LFRChickenLLCOneMember sar:TotalRestaurantMember 2023-02-28 0001377936 sar:LFRChickenLLCTwoMember sar:TotalRestaurantMember 2022-03-01 2023-02-28 0001377936 sar:LFRChickenLLCTwoMember sar:TotalRestaurantMember 2023-02-28 0001377936 sar:TMACAcquisitionCoLLCMember sar:TotalRestaurantMember 2022-03-01 2023-02-28 0001377936 sar:TMACAcquisitionCoLLCMember sar:TotalRestaurantMember 2023-02-28 0001377936 sar:TotalRestaurantMember 2023-02-28 0001377936 sar:PepperPalaceIncMember sar:TotalSpecialtyFoodRetailer1Member 2022-03-01 2023-02-28 0001377936 sar:PepperPalaceIncMember sar:TotalSpecialtyFoodRetailer1Member 2023-02-28 0001377936 sar:PepperPalaceIncOneMember sar:TotalSpecialtyFoodRetailer1Member 2023-02-28 0001377936 sar:PepperPalaceIncOneMember sar:TotalSpecialtyFoodRetailer1Member 2022-03-01 2023-02-28 0001377936 sar:PepperPalaceIncTwoMember sar:TotalSpecialtyFoodRetailer1Member 2023-02-28 0001377936 sar:PepperPalaceIncTwoMember sar:TotalSpecialtyFoodRetailer1Member 2022-03-01 2023-02-28 0001377936 sar:PepperPalaceIncThreeMember sar:TotalSpecialtyFoodRetailer1Member 2023-02-28 0001377936 sar:PepperPalaceIncThreeMember sar:TotalSpecialtyFoodRetailer1Member 2022-03-01 2023-02-28 0001377936 sar:TotalSpecialtyFoodRetailer1Member 2023-02-28 0001377936 sar:ArbiterSportsLLCMember sar:TotalSportsManagement1Member 2022-03-01 2023-02-28 0001377936 sar:ArbiterSportsLLCMember sar:TotalSportsManagement1Member 2023-02-28 0001377936 sar:ArbiterSportsLLCOneMember sar:ArbiterSportsLLCOneMember 2022-03-01 2023-02-28 0001377936 sar:ArbiterSportsLLCOneMember sar:ArbiterSportsLLCOneMember 2023-02-28 0001377936 sar:ArbiterSportsLLCOneMember sar:TotalSportsManagement1Member 2023-02-28 0001377936 sar:TotalSportsManagement1Member 2023-02-28 0001377936 sar:AvionteHoldingsLLCMember sar:TotalStaffingServicesMember 2022-03-01 2023-02-28 0001377936 sar:AvionteHoldingsLLCMember sar:TotalStaffingServicesMember 2023-02-28 0001377936 sar:TotalStaffingServicesMember 2023-02-28 0001377936 sar:JDXpertMember sar:TotalTalentAcquisitionSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:JDXpertMember sar:TotalTalentAcquisitionSoftwareMember 2023-02-28 0001377936 sar:JDXpertOneMember sar:TotalTalentAcquisitionSoftwareMember 2023-02-28 0001377936 sar:JDXpertOneMember sar:TotalTalentAcquisitionSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:JobviteIncMember sar:TotalTalentAcquisitionSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:JobviteIncMember sar:TotalTalentAcquisitionSoftwareMember 2023-02-28 0001377936 sar:TotalTalentAcquisitionSoftwareMember 2023-02-28 0001377936 sar:JobviteIncMember sar:SubTotalNoncontrolNonaffiliateInvestmentsMember 2023-02-28 0001377936 sar:ETUHoldingsIncMember sar:TotalCorporateEducationSoftware1Member 2022-03-01 2023-02-28 0001377936 sar:ETUHoldingsIncMember sar:TotalCorporateEducationSoftware1Member 2023-02-28 0001377936 sar:ETUHoldingsInc1Member sar:TotalCorporateEducationSoftware1Member 2022-03-01 2023-02-28 0001377936 sar:ETUHoldingsInc1Member sar:TotalCorporateEducationSoftware1Member 2023-02-28 0001377936 sar:ETUHoldingsInc2Member sar:TotalCorporateEducationSoftwareMember 2022-03-01 2023-02-28 0001377936 sar:ETUHoldingsInc2Member sar:TotalCorporateEducationSoftwareMember 2023-02-28 0001377936 sar:TotalCorporateEducationSoftwareOneMember 2023-02-28 0001377936 sar:AxeroHoldingsLLCMember sar:TotalEmployeeCollaborationSoftware1Member 2022-03-01 2023-02-28 0001377936 sar:AxeroHoldingsLLCMember sar:TotalEmployeeCollaborationSoftware1Member 2023-02-28 0001377936 sar:AxeroHoldingsLLCOneMember sar:TotalEmployeeCollaborationSoftware1Member 2022-03-01 2023-02-28 0001377936 sar:AxeroHoldingsLLCOneMember sar:TotalEmployeeCollaborationSoftware1Member 2023-02-28 0001377936 sar:AxeroHoldingsLLCTwoMember sar:TotalEmployeeCollaborationSoftware1Member 2023-02-28 0001377936 sar:AxeroHoldingsLLCTwoMember sar:TotalEmployeeCollaborationSoftware1Member 2022-03-01 2023-02-28 0001377936 sar:AxeroHoldingsLLCThreeMember sar:TotalEmployeeCollaborationSoftware1Member 2022-03-01 2023-02-28 0001377936 sar:AxeroHoldingsLLCThreeMember sar:TotalEmployeeCollaborationSoftware1Member 2023-02-28 0001377936 sar:AxeroHoldingsLLCFourMember sar:TotalEmployeeCollaborationSoftware1Member 2022-03-01 2023-02-28 0001377936 sar:AxeroHoldingsLLCFourMember sar:TotalEmployeeCollaborationSoftware1Member 2023-02-28 0001377936 sar:TotalEmployeeCollaborationSoftware1Member 2023-02-28 0001377936 sar:SubTotalAffiliateInvestmentsMember 2023-02-28 0001377936 sar:NetreoHoldingsLLCMember sar:TotalITServicesMember 2022-03-01 2023-02-28 0001377936 sar:NetreoHoldingsLLCMember sar:TotalITServicesMember 2023-02-28 0001377936 sar:NetreoHoldingsLLCOneMember sar:TotalITServicesMember 2022-03-01 2023-02-28 0001377936 sar:NetreoHoldingsLLCOneMember sar:TotalITServicesMember 2023-02-28 0001377936 sar:NetreoHoldingsLLCTwoMember sar:TotalITServicesMember 2022-03-01 2023-02-28 0001377936 sar:NetreoHoldingsLLCTwoMember sar:TotalITServicesMember 2023-02-28 0001377936 sar:TotalITServicesOneMember 2023-02-28 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdMember sar:TotalStructuredFinanceSecurities1Member 2022-03-01 2023-02-28 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdMember sar:TotalStructuredFinanceSecurities1Member 2023-02-28 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember sar:TotalStructuredFinanceSecurities1Member 2022-03-01 2023-02-28 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember sar:TotalStructuredFinanceSecurities1Member 2023-02-28 0001377936 sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember sar:TotalStructuredFinanceSecurities1Member 2022-03-01 2023-02-28 0001377936 sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember sar:TotalStructuredFinanceSecurities1Member 2023-02-28 0001377936 sar:TotalStructuredFinanceSecurities1Member 2023-02-28 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:TotalInvestmentFund1Member 2022-03-01 2023-02-28 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:TotalInvestmentFund1Member 2023-02-28 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:TotalInvestmentFundMember 2023-02-28 0001377936 sar:SaratogaSeniorLoanFundIJVLLCOneMember sar:TotalInvestmentFund1Member 2022-03-01 2023-02-28 0001377936 sar:SaratogaSeniorLoanFundIJVLLCOneMember sar:TotalInvestmentFund1Member 2023-02-28 0001377936 sar:TotalInvestmentFundMember 2023-02-28 0001377936 sar:SubTotalControlInvestmentsMember 2023-02-28 0001377936 sar:TotalInvestmentsMember 2023-02-28 0001377936 us-gaap:CashAndCashEquivalentsMember 2024-02-29 0001377936 us-gaap:CashAndCashEquivalentsMember 2023-02-28 0001377936 us-gaap:OtherAffiliatesMember sar:AxeroHoldingsLLCMember 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember sar:AxeroHoldingsLLCMember 2023-03-01 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember sar:ETUHoldingsIncMember 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember sar:ETUHoldingsIncMember 2023-03-01 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember sar:ModisDentalPartnersOpCoLLCMember 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember sar:ModisDentalPartnersOpCoLLCMember 2023-03-01 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember sar:AlphaAestheticsPartnersOpCoLLCMember 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember sar:AlphaAestheticsPartnersOpCoLLCMember 2023-03-01 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember 2023-03-01 2024-02-29 0001377936 sar:ControlMember sar:NetreoHoldingsLLCMember 2024-02-29 0001377936 sar:ControlMember sar:NetreoHoldingsLLCMember 2023-03-01 2024-02-29 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2023-03-01 2024-02-29 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdMember 2024-02-29 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdMember 2023-03-01 2024-02-29 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2024-02-29 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2023-03-01 2024-02-29 0001377936 sar:ControlMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2024-02-29 0001377936 sar:ControlMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2023-03-01 2024-02-29 0001377936 sar:ControlMember sar:SaratogaSeniorLoanFundIJVLLCOneMember 2024-02-29 0001377936 sar:ControlMember sar:SaratogaSeniorLoanFundIJVLLCOneMember 2023-03-01 2024-02-29 0001377936 sar:ControlMember 2024-02-29 0001377936 sar:ControlMember 2023-03-01 2024-02-29 0001377936 us-gaap:OtherAffiliatesMember sar:ArtemisWaxCorpMember 2023-02-28 0001377936 us-gaap:OtherAffiliatesMember sar:ArtemisWaxCorpMember 2022-03-01 2023-02-28 0001377936 us-gaap:OtherAffiliatesMember sar:AxeroHoldingsLLCMember 2023-02-28 0001377936 us-gaap:OtherAffiliatesMember sar:AxeroHoldingsLLCMember 2022-03-01 2023-02-28 0001377936 us-gaap:OtherAffiliatesMember sar:ETUHoldingsInc1Member 2023-02-28 0001377936 us-gaap:OtherAffiliatesMember sar:ETUHoldingsInc1Member 2022-03-01 2023-02-28 0001377936 us-gaap:OtherAffiliatesMember 2023-02-28 0001377936 us-gaap:OtherAffiliatesMember 2022-03-01 2023-02-28 0001377936 sar:ControlMember sar:NetreoHoldingsLLCMember 2023-02-28 0001377936 sar:ControlMember sar:NetreoHoldingsLLCMember 2022-03-01 2023-02-28 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2023-02-28 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2022-03-01 2023-02-28 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdMember 2023-02-28 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdMember 2022-03-01 2023-02-28 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2023-02-28 0001377936 sar:ControlMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2022-03-01 2023-02-28 0001377936 sar:ControlMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2023-02-28 0001377936 sar:ControlMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2022-03-01 2023-02-28 0001377936 sar:ControlMember sar:SaratogaSeniorLoanFundIJVLLCOneMember 2023-02-28 0001377936 sar:ControlMember sar:SaratogaSeniorLoanFundIJVLLCOneMember 2022-03-01 2023-02-28 0001377936 sar:ControlMember 2023-02-28 0001377936 sar:ControlMember 2022-03-01 2023-02-28 0001377936 2023-12-01 2024-02-29 0001377936 srt:MinimumMember sar:SBADebenturesMember 2024-02-29 0001377936 srt:MaximumMember sar:SBADebenturesMember 2024-02-29 0001377936 sar:SBADebenturesMember 2023-03-01 2024-02-29 0001377936 us-gaap:CollateralizedLoanObligationsMember 2022-10-28 2022-10-28 0001377936 sar:SLFJVMember 2024-02-29 0001377936 us-gaap:CashAndCashEquivalentsMember 2024-02-29 0001377936 srt:MinimumMember 2024-02-29 0001377936 srt:MaximumMember 2024-02-29 0001377936 srt:MinimumMember sar:AffiliatedInvestmentsMember 2024-02-29 0001377936 srt:MaximumMember sar:AffiliatedInvestmentsMember 2024-02-29 0001377936 sar:SaratogaInvestmentCorpMember 2023-03-01 2024-02-29 0001377936 us-gaap:FairValueInputsLevel1Member 2024-02-29 0001377936 us-gaap:FairValueInputsLevel2Member 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member 2024-02-29 0001377936 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel1Member 2023-03-01 2024-02-29 0001377936 us-gaap:FairValueInputsLevel2Member 2023-03-01 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member 2023-03-01 2024-02-29 0001377936 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2023-03-01 2024-02-29 0001377936 us-gaap:FairValueInputsLevel1Member 2023-02-28 0001377936 us-gaap:FairValueInputsLevel2Member 2023-02-28 0001377936 us-gaap:FairValueInputsLevel3Member 2023-02-28 0001377936 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2023-02-28 0001377936 us-gaap:FairValueInputsLevel1Member 2022-03-01 2023-02-28 0001377936 us-gaap:FairValueInputsLevel2Member 2022-03-01 2023-02-28 0001377936 us-gaap:FairValueInputsLevel3Member 2022-03-01 2023-02-28 0001377936 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2022-03-01 2023-02-28 0001377936 sar:FirstLienTermLoansMember 2023-02-27 0001377936 sar:SecondLienTermLoansMember 2023-02-27 0001377936 sar:UnsecuredTermLoansMember 2023-02-27 0001377936 sar:StructuredFinanceSecuritiesMember 2023-02-27 0001377936 sar:EquityInterestsMember 2023-02-27 0001377936 2023-02-27 0001377936 sar:FirstLienTermLoansMember 2023-03-01 2024-02-29 0001377936 sar:SecondLienTermLoansMember 2023-03-01 2024-02-29 0001377936 sar:UnsecuredTermLoansMember 2023-03-01 2024-02-29 0001377936 sar:StructuredFinanceSecuritiesMember 2023-03-01 2024-02-29 0001377936 sar:EquityInterestsMember 2023-03-01 2024-02-29 0001377936 sar:FirstLienTermLoansMember 2024-02-29 0001377936 sar:SecondLienTermLoansMember 2024-02-29 0001377936 sar:UnsecuredTermLoansMember 2024-02-29 0001377936 sar:StructuredFinanceSecuritiesMember 2024-02-29 0001377936 sar:EquityInterestsMember 2024-02-29 0001377936 sar:FirstLienTermLoansMember 2022-02-28 0001377936 sar:SecondLienTermLoansMember 2022-02-28 0001377936 sar:UnsecuredTermLoansMember 2022-02-28 0001377936 sar:StructuredFinanceSecuritiesMember 2022-02-28 0001377936 sar:EquityInterestsMember 2022-02-28 0001377936 sar:FirstLienTermLoansMember 2021-03-01 2023-02-27 0001377936 sar:SecondLienTermLoansMember 2021-03-01 2023-02-27 0001377936 sar:UnsecuredTermLoansMember 2021-03-01 2023-02-27 0001377936 sar:StructuredFinanceSecuritiesMember 2021-03-01 2023-02-27 0001377936 sar:EquityInterestsMember 2021-03-01 2023-02-27 0001377936 2021-03-01 2023-02-27 0001377936 sar:FirstLienTermLoansMember 2022-03-01 2023-02-28 0001377936 sar:SecondLienTermLoansMember 2022-03-01 2023-02-28 0001377936 sar:UnsecuredTermLoansMember 2022-03-01 2023-02-28 0001377936 sar:StructuredFinanceSecuritiesMember 2022-03-01 2023-02-28 0001377936 sar:EquityInterestsMember 2022-03-01 2023-02-28 0001377936 us-gaap:FirstMortgageMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FirstMortgageMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember us-gaap:FirstMortgageMember 2023-03-01 2024-02-29 0001377936 sar:FirstMortgageOneMember 2024-02-29 0001377936 srt:MinimumMember sar:FirstMortgageOneMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:FirstMortgageOneMember 2023-03-01 2024-02-29 0001377936 sar:FirstMortgageTwoMember 2024-02-29 0001377936 srt:MinimumMember sar:FirstMortgageTwoMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:FirstMortgageTwoMember 2023-03-01 2024-02-29 0001377936 sar:ThirdpartyBidOneMember 2024-02-29 0001377936 srt:MinimumMember sar:ThirdpartyBidOneMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:ThirdpartyBidOneMember 2023-03-01 2024-02-29 0001377936 us-gaap:SecondMortgageMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:SecondMortgageMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember us-gaap:SecondMortgageMember 2023-03-01 2024-02-29 0001377936 sar:SecondMortgageOneMember 2024-02-29 0001377936 sar:SecondMortgageOneMember 2023-03-01 2024-02-29 0001377936 sar:ThirdpartyBidTwoMember 2024-02-29 0001377936 sar:ThirdpartyBidTwoMember 2023-03-01 2024-02-29 0001377936 srt:MinimumMember sar:StructuredFinanceSecuritiesMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:StructuredFinanceSecuritiesMember 2023-03-01 2024-02-29 0001377936 sar:StructuredFinanceSecuritiesOneMember 2024-02-29 0001377936 srt:MinimumMember sar:StructuredFinanceSecuritiesOneMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:StructuredFinanceSecuritiesOneMember 2023-03-01 2024-02-29 0001377936 sar:StructuredFinanceSecuritiesTwoMember 2024-02-29 0001377936 sar:StructuredFinanceSecuritiesTwoMember 2023-03-01 2024-02-29 0001377936 srt:MinimumMember sar:EquityInterestsMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:EquityInterestsMember 2023-03-01 2024-02-29 0001377936 sar:EquityInterestsOneMember 2024-02-29 0001377936 srt:MinimumMember sar:EquityInterestsOneMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:EquityInterestsOneMember 2023-03-01 2024-02-29 0001377936 sar:ThirdpartyBidThreeMember 2024-02-29 0001377936 sar:ThirdpartyBidThreeMember 2023-03-01 2024-02-29 0001377936 us-gaap:FirstMortgageMember 2023-02-28 0001377936 us-gaap:FirstMortgageMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember us-gaap:FirstMortgageMember 2023-02-28 0001377936 sar:FirstMortgageOneMember 2023-02-28 0001377936 sar:FirstMortgageOneMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:FirstMortgageOneMember 2023-02-28 0001377936 sar:FirstMortgageTwoMember 2023-02-28 0001377936 sar:FirstMortgageTwoMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:FirstMortgageTwoMember 2023-02-28 0001377936 us-gaap:SecondMortgageMember 2023-02-28 0001377936 us-gaap:SecondMortgageMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember us-gaap:SecondMortgageMember 2023-02-28 0001377936 sar:UnsecuredTermLoansMember 2023-02-28 0001377936 srt:MinimumMember sar:UnsecuredTermLoansMember 2023-02-28 0001377936 sar:UnsecuredTermLoansOneMember 2023-02-28 0001377936 sar:UnsecuredTermLoansOneMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:UnsecuredTermLoansOneMember 2023-02-28 0001377936 sar:UnsecuredTermLoansTwoMember 2023-02-28 0001377936 sar:UnsecuredTermLoansTwoMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:UnsecuredTermLoansTwoMember 2023-02-28 0001377936 sar:StructuredFinanceSecuritiesMember 2023-02-28 0001377936 srt:MinimumMember sar:StructuredFinanceSecuritiesMember 2023-02-28 0001377936 sar:StructuredFinanceSecuritiesOneMember 2023-02-28 0001377936 sar:StructuredFinanceSecuritiesOneMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:StructuredFinanceSecuritiesOneMember 2023-02-28 0001377936 sar:StructuredFinanceSecuritiesTwoMember 2023-02-28 0001377936 sar:StructuredFinanceSecuritiesTwoMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:StructuredFinanceSecuritiesTwoMember 2023-02-28 0001377936 sar:EquityInterestsMember 2023-02-28 0001377936 srt:MinimumMember sar:EquityInterestsMember 2023-02-28 0001377936 sar:EquityInterestsOneMember 2023-02-28 0001377936 sar:EquityInterestsOneMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:EquityInterestsOneMember 2023-02-28 0001377936 us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:StructuredFinanceMember 2024-02-29 0001377936 us-gaap:UnsecuredDebtMember 2023-02-28 0001377936 us-gaap:StructuredFinanceMember 2023-02-28 0001377936 2018-12-01 2018-12-14 0001377936 srt:MinimumMember 2018-12-14 0001377936 srt:MaximumMember 2018-12-14 0001377936 srt:MinimumMember sar:SaratogaCLOMember 2021-02-26 0001377936 srt:MaximumMember sar:SaratogaCLOMember 2021-02-26 0001377936 2021-02-26 2021-02-26 0001377936 sar:TheClassFR3NotesMember 2021-02-26 0001377936 sar:TheClassFR2Member 2021-02-26 0001377936 sar:TheClassGR2Member 2021-02-26 0001377936 sar:TheCLO20131Member 2021-02-26 0001377936 2021-02-26 0001377936 2021-08-31 2021-08-31 0001377936 sar:ClassFR3NoteMember 2021-08-09 0001377936 sar:TheClassF1R3NotesMember 2021-08-09 0001377936 sar:TheClassF2R3NotesMember 2021-08-09 0001377936 sar:TheClassF1R3NotesMember 2021-08-11 2021-08-11 0001377936 sar:SaratogaCLOMember 2023-03-01 2024-02-29 0001377936 sar:SaratogaCLOMember 2022-03-01 2023-02-28 0001377936 sar:SaratogaCLOMember 2021-03-01 2022-02-28 0001377936 sar:TheSubordinatedNotesMember 2024-02-29 0001377936 sar:SaratogaCLOMember 2024-02-29 0001377936 sar:SaratogaCLOMember 2008-01-01 2008-01-31 0001377936 sar:SaratogaCLOMember 2018-12-01 2018-12-31 0001377936 sar:SaratogaCLOMember 2021-02-28 2021-02-28 0001377936 sar:TheSubordinatedNotesMember 2023-02-28 0001377936 sar:SaratogaCLOMember 2023-02-28 0001377936 sar:SaratogaCLOMember 2008-01-31 0001377936 sar:SaratogaCLOMember 2018-12-31 0001377936 sar:SaratogaCLOMember 2021-02-28 0001377936 sar:TheSubordinatedNotesMember sar:CLOMember 2022-03-01 2023-02-28 0001377936 sar:SLFJVMember 2023-03-01 2024-02-29 0001377936 sar:SLFJVMember 2024-02-29 0001377936 sar:SLFJVOneMember 2024-02-29 0001377936 sar:TJHAMember 2024-02-29 0001377936 srt:MaximumMember sar:TJHAMember 2024-02-29 0001377936 srt:MinimumMember sar:TJHAMember 2024-02-29 0001377936 sar:TJHAMember 2022-03-01 2023-02-28 0001377936 sar:SLFJVMember 2022-03-01 2023-02-28 0001377936 sar:TJHAMember 2023-02-28 0001377936 sar:SLFJVMember 2023-02-28 0001377936 sar:TJHAMember sar:SLFJVMember 2024-02-29 0001377936 sar:TJHAMember sar:SLFJVMember 2023-02-28 0001377936 sar:VotingInterestInSLFJVMember 2024-02-29 0001377936 sar:SLFJVMember 2023-03-01 2024-02-29 0001377936 sar:SLFJVOneMember 2023-03-01 2024-02-29 0001377936 sar:SLFJVOneMember 2022-03-01 2023-02-28 0001377936 sar:SLFJVMember 2021-10-26 2022-02-28 0001377936 sar:SLFJVOneMember 2022-02-28 2022-02-28 0001377936 sar:SLFJVMember 2022-10-28 0001377936 sar:ClassEMember 2022-10-28 2022-10-28 0001377936 sar:ClassEMember 2024-02-29 0001377936 sar:ClassEMember 2023-02-28 0001377936 sar:SaratogaCLOMember 2024-02-29 0001377936 sar:SIAVRIncMember 2024-02-29 0001377936 sar:SIATTIncMember 2024-02-29 0001377936 sar:SIATTInc1Member 2024-02-29 0001377936 sar:ManagementAgreementMember 2010-05-01 2010-05-31 0001377936 2010-05-01 2010-05-31 0001377936 srt:MaximumMember 2023-03-01 2024-02-29 0001377936 srt:MinimumMember 2023-03-01 2024-02-29 0001377936 srt:MinimumMember 2022-03-01 2023-02-28 0001377936 srt:MaximumMember 2022-03-01 2023-02-28 0001377936 sar:AdministrationAgreementsMember 2010-07-01 2010-07-30 0001377936 sar:AdministrationAgreementsMember srt:MinimumMember 2023-07-01 2023-07-06 0001377936 sar:AdministrationAgreementsMember srt:MaximumMember 2023-08-01 2023-08-01 0001377936 sar:AdministrationAgreementsMember 2022-03-01 2023-02-28 0001377936 sar:AdministrationAgreementsMember 2021-03-01 2022-02-28 0001377936 sar:SaratogaCLOMember 2018-12-14 0001377936 2018-12-14 0001377936 sar:SaratogaCLOMember 2021-02-26 0001377936 sar:ClassFRThreeNotesTrancheMember 2021-02-26 0001377936 sar:ClassFRTwoNotesTrancheMember 2021-02-26 0001377936 sar:ClassGRTwoNotesTrancheMember 2021-02-26 0001377936 srt:WarehouseMember 2021-02-01 2021-02-26 0001377936 sar:SaratogaCLOMember 2021-02-01 2021-02-26 0001377936 sar:SaratogaCLOMember 2021-11-30 0001377936 sar:ClassFR3NotesMember 2021-08-09 0001377936 sar:ClassF1R3NotesMember 2021-08-09 0001377936 sar:ClassF2R3NotesMember 2021-08-09 0001377936 sar:ClassF1R3NotesMember 2021-08-01 2021-08-11 0001377936 sar:ClassF2R3NotesMember sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassF2R3NotesMember sar:SaratogaCLOMember 2023-02-28 0001377936 sar:ClassF2R3NotesMember sar:SaratogaCLOMember 2023-03-01 2024-02-29 0001377936 sar:ClassF2R3NotesMember sar:SaratogaCLOMember 2022-03-01 2023-02-28 0001377936 sar:ClassF2R3NotesMember sar:SaratogaCLOMember 2021-03-01 2022-02-28 0001377936 sar:SubordinatedNoteMember sar:SaratogaCLOMember 2023-03-01 2024-02-29 0001377936 sar:SubordinatedNoteMember sar:SaratogaCLOMember 2022-03-01 2023-02-28 0001377936 sar:SubordinatedNoteMember sar:SaratogaCLOMember 2021-03-01 2022-02-28 0001377936 2022-10-26 0001377936 2022-10-28 0001377936 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateJointVentureMember 2024-02-29 0001377936 sar:MembershipInterestMember us-gaap:FairValueInputsLevel1Member 2023-02-28 0001377936 srt:MinimumMember us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:UnsecuredDebtMember 2023-02-28 0001377936 sar:InterestReceivableMember sar:SLFJVOneMember 2023-03-01 2024-02-29 0001377936 sar:SLFJVMember 2023-02-28 2023-02-28 0001377936 sar:SLFJVMember 2022-02-28 2022-02-28 0001377936 sar:OneNineFourZeroMember 2023-03-01 2024-02-29 0001377936 srt:MinimumMember 2018-03-01 2018-03-23 0001377936 us-gaap:RevolvingCreditFacilityMember 2019-04-01 2019-04-16 0001377936 us-gaap:RevolvingCreditFacilityMember 2007-04-11 0001377936 us-gaap:RevolvingCreditFacilityMember 2007-05-01 0001377936 us-gaap:RevolvingCreditFacilityMember sar:LIBORMember 2007-04-11 2007-04-11 0001377936 sar:MadisonCreditFacilityMember 2010-07-30 0001377936 sar:MadisonCreditFacilityMember 2023-03-01 2024-02-29 0001377936 sar:MadisonCreditFacilityMember 2021-10-04 2021-10-04 0001377936 sar:EncinaCreditFacilityMember 2021-10-04 0001377936 srt:MinimumMember 2021-10-04 2021-10-04 0001377936 srt:MaximumMember 2021-10-04 2021-10-04 0001377936 sar:EncinaCreditFacilityMember 2021-10-04 2021-10-04 0001377936 sar:EncinaCreditFacilityMember 2023-03-01 2024-02-29 0001377936 sar:EncinaCreditFacilityMember 2023-01-01 2023-01-27 0001377936 sar:EncinaCreditFacilityMember 2022-03-01 2023-02-28 0001377936 sar:EncinaCreditFacilityMember 2021-03-01 2022-02-28 0001377936 sar:EncinaCreditFacilityMember 2023-03-01 2024-02-29 0001377936 sar:EncinaCreditFacilityMember 2024-02-29 0001377936 sar:EncinaCreditFacilityAndTheMadisonCreditFacilityMember 2023-03-01 2024-02-29 0001377936 sar:EncinaCreditFacilityAndTheMadisonCreditFacilityMember 2024-02-29 0001377936 sar:EncinaCreditFacilityAndTheMadisonCreditFacilityMember 2022-03-01 2023-02-28 0001377936 sar:EncinaCreditFacilityAndTheMadisonCreditFacilityMember 2023-02-28 0001377936 sar:EncinaCreditFacilityMember 2024-02-29 0001377936 sar:SBICLPMember 2024-02-29 0001377936 sar:SBICMember 2024-02-29 0001377936 sar:SBICLPMember 2024-02-29 0001377936 sar:SBICMember 2024-02-29 0001377936 sar:SBICMember 2023-03-01 2024-02-29 0001377936 sar:SmallerEnterpriseMember 2024-02-29 0001377936 sar:SmallerEnterpriseMember 2023-03-01 2024-02-29 0001377936 sar:SBICMember sar:SBADebenturesMember 2023-03-01 2024-02-29 0001377936 sar:SBICIILPMember 2023-03-01 2024-02-29 0001377936 sar:SBICIIILPMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:SBADebenturesMember 2023-03-01 2024-02-29 0001377936 sar:SBADebenturesMember 2023-03-01 2024-02-29 0001377936 sar:SBADebenturesMember 2022-03-01 2023-02-28 0001377936 sar:SBADebenturesMember 2021-03-01 2022-02-28 0001377936 sar:SBADebenturesMember 2022-03-01 2023-02-28 0001377936 sar:SBADebenturesMember 2021-03-01 2022-02-28 0001377936 us-gaap:RevolvingCreditFacilityMember sar:SBADebenturesMember 2023-03-01 2024-02-29 0001377936 us-gaap:RevolvingCreditFacilityMember sar:SBADebenturesMember 2022-03-01 2023-02-28 0001377936 sar:NoteFourYearMember 2018-08-01 2018-08-28 0001377936 sar:NoteFourYearMember 2019-02-05 0001377936 sar:TwoThousandTwentyFiveMember 2019-02-05 0001377936 sar:NoteFourYearMember 2019-02-01 2019-02-05 0001377936 sar:NoteFourYearMember 2021-08-31 0001377936 sar:TwoThousandTwentyFiveMember 2021-08-31 0001377936 2021-08-31 0001377936 sar:NoteFourYearMember 2021-03-10 2021-03-10 0001377936 sar:NotesOneMember 2020-06-24 0001377936 sar:NotesOneMember 2020-06-01 2020-06-24 0001377936 sar:FourPointThreeFivePercentMember 2022-01-19 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2020-07-01 2020-07-06 0001377936 srt:MinimumMember sar:NotesOneMember 2022-07-14 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2022-07-14 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2022-07-14 2022-07-14 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2023-03-01 2024-02-29 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2022-03-01 2023-02-28 0001377936 sar:SevenPointSevenFiveTwoThousandTwentyFiveNotesMember 2023-03-01 2024-02-29 0001377936 sar:SevenPointSevenFiveTwoThousandTwentyFiveNotesMember 2022-03-01 2023-02-28 0001377936 sar:NotesOneMember 2024-02-29 0001377936 sar:NotesOneMember 2023-02-28 0001377936 sar:NotesOneMember 2023-03-01 2024-02-29 0001377936 sar:NotesOneMember 2022-03-01 2023-02-28 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2020-07-09 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2020-07-09 2020-07-09 0001377936 sar:SixPointTwoFiveTwoZeroTwoSevenNotesMember 2020-12-29 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember us-gaap:BorrowingsMember 2024-02-29 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2024-02-29 0001377936 sar:SevenPointSevenFiveTwoThousandTwentyFiveNotesMember 2023-02-28 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2023-03-01 2024-02-29 0001377936 sar:SevenPointSevenFiveTwoZeroTwoFiveMember 2022-03-01 2023-02-28 0001377936 sar:SixPointTwoFiveTwoZeroTwoSevenNotesMember us-gaap:BorrowingsMember 2020-12-29 0001377936 sar:SixPointTwoFiveTwoZeroTwoSevenNotesMember 2020-12-29 2020-12-29 0001377936 sar:SixPointTwoFiveTwoZeroTwoSevenNotesMember 2021-01-28 0001377936 sar:SixPointTwoFiveTwoZeroTwoSevenNotesMember 2021-01-28 2021-01-28 0001377936 sar:SixPointTwoFiveTwoZeroTwoSevenNotesMember 2024-02-29 0001377936 sar:SixPointTwoFiveMember 2024-02-29 0001377936 sar:SixPointTwoFiveMember 2023-02-28 0001377936 sar:SixPointTwoFiveTwoZeroTwoSevenNotesMember 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveTwoZeroTwoSevenNotesMember 2022-03-01 2023-02-28 0001377936 sar:FourPointThreeSevenFiveMember 2021-03-10 0001377936 sar:FourPointThreeSevenFiveMember us-gaap:BorrowingsMember 2021-03-10 0001377936 sar:FourPointThreeSevenFiveMember 2021-03-10 2021-03-10 0001377936 2022-01-19 2022-01-19 0001377936 sar:FourPointThreeSevenFiveMember 2024-02-29 0001377936 sar:FourPointThreeSevenFiveMember 2021-07-15 0001377936 sar:FourPointThreeSevenFiveMember 2021-07-15 2021-07-15 0001377936 sar:TwoZeroTwoSixNotesMember 2023-03-01 2024-02-29 0001377936 2022-10-27 2022-10-27 0001377936 sar:FourPointThreeSevenFiveMember 2023-02-28 0001377936 srt:MaximumMember sar:FourPointThreeSevenFiveMember 2023-03-01 2024-02-29 0001377936 srt:MaximumMember sar:FourPointThreeSevenFiveMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:FourPointThreeSevenFiveMember 2022-03-01 2023-02-28 0001377936 sar:FourPointThreeSevenFiveMember 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeSevenFiveMember 2022-03-01 2023-02-28 0001377936 sar:FourPointThreeFivePercentMember 2022-01-19 2022-01-19 0001377936 sar:FourPointThreeFivePercentMember 2024-02-29 0001377936 sar:FourPointThreeFivePercentMember 2023-02-28 0001377936 sar:FourPointThreeFivePercentMember us-gaap:FairValueInputsLevel3Member 2023-02-28 0001377936 sar:FourPointThreeFivePercentMember 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeFivePercentMember 2022-03-01 2023-02-28 0001377936 srt:MinimumMember sar:FourPointThreeSevenFiveMember 2023-03-01 2024-02-29 0001377936 sar:SixPointZeroZeroPercentMember 2022-04-27 0001377936 sar:SixPointZeroZeroPercentMember 2022-04-27 2022-04-27 0001377936 sar:SixPointZeroZeroPercentMember 2022-05-10 0001377936 sar:SixPointZeroZeroPercentMember 2022-05-10 2022-05-10 0001377936 sar:SixPointZeroZeroTwoZeroTwoSevenMember 2023-03-01 2024-02-29 0001377936 sar:SixPointZeroZeroPercentMember 2022-08-15 0001377936 sar:SixPointZeroZeroPercentMember 2022-08-15 2022-08-15 0001377936 srt:MaximumMember sar:SixPointZeroZeroTwoZeroTwoSevenMember 2024-02-29 0001377936 srt:MinimumMember sar:SixPointZeroZeroTwoZeroTwoSevenMember 2024-02-29 0001377936 srt:MaximumMember sar:SixPointZeroZeroTwoZeroTwoSevenMember 2023-02-28 0001377936 srt:MinimumMember sar:SixPointZeroZeroTwoZeroTwoSevenMember 2023-02-28 0001377936 sar:SixPointZeroZeroPercentMember 2023-03-01 2024-02-29 0001377936 sar:SevenPointZeroZeroPercentMember 2022-09-08 0001377936 sar:SevenPointZeroZeroPercentMember 2022-09-08 2022-09-08 0001377936 sar:SevenPointZeroZeroTwoZeroTwoFiveMember 2023-03-01 2024-02-29 0001377936 sar:EightPointZeroPercentMember 2022-10-27 0001377936 sar:EightPointZeroZeroTwoZeroTwoSevenMember 2022-10-27 2022-10-27 0001377936 sar:EightPointZeroZeroTwoZeroTwoSevenMember 2022-11-10 0001377936 srt:MinimumMember sar:EightPointZeroPercentMember 2022-11-10 2022-11-10 0001377936 sar:EightPointZeroPercentMember 2022-11-10 2022-11-10 0001377936 sar:EightPointZeroZeroTwoZeroTwoSevenMember 2023-03-01 2024-02-29 0001377936 sar:SevenPointSevenFiveMember 2024-02-29 0001377936 srt:MinimumMember sar:EightPointZeroZeroTwoZeroTwoSevenMember 2023-02-28 0001377936 srt:MaximumMember sar:EightPointZeroZeroTwoZeroTwoSevenMember 2023-02-28 0001377936 srt:MaximumMember sar:EightPointOneHunderedTwentyFivePercentMember 2023-03-01 2024-02-29 0001377936 srt:MinimumMember sar:EightPointOneHunderedTwentyFivePercentMember 2022-03-01 2023-02-28 0001377936 sar:EightPointZeroPercentMember 2023-03-01 2024-02-29 0001377936 sar:EightPointZeroPercentMember 2022-03-01 2023-02-28 0001377936 sar:EightPointOneHunderedTwentyFivePercentMember 2022-12-13 0001377936 sar:EightPointOneHunderedTwentyFivePercentMember 2022-12-13 2022-12-13 0001377936 sar:EightPointOneHunderedTwentyFivePercentMember 2022-12-21 2022-12-21 0001377936 sar:EightPointOneHunderedTwentyFivePercentMember 2024-02-29 0001377936 srt:MinimumMember sar:EightPointOneHunderedTwentyFivePercentMember 2024-02-29 0001377936 srt:MaximumMember sar:EightPointOneHunderedTwentyFivePercentMember 2024-02-29 0001377936 srt:MinimumMember sar:EightPointOneHunderedTwentyFivePercentMember 2023-02-28 0001377936 srt:MaximumMember sar:EightPointOneHunderedTwentyFivePercentMember 2023-02-28 0001377936 sar:NotesOneMember sar:EightPointOneHunderedTwentyFivePercentMember 2023-03-01 2024-02-29 0001377936 sar:NotesOneMember sar:EightPointOneHunderedTwentyFivePercentMember 2022-03-01 2023-02-28 0001377936 sar:EightPointOneHunderedTwentyFivePercentMember 2023-03-01 2024-02-29 0001377936 sar:EightPointOneHunderedTwentyFivePercentMember 2022-03-01 2023-02-28 0001377936 sar:EightPointSeventyfivePercentageMember 2023-03-31 0001377936 sar:EightPointSeventyfivePercentageMember 2023-03-31 2023-03-31 0001377936 sar:EightPointSeventyfivePercentageMember 2023-05-01 2023-05-01 0001377936 sar:EightPointFiftyPercentageMember 2023-04-14 2023-04-14 0001377936 sar:EightPointSeventyfivePercentageMember 2024-02-29 0001377936 sar:EightPointSeventyfivePercentageMember 2023-02-28 0001377936 sar:EightPointSeventyfivePercentageMember us-gaap:FairValueInputsLevel3Member 2023-02-28 0001377936 sar:EightPointSeventyfivePercentageMember 2023-03-01 2024-02-29 0001377936 sar:EightPointSeventyfivePercentageMember 2022-03-01 2023-02-28 0001377936 sar:EightPointFiftyPercentageMember 2023-04-14 0001377936 sar:EightPointSeventyfivePercentageMember 2023-05-01 0001377936 sar:EightPointFiftyPercentageMember 2023-04-26 0001377936 sar:EightPointFiftyPercentageMember 2023-04-26 2023-04-26 0001377936 sar:EightPointFiftyPercentageMember 2024-02-29 0001377936 sar:EightPointFiveZeroPercentMember 2024-02-29 0001377936 sar:EightPointFiftyPercentageMember us-gaap:FairValueInputsLevel1Member 2024-02-29 0001377936 sar:EightPointFiftyPercentageMember us-gaap:FairValueInputsLevel1Member 2023-02-28 0001377936 srt:MinimumMember sar:EightPointFiftyPercentageMember 2023-02-28 0001377936 srt:MaximumMember sar:EightPointFiftyPercentageMember 2023-02-28 0001377936 sar:EightPointFiftyPercentageMember 2023-03-01 2024-02-29 0001377936 sar:EightPointFiftyPercentageMember 2022-03-01 2023-02-28 0001377936 sar:SBADebenturesMember 2024-02-29 0001377936 2019-12-21 2019-12-21 0001377936 2020-02-07 2020-02-07 0001377936 sar:TwoThousandTwentyFiveMember sar:EightPointFiveZeroPercentMember 2021-08-31 0001377936 2021-07-31 2021-07-31 0001377936 sar:NotesOfferingMember 2021-07-31 2021-07-31 0001377936 2022-07-14 2022-07-14 0001377936 sar:CreditFacilityWithEncinaLenderFinanceLLCMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:CreditFacilityWithEncinaLenderFinanceLLCMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithEncinaLenderFinanceLLCMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:CreditFacilityWithEncinaLenderFinanceLLCMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithEncinaLenderFinanceLLCMember sar:FiscalYaer2022asOfFebruary282022Member 2024-02-29 0001377936 sar:CreditFacilityWithEncinaLenderFinanceLLCMember sar:FiscalYaer2022asOfFebruary282022Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2021asOfFebruary282021Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2021asOfFebruary282021Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2020asOfFebruary292020Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2020asOfFebruary292020Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2019asOfFebruary282019Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2019asOfFebruary282019Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2018asOfFebruary282018Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2018asOfFebruary282018Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2017asOfFebruary282017Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2017asOfFebruary282017Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2016asOfFebruary292016Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2016asOfFebruary292016Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2015asOfFebruary282015Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2015asOfFebruary282015Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2014asOfFebruary282014Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2014asOfFebruary282014Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2013asOfFebruary282013Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2013asOfFebruary282013Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2012asOfFebruary292012Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2012asOfFebruary292012Member 2023-03-01 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2011asOfFebruary282011Member 2024-02-29 0001377936 sar:CreditFacilityWithMadisonCapitalFundingMember sar:FiscalYear2011asOfFebruary282011Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember sar:FiscalYear2017asOfFebruary282017Member 2024-02-29 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember sar:FiscalYear2017asOfFebruary282017Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember sar:FiscalYear2016asOfFebruary292016Member 2024-02-29 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember sar:FiscalYear2016asOfFebruary292016Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember sar:FiscalYear2015asOfFebruary282015Member 2024-02-29 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember sar:FiscalYear2015asOfFebruary282015Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember sar:FiscalYear2014asOfFebruary282014Member 2024-02-29 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember sar:FiscalYear2014asOfFebruary282014Member 2023-03-01 2024-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember sar:FiscalYear2020asOfFebruary292020Member 2024-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember sar:FiscalYear2020asOfFebruary292020Member 2023-03-01 2024-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember sar:FiscalYear2019asOfFebruary282019Member 2024-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember sar:FiscalYear2019asOfFebruary282019Member 2023-03-01 2024-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember sar:FiscalYear2018asOfFebruary282018Member 2024-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember sar:FiscalYear2018asOfFebruary282018Member 2023-03-01 2024-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember sar:FiscalYear2017asOfFebruary282017Member 2024-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember sar:FiscalYear2017asOfFebruary282017Member 2023-03-01 2024-02-29 0001377936 sar:EightPointSevenFiveNoteDueTwoZeroTwoFourMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:EightPointSevenFiveNoteDueTwoZeroTwoFourMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2022asOfFebruary282022Member 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2022asOfFebruary282022Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2021asOfFebruary282021Member 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2021asOfFebruary282021Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2020asOfFebruary292020Member 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2020asOfFebruary292020Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2019asOfFebruary282019Member 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2019asOfFebruary282019Member 2023-03-01 2024-02-29 0001377936 sar:FiscalYear2024asOfFebruary292024Member sar:FiscalYear2024asOfAugust312023Member 2024-02-29 0001377936 sar:FiscalYear2024asOfFebruary292024Member sar:FiscalYear2024asOfAugust312023Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointZeroZeroNotesDueTwoZeroTwoFiveMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:SevenPointZeroZeroNotesDueTwoZeroTwoFiveMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:SevenPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2022asOfFebruary282022Member 2024-02-29 0001377936 sar:SevenPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2022asOfFebruary282022Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2021asOfFebruary282021Member 2024-02-29 0001377936 sar:SevenPointTwoFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2021asOfFebruary282021Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointSevenFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:SevenPointSevenFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointSevenFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:SevenPointSevenFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointSevenFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2022asOfFebruary282022Member 2024-02-29 0001377936 sar:SevenPointSevenFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2022asOfFebruary282022Member 2023-03-01 2024-02-29 0001377936 sar:SevenPointSevenFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2021asOfFebruary282021Member 2024-02-29 0001377936 sar:SevenPointSevenFiveNotesDueTwoZeroTwoFiveMember sar:FiscalYear2021asOfFebruary282021Member 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeSevenFiveNotesDueTwoZeroTwoSixMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:FourPointThreeSevenFiveNotesDueTwoZeroTwoSixMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeSevenFiveNotesDueTwoZeroTwoSixMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:FourPointThreeSevenFiveNotesDueTwoZeroTwoSixMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeSevenFiveNotesDueTwoZeroTwoSixMember sar:FiscalYear2022asOfFebruary282022Member 2024-02-29 0001377936 sar:FourPointThreeSevenFiveNotesDueTwoZeroTwoSixMember sar:FiscalYear2022asOfFebruary282022Member 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:FourPointThreeFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:FourPointThreeFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2022asOfFebruary282022Member 2024-02-29 0001377936 sar:FourPointThreeFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2022asOfFebruary282022Member 2023-03-01 2024-02-29 0001377936 sar:SixPointZeroZeroNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:SixPointZeroZeroNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:SixPointZeroZeroNotesDueTwoZeroTwoSevenMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:SixPointZeroZeroNotesDueTwoZeroTwoSevenMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2022asOfFebruary282022Member 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2022asOfFebruary282022Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2021asOfFebruary282021Member 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2021asOfFebruary282021Member 2023-03-01 2024-02-29 0001377936 sar:EightPointZeroZeroNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:EightPointZeroZeroNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:EightPointOneTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:EightPointOneTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:EightPointOneTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2023asOfFebruary282023Member 2024-02-29 0001377936 sar:EightPointOneTwoFiveNotesDueTwoZeroTwoSevenMember sar:FiscalYear2023asOfFebruary282023Member 2023-03-01 2024-02-29 0001377936 sar:EightPointFiveZeroNotesDueTwoZeroTwoEightMember sar:FiscalYear2024asOfFebruary292024Member 2024-02-29 0001377936 sar:EightPointFiveZeroNotesDueTwoZeroTwoEightMember sar:FiscalYear2024asOfFebruary292024Member 2023-03-01 2024-02-29 0001377936 sar:EncinaCreditsFacilityMember 2024-02-29 0001377936 sar:EncinaCreditsFacilityMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:EncinaCreditsFacilityMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:EncinaCreditsFacilityMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:EncinaCreditsFacilityMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:EncinaCreditsFacilityMember 2024-02-29 0001377936 sar:SBADebenturesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:SBADebenturesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:SBADebenturesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:SBADebenturesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:SBADebenturesMember 2024-02-29 0001377936 sar:EightPointSevenFivePercentageNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:EightPointSevenFivePercentageNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:EightPointSevenFivePercentageNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:EightPointSevenFivePercentageNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:EightPointSevenFivePercentageNotesMember 2024-02-29 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-02-29 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 sar:OneToThreeYearsMember sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 sar:LessThanOneYearMember 2024-02-29 0001377936 sar:OneToThreeYearsMember 2024-02-29 0001377936 sar:ThreeToFiveYearsMember 2024-02-29 0001377936 sar:MoreThanFiveYearsMember 2024-02-29 0001377936 sar:ActiveProspectIncMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:ActiveProspectIncMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:ArtemisWaxCorpMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:ArtemisWaxCorpMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:AscendSoftwareLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:AscendSoftwareLLCMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:GraniteComfortLPMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:GraniteComfortLPMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:JDXpertMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:JDXpertMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:LFRChickenLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:LFRChickenLLCMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:PepperPalaceIncMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:PepperPalaceIncMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:ProcurementPartnersLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:ProcurementPartnersLLCMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:SceptreHospitalityResourcesLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:SceptreHospitalityResourcesLLCMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:StretchZoneFranchisingLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:VetnCareMSOLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:VetnCareMSOLLCMember sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:CompanysDiscretionMember 2023-02-28 0001377936 sar:AlphaAestheticsPartnersOpCoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:AlphaAestheticsPartnersOpCoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:ARCHealthOpCoLLC1Member sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ARCHealthOpCoLLC1Member sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:ArtemisWaxCorpMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ArtemisWaxCorpMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:AscendSoftwareLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:AscendSoftwareLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:AxeroHoldingsRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:AxeroHoldingsRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:AxiomMedicalConsultingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:AxiomMedicalConsultingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:BQESoftwareIncMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:BQESoftwareIncMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:C2EducationalSystemsMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:C2EducationalSystemsMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:DaviswareLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:DaviswareLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:ExigoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ExigoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:ExigoRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ExigoRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:Gen4DentalPartnersHoldingsLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:Gen4DentalPartnersHoldingsLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:GoReactMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:GoReactMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:GraniteComfortLPMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:JDXpertMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:JDXpertMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:InspectPointHoldingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:InspectPointHoldingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:PepperPalaceIncDelayedDrawTermLoanMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:PepperPalaceIncDelayedDrawTermLoanMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:PepperPalaceRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:PepperPalaceRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:ProcurementPartnersLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ProcurementPartnersLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:StretchZoneFranchisingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:VetnCareMSOLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:VetnCareMSOLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:ZollegePBCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ZollegePBCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:DefinedBenefitPlanPortfolioMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:DefinedBenefitPlanPortfolioMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2023-02-28 0001377936 sar:ShareRepurchasePlanMember us-gaap:CommonStockMember 2014-09-24 0001377936 sar:ShareRepurchasePlanMember 2014-09-24 0001377936 sar:SaleOfStockUnderTheShareRepurchaseProgramTrancheOneMember sar:ShareRepurchasePlanMember 2024-02-29 0001377936 sar:SaleOfStockUnderTheShareRepurchaseProgramTrancheOneMember sar:ShareRepurchasePlanMember us-gaap:CommonStockMember 2024-02-29 0001377936 sar:SaleOfStockUnderTheShareRepurchaseProgramTrancheTwoMember sar:ShareRepurchasePlanMember 2023-03-01 2024-02-29 0001377936 sar:SaleOfStockUnderTheShareRepurchaseProgramTrancheTwoMember sar:ShareRepurchasePlanMember 2024-02-29 0001377936 2018-07-13 2018-07-13 0001377936 2018-07-13 0001377936 2017-03-16 2017-03-16 0001377936 2019-07-11 2019-07-11 0001377936 2019-10-08 2019-10-08 0001377936 2021-07-29 2021-07-29 0001377936 2021-07-29 0001377936 2021-07-30 2021-07-30 0001377936 srt:MaximumMember 2023-07-06 2023-07-06 0001377936 srt:MinimumMember 2023-07-06 2023-07-06 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheOneMember 2024-02-29 2024-02-29 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheOneMember 2024-02-29 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheTwoMember 2024-02-29 2024-02-29 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheTwoMember 2024-02-29 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheThreeMember 2023-03-01 2024-02-29 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheThreeMember sar:EquityATMProgramMember 2024-02-29 2024-02-29 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheThreeMember sar:EquityATMProgramMember 2024-02-29 0001377936 2024-02-29 2024-02-29 0001377936 us-gaap:CommonStockMember 2022-02-28 0001377936 us-gaap:AdditionalPaidInCapitalMember 2022-02-28 0001377936 us-gaap:RetainedEarningsMember 2022-02-28 0001377936 us-gaap:CommonStockMember 2022-03-01 2022-05-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2022-03-01 2022-05-31 0001377936 us-gaap:RetainedEarningsMember 2022-03-01 2022-05-31 0001377936 2022-03-01 2022-05-31 0001377936 us-gaap:CommonStockMember 2022-05-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2022-05-31 0001377936 us-gaap:RetainedEarningsMember 2022-05-31 0001377936 2022-05-31 0001377936 us-gaap:CommonStockMember 2022-06-01 2022-08-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2022-06-01 2022-08-31 0001377936 us-gaap:RetainedEarningsMember 2022-06-01 2022-08-31 0001377936 2022-06-01 2022-08-31 0001377936 us-gaap:CommonStockMember 2022-08-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2022-08-31 0001377936 us-gaap:RetainedEarningsMember 2022-08-31 0001377936 2022-08-31 0001377936 us-gaap:CommonStockMember 2022-09-01 2022-11-30 0001377936 us-gaap:AdditionalPaidInCapitalMember 2022-09-01 2022-11-30 0001377936 us-gaap:RetainedEarningsMember 2022-09-01 2022-11-30 0001377936 2022-09-01 2022-11-30 0001377936 us-gaap:CommonStockMember 2022-11-30 0001377936 us-gaap:AdditionalPaidInCapitalMember 2022-11-30 0001377936 us-gaap:RetainedEarningsMember 2022-11-30 0001377936 2022-11-30 0001377936 us-gaap:CommonStockMember 2022-12-01 2023-02-28 0001377936 us-gaap:AdditionalPaidInCapitalMember 2022-12-01 2023-02-28 0001377936 us-gaap:RetainedEarningsMember 2022-12-01 2023-02-28 0001377936 2022-12-01 2023-02-28 0001377936 us-gaap:CommonStockMember 2023-02-28 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-02-28 0001377936 us-gaap:RetainedEarningsMember 2023-02-28 0001377936 us-gaap:CommonStockMember 2023-03-01 2023-05-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-03-01 2023-05-31 0001377936 us-gaap:RetainedEarningsMember 2023-03-01 2023-05-31 0001377936 2023-03-01 2023-05-31 0001377936 us-gaap:CommonStockMember 2023-05-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-05-31 0001377936 us-gaap:RetainedEarningsMember 2023-05-31 0001377936 2023-05-31 0001377936 us-gaap:CommonStockMember 2023-06-01 2023-08-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-06-01 2023-08-31 0001377936 us-gaap:RetainedEarningsMember 2023-06-01 2023-08-31 0001377936 2023-06-01 2023-08-31 0001377936 us-gaap:CommonStockMember 2023-08-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-08-31 0001377936 us-gaap:RetainedEarningsMember 2023-08-31 0001377936 us-gaap:CommonStockMember 2023-09-01 2023-11-30 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-09-01 2023-11-30 0001377936 us-gaap:RetainedEarningsMember 2023-09-01 2023-11-30 0001377936 2023-09-01 2023-11-30 0001377936 us-gaap:CommonStockMember 2023-11-30 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-11-30 0001377936 us-gaap:RetainedEarningsMember 2023-11-30 0001377936 2023-11-30 0001377936 us-gaap:CommonStockMember 2023-12-01 2024-02-29 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-12-01 2024-02-29 0001377936 us-gaap:RetainedEarningsMember 2023-12-01 2024-02-29 0001377936 us-gaap:CommonStockMember 2024-02-29 0001377936 us-gaap:AdditionalPaidInCapitalMember 2024-02-29 0001377936 us-gaap:RetainedEarningsMember 2024-02-29 0001377936 2023-03-30 2023-03-30 0001377936 2023-03-30 0001377936 2023-01-04 2023-01-04 0001377936 2023-01-04 0001377936 2022-09-29 2022-09-29 0001377936 2022-09-29 0001377936 2022-06-29 2022-06-29 0001377936 2022-06-29 0001377936 2022-03-28 2022-03-28 0001377936 2022-03-28 0001377936 2022-01-19 0001377936 2021-09-28 2021-09-28 0001377936 2021-09-28 0001377936 2021-06-29 2021-06-29 0001377936 2021-06-29 0001377936 2021-04-22 2021-04-22 0001377936 2021-04-22 0001377936 2021-02-10 2021-02-10 0001377936 2021-02-10 0001377936 2020-11-10 2020-11-10 0001377936 2020-11-10 0001377936 2020-08-12 2020-08-12 0001377936 2020-08-12 0001377936 2020-02-06 2020-02-06 0001377936 2020-02-06 0001377936 2019-09-26 2019-09-26 0001377936 2019-09-26 0001377936 2019-06-27 2019-06-27 0001377936 2019-06-27 0001377936 2019-03-28 2019-03-28 0001377936 2019-03-28 0001377936 2019-01-02 2019-01-02 0001377936 2019-01-02 0001377936 2018-09-27 2018-09-27 0001377936 2018-09-27 0001377936 2018-06-27 2018-06-27 0001377936 2018-06-27 0001377936 2018-03-26 2018-03-26 0001377936 2018-03-26 0001377936 2017-12-27 2017-12-27 0001377936 2017-12-27 0001377936 2017-09-26 2017-09-26 0001377936 2017-09-26 0001377936 2017-06-27 2017-06-27 0001377936 2017-06-27 0001377936 2017-03-28 2017-03-28 0001377936 2017-03-28 0001377936 2017-02-09 2017-02-09 0001377936 2017-02-09 0001377936 2016-11-09 2016-11-09 0001377936 2016-11-09 0001377936 2016-09-02 2016-09-02 0001377936 2016-09-02 0001377936 2016-08-09 2016-08-09 0001377936 2016-08-09 0001377936 2016-04-27 2016-04-27 0001377936 2016-04-27 0001377936 2016-02-29 2016-02-29 0001377936 2016-02-29 0001377936 2015-11-30 2015-11-30 0001377936 2015-11-30 0001377936 2015-08-31 2015-08-31 0001377936 2015-08-31 0001377936 2015-06-05 2015-06-05 0001377936 2015-06-05 0001377936 2015-05-29 2015-05-29 0001377936 2015-05-29 0001377936 2015-02-27 2015-02-27 0001377936 2015-02-27 0001377936 2014-11-28 2014-11-28 0001377936 2014-11-28 0001377936 2013-12-16 2013-12-16 0001377936 2013-12-16 0001377936 2012-12-19 2012-12-19 0001377936 2012-12-19 0001377936 2011-12-22 2011-12-22 0001377936 2011-12-22 0001377936 2010-12-22 2010-12-22 0001377936 2010-12-22 0001377936 2009-12-28 2009-12-28 0001377936 2009-12-28 0001377936 2023-06-29 2023-06-29 0001377936 2023-06-29 0001377936 2023-09-28 2023-09-28 0001377936 2023-09-28 0001377936 2023-12-28 2023-12-28 0001377936 2023-12-28 0001377936 us-gaap:SubsequentEventMember 2024-03-15 2024-03-15 0001377936 us-gaap:SubsequentEventMember 2024-03-15 0001377936 srt:ScenarioForecastMember sar:March282024Member 2024-03-01 2025-02-18 0001377936 srt:ScenarioForecastMember 2024-03-01 2025-02-18 0001377936 sar:December282023Member 2023-03-01 2024-02-29 0001377936 sar:September282023Member 2023-03-01 2024-02-29 0001377936 sar:June292023Member 2023-03-01 2024-02-29 0001377936 sar:March302023Member 2023-03-01 2024-02-29 0001377936 sar:January42023Member 2022-03-01 2023-02-28 0001377936 sar:September292022Member 2022-03-01 2023-02-28 0001377936 sar:June292022Member 2022-03-01 2023-02-28 0001377936 sar:March282022Member 2022-03-01 2023-02-28 0001377936 sar:January192022Member 2021-03-01 2022-02-28 0001377936 sar:September282021Member 2021-03-01 2022-02-28 0001377936 sar:June292021Member 2021-03-01 2022-02-28 0001377936 sar:April222021Member 2021-03-01 2022-02-28 0001377936 sar:February102021Member 2020-03-01 2021-02-28 0001377936 sar:November102020Member 2020-03-01 2021-02-28 0001377936 sar:August122020Member 2020-03-01 2021-02-28 0001377936 2020-03-01 2021-02-28 0001377936 sar:February62020Member 2019-03-01 2020-02-29 0001377936 sar:September262019Member 2019-03-01 2020-02-29 0001377936 sar:June272019Member 2019-03-01 2020-02-29 0001377936 sar:March282019Member 2019-03-01 2020-02-29 0001377936 2019-03-01 2020-02-29 0001377936 sar:January22019Member 2018-03-01 2019-02-28 0001377936 sar:September272018Member 2018-03-01 2019-02-28 0001377936 sar:June272018Member 2018-03-01 2019-02-28 0001377936 sar:March262018Member 2018-03-01 2019-02-28 0001377936 2018-03-01 2019-02-28 0001377936 sar:December272017Member 2017-03-01 2018-02-28 0001377936 sar:September262017Member 2017-03-01 2018-02-28 0001377936 sar:June272017Member 2017-03-01 2018-02-28 0001377936 sar:March282017Member 2017-03-01 2018-02-28 0001377936 2017-03-01 2018-02-28 0001377936 sar:February92017Member 2016-03-01 2017-02-28 0001377936 sar:November92016Member 2016-03-01 2017-02-28 0001377936 sar:September52016Member 2016-03-01 2017-02-28 0001377936 sar:August92016Member 2016-03-01 2017-02-28 0001377936 sar:April272016Member 2016-03-01 2017-02-28 0001377936 2016-03-01 2017-02-28 0001377936 sar:February292016Member 2015-03-01 2016-02-29 0001377936 sar:November302015Member 2015-03-01 2016-02-29 0001377936 sar:August312015Member 2015-03-01 2016-02-29 0001377936 sar:June52015Member 2015-03-01 2016-02-29 0001377936 sar:May292015Member 2015-03-01 2016-02-29 0001377936 2015-03-01 2016-02-29 0001377936 sar:February272015Member 2014-03-01 2015-02-28 0001377936 sar:November282014Member 2014-03-01 2015-02-28 0001377936 2014-03-01 2015-02-28 0001377936 sar:December272013Member 2013-03-01 2014-02-28 0001377936 2013-03-01 2014-02-28 0001377936 sar:December312012Member 2012-03-01 2013-02-28 0001377936 2012-03-01 2013-02-28 0001377936 sar:December302011Member 2011-03-01 2012-02-28 0001377936 2011-03-01 2012-02-28 0001377936 sar:December292010Member 2010-03-01 2011-02-28 0001377936 2010-03-01 2011-02-28 0001377936 sar:December312009Member 2009-03-01 2010-02-28 0001377936 2009-03-01 2010-02-28 0001377936 sar:February152024Member 2023-03-01 2024-02-29 0001377936 sar:February152024Member 2024-02-29 0001377936 sar:November152023Member 2023-03-01 2024-02-29 0001377936 sar:November152023Member 2024-02-29 0001377936 sar:August142023Member 2023-03-01 2024-02-29 0001377936 sar:August142023Member 2024-02-29 0001377936 sar:May222023Member 2023-03-01 2024-02-29 0001377936 sar:May222023Member 2024-02-29 0001377936 sar:February282023Member 2022-03-01 2023-02-28 0001377936 sar:February282023Member 2023-02-28 0001377936 sar:November152022Member 2022-03-01 2023-02-28 0001377936 sar:November152022Member 2023-02-28 0001377936 sar:August292022Member 2022-03-01 2023-02-28 0001377936 sar:August292022Member 2023-02-28 0001377936 sar:May262022Member 2022-03-01 2023-02-28 0001377936 sar:May262022Member 2023-02-28 0001377936 sar:February242022Member 2021-03-01 2022-02-28 0001377936 sar:February242022Member 2022-02-28 0001377936 sar:August262021Member 2021-03-01 2022-02-28 0001377936 sar:August262021Member 2022-02-28 0001377936 sar:May272021Member 2021-03-01 2022-02-28 0001377936 sar:May272021Member 2022-02-28 0001377936 sar:March222021Member 2021-03-01 2022-02-28 0001377936 sar:March222021Member 2022-02-28 0001377936 sar:January52021Member 2020-03-01 2021-02-28 0001377936 sar:January52021Member 2021-02-28 0001377936 sar:October72020Member 2020-03-01 2021-02-28 0001377936 sar:October72020Member 2021-02-28 0001377936 sar:July72020Member 2020-03-01 2021-02-28 0001377936 sar:July72020Member 2021-02-28 0001377936 sar:January72020Member 2019-03-01 2020-02-29 0001377936 sar:January72020Member 2020-02-29 0001377936 sar:August272019Member 2019-03-01 2020-02-29 0001377936 sar:August272019Member 2020-02-29 0001377936 sar:May282019Member 2019-03-01 2020-02-29 0001377936 sar:May282019Member 2020-02-29 0001377936 sar:February262019Member 2019-03-01 2020-02-29 0001377936 sar:February262019Member 2020-02-29 0001377936 2020-02-29 0001377936 2019-12-01 2019-12-21 0001377936 2020-02-01 2020-02-07 0001377936 2021-08-01 2021-08-31 0001377936 2022-07-01 2022-07-14 0001377936 2019-02-28 0001377936 sar:NotesPayableTwoMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableTwoMember 2022-03-01 2023-02-28 0001377936 sar:NotesPayableTwoMember 2021-03-01 2022-02-28 0001377936 sar:NotesPayableTwoMember 2020-03-01 2021-02-28 0001377936 sar:NotesPayableTwoMember 2019-03-01 2020-02-29 0001377936 sar:NotesPayableThreeMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableThreeMember 2022-03-01 2023-02-28 0001377936 sar:NotesPayableThreeMember 2021-03-01 2022-02-28 0001377936 sar:NotesPayableThreeMember 2020-03-01 2021-02-28 0001377936 sar:NotesPayableThreeMember 2019-03-01 2020-02-29 0001377936 sar:NotesPayableFourMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableFourMember 2022-03-01 2023-02-28 0001377936 sar:NotesPayableFourMember 2021-03-01 2022-02-28 0001377936 sar:NotesPayableFourMember 2020-03-01 2021-02-28 0001377936 sar:NotesPayableFourMember 2019-03-01 2020-02-29 0001377936 sar:NotesPayableFiveMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableFiveMember 2022-03-01 2023-02-28 0001377936 sar:NotesPayableFiveMember 2021-03-01 2022-02-28 0001377936 sar:NotesPayableFiveMember 2020-03-01 2021-02-28 0001377936 sar:NotesPayableFiveMember 2019-03-01 2020-02-29 0001377936 sar:NotesPayableSixMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableSixMember 2022-03-01 2023-02-28 0001377936 sar:NotesPayableSixMember 2021-03-01 2022-02-28 0001377936 sar:NotesPayableSixMember 2020-03-01 2021-02-28 0001377936 sar:NotesPayableSixMember 2019-03-01 2020-02-29 0001377936 sar:NotesPayableSevenMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableSevenMember 2022-03-01 2023-02-28 0001377936 sar:NotesPayableSevenMember 2021-03-01 2022-02-28 0001377936 sar:NotesPayableSevenMember 2020-03-01 2021-02-28 0001377936 sar:NotesPayableSevenMember 2019-03-01 2020-02-29 0001377936 sar:NotesPayableEightMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableEightMember 2022-03-01 2023-02-28 0001377936 sar:NotesPayableEightMember 2021-03-01 2022-02-28 0001377936 sar:NotesPayableEightMember 2020-03-01 2021-02-28 0001377936 sar:NotesPayableEightMember 2019-03-01 2020-02-29 0001377936 sar:NotesPayableNineMember 2023-03-01 2024-02-29 0001377936 sar:NotesPayableNineMember 2022-03-01 2023-02-28 0001377936 sar:NotesPayableNineMember 2021-03-01 2022-02-28 0001377936 sar:NotesPayableNineMember 2020-03-01 2021-02-28 0001377936 sar:NotesPayableNineMember 2019-03-01 2020-02-29 0001377936 sar:NotePayableTenMember 2023-03-01 2024-02-29 0001377936 sar:NotePayableTenMember 2022-03-01 2023-02-28 0001377936 sar:NotePayableTenMember 2021-03-01 2022-02-28 0001377936 sar:NotePayableTenMember 2020-03-01 2021-02-28 0001377936 sar:NotePayableTenMember 2019-03-01 2020-02-29 0001377936 sar:NotePayableElevenMember 2023-03-01 2024-02-29 0001377936 sar:NotePayableElevenMember 2022-03-01 2023-02-28 0001377936 sar:NotePayableElevenMember 2021-03-01 2022-02-28 0001377936 sar:NotePayableElevenMember 2020-03-01 2021-02-28 0001377936 sar:NotePayableElevenMember 2019-03-01 2020-02-29 0001377936 sar:NotePayableTwelveMember 2023-03-01 2024-02-29 0001377936 sar:NotePayableTwelveMember 2022-03-01 2023-02-28 0001377936 sar:NotePayableTwelveMember 2021-03-01 2022-02-28 0001377936 sar:NotePayableTwelveMember 2020-03-01 2021-02-28 0001377936 sar:NotePayableTwelveMember 2019-03-01 2020-02-29 0001377936 sar:NotePayableThirteenMember 2023-03-01 2024-02-29 0001377936 sar:NotePayableThirteenMember 2022-03-01 2023-02-28 0001377936 sar:NotePayableThirteenMember 2021-03-01 2022-02-28 0001377936 sar:NotePayableThirteenMember 2020-03-01 2021-02-28 0001377936 sar:NotePayableThirteenMember 2019-03-01 2020-02-29 0001377936 sar:NotePayableFourteenMember 2023-03-01 2024-02-29 0001377936 sar:NotePayableFourteenMember 2022-03-01 2023-02-28 0001377936 sar:NotePayableFourteenMember 2021-03-01 2022-02-28 0001377936 sar:NotePayableFourteenMember 2020-03-01 2021-02-28 0001377936 sar:NotePayableFourteenMember 2019-03-01 2020-02-29 0001377936 sar:QuarterlyFourMember 2023-03-01 2024-02-29 0001377936 sar:QuarterlyThreeMember 2023-03-01 2024-02-29 0001377936 sar:QuarterlyTwoMember 2023-03-01 2024-02-29 0001377936 sar:QuarterlyOneMember 2023-03-01 2024-02-29 0001377936 sar:QuarterlyFourMember 2022-03-01 2023-02-28 0001377936 sar:QuarterlyThreeMember 2022-03-01 2023-02-28 0001377936 sar:QuarterlyTwoMember 2022-03-01 2023-02-28 0001377936 sar:QuarterlyOneMember 2022-03-01 2023-02-28 0001377936 sar:QuarterlyFourMember 2021-03-01 2022-02-28 0001377936 sar:QuarterlyThreeMember 2021-03-01 2022-02-28 0001377936 sar:QuarterlyTwoMember 2021-03-01 2022-02-28 0001377936 sar:QuarterlyOneMember 2021-03-01 2022-02-28 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares

Exhibit 19

 

 

 

 

 

 

 

Statement of Policy on Insider Trading

 

 

 

 

 

 

 

 

 

 

 

 

SARATOGA INVESTMENT CORP.

 

Statement of Policy on Insider Trading

 

Introduction

 

It is illegal for any person, either personally or on behalf of others, to trade in securities on the basis of material, non-public information. It is also illegal to communicate (or “tip”) material, non-public information to others who may trade in securities on the basis of that information. These illegal activities are commonly referred to as “insider trading.”

 

Employees should be aware that in addition to the Company's policy against insider trading, all employees, not just directors, officers and managerial personnel, could be held liable, both civilly and criminally, for trading on or disclosing to third parties material non-public information concerning the Company. Potential penalties for insider trading violations include imprisonment for up to 10 years, civil fines of up to three times the profit gained or loss avoided by the trading, and criminal fines of up to $1 million. In addition, a company whose director, officer or employee violates the insider trading prohibitions may be liable for a civil fine of up to the greater of $1 million or three times the profit gained or loss avoided as a result of the director, officer or employee’s insider trading violations.

 

Moreover, a director, officer or employee’s failure to comply with Saratoga Investment Corp.’s (“Saratoga”) insider trading policy may subject such person to sanctions imposed by Saratoga, including dismissal for cause, whether or not such person’s failure to comply with this policy results in a violation of law.

 

This memorandum sets forth Saratoga’s policy against insider trading. The objective of this policy is to protect both you and Saratoga from securities law violations, or even the appearance thereof. All directors, officers and employees (including temporary employees) of Saratoga and its investment adviser, Saratoga Investment Advisors, LLC (the “investment adviser”) must comply with this policy.

 

You are encouraged to ask questions and seek any follow-up information that you may require with respect to the matters set forth in this policy. Please direct your questions to Henri Steenkamp, Saratoga’s Chief Compliance Officer.

 

Statement of Policy

 

It is the policy of Saratoga that no director, officer or employee (including a temporary employee) of Saratoga or the investment adviser who is aware of material nonpublic information relating to Saratoga or the investment adviser may, directly or through family members or other persons or entities, (a) buy or sell securities of Saratoga (other than pursuant to a pre-approved trading plan that complies with Rule 10b5-1 of the Securities Exchange Act of 1934), or engage in any other action to take personal advantage of that information, or (b) pass that information on to others outside of Saratoga, including family and friends.

 

1

 

 

In addition, it is the policy of Saratoga that no director, officer or employee (including a temporary employee) of Saratoga or the investment adviser who, in the course of working for Saratoga, learns of material nonpublic information about a company with which Saratoga does business, including a customer or supplier of Saratoga, may trade in that company’s securities until the information becomes public or is no longer material.

 

Transactions that may be necessary or justifiable for independent reasons (such as the need to raise money for an emergency expenditure) are not excepted from the policy. The securities laws do not recognize such mitigating circumstances, and, in any event, even the appearance of an improper transaction must be avoided to preserve Saratoga’s reputation for adhering to the highest standards of conduct.

 

What information is material? All information that an investor might consider important in deciding whether to buy, sell, or hold securities is considered material. Information that is likely to affect the price of a company’s securities is almost always material. Examples of some types of material information are:

 

financial results or expectations for the quarter or the year;

 

financial forecasts;

 

changes in dividends;

 

possible mergers, acquisitions, joint ventures and other purchases and sales of companies and investments in companies;

 

changes in customer relationships with significant customers;

 

obtaining or losing important contracts;

 

important product developments;

 

major financing developments;

 

major personnel changes; and

 

major litigation developments.

 

What is non-public information? Information is considered to be non-public unless it has been effectively disclosed to the public. Examples of public disclosure include public filings with the Securities and Exchange Commission and company press releases. Not only must the information have been publicly disclosed, but there must also have been adequate time for the market as a whole to digest the information.

 

2

 

 

What transactions are prohibited? When you know material, non-public information about Saratoga, you, your spouse and members of your immediate family living in your household are prohibited from the following activities:

 

trading in Saratoga’s securities (including trading in puts and calls for Saratoga’s securities);

 

having others trade for you in Saratoga’s securities; and

 

disclosing the information to anyone else who might then trade.

 

Neither you nor anyone acting on your behalf nor anyone who learns the information from you (including your spouse and family members) can trade. This prohibition continues whenever and for as long as you know material, non-public information.

 

Although it is most likely that any material, non-public information you might learn would be about Saratoga or its subsidiaries, these prohibitions also apply to trading in the securities of any company including any portfolio company or potential merger partner about which you have material, non-public information.

 

Transactions by Family Members.  As noted above, Saratoga’s insider trading policy applies to your family members who reside with you, anyone else who lives in your household, and any family members who do not live in your household but whose transactions in Saratoga’s securities are directed by you or are subject to your influence or control (such as parents or children who consult with you before they trade in Saratoga’s securities). You are responsible for the transactions of these other persons and therefore should make them aware of the need to confer with you before they trade in Saratoga’s securities.

 

What is a Rule 10b5-1 trading plan? Notwithstanding the prohibition against insider trading, Rule 10b5-1 of the Securities Exchange Act of 1934 and this policy permit directors, officers and employees to trade in Saratoga’s securities regardless of their awareness of inside information if the transaction is made pursuant to a pre-arranged trading plan that was entered into when the director, officer or employee was not in possession of material nonpublic information. This policy requires trading plans to be written and to specify the amount of, date on, and price at which the securities are to be traded or establish a formula for determining such items. Trading plans may not be adopted when the director, officer or employee is in possession of material nonpublic information about Saratoga. A director, officer or employee may amend or replace his or her trading plan only during periods when trading is permitted in accordance with this policy.

 

In December 2022, the SEC adopted amendments to Rule 10b5-1, which went into effect February 27, 2023. The amended Rule 10b5-1 includes, among other changes, (1) implementation of a “cooling-off period” for trading under 10b5-1 plans; (2) required certifications about knowledge of material, non-public information and good faith; (3) changes to how 10b5-1 Plans may be used; and (4) new disclosure requirements for registrants and individuals.

 

3

 

 


Pursuant to the amended Rule 10b5-1, the cooling-off period for officers and directors of the Company will be either 90 days following adoption or modification of a 10b5-1 Plan or two business days following the disclosure of the Company’s financial results in a Form 10-Q or Form 10-K for the fiscal quarter in which the 10b5-1 Plan was adopted, whichever is later (resulting in a mandatory cooling-off period of 90 to 120 days). For persons other than officers and directors of the Company, the cooling-off period is 30 days following adoption or modification of a 10b5-1 Plan. Further, pursuant to the amended Rule 10b5-1, officers and directors must certify at the time they enter into or modify a 10b5-1 plan that (1) they are not aware of material nonpublic information about the issuer or its securities; and (2) they are adopting the contract, instruction, or plan “in good faith and not as part of a plan or scheme to evade the prohibitions” of Rule 10b-5. Two separate 10b5-1 trading plans for one person may exist at the same time if trading under the later-commencing plan is not authorized to begin until after all trades under the earlier-commencing plan are completed or expire without execution.

 

A director, officer or employee who wishes to enter into a trading plan must submit the trading plan to the Chief Compliance Officer for its approval prior to the adoption or amendment of the trading plan. Trades executed under Rule 10b5-1 trading plans must be timely disclosed on Forms 4 and 5.

 

Transactions Under Company Dividend Reinvestment Plan

 

Dividend Reinvestment Plan. Saratoga’s insider trading policy does not apply to purchases of Saratoga’s securities under Saratoga’s dividend reinvestment plan resulting from your reinvestment of dividends paid on Saratoga’s securities. The policy does apply, however, to voluntary purchases of Saratoga’s securities resulting from your election to participate in the plan or your increase in the level of participation in the plan. The policy also applies to your sale of any securities of Saratoga purchased pursuant to the plan.

 

Additional Prohibited Transactions

 

Saratoga considers it improper and inappropriate for any director, officer or other employee of Saratoga to engage in short-term or speculative transactions in Saratoga’s securities. It therefore is Saratoga’s policy that directors, officers and other employees may not engage in any of the following transactions:

 

Short-Term Trading.  An employee’s short-term trading of Saratoga’s securities may be distracting to the employee and may unduly focus the employee on Saratoga’s short-term stock market performance instead of Saratoga’s long-term business objectives. For these reasons, any director, officer or other employee of Saratoga who purchases Saratoga’s securities in the open market may not sell any of Saratoga’s securities of the same class during the six months following the purchase.

 

Short Sales. Short sales of Saratoga’s securities evidence an expectation on the part of the seller that the securities will decline in value, and therefore signal to the market that the seller has no confidence in Saratoga or its short-term prospects. In addition, short sales may reduce the seller’s incentive to improve Saratoga’s performance. For these reasons, short sales of Saratoga’s securities are prohibited by this insider trading policy. In addition, Section 16(c) of the Securities Exchange Act of 1934 prohibits officers and directors from engaging in short sales.

 

4

 

 

Publicly Traded Options. A transaction in options is, in effect, a bet on the short-term movement of Saratoga’s stock and therefore creates the appearance that the director, officer or employee is trading based on inside information. Transactions in options also may focus the director, officer or employee’s attention on short-term performance at the expense of Saratoga’s long-term objectives. Accordingly, transactions in puts, calls or other derivative securities, on an exchange or in any other organized market, are prohibited by this policy. (Option positions arising from certain types of hedging transactions are governed by the section below captioned “Hedging Transactions.”)

 

Hedging Transactions. Certain forms of hedging or monetization transactions, such as zero-cost collars and forward sale contracts, allow a director, officer or employee to lock in much of the value of his or her stock holdings, often in exchange for all or part of the potential for upside appreciation in the stock. These transactions allow the director, officer or employee to continue to own the covered securities, but without the full risks and rewards of ownership. When that occurs, the director, officer or employee may no longer have the same objectives as Saratoga’s other shareholders. Therefore, Saratoga strongly discourages you from engaging in such transactions. Any person wishing to enter into such an arrangement must first pre-clear the proposed transaction with the Chief Compliance Officer. Any request for pre-clearance of a hedging or similar arrangement must be submitted to the Chief Compliance Officer at least two weeks prior to the proposed execution of documents evidencing the proposed transaction and must set forth a justification for the proposed transaction.

 

Margin Accounts and Pledges. Securities held in a margin account may be sold by the broker without the customer’s consent if the customer fails to meet a margin call. Similarly, securities pledged (or hypothecated) as collateral for a loan may be sold in foreclosure if the borrower defaults on the loan. Because a margin sale or foreclosure sale may occur at a time when the pledgor is aware of material nonpublic information or otherwise is not permitted to trade in Saratoga’s securities, directors, officers and employees are prohibited from holding Saratoga’s securities in a margin account or pledging Saratoga’s securities as collateral for a loan. An exception to this prohibition may be granted where a person wishes to pledge Saratoga’s securities as collateral for a loan (not including margin debt) and clearly demonstrates the financial capacity to repay the loan without resort to the pledged securities. Any person who wishes to pledge Saratoga’s securities as collateral for a loan must submit a request for approval to the Chief Compliance Officer at least two weeks prior to the proposed execution of documents evidencing the proposed pledge.

 

Post-Termination Transactions

The policy continues to apply to your transactions in Saratoga’s securities even after you have terminated employment. If you are in possession of material nonpublic information when your employment terminates, you may not trade in Saratoga’s securities until that information has become public or is no longer material.

 

Unauthorized Disclosure

 

As discussed above, the disclosure of material, non-public information to others can lead to significant legal difficulties. Therefore, you should not discuss material, non-public information about Saratoga with anyone, including other employees, except as required in the performance of your regular duties.

 

Also, it is important that only specifically designated representatives of Saratoga discuss Saratoga with the news media, securities analysts, and investors. Inquiries of this type received by any employee should be referred to the Chief Executive Officer, President, Chief Compliance Officer or Chief Financial Officer.

 

5

 

 

Pre-Clearance Procedures

 

To help prevent inadvertent violations of the federal securities laws and to avoid even the appearance of trading on inside information, directors and executive officers of Saratoga and any other persons designated by the Chief Compliance Officer as being subject to Saratoga’s pre-clearance procedures, together with their family members, may not engage in any transaction involving Saratoga’s securities (including a stock plan transaction such as a gift, loan or pledge or hedge, contribution to a trust, or any other transfer) without first obtaining pre-clearance of the transaction from the Chief Compliance Officer. A request for pre-clearance should be submitted to the Chief Compliance Officer at least two days in advance of the proposed transaction. The Chief Compliance Officer is under no obligation to approve a trade submitted for pre-clearance, and may determine not to permit the trade.

 

Any person subject to the pre-clearance requirements who wishes to implement a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934 must first pre-clear the plan with the Chief Compliance Officer. As required by Rule 10b5-1, you may enter into a trading plan only when you are not in possession of material nonpublic information. In addition, you may not enter into a trading plan during a blackout period. Transactions effected pursuant to a pre-cleared trading plan will not require further pre-clearance at the time of the transaction if the plan specifies the dates, prices and amounts of the contemplated trades, or establishes a formula for determining the dates, prices and amounts.

 

Blackout Periods

 

Quarterly Blackout Periods. Saratoga’s announcement of its quarterly financial results almost always has the potential to have a material effect on the market for Saratoga’s securities. Therefore, you can anticipate that, to avoid even the appearance of trading while aware of material nonpublic information, persons who are or may be expected to be aware of Saratoga’s quarterly financial results generally will not be pre-cleared to trade in Saratoga’s securities during the period beginning five business days prior to the end of Saratoga’s fiscal quarter and ending 24 hours following Saratoga’s issuance of its quarterly or annual earnings release, analyst conference call or the filing of Saratoga’s Annual Report on Form 10-K or Quarterly Report on Form 10-Q with the Securities and Exchange Commission. Persons subject to these quarterly blackout periods include all directors and executive officers, all employees of the accounting department, and all other persons who are informed by the Chief Compliance Officer that they are subject to the quarterly blackout periods. To aid in your compliance with this policy, the Chief Compliance Officer will provide persons subject to these quarterly blackout periods with notice of the beginning and ending of such blackout period.

 

Event-specific Blackout Periods. From time to time, an event may occur that is material to Saratoga and is known by only a few directors or executives. So long as the event remains material and nonpublic, directors, executive officers, and such other persons as are designated by the Chief Compliance Officer may not trade in Saratoga’s securities. The existence of an event-specific blackout will not be announced, other than to those who are aware of the event giving rise to the blackout. If, however, a person whose trades are subject to pre-clearance requests permission to trade in Saratoga’s securities during an event-specific blackout, the Chief Compliance Officer will inform the requester of the existence of a blackout period, without disclosing the reason for the blackout. Any person made aware of the existence of an event-specific blackout should not disclose the existence of the blackout to any other person. The failure of the Chief Compliance Officer to designate a person as being subject to an event-specific blackout will not relieve that person of the obligation not to trade while aware of material nonpublic information.

 

Hardship Exceptions. A person who is subject to a quarterly earnings blackout period and who has an unexpected and urgent need to sell Saratoga’s stock in order to generate cash may, in appropriate circumstances, be permitted to sell such stock even during the blackout period. Hardship exceptions may be granted only by the Chief Compliance Officer and must be requested at least two days in advance of the proposed trade. A hardship exception may be granted only if the Chief Compliance Officer concludes that Saratoga’s earnings information for the applicable quarter does not constitute material non-public information. Under no circumstance will a hardship exception be granted during an event-specific blackout period.

 

Questions about this Policy

 

Compliance by all directors, officers and employees with this policy is of the utmost importance both for you and for Saratoga. If you have any questions about the application of this policy to any particular case, please immediately contact the Chief Compliance Officer.

 

Your failure to observe this policy could lead to significant legal problems, as well as other serious consequences, including termination of your employment.

 

 

6

 

 

Exhibit 21

 

Name   Jurisdiction
Saratoga Investment Funding II LLC   Delaware
Saratoga Investment Corp. SBIC II LP   Delaware
Saratoga Investment Corp. SBIC III LP   Delaware
Saratoga Investment Corp. GP, LLC   Delaware

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference of our report dated May 6, 2024, with respect to the consolidated financial statements of Saratoga Investment Corp. included in this Annual Report (Form 10-K) for the year ended February 29, 2024, into the Registration Statement (Form N-2, File No. 333-269186), filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP

 

New York, New York

May 6, 2024

 

Exhibit 23.2

 

 

 

Consent of Independent Auditors

 

We consent to the incorporation by reference in Registration Statement (No. 333-269186) on Form N-2 of Saratoga Investment Corp. of our report dated May 6, 2024 with respect to the statements of assets and liabilities, including the schedules of investments, as of February 29, 2024 and February 28, 2023, and the related statements of operations, changes in net assets, and cash flows for the years ended February 29, 2024, February 28, 2023, and February 28, 2022, and the related notes to the financial statements of Saratoga Investment Corp. CLO 2013-1, Ltd. included in this Annual Report (Form 10-K) of Saratoga Investment Corp. for the year ended February 29, 2024.

 

/s/ CohnReznick LLP

 

Parsippany, New Jersey

May 6, 2024

 

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

RULE 13a-14(a) and 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Christian L. Oberbeck, certify that:

 

1.I have reviewed this Annual Report on Form 10-K of Saratoga Investment Corp. (the “registrant”);

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 6, 2024  
   
  /s/ CHRISTIAN L. OBERBECK
  Christian L. Oberbeck
  Chief Executive Officer

 

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

RULE 13a-14(a) and 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Henri J. Steenkamp, certify that:

 

1.I have reviewed this Annual Report on Form 10-K of Saratoga Investment Corp. (the “registrant”);

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant ‘s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 6, 2024  
   
  /s/ HENRI J. STEENKAMP
  Name: Henri J. Steenkamp
  Chief Financial Officer and Chief Compliance Officer

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The certification set forth below is being submitted in connection with the accompanying Annual Report of Saratoga Investment Corp. on Form 10-K (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

 

Christian L. Oberbeck, the Chief Executive Officer, certifies that, to the best of his knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 6, 2024  
   
  /s/ CHRISTIAN L. OBERBECK
  Christian L. Oberbeck
  Chief Executive Officer

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The certification set forth below is being submitted in connection with the accompanying Annual Report of Saratoga Investment Corp. on Form 10-K (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

 

Henri J. Steenkamp, the Chief Financial Officer, Chief Compliance Officer and Secretary of Saratoga Investment Corp. certifies that, to the best of his knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Saratoga Investment Corp.

 

Date: May 6, 2024  
   
  /s/ HENRI J. STEENKAMP
  Name: Henri J. Steenkamp
  Chief Financial Officer and Chief Compliance Officer

 

 

Exhibit 97.1

 

 

 

 

 

 

 

 

 

 

 

Compensation Recoupment Policy

 

 

 

 

 

 

 

 

 

 

 

 

SARATOGA INVESTMENT CORP.

 

COMPENSATION RECOUPMENT POLICY

 

The Board of Directors of Saratoga Investment Corp. has adopted the following Compensation Recoupment Policy effective as of November 27, 2023.

 

Purpose

 

It is the intention of the Board that this Compensation Recoupment Policy be interpreted and administered in a manner consistent with applicable laws and regulations and Securities Exchange listing requirements, including Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (including Rule 10D-1 under the Securities and Exchange Act of 1934, as amended, promulgated thereunder), and Section 303A.14 of the New York Stock Exchange Listing Company Manual. This Compensation Recoupment Policy applies to awards of Incentive-Based Compensation, if any, received on or after the Effective Date by Executive Officers of the Company.

 

Definitions

 

“Board” means the Board of Directors of the Company.

 

“Committee” means the Compensation Committee of the Board of Directors of the Company.

 

“Company” means Saratoga Investment Corp.

 

“Effective Date” means October 2, 2023.

 

“Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policymaking functions for the Company. Executive officers of the Company’s subsidiaries are deemed Executive Officers of the Company if they perform such policymaking functions for the Company.

 

“Excess Incentive-Based Compensation” means the amount of Incentive-Based Compensation received by a current or former Executive Officer that exceeds the amount of Incentive-Based Compensation that otherwise would have been received had the amount of such Incentive-Based Compensation been determined based on the accounting restatement, computed without regard to taxes paid by the Executive Officer. With regards to Incentive-Based Compensation based on stock price or total shareholder return, where the amount of Excess Incentive-Based Compensation is not subject to mathematical recalculation directly from the information in an accounting restatement, Excess Incentive-Based Compensation means a reasonable estimate of the effect of the accounting restatement on the applicable Financial Reporting Measure.

 

1

 

 

“Financial Reporting Measure” means any measure that is determined and presented in accordance with the accounting principles used to preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures. “Stock price” and “total shareholder return” metrics are also Financial Reporting Measures. For the avoidance of doubt, a Financial Reporting Measure need not be presented in the Company’s financial statements or included in a filing with the U.S. Securities and Exchange Commission.

 

“Incentive-Based Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure. Company does not directly compensate any of its Executive Officers. The Executive Officers are compensated by the Company’s external investment adviser for the work they perform on behalf of the Company. Therefore, the Company does not pay compensation, including Incentive-Based Compensation, to its Executive Officers.

 

“Lookback Period” means the three-year period preceding the date on which the Company is required to prepare an accounting restatement. For purposes of this definition, the date on which the Company is required to prepare an accounting restatement shall be deemed to be the earlier of (i) the date the Board, a committee of the Board, or the officer(s) of the Company authorized to take such action (if Board action is not required) concludes, or reasonably should have concluded, that the Company is required to prepare an accounting restatement; and (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an accounting restatement.

 

“Securities Exchange” means the New York Stock Exchange, the securities exchange upon which the Company’s shares of common stock, par value $0.001 per share, trades.

 

Recoupment for an Accounting Restatement

 

The Company shall recover reasonably promptly any Excess Incentive-Based Compensation in the event that the Company is required to restate its financial statements due to the material noncompliance of the Company with any financial reporting requirement under the federal securities laws, including any required accounting restatement to correct an error (i) in previously issued financial statements that is material to the previously issued financial statements or (ii) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. The preceding sentence shall apply to Excess Incentive-Based Compensation received by any current or former Executive Officer: (a) after beginning service as an Executive Officer; (b) who served as an Executive Officer at any time during the performance period for the applicable Incentive-Based Compensation; (c) while the Company has a class of securities listed on a national securities exchange or a national securities association; and (d) during the Lookback Period. For purposes of this paragraph, Incentive-Based Compensation is deemed “received” in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period.

 

2

 

 

If the Company is required to recoup Excess Incentive-Based Compensation following an accounting restatement based on adjustments to stock price or total shareholder return, the Company shall determine the amount of such Excess Incentive-Based Compensation subject to recoupment, which amount shall be a reasonable estimate of the effect of the accounting restatement on the applicable Financial Reporting Measure.

 

Notwithstanding the foregoing, if the Committee makes a determination that recovery would be impracticable, and one of the following enumerated conditions is satisfied, the Company need not recover such Excess Incentive-Based Compensation.

 

Expenses Exceed Recovery Amount: The Company need not recover the Excess Incentive-Based Compensation at issue if the direct expense to be paid to a third party to assist in enforcing this Compensation Recoupment Policy would exceed the amount to be recovered; provided, however, that the Company must make a reasonable attempt to recover the Excess Incentive-Based Compensation and document such attempt(s) prior to the Committee’s determination that recovery would be impracticable. The Company must provide the documentation evidencing the attempt(s) to the Securities Exchange consistent with the listing standards of the Securities Exchange.

 

Recovery Would Violate Home Country Law: The Company need not recover the Excess Incentive-Based Compensation at issue if recovery would violate home country law where that law was adopted prior to November 28, 2022; provided, however, that the Company must obtain an opinion of home country counsel, in a form acceptable to the Securities Exchange, that recovery would result in such violation. The Company must provide the opinion to the Securities Exchange consistent with the listing standards of the Securities Exchange.

 

Recovery Would Violate ERISA Anti-Alienation Provisions: The Company need not recover the Excess Incentive-Based Compensation at issue if recovery would violate the anti-alienation provisions of the Employee Retirement Income Security Act of 1974, as amended, contained in 26 U.S.C. § 401(a)(13) or 26 U.S.C. § 411(a), or regulations promulgated thereunder.

 

Method of Recoupment

 

The Committee shall have the sole discretion and authority to determine the means, timing (which shall in all circumstances be reasonably prompt) and any other requirements by which any recoupment required by this Compensation Recoupment Policy shall occur and impose any other terms, conditions or procedures (e.g., the imposition of interest charges on un-repaid amounts) to govern the current or former Executive Officer’s repayment of Excess Incentive-Based Compensation.

 

Other Policy Terms

 

Any applicable award agreement, plan or other document setting forth the terms and conditions of any Incentive-Based Compensation or other compensation covered by this Compensation Recoupment Policy received on or after the Effective Date shall be deemed to (i) include the restrictions imposed herein; (ii) incorporate this Compensation Recoupment Policy by reference; and (iii) govern the terms of such award agreement, plan or other document in the event of any inconsistency. Eligibility for participation in and for payment under any such award agreement, plan or other document is contingent upon acceptance of the terms of this Compensation Recoupment Policy.

 

3

 

 

Any recoupment under this Compensation Recoupment Policy is in addition to, and not in lieu of, any other remedies or rights that may be available to the Company or its affiliates under applicable law, including, without limitation: (i) dismissing the current or former Executive Officer; (ii) adjusting the future compensation of the current or former Executive Officer; or (iii) authorizing legal action or taking such other action to enforce the current or former Executive Officer’s obligations to the Company or its affiliates as it may deem appropriate in view of all of the facts and circumstances surrounding the particular case.

 

Incentive-Based Compensation and other compensation paid to employees of the Company and its affiliates may also be subject to other recoupment or similar policies, and this policy does not supersede any such other policies. However, in the event of any conflict between any such policy and this Compensation Recoupment Policy, this policy shall govern. In addition, no Executive Officer shall be subject to recoupment more than one time with respect to the same compensation.

 

Current or former Executive Officers shall not be entitled to any indemnification by or from the Company or its affiliates with respect to any amounts subject to recoupment pursuant to this Compensation Recoupment Policy.

 

Administration

 

The Board has delegated the administration of this policy to the Committee. The Committee is responsible for monitoring the application of this policy with respect to all Executive Officers. The Committee shall have the sole authority to review, interpret, construe and implement the provisions of this Compensation Recoupment Policy and to delegate to one or more executive officers and/or employees certain administrative and record-keeping responsibilities, as appropriate, with respect to the implementation of this Compensation Recoupment Policy; provided, however, that no such action shall contravene the federal securities laws. Any determinations of the Board or Committee under this Compensation Recoupment Policy shall be binding on the applicable individual.

 

The Board may amend, modify or change this Compensation Recoupment Policy, as well as any related rules and procedures, at any time and from time to time as it may determine, in its sole discretion, is necessary or appropriate.

 

Adopted: November 27, 2023

 

 

4